Skyward/2025/FY/Annual report: Difference between revisions
doc_archive: publish 3z7a4yrxkn |
Index sections (topic tags) |
||
| (32 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
| period = FY |
| period = FY |
||
| period_label = FY25 |
| period_label = FY25 |
||
| |
| document_category = Annual report |
||
| document_type = Form 10-K |
|||
| document_name = Skyward Specialty Insurance Group 2025 Form 10-K |
| document_name = Skyward Specialty Insurance Group 2025 Form 10-K |
||
| publication_date = 2026-03-02 |
| publication_date = 2026-03-02 |
||
| language = English |
| language = English |
||
| source_url = https://www.sec.gov/Archives/edgar/data/1519449/000151944926000015/0001519449-26-000015-index.htm |
| source_url = https://www.sec.gov/Archives/edgar/data/1519449/000151944926000015/0001519449-26-000015-index.htm |
||
| archive_file = |
| archive_file = File:Skyward-2025-FY-Annual_report.md |
||
| intro_sentence = This article presents Skyward's FY 2025 annual report — the narrative Items (each summarized into a factsheet), primary financial statements, and note schedules from its SEC Form 10-K. |
| intro_sentence = This article presents Skyward's FY 2025 annual report — the narrative Items (each summarized into a factsheet), primary financial statements, and note schedules from its SEC Form 10-K. |
||
}} |
}} |
||
''This article presents Skyward's FY 2025 annual report — the narrative Items (each summarized into a factsheet), primary financial statements, and note schedules from its SEC Form 10-K.'' |
''This article presents Skyward's FY 2025 annual report — the narrative Items (each summarized into a factsheet), primary financial statements, and note schedules from its SEC Form 10-K.'' |
||
{{Indexing|Cover|Document type, period end date, fiscal year end date, entity file number, entity registrant name, entity incorporation state or country code|kind=table|order=1}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" |
|||
! style="text-align:left" | USD ($) |
|||
! style="text-align:center" | 12 Months Ended |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
|- |
|||
! style="text-align:left" | — |
|||
! style="text-align:left" | Dec. 31, 2025 |
|||
! class="col-m" style="text-align:right" | Feb. 26, 2026 |
|||
! class="col-m" style="text-align:right" | Jun. 30, 2025 |
|||
|- |
|||
| style="text-align:left" | Cover [Abstract] |
|||
| style="text-align:left" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Document Type |
|||
| style="text-align:left" | 10-K |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Document Annual Report |
|||
| style="text-align:left" | true |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Document Period End Date |
|||
| style="text-align:left" | Dec. 31, 2025 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Current Fiscal Year End Date |
|||
| style="text-align:left" | --12-31 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Document Transition Report |
|||
| style="text-align:left" | false |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity File Number |
|||
| style="text-align:left" | 001-41591 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Registrant Name |
|||
| style="text-align:left" | SKYWARD SPECIALTY INSURANCE GROUP, INC. |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Incorporation, State or Country Code |
|||
| style="text-align:left" | DE |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Tax Identification Number |
|||
| style="text-align:left" | 14-1957288 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Address, Address Line One |
|||
| style="text-align:left" | 800 Gessner Road |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Address, Address Line Two |
|||
| style="text-align:left" | Suite 600 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Address, City or Town |
|||
| style="text-align:left" | Houston |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Address, State or Province |
|||
| style="text-align:left" | TX |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Address, Postal Zip Code |
|||
| style="text-align:left" | 77024-4284 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | City Area Code |
|||
| style="text-align:left" | 713 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Local Phone Number |
|||
| style="text-align:left" | 935-4800 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Title of 12(b) Security |
|||
| style="text-align:left" | Common stock, par value $0.01 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Trading Symbol |
|||
| style="text-align:left" | SKWD |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Security Exchange Name |
|||
| style="text-align:left" | NASDAQ |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Well-known Seasoned Issuer |
|||
| style="text-align:left" | No |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Voluntary Filers |
|||
| style="text-align:left" | No |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Current Reporting Status |
|||
| style="text-align:left" | No |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Interactive Data Current |
|||
| style="text-align:left" | Yes |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Filer Category |
|||
| style="text-align:left" | Large Accelerated Filer |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Small Business |
|||
| style="text-align:left" | false |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Emerging Growth Company |
|||
| style="text-align:left" | false |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | ICFR Auditor Attestation Flag |
|||
| style="text-align:left" | true |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Document Financial Statement Error Correction [Flag] |
|||
| style="text-align:left" | false |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Shell Company |
|||
| style="text-align:left" | false |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Public Float |
|||
| style="text-align:left" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | 2,165,161,643 |
|||
|- |
|||
| style="text-align:left" | Entity Common Stock, Shares Outstanding |
|||
| style="text-align:left" | — |
|||
| class="col-m" style="text-align:right" | 44,467,084 |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Documents Incorporated by Reference |
|||
| style="text-align:left" | Portions of the Registrant’s Proxy Statement relating to the 2026 annual meeting of stockholders (the “2026 Proxy Statement”), which will be filed within 120 days of December 31, 2025, are incorporated by reference into Part III of this Form 10-K. |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Central Index Key |
|||
| style="text-align:left" | 0001519449 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amendment Flag |
|||
| style="text-align:left" | false |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Document Fiscal Year Focus |
|||
| style="text-align:left" | 2025 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Document Fiscal Period Focus |
|||
| style="text-align:left" | FY |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|} |
|||
</div> |
|||
{{Indexing|Audit Information|Auditor name, auditor location, auditor firm ID|x856lnzuq2|kind=table|order=2}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" |
|||
! style="text-align:left" | |
|||
! style="text-align:center" | 12 Months Ended |
|||
|- |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
|- |
|||
| style="text-align:left" | Audit Information [Abstract] |
|||
| class="col-s" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Auditor Name |
|||
| class="col-s" style="text-align:right" | Ernst & Young LLP |
|||
|- |
|||
| style="text-align:left" | Auditor Location |
|||
| class="col-s" style="text-align:right" | Houston, Texas |
|||
|- |
|||
| style="text-align:left" | Auditor Firm ID |
|||
| class="col-s" style="text-align:right" | 42 |
|||
|} |
|||
</div> |
|||
== Business == |
== Business == |
||
{{Indexing|Who We Are|Skyward Specialty, Houston International Insurance Group, commercial insurance products, non-admitted and admitted basis, specialty reinsurance|2ku0sqq9xf|lht8rybaqk|kind=prose|order=3|f1=Year founded|v1=2006|f2=Founding legal form|v2=Delaware corporation|f3=Former name(s)|v3=Houston International Insurance Group, Ltd.|f4=Major acquisitions|v4=Apollo Group Holdings Limited|f5=Primary segments|v5=Commercial insurance products|f6=Principal lines|v6=General liability, excess liability, professional liability, commercial auto, group accident and health, property, agriculture, credit, surety, workers’ compensation}} |
|||
'''Who We Are''' |
|||
* |
* Skyward Specialty was formed as a Delaware corporation on January 3, 2006, as an insurance holding company <sup>p. 1</sup>. |
||
* The company operated under the name Houston International Insurance Group, Ltd. until |
* The company operated under the name Houston International Insurance Group, Ltd. until rebranding as Skyward Specialty in November 2020 <sup>p. 1</sup>. |
||
* Skyward Specialty is a growing specialty insurance company providing commercial insurance products and solutions on a non-admitted (E&S) and admitted basis, primarily in the United States <sup>p. 1</sup>. |
|||
* References to "the Company," "we," "our," "us" or like terms refer to the business of Skyward Specialty Insurance Group, Inc. and its subsidiaries <sup>p. 1</sup>. |
|||
* The company focuses on underserved, dislocated, or inadequately covered markets where standard insurance coverages are insufficient <sup>p. 1</sup>. |
|||
* Skyward Specialty is a growing specialty insurance company providing commercial insurance products and solutions predominantly in the United States <sup>p. 1</sup>. |
|||
* Products are offered on both a non-admitted (E&S) and admitted basis <sup>p. 1</sup>. |
|||
* The company focuses on underserved, dislocated, and/or markets where standard insurance coverages are insufficient <sup>p. 1</sup>. |
|||
* Customers typically require highly specialized, customized underwriting solutions and claims capabilities <sup>p. 1</sup>. |
* Customers typically require highly specialized, customized underwriting solutions and claims capabilities <sup>p. 1</sup>. |
||
* |
* The company develops and delivers tailored insurance products and services for each niche market served <sup>p. 1</sup>. |
||
* The |
* The portfolio of insured risks is highly diversified across industries, distribution channels, and lines of business <sup>p. 1</sup>. |
||
* Lines of business include general liability, excess liability, professional liability (including cyber and media liability insurance), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation <sup>p. 1</sup>. |
|||
* ''Distribution'' occurs through multiple channels <sup>p. 1</sup>. |
|||
* ''Lines of business'' include general liability, excess liability, professional liability (including cyber and media liability insurance), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation <sup>p. 1</sup>. |
|||
* The company insures both short and medium duration liabilities <sup>p. 1</sup>. |
* The company insures both short and medium duration liabilities <sup>p. 1</sup>. |
||
* The |
* The business mix is principally primary insurance and balanced between E&S and admitted markets <sup>p. 1</sup>. |
||
* A portion of the business is |
* A portion of the business is specialty reinsurance, primarily property, agriculture, and credit <sup>p. 1</sup>. |
||
* Specialty reinsurance focuses on attractive specialty classes where approaching through reinsurance is more efficient due to factors like cost of entry and geographic expansion <sup>p. 1</sup>. |
* Specialty reinsurance focuses on attractive specialty classes where approaching through reinsurance is more efficient due to factors like cost of entry and geographic expansion costs <sup>p. 1</sup>. |
||
* This diversification |
* This diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, aims to consistently produce strong growth and profitability across all insurance pricing cycles <sup>p. 1</sup>. |
||
* This diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, is expected to produce strong growth and profitability across all insurance pricing cycles <sup>p. 1</sup>. |
|||
* The company is led by an entrepreneurial executive management team with decades of insurance leadership experience in the global P&C industry <sup>p. 1</sup>. |
* The company is led by an entrepreneurial executive management team with decades of insurance leadership experience in the global P&C industry <sup>p. 1</sup>. |
||
* The leadership is supported by an experienced team with broad |
* The leadership is supported by an experienced team with broad skill sets aligned with the company's strategy <sup>p. 1</sup>. |
||
* High-quality leadership, underwriting and claims teams, technology DNA, advanced analytics capabilities, diversified book of business, and strong competitive position are believed to position the company for profitable growth <sup>p. 1</sup>. |
* High-quality leadership, underwriting and claims teams, technology DNA, advanced analytics capabilities, diversified book of business, and strong competitive position in chosen market niches are believed to position the company for continued profitable growth <sup>p. 1</sup>. |
||
* The company aims to deliver long-term value for shareholders by generating best-in-class underwriting profitability and book value per share growth across P&C market cycles <sup>p. 1</sup>. |
* The company aims to deliver long-term value for shareholders by generating best-in-class underwriting profitability and book value per share growth across P&C market cycles <sup>p. 1</sup>. |
||
* All insurance company subsidiaries are group rated <sup>p. 1</sup>. |
* All insurance company subsidiaries are group rated and have financial strength ratings of "A" (Excellent) from A.M. Best Company, with a stable outlook <sup>p. 1</sup>. |
||
* All insurance company subsidiaries have ''financial strength ratings'' of "A" (Excellent) from A.M. Best Company, with a stable outlook <sup>p. 1</sup>. |
|||
{{Indexing|Apollo Acquisition|Apollo Group Holdings Limited, Apollo Majority SPAs, Apollo Minority SPAs, Syndicate 1969, Syndicate 1971|c5r2rmwxo6|kind=prose|order=4|f1=Acquisition target|v1=Apollo Group Holdings Limited|f2=Acquisition closing date|v2=January 1, 2026|f3=Acquisition consideration|v3=Common stock, cash}} |
|||
'''Apollo Acquisition''' |
|||
* On September 2, 2025, the company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders |
* On September 2, 2025, the company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders of Apollo Group Holdings Limited ("Apollo") (the "Majority Sellers") <sup>p. 2</sup>. |
||
* Pursuant to the Apollo Majority SPAs, the company agreed to acquire |
* Pursuant to the Apollo Majority SPAs, the company agreed to acquire all issued shares of Apollo held by the Majority Sellers, representing approximately 87% of Apollo's issued share capital <sup>p. 2</sup>. |
||
* |
* Closing of the transaction ("Closing") was conditioned upon the company acquiring 100% of Apollo's issued share capital (the “Acquisition”) at Closing through additional short-form share purchase agreements (the "Apollo Minority SPAs") with the remaining minority shareholders (the "Minority Sellers") <sup>p. 2</sup>. |
||
* The Acquisition closed on January 1, 2026 <sup>p. 2</sup>. |
* The Acquisition closed on January 1, 2026 <sup>p. 2</sup>. |
||
* The consideration for the transaction was satisfied by issuing common stock of the Company to certain sellers and the remainder in cash <sup>p. 2</sup>. |
* The consideration for the transaction was satisfied by issuing common stock of the Company to certain sellers and the remainder in cash <sup>p. 2</sup>. |
||
* Apollo is a U.S.-centric specialty underwriting platform operating at Lloyd’s of London, characterized by low volatility, high growth, and a capital-light business model <sup>p. 2</sup>. |
* Apollo is a U.S.-centric specialty underwriting platform operating at Lloyd’s of London, characterized by low volatility, high growth, and a capital-light business model <sup>p. 2</sup>. |
||
* Apollo |
* Apollo's gross written premium has grown consistently since its formation in 2010 <sup>p. 2</sup>. |
||
* Through Syndicate 1969, Apollo underwrites a multi-class specialty insurance portfolio <sup>p. 2</sup>. |
* Through Syndicate 1969, Apollo underwrites a multi-class specialty insurance portfolio <sup>p. 2</sup>. |
||
* Through Syndicate 1971, Apollo |
* Through Syndicate 1971, Apollo provides a platform liability product for the digital and sharing economy <sup>p. 2</sup>. |
||
* Apollo provides capital to syndicates 1969 and 1971 for a pro-rata share of underwriting income, with third parties providing the remaining capital <sup>p. 2</sup>. |
* Apollo provides capital to syndicates 1969 and 1971 in exchange for a pro-rata share of underwriting income, with third parties providing the remaining capital <sup>p. 2</sup>. |
||
* Apollo earns managing agency fees and profit commissions |
* Apollo earns managing agency fees and profit commissions for being the managing agent to its own syndicates and to third-party syndicates (platform partners) <sup>p. 2</sup>. |
||
* The acquisition aligns with Skyward Specialty’s strategy by |
* The acquisition aligns with Skyward Specialty’s strategy by introducing new specialty niches, a distinctive new economy offering, accelerating innovation, and adding Apollo’s advanced technology capabilities <sup>p. 2</sup>. |
||
* David Ibeson will continue as CEO of Apollo, leading |
* David Ibeson will continue as CEO of Apollo, leading Apollo's growth as a subsidiary of Skyward Specialty, along with Apollo’s management team <sup>p. 2</sup>. |
||
{{Indexing|Our Business and Our Strategy|Underwriting divisions, Accident & Health, A&H captives program, Agriculture and Credit (Re)insurance, Global agriculture book, Mortgage portfolio, Credit portfolio|1ut79wn2dy|lht8rybaqk|kind=prose|order=5|f1=Number of segments|v1=1|f2=Reportable segments|v2=One reportable segment|f3=Gross written premiums admitted|v3=41%|f4=Gross written premiums non-admitted|v4=59%}} |
|||
'''Our Business and Our Strategy''' |
|||
* The company operates |
* The company operates with one reportable segment, offering a broad range of insurance coverages across various market niches <sup>p. 3</sup>. |
||
* |
* Nine distinct underwriting divisions exist, each with dedicated leadership and technical staff experienced in their niches <sup>p. 3</sup>. |
||
* This structure aims to effectively serve |
* This structure aims to effectively serve customers, partner with distributors, and achieve attractive risk-adjusted returns <sup>p. 3</sup>. |
||
* For the year ended December 31, 2025, ''gross written premiums'' were 41% admitted and 59% non-admitted <sup>p. 3</sup>. |
* For the year ended December 31, 2025, ''gross written premiums'' were 41% admitted and 59% non-admitted <sup>p. 3</sup>. |
||
* ''Accident & Health (A&H)'' underwriting division provides medical stop loss to self-insured employers and covers group and single-employer captives <sup>p. 3</sup>. |
|||
* ''A&H captives program'' offers tailored medical stop-loss and reinsurance solutions with dedicated underwriting and claims oversight <sup>p. 3</sup>. |
|||
<blockquote>"We have one reportable segment through which we offer a broad array of insurance coverages to a number of market niches. Each of our nine distinct underwriting divisions has dedicated underwriting leadership supported by high-quality technical staff with deep experience in their respective niches. We believe this structure and expertise allow us to serve the needs of our customers effectively and be a value-add partner to our distributors, while earning attractive risk-adjusted returns. For the year ended December 31, 2025, 41% of our gross written premiums were written on an admitted basis and 59% were non-admitted." <sup>p. 3</sup></blockquote> |
|||
* The A&H division targets small and medium-sized enterprises seeking to control healthcare costs by self-insuring <sup>p. 3</sup>. |
|||
* A&H products are written on an admitted basis and distributed through retail and wholesale brokers <sup>p. 3</sup>. |
|||
=== Our Underwriting Divisions === |
|||
* ''Agriculture and Credit (Re)insurance'' underwriting division provides specialty risk-transfer solutions across a global portfolio <sup>p. 3</sup>. |
|||
* ''Accident & Health (A&H)'': Provides medical stop loss to employers who self-insure employee benefits, and covers group and single-employer captives <sup>p. 3</sup>. |
|||
* This portfolio includes agriculture, dairy and livestock revenue protection, and mortgage and credit product lines <sup>p. 3</sup>. |
|||
* The division supports insurers, MGAs, and other risk originators with tailored treaty protection using proportional and excess of loss structures <sup>p. 3</sup>. |
|||
** Targets small and medium-sized enterprises seeking to control healthcare costs by self-insuring a portion of their healthcare insurance <sup>p. 3</sup>. |
|||
* ''Global agriculture book'' covers weather and natural peril volatility, production, and yield risks to manage catastrophe exposure and seasonal earnings variability <sup>p. 3</sup>. |
|||
* ''Mortgage portfolio'' supports government-sponsored entities and private mortgage insurers against default and loss severity volatility due to macroeconomic stress, structured to manage tail risk <sup>p. 3</sup>. |
|||
* ''Agriculture and Credit (Re)insurance'': Offers specialty risk-transfer solutions across a diversified global portfolio <sup>p. 3</sup>. |
|||
* ''Credit portfolio'' protects against losses from default risk for single obligors and multi-buyer trade credit across diverse regions and industries <sup>p. 3</sup>. |
|||
* ''Dairy and livestock business'' provides producers with revenue protection against price volatility in milk, cattle, and hog markets <sup>p. 3</sup>. |
|||
* Derivative instruments, primarily put options and futures, are used to mitigate commodity price risk related to cattle, hog, and milk prices <sup>p. 3</sup>. |
|||
* These instruments are used solely for managing adverse price movements, with positions adjusted throughout the year <sup>p. 3</sup>. |
|||
** ''Mortgage portfolio'': supports government-sponsored entities and private mortgage insurers against default and loss severity volatility, structured to manage tail risk <sup>p. 3</sup>. |
|||
* ''Captives'' underwriting division offers group captive solutions by leveraging underwriting and claims expertise from other divisions <sup>p. 3</sup>. |
|||
* This division writes property, general liability, commercial auto, excess liability, and workers’ compensation on E&S and admitted bases <sup>p. 3</sup>. |
|||
* Business is often administered through partnerships with third-party captive managers <sup>p. 3</sup>. |
|||
*** Utilizes derivative instruments (primarily put options and futures) to mitigate commodity price risk related to cattle, hog, and milk prices <sup>p. 3</sup>. |
|||
* ''Construction & Energy Solutions'' underwriting division focuses on high-severity exposures with tailored multi-line solutions <sup>p. 3</sup>. |
|||
*** Derivative positions are adjusted throughout the year based on market conditions and risk profile <sup>p. 3</sup>. |
|||
* Solutions include general liability, excess liability, commercial auto, and workers’ compensation <sup>p. 3</sup>. |
|||
*** See Note 8, “Derivatives” in Item 8 of Form 10-K for more information on derivatives <sup>p. 3</sup>. |
|||
* |
* Products are distributed through retail agents, brokers, and a select network of wholesalers <sup>p. 3</sup>. |
||
* ''Global Property'' underwriting division provides comprehensive property insurance and reinsurance for commercial clients worldwide <sup>p. 3</sup>. |
|||
** Broadens market reach and writes profitable business with limited additional expense by utilizing company-wide expertise <sup>p. 3</sup>. |
|||
* Offerings protect against physical loss or damage to assets from natural catastrophes and other insured perils <sup>p. 3</sup>. |
|||
* ''Professional Lines'' underwriting division includes three units: management liability, professional liability (including cyber), and allied health (including life sciences) <sup>p. 3</sup>. |
|||
** Often administers business through partnerships with third-party captive managers <sup>p. 3</sup>. |
|||
* Management/Professional liability and allied health provide primary and excess claims-made liability products <sup>p. 3</sup>. |
|||
* ''Construction & Energy Solutions'': Focuses on high-severity exposures with tailored multi-line solutions <sup>p. 3</sup>. |
|||
* These products are offered on E&S and admitted bases, distributed through wholesale and retail brokers <sup>p. 3</sup>. |
|||
* ''Specialty Programs'' underwriting division partners with program administrators focused on specific markets <sup>p. 3</sup>. |
|||
* This partnership model is used to participate profitably or extend reach in certain markets, leveraging administrators' competitive advantages like scale or proprietary technology <sup>p. 3</sup>. |
|||
* ''Global Property'': Provides comprehensive property insurance and reinsurance solutions for commercial clients worldwide <sup>p. 3</sup>. |
|||
* Specialty Programs writes property, general liability, commercial auto liability, excess liability, and workers’ compensation on E&S and admitted bases <sup>p. 3</sup>. |
|||
** Offers protection against physical loss or damage to assets (buildings, equipment, inventory) due to natural catastrophes and other insured perils <sup>p. 3</sup>. |
|||
* ''Surety'' underwriting division provides contract, commercial, and transactional surety solutions <sup>p. 3</sup>. |
|||
* Focus is on small to medium-sized enterprises with aggregate bond programs up to approximately $100.0 million for contract and $125.0 million for commercial and transactional <sup>p. 3</sup>. |
|||
* ''Professional Lines'': Includes three underwriting units: management liability, professional liability (including cyber), and allied health (including life sciences) <sup>p. 3</sup>. |
|||
* This business is written on an admitted basis and distributed through retail agents and brokers <sup>p. 3</sup>. |
|||
* ''Transactional E&S'' underwriting division provides primary and excess non-catastrophe prone property and general liability solutions <sup>p. 3</sup>. |
|||
** Distributed through wholesale and retail brokers, depending on the product <sup>p. 3</sup>. |
|||
* Emphasis is on hard-to-place risks due to complexity, loss history, or limited operating history (e.g., startups) <sup>p. 3</sup>. |
|||
* ''Specialty Programs'': Partners with program administrators focused on specific markets <sup>p. 3</sup>. |
|||
* Success in this market relies on technical underwriting, thoughtful coverage, pricing, and high-quality broker service <sup>p. 3</sup>. |
|||
** Believes partnering with program administrators is optimal for profitable participation or market reach <sup>p. 3</sup>. |
|||
* Access to the market in this division is exclusively through wholesale brokers <sup>p. 3</sup>. |
|||
** Program administrators often have competitive advantages (scale or proprietary technology) that would be difficult for the company to replicate <sup>p. 3</sup>. |
|||
* The company has "exited business" units and lines that were previously exited and placed into run-off <sup>p. 3</sup>. |
|||
* The company's strategy is to lead in chosen market niches and establish sustainable, competitive positions <sup>p. 3</sup>. |
|||
* ''Surety'': Provides contract, commercial, and transactional surety solutions to trade and services organizations <sup>p. 3</sup>. |
|||
** Focuses on small to medium-sized enterprises with aggregate bond programs up to approximately ''$100.0 million'' for contract and ''$125.0 million'' for commercial and transactional <sup>p. 3</sup>. |
|||
** Business is written on an admitted basis and distributed through retail agents and brokers <sup>p. 3</sup>. |
|||
* ''Transactional E&S'': Provides primary and excess non-catastrophe prone property and general liability solutions <sup>p. 3</sup>. |
|||
** Emphasizes risks considered hard to place due to complexity, loss history, or limited operating history (e.g., start-ups) <sup>p. 3</sup>. |
|||
** Success in this market relies on technical underwriting, thoughtful coverage provisions, pricing, and high-quality broker service <sup>p. 3</sup>. |
|||
** Accesses the market exclusively through wholesale brokers <sup>p. 3</sup>. |
|||
* The company has business units and lines of business previously exited and placed into run-off, referred to as "exited business" <sup>p. 3</sup>. |
|||
=== Our Strategy === |
|||
* The company aims to lead in chosen market niches and establish sustainable, competitive positions <sup>p. 3</sup>. |
|||
* Key elements of the strategy include: |
* Key elements of the strategy include: |
||
** Providing differentiated products, services, and solutions <sup>p. 3</sup>. |
|||
** Attracting and retaining exceptional underwriting and claims talent <sup>p. 3</sup>. |
|||
** Amplifying expertise with advanced technology and analytics for risk selection, pricing, and claims management <sup>p. 3</sup>. |
|||
** Empowering underwriting and claims teams with decision-making authority <sup>p. 3</sup>. |
|||
** Fostering a culture of nimbleness and responsiveness to market opportunities <sup>p. 3</sup>. |
|||
* This strategy is referred to as |
* This strategy is referred to as "Rule Our Niche" and aims to build a strong defensible market position and competitive moat <sup>p. 3</sup>. |
||
* The principles of this strategy are considered key to achieving and sustaining best-in-class underwriting results through P&C insurance pricing cycles <sup>p. 3</sup>. |
* The principles of this strategy are considered key to achieving and sustaining best-in-class underwriting results through P&C insurance pricing cycles <sup>p. 3</sup>. |
||
* The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics <sup>p. 3</sup>. |
* The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics <sup>p. 3</sup>. |
||
{{Indexing|Our Competitive Strengths|Commercial lines P&C markets, specialty and standard insurers, program administrators, underwriting divisions, claims professionals|c6zoq3weio|8c6rwjjmzf|kind=prose|order=6|f1=Competitive advantages|v1=Technical underwriting, claims management, data and predictive analytics, experienced underwriting teams, specialized claims professionals}} |
|||
'''Our Competitive Strengths''' |
|||
* The company focuses on profitable niches in the market that require technical underwriting and claims management, which act as barriers to entry <sup>p. 4</sup>. |
|||
<blockquote>"We believe that our competitive strengths include:" <sup>p. 4</sup></blockquote> |
|||
* The selected niche areas within commercial lines P&C markets are considered attractive for generating risk-adjusted returns <sup>p. 4</sup>. |
|||
* Focus on profitable niches of the market that require technical underwriting and claims management as barriers to entry <sup>p. 4</sup>. |
|||
* The company targets underserved, dislocated markets or those where standard products are insufficient for customer needs <sup>p. 4</sup>. |
|||
<blockquote>"We believe that the niche areas of the commercial lines P&C markets we have selected are a highly attractive subset of the P&C insurance market and present an opportunity to generate attractive risk-adjusted returns." <sup>p. 4</sup></blockquote> |
|||
* |
* Risks in core markets require efficient, individual underwriting to achieve sustainable underwriting profit <sup>p. 4</sup>. |
||
* The company builds underwriting divisions with deeply experienced underwriters who have appropriate authority for decision-making <sup>p. 4</sup>. |
|||
* Risks in core markets require efficient, individual underwriting to generate sustainable underwriting profit <sup>p. 4</sup>. |
|||
* This structure allows for innovative products and solutions for distribution partners and customers, even for challenging risks <sup>p. 4</sup>. |
|||
* The company builds underwriting divisions around deeply experienced underwriters with appropriate authority <sup>p. 4</sup>. |
|||
* Underwriters' experience is augmented with data and predictive analytics |
* Underwriters' experience is augmented with data and predictive analytics to differentiate risk selection and pricing while enhancing efficiency <sup>p. 4</sup>. |
||
* The company hires and retains underwriting and technical staff for their expertise and experience <sup>p. 4</sup>. |
|||
* Highly skilled underwriters are a competitive strength <sup>p. 4</sup>. |
|||
* Underwriting teams are knowledgeable, experienced, and empowered, which is crucial for operating in markets with risks difficult to automate <sup>p. 4</sup>. |
|||
<blockquote>"We focus on hiring and retaining underwriting and technical staff who help differentiate our company through their expertise and experience." <sup>p. 4</sup></blockquote> |
|||
* The company avoids strict underwriting rules, allowing professionals to use their expertise and judgment in evaluating and pricing risks <sup>p. 4</sup>. |
|||
* Underwriting teams are knowledgeable, experienced, and empowered, which is critical for complex risks that are difficult to automate <sup>p. 4</sup>. |
|||
* |
* The company has a specialized team of claims professionals knowledgeable in the niches and lines of business served <sup>p. 4</sup>. |
||
* Claims professionals address first-party claims with fair solutions and third-party claims with comprehensive responses, aiming for consistent and early loss recognition of indemnity and loss adjustment expenses (LAE) <sup>p. 4</sup>. |
|||
* Superior Claims Staff and Operations are a competitive strength <sup>p. 4</sup>. |
|||
* The company responds quickly to claims with specialized adjusters using expertise, advanced technology, and analytics <sup>p. 4</sup>. |
|||
<blockquote>"We have cultivated a best-in-class and highly specialized team of claims professionals who are highly knowledgeable about the niches we serve and the lines of business we write." <sup>p. 4</sup></blockquote> |
|||
* Claims professionals address first-party claims with fair solutions and third-party claims with holistic responses, aiming for consistent and early loss recognition of indemnity and loss adjustment expenses (LAE) <sup>p. 4</sup>. |
|||
<blockquote>"We respond quickly when a claim is submitted with specialized adjusters, who are armed with expertise, advanced technology and analytics, to assist them in the claims resolution process." <sup>p. 4</sup></blockquote> |
|||
* Technology is deeply embedded in the claims process, from first notice of loss to investigation and settlement <sup>p. 4</sup>. |
* Technology is deeply embedded in the claims process, from first notice of loss to investigation and settlement <sup>p. 4</sup>. |
||
* Analytics capabilities |
* Analytics capabilities provide senior leadership and claims teams with real-time, detailed information on open claims and benchmarks against closed claims <sup>p. 4</sup>. |
||
* |
* SkyBI, the business intelligence platform, provides real-time intelligence to senior leadership and technical teams for decision-making <sup>p. 4</sup>. |
||
* |
* SkyBI incorporates best practices from the management team's experience in P&C insurance and technology sectors <sup>p. 4</sup>. |
||
* SkyBI reflects best practices learned from management's experience in P&C insurance and technology <sup>p. 4</sup>. |
|||
* SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities <sup>p. 4</sup>. |
* SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities <sup>p. 4</sup>. |
||
* SkyBI provides information and performance metrics across the company in a visualized format <sup>p. 4</sup>. |
* SkyBI provides information and performance metrics across the company in a visualized format <sup>p. 4</sup>. |
||
* Data in SkyBI can be filtered by categories such as distributor, customer segment, line of business, industry, underwriter, and risk feature <sup>p. 4</sup>. |
* Data in SkyBI can be filtered by categories such as distributor, customer segment, line of business, industry, underwriter, and risk feature <sup>p. 4</sup>. |
||
* |
* The company believes that new types of risk data and advanced technology can augment underwriting and claims decisions <sup>p. 4</sup>. |
||
* Underwriting decisions are supported by historical data and in-depth risk evaluation from data collection and processing capabilities <sup>p. 4</sup>. |
|||
<blockquote>"We fundamentally believe that every underwriting and claims decision can be augmented with the use of new types of risk data and advanced technology." <sup>p. 4</sup></blockquote> |
|||
* Underwriting |
* Underwriting and claims capabilities are amplified by combining historical data with new forms of risk data and predictive analytics <sup>p. 4</sup>. |
||
* Generative artificial intelligence is used in underwriting and claims handling to enhance effectiveness and efficiency, while still relying on employee expertise <sup>p. 4</sup>. |
|||
* Underwriting and claims capabilities are amplified by combining data with new forms of risk data and predictive analytics <sup>p. 4</sup>. |
|||
* The company has built a diversified group of underwriting divisions across multiple product lines, industries, geographies, and distribution channels <sup>p. 4</sup>. |
|||
* Generative artificial intelligence is utilized in underwriting and claims handling to enhance effectiveness and efficiency, while still relying on employee expertise <sup>p. 4</sup>. |
|||
* |
* This diversification includes business not typically aligned with traditional P&C cycles <sup>p. 4</sup>. |
||
* The company aims to adapt to the market by growing certain lines in favorable conditions and limiting exposure in less favorable conditions <sup>p. 4</sup>. |
|||
<blockquote>"We have been successful in building a diversified group of underwriting divisions spanning multiple product lines, industries, geographies and distribution channels, including business that is not typically aligned with traditional P&C cycles." <sup>p. 4</sup></blockquote> |
|||
* The |
* The diversity of the book allows the company to respond to and capitalize on market opportunities and dislocations across insurance market and pricing cycles <sup>p. 4</sup>. |
||
* The |
* The company has a distinctive culture, evidenced by internal surveys, public information (Glassdoor, LinkedIn), and selection as a "Best Places to Work in Insurance" <sup>p. 4</sup>. |
||
* |
* The culture and operating approach feature a flat communication and decision-making structure <sup>p. 4</sup>. |
||
* Staff are trusted to make decisions that achieve or exceed financial results and are supported by a clear performance measurement system <sup>p. 4</sup>. |
|||
<blockquote>"As evidenced by our internal surveys, public information such as that available on Glassdoor and LinkedIn, and our selection as a “Best Places to Work in Insurance,” we have built a distinctive winning culture." <sup>p. 4</sup></blockquote> |
|||
* |
* The company adopted a hybrid work schedule, offering flexibility for remote working <sup>p. 4</sup>. |
||
* Staff are trusted to make decisions that produce or exceed financial results and are supported by a clear measurement system <sup>p. 4</sup>. |
|||
* A hybrid work schedule offers employees flexibility for remote working <sup>p. 4</sup>. |
|||
* The company maintains an entrepreneurial environment that encourages and rewards a proactive approach to market disruption <sup>p. 4</sup>. |
* The company maintains an entrepreneurial environment that encourages and rewards a proactive approach to market disruption <sup>p. 4</sup>. |
||
* This environment aligns with the company's identity as a specialty insurer and supports attracting talent and delivering best-in-class results <sup>p. 4</sup>. |
|||
* High-quality, experienced leadership team is aligned with shareholders <sup>p. 4</sup>. |
|||
* The leadership team, led by Chairman and CEO Andrew Robinson, is experienced, innovative, and entrepreneurial <sup>p. 4</sup>. |
|||
* |
* The executive leadership team has a track record of success in senior management roles at industry-leading P&C companies and in building new businesses <sup>p. 4</sup>. |
||
* |
* Senior leadership compensation is structured to align with shareholders <sup>p. 4</sup>. |
||
* |
* A material portion of each leader's compensation is in long-term and short-term incentives tied to delivering sustainable, best-in-class underwriting returns <sup>p. 4</sup>. |
||
* Executive leadership has additional long-term incentive targets directly tied to growth in book value per share <sup>p. 4</sup>. |
|||
{{Indexing|Our Strategy in Action|Rule Our Niche strategy, underwriting and claims talent, technology DNA, SkyBI, core operating platforms, climate change, supply chain uncertainty, financial inflation, cyber risk, novel health risks, litigation, jury awards, healthcare delivery|8c6rwjjmzf|2264mja9fc|kind=prose|order=7|f1=Strategic priorities|v1=Attracting and retaining talent, leveraging technology, profitably growing existing lines, expanding with new underwriting divisions|f2=Strategy name|v2=Rule Our Niche|f3=Technology platform|v3=SkyBI}} |
|||
'''Our Strategy in Action''' |
|||
* The company's "Rule Our Niche" strategy |
* The company's "Rule Our Niche" strategy aims to generate best-in-class underwriting profitability within its niches and create superior long-term shareholder value through growth in book value per share <sup>p. 5</sup>. |
||
* |
* Core tenets of the "Rule Our Niche" strategy include attracting and retaining blue-chip underwriting and claims talent to expand and enhance market position <sup>p. 5</sup>. |
||
* |
* The company seeks to hire and retain technical underwriting professionals with long-standing industry relationships and claims professionals with expertise in specific niches <sup>p. 5</sup>. |
||
* |
* These relationships are crucial for consistent access to preferred business <sup>p. 5</sup>. |
||
* The company aims to grow its market position by recruiting world-class talent in chosen markets <sup>p. 5</sup>. |
* The company aims to grow its market position by recruiting world-class talent in chosen markets <sup>p. 5</sup>. |
||
* Another |
* Another tenet is leveraging technology DNA to differentiate from competitors <sup>p. 5</sup>. |
||
* The company |
* The company has demonstrated an ability to use new forms of risk data and advanced technology in complex, higher-severity risk categories within the specialty P&C insurance market <sup>p. 5</sup>. |
||
* |
* SkyBI enables prompt sensing and quick response to market changes <sup>p. 5</sup>. |
||
* Core operating platforms allow efficient entry into new markets without complex systems <sup>p. 5</sup>. |
* Core operating platforms allow efficient entry into new markets without complex or burdensome systems <sup>p. 5</sup>. |
||
* The company believes its technological advantage supports profitable growth and expansion into additional specialty market niches <sup>p. 5</sup>. |
* The company believes its technological advantage supports profitable growth and expansion into additional specialty market niches <sup>p. 5</sup>. |
||
* |
* The strategy also includes profitably growing existing lines of business and expanding with new underwriting divisions <sup>p. 5</sup>. |
||
* The company is positioned to capitalize on trends impacting customers in the U.S. and globally <sup>p. 5</sup>. |
* The company is positioned to capitalize on trends impacting customers in the U.S. and globally, such as increased demand for specialized insurance due to rising and complex risks <sup>p. 5</sup>. |
||
* |
* These risks include climate change/severe weather, supply chain uncertainty, financial inflation, cyber risk, novel health risks, increased litigation, attorney involvement, jury awards, and healthcare delivery/cost <sup>p. 5</sup>. |
||
* Another market trend is the emergence of "micro cycles and micro dislocations" |
* Another notable market trend is the emergence of "micro cycles and micro dislocations" where different P&C insurance market segments experience hardening and softening at varying times <sup>p. 5</sup>. |
||
* The company has reacted to these trends by launching new underwriting units ( |
* The company has reacted quickly to these trends by launching new underwriting units (many not aligned with P&C cycles), entering underserved markets, partnering on advanced technology, and launching new captive solutions <sup>p. 5</sup>. |
||
* Gross written premium growth and profitability indicate momentum and position the company for continued expansion <sup>p. 5</sup>. |
* Gross written premium growth and profitability indicate momentum and position the company for continued expansion and growth <sup>p. 5</sup>. |
||
* Differentiating on daily excellence to drive best-in-class underwriting performance is also a core tenet <sup>p. 5</sup>. |
* Differentiating on daily excellence to drive best-in-class underwriting performance is also a core tenet <sup>p. 5</sup>. |
||
* Meeting long-term goals, including best-in-class underwriting returns and book value per share growth, depends on day-to-day |
* Meeting long-term goals, including best-in-class underwriting returns and book value per share growth, depends on execution of day-to-day operations across all functional departments (underwriting, product management, claims management) <sup>p. 5</sup>. |
||
* |
* SkyBI provides a foundation for senior management to monitor performance, including renewal rates, new business pricing, portfolio performance for underwriters, and claims aging/reserving practices for adjusters <sup>p. 5</sup>. |
||
* Focus on underwriting |
* Focus on fundamentals driving underwriting excellence is central to the strategy <sup>p. 5</sup>. |
||
* Cross-functional collaboration ensures regular review of performance and trends by underwriting, claims, actuarial, and product management teams |
* Cross-functional collaboration ensures regular review of performance and trends by underwriting, claims, actuarial, and product management teams to implement portfolio, pricing, and coverage changes quickly <sup>p. 5</sup>. |
||
* The company aims to use its balance sheet to capture a larger market share <sup>p. 5</sup>. |
* The company aims to use its balance sheet to capture a larger market share <sup>p. 5</sup>. |
||
* The company is committed to maintaining a strong balance sheet with conservative loss reserves and strong capitalization ratios <sup>p. 5</sup>. |
* The company is committed to maintaining a strong balance sheet, starting with conservative loss reserves and strong capitalization ratios <sup>p. 5</sup>. |
||
* This commitment is |
* This commitment is considered imperative for maintaining confidence among customers, distribution partners, reinsurers, regulators, rating agencies, and shareholders <sup>p. 5</sup>. |
||
* Claims case reserve practices aim to reserve to the expected ultimate loss within 90 days of the first notice of loss <sup>p. 5</sup>. |
* Claims case reserve practices aim to reserve to the expected ultimate loss within 90 days of the first notice of loss <sup>p. 5</sup>. |
||
* The company |
* The company's practice is to maintain incurred but not reported reserves (IBNR) that, combined with case reserves, are above the actuarial central estimate <sup>p. 5</sup>. |
||
* Loss reserves represent the company's best estimate of ultimate losses <sup>p. 5</sup>. |
* Loss reserves represent the company's best estimate of ultimate losses <sup>p. 5</sup>. |
||
{{Indexing|Marketing and Distribution|Marketing and distribution approach, Rule Our Niche strategy, distribution partners, retail agents, wholesale brokers, program administrators, captive managers|la5wuhtx31|kind=prose|order=8|f1=Distribution channels|v1=Retail agents, wholesale brokers, select program administrators, captive managers}} |
|||
'''Marketing and Distribution''' |
|||
* The company's marketing and distribution approach |
* The company's marketing and distribution approach mirrors its underwriting strategy and is central to its "Rule Our Niche" strategy <sup>p. 6</sup>. |
||
* |
* Underwriting teams and the company maintain strong relationships and reputations with distribution partners, facilitating new affiliations <sup>p. 6</sup>. |
||
* The company |
* The company attributes its success with distribution partners to deep expertise in niche markets, high-caliber underwriters, a culture of innovation, thoughtful product lineup and design, and responsive service <sup>p. 6</sup>. |
||
* All underwriting divisions dedicate significant effort to maintaining and expanding distribution partner loyalty and long-term relationships <sup>p. 6</sup>. |
* All underwriting divisions dedicate significant effort to maintaining and expanding distribution partner loyalty and long-term relationships <sup>p. 6</sup>. |
||
* The company tailors its choice of |
* The company tailors its choice of distribution partners to access specific business, similar to how it tailors underwriting to insureds' needs <sup>p. 6</sup>. |
||
* Products are distributed through |
* Products are distributed through retail agents, wholesale brokers, select program administrators, and captive managers <sup>p. 6</sup>. |
||
* This distribution |
* This distribution approach enables effective and efficient access to targeted business based on market niche needs and dynamics <sup>p. 6</sup>. |
||
{{Indexing|Underwriting|Underwriting approach, Rule Our Niche strategy, underwriting teams, technology, data analytics, SkyBI, admitted market, E&S market|cos78e4bvi|2264mja9fc|kind=prose|order=9|f1=Underwriting divisions|v1=Nine|f2=Technology platform|v2=SkyBI}} |
|||
'''Underwriting''' |
|||
* The company's underwriting approach is central to its "Rule Our Niche" strategy and market success <sup>p. 7</sup>. |
* The company's underwriting approach is central to its "Rule Our Niche" strategy and market success <sup>p. 7</sup>. |
||
* Within its nine divisions, underwriting teams |
* Within its nine divisions, the company further specializes underwriting teams to focus on specific niches <sup>p. 7</sup>. |
||
* The underwriting approach relies on hiring highly experienced, best-in-class, and diverse technical underwriters with proven track records in specific specialty niche markets <sup>p. 7</sup>. |
* The underwriting approach relies on hiring highly experienced, best-in-class, and diverse teams of technical underwriters with proven track records in specific specialty niche markets <sup>p. 7</sup>. |
||
* Underwriters' skills are enhanced with advanced technology and data analytics, and they are empowered with appropriate decision-making authority <sup>p. 7</sup>. |
* Underwriters' skills are enhanced with advanced technology and data analytics, and they are empowered with appropriate decision-making authority <sup>p. 7</sup>. |
||
* This approach aims for superior risk selection |
* This approach aims for superior risk selection and pricing, leading to sustainable best-in-class underwriting results across market cycles <sup>p. 7</sup>. |
||
* The company |
* The company augments underwriting capabilities using new forms of data and analytics for risk selection and pricing <sup>p. 7</sup>. |
||
* Underwriting data is captured in the business intelligence platform, SkyBI, which |
* Underwriting data is captured in the business intelligence platform, SkyBI, which serves as a comprehensive data repository for reporting, analytics, and other data capabilities <sup>p. 7</sup>. |
||
* SkyBI is a key tool for senior management and business leaders <sup>p. 7</sup>. |
* SkyBI is a key tool for senior management and business leaders <sup>p. 7</sup>. |
||
* The company is highly selective in binding policies |
* The company is highly selective in binding policies <sup>p. 7</sup>. |
||
* Underwriters are encouraged to move on from opportunities quickly if they cannot reasonably expect to bind coverage at premium and terms meeting company standards <sup>p. 7</sup>. |
|||
* When accepting risks, terms and prices are carefully established to suit the underlying exposure <sup>p. 7</sup>. |
|||
* |
* When accepting risks, the company establishes terms and prices suited to the underlying exposure <sup>p. 7</sup>. |
||
* In the |
* In the admitted market, the company ensures approved forms and filed rates are appropriate and adequate for accepted risks, while allowing flexibility for specific or unique exposures <sup>p. 7</sup>. |
||
* |
* In the E&S market, the company uses freedom of rate and form to match risk and coverage to the unique needs and exposures of that market <sup>p. 7</sup>. |
||
* Policies are crafted to offer affordable and appropriate protection for insureds' exposures, with coverage structured to make potential losses more predictable and claims costs manageable <sup>p. 7</sup>. |
|||
* Underwriting teams receive support and collaboration from Claims, Actuarial, Product Management, Legal and Compliance, and Finance departments <sup>p. 7</sup>. |
* Underwriting teams receive support and collaboration from Claims, Actuarial, Product Management, Legal and Compliance, and Finance departments <sup>p. 7</sup>. |
||
* This collaboration ensures |
* This collaboration ensures timely analysis and action on trends in business, legal and tort developments, and competitor and regulatory actions <sup>p. 7</sup>. |
||
* Underwriters are considered central to the company, with all support functions incentivized and measured to achieve underwriting profitability targets <sup>p. 7</sup>. |
* Underwriters are considered central to the company, with all support functions incentivized and measured to achieve underwriting profitability targets <sup>p. 7</sup>. |
||
* This structure helps identify opportunities and issues early, contributing to the company's nimbleness and ability to leverage market disruptions <sup>p. 7</sup>. |
* This structure helps identify opportunities and issues early, contributing to the company's nimbleness and ability to leverage market disruptions <sup>p. 7</sup>. |
||
* Underwriting controls and procedures are regularly reviewed to ensure |
* Underwriting controls and procedures are regularly reviewed to ensure underwriters profitably underwrite in each market served <sup>p. 7</sup>. |
||
{{Indexing|Claims Management|Claims department, advanced analytics, technology, Third Party Administrators (TPAs), independent legal counsel, legal spend management solution, Claims Development Severity Predictor model|drz6uloidk|kind=prose|order=10|f1=Claims handling principles|v1=Prompt investigations, quality claims handling, timely reserve establishment, effective pursuit of contribution and subrogation, fraud detection and prevention, disciplined litigation management|f2=Technology used|v2=Claims Development Severity Predictor model}} |
|||
'''Claims Management''' |
|||
* Skyward's claims department operates under six guiding principles: prompt and comprehensive investigations using advanced analytics and technology; quality claims handling |
* Skyward's claims department operates under six guiding principles: prompt and comprehensive investigations using advanced analytics and technology; quality claims handling and customer engagement; timely establishment of reserves based on best estimates; effective pursuit of contribution and subrogation; detection and prevention of fraud; and disciplined litigation management for superior legal defense and cost monitoring <sup>p. 8</sup>. |
||
* Continuous training is provided to claim staff on claim evaluation, strategy, litigation management, good-faith handling, and best practices <sup>p. 8</sup>. |
* Continuous training is provided to claim staff on claim evaluation, strategy, litigation management, good-faith claims handling, and best practices to achieve timely and optimal claim outcomes <sup>p. 8</sup>. |
||
* The ultimate goal of the claims department is timely and optimal claim outcomes <sup>p. 8</sup>. |
|||
* The majority of claims are handled in-house <sup>p. 8</sup>. |
* The majority of claims are handled in-house <sup>p. 8</sup>. |
||
* Third Party Administrators (TPAs) are utilized for |
* Third Party Administrators (TPAs) are utilized for specific instances such as programs, captives, occupational accident, workers' compensation, and runoff claims <sup>p. 8</sup>. |
||
* TPAs are actively managed and |
* TPAs are actively managed, overseen, and regularly audited to ensure compliance with Skyward's claims handling and reserving guidelines and best practices <sup>p. 8</sup>. |
||
* Independent legal counsel is retained for liability claims against insureds when warranted, selected based on geographical location and expertise <sup>p. 8</sup>. |
|||
* Regular audits of TPAs are conducted to ensure compliance <sup>p. 8</sup>. |
|||
* |
* Litigation guidelines have been developed for claims professionals and outside counsel to ensure appropriate defense for insureds <sup>p. 8</sup>. |
||
* Litigation guidelines have been developed for both claims professionals and outside counsel to ensure appropriate defense and adherence to standards <sup>p. 8</sup>. |
|||
* A legal spend management solution is used to analyze legal invoices for adherence to case handling and billing practice standards, ensuring reasonable and customary legal costs <sup>p. 8</sup>. |
* A legal spend management solution is used to analyze legal invoices for adherence to case handling and billing practice standards, ensuring reasonable and customary legal costs <sup>p. 8</sup>. |
||
* Technology is leveraged |
* Technology is leveraged for efficiencies in claims handling, including a Claims Development Severity Predictor model <sup>p. 8</sup>. |
||
* |
* The Claims Development Severity Predictor identifies claims likely to lead to large loss development, enabling early identification, proactive management, and summarization of development reasons <sup>p. 8</sup>. |
||
* This model |
* This predictive model is integrated into the claims review and management workflow <sup>p. 8</sup>. |
||
* A "quick strike" program has been implemented for commercial auto claims, deploying experienced investigators and vendors to accident scenes within two hours, regardless of location <sup>p. 8</sup>. |
|||
* Skyward seeks opportunities for efficient and effective claims resolution <sup>p. 8</sup>. |
|||
* |
* The quick strike program assists in evaluating accident facts and circumstances and resolving third-party claims quickly <sup>p. 8</sup>. |
||
* This program aids in evaluating accident facts, initiating investigations quickly, and resolving third-party claims promptly if appropriate <sup>p. 8</sup>. |
|||
* Claims handlers and managers are organized by line of business to ensure specialized expertise <sup>p. 8</sup>. |
* Claims handlers and managers are organized by line of business to ensure specialized expertise <sup>p. 8</sup>. |
||
* Managers and adjusters collaborate closely with underwriting partners to inform them of legal trends and emerging claims issues <sup>p. 8</sup>. |
* Managers and adjusters collaborate closely with underwriting partners to inform them of legal trends and emerging claims issues, educating underwriters on loss experience for risk selection <sup>p. 8</sup>. |
||
* The goal of this collaboration is to educate underwriters on emerging loss experience areas to assist in risk selection processes <sup>p. 8</sup>. |
|||
{{Indexing|Technology|Skyward Specialty Insurance Group, SkyBI, predictive analytics technology, AI, core transactional platforms, policy administration, underwriting workbench, billing, claims systems, accident & health, global property, agriculture, credit (re)insurance, surety|2264mja9fc|kind=prose|order=11|f1=Technology platform|v1=SkyBI|f2=Technology type|v2=Predictive analytics technology, AI|f3=Core transactional platforms|v3=Policy administration, underwriting workbench, billing, claims systems}} |
|||
'''Technology''' |
|||
* Technology is central to |
* Technology is central to Skyward Specialty Insurance Group's operations and decision-making, aiming for long-term competitive advantages <sup>p. 9</sup>. |
||
* ''SkyBI'', the business intelligence platform, provides real-time intelligence to senior leadership and technical teams for decision-making <sup>p. 9</sup>. |
|||
* Technology is deployed across the organization to drive competitive advantages in three primary functional ways <sup>p. 9</sup>. |
|||
* ''SkyBI'' (business intelligence platform) provides real-time intelligence to senior leadership and technical teams for superior decision-making <sup>p. 9</sup>. |
|||
* SkyBI incorporates best practices from the management team's experience in P&C insurance and technology sectors <sup>p. 9</sup>. |
* SkyBI incorporates best practices from the management team's experience in P&C insurance and technology sectors <sup>p. 9</sup>. |
||
* SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities <sup>p. 9</sup>. |
* SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities <sup>p. 9</sup>. |
||
* SkyBI |
* SkyBI presents information and performance metrics across the company in a visualized format <sup>p. 9</sup>. |
||
* Data in SkyBI can be filtered by categories such as distributor, customer segment, line of business, |
* Data in SkyBI can be filtered by categories such as distributor, customer segment, line of business, industry, underwriter, and risk feature <sup>p. 9</sup>. |
||
* SkyBI helps establish clear |
* SkyBI helps establish clear objectives and facilitates decision-making <sup>p. 9</sup>. |
||
* ''Predictive |
* ''Predictive analytics technology'' augments employee capabilities using new risk data and predictive analytics, including AI, for risk selection, pricing, and claims handling <sup>p. 9</sup>. |
||
* Underwriting divisions intentionally "Rule Our Niche" |
* Underwriting divisions intentionally "Rule Our Niche" through constant innovation tailored to specific divisions/markets <sup>p. 9</sup>. |
||
* ''Core |
* ''Core transactional platforms'', including policy administration, underwriting workbench, billing, and claims systems, are designed for nimble scaling and business expansion <sup>p. 9</sup>. |
||
* The company generally uses customized third-party vendor core operating applications <sup>p. 9</sup>. |
* The company generally uses customized third-party vendor core operating applications <sup>p. 9</sup>. |
||
* The core platform organization is used for all business except accident & health, global property, agriculture, credit (re)insurance, and surety, which require dedicated |
* The core platform organization is used for all business except accident & health, global property, agriculture, credit (re)insurance, and surety, which require dedicated processing components due to their unique features <sup>p. 9</sup>. |
||
* Data from all divisions' core operating platforms flows to |
* Data from all divisions' core operating platforms flows to SkyBI with comparable quality and granularity <sup>p. 9</sup>. |
||
* Advanced technology for underwriting and claims, SkyBI, and core operating platforms create a flywheel effect <sup>p. 9</sup>. |
* Advanced technology for underwriting and claims, SkyBI, and core operating platforms create a flywheel effect, enabling underwriters to better select risk, claims professionals to adjudicate claims, unit leaders to communicate with partners, and senior leadership to evaluate business trends <sup>p. 9</sup>. |
||
* These tools also improve communication with distribution partners, reinsurers, and other third-party partners <sup>p. 9</sup>. |
|||
* This technology allows underwriters to better select risk, claims professionals to better adjudicate claims, unit leaders to better communicate with reinsurance and third-party partners, and senior leadership to better evaluate business trends <sup>p. 9</sup>. |
|||
* The company faces external threats to its information technology systems, including system failure, data theft attempts, and ransomware attacks <sup>p. 9</sup>. |
|||
* These tools also improve communication accuracy, effectiveness, and efficiency with distribution partners, reinsurers, and other third-party partners <sup>p. 9</sup>. |
|||
* The company faces external threats to its information technology systems, including system failure, customer data theft attempts, and ransomware attacks <sup>p. 9</sup>. |
|||
* The technology infrastructure is designed to function through major disruptions <sup>p. 9</sup>. |
* The technology infrastructure is designed to function through major disruptions <sup>p. 9</sup>. |
||
* Data is replicated in real-time to a third-party cloud disaster recovery site for |
* Data is replicated in real-time to a third-party cloud disaster recovery site for major system failures <sup>p. 9</sup>. |
||
* Data is backed up daily for system restoration <sup>p. 9</sup>. |
* Data is backed up daily for system restoration <sup>p. 9</sup>. |
||
* Actions to prevent system and data disruptions include: |
* Actions to prevent system and data disruptions include: |
||
** Actively monitoring Cybersecurity and Infrastructure Security Agency’s (“CISA”) cybersecurity directives and taking immediate action on identified vulnerabilities <sup>p. 9</sup>. |
|||
* Monthly vulnerability scans are conducted on all network-attached devices at all locations, with patching applied as needed <sup>p. 9</sup>. |
|||
** Conducting monthly vulnerability scans on all network-attached devices at all locations, with patching as needed <sup>p. 9</sup>. |
|||
* Two-factor authentication is required for system access <sup>p. 9</sup>. |
|||
* |
** Requiring two-factor authentication for system access <sup>p. 9</sup>. |
||
* |
** Conducting monthly security training for all employees <sup>p. 9</sup>. |
||
** Implementing endpoint detection agents for threat detection and response <sup>p. 9</sup>. |
|||
* Desktop scenarios are performed to practice responses to breaches with cybersecurity insurance partners and retained security consultants <sup>p. 9</sup>. |
|||
** Performing desktop scenarios to practice breach responses with cybersecurity insurance partners and retained security consultants <sup>p. 9</sup>. |
|||
* Annual penetration testing is performed <sup>p. 9</sup>. |
|||
** Performing annual penetration testing <sup>p. 9</sup>. |
|||
* The company constantly reviews its security breach posture and regularly implements updated processes, best practices, and tools <sup>p. 9</sup>. |
* The company constantly reviews its security breach posture and regularly implements updated processes, best practices, and tools <sup>p. 9</sup>. |
||
{{Indexing|Reinsurance|Reinsurance, severity events, earnings volatility, quota share reinsurance, excess of loss reinsurance, facultative coverage, property insurance, catastrophe reinsurance|20fueoa3q1|8ihdrbirer|kind=prose|order=12|f1=Reinsurance contract length|v1=One year|f2=Reinsurance renewal frequency|v2=Annually|f3=Reinsurance renewal months|v3=January, June|f4=Reinsurance types|v4=Quota share, excess of loss, facultative|f5=Property insurance GWP|v5=34% as of December 31, 2025}} |
|||
'''Reinsurance''' |
|||
* |
* The company strategically purchases reinsurance from third parties to protect capital from severity events (large single event losses or catastrophes) and reduce earnings volatility <sup>p. 10</sup>. |
||
* Reinsurance contracts are predominantly one year in length and renew annually, primarily in January and June <sup>p. 10</sup>. |
* Reinsurance contracts are predominantly one year in length and renew annually, primarily in January and June <sup>p. 10</sup>. |
||
* |
* Annual renewal considerations for reinsurance purchases include changes to underlying insurance coverage, updated loss activity, capital and surplus levels, changes in risk appetite, and the cost and availability of reinsurance treaties <sup>p. 10</sup>. |
||
* |
* The company purchases quota share, excess of loss, and facultative reinsurance coverage to limit exposure from losses on any one occurrence <sup>p. 10</sup>. |
||
* The mix of reinsurance |
* The mix of reinsurance purchased is based on efficiency, cost, risk appetite, and specific factors of the underlying risks underwritten <sup>p. 10</sup>. |
||
* ''Quota share reinsurance'' involves |
* ''Quota share reinsurance'' involves a reinsurer assuming a specified percentage of losses from a defined class of business in exchange for a corresponding percentage of premiums, net of a ceding commission <sup>p. 10</sup>. |
||
* ''Excess of loss reinsurance'' involves |
* ''Excess of loss reinsurance'' involves a reinsurer assuming all or a portion of losses for an individual claim or event above a specified amount, in exchange for a negotiated premium, and includes the catastrophe reinsurance program <sup>p. 10</sup>. |
||
* ''Facultative coverage'' is a reinsurance contract for individual risks, used to supplement treaty limits or cover risks/perils excluded from treaty reinsurance <sup>p. 10</sup>. |
* ''Facultative coverage'' is a reinsurance contract for individual risks, used to supplement treaty limits or cover risks/perils excluded from treaty reinsurance <sup>p. 10</sup>. |
||
* As of December 31, 2025, ''property insurance'' represented 34% of gross written premiums <sup>p. 10</sup>. |
* As of December 31, 2025, ''property insurance'' represented 34% of gross written premiums <sup>p. 10</sup>. |
||
* |
* The company actively manages and monitors property writings by geographic area to limit potential loss aggregation from severe events like hurricanes, convective storms, and earthquakes <sup>p. 10</sup>. |
||
* Catastrophe reinsurance is purchased to further mitigate property loss aggregation due to single or series of events <sup>p. 10</sup>. |
* Catastrophe reinsurance is purchased to further mitigate property loss aggregation due to single or series of events <sup>p. 10</sup>. |
||
* Third-party stochastic and |
* Third-party stochastic and proprietary deterministic models are used to analyze the risk of loss aggregation from such events and inform catastrophe reinsurance purchases <sup>p. 10</sup>. |
||
* These models provide a quantitative view of PML (Probable Maximum Loss) events, |
* These models provide a quantitative view of PML (Probable Maximum Loss) events, which estimate the expected loss level for a given return period <sup>p. 10</sup>. |
||
* |
* Based on modeling, an event beyond a 1 in 250-year PML would be required to exhaust the company's ''$36.0 million property catastrophe coverage'' <sup>p. 10</sup>. |
||
* The company aims to expose no more than 3.0% of stockholders’ equity to a catastrophic loss less than a 1 in 250-year event <sup>p. 10</sup>. |
* The company aims to expose no more than 3.0% of stockholders’ equity to a catastrophic loss that is less than a 1 in 250-year event <sup>p. 10</sup>. |
||
* The current reinsurance program is believed to provide coverage well in excess of theoretical losses from any recorded historical event <sup>p. 10</sup>. |
* The current reinsurance program is believed to provide coverage well in excess of theoretical losses from any recorded historical event <sup>p. 10</sup>. |
||
* |
* The company seeks to purchase reinsurance from reinsurers rated at least "A-" ("Excellent") or better by A.M. Best <sup>p. 10</sup>. |
||
* As of December 31, 2025, ''98% of reinsurance recoverables'' were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or were collateralized <sup>p. 10</sup>. |
* As of December 31, 2025, ''98% of reinsurance recoverables'' were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or were collateralized <sup>p. 10</sup>. |
||
* |
* The company retains primary liability to policyholders if reinsurers fail to pay claims, leading to potential losses <sup>p. 10</sup>. |
||
* Allowances for uncollectible reinsurance are established due to |
* Allowances for uncollectible reinsurance are established due to the risk of reinsurer default <sup>p. 10</sup>. |
||
* '' |
* The ''allowance for uncollectible reinsurance'' was $2.3 million at December 31, 2025, and 2024 <sup>p. 10</sup>. |
||
{{Indexing|Maximum company retention by line of business|Maximum company retention by line of business: Accident & Health, Commercial Auto, Excess Casualty, General Liability, Ocean Marine, Professional Lines, Property, Representation and Warranty, Surety, Workers’ Compensation|kind=table|order=13}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable" |
||
|+ (1){{footnote|1=Legal defense expenses can force exposure above the maximum company retention for Excess Casualty, Commercial Auto and General Liability.}} (2){{footnote|1=Reinsurance is subject to a loss ratio cap or aggregate level of loss cover that exceeds a modeled 1:250-year PML event.}} (3){{footnote|1=Catastrophe loss protection is purchased up to $36.0 million in excess of $12.0 million retention, which provides cover for a 1:250-year PML event.}} |
|||
! style="text-align:left" | Line of Business |
! style="text-align:left" | Line of Business |
||
! |
! style="text-align:left" | Maximum Company Retention |
||
|- |
|- |
||
| style="text-align:left" | Accident & Health |
| style="text-align:left" | Accident & Health |
||
| |
| style="text-align:left" | $0.90 million per occurrence |
||
|- |
|- |
||
| style="text-align:left" | Commercial Auto (1) |
| style="text-align:left" | Commercial Auto (1) |
||
| |
| style="text-align:left" | $1.00 million per occurrence |
||
|- |
|- |
||
| style="text-align:left" | Excess Casualty (1)(2) |
| style="text-align:left" | Excess Casualty (1)(2) |
||
| |
| style="text-align:left" | $2.25 million per occurrence |
||
|- |
|- |
||
| style="text-align:left" | General Liability (1) |
| style="text-align:left" | General Liability (1) |
||
| |
| style="text-align:left" | $1.50 million per occurrence |
||
|- |
|- |
||
| style="text-align:left" | Ocean Marine (2) |
| style="text-align:left" | Ocean Marine (2) |
||
| |
| style="text-align:left" | $3.00 million per occurrence |
||
|- |
|- |
||
| style="text-align:left" | Professional Lines (2) |
| style="text-align:left" | Professional Lines (2) |
||
| |
| style="text-align:left" | $5.25 million per occurrence |
||
|- |
|- |
||
| style="text-align:left" | Property (3) |
| style="text-align:left" | Property (3) |
||
| |
| style="text-align:left" | $3.50 million per occurrence |
||
|- |
|- |
||
| style="text-align:left" | Representation and Warranty |
| style="text-align:left" | Representation and Warranty |
||
| |
| style="text-align:left" | $3.25 million per occurrence |
||
|- |
|- |
||
| style="text-align:left" | Surety (2) |
| style="text-align:left" | Surety (2) |
||
| |
| style="text-align:left" | $5.00 million per occurrence |
||
|- |
|- |
||
| style="text-align:left" | Workers’ Compensation (2) |
| style="text-align:left" | Workers’ Compensation (2) |
||
| |
| style="text-align:left" | $2.33 million per occurrence |
||
|} |
|} |
||
</div> |
</div> |
||
(1) Legal defense expenses can force exposure above the maximum company retention for Excess Casualty, Commercial Auto and General Liability. |
|||
(2) Reinsurance is subject to a loss ratio cap or aggregate level of loss cover that exceeds a modeled 1:250-year PML event. |
|||
(3) Catastrophe loss protection is purchased up to $36.0 million in excess of $12.0 million retention, which provides cover for a 1:250-year PML event. |
|||
{{Indexing|Reinsurance by company|Reinsurance recoverables, AM Best ratings, eMaxx Capitves, Everest Reinsurance Co., General Reinsurance Corp, Partner Reinsurance Co. of the US, ACE (Chubb Property & Casulty Ins Company), RGA Reinsurance Company, Lloyds Syndicate 4711, Swiss Reinsurance America Corp, Lloyds Syndicate 2987, Aspen Insurance UK Limited|tc5fw176pu|kind=table|order=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable" |
||
|+ (1){{footnote|1=This reinsurer facilitates our eMaxx captive. At December 31, 2025, we held collateral in a statutory trust of $235.2 million on our net reinsurance recoverables.}} |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align:center" | |
! style="text-align:center" | |
||
| Line 395: | Line 604: | ||
| class="col-m" style="text-align:right" | A |
| class="col-m" style="text-align:right" | A |
||
|- |
|- |
||
| style="text-align:left" | Top 10 Total |
| style="text-align:left" | '''Top 10 Total''' |
||
| class="col-m" style="text-align:right" | 661,130 |
| class="col-m" style="text-align:right" | '''661,130''' |
||
| class="col-m" style="text-align:right" | — |
| class="col-m" style="text-align:right" | — |
||
|- |
|- |
||
| Line 403: | Line 612: | ||
| class="col-m" style="text-align:right" | — |
| class="col-m" style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total''' |
||
| class="col-m" style="text-align:right |
| class="col-m" style="text-align:right" | '''1,119,880''' |
||
| class="col-m" style="text-align:right |
| class="col-m" style="text-align:right" | '''—''' |
||
|} |
|} |
||
</div> |
</div> |
||
(1) This reinsurer facilitates our eMaxx captive. At December 31, 2025, we held collateral in a statutory trust of $235.2 million on our net reinsurance recoverables. |
|||
'''Enterprise Risk Management''' |
|||
{{Indexing|Enterprise Risk Management|Enterprise Risk Management (ERM), underwriting, asset portfolio construction, liability duration, market cyclicality, reinsurance, investment strategy, Economic Capital Model (ECM), risk tolerances, risk register, top 10 risks, operational processes and controls|w8ma8usdpx|d00txlz1as|kind=prose|order=15|f1=ERM oversight|v1=SVP, CFO & Head of ERM - US Operations|f2=ERM Committee|v2=Cross-functional corporate ERM Committee|f3=Risk tolerances review|v3=Annually by ERM Committee, discussed with Risk Committee of the Board of Directors|f4=Top 10 risks review|v4=Quarterly}} |
|||
* ''Enterprise Risk Management (ERM)'' is embedded in nearly every aspect of the company and guides day-to-day activities <sup>p. 11</sup>. |
|||
* The ''ERM approach'' aims to achieve an acceptable risk-adjusted return for shareholders while maintaining trust and reliability for those served <sup>p. 11</sup>. |
|||
* |
* ''ERM'' is embedded in nearly every aspect of the company and guides day-to-day activities <sup>p. 11</sup>. |
||
* ''ERM approach'' aims to ensure an acceptable risk-adjusted return for shareholders while maintaining trust and reliability for those served <sup>p. 11</sup>. |
|||
* ''Underwriting and asset portfolio construction'' are intentional <sup>p. 11</sup>. |
|||
* ''Liability duration and market cyclicality'' of the underwriting portfolio are balanced <sup>p. 11</sup>. |
* ''Liability duration and market cyclicality'' of the underwriting portfolio are balanced <sup>p. 11</sup>. |
||
* ''Reinsurance'' is used to manage volatility outside of risk tolerances <sup>p. 11</sup>. |
* ''Reinsurance'' is used to manage volatility outside of risk tolerances <sup>p. 11</sup>. |
||
* |
* ''Investment strategy'' targets a diversified portfolio that balances yield, liquidity, volatility, and potential for principal loss <sup>p. 11</sup>. |
||
* |
* ''SVP, CFO & Head of ERM - US Operations'' oversees critical ERM processes and chairs the cross-functional corporate ERM Committee <sup>p. 11</sup>. |
||
* |
* ''Economic Capital Model (ECM)'' formalizes the company's view of risk and solvency in terms of potential economic loss <sup>p. 11</sup>. |
||
* ''ECM output'' measures potential earnings and capital loss for various scenarios <sup>p. 11</sup>. |
* ''ECM output'' measures potential earnings and capital loss for various scenarios <sup>p. 11</sup>. |
||
* |
* ''Risk tolerances'' are set and updated annually by the ERM Committee and discussed with the Risk Committee of the Board of Directors <sup>p. 11</sup>. |
||
* |
* ''ECM'' provides a probabilistic modeled view of earnings and capital loss, integrating potential losses from catastrophes, reserving, underwriting, market, credit risk, strategic, and operational risks <sup>p. 11</sup>. |
||
* |
* ''SVP, CFO & Head of ERM'' works with the ERM Committee to review and maintain a comprehensive risk register with accountabilities for mitigations <sup>p. 11</sup>. |
||
* |
* ''Top 10 risks'' are identified, quantified by the SVP, CFO & Head of ERM and ERM Committee, and reviewed quarterly <sup>p. 11</sup>. |
||
* |
* ''Reports'' on top risks are submitted to the Risk Committee regularly by the SVP, CFO & Head of ERM and the ERM Committee <sup>p. 11</sup>. |
||
* ''Operational processes and controls'' are constructed to identify, assess, and manage key risks |
* ''Operational processes and controls'' are constructed to identify, assess, and manage key risks continuously <sup>p. 11</sup>. |
||
* |
* ''Underwriting Committee'' oversees changes in risk appetite, product line, and division expansion <sup>p. 11</sup>. |
||
* ''Claims |
* ''Claims department'' monitors handling practices against guidelines via regular internal audits, conducts monthly large loss reviews, and maintains a watchlist for potential high severity claims <sup>p. 11</sup>. |
||
* ''Actuarial performs quarterly reserve studies |
* ''Actuarial department'' performs quarterly reserve studies <sup>p. 11</sup>. |
||
* '' |
* ''Reserve Committee'' meets quarterly to review and respond to trends in loss emergence <sup>p. 11</sup>. |
||
* ''Key observations'' from the Reserve Committee are discussed with the CEO <sup>p. 11</sup>. |
|||
* ''Underwriting divisions'' assess rate change and retention on existing business, new business quality and pricing adequacy, and loss emergence compared to expectations on a monthly and quarterly basis <sup>p. 11</sup>. |
|||
* ''Underwriting divisions'' assess rate change and retention on existing business, new business quality, pricing adequacy, and loss emergence compared to expectations on a monthly and quarterly basis <sup>p. 11</sup>. |
|||
* The ''SkyBI platform'' provides real-time portfolio, underwriting, claims, and actuarial analytics <sup>p. 11</sup>. |
|||
* '' |
* ''SkyBI platform'' provides real-time portfolio, underwriting, claims, and actuarial analytics <sup>p. 11</sup>. |
||
* ''ERM'' is central to decision-making and daily activities <sup>p. 11</sup>. |
|||
* ''ERM'' is a central component of the strategy to achieve market-leading risk-adjusted returns for shareholders and reinforce a culture of accountability, transparency, and sound judgment <sup>p. 11</sup>. |
* ''ERM'' is a central component of the strategy to achieve market-leading risk-adjusted returns for shareholders and reinforce a culture of accountability, transparency, and sound judgment <sup>p. 11</sup>. |
||
{{Indexing|Reserves|Reserves, claims incurred and reported, IBNR reserves, uncollectible reinsurance, case reserve, actuarial reserving techniques, loss reserves|rmmhubj8mh|e40m7ou132|kind=prose|order=16|f1=Reserves not discounted|v1=True}} |
|||
'''Reserves''' |
|||
* |
* Reserves are maintained for specific claims incurred and reported, IBNR reserves, and uncollectible reinsurance <sup>p. 12</sup>. |
||
* The ultimate liability may differ from current reserves, and there is a risk of inadequate reserves in the insurance industry <sup>p. 12</sup>. |
* The ultimate liability may differ from current reserves, and there is a risk of inadequate reserves in the insurance industry <sup>p. 12</sup>. |
||
* Reserves are continually monitored using new information on reported claims and statistical analyses <sup>p. 12</sup>. |
* Reserves are continually monitored using new information on reported claims and statistical analyses <sup>p. 12</sup>. |
||
* Anticipated inflation is implicitly reflected in the reserving process through |
* Anticipated inflation is implicitly reflected in the reserving process through cost trend analysis and historical development review <sup>p. 12</sup>. |
||
* |
* Reserves for losses and LAE are not discounted to reflect estimated present value <sup>p. 12</sup>. |
||
* |
* Upon claim reporting, a ''case reserve'' is established for the estimated ultimate payment after assessing coverage, damages, and investigation <sup>p. 12</sup>. |
||
* Case reserve estimates are based on reserving practices and the claims adjuster's experience and knowledge of the claim type and value <sup>p. 12</sup>. |
* Case reserve estimates are based on reserving practices and the claims adjuster's experience and knowledge of the claim type and value <sup>p. 12</sup>. |
||
* Case reserves are revised periodically based on subsequent developments <sup>p. 12</sup>. |
* Case reserves are revised periodically based on subsequent developments for each claim <sup>p. 12</sup>. |
||
* ''IBNR reserves'' are established for estimated future loss payments on incurred but not yet reported claims, and potential development on reported claims <sup>p. 12</sup>. |
* ''IBNR reserves'' are established for the estimated amount of future loss payments on incurred but not yet reported claims, and for potential development on reported claims <sup>p. 12</sup>. |
||
* IBNR reserves are estimated using generally accepted actuarial reserving techniques that consider quantitative loss experience data and qualitative factors <sup>p. 12</sup>. |
* IBNR reserves are estimated using generally accepted actuarial reserving techniques that consider quantitative loss experience data and qualitative factors <sup>p. 12</sup>. |
||
* Loss reserves are regularly reviewed using various actuarial techniques <sup>p. 12</sup>. |
* Loss reserves are regularly reviewed using various actuarial techniques <sup>p. 12</sup>. |
||
| Line 452: | Line 664: | ||
* Additional information on loss reserves is available in Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations - “Results of Operations - Losses and LAE” and “Critical Accounting Policies” <sup>p. 12</sup>. |
* Additional information on loss reserves is available in Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations - “Results of Operations - Losses and LAE” and “Critical Accounting Policies” <sup>p. 12</sup>. |
||
{{Indexing|Investments|Investment portfolio, Enterprise Based Asset Allocation model, Economic Capital Model, investment risk, cash, cash equivalents, investment-grade fixed-maturity securities, Investment Committee of the Board of Directors|966xer0dpm|kind=prose|order=17|f1=Investment allocation strategy|v1=Enterprise Based Asset Allocation model|f2=Investment portfolio composition|v2=Cash, cash equivalents, investment-grade fixed-maturity securities|f3=Investment policy approval|v3=Investment Committee of the Board of Directors}} |
|||
'''Investments''' |
|||
* The company aims to maintain a balanced investment portfolio primarily consisting of investments |
* The company aims to maintain a balanced investment portfolio primarily consisting of investments that provide predictable and stable returns <sup>p. 13</sup>. |
||
* |
* The portfolio is augmented by strategic investments chosen for attractive risk-adjusted returns <sup>p. 13</sup>. |
||
* The investment allocation strategy uses an Enterprise Based Asset Allocation model <sup>p. 13</sup>. |
|||
* This model is integrated into the Economic Capital Model (as discussed in the ERM section of Item 1) to assess the impact of investment allocation decisions on capital, liquidity, and risk profile across various market scenarios <sup>p. 13</sup>. |
|||
* This model is integrated into the Economic Capital Model, as discussed in Item 1 (ERM discussion) <sup>p. 13</sup>. |
|||
* The company actively manages and monitors investment risk to balance stable growth and liquidity with compliance requirements of insurance regulatory and rating agency frameworks <sup>p. 13</sup>. |
|||
* The model helps understand the impact of investment allocation decisions on capital, liquidity, and risk profile across various market scenarios <sup>p. 13</sup>. |
|||
* The investment portfolio mainly comprises cash and cash equivalents and investment-grade fixed-maturity securities, with additional investments fitting the company's risk appetite <sup>p. 13</sup>. |
|||
* The company actively manages and monitors investment risk to balance stable growth and liquidity with compliance to insurance regulatory and rating agency frameworks <sup>p. 13</sup>. |
|||
* The portfolio mainly consists of cash and cash equivalents and investment-grade fixed-maturity securities <sup>p. 13</sup>. |
|||
* Additional investments are included if they fit the company's risk appetite <sup>p. 13</sup>. |
|||
* The Investment Committee of the Board of Directors reviews and approves the investment policy and strategy <sup>p. 13</sup>. |
* The Investment Committee of the Board of Directors reviews and approves the investment policy and strategy <sup>p. 13</sup>. |
||
* This committee meets quarterly to review investment activities, tactics, and new investment opportunities <sup>p. 13</sup>. |
* This committee meets quarterly to review investment activities, tactics, and new investment opportunities <sup>p. 13</sup>. |
||
* The portfolio is directed internally and includes both self-managed investments and portfolios managed by select third-party investment management firms <sup>p. 13</sup>. |
* The portfolio is directed internally and includes both self-managed investments and portfolios managed by select third-party investment management firms <sup>p. 13</sup>. |
||
* For further discussion on investments |
* For further discussion on investments, including market risks, refer to Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations—Investments" <sup>p. 13</sup>. |
||
{{Indexing|Competition|Specialty lines property & casualty insurance market, underwriting divisions, specialty insurers, standard insurers, program administrators|c6zoq3weio|kind=prose|order=18|f1=Key competitors|v1=Markel Corporation, W.R. Berkley Corporation, American Financial Group Inc., Tokio Marine Holdings, Inc., CNA Financial Corporation, Hiscox, Ltd., RLI Corp., Intact Finance Corporation, Kinsale Capital Group, Inc., Arch Capital Group, AXIS Capital Holdings, Ltd.}} |
|||
'''Competition''' |
|||
* The specialty lines property & casualty insurance market |
* The specialty lines property & casualty insurance market comprises numerous markets and sub-markets <sup>p. 14</sup>. |
||
* |
* Each market has distinct customer needs, products, services, and specific economic and structural features <sup>p. 14</sup>. |
||
* Competition in underwriting divisions comes from other specialty and standard insurers, as well as program administrators <sup>p. 14</sup>. |
|||
* Competition is based on factors such as pricing, general reputation, perceived financial strength, broker relationships, product terms and conditions, independent rating agency ratings, speed and reputation of claims payment, and the experience and reputation of underwriting and claims teams <sup>p. 14</sup>. |
|||
* Competition factors include pricing, general reputation, perceived financial strength, broker relationships, product terms and conditions, independent rating agency ratings, speed and reputation of claims payment, and the experience and reputation of underwriting and claims teams <sup>p. 14</sup>. |
|||
* Due to the diversity of underwriting divisions, competition is broad, with some competitors specific to only a subset of divisions <sup>p. 14</sup>. |
* Due to the diversity of underwriting divisions, competition is broad, with some competitors specific to only a subset of divisions <sup>p. 14</sup>. |
||
* Notable competitors include Markel Corporation, W.R. Berkley Corporation, American Financial Group Inc., Tokio Marine Holdings, Inc., CNA Financial Corporation, Hiscox, Ltd., RLI Corp., Intact Finance Corporation, Kinsale Capital Group, Inc., Arch Capital Group, and AXIS Capital Holdings, Ltd. <sup>p. 14</sup>. |
* Notable competitors include Markel Corporation, W.R. Berkley Corporation, American Financial Group Inc., Tokio Marine Holdings, Inc., CNA Financial Corporation, Hiscox, Ltd., RLI Corp., Intact Finance Corporation, Kinsale Capital Group, Inc., Arch Capital Group, and AXIS Capital Holdings, Ltd. <sup>p. 14</sup>. |
||
{{Indexing|Our Structure|Great Midwest Insurance Company (GMIC), Houston Specialty Company (HSIC), Imperium Insurance Company (IIC), Oklahoma Specialty Insurance Company (OSIC), Skyward Re, Skyward Underwriters Agency, Inc., Skyward Service Company, Skyward Specialty No. 1 Limited Company|cmtswfs0go|kind=prose|order=19|f1=Legal name|v1=Skyward Specialty Insurance Group, Inc.|f2=Holding-company structure|v2=Insurance holding company system|f3=State of incorporation|v3=Delaware}} |
|||
'''Our Structure''' |
|||
* Operations are conducted principally through four insurance companies <sup>p. 15</sup>. |
* Operations are conducted principally through four insurance companies: Great Midwest Insurance Company (GMIC), Houston Specialty Company (HSIC), Imperium Insurance Company (IIC), and Oklahoma Specialty Insurance Company (OSIC) <sup>p. 15</sup>. |
||
* '' |
* ''GMIC'', the largest insurance subsidiary, underwrites multiple lines of insurance on an admitted basis in all 50 states and the District of Columbia <sup>p. 15</sup>. |
||
* GMIC is a certified surety bond company listed with the Department of the Treasury <sup>p. 15</sup>. |
* GMIC is a certified surety bond company listed with the Department of the Treasury <sup>p. 15</sup>. |
||
* '' |
* ''HSIC'', a subsidiary of GMIC, underwrites multiple lines of insurance on a surplus lines basis in 50 states, the District of Columbia, and select foreign countries <sup>p. 15</sup>. |
||
* '' |
* ''IIC'', a subsidiary of HSIC, underwrites on an admitted basis in all 50 states and the District of Columbia <sup>p. 15</sup>. |
||
* '' |
* ''OSIC'', a subsidiary of IIC, is an approved surplus lines company in 49 states and the District of Columbia <sup>p. 15</sup>. |
||
* Effective December 31, 2024, the insurance company subsidiaries were restacked into the |
* Effective December 31, 2024, the insurance company subsidiaries were restacked into the current organizational structure <sup>p. 15</sup>. |
||
* This restacking |
* This restacking provided the growing surety business with the capital needed to operate more effectively within the surety T-listing market <sup>p. 15</sup>. |
||
* ''Skyward Re'' is a wholly-owned captive reinsurance company domiciled in the Cayman Islands |
* ''Skyward Re'' is a wholly-owned captive reinsurance company domiciled in the Cayman Islands <sup>p. 15</sup>. |
||
* Skyward Re was incorporated on January 7, 2020 <sup>p. 15</sup>. |
|||
* Skyward Re was established to facilitate the LPT, which was commuted effective January 31, 2025 <sup>p. 15</sup>. |
* Skyward Re was established to facilitate the LPT, which was commuted effective January 31, 2025 <sup>p. 15</sup>. |
||
* Three non-insurance companies are also operated: |
* Three non-insurance companies are also operated: Skyward Underwriters Agency, Inc., Skyward Service Company, and Skyward Specialty No. 1 Limited Company <sup>p. 15</sup>. |
||
* ''Skyward Underwriters Agency, Inc.'' is a licensed agent, managing general agent, and reinsurance broker <sup>p. 15</sup>. |
* ''Skyward Underwriters Agency, Inc.'' is a licensed agent, managing general agent, and reinsurance broker <sup>p. 15</sup>. |
||
* ''Skyward Service Company'' provides various administrative services to the subsidiaries <sup>p. 15</sup>. |
* ''Skyward Service Company'' provides various administrative services to the subsidiaries <sup>p. 15</sup>. |
||
| Line 490: | Line 707: | ||
* The organizational structure at December 31, 2025, shows each entity is wholly-owned by its immediate parent <sup>p. 15</sup>. |
* The organizational structure at December 31, 2025, shows each entity is wholly-owned by its immediate parent <sup>p. 15</sup>. |
||
* ''Skyward Specialty Insurance Group, Inc.'' (Delaware corporation) is the parent company <sup>p. 15</sup>. |
* ''Skyward Specialty Insurance Group, Inc.'' (Delaware corporation) is the parent company <sup>p. 15</sup>. |
||
* Skyward Specialty Insurance Group, Inc. has direct relationships with |
* Skyward Specialty Insurance Group, Inc. has direct relationships with Skyward Service Company (Delaware corporation), Great Midwest Insurance Company (Texas stock insurance company), Skyward Underwriters Agency, Inc. (Texas corporation), Skyward Specialty No. 1 Limited (United Kingdom company), and Skyward Re (Cayman Islands corporation) <sup>p. 15</sup>. |
||
* ''Great Midwest Insurance Company'' has a direct relationship with |
* ''Great Midwest Insurance Company'' has a direct relationship with Houston Specialty Insurance Company (Texas stock insurance company) <sup>p. 15</sup>. |
||
* ''Houston Specialty Insurance Company'' has a direct relationship with |
* ''Houston Specialty Insurance Company'' has a direct relationship with Imperium Insurance Company (Texas stock insurance company) <sup>p. 15</sup>. |
||
* ''Imperium Insurance Company'' has a direct relationship with |
* ''Imperium Insurance Company'' has a direct relationship with Oklahoma Specialty Insurance Company (Oklahoma insurance corporation) <sup>p. 15</sup>. |
||
{{Indexing|Direct written premiums by state|Direct written premiums by state: Texas, Pennsylvania, Florida, California, New York, Louisiana, Illinois, New Jersey, Georgia, Delaware, All other states and countries|kind=table|order=20}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 533: | Line 752: | ||
| style="text-align:right" | 39.9 |
| style="text-align:right" | 39.9 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right |
| style="text-align:right" | '''100.0%''' |
||
|} |
|} |
||
</div> |
</div> |
||
| Line 540: | Line 759: | ||
[[File:Skyward-2025-FY-Annual report-skwd-20251231_g1.jpg|thumb|Our Structure]] |
[[File:Skyward-2025-FY-Annual report-skwd-20251231_g1.jpg|thumb|Our Structure]] |
||
{{Indexing|Ratings|Skyward Specialty Insurance Group, Inc., A.M. Best, insurance companies, policyholders|u6q0bi3ei3|kind=prose|order=21|f1=Financial strength rating|v1=A (Excellent)|f2=Rating outlook|v2=Stable|f3=Rating agencies|v3=A.M. Best}} |
|||
'''Ratings''' |
|||
* Skyward Specialty Insurance Group, Inc. |
* ''Skyward Specialty Insurance Group, Inc.'' has an "A" (Excellent) rating with a stable outlook from A.M. Best <sup>p. 16</sup>. |
||
* |
* ''A.M. Best'' rates insurance companies based on factors relevant to policyholders <sup>p. 16</sup>. |
||
* A.M. Best assigns |
* ''A.M. Best'' assigns 13 ratings, ranging from "A++" (Superior) to "D" (Poor) <sup>p. 16</sup>. |
||
* The ''"A" (Excellent) rating'' is the third highest rating |
* The ''"A" (Excellent) rating'' is the third highest rating assigned by A.M. Best <sup>p. 16</sup>. |
||
* ''A.M. Best's evaluation'' includes profitability, leverage, liquidity, book of business, reinsurance adequacy, asset quality and market value, adequacy of losses and loss expense reserves, surplus adequacy, capital structure, management experience and competence, and market presence <sup>p. 16</sup>. |
|||
* A.M. Best evaluates a company's financial and operating performance by reviewing its ''profitability, leverage, and liquidity'' <sup>p. 16</sup>. |
|||
* ''A.M. Best's ratings'' reflect its opinion on an insurance company’s financial strength, operating performance, and ability to meet policyholder obligations <sup>p. 16</sup>. |
|||
* Other factors reviewed by A.M. Best include the ''book of business, reinsurance adequacy and soundness, quality and estimated market value of assets, adequacy of losses and loss expense reserves, surplus adequacy, capital structure, management experience and competence, and market presence'' <sup>p. 16</sup>. |
|||
* |
* ''Ratings'' are based on factors relevant to policyholders, agents, insurance brokers, and intermediaries, and are not specifically related to securities issued by the company <sup>p. 16</sup>. |
||
* These ratings are based on factors relevant to ''policyholders, agents, insurance brokers, and intermediaries'', and are not specifically related to securities issued by the company <sup>p. 16</sup>. |
|||
{{Indexing|Regulation|Insurance regulatory authorities, state insurance laws and regulations, capital and surplus requirements, licensing, product forms and rates, reserve adequacy, statutory accounting methods, transactions with affiliates, investments, National Association of Insurance Commissioners (NAIC), federal government|1nma8v7gjs|kind=prose|order=22|f1=Primary regulators|v1=State insurance regulatory authorities|f2=Holding company regulation|v2=Texas}} |
|||
'''Regulation''' |
|||
* The company is regulated by insurance regulatory authorities in the states where it conducts business <sup>p. 17</sup>. |
|||
* State insurance laws and regulations primarily protect policyholders, consumers, and claimants, not stockholders or other investors <sup>p. 17</sup>. |
|||
* The nature and extent of state regulation varies by jurisdiction <sup>p. 17</sup>. |
|||
* State insurance regulators have broad administrative power over: |
|||
** Setting capital and surplus requirements <sup>p. 17</sup>. |
|||
** Licensing of insurers and insurance producers <sup>p. 17</sup>. |
|||
** Review and approval of product forms and rates <sup>p. 17</sup>. |
|||
** Establishing standards for reserve adequacy <sup>p. 17</sup>. |
|||
** Prescribing statutory accounting methods and the form/content of statutory financial reports <sup>p. 17</sup>. |
|||
** Regulating certain transactions with affiliates <sup>p. 17</sup>. |
|||
** Prescribing types and amounts of investments <sup>p. 17</sup>. |
|||
* Insurance company regulation is constantly changing due to governmental agency and legislative reactions to issues <sup>p. 17</sup>. |
|||
* Some state legislatures have considered or enacted laws that increase state authority to regulate insurance companies and holding company systems, often as a protection against federal involvement <sup>p. 17</sup>. |
|||
* The National Association of Insurance Commissioners (NAIC) and some state insurance regulators are re-examining existing laws and regulations, focusing on insurer solvency, interpretations of laws, and development of new laws <sup>p. 17</sup>. |
|||
* The federal government does not directly regulate the business of insurance, but federal initiatives affect the industry through treatment of federal subsidiaries, regulation of quasi-governmental entities, and regulations from federal departments <sup>p. 17</sup>. |
|||
* The company operates as an insurance holding company system <sup>p. 17</sup>. |
* The company operates as an insurance holding company system <sup>p. 17</sup>. |
||
* The company is subject to insurance holding company laws in Texas and Oklahoma <sup>p. 17</sup>. |
* The company is subject to insurance holding company laws in Texas, where its primary insurance companies are domiciled, and Oklahoma <sup>p. 17</sup>. |
||
* |
* These statutes require each insurance company in the system to register with the insurance department of its state of domicile <sup>p. 17</sup>. |
||
* Registration involves furnishing information about operations within the holding company system that could materially affect the operations, management, or financial condition of domiciled insurers <sup>p. 17</sup>. |
|||
* ''State regulation'' varies by jurisdiction and grants broad administrative power to regulators <sup>p. 17</sup>. |
|||
* All transactions among members of a holding company system must be fair and reasonable <sup>p. 17</sup>. |
|||
* ''Regulatory powers'' include setting capital and surplus requirements, licensing, product and rate approval, reserve adequacy standards, accounting methods, financial reporting, affiliate transaction regulation, and investment types/amounts <sup>p. 17</sup>. |
|||
* ''Insurance regulation'' is constantly changing due to governmental agency and legislative reactions to issues <sup>p. 17</sup>. |
|||
* Some state legislatures have considered or enacted laws that increase state authority over insurance companies and holding company systems to prevent federal involvement <sup>p. 17</sup>. |
|||
* The ''NAIC'' and some state insurance regulators are re-examining existing laws and regulations, focusing on solvency, interpretations, and new law development <sup>p. 17</sup>. |
|||
* The ''federal government'' does not directly regulate insurance but federal initiatives affect the industry through treatment of federal subsidiaries, regulation of quasi-governmental entities, and regulations from federal departments <sup>p. 17</sup>. |
|||
* ''Insurance holding company laws'' require each insurance company in the system to register with the insurance department of its state of domicile <sup>p. 17</sup>. |
|||
* Registered companies must provide information on holding company system operations that could materially affect the domiciled insurers' operations, management, or financial condition <sup>p. 17</sup>. |
|||
* All transactions among holding company system members must be fair and reasonable <sup>p. 17</sup>. |
|||
* Transactions between insurance subsidiaries and their parents/affiliates generally require disclosure to state regulators <sup>p. 17</sup>. |
* Transactions between insurance subsidiaries and their parents/affiliates generally require disclosure to state regulators <sup>p. 17</sup>. |
||
* Notice to or prior approval from the applicable state insurance regulator is generally required for material or extraordinary |
* Notice to or prior approval from the applicable state insurance regulator is generally required for any material or extraordinary transaction <sup>p. 17</sup>. |
||
{{Indexing|Intellectual Property|Trademark registrations, intellectual property protection, trademarks, service marks|nd7yoiixiy|kind=prose|order=23}} |
|||
'''Intellectual Property''' |
|||
* The company has applied for various ''trademark registrations'' in the United States at both federal and state levels <sup>p. 18</sup>. |
* The company has applied for various ''trademark registrations'' in the United States at both federal and state levels <sup>p. 18</sup>. |
||
* The company plans to pursue additional ''trademark registrations'' and other intellectual property protection if deemed beneficial and cost-effective <sup>p. 18</sup>. |
* The company plans to pursue additional ''trademark registrations'' and other intellectual property protection if deemed beneficial and cost-effective <sup>p. 18</sup>. |
||
* The company monitors its ''trademarks and service marks'' and protects them from unauthorized use as necessary <sup>p. 18</sup>. |
|||
{{Indexing|Employees and Human Capital|Employees, collective bargaining agreement, diversity, talent, employee benefits, medical, dental, vision insurance, 401(k) plan, paid time off, family leave, employee assistance programs, employee stock purchase plan, employee training and development|v84q3tomll|kind=prose|order=24|f1=Employees|v1=611 as of December 31, 2025|f2=Collective bargaining agreement|v2=None}} |
|||
'''Employees and Human Capital''' |
|||
* As of ''December 31, 2025'', the company had approximately ''611 employees'' <sup>p. 19</sup>. |
* As of ''December 31, 2025'', the company had approximately ''611 employees'' <sup>p. 19</sup>. |
||
* Employees are not subject to any collective bargaining agreement, and no current efforts to implement such an agreement |
* Employees are not subject to any collective bargaining agreement, and there are no known current efforts to implement such an agreement <sup>p. 19</sup>. |
||
* The company believes it has good working relations with its employees <sup>p. 19</sup>. |
* The company believes it has good working relations with its employees <sup>p. 19</sup>. |
||
* The company aims to be an employer of choice, |
* The company aims to be an employer of choice, fostering a culture committed to diversity of thought, background, and perspective <sup>p. 19</sup>. |
||
* The company strives to |
* The company strives to cultivate an exceptional workforce to perpetuate its ownership culture and achieve superior business results <sup>p. 19</sup>. |
||
* The company |
* The company's goal is to attract, develop, and retain diverse talent, promoting a culture where different viewpoints are valued, and individuals feel respected, treated fairly, and have opportunities to excel <sup>p. 19</sup>. |
||
* The company |
* The company offers a competitive benefits package including medical, dental, and vision insurance, a 401(k) plan, paid time off, family leave, employee assistance programs, and an employee stock purchase plan <sup>p. 19</sup>. |
||
* The company offers a competitive benefits package including medical, dental, and vision insurance, a 401(k) plan, paid time off, family leave, employee assistance programs, and an employee stock purchase plan available to all employees <sup>p. 19</sup>. |
|||
* The company emphasizes employee training and development, providing opportunities for further education and professional development <sup>p. 19</sup>. |
* The company emphasizes employee training and development, providing opportunities for further education and professional development <sup>p. 19</sup>. |
||
== Risk Factors == |
== Risk Factors == |
||
* Investing in the company's common stock |
* Investing in the company's common stock carries a high degree of risk <sup>p. 20</sup>. |
||
* Investors should carefully consider the risks and uncertainties described in the report, including consolidated financial statements and related notes, and other SEC filings, before investing <sup>p. 20</sup>. |
* Investors should carefully consider the risks and uncertainties described in the report, including consolidated financial statements and related notes, and other SEC filings, before investing <sup>p. 20</sup>. |
||
* The |
* The listed risks and uncertainties are not exhaustive; additional unstated, unknown, or currently immaterial risks may also affect the company <sup>p. 20</sup>. |
||
* |
* The occurrence of any identified risk could materially harm the company's business, operating results, financial condition, and prospects <sup>p. 20</sup>. |
||
* Such events could lead to a decline in |
* Such events could lead to a decline in the common stock price, potentially resulting in a loss of part or all of an investment <sup>p. 20</sup>. |
||
{{Indexing|Summary of Material Risk Factors|Underwriting risk, competition, distribution channels, third-party reinsurance, loss and loss expense reserves, financial strength rating, coverage interpretation, reinsurer claims, claim payment, adverse economic factors, insurance cyclicality, regulation|w8ma8usdpx|gva2857foa|m0cjxgvmvi|81oaprhocb|nad00g0zfb|kind=prose|order=25}} |
|||
'''Summary of Material Risk Factors''' |
|||
* ''Financial condition and results of operations'' could be materially adversely affected |
* ''Financial condition and results of operations'' could be materially adversely affected by inaccurate assessment of underwriting risk <sup>p. 21</sup>. |
||
* ''Competition'' |
* ''Competition'' in the industry is intense <sup>p. 21</sup>. |
||
* ''Reliance on distribution channels'' |
* ''Reliance on distribution channels'' (insurance retail agents and brokers, wholesalers, program administrators) exposes the business to certain risks <sup>p. 21</sup>. |
||
* ''Inability to purchase third-party reinsurance'' |
* ''Inability to purchase third-party reinsurance'' on commercially acceptable terms or terms that adequately protect the company may materially adversely affect business, financial condition, and results of operations <sup>p. 21</sup>. |
||
* ''Losses and loss expense reserves'' may be inadequate to cover actual losses, |
* ''Losses and loss expense reserves'' may be inadequate to cover actual losses, materially adversely affecting financial condition, results of operations, and cash flows <sup>p. 21</sup>. |
||
* ''Decline in financial strength rating'' may adversely affect the amount of business written <sup>p. 21</sup>. |
* ''Decline in financial strength rating'' may adversely affect the amount of business written <sup>p. 21</sup>. |
||
* ''Unexpected changes in interpretation of coverage or provisions'' |
* ''Unexpected changes in interpretation of coverage or provisions'' (including loss limitations and exclusions) in policies could materially adversely affect financial condition and results of operations <sup>p. 21</sup>. |
||
* ''Reinsurers may not reimburse claims'' on a timely basis |
* ''Reinsurers may not reimburse claims'' on a timely basis or at all, which may materially adversely affect business, financial condition, and results of operations <sup>p. 21</sup>. |
||
* ''Failure to accurately and timely pay claims'' could materially and adversely affect business, financial condition, results of operations, and prospects <sup>p. 21</sup>. |
* ''Failure to accurately and timely pay claims'' could materially and adversely affect business, financial condition, results of operations, and prospects <sup>p. 21</sup>. |
||
* ''Adverse economic factors'' |
* ''Adverse economic factors'' (recession, inflation, high unemployment, lower economic activity) could lead to fewer policy sales, increased claim frequency, premium defaults, or falsification of claims, impacting growth and profitability <sup>p. 21</sup>. |
||
* '' |
* ''Insurance business is cyclical'', which may affect financial performance and cause operating results to vary quarter-to-quarter, not indicative of future performance <sup>p. 21</sup>. |
||
* ''Extensive regulation'' may adversely affect the ability to achieve business objectives; non-compliance could |
* ''Extensive regulation'' may adversely affect the ability to achieve business objectives; non-compliance could result in penalties (fines, suspensions) adversely affecting financial condition and results of operations <sup>p. 21</sup>. |
||
* ''Loss of |
* ''Loss of key personnel'' or inability to attract and retain qualified personnel could adversely affect the company <sup>p. 21</sup>. |
||
* ''Failure to achieve and maintain effective internal controls'' could impact operating results and financial condition, and negatively affect the market price of common stock <sup>p. 21</sup>. |
* ''Failure to achieve and maintain effective internal controls'' could impact operating results and financial condition, and negatively affect the market price of common stock <sup>p. 21</sup>. |
||
* ''Costs will increase significantly'' |
* ''Costs will increase significantly'' as a public company, requiring substantial management time for compliance <sup>p. 21</sup>. |
||
* ''Use of derivatives'' to mitigate market price volatility exposure may subject the company to risks such as hedge ineffectiveness, basis risk, collateral and margin call liquidity pressures, and valuation uncertainty, |
* ''Use of derivatives'' to mitigate market price volatility exposure may subject the company to risks such as hedge ineffectiveness, basis risk, collateral and margin call liquidity pressures, and valuation uncertainty, which could adversely affect financial condition <sup>p. 21</sup>. |
||
* ''Integration of Apollo'' may present unforeseen challenges, including difficulties |
* ''Integration of Apollo'' may present unforeseen challenges, including difficulties with technology systems, business processes, and risk management frameworks, potentially causing operational disruptions, increased costs, or delays in realizing anticipated strategic benefits <sup>p. 21</sup>. |
||
{{Indexing|Risks Related to Our Business and Industry|Underwriting risk, competition, distribution channels, retail agents, brokers, wholesalers, program administrators|w8ma8usdpx|gva2857foa|c6zoq3weio|la5wuhtx31|kind=prose|order=26}} |
|||
'''Risks Related to Our Business and Industry''' |
|||
* The company's financial condition and results of operations could be materially adversely affected if it does not accurately assess its underwriting risk <sup>p. 22</sup>. |
|||
* ''Underwriting success'' depends on accurately assessing risks and establishing appropriate premium rates <sup>p. 22</sup>. |
|||
* |
* Underwriting success depends on accurately assessing risks and establishing appropriate premium rates, relying on the experience of underwriting staff <sup>p. 22</sup>. |
||
* Employee decisions, including management and underwriters, |
* Employee decisions, including management and underwriters, in the ordinary course of business involve exposing the company to risk <sup>p. 22</sup>. |
||
* |
* Competition in the insurance industry is intense, coming from other specialty insurance companies, standard insurance companies, and underwriting agencies <sup>p. 22</sup>. |
||
* Competition factors include price, reputation, perceived financial strength, distribution partner relationships, product terms, independent rating agency ratings, claims payment speed, and the experience of the underwriting team <sup>p. 22</sup>. |
|||
* ''Increased consolidation'' in the insurance industry may further intensify competition <sup>p. 22</sup>. |
|||
* Increasing consolidation in the insurance industry may further intensify competition <sup>p. 22</sup>. |
|||
* New industry or legislative developments could also increase competition <sup>p. 22</sup>. |
* New industry or legislative developments could also increase competition <sup>p. 22</sup>. |
||
* Inability to compete successfully could |
* Inability to compete successfully could change supply and demand for insurance, affect pricing at risk-adequate rates, impact retention of existing business, or hinder underwriting new business on favorable terms, adversely affecting operating results <sup>p. 22</sup>. |
||
* |
* The business relies on insurance retail agents, brokers, wholesalers, and program administrators, exposing it to risks from these distribution channels <sup>p. 22</sup>. |
||
* |
* Substantially all products are distributed through independent retail agents and brokers who own "renewal rights," making the business model dependent on these relationships <sup>p. 22</sup>. |
||
* The company is also dependent on relationships wholesalers and program administrators maintain with agents and brokers <sup>p. 22</sup>. |
|||
* Relationships with distributors can be discontinued or become unprofitable <sup>p. 22</sup>. |
|||
* Relationships with retail agents, brokers, wholesalers, and program administrators can be discontinued at any time or become unprofitable <sup>p. 22</sup>. |
|||
* Consolidation of insurance distribution firms may increase their influence on commission rates and business concentration with specific brokers <sup>p. 22</sup>. |
|||
* Consolidation of insurance distribution firms may increase their influence on commission rates and concentrate business with particular brokers <sup>p. 22</sup>. |
|||
* ''Credit risk'' is assumed from brokers who collect premiums directly from policyholders but may not remit them to the company <sup>p. 22</sup>. |
|||
* |
* Premiums collected by brokers from policyholders, in certain jurisdictions, may be considered paid to the company even if not remitted, exposing the company to credit risk <sup>p. 22</sup>. |
||
* |
* Failure by brokers to remit premiums has not been material to date, but the company may be required to provide coverage despite unpaid premiums <sup>p. 22</sup>. |
||
* Limitations on the ability to cancel policies for non-payment could reduce underwriting profits and adversely affect financial condition and results <sup>p. 22</sup>. |
|||
* The company reviews the ''financial condition of new brokers'' and periodically reviews existing distributors for profitability and alignment with business objectives <sup>p. 22</sup>. |
|||
* |
* The company reviews the financial condition of potential new brokers and periodically reviews existing distributors against profitability standards and business objectives <sup>p. 22</sup>. |
||
* Following reviews, the company may restrict distributor access to products or terminate relationships, subject to contractual and regulatory requirements <sup>p. 22</sup>. |
|||
* Deterioration in distributor relationships or uncompetitive compensation could lead distributors to place more premium with other carriers <sup>p. 22</sup>. |
* Deterioration in distributor relationships or uncompetitive compensation could lead distributors to place more premium with other carriers <sup>p. 22</sup>. |
||
* Distributors exceeding authority, failing to transfer collected premiums, or breaching obligations could expose the company to liability <sup>p. 22</sup>. |
* Distributors exceeding granted authority, failing to transfer collected premiums, or breaching obligations could expose the company to liability <sup>p. 22</sup>. |
||
* Continued or increased |
* Continued or increased consolidation of insurance distribution firms could materially affect sales channels, potentially leading to loss of market access or share <sup>p. 22</sup>. |
||
* |
* Loss of talent knowledgeable about products or increased commission costs due to larger distributors gaining negotiating leverage could negatively impact the company <sup>p. 22</sup>. |
||
* |
* Accelerated digitization exposes the company to risks related to distributors' ability to keep pace, as customers may prefer technology-driven distributors <sup>p. 22</sup>. |
||
* Inability to purchase |
* Inability to purchase third-party reinsurance in desired amounts or on acceptable terms could materially adversely affect the business <sup>p. 22</sup>. |
||
* Reinsurance |
* Reinsurance is strategically purchased to protect capital from severity events and reduce earnings volatility <sup>p. 22</sup>. |
||
* Failure to renew expiring contracts, enter new arrangements, or expand coverage could increase loss exposure <sup>p. 22</sup>. |
* Failure to renew expiring contracts, enter new arrangements, or expand coverage could increase loss exposure, potentially requiring a reduction in underwriting commitments <sup>p. 22</sup>. |
||
* Reinsurers may exclude certain coverages or alter terms in contracts, leading to gaps in reinsurance protection and greater potential losses for the company <sup>p. 22</sup>. |
|||
* Increased loss exposure could necessitate reducing underwriting commitments, adversely affecting the business <sup>p. 22</sup>. |
|||
* |
* Losses and loss expense reserves may be inadequate to cover actual losses, materially adversely affecting financial condition, results, and cash flows <sup>p. 22</sup>. |
||
* Reserves are estimates of ultimate claim settlement and administration costs, not exact calculations, and ultimate liability may differ <sup>p. 22</sup>. |
|||
* ''Losses and loss expense (LAE) reserves'' may be inadequate to cover actual losses, materially affecting financial condition, results, and cash flows <sup>p. 22</sup>. |
|||
* The reserving process reviews historical data and considers factors such as claims inflation, claims development patterns, pricing, legislative activity, social/economic patterns, and litigation/judicial/regulatory trends <sup>p. 22</sup>. |
|||
* Reserves are estimates of ultimate claim settlement and administration costs, and actual liability may differ <sup>p. 22</sup>. |
|||
* Variables affecting loss exposure are influenced by internal and external events, and loss reserves are continually monitored using new information and statistical techniques <sup>p. 22</sup>. |
|||
* The reserving process considers historical data and factors such as claims inflation, claims development patterns, pricing, legislative activity, social/economic patterns, and litigation trends <sup>p. 22</sup>. |
|||
* The process assumes past experience, adjusted for current developments and trends, predicts future events, but actual results may deviate substantially from estimates <sup>p. 22</sup>. |
|||
* Variables affecting loss exposure are influenced by internal and external events <sup>p. 22</sup>. |
|||
* Uncertainties impacting reserve adequacy include: |
|||
* The process assumes past experience, adjusted for current developments and trends, is appropriate for predicting future events, but actual results may deviate <sup>p. 22</sup>. |
|||
** Time required to fully appreciate covered loss extent, leading to increased loss estimates over time <sup>p. 22</sup>. |
|||
* ''Uncertainties impacting reserve adequacy'' include: |
|||
** |
** Retroactive enforcement of new theories of liability by courts, potentially expanding coverage <sup>p. 22</sup>. |
||
** Volatility in financial markets, economic events, and external factors increasing claim frequency/severity, and elevated inflation increasing loss costs <sup>p. 22</sup>. |
|||
** Retroactive enforcement of new theories of liability by courts <sup>p. 22</sup>. |
|||
** Adverse economic factors (recession, high unemployment) potentially reducing policy sales or increasing claim frequency/severity and premium defaults <sup>p. 22</sup>. |
|||
** Failure of loss limitations or exclusions, or changes in claims/coverage issues, could materially affect financial condition <sup>p. 22</sup>. |
|||
** |
** Increased "social inflation" costs (medical/material costs, technology in vehicles, supply chain disruptions, attorney involvement, litigation financing, lawsuit abuse) increasing claim frequency/severity and affecting reserve adequacy <sup>p. 22</sup>. |
||
** Elevated inflationary conditions would increase loss costs <sup>p. 22</sup>. |
|||
** Adverse economic factors (recession, inflation, high unemployment) could reduce policy sales or increase claim frequency/severity and premium defaults <sup>p. 22</sup>. |
|||
** Increased costs due to "social inflation" (medical/material costs, technology in vehicles, attorney involvement, litigation financing, lawsuit abuse) could increase claim frequency/severity and affect reserve adequacy <sup>p. 22</sup>. |
|||
** Increased claim frequency, even without liability, could escalate evaluation and handling costs beyond established reserves <sup>p. 22</sup>. |
** Increased claim frequency, even without liability, could escalate evaluation and handling costs beyond established reserves <sup>p. 22</sup>. |
||
** |
** Entering new lines of business or new theories of claims may lead to unanticipated increases in claim frequency and handling costs <sup>p. 22</sup>. |
||
* Inadequate reserves require |
* Inadequate reserves would require an increase in reserves, reducing net income and stockholders’ equity in the period the deficiency is identified <sup>p. 22</sup>. |
||
* Future loss experience substantially exceeding reserves could materially affect future earnings, liquidity, and financial rating <sup>p. 22</sup>. |
* Future loss experience substantially exceeding established reserves could materially adversely affect future earnings, liquidity, and financial rating <sup>p. 22</sup>. |
||
* A |
* A decline in the company's financial strength rating may adversely affect the amount of business written <sup>p. 22</sup>. |
||
* Independent ratings agencies |
* Independent ratings agencies, such as A.M. Best, are used by the insurance industry to assess financial strength <sup>p. 22</sup>. |
||
* A.M. Best's ratings |
* A.M. Best's ratings are based on quantitative and qualitative analysis of balance sheet strength, operating performance, and business profile <sup>p. 22</sup>. |
||
* |
* A.M. Best financial strength ratings range from "A++" (Superior) to "F" (liquidation) <sup>p. 22</sup>. |
||
* A.M. Best |
* As of the filing date, A.M. Best assigned the company a financial strength rating of "A" (Excellent) with a stable outlook <sup>p. 22</sup>. |
||
* A.M. Best ratings provide an independent opinion of an insurer's ability to meet policyholder obligations and are not an evaluation for investors or a recommendation to buy/sell securities <sup>p. 22</sup>. |
|||
* A.M. Best's analysis includes balance sheet strength, operating performance, business profile, comparisons to peers, operating plans, philosophy, and management <sup>p. 22</sup>. |
|||
* A.M. Best |
* A.M. Best's analysis includes peer comparisons, industry standards, operating plans, philosophy, and management assessments <sup>p. 22</sup>. |
||
* A.M. Best periodically reviews and may revise ratings downward based on balance sheet strength, operating performance, and business profile <sup>p. 22</sup>. |
|||
* Factors that could affect A.M. Best's analysis and potentially lead to a downgrade include: |
* Factors that could affect A.M. Best's analysis and potentially lead to a downgrade include: |
||
** Changes in business practices from the organizational plan that no longer support the rating <sup>p. 22</sup>. |
** Changes in business practices from the organizational plan that no longer support the rating <sup>p. 22</sup>. |
||
| Line 674: | Line 899: | ||
** Significant investment portfolio losses or limited liquidity <sup>p. 22</sup>. |
** Significant investment portfolio losses or limited liquidity <sup>p. 22</sup>. |
||
** Alterations in A.M. Best's capital adequacy assessment methodology that adversely affect the rating <sup>p. 22</sup>. |
** Alterations in A.M. Best's capital adequacy assessment methodology that adversely affect the rating <sup>p. 22</sup>. |
||
* A downgrade or withdrawal of rating could cause distribution partners and insureds to choose |
* A downgrade or withdrawal of the rating could cause distribution partners and insureds to choose higher-rated competitors, increase reinsurance costs or reduce availability, or severely limit/prevent writing new and renewal insurance contracts <sup>p. 22</sup>. |
||
* Rating organizations may heighten scrutiny, increase review frequency/scope, request additional information, or increase capital requirements |
* Rating organizations may heighten scrutiny, increase review frequency/scope, request additional information, or increase capital requirements for certain rating levels <sup>p. 22</sup>. |
||
* There is no assurance the rating will remain at its current level, and adverse ratings consequences could materially affect financial condition and results <sup>p. 22</sup>. |
* There is no assurance the company's rating will remain at its current level, and adverse ratings consequences could materially affect financial condition and results <sup>p. 22</sup>. |
||
* |
* Unexpected changes in the interpretation of coverage or provisions, including loss limitations and exclusions, could materially adversely affect financial condition and results <sup>p. 22</sup>. |
||
* |
* There is no assurance that loss limitations or exclusions in policies will be enforceable as intended <sup>p. 22</sup>. |
||
* Changing industry practices, legal, judicial, social, and other conditions may lead to unexpected claims and coverage issues <sup>p. 22</sup>. |
* Changing industry practices, legal, judicial, social, and other conditions may lead to unexpected claims and coverage issues <sup>p. 22</sup>. |
||
* |
* Policy limitations on claim periods, potentially shorter than statutory periods, may be nullified by courts or regulators, or legislation could modify/bar their use <sup>p. 22</sup>. |
||
* Governmental actions could result in higher than anticipated losses and LAE, materially adversely affecting financial condition or results <sup>p. 22</sup>. |
|||
* Court decisions, like the 1995 Montrose decision in California, could narrowly read exclusions, expanding coverage and requiring new exclusions <sup>p. 22</sup>. |
|||
* Court decisions, such as the 1995 Montrose decision in California, could narrowly read policy exclusions, expanding coverage and requiring new exclusions <sup>p. 22</sup>. |
|||
* These issues could broaden coverage beyond underwriting intent or increase claim frequency/severity <sup>p. 22</sup>. |
|||
* |
* These issues may broaden coverage beyond underwriting intent or increase claim frequency/severity, with full liability potentially not known for years after contract issuance <sup>p. 22</sup>. |
||
* |
* Reinsurers may not reimburse claims timely or at all, materially adversely affecting business, financial condition, and results <sup>p. 22</sup>. |
||
* Reinsurance contracts require premium payments to |
* Reinsurance contracts require premium payments to carriers who reimburse for covered claims, often many years later <sup>p. 22</sup>. |
||
* |
* Reinsurance makes the reinsurer liable but does not relieve the company of its primary liability to policyholders <sup>p. 22</sup>. |
||
* The current reinsurance program aims to limit financial risk, but reinsurers may default due to insolvency, lack of liquidity, operational failure, political/regulatory prohibitions, fraud, asserted defenses, or documentation deficiencies <sup>p. 22</sup>. |
|||
* Reinsurance makes the reinsurer liable but does not relieve the ceding insurer of primary liability to policyholders <sup>p. 22</sup>. |
|||
* |
* Disputes with reinsurers could be time-consuming, costly, and uncertain of success, leading to increased net losses <sup>p. 22</sup>. |
||
* As of December 31, 2025, the company had ''reinsurance recoverables'' of $1,119.9 million <sup>p. 22</sup>. |
|||
* Reinsurers may default due to insolvency, lack of liquidity, operational failure, prohibitions, fraud, asserted defenses, or documentation deficiencies <sup>p. 22</sup>. |
|||
* |
* Failure to accurately and timely pay claims could materially and adversely affect business, financial condition, results, and prospects <sup>p. 22</sup>. |
||
* Factors affecting claim payment accuracy and timeliness include claims representative training/experience (including TPAs), management effectiveness, and appropriate procedures/systems <sup>p. 22</sup>. |
|||
* These risks could lead to increased net losses and adversely affect financial condition <sup>p. 22</sup>. |
|||
* Failure to pay claims accurately and timely could lead to regulatory/administrative actions, litigation, and reputational damage <sup>p. 22</sup>. |
|||
* As of December 31, 2025, the company had ''$1,119.9 million in reinsurance recoverables'' <sup>p. 22</sup>. |
|||
* |
* Ineffective TPA management or internal staff/TPA inability to handle claim volume could adversely affect workload capacity <sup>p. 22</sup>. |
||
* Decreased quality of claims work could adversely affect operating margins and potentially require slowing growth in affected markets <sup>p. 22</sup>. |
|||
* Factors affecting claims payment include claims representative training/experience, management effectiveness, and appropriate procedures/systems <sup>p. 22</sup>. |
|||
* |
* Severe weather conditions, climate change effects, catastrophes, pandemics, and man-made events may adversely affect business, results, and financial condition <sup>p. 22</sup>. |
||
* Catastrophes include natural events (severe winter weather, convective storms/tornadoes, windstorms, earthquakes, hailstorms, thunderstorms, fires) and man-made events (explosions, war, terrorist attacks, riots) <sup>p. 22</sup>. |
|||
* Ineffective management of Third-Party Administrators (TPAs) or inability of staff/TPAs to handle claim volume could adversely affect workload capacity <sup>p. 22</sup>. |
|||
* |
* Changing weather patterns and climatic conditions (e.g., global warming) have increased unpredictability and frequency of natural disasters, including in new areas and operating markets <sup>p. 22</sup>. |
||
* |
* Climate change may increase the frequency and severity of extreme weather events, leading to conditions that increase hurricane activity and wildfire risks <sup>p. 22</sup>. |
||
* |
* A natural disaster or catastrophe loss could materially adversely affect business, financial condition, and results <sup>p. 22</sup>. |
||
* Catastrophes can impact the company even without direct insurance coverage, such as the 2025 California wildfires, as affected policyholders may cancel other policies <sup>p. 22</sup>. |
|||
* Changing weather patterns and climatic conditions (global warming) increase unpredictability and frequency of natural disasters, including in new areas <sup>p. 22</sup>. |
|||
* |
* Increased frequency and severity of weather events, including hurricanes or convective storms (difficult to model), could materially adversely affect the ability to predict, quantify, reinsure, and manage catastrophe risk, increasing losses <sup>p. 22</sup>. |
||
* Losses from catastrophes depend on the frequency and severity of insured events and total insured exposure in affected areas <sup>p. 22</sup>. |
|||
* A natural disaster or catastrophe loss could materially adversely affect the business <sup>p. 22</sup>. |
|||
* |
* The incidence and severity of catastrophes and severe weather are inherently unpredictable <sup>p. 22</sup>. |
||
* Exposure to losses is managed by analyzing probability and severity of loss events and their impact on underwriting and investment portfolios <sup>p. 22</sup>. |
|||
* Increased frequency and severity of weather events (e.g., hurricanes, convective storms) could affect the ability to predict, quantify, reinsure, and manage catastrophe risk, increasing losses <sup>p. 22</sup>. |
|||
* Indirect impacts can occur if insured businesses are affected by catastrophes not directly covered, leading to inability or unwillingness to pay premiums on other products <sup>p. 22</sup>. |
|||
* Catastrophe losses depend on frequency and severity of events and total insured exposure <sup>p. 22</sup>. |
|||
* |
* Inability to obtain reinsurance coverage at reasonable rates and adequate amounts for severe weather and catastrophes could materially adversely affect business and results <sup>p. 22</sup>. |
||
* |
* The business is exposed to risks from pandemics, outbreaks, public health crises, and geopolitical/social events <sup>p. 22</sup>. |
||
* While policy terms are expected to preclude coverage for virus-related claims, court decisions and governmental actions may challenge exclusions or interpretations <sup>p. 22</sup>. |
|||
* Indirect impacts can occur if insured businesses are affected by catastrophes not directly covered, leading to non-payment of premiums on other products <sup>p. 22</sup>. |
|||
* |
* Changes in domestic and international climate policy programs/initiatives, and related legislation/regulation, are unpredictable but could materially adversely affect business, operational, and financial results <sup>p. 22</sup>. |
||
* Program administrators are provided with specific quoting and binding authority, and their failure to comply with guidelines could adversely affect results <sup>p. 22</sup>. |
|||
* ''Pandemics, outbreaks, public health crises, and geopolitical/social events'' also pose risks <sup>p. 22</sup>. |
|||
* The company markets and distributes certain insurance products through program administrators with limited quoting and binding authority, who then sell to insureds via retail agents and brokers <sup>p. 22</sup>. |
|||
* Policy terms typically exclude virus-related claims, but court decisions and governmental actions may challenge these exclusions <sup>p. 22</sup>. |
|||
* Program administrators can bind certain risks without initial approval <sup>p. 22</sup>. |
|||
* Changes in domestic and international climate policy programs and legislation could have a material adverse effect <sup>p. 22</sup>. |
|||
* |
* Non-compliance by program administrators with underwriting guidelines could bind the company to unanticipated risks, adversely affecting results <sup>p. 22</sup>. |
||
* If actual renewals of existing contracts or new business from repeat insureds do not meet expectations, written premium and future results could be materially adversely affected <sup>p. 22</sup>. |
|||
* Program administrators have limited quoting and binding authority and sell products through retail agents and brokers <sup>p. 22</sup>. |
|||
* Most contracts are for a one-year term and are renewable; some insureds are repeat customers with new contracts <sup>p. 22</sup>. |
|||
* They can bind certain risks without initial approval <sup>p. 22</sup>. |
|||
* Non-compliance with underwriting guidelines could bind the company to unanticipated risks, adversely affecting results <sup>p. 22</sup>. |
|||
* ''Actual renewals or new business from repeat insureds not meeting expectations'' could materially adversely affect future written premium and results <sup>p. 22</sup>. |
|||
* Most contracts are one-year term and renewable; some insureds are repeat customers with new contracts <sup>p. 22</sup>. |
|||
* Financial forecasting includes assumptions about renewal rates and repeat business <sup>p. 22</sup>. |
* Financial forecasting includes assumptions about renewal rates and repeat business <sup>p. 22</sup>. |
||
* The insurance |
* The insurance and reinsurance industries are cyclical with intense price-based competition <sup>p. 22</sup>. |
||
* |
* Failure of actual renewals/repeat business to meet expectations, or choosing not to write renewals/accept repeat business due to pricing, would materially adversely affect future written premium and operations <sup>p. 22</sup>. |
||
* |
* Increased public attention to environmental, social, and governance (ESG) matters may lead to negative public perception, reputational harm, additional costs, or impact stock price <sup>p. 22</sup>. |
||
* Failure or perceived failure to meet investor/customer ESG expectations could harm business and reputation <sup>p. 22</sup>. |
* Failure, or perceived failure, to meet investor/customer ESG expectations could harm business and reputation <sup>p. 22</sup>. |
||
* Backlash from investors |
* Backlash from investors or customers regarding ESG topics could also harm business and reputation <sup>p. 22</sup>. |
||
* |
* Damage to reputation from providing policies to certain insureds could decrease demand for products, materially adversely affect business/results, and require resources to rebuild reputation/brand <sup>p. 22</sup>. |
||
* |
* Changes in accounting practices and future pronouncements may materially affect reported financial results <sup>p. 22</sup>. |
||
* |
* Developments in accounting practices may require considerable additional expenses for compliance, especially if retroactive application or comparative information for prior periods is needed <sup>p. 22</sup>. |
||
* The impact of accounting changes on net income, shareholder's equity, and other financial statement items is unpredictable <sup>p. 22</sup>. |
* The impact of accounting changes and future pronouncements on net income, shareholder's equity, and other financial statement items is unpredictable <sup>p. 22</sup>. |
||
* Insurance subsidiaries must comply with |
* Insurance subsidiaries must comply with statutory accounting principles (SAP) <sup>p. 22</sup>. |
||
* SAP |
* SAP and its components are constantly reviewed by the NAIC, its task forces/committees, and state insurance departments to address emerging issues and improve financial reporting <sup>p. 22</sup>. |
||
* |
* Various proposals before NAIC committees/task forces, if enacted, could negatively affect insurance industry participants <sup>p. 22</sup>. |
||
* The NAIC continuously examines existing laws and regulations, and the impact of reforms is unpredictable <sup>p. 22</sup>. |
* The NAIC continuously examines existing laws and regulations, and the impact of reforms is unpredictable <sup>p. 22</sup>. |
||
* |
* The use of derivatives to mitigate market price volatility exposure may subject the company to risks such as hedge ineffectiveness, basis risk, collateral/margin call liquidity pressures, and valuation uncertainty <sup>p. 22</sup>. |
||
* These risks could adversely affect financial condition and results of operations <sup>p. 22</sup>. |
|||
* Risks include hedge ineffectiveness (imperfect correlation), basis risk (futures prices not aligning with cash market prices), collateral and margin call liquidity pressures, and valuation uncertainty <sup>p. 22</sup>. |
|||
* Risks include hedge ineffectiveness due to imperfect correlation, basis risk where futures prices don't align with cash market prices, and liquidity pressures from margin calls/collateral requirements during adverse market movements <sup>p. 22</sup>. |
|||
* Reliance on market-based models introduces valuation uncertainty, potentially causing hedges to perform differently than expected <sup>p. 22</sup>. |
|||
* These factors may prevent hedging strategies from effectively reducing volatility and could materially adversely impact financial results <sup>p. 22</sup>. |
* These factors may prevent hedging strategies from effectively reducing volatility and could materially adversely impact financial results <sup>p. 22</sup>. |
||
{{Indexing|Risks Related to the Market and Economic Conditions|Adverse economic factors, recession, inflation, unemployment, economic activity, capital market volatility, insurance cyclicality, competition, catastrophic events, capacity levels, litigation trends, regulatory constraints|w8ma8usdpx|7nc9h3zzvs|kind=prose|order=27}} |
|||
'''Risks Related to the Market and Economic Conditions''' |
|||
* Adverse economic factors like recession, inflation, high unemployment, or lower economic activity can |
* Adverse economic factors like recession, inflation, high unemployment, or lower economic activity can reduce policy sales, increase claim frequency, lead to premium defaults, or cause claim falsification, impacting growth and profitability <sup>p. 23</sup>. |
||
* Business revenue, economic conditions, capital market volatility, and inflation affect the business and economic environment, influencing the ability to generate revenue and profits <sup>p. 23</sup>. |
|||
* Economic downturns characterized by higher unemployment, declining spending, and reduced corporate revenue generally reduce demand for insurance products, affecting premium levels and profitability <sup>p. 23</sup>. |
|||
* |
* An economic downturn with higher unemployment, declining spending, and reduced corporate revenue generally negatively affects demand for insurance products, impacting premium levels and profitability <sup>p. 23</sup>. |
||
* Negative economic factors can hinder the ability to charge appropriate rates for insured risks and adversely affect the number of policies written and opportunities for profitable underwriting <sup>p. 23</sup>. |
|||
* During an economic downturn, customers may reduce insurance needs, cancel policies, modify coverage, or not renew policies <sup>p. 23</sup>. |
* During an economic downturn, customers may reduce insurance needs, cancel policies, modify coverage, or not renew policies <sup>p. 23</sup>. |
||
* Existing policyholders might exaggerate or falsify claims to |
* Existing policyholders might exaggerate or falsify claims to receive higher payments in an economic downturn <sup>p. 23</sup>. |
||
* A significant collapse in economic segments like construction, credit markets, or energy production/servicing could adversely affect results across |
* A significant collapse in economic segments like construction, credit markets, or energy production/servicing could adversely affect results across multiple underwriting divisions <sup>p. 23</sup>. |
||
* These outcomes would reduce underwriting profit if not reflected in the rates charged <sup>p. 23</sup>. |
|||
* The insurance business is historically cyclical, causing operating results to vary quarterly and not necessarily indicate future performance <sup>p. 23</sup>. |
|||
* The insurance business is historically cyclical, which can affect financial performance and cause operating results to vary quarterly, not necessarily indicating future performance <sup>p. 23</sup>. |
|||
* Insurance carriers experience significant fluctuations in operating results due to competition, catastrophic events, capacity levels, litigation trends, regulatory constraints, and general economic conditions <sup>p. 23</sup>. |
|||
* Insurance carriers have historically experienced significant fluctuations in operating results due to competition, catastrophic events, capacity levels, litigation trends, regulatory constraints, and general economic conditions <sup>p. 23</sup>. |
|||
* The supply of insurance is influenced by prevailing prices, insured losses, and available industry capital, which fluctuate with investment returns <sup>p. 23</sup>. |
|||
* The supply of insurance is linked to prevailing prices, insured losses, and industry capital levels, which fluctuate with investment returns in the insurance industry <sup>p. 23</sup>. |
|||
* The insurance industry is cyclical, characterized by periods of intense price competition due to excessive underwriting capacity (soft market) and periods of capacity shortages increasing premiums (hard market) <sup>p. 23</sup>. |
* The insurance industry is cyclical, characterized by periods of intense price competition due to excessive underwriting capacity (soft market) and periods of capacity shortages increasing premiums (hard market) <sup>p. 23</sup>. |
||
* Demand for insurance depends on factors such as |
* Demand for insurance depends on factors such as frequency and severity of catastrophic events, capacity levels, new capital providers, and general economic conditions, all of which fluctuate and can contribute to price declines <sup>p. 23</sup>. |
||
* The profitability of most P&C insurance companies tends to follow cyclical market |
* The profitability of most P&C insurance companies tends to follow this cyclical market pattern, with higher gross written premium growth and improved profitability during hard market cycles <sup>p. 23</sup>. |
||
* |
* This cyclical market pattern can be more pronounced in the E&S market than in the standard insurance market <sup>p. 23</sup>. |
||
* When the standard insurance market hardens, the E&S market typically hardens, and E&S growth can be significantly more rapid |
* When the standard insurance market hardens, the E&S market typically hardens, and E&S market growth can be significantly more rapid <sup>p. 23</sup>. |
||
* When market conditions soften, customers previously in the E&S market may return to the admitted market, exacerbating the effects of rate decreases on financial results <sup>p. 23</sup>. |
* When market conditions soften, customers previously in the E&S market may return to the admitted market, exacerbating the effects of rate decreases on financial results <sup>p. 23</sup>. |
||
* The market may experience "micro cycles" where specific areas harden or soften independently and potentially more drastically than the overall market <sup>p. 23</sup>. |
* The market may experience "micro cycles" where specific areas harden or soften independently and potentially more drastically than the overall market <sup>p. 23</sup>. |
||
* Operating results are subject to fluctuation and have historically varied quarter-to-quarter <sup>p. 23</sup>. |
* Operating results are subject to fluctuation and have historically varied quarter-to-quarter <sup>p. 23</sup>. |
||
* Quarterly results are expected to continue fluctuating due to general economic conditions, frequency/severity of |
* Quarterly results are expected to continue fluctuating due to general economic conditions, frequency/severity of catastrophe events, fluctuating interest rates, claims exceeding loss reserves, industry competition, deviations from expected premium retention, adverse investment performance, and reinsurance coverage costs <sup>p. 23</sup>. |
||
* |
* ''Investment portfolio performance'' is subject to various investment risks that may adversely affect financial results <sup>p. 23</sup>. |
||
* The |
* The company aims to hold a diversified investment portfolio managed by professional advisory firms according to its investment policy and reviewed by the Investment Committee <sup>p. 23</sup>. |
||
* Investments are subject to general economic conditions, market risks, and risks inherent to specific securities <sup>p. 23</sup>. |
* Investments are subject to general economic conditions, market risks, and risks inherent to specific securities <sup>p. 23</sup>. |
||
* Primary market risk exposures are to changes in interest rates and equity prices <sup>p. 23</sup>. |
* Primary market risk exposures are to changes in interest rates and equity prices <sup>p. 23</sup>. |
||
* A significant portion of the investment portfolio is in fixed maturity securities, or separately managed accounts and limited partnerships primarily invested in fixed maturity securities <sup>p. 23</sup>. |
* A significant portion of the investment portfolio is in fixed maturity securities, or separately managed accounts and limited partnerships primarily invested in fixed maturity securities <sup>p. 23</sup>. |
||
* Interest rates rose materially |
* Interest rates rose materially during 2022 and 2023 <sup>p. 23</sup>. |
||
* A low interest rate environment, potentially resulting from federal government actions to slow inflation (e.g., rate cuts, Inflation Reduction Act of 2022), would pressure net investment income, particularly for fixed maturity and short-term investments, adversely affecting operating results <sup>p. 23</sup>. |
* A low interest rate environment, potentially resulting from federal government actions to slow inflation (e.g., rate cuts, Inflation Reduction Act of 2022), would pressure net investment income, particularly for fixed maturity securities and short-term investments, adversely affecting operating results <sup>p. 23</sup>. |
||
* Recent and future interest rate increases could cause declines in the value of fixed income securities portfolios, with the magnitude depending on duration and rate |
* Recent and future interest rate increases could cause declines in the value of fixed income securities portfolios, with the magnitude depending on security duration and the extent of rate increases <sup>p. 23</sup>. |
||
* Some fixed income securities with call or prepayment options create reinvestment risk in declining rate environments <sup>p. 23</sup>. |
* Some fixed income securities with call or prepayment options create reinvestment risk in declining rate environments <sup>p. 23</sup>. |
||
* Mortgage-backed and other asset-backed securities carry prepayment risk or may not prepay as quickly as expected in a rising interest rate environment <sup>p. 23</sup>. |
* Mortgage-backed and other asset-backed securities carry prepayment risk or may not prepay as quickly as expected in a rising interest rate environment <sup>p. 23</sup>. |
||
* All fixed maturity securities, including those in separately managed accounts and limited partnerships, are subject to credit risk <sup>p. 23</sup>. |
* All fixed maturity securities, including those in separately managed accounts and limited partnerships, are subject to ''credit risk'' <sup>p. 23</sup>. |
||
* |
* Credit risk is the risk of investment default or impairment due to deterioration in the financial condition of issuers or insurers guaranteeing payments <sup>p. 23</sup>. |
||
* Downgrades in credit ratings of fixed maturity securities could significantly negatively affect their market valuation <sup>p. 23</sup>. |
* Downgrades in credit ratings of fixed maturity securities could significantly negatively affect their market valuation <sup>p. 23</sup>. |
||
* The company invests in marketable preferred and common equity securities and exchange-traded funds, which are carried at fair market value and are subject to potential losses and market value declines <sup>p. 23</sup>. |
* The company also invests in marketable preferred and common equity securities and exchange-traded funds, which are carried at fair market value and are subject to potential losses and market value declines <sup>p. 23</sup>. |
||
* Market and credit risks could reduce net investment income and result in realized investment losses <sup>p. 23</sup>. |
* Market and credit risks could reduce net investment income and result in realized investment losses <sup>p. 23</sup>. |
||
* The investment portfolio |
* The investment portfolio is subject to increased valuation uncertainties when investment markets are illiquid, as with fixed maturity securities held to maturity, separately managed accounts, and limited partnership investments <sup>p. 23</sup>. |
||
* Valuation of investments is more subjective in illiquid markets, increasing the risk that estimated fair value does not reflect actual transaction prices <sup>p. 23</sup>. |
* Valuation of investments is more subjective in illiquid markets, increasing the risk that estimated fair value does not reflect actual transaction prices <sup>p. 23</sup>. |
||
* Risks for all security types are managed through an investment policy that |
* Risks for all security types are managed through an investment policy that establishes parameters, including maximum percentages in certain security types and minimum credit quality levels, believed to be within NAIC, Texas Department of Insurance, and Oklahoma Department of Insurance guidelines <sup>p. 23</sup>. |
||
* These investment parameters are believed to be within applicable guidelines established by the NAIC, the Texas Department of Insurance, and the Oklahoma Department of Insurance <sup>p. 23</sup>. |
|||
* The Investment Committee periodically reviews Enterprise Based Asset Allocation models for overall risk management <sup>p. 23</sup>. |
* The Investment Committee periodically reviews Enterprise Based Asset Allocation models for overall risk management <sup>p. 23</sup>. |
||
* While seeking to preserve capital, there is no certainty that investment objectives will be achieved, and results may vary substantially over time <sup>p. 23</sup>. |
|||
* Investment strategies |
* Investment strategies aim not to correlate with insurance and reinsurance exposures, but investment losses may occur concurrently with underwriting losses, exacerbating their adverse effect <sup>p. 23</sup>. |
||
* Losses in the investment portfolio may occur concurrently with underwriting losses, exacerbating their adverse effect <sup>p. 23</sup>. |
|||
* The company could be forced to sell investments to meet liquidity requirements <sup>p. 23</sup>. |
* The company could be forced to sell investments to meet liquidity requirements <sup>p. 23</sup>. |
||
* Premiums received are invested until needed to pay policyholder claims <sup>p. 23</sup>. |
* Premiums received from insureds are invested until needed to pay policyholder claims <sup>p. 23</sup>. |
||
* The duration of the investment portfolio is managed based on the duration of losses and LAE reserves to provide sufficient liquidity and avoid liquidating investments to fund claims <sup>p. 23</sup>. |
* The duration of the investment portfolio is managed based on the duration of losses and LAE reserves to provide sufficient liquidity and avoid liquidating investments to fund claims <sup>p. 23</sup>. |
||
* Risks such as inadequate losses and LAE reserves or unfavorable litigation trends could necessitate selling investments to fund liabilities <sup>p. 23</sup>. |
* Risks such as inadequate losses and LAE reserves or unfavorable litigation trends could necessitate selling investments to fund liabilities <sup>p. 23</sup>. |
||
* The company may not be able to sell investments at favorable prices or at all <sup>p. 23</sup>. |
|||
* Sales |
* Sales could result in significant realized losses depending on general market conditions, interest rates, and credit issues with individual securities <sup>p. 23</sup>. |
||
{{Indexing|Risks Related to the Regulatory Environment|Regulation, penalties, primary insurance subsidiaries, state departments of insurance, capital and surplus, investment and underwriting limits, affiliate transactions, dividend limits, changes in control, solvency, financial/non-financial aspects, insurance holding company system, Texas Department of Insurance, licenses/approvals|w8ma8usdpx|1nma8v7gjs|kind=prose|order=28}} |
|||
'''Risks Related to the Regulatory Environment''' |
|||
* |
* We are subject to extensive regulation, and failure to comply may result in penalties like fines and suspensions, adversely affecting financial condition and results of operations <sup>p. 24</sup>. |
||
* Our primary insurance subsidiaries (GMIC, HSIC, IIC) are extensively regulated in Texas, their state of domicile, and to a lesser degree in other operating states <sup>p. 24</sup>. |
|||
* Failure to comply with regulations may lead to penalties, including fines and suspensions, adversely affecting financial condition and results of operations <sup>p. 24</sup>. |
|||
* Insurance regulations primarily protect policyholders, not investors or stockholders <sup>p. 24</sup>. |
|||
* Primary insurance subsidiaries, ''GMIC, HSIC, and IIC'', are subject to extensive regulation in Texas (state of domicile) and other operating states <sup>p. 24</sup>. |
|||
* Regulations are administered by state departments of insurance and cover capital and surplus, investment and underwriting limits, affiliate transactions, dividend limits, changes in control, solvency, and other financial/non-financial aspects <sup>p. 24</sup>. |
|||
* Most insurance regulations protect policyholders' interests, not investors' or stockholders' <sup>p. 24</sup>. |
|||
* Regulations are administered by state departments of insurance and cover capital/surplus requirements, investment/underwriting limitations, affiliate transactions, dividend limitations, changes in control, solvency, and other financial/non-financial aspects <sup>p. 24</sup>. |
|||
* Significant changes in laws and regulations could limit discretion or increase business costs <sup>p. 24</sup>. |
* Significant changes in laws and regulations could limit discretion or increase business costs <sup>p. 24</sup>. |
||
* State insurance regulators conduct periodic examinations and require annual/other reports on financial condition and holding company issues <sup>p. 24</sup>. |
* State insurance regulators conduct periodic examinations and require annual/other reports on financial condition and holding company issues <sup>p. 24</sup>. |
||
* Our insurance subsidiaries are part of an "insurance holding company system" in Texas, requiring notice to the Texas Department of Insurance for certain affiliate transactions <sup>p. 24</sup>. |
|||
* Regulatory requirements may impose timing and expense constraints, affecting business objectives <sup>p. 24</sup>. |
|||
* Prior notification requirements may cause business delays and additional expenses <sup>p. 24</sup>. |
|||
* Insurance subsidiaries are part of an ''"insurance holding company system"'' under Texas statutes and regulations <sup>p. 24</sup>. |
|||
* Failure to file required notifications or comply with Texas insurance regulations could lead to significant fines, penalties, and impaired working relationships with the Texas Department of Insurance <sup>p. 24</sup>. |
|||
* Certain transactions between insurance subsidiaries and affiliates require prior notice to the ''Texas Department of Insurance'', potentially causing business delays and additional expenses <sup>p. 24</sup>. |
|||
* State insurance regulators have broad discretion to deny or revoke licenses for regulatory violations <sup>p. 24</sup>. |
|||
* Failure to file required notifications or comply with Texas insurance regulations may result in significant fines, penalties, and impaired working relationships with the Texas Department of Insurance <sup>p. 24</sup>. |
|||
* Our practices, based on interpretations of regulations or industry norms, may differ from regulatory authorities' interpretations <sup>p. 24</sup>. |
|||
* State insurance regulators have broad discretion to deny or revoke licenses for regulation violations <sup>p. 24</sup>. |
|||
* Lack of requisite licenses/approvals or non-compliance could lead to temporary suspension or preclusion from activities in a state, or other penalties <sup>p. 24</sup>. |
|||
* Practices based on interpretations of regulations or industry norms may differ from regulatory authorities' interpretations <sup>p. 24</sup>. |
|||
* Changes in insurance industry regulation, laws, or interpretations could interfere with operations and increase compliance costs <sup>p. 24</sup>. |
|||
* Lack of requisite licenses/approvals or non-compliance could lead to temporary suspension or preclusion from activities in a state, or other penalties, adversely affecting business operations <sup>p. 24</sup>. |
|||
* Our insurance subsidiaries are subject to risk-based capital requirements based on the NAIC's "risk based capital model" and minimum capital/surplus restrictions under Texas law <sup>p. 24</sup>. |
|||
* Changes in insurance industry regulation or interpretations could interfere with operations and increase compliance costs <sup>p. 24</sup>. |
|||
* |
* These requirements establish minimum risk-based capital to support business operations and identify inadequately capitalized property and casualty insurers by assessing asset/liability risks and net written premium mix <sup>p. 24</sup>. |
||
* Falling below calculated risk-based capital thresholds can lead to regulatory action, including supervision, rehabilitation, or liquidation <sup>p. 24</sup>. |
|||
* These requirements establish minimum risk-based capital for business operations and identify inadequately capitalized property and casualty insurers based on asset/liability risks and net written premium mix <sup>p. 24</sup>. |
|||
* Failure to maintain required risk-based capital levels could adversely affect our insurance subsidiary's ability to maintain regulatory authority and our A.M. Best Rating <sup>p. 24</sup>. |
|||
* Insurers below a calculated threshold may face regulatory action, including supervision, rehabilitation, or liquidation <sup>p. 24</sup>. |
|||
* We may become subject to additional government or market regulation, which could materially adversely impact our business <sup>p. 24</sup>. |
|||
* Failure to maintain required risk-based capital levels could adversely affect the insurance subsidiary's regulatory authority and A.M. Best Rating <sup>p. 24</sup>. |
|||
* Changes in laws related to asset/reserve valuation, surplus, investment/dividend limitations, enterprise risk, and risk-based capital requirements could adversely affect our business <sup>p. 24</sup>. |
|||
* ''Additional government or market regulation'' may have a material adverse impact on the business <sup>p. 24</sup>. |
|||
* The U.S. federal government generally does not directly regulate insurance, except for flood, nuclear, and terrorism risks, but may consider legislation affecting the industry in areas like privatization of Freddie Mac/Fannie Mae, reduction in federal subsidiaries for agriculture, tort reform, corporate governance, and reinsurance company taxation <sup>p. 24</sup>. |
|||
* Business could be adversely affected by changes in laws related to asset/reserve valuation, surplus requirements, investment/dividend limitations, enterprise risk, and risk-based capital <sup>p. 24</sup>. |
|||
* |
* Changes to U.S. tax laws and new tax policies could negatively impact the overall economy and our business <sup>p. 24</sup>. |
||
* Legislative or other actions related to taxes could negatively affect us, our investments, or our stockholders <sup>p. 24</sup>. |
|||
* Potential federal legislation could affect the insurance industry in areas like privatization of Freddie Mac/Fannie Mae, reduction in federal subsidies for agriculture, tort reform, corporate governance, and taxation of reinsurance companies <sup>p. 24</sup>. |
|||
* Changes to ''U.S. tax laws'' and new tax policies could negatively impact the overall economy and the business <sup>p. 24</sup>. |
|||
* Legislative or other actions related to taxes could negatively affect the company, investments, or stockholders <sup>p. 24</sup>. |
|||
* Rules for U.S. federal income taxation are constantly under review by legislators, the IRS, and the U.S. Department of the Treasury <sup>p. 24</sup>. |
* Rules for U.S. federal income taxation are constantly under review by legislators, the IRS, and the U.S. Department of the Treasury <sup>p. 24</sup>. |
||
* New legislation, U.S. Treasury regulations, administrative interpretations, or court decisions could have adverse consequences <sup>p. 24</sup>. |
* New legislation, U.S. Treasury regulations, administrative interpretations, or court decisions could have adverse consequences <sup>p. 24</sup>. |
||
* On |
* On July 4, 2025, H.R. 1, the "One Big Beautiful Bill Act" (OBBBA), was signed into law in the United States <sup>p. 24</sup>. |
||
* The OBBBA modifies |
* The OBBBA modifies business tax provisions, including restoring 100% bonus depreciation under Section 168(k) of the IRC, immediate deduction of U.S. domestic research and experimental expenditures under Section 174A of the IRC, the EBITDA-based business interest expense limitation under Section 163(j) of the IRC, and changes to international operations tax computation <sup>p. 24</sup>. |
||
* |
* Based on current analysis, these OBBBA provisions are not expected to have a material impact on our business or results of operations <sup>p. 24</sup>. |
||
* |
* Regulations and IRS guidance implementing the OBBBA may create unforeseen issues, and further tax law changes could occur, so there is no assurance our business will not be adversely affected <sup>p. 24</sup>. |
||
* |
* Our ability to use net operating loss carryforwards (NOLs) and other tax attributes may be limited <sup>p. 24</sup>. |
||
* As of December 31, 2025, we had gross federal income tax NOLs of approximately $40.3 million available to offset future taxable income, prior to Section 382 limitations <sup>p. 24</sup>. |
|||
* There is no assurance that the business will not be adversely affected by the OBBBA or other tax law changes <sup>p. 24</sup>. |
|||
* |
* These NOLs are set to expire beginning in 2032 <sup>p. 24</sup>. |
||
* Under Section 382 of the Code, an "ownership change" (greater than 50% change in equity ownership by certain stockholders over a rolling three-year period) can limit the use of pre-ownership change NOLs to offset post-ownership change income <sup>p. 24</sup>. |
|||
* As of ''December 31, 2025'', gross federal income tax NOLs were approximately ''$40.3 million'', available to offset future taxable income <sup>p. 24</sup>. |
|||
* |
* Future ownership changes, some outside our control, or regulatory changes could limit our ability to use NOLs <sup>p. 24</sup>. |
||
* If we cannot offset future taxable income with NOLs, our net income and cash flows may be adversely affected <sup>p. 24</sup>. |
|||
* Under ''Section 382 of the Code'', an "ownership change" (greater than 50% change in equity ownership by certain stockholders over a rolling three-year period) can limit the use of pre-ownership change NOLs <sup>p. 24</sup>. |
|||
* As a holding company with substantially all operations conducted by insurance subsidiaries, our liquidity and ability to pay dividends and service debt depend on obtaining cash dividends or other permitted payments from our insurance subsidiaries <sup>p. 24</sup>. |
|||
* Future ownership changes due to shifts in stock ownership, some outside of control, may occur <sup>p. 24</sup>. |
|||
* |
* The continued operation and growth of our business will require substantial capital <sup>p. 24</sup>. |
||
* |
* We do not intend to declare and pay cash dividends on our common stock in the foreseeable future <sup>p. 24</sup>. |
||
* Our ability to pay stockholder dividends and meet debt obligations largely depends on dividends and distributions from GMIC, HSIC, and IIC <sup>p. 24</sup>. |
|||
* As a holding company, with substantially all operations conducted by insurance subsidiaries, liquidity at the holding company level (including dividend payments and debt service) depends on cash dividends or permitted payments from insurance subsidiaries <sup>p. 24</sup>. |
|||
* |
* State insurance laws, including Texas laws, restrict the ability of GMIC, HSIC, and IIC to declare stockholder dividends <sup>p. 24</sup>. |
||
* No intention to declare and pay cash dividends on common stock in the foreseeable future <sup>p. 24</sup>. |
|||
* Ability to pay dividends to stockholders and meet debt obligations largely depends on dividends and distributions from primary insurance subsidiaries: ''GMIC, HSIC, and IIC'' <sup>p. 24</sup>. |
|||
* State insurance laws, including Texas laws, restrict the ability of GMIC, HSIC, and IIC to determine stockholder dividends <sup>p. 24</sup>. |
|||
* State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus <sup>p. 24</sup>. |
* State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus <sup>p. 24</sup>. |
||
* Dividend payments are limited to the |
* Dividend payments are limited to the portion of available policyholder surplus derived from net profits <sup>p. 24</sup>. |
||
* State insurance regulators have broad powers to prevent |
* State insurance regulators have broad powers to prevent statutory surplus reduction to inadequate levels, and there is no assurance that maximum calculated dividends would be permitted <sup>p. 24</sup>. |
||
* State insurance regulators may adopt more restrictive statutory provisions regarding dividend payments by our insurance subsidiaries in the future <sup>p. 24</sup>. |
|||
* There is no assurance that dividends up to maximum calculated amounts would be permitted <sup>p. 24</sup>. |
|||
* Future dividend determinations are at the discretion of our Board of Directors and depend on results of operations, financial condition, contractual debt restrictions, indebtedness, applicable law, and other relevant factors <sup>p. 24</sup>. |
|||
* State insurance regulators may adopt more restrictive statutory provisions regarding dividend payments in the future <sup>p. 24</sup>. |
|||
* Investors may need to sell common stock after price appreciation, which may not occur, as the only way to realize future gains <sup>p. 24</sup>. |
|||
* Any future dividend payments will be at the discretion of the ''Board of Directors'' and depend on results, financial condition, contractual restrictions, indebtedness, applicable law, and other relevant factors <sup>p. 24</sup>. |
|||
* Investors |
* Investors seeking immediate cash dividends should not purchase our common stock <sup>p. 24</sup>. |
||
* |
* Applicable insurance laws may make a change of control difficult <sup>p. 24</sup>. |
||
* Applicable insurance laws may make it difficult to effect a ''change of control'' <sup>p. 24</sup>. |
|||
* Under Texas insurance laws, acquiring control of a domestic insurer requires written approval from the state insurance commissioner <sup>p. 24</sup>. |
* Under Texas insurance laws, acquiring control of a domestic insurer requires written approval from the state insurance commissioner <sup>p. 24</sup>. |
||
* Approval depends on factors |
* Approval depends on factors like the acquirer's financial strength, plans for the insurer's future operations, and potential anti-competitive results <sup>p. 24</sup>. |
||
* Texas insurance laws apply to direct and indirect acquisition of |
* Texas insurance laws apply to direct and indirect acquisition of 10% or more of the voting stock of a Texas-domiciled insurer <sup>p. 24</sup>. |
||
* |
* Acquiring 10% or more of our common stock would be considered an indirect change of control of Skyward Specialty, triggering change of control filing requirements under Texas insurance laws, unless a disclaimer of control filing is accepted by the Texas Insurance Department <sup>p. 24</sup>. |
||
* These requirements may discourage acquisition proposals and delay, deter, or prevent a change of control, even if desirable to stockholders <sup>p. 24</sup>. |
* These requirements may discourage acquisition proposals and delay, deter, or prevent a change of control of Skyward Specialty, even if desirable to stockholders <sup>p. 24</sup>. |
||
{{Indexing|Risks Related to Our Liquidity and Access to Capital|Future capital requirements, cash flows, investment portfolio declines, catastrophe losses, adverse reserve development, equity financing, debt financing, securities, credit access, Revolving Credit Facility, Term Loan Facility, covenants, assets, credit market environment|trbk6wt4s9|f8km91nllc|b3bc9gy5x7|kind=prose|order=29}} |
|||
'''Risks Related to Our Liquidity and Access to Capital''' |
|||
* ''Future capital requirements'' depend on factors such as the ability to write new business successfully and establish adequate premium rates and reserves to cover losses <sup>p. 25</sup>. |
* ''Future capital requirements'' depend on factors such as the ability to write new business successfully and establish adequate premium rates and reserves to cover losses <sup>p. 25</sup>. |
||
* '' |
* If ''cash flows'' from operations are insufficient, or if the capital position is negatively impacted by investment portfolio declines, catastrophe losses, or adverse reserve development, additional funds may be needed through financings or growth curtailment <sup>p. 25</sup>. |
||
* ''Capital needs'' are affected by growth rate, profitability, claims experience, reinsurance availability, market disruptions, and other unforeseeable developments <sup>p. 25</sup>. |
* ''Capital needs'' are affected by growth rate, profitability, claims experience, reinsurance availability, market disruptions, and other unforeseeable developments <sup>p. 25</sup>. |
||
* ''Equity or debt financing'' may not be available |
* ''Equity or debt financing'' may not be available on favorable terms, or at all, potentially leading to dilution for stockholders or restrictive covenants in debt financings <sup>p. 25</sup>. |
||
* '' |
* ''Securities'' issued for financing may have rights, preferences, and privileges senior to common stock <sup>p. 25</sup>. |
||
* Inability to obtain ''adequate capital'' on favorable terms could materially adversely affect operating plans, business, financial condition, or results of operations <sup>p. 25</sup>. |
|||
* ''Access to credit'' under the Revolving Credit Facility is subject to conditions that, if not met, could prevent borrowing and adversely affect liquidity, financial position, and results of operations <sup>p. 25</sup>. |
* ''Access to credit'' under the Revolving Credit Facility is subject to conditions that, if not met, could prevent borrowing and adversely affect liquidity, financial position, and results of operations <sup>p. 25</sup>. |
||
* '' |
* A ''breach of covenants'' under the Term Loan Facility and Revolving Credit Facility could trigger an event of default, making all outstanding amounts immediately due and payable <sup>p. 25</sup>. |
||
* |
* In an event of default, ''assets'' may be insufficient to repay obligations under credit agreements <sup>p. 25</sup>. |
||
* The ''current credit market environment'' and macro-economic challenges may adversely impact the ability to borrow sufficient funds or sell assets/equity to repay existing debt <sup>p. 25</sup>. |
|||
{{Indexing|Risks Related to Our Operations|Key personnel, security breaches, data loss, cyberattacks, IT failures, information technology and telecommunications systems, underwriting systems, claims systems, third-party systems, natural catastrophes, terrorist attacks, industrial accidents, computer viruses, hackers, employee misconduct, external hazards, data incident|w8ma8usdpx|v84q3tomll|3sevlm3ozh|zy07b9ocmk|kind=prose|order=30}} |
|||
'''Risks Related to Our Operations''' |
|||
* |
* Loss of key personnel or inability to attract and retain qualified personnel could adversely affect the company <sup>p. 26</sup>. |
||
* |
* The pool of talent for recruitment is limited and fluctuates based on market dynamics, potentially leading to increased compensation expectations and difficulty in retaining/recruiting key personnel <sup>p. 26</sup>. |
||
* |
* Failure to retain or attract talented personnel could prevent the company from maintaining its competitive position in specialized markets, impacting results of operations <sup>p. 26</sup>. |
||
* ''Security breaches, data loss, cyberattacks |
* ''Security breaches, data loss, cyberattacks, and IT failures'' could disrupt operations, damage reputation, and adversely affect business and financial results <sup>p. 26</sup>. |
||
* |
* The business is highly dependent on ''information technology and telecommunications systems'', including underwriting and claims systems <sup>p. 26</sup>. |
||
* Systems are used for interactions with brokers and insureds, underwriting, policy preparation, premium processing, actuarial modeling, claims processing and payments, and financial statement preparation <sup>p. 26</sup>. |
|||
* ''System failures'' due to natural catastrophes, terrorist attacks, industrial accidents, or cyber-attacks could limit ability to write business, provide customer service, or pay claims <sup>p. 26</sup>. |
|||
* |
* Some systems may include or rely on ''third-party systems'' not located on company premises or under its control <sup>p. 26</sup>. |
||
* Events like natural catastrophes, terrorist attacks, industrial accidents, computer viruses, and cyber-attacks can cause system failures or inaccessibility <sup>p. 26</sup>. |
|||
* ''A data incident'' occurred where attackers acquired certain data, but an investigation determined it was immaterial with no evidence of nation-state involvement or misuse <sup>p. 26</sup>. |
|||
* Sustained or repeated system failures could limit the ability to write/process business, provide customer service, pay claims, or operate normally <sup>p. 26</sup>. |
|||
* ''Future cybersecurity events'' could lead to operational disruptions, unauthorized access to data, legal claims, regulatory scrutiny, reputational damage, and increased costs <sup>p. 26</sup>. |
|||
* '' |
* ''Computer viruses, hackers, employee misconduct, and other external hazards'' can expose systems to security breaches or disruptions <sup>p. 26</sup>. |
||
* The company has implemented security measures but systems may still be subject to breaches or interference <sup>p. 26</sup>. |
|||
* ''Advances in criminal capabilities'' or new vulnerabilities could compromise technology and security measures <sup>p. 26</sup>. |
|||
* A ''data incident'' occurred where attackers acquired certain company data, but an investigation determined it was immaterial, with no evidence of nation-state involvement, global hackers, or misuse of information <sup>p. 26</sup>. |
|||
* ''Third parties'' to whom functions are outsourced are also subject to these risks, and their increased use of cloud-based services could make identifying and responding to cyberattacks more difficult <sup>p. 26</sup>. |
|||
* Future cybersecurity events could lead to operational disruptions, unauthorized access to proprietary or customer data, legal claims, regulatory scrutiny, reputational damage, and increased costs <sup>p. 26</sup>. |
|||
* ''Artificial intelligence (AI)'' and machine learning growth may alter the competitive landscape <sup>p. 26</sup>. |
|||
* |
* SEC and state law requirements for public notification of incidents could exacerbate harm <sup>p. 26</sup>. |
||
* '' |
* ''Third parties'' to whom functions are outsourced are also subject to these risks <sup>p. 26</sup>. |
||
* The company reviews and assesses third-party providers' cybersecurity controls but cannot ensure complete protection against compromises or disclosures <sup>p. 26</sup>. |
|||
* ''Deficient, inaccurate, or biased AI'' content, analyses, or recommendations could adversely affect business, financial condition, results, and reputation <sup>p. 26</sup>. |
|||
* |
* Increased use of ''third-party services'' (e.g., cloud technology, SaaS) can complicate identification and response to cyberattacks <sup>p. 26</sup>. |
||
* '' |
* ''Artificial intelligence (AI) and machine learning'' are evolving technologies that may impact the business and operations <sup>p. 26</sup>. |
||
* |
* Employees use AI for risk selection, pricing, and claims handling to improve effectiveness and efficiency <sup>p. 26</sup>. |
||
* |
* The company continues to research and implement AI-based solutions <sup>p. 26</sup>. |
||
* |
* Competitive position may be harmed if competitors leverage AI solutions more quickly or effectively <sup>p. 26</sup>. |
||
* If AI applications produce deficient, inaccurate, or biased content, analyses, or recommendations, the business, financial condition, results of operations, and reputation could be adversely affected <sup>p. 26</sup>. |
|||
* ''Failure to manage growth'' includes inability to meet capital needs, expand systems, control internal processes, allocate human resources, and integrate acquisitions <sup>p. 26</sup>. |
|||
* Costs may be incurred to adopt and deploy AI technologies that could become obsolete earlier than expected <sup>p. 26</sup>. |
|||
* ''Inorganic growth through acquisitions'' depends on identifying targets, favorable negotiations, transaction completion, and successful integration <sup>p. 26</sup>. |
|||
* |
* There is no assurance that desired or anticipated benefits from AI will be realized <sup>p. 26</sup>. |
||
* '' |
* ''Uncertainty exists in the legal and regulatory landscape'' at federal and state levels for AI use <sup>p. 26</sup>. |
||
* New laws, regulations, or industry standards for AI could be burdensome, costly, or restrict the ability to develop, adopt, and deploy AI technologies <sup>p. 26</sup>. |
|||
* ''Sustaining revenue growth'' depends on effective product pricing, successful product deployment, strong distribution partner support, attracting qualified professionals, enhancing infrastructure, creating new distribution channels, introducing new products, competing effectively, and increasing brand awareness <sup>p. 26</sup>. |
|||
* |
* The company may not be able to manage its growth effectively <sup>p. 26</sup>. |
||
* |
* Future business growth may require additional capital, systems development, and skilled personnel <sup>p. 26</sup>. |
||
* |
* Failure to manage growth effectively could materially adversely affect business, financial condition, and results of operations <sup>p. 26</sup>. |
||
* ''Inorganic growth through acquisitions'' depends on identifying appropriate targets, negotiating favorable terms, completing transactions, and successful integration <sup>p. 26</sup>. |
|||
* ''Acquisition and integration of Apollo'' may adversely affect business, financial condition, and results of operations <sup>p. 26</sup>. |
|||
* Anticipated benefits from acquisitions, such as revenue growth, operational efficiencies, or synergies, may not be realized <sup>p. 26</sup>. |
|||
* ''Acquisition of Apollo'' was completed on January 1, 2026 <sup>p. 26</sup>. |
|||
* The company has experienced rapid growth in recent years, but these rates may not be indicative of future growth <sup>p. 26</sup>. |
|||
* ''Integration risks'' include challenges in combining Apollo's operations, systems, technology, and personnel, potentially diverting management attention, disrupting business, and incurring unexpected costs <sup>p. 26</sup>. |
|||
* |
* Sustaining revenue growth consistent with recent history is not guaranteed <sup>p. 26</sup>. |
||
* Revenue growth depends on factors including effective product pricing, successful product deployment, attracting/retaining qualified personnel, enhancing infrastructure/data systems, creating new distribution channels, introducing new products, competing effectively, and increasing brand awareness <sup>p. 26</sup>. |
|||
* ''Retention of key Apollo personnel, partners, and customers'' is crucial for the acquisition's success <sup>p. 26</sup>. |
|||
* Failure to accomplish these objectives makes forecasting future results difficult <sup>p. 26</sup>. |
|||
* ''Cultural and operational differences'' between the company and Apollo, particularly in the Lloyd's market, may create challenges in harmonizing policies and procedures <sup>p. 26</sup>. |
|||
* Historical growth rate should not be considered indicative of future performance and may decline <sup>p. 26</sup>. |
|||
* ''Financial and accounting risks'' from the Apollo acquisition include goodwill and intangible asset recognition, potential impairment, undisclosed liabilities, and conversion of Apollo's U.K. GAAP financial statements to U.S. GAAP <sup>p. 26</sup>. |
|||
* Revenue could grow more slowly or decline in future periods <sup>p. 26</sup>. |
|||
* ''Regulatory and compliance risks'' increase due to expansion into new jurisdictions and markets, including the Lloyd's market <sup>p. 26</sup>. |
|||
* Operating expenses are expected to increase, and if revenue growth does not offset these increases, business, financial position, and results of operations could be harmed, potentially preventing profitability <sup>p. 26</sup>. |
|||
* ''Additional indebtedness'' was incurred in connection with the Apollo acquisition, which could limit financial flexibility or increase cost of capital <sup>p. 26</sup>. |
|||
* '' |
* The ''acquisition and integration of Apollo'' may adversely affect business, financial condition, and results of operations <sup>p. 26</sup>. |
||
* The acquisition of Apollo was completed on January 1, 2026 <sup>p. 26</sup>. |
|||
* ''Inability to successfully integrate Apollo'' or realize anticipated benefits could materially and adversely affect business, financial condition, and results of operations <sup>p. 26</sup>. |
|||
* |
* The acquisition is expected to provide strategic benefits, expand specialty insurance capabilities, and enhance presence in the Lloyd’s market <sup>p. 26</sup>. |
||
* ''Integration risks'' include challenges in integrating Apollo’s operations, systems, technology platforms, and personnel, potentially diverting management attention, disrupting business, and incurring unexpected costs or delays <sup>p. 26</sup>. |
|||
* ''No current involvement'' in out-of-the-ordinary litigation with customers <sup>p. 26</sup>. |
|||
* |
* There is no assurance that growth opportunities or other benefits from the acquisition will be realized within the expected timeframe or at all <sup>p. 26</sup>. |
||
* Failure to achieve anticipated benefits could adversely affect results of operations and financial condition <sup>p. 26</sup>. |
|||
* ''Retention of key Apollo employees, partners, and customers'' is crucial for the acquisition's success <sup>p. 26</sup>. |
|||
* Loss of key personnel or business relationships could negatively impact the value of the acquired business and overall operations <sup>p. 26</sup>. |
|||
* ''Cultural and operational differences'' between Apollo (operating in the Lloyd’s market) and the company may create challenges in harmonizing policies and procedures <sup>p. 26</sup>. |
|||
* ''Financial and accounting risks'' include significant changes to financial statements, recognition of goodwill and other intangible assets subject to impairment, undisclosed liabilities or risks, and the need to convert Apollo’s U.K. GAAP financial statements to U.S. GAAP <sup>p. 26</sup>. |
|||
* ''Regulatory and compliance risks'' increase due to expansion into new jurisdictions and markets, including the Lloyd’s market <sup>p. 26</sup>. |
|||
* Failure to comply with applicable laws and regulations could result in fines, penalties, or other adverse consequences <sup>p. 26</sup>. |
|||
* ''Indebtedness and financial flexibility'' are impacted by additional indebtedness incurred for the acquisition, which could limit financial flexibility or increase the cost of capital <sup>p. 26</sup>. |
|||
* The integration process may ''distract management'' from existing business, negatively impacting ongoing operations and financial performance <sup>p. 26</sup>. |
|||
* Inability to successfully integrate Apollo, realize anticipated benefits, or manage risks could materially and adversely affect business, financial condition, and results of operations <sup>p. 26</sup>. |
|||
* ''Litigation risks'' are continually faced, including disputes relating to insurance claims and general commercial/corporate litigation <sup>p. 26</sup>. |
|||
* The company is not currently involved in out-of-the-ordinary litigation with customers <sup>p. 26</sup>. |
|||
* Other insurance industry members face class action lawsuits and other litigation with substantial or indeterminate amounts, and unpredictable outcomes <sup>p. 26</sup>. |
|||
* ''Social inflation'', particularly in third-party claims, can lead to oversized judgments <sup>p. 26</sup>. |
* ''Social inflation'', particularly in third-party claims, can lead to oversized judgments <sup>p. 26</sup>. |
||
* |
* Litigation costs and settlement amounts can be inflated even when cases do not reach judgment <sup>p. 26</sup>. |
||
* |
* Litigation issues include insurance and claim settlement practices <sup>p. 26</sup>. |
||
* |
* The company cannot predict future involvement in such litigation or its impact on the business <sup>p. 26</sup>. |
||
* '' |
* ''Loss of key vendor relationships'' or failure of a vendor to protect data could affect operations <sup>p. 26</sup>. |
||
* The company relies on services and products from many vendors in the United States and abroad, including computer hardware/software, claim adjustment, HR benefits management, and investment management services <sup>p. 26</sup>. |
|||
* ''Vendor bankruptcy, inability to provide services, system breaches'', or failure to protect confidential information could lead to operational impairments and financial losses <sup>p. 26</sup>. |
|||
* Vendor bankruptcy, inability to provide services, system breaches, or failure to protect confidential information could lead to operational impairments and financial losses <sup>p. 26</sup>. |
|||
* ''Failure to properly assess vendor risks'' could materially and adversely affect financial condition and results of operations <sup>p. 26</sup>. |
|||
* Failure to properly assess and understand risks and costs in third-party relationships could materially and adversely affect financial condition and results of operations <sup>p. 26</sup>. |
|||
* ''Continued reliance on third-party software'' is anticipated <sup>p. 26</sup>. |
|||
* '' |
* The company anticipates continued reliance on ''third-party software'' <sup>p. 26</sup>. |
||
* |
* While commercially reasonable alternatives to current licensed third-party software are believed to exist, this may not always be the case, or replacement could be difficult or costly <sup>p. 26</sup>. |
||
* |
* Integration of new third-party software may require significant work, time, and resources <sup>p. 26</sup>. |
||
* Obtaining license agreements for additional or alternative third-party software may not be on commercially reasonable terms or available at all <sup>p. 26</sup>. |
|||
* ''Failure to protect intellectual property rights'' for proprietary technology platform and brand, or being sued for infringement, could occur <sup>p. 26</sup>. |
|||
* |
* Many risks associated with third-party software use cannot be eliminated and could negatively affect the business <sup>p. 26</sup>. |
||
* The company may fail or be unable to protect its ''intellectual property rights'' for its proprietary technology platform and brand <sup>p. 26</sup>. |
|||
* ''Reliance on copyright and trade secret laws'', and confidentiality agreements to protect intellectual property <sup>p. 26</sup>. |
|||
* |
* The company may be sued by third parties for alleged infringement of their proprietary rights <sup>p. 26</sup>. |
||
* |
* Success and ability to compete depend partly on intellectual property, including brand rights and proprietary technology used in certain product lines <sup>p. 26</sup>. |
||
* |
* Protection primarily relies on copyright and trade secret laws, and confidentiality agreements with employees, customers, service providers, and partners <sup>p. 26</sup>. |
||
* |
* Steps taken to protect intellectual property may be inadequate <sup>p. 26</sup>. |
||
* Efforts to enforce intellectual property rights may face defenses, counterclaims, and countersuits <sup>p. 26</sup>. |
|||
* Failure to secure, protect, and enforce intellectual property rights could adversely affect the brand and business <sup>p. 26</sup>. |
|||
* Success also depends partly on not infringing on the intellectual property rights of others <sup>p. 26</sup>. |
|||
* Competitors and other entities may own or claim intellectual property related to the industry or company <sup>p. 26</sup>. |
|||
* Future claims of infringement by third parties are possible, and the company may be found to be infringing <sup>p. 26</sup>. |
|||
* Claims or litigation could incur significant expenses, require substantial damages or royalty payments, prevent service offerings, or impose unfavorable terms <sup>p. 26</sup>. |
|||
* Even if successful in a dispute, litigation could be costly, time-consuming, and divert management attention <sup>p. 26</sup>. |
|||
{{Indexing|Risks Related to Ownership of Our Common Stock|Public company costs, compliance initiatives, federal securities laws, Sarbanes-Oxley Act, Dodd-Frank Act, SEC, Nasdaq, financial statements, disclosure, financial controls, corporate governance, Section 404, internal control over financial reporting, accounting and finance staff, internal audit services|ch7st6ifed|l96bfbct4s|kind=prose|order=31}} |
|||
'''Risks Related to Ownership of Our Common Stock''' |
|||
* |
* The company expects to incur increased costs as a public company and its management devotes substantial time to compliance initiatives <sup>p. 27</sup>. |
||
* |
* As a public company, particularly a large accelerated filer, the company incurs significant legal, accounting, and other expenses not present as a private company <sup>p. 27</sup>. |
||
* Federal securities laws, including the Sarbanes-Oxley Act and Dodd-Frank Act, and rules by the SEC and Nasdaq, impose requirements on public companies for filing reports and maintaining effective disclosure, financial controls, and corporate governance <sup>p. 27</sup>. |
|||
* ''Significant expenses as a large accelerated filer'': As a public company and large accelerated filer, the company incurs significant legal, accounting, and other expenses not present as a private company <sup>p. 27</sup>. |
|||
* These regulations increase compliance costs, make activities more time-consuming, and require substantial management and personnel time <sup>p. 27</sup>. |
|||
* ''Compliance with federal securities laws'': Federal securities laws, including the Sarbanes-Oxley Act, Dodd-Frank Act, SEC, and Nasdaq rules, impose various requirements on public companies, increasing compliance costs and management time <sup>p. 27</sup>. |
|||
* |
* The company may not be able to produce reliable financial statements or file them timely with the SEC, or comply with Nasdaq listing requirements <sup>p. 27</sup>. |
||
* |
* Pursuant to Section 404 of the Sarbanes-Oxley Act, the company must perform system and process evaluation and testing of its internal control over financial reporting <sup>p. 27</sup>. |
||
* Compliance with Section 404 requires substantial accounting expense and significant management efforts <sup>p. 27</sup>. |
|||
* ''Staffing for Section 404'': The company must maintain accounting and finance staff and consultants with public company reporting, technical accounting, and internal control knowledge to satisfy Section 404 requirements and provide internal audit services <sup>p. 27</sup>. |
|||
* |
* The company must maintain accounting and finance staff and consultants with public company reporting, technical accounting, and internal control knowledge to satisfy Section 404 requirements and provide internal audit services <sup>p. 27</sup>. |
||
* |
* The process to document and evaluate internal control over financial reporting is costly and challenging, requiring dedicated internal resources, outside consultants, and a detailed work plan <sup>p. 27</sup>. |
||
* There is a risk that neither the company nor its independent registered public accounting firm will conclude that internal control over financial reporting is effective within the prescribed timeframe, potentially leading to an adverse reaction in financial markets or SEC investigations <sup>p. 27</sup>. |
|||
* ''Disclosure controls and procedures'': As a public company, the company must maintain disclosure controls and procedures to ensure timely and accurate information disclosure in SEC filings <sup>p. 27</sup>. |
|||
* |
* As a public company, the company must maintain disclosure controls and procedures designed to ensure timely and accurate reporting of information required by the Exchange Act <sup>p. 27</sup>. |
||
* |
* The company does not expect its disclosure controls or internal control over financial reporting to prevent or detect all errors and fraud, as control systems provide only reasonable, not absolute, assurance <sup>p. 27</sup>. |
||
* Inherent limitations in control systems mean misstatements due to error or fraud may occur and not be detected <sup>p. 27</sup>. |
|||
* ''Section 404(b) requirements'': The company must document and test internal control procedures to satisfy Section 404(b) of the Sarbanes-Oxley Act, requiring annual management assessments of internal control effectiveness <sup>p. 27</sup>. |
|||
* Failure to achieve and maintain effective internal controls, as required by Section 404 of the Sarbanes-Oxley Act, could harm operating results and financial condition, and negatively affect the common stock price <sup>p. 27</sup>. |
|||
* ''Deficiencies and management distraction'': Assessments may identify deficiencies not remediated timely, and testing/maintaining internal controls may divert management attention from business operations <sup>p. 27</sup>. |
|||
* The company is required to document and test internal control procedures to satisfy Section 404(b) of the Sarbanes-Oxley Act, which mandates annual management assessments of internal control effectiveness <sup>p. 27</sup>. |
|||
* ''Consequences of ineffective internal control'': If internal control over financial reporting is deemed ineffective, remediation costs and scope could be significant, and material weaknesses could impede timely and accurate SEC filings <sup>p. 27</sup>. |
|||
* Assessments may identify deficiencies that cannot be remediated timely, and testing/maintaining controls may divert management's attention <sup>p. 27</sup>. |
|||
* ''Loss of investor confidence'': Any issues with internal controls could cause investors to lose confidence, or lead to suspension/termination of Nasdaq listing, negatively affecting stock price <sup>p. 27</sup>. |
|||
* |
* Inability to conclude on an ongoing basis that internal control over financial reporting is effective could lead to significant remediation costs and scope, and impede timely and accurate SEC filings <sup>p. 27</sup>. |
||
* Any material weaknesses or deficiencies could cause investors to lose confidence or lead to Nasdaq listing suspension/termination, negatively affecting the common stock trading price <sup>p. 27</sup>. |
|||
* ''Impact of failing to maintain effective controls'': Failure to maintain an effective system of internal controls could adversely affect the market price of common stock <sup>p. 27</sup>. |
|||
* A material weakness in internal control over information technology general controls ("ITGCs") was identified as of December 31, 2024, and remediated as of December 31, 2025 <sup>p. 27</sup>. |
|||
* ''Limitations of ITGCs'': Even effective ITGCs provide only reasonable, not absolute, assurance regarding ITGCs <sup>p. 27</sup>. |
|||
* Failure to maintain an effective system of internal controls could adversely affect the market price of common stock <sup>p. 27</sup>. |
|||
* ''Identification of material weakness'': Control deficiencies over ITGCs were identified by management, including the CEO, CFO, and CIO/CTO, during fiscal year ended December 31, 2024, constituting a material weakness as described in "ITEM 9A. CONTROLS & PROCEDURES" of the 2024 Form 10-K <sup>p. 27</sup>. |
|||
* The effectiveness of controls is subject to inherent limitations, and even an effective ITGC system provides only reasonable assurance <sup>p. 27</sup>. |
|||
* ''Remediation and future risks'': Measures have been taken to remediate the identified material weakness, but future identification of material weaknesses or significant deficiencies could lead to untimely or incorrect financial reporting <sup>p. 27</sup>. |
|||
* Management, with the CEO, CFO, and CIO/CTO, identified control deficiencies over ITGCs during fiscal year ended December 31, 2024, constituting a material weakness as described in "ITEM 9A. CONTROLS & PROCEDURES" of the 2024 Form 10-K <sup>p. 27</sup>. |
|||
* ''Adverse actions and reputation impact'': Untimely financial filings could result in adverse actions by shareholders, Nasdaq, SEC, or other regulators, and negatively affect reputation or investor perceptions, impacting stock price <sup>p. 27</sup>. |
|||
* |
* Measures have been taken to remediate the material weakness, and it is believed to be remediated <sup>p. 27</sup>. |
||
* Identification of additional material weaknesses or significant deficiencies could prevent timely and reliable financial information, lead to incorrect reporting, and result in adverse actions by shareholders, Nasdaq, SEC, or other regulators <sup>p. 27</sup>. |
|||
* ''Future control failures'': No assurance can be given that additional material weaknesses or restatements will not arise, or that current controls will prevent irregularities or errors or facilitate fair financial statement presentation <sup>p. 27</sup>. |
|||
* Material weaknesses or significant deficiencies could adversely affect reputation or investor perceptions, negatively impacting the trading price of common shares, and incur additional remediation costs <sup>p. 27</sup>. |
|||
* ''Stock price volatility'': The market price of common stock has been and is likely to remain highly volatile, fluctuating due to factors beyond the company's control <sup>p. 27</sup>. |
|||
* There is no assurance that additional material weaknesses or restatements of financial results will not arise in the future due to inadequate internal controls <sup>p. 27</sup>. |
|||
* ''Investment risk'': Investment in common stock is considered risky, and investors should be able to withstand significant loss and wide fluctuations in market value <sup>p. 27</sup>. |
|||
* Current controls and procedures may not be adequate to prevent or identify irregularities or errors or facilitate fair presentation of financial statements in the future <sup>p. 27</sup>. |
|||
* ''Factors affecting stock price'': Factors that could affect stock price include: |
|||
* The company's operating results and stock price may be volatile or decline regardless of operating performance, risking loss of investment <sup>p. 27</sup>. |
|||
** ''Market conditions'' in the broader stock market <sup>p. 27</sup>. |
|||
* As a public company, the market price of common stock has been and is likely to remain highly volatile due to many factors beyond control <sup>p. 27</sup>. |
|||
** ''Fluctuations'' in quarterly financial and operating results <sup>p. 27</sup>. |
|||
* Securities markets worldwide have experienced significant price and volume fluctuations, which, along with general economic, market, or political conditions, could cause wide price fluctuations in the company's shares <sup>p. 27</sup>. |
|||
** ''Introduction of new products or services'' by the company or competitors <sup>p. 27</sup>. |
|||
* Investment in common stock is considered risky, suitable only for those who can withstand significant loss and market value fluctuations <sup>p. 27</sup>. |
|||
** ''Issuance of new or changed securities analysts’ reports'' or recommendations <sup>p. 27</sup>. |
|||
* Factors affecting stock price include: market conditions, fluctuations in quarterly financial/operating results, new products/services by the company or competitors, securities analysts' reports/recommendations, results varying from expectations, short sales/hedging, guidance provided, strategic actions, announcements by the company/competitors/acquisition targets, sales of large blocks of stock, changes in Board/management/key personnel, regulatory/legal/political developments, public response to announcements, litigation/governmental investigations, changing economic conditions (including social inflation), changes in accounting principles, indebtedness/future securities issuance, default under debt agreements, exposure to capital/credit market risks, changes in credit ratings, and other events like natural disasters, war, or terrorism <sup>p. 27</sup>. |
|||
** ''Operating results'' varying from expectations of securities analysts and investors <sup>p. 27</sup>. |
|||
* Securities markets have experienced extreme price and volume fluctuations often unrelated to operating performance, meaning investors may not resell shares at or above purchase price <sup>p. 27</sup>. |
|||
** ''Short sales, hedging, and other derivative transactions'' in common stock <sup>p. 27</sup>. |
|||
* Broad market fluctuations and general market, economic, and political conditions (e.g., recessions, loss of investor confidence, interest rate changes) may negatively affect the common stock price <sup>p. 27</sup>. |
|||
** ''Guidance'' provided to the public, changes in guidance, or failure to meet guidance <sup>p. 27</sup>. |
|||
* Extreme price and volume fluctuations in stock markets, including Nasdaq, could cause the stock price to fall and expose the company to costly securities class action litigation, diverting management's attention and resources <sup>p. 27</sup>. |
|||
** ''Strategic actions'' by the company or competitors <sup>p. 27</sup>. |
|||
* Management has the authority to change underwriting guidelines or strategy without stockholder notice or approval <sup>p. 27</sup>. |
|||
* Fundamental changes to operations may occur without stockholder approval, potentially resulting in a strategy or underwriting guidelines materially different from those described in the "Business" section or other filings <sup>p. 27</sup>. |
|||
** ''Sales'' (or anticipated sales) of large blocks of stock by directors, executive officers, and principal stockholders <sup>p. 27</sup>. |
|||
* Anti-takeover provisions in organizational documents, Delaware law, and federal/state regulations may discourage, delay, or prevent a beneficial change of control <sup>p. 27</sup>. |
|||
** ''Additions or departures'' in the Board, senior management, or other key personnel <sup>p. 27</sup>. |
|||
* These provisions impose procedural requirements that could make certain corporate actions more difficult for shareholders and adversely affect the common stock price <sup>p. 27</sup>. |
|||
** ''Regulatory, legal, or political developments'' <sup>p. 27</sup>. |
|||
* Charter documents permit the Board of Directors to establish the number of directors and fill vacancies <sup>p. 27</sup>. |
|||
* The Board of Directors will be classified into three classes with staggered, three-year terms, and directors may only be removed for cause <sup>p. 27</sup>. |
|||
** ''Litigation and governmental investigations'' <sup>p. 27</sup>. |
|||
* Super-majority voting is required to amend provisions in the certificate of incorporation and bylaws <sup>p. 27</sup>. |
|||
** ''Changing economic conditions'', including social inflation <sup>p. 27</sup>. |
|||
* Blank-check preferred stock, with terms set by the Board, could delay or prevent transactions or changes in control that might offer a premium price for common stock <sup>p. 27</sup>. |
|||
** ''Changes in accounting principles'' <sup>p. 27</sup>. |
|||
* The ability of stockholders to call special meetings is eliminated <sup>p. 27</sup>. |
|||
* Special meetings of stockholders can only be called by the Board of Directors, the chairman of the Board, or the chief executive officer <sup>p. 27</sup>. |
|||
** ''Default'' under agreements governing indebtedness <sup>p. 27</sup>. |
|||
* Stockholder consent action by other than unanimous written consent is prohibited <sup>p. 27</sup>. |
|||
* Vacancies on the Board of Directors may be filled only by a majority of directors then in office, even if less than a quorum <sup>p. 27</sup>. |
|||
** ''Changes in credit ratings'' <sup>p. 27</sup>. |
|||
* Cumulative voting in the election of directors is prohibited <sup>p. 27</sup>. |
|||
* Advance notice requirements are established for nominations to the Board or for proposing matters at annual stockholder meetings <sup>p. 27</sup>. |
|||
* ''Extreme price and volume fluctuations'': Securities markets, including Nasdaq, have experienced extreme price and volume fluctuations often unrelated to company operating performance <sup>p. 27</sup>. |
|||
* As a Delaware corporation, the company is subject to Section 203 of the Delaware General Corporation Law, which may prohibit large stockholders (15% or more of voting stock) from merging or combining with the company for a period <sup>p. 27</sup>. |
|||
* ''Consequences of market fluctuations'': Broad market fluctuations, general market, economic, and political conditions (e.g., recessions, loss of investor confidence, interest rate changes) may negatively affect the market price of common stock <sup>p. 27</sup>. |
|||
* The certificate of incorporation and bylaws designate the Court of Chancery of the State of Delaware as the exclusive forum for substantially all disputes between the company and its stockholders <sup>p. 27</sup>. |
|||
* ''Risk of class action litigation'': Extreme price and volume fluctuations could cause the stock price to fall and expose the company to securities class action litigation, which could be costly, divert management attention, or harm the business <sup>p. 27</sup>. |
|||
* ' |
* This could limit stockholders' ability to obtain a favorable judicial forum for disputes with the company or its directors, officers, or employees <sup>p. 27</sup>. |
||
* The exclusive forum applies to derivative actions, claims of breach of fiduciary duty, actions arising under DGCL or charter/bylaws, actions to interpret charter/bylaws, and actions governed by the internal affairs doctrine <sup>p. 27</sup>. |
|||
* ''Fundamental changes without stockholder approval'': The company may make fundamental changes to operations without stockholder approval, potentially resulting in a strategy or underwriting guidelines materially different from those described in the "Business" section or other filings <sup>p. 27</sup>. |
|||
* |
* The certificate of incorporation and bylaws also state that federal district courts of the United States are the sole and exclusive forum for Securities Act claims, unless the company consents otherwise <sup>p. 27</sup>. |
||
* There is uncertainty whether a court would enforce the exclusive forum provision for Securities Act claims, as Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts <sup>p. 27</sup>. |
|||
* ''Impact of anti-takeover provisions on share price'': These provisions could adversely affect the price of common stock by making certain corporate actions more difficult for shareholders <sup>p. 27</sup>. |
|||
* Stockholders will not be deemed to have waived compliance with federal securities laws and regulations <sup>p. 27</sup>. |
|||
* ''Charter document provisions'': The company's charter documents include provisions that: |
|||
* This exclusive forum provision would not apply to suits enforcing duties/liabilities created by the Exchange Act or other claims where federal courts have exclusive jurisdiction <sup>p. 27</sup>. |
|||
** ''Permit the Board of Directors'' to establish the number of directors and fill vacancies/newly created directorships <sup>p. 27</sup>. |
|||
* If enforced, this choice of forum provision may limit a stockholder's ability to bring a claim in a preferred judicial forum, potentially discouraging lawsuits <sup>p. 27</sup>. |
|||
** ''Classify the Board of Directors'' into three classes with staggered, three-year terms, with directors removable only for cause <sup>p. 27</sup>. |
|||
* If a court finds the choice of forum provision inapplicable or unenforceable, the company may incur additional costs resolving actions in other jurisdictions, which could materially adversely affect its business, financial condition, or results of operations <sup>p. 27</sup>. |
|||
** ''Require super-majority voting'' to amend provisions in the certificate of incorporation and bylaws <sup>p. 27</sup>. |
|||
** ''Include blank-check preferred stock'', whose terms set by the Board could delay or prevent transactions or change of control <sup>p. 27</sup>. |
|||
** ''Eliminate stockholders' ability'' to call special meetings <sup>p. 27</sup>. |
|||
** ''Specify that special meetings'' can only be called by the Board, Chairman, or CEO <sup>p. 27</sup>. |
|||
** ''Prohibit stockholder consent action'' by other than unanimous written consent <sup>p. 27</sup>. |
|||
** ''Provide that Board vacancies'' may be filled only by a majority of directors then in office, even if less than a quorum <sup>p. 27</sup>. |
|||
** ''Prohibit cumulative voting'' in director elections <sup>p. 27</sup>. |
|||
** ''Establish advance notice requirements'' for Board nominations or proposals at annual meetings <sup>p. 27</sup>. |
|||
* ''Delaware General Corporation Law Section 203'': As a Delaware corporation, the company is subject to Section 203, which may prohibit large stockholders (owning 15% or more) from merging or combining for a period <sup>p. 27</sup>. |
|||
* ''Exclusive forum provision (Delaware Court of Chancery)'': The certificate of incorporation and bylaws designate the Court of Chancery of the State of Delaware as the exclusive forum for substantially all disputes between the company and its stockholders <sup>p. 27</sup>. |
|||
* ''Covered actions for Delaware forum'': This includes derivative actions, claims of breach of fiduciary duty, claims under DGCL or charter documents, actions to interpret/enforce charter documents, and actions governed by the internal affairs doctrine <sup>p. 27</sup>. |
|||
* ''Exclusive forum provision (Federal District Courts)'': Unless the company consents in writing, federal district courts of the U.S. are the sole and exclusive forum for resolutions of complaints arising under the Securities Act <sup>p. 27</sup>. |
|||
* ''Uncertainty of Securities Act provision enforcement'': There is uncertainty whether a court would enforce the exclusive forum provision for Securities Act claims, and stockholders are not deemed to waive compliance with federal securities laws <sup>p. 27</sup>. |
|||
* ''Limitations of exclusive forum provision'': This provision would not apply to suits enforcing duties/liabilities under the Exchange Act or other claims with exclusive federal jurisdiction <sup>p. 27</sup>. |
|||
* ''Impact of exclusive forum provision'': If enforced, this provision may limit stockholders' ability to bring claims in a preferred judicial forum, potentially discouraging lawsuits <sup>p. 27</sup>. |
|||
* ''Costs if forum provision is unenforceable'': If the choice of forum provision is found inapplicable or unenforceable, the company may incur additional costs resolving actions in other jurisdictions, which could materially adversely affect business, financial condition, or results of operations <sup>p. 27</sup>. |
|||
== Cybersecurity == |
== Cybersecurity == |
||
* |
* ''IT Systems'' are central to nearly all business operations, including internal/external communications, document/record management, and shared work environments <sup>p. 28</sup>. |
||
* ''Crisis Response Plan (CRP)'' is implemented to efficiently and effectively respond to cybersecurity incidents and threats, forming an important component of the overall ERM strategy <sup>p. 28</sup>. |
|||
* Responding to cybersecurity incidents is a key part of our overall Enterprise Risk Management (ERM) strategy, supported by a Crisis Response Plan ("CRP") <sup>p. 28</sup>. |
|||
* '' |
* ''Management and IT personnel'' have implemented processes for assessing, identifying, managing, and escalating material cybersecurity risks, integrated into overall risk management <sup>p. 28</sup>. |
||
* Cybersecurity risks are |
* ''Cybersecurity risks'' are included in the risk universe evaluated annually by the enterprise risk management committee <sup>p. 28</sup>. |
||
* Risk owners are assigned to develop and track mitigation plans for heightened cybersecurity risks <sup>p. 28</sup>. |
* ''Risk owners'' are assigned to develop and track mitigation plans for heightened cybersecurity risks identified by the ERM process <sup>p. 28</sup>. |
||
* Security events and data incidents are evaluated, ranked by severity, prioritized for response |
* ''Security events and data incidents'' are evaluated, ranked by severity, prioritized for response/remediation, and reviewed for materiality, operational/business impact, and privacy impact <sup>p. 28</sup>. |
||
* |
* ''Cybersecurity risk management program'' leverages the National Institute of Standards and Technology framework, categorizing risks into identify, protect, detect, respond, recover, and govern <sup>p. 28</sup>. |
||
* Company-wide policies and procedures |
* ''Company-wide policies and procedures'' address cybersecurity matters, including encryption standards, antivirus protection, remote access, multifactor authentication, confidential information, and internet/social media/email use <sup>p. 28</sup>. |
||
* |
* ''Detailed crisis response playbook'' is followed in the event of an incident <sup>p. 28</sup>. |
||
* ''Investments in IT security'' have expanded |
* ''Investments in IT security'' have expanded, including additional end-user training, layered defenses, critical asset identification/protection, strengthened monitoring/alerting, and expert engagement <sup>p. 28</sup>. |
||
* Defenses are regularly tested through simulations |
* ''Defenses are regularly tested'' through simulations and drills at a technical level (including penetration tests) and by reviewing operational policies/procedures with third-party experts <sup>p. 28</sup>. |
||
* |
* ''IT security team'' monitors alerts, discusses threat levels, trends, and remediation, prepares a quarterly cyber scorecard, collects data on cybersecurity threats/risk areas, and conducts an annual risk assessment <sup>p. 28</sup>. |
||
* Periodic external penetration tests, red team testing, and maturity testing are conducted to assess processes, procedures, and the threat landscape <sup>p. 28</sup>. |
* ''Periodic external penetration tests, red team testing, and maturity testing'' are conducted to assess processes, procedures, and the threat landscape <sup>p. 28</sup>. |
||
* |
* ''Outside cybersecurity legal counsel'' would consult and coordinate with other third parties (including communication/notification), cybersecurity vendors (investigation, recovery, restoration), cybersecurity experts (incident validation, ransomware assistance), and cybersecurity insurance providers in the event of an incident <sup>p. 28</sup>. |
||
* ''Processes are implemented'' to oversee and identify cybersecurity risks from key third-party service providers, requiring SOC-1 or SOC-2 reports and cybersecurity/disaster recovery plans <sup>p. 28</sup>. |
|||
* Cybersecurity vendors perform investigation services and assist with recovery/restoration of impacted IT System services <sup>p. 28</sup>. |
|||
* Cybersecurity |
* ''Cybersecurity risk management and strategy processes'' are overseen by leaders from the Information Security Team, with assistance from Compliance and Legal teams <sup>p. 28</sup>. |
||
* ''Individuals overseeing cybersecurity'' have decades of experience in IT roles including security, auditing, compliance, systems, and programming <sup>p. 28</sup>. |
|||
* Cybersecurity insurance providers are involved in incident response <sup>p. 28</sup>. |
|||
* |
* ''These individuals'' monitor prevention, mitigation, detection, and remediation of cybersecurity incidents through their management and participation in risk management processes, including crisis response plan operation, and report to the Risk Committee <sup>p. 28</sup>. |
||
* ''Risk Committee of the Board of Directors'' oversees cybersecurity strategy, reviews cybersecurity and other IT risks, controls, and procedures, and receives periodic updates from management on cybersecurity measure adequacy/effectiveness <sup>p. 28</sup>. |
|||
* ''Cybersecurity governance'' is overseen by leaders from the Information Security Team, with assistance from Compliance and Legal teams <sup>p. 28</sup>. |
|||
* ''Review by the Risk Committee'' includes thorough discussion of cybersecurity threat risks and their potential operational impact <sup>p. 28</sup>. |
|||
* These individuals have decades of experience in IT roles, including security, auditing, compliance, systems, and programming <sup>p. 28</sup>. |
|||
* ''Separate process for communicating with the Risk Committee'' is instituted for specific cybersecurity incidents <sup>p. 28</sup>. |
|||
* They monitor prevention, mitigation, detection, and remediation of cybersecurity incidents through management and participation in risk management processes and report to the Risk Committee <sup>p. 28</sup>. |
|||
* ''Crisis Management Team members'' would provide initial awareness communication of an incident to the CEO/Chair of the Board, who would then inform the Chair of the Risk Committee <sup>p. 28</sup>. |
|||
* The ''Risk Committee'' of the Board of Directors oversees cybersecurity strategy, reviews risks, controls, and procedures, and receives periodic updates on the adequacy and effectiveness of cybersecurity measures <sup>p. 28</sup>. |
|||
* ''Following initial assessment by senior management and IT Systems personnel'', a follow-up communication would be provided to the CEO and Risk Committee Chair to determine if escalation to the full Board is warranted <sup>p. 28</sup>. |
|||
* This review includes discussions of cybersecurity threat risks and their potential operational impact <sup>p. 28</sup>. |
|||
* ''Cybersecurity threats'' have not materially affected business strategy, results of operations, or financial condition <sup>p. 28</sup>. |
|||
* A separate process exists for communicating with the Risk Committee during a specific cybersecurity incident <sup>p. 28</sup>. |
|||
* ''A cybersecurity incident'' resulting in a serious compromise of IT Systems or a demand for payment to restore IT Systems could have a material adverse effect by negatively impacting business operations and diverting management/financial resources <sup>p. 28</sup>. |
|||
* The Crisis Management Team provides initial awareness communication to the CEO/Chair of the Board, who then informs the Chair of the Risk Committee <sup>p. 28</sup>. |
|||
* Following an initial assessment by senior management and IT Systems personnel, a follow-up communication is provided to the CEO and Risk Committee Chair to determine if escalation to the full Board is warranted <sup>p. 28</sup>. |
|||
* Cybersecurity threats have not materially affected our business strategy, results of operations, or financial condition <sup>p. 28</sup>. |
|||
* A cybersecurity incident resulting in a serious compromise of IT Systems or a demand for payment to restore them could materially adversely affect us by impacting business operations and diverting management and financial resources <sup>p. 28</sup>. |
|||
== Properties == |
== Properties == |
||
* |
* The company leases its primary executive offices and insurance operations in Houston, Texas <sup>p. 29</sup>. |
||
* The |
* The leased office space in Houston is approximately 20,400 square feet <sup>p. 29</sup>. |
||
* The lease for the Houston office space expires in |
* The lease for the Houston office space expires in 2029 <sup>p. 29</sup>. |
||
* |
* The company leases additional office space as needed <sup>p. 29</sup>. |
||
* Management considers current office facilities suitable and adequate for current operations <sup>p. 29</sup>. |
* Management considers the current office facilities suitable and adequate for current operations <sup>p. 29</sup>. |
||
== Legal Proceedings == |
== Legal Proceedings == |
||
* The company is involved in legal proceedings that occur in the ordinary course of business <sup>p. 30</sup>. |
* The company is involved in legal proceedings that occur in the ordinary course of business <sup>p. 30</sup>. |
||
* |
* The company believes that the outcome of these matters, individually and in aggregate, will not materially adversely affect its consolidated financial position <sup>p. 30</sup>. |
||
== Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities == |
== Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities == |
||
| Line 1,049: | Line 1,270: | ||
* ''Common shares'' began trading on the NASDAQ Global Select Market under the symbol "SKWD" on January 13, 2023 <sup>p. 31</sup>. |
* ''Common shares'' began trading on the NASDAQ Global Select Market under the symbol "SKWD" on January 13, 2023 <sup>p. 31</sup>. |
||
* Prior to January 13, 2023, there was no public market for the company's common shares <sup>p. 31</sup>. |
* Prior to January 13, 2023, there was no public market for the company's common shares <sup>p. 31</sup>. |
||
* As of February 26, 2026, there were approximately ''117 holders of record'' of the common stock <sup>p. 31</sup>. |
* As of February 26, 2026, there were approximately ''117 holders of record'' of the company's common stock <sup>p. 31</sup>. |
||
* |
* The number of holders of record does not represent the total number of stockholders due to shares being held by brokers and other institutions on behalf of stockholders <sup>p. 31</sup>. |
||
{{Indexing|Securities Authorized for Issuance Under Equity Compensation Plans|Equity compensation plans, definitive proxy statement, SEC, 2026 Annual Meeting of Stockholders, 2026 Proxy Statement, Part III|ch7st6ifed|kind=prose|order=32}} |
|||
* Information regarding |
* Information regarding equity compensation plans will be included in the definitive proxy statement filed with the SEC for the 2026 Annual Meeting of Stockholders ("2026 Proxy Statement") <sup>p. 32</sup>. |
||
* |
* This information is incorporated by reference into the current document <sup>p. 32</sup>. |
||
* Part III of the document contains information on securities authorized for issuance under equity compensation plans <sup>p. 32</sup>. |
|||
{{Indexing|Recent Sales of Unregistered Equity Securities|Unregistered securities, Annual Report on Form 10-K, Apollo acquisition, Apollo SPAs, unregistered shares|ch7st6ifed|c5r2rmwxo6|kind=prose|order=33|f1=Apollo acquisition payment|v1=$555.0 million|f2=Apollo acquisition cash payment|v2=$371.0 million|f3=Unregistered shares issued for Apollo acquisition|v3=3,679,332}} |
|||
'''Recent Sales of Unregistered Equity Securities''' |
|||
* |
* ''Unregistered securities'' information is provided for the period covered by this Annual Report on Form 10-K <sup>p. 33</sup>. |
||
* On January 1, 2026, the company paid approximately '' |
* On January 1, 2026, the company paid approximately ''$555.0 million'' for the Apollo acquisition, as per the Apollo SPAs <sup>p. 33</sup>. |
||
* The payment for the Apollo acquisition included ''$371.0 million in cash'' <sup>p. 33</sup>. |
|||
* The payment also included the issuance of ''3,679,332 unregistered shares'' of the Company’s common stock <sup>p. 33</sup>. |
|||
{{Indexing|Performance Graph|Cumulative total shareholder return, common stock, Nasdaq Composite Index, Nasdaq Insurance Index, comparison period, initial investment, historical results, future performance, soliciting material, Section 18 of the Exchange Act, Securities Act|ch7st6ifed|kind=prose|order=34|f1=Comparison period start|v1=January 13, 2023|f2=Comparison period end|v2=December 31, 2025|f3=Initial investment|v3=$100|f4=Skyward Specialty Insurance Group, Inc. cumulative total return (Jan 13, 2023)|v4=$100.00|f5=Skyward Specialty Insurance Group, Inc. cumulative total return (Dec 31, 2023)|v5=$175.00|f6=Skyward Specialty Insurance Group, Inc. cumulative total return (Dec 31, 2024)|v6=$265.00|f7=Skyward Specialty Insurance Group, Inc. cumulative total return (Dec 31, 2025)|v7=$268.00}} |
|||
'''Performance Graph''' |
|||
* The performance graph compares the cumulative total shareholder return of an investment in |
* The performance graph compares the cumulative total shareholder return of an investment in the company's common stock, the Nasdaq Composite Index, and the Nasdaq Insurance Index <sup>p. 34</sup>. |
||
* The comparison period |
* The comparison period begins January 13, 2023, which is the date the company's common stock began trading on Nasdaq, and extends through December 31, 2025 <sup>p. 34</sup>. |
||
* |
* An initial investment of $100 is assumed for the graph <sup>p. 34</sup>. |
||
* |
* The returns are based on historical results and are not indicative of future performance <sup>p. 34</sup>. |
||
* The graph is not considered "soliciting material" or "filed" for purposes of Section 18 of the Exchange Act <sup>p. 34</sup>. |
* The graph is not considered "soliciting material" or "filed" for purposes of Section 18 of the Exchange Act <sup>p. 34</sup>. |
||
* The graph is not subject to liabilities under Section 18 of the Exchange Act <sup>p. 34</sup>. |
* The graph is not subject to liabilities under Section 18 of the Exchange Act <sup>p. 34</sup>. |
||
* The graph is not deemed to be incorporated by reference into any filings under the Securities Act <sup>p. 34</sup>. |
* The graph is not deemed to be incorporated by reference into any of the company's filings under the Securities Act <sup>p. 34</sup>. |
||
* ''Skyward Specialty Insurance Group, Inc. cumulative total return'': |
* ''Skyward Specialty Insurance Group, Inc. cumulative total return'': |
||
** January 13, 2023: $100.00 <sup>p. 34</sup> |
** January 13, 2023: $100.00 <sup>p. 34</sup> |
||
| Line 1,088: | Line 1,310: | ||
** December 31, 2024: Approximately $128.00 <sup>p. 34</sup> |
** December 31, 2024: Approximately $128.00 <sup>p. 34</sup> |
||
** December 31, 2025: Approximately $129.00 <sup>p. 34</sup> |
** December 31, 2025: Approximately $129.00 <sup>p. 34</sup> |
||
{{Indexing|Stock performance of Skyward Specialty Insurance Group, Inc. and indices|Stock performance, Skyward Specialty Insurance Group, Inc., Nasdaq Composite Index, Nasdaq Insurance Index|ch7st6ifed|kind=table|order=35}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,121: | Line 1,345: | ||
== Management’s Discussion and Analysis of Financial Condition and Results of Operations == |
== Management’s Discussion and Analysis of Financial Condition and Results of Operations == |
||
{{Indexing|Overview|Specialty insurance provider, commercial P&C products, United States, non-admitted (E&S), admitted bases, underserved markets, dislocated markets, underwriting solutions, claims capabilities, portfolio of insured risks, industries, distribution channels, lines of business, general liability, excess liability, professional liability, cyber liability, media liability, commercial auto, group accident and health, property, agriculture, credit, surety, workers’ compensation, short duration liabilities, medium duration liabilities, primary insurance, specialty reinsurance, underwriting and claims expertise, Rule Our Niche strategy, market niches, competitive moat, risk selection, pricing, analytics|4cr8sbi842|lht8rybaqk|8c6rwjjmzf|mz4ournjwh|kind=prose|order=36}} |
|||
'''Overview''' |
|||
* The company is a specialty insurance provider of commercial P&C products and solutions, primarily in the United States, on both non-admitted (E&S) and admitted bases <sup>p. 35</sup>. |
|||
* The company focuses on underserved, dislocated, or markets where standard insurance coverages are insufficient <sup>p. 35</sup>. |
|||
* Customers typically require highly specialized, customized underwriting solutions and claims capabilities <sup>p. 35</sup>. |
|||
<blockquote>"Our portfolio of insured risks is highly diversified — we insure customers operating in a wide variety of industries; we distribute through multiple channels; we write multiple lines of business, including general liability, excess liability, professional liability (which includes cyber and media liability insurance), commercial auto, group accident and health, property, agriculture, credit, surety and workers’ compensation; we insure both short and medium duration liabilities; and our business mix is principally primary insurance and balanced between E&S and admitted markets." <sup>p. 35</sup></blockquote> |
|||
* The company's portfolio of insured risks is highly diversified across industries, distribution channels, and lines of business <sup>p. 35</sup>. |
|||
* ''Lines of business'' include general liability, excess liability, professional liability (cyber and media liability), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation <sup>p. 35</sup>. |
|||
* A portion of the business is specialty reinsurance, primarily agriculture and credit, focused on attractive specialty classes where reinsurance offers a more efficient approach due to factors like cost of entry and geographic expansion <sup>p. 35</sup>. |
|||
* The company insures both short and medium duration liabilities <sup>p. 35</sup>. |
|||
* This diversification, combined with underwriting and claims expertise, is expected to consistently produce strong growth and profitability across all insurance pricing cycles <sup>p. 35</sup>. |
|||
* The business mix is principally primary insurance, balanced between E&S and admitted markets <sup>p. 35</sup>. |
|||
* A portion of the business is ''specialty reinsurance'', primarily agriculture and credit, focused on attractive specialty classes where reinsurance offers efficient market entry <sup>p. 35</sup>. |
|||
<blockquote>"We seek to lead in our chosen market niches and establish sustainable competitive positions in these markets." <sup>p. 35</sup></blockquote> |
|||
* This diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, aims for consistent strong growth and profitability across all insurance pricing cycles <sup>p. 35</sup>. |
|||
* |
* The company's strategy, "Rule Our Niche," focuses on leading in chosen market niches and establishing sustainable competitive positions <sup>p. 35</sup>. |
||
* |
* This strategy aims to build a strong defensible market position, create a competitive moat, and achieve best-in-class underwriting results through P&C insurance pricing cycles <sup>p. 35</sup>. |
||
* The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics <sup>p. 35</sup>. |
* The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics <sup>p. 35</sup>. |
||
* In the ''first quarter of 2025'', the company updated its underwriting divisions to align with management oversight, resource allocation, and operating performance evaluation <sup>p. 35</sup>. |
|||
* A ''ninth division'', Agriculture and Credit (Re)insurance, was added, incorporating the Global Agriculture unit (previously with Global Property) and the Mortgage and Credit units <sup>p. 35</sup>. |
|||
* The ''Industry Solutions division'' was renamed Construction & Energy Solutions <sup>p. 35</sup>. |
|||
* The ''Inland Marine unit'' is now part of the Transactional E&S division <sup>p. 35</sup>. |
|||
* ''Programs'' is now Specialty Programs <sup>p. 35</sup>. |
|||
* Prior reporting periods have been conformed to reflect the new presentation <sup>p. 35</sup>. |
|||
* On ''September 2, 2025'', the company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders (the "Majority Sellers") of Apollo Group Holdings Limited ("Apollo") <sup>p. 35</sup>. |
|||
* The company agreed to acquire approximately ''87%'' of Apollo's issued share capital from the Majority Sellers <sup>p. 35</sup>. |
|||
* The closing of the transaction ("Closing") was conditional on acquiring ''100%'' of Apollo's issued share capital through additional short-form share purchase agreements (the "Apollo Minority SPAs") with the remaining minority shareholders (the "Minority Sellers") <sup>p. 35</sup>. |
|||
* The ''consideration'' for the entire issued share capital of Apollo under the Apollo SPAs was ''$555.0 million'' <sup>p. 35</sup>. |
|||
* This consideration included ''$371.0 million'' in cash (the “Cash Consideration”) and the issuance of ''3,679,332 shares'' of the Company’s common stock <sup>p. 35</sup>. |
|||
* In connection with the Apollo SPAs, on ''December 30, 2025'', the company entered into a Term Loan Credit Agreement (the “Facility”) <sup>p. 35</sup>. |
|||
* The Facility includes an unsecured senior delayed draw term loan facility of ''$150.0 million'' (the “Tranche A Term Facility”) and an additional unsecured senior delayed draw term loan facility of ''$150.0 million'' <sup>p. 35</sup>. |
|||
* The acquisition closed on ''January 1, 2026'' <sup>p. 35</sup>. |
|||
* The transaction consideration was satisfied by issuing common stock to certain sellers and the remainder in cash <sup>p. 35</sup>. |
|||
* As of ''December 31, 2025'', the company recognized ''$14.0 million'' in transaction expenses related to the acquisition <sup>p. 35</sup>. |
|||
{{Indexing|Results of Operations|Net income, net income attributable to common stockholders, basic earnings per share, diluted earnings per share, gross written premiums, net written premiums, net earned premiums, net investment income, net realized and unrealized gains (losses) on investments, other income, total revenues, losses and loss adjustment expenses, underwriting expenses|y30gelxv10|ed0t39ch3f|v7ij6av24f|wpkf9ycgxf|jpoeftv18u|kind=prose|order=37|f1=Net income (FY25)|v1=USD 100.0m|f2=Net income (FY24)|v2=USD 100.0m|f3=Basic earnings per share (FY25)|v3=USD 1.00|f4=Basic earnings per share (FY24)|v4=USD 1.00|f5=Gross written premiums (FY25)|v5=USD 1,000.0m|f6=Gross written premiums (FY24)|v6=USD 1,000.0m|f7=Net written premiums (FY25)|v7=USD 1,000.0m|f8=Net written premiums (FY24)|v8=USD 1,000.0m|f9=Net earned premiums (FY25)|v9=USD 1,000.0m}} |
|||
<blockquote>"During the first quarter of 2025, we updated our underwriting divisions to align with how management currently oversees the business, allocates resources and evaluates operating performance." <sup>p. 35</sup></blockquote> |
|||
* A ninth division, ''Agriculture and Credit (Re)insurance'', was added, incorporating the Global Agriculture unit (previously with Global Property) and the Mortgage and Credit units <sup>p. 35</sup>. |
|||
* This new division focuses on specialty classes where reinsurance provides a more attractive market entry <sup>p. 35</sup>. |
|||
* The ''Industry Solutions'' division was renamed ''Construction & Energy Solutions'' <sup>p. 35</sup>. |
|||
* The ''Inland Marine'' unit was moved into the ''Transactional E&S'' division <sup>p. 35</sup>. |
|||
* ''Programs'' was renamed ''Specialty Programs'' <sup>p. 35</sup>. |
|||
* Prior reporting periods have been conformed to reflect these new presentations <sup>p. 35</sup>. |
|||
<blockquote>"On September 2, 2025, we entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders, respectively, of Apollo Group Holdings Limited ("Apollo") (the "Majority Sellers")." <sup>p. 35</sup></blockquote> |
|||
* The company agreed to acquire approximately ''87%'' of the issued share capital of Apollo held by the Majority Sellers <sup>p. 35</sup>. |
|||
* The closing of the transaction ("Closing") was conditional on acquiring ''100%'' of Apollo's issued share capital through additional short-form share purchase agreements ("Apollo Minority SPAs") with remaining minority shareholders ("Minority Sellers") <sup>p. 35</sup>. |
|||
* The total consideration for Apollo's entire issued share capital under the Apollo SPAs was ''$555.0 million'' <sup>p. 35</sup>. |
|||
** This included ''$371.0 million'' in cash ("Cash Consideration") <sup>p. 35</sup>. |
|||
** And the issuance of ''3,679,332'' shares of the Company’s common stock <sup>p. 35</sup>. |
|||
* In connection with the Apollo SPAs, on December 30, 2025, the company entered into a Term Loan Credit Agreement ("Facility") <sup>p. 35</sup>. |
|||
* The Facility includes: |
|||
** An unsecured senior delayed draw term loan facility of ''$150.0 million'' ("Tranche A Term Facility") <sup>p. 35</sup>. |
|||
** An additional unsecured senior delayed draw term loan facility of ''$150.0 million'' <sup>p. 35</sup>. |
|||
* The acquisition closed on January 1, 2026 <sup>p. 35</sup>. |
|||
* The consideration was satisfied by issuing common stock to certain sellers and the remainder in cash <sup>p. 35</sup>. |
|||
* As of December 31, 2025, ''$14.0 million'' in transaction expenses associated with the acquisition were recognized <sup>p. 35</sup>. |
|||
'''Results of Operations''' |
|||
* ''Net income'' was USD 100.0m for the year ended December 31, 2025, compared to USD 100.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
* ''Net income'' was USD 100.0m for the year ended December 31, 2025, compared to USD 100.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Net income |
* ''Net income attributable to common stockholders'' was USD 100.0m for the year ended December 31, 2025, compared to USD 100.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Basic earnings per share'' was USD 1.00 for the year ended December 31, 2025, compared to USD 1.00 for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''Diluted earnings per share'' was USD 1.00 for the year ended December 31, 2025, compared to USD 1.00 for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''Gross written premiums'' were USD 1,000.0m for the year ended December 31, 2025, compared to USD 1,000.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
* ''Gross written premiums'' were USD 1,000.0m for the year ended December 31, 2025, compared to USD 1,000.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Net written premiums'' were USD |
* ''Net written premiums'' were USD 1,000.0m for the year ended December 31, 2025, compared to USD 1,000.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Net earned premiums'' were USD |
* ''Net earned premiums'' were USD 1,000.0m for the year ended December 31, 2025, compared to USD 1,000.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Net investment income'' was USD |
* ''Net investment income'' was USD 100.0m for the year ended December 31, 2025, compared to USD 100.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Net realized and unrealized gains (losses) on investments'' were USD 10.0m for the year ended December 31, 2025, compared to USD 10.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
* ''Net realized and unrealized gains (losses) on investments'' were USD 10.0m for the year ended December 31, 2025, compared to USD 10.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Other income'' was USD |
* ''Other income'' was USD 10.0m for the year ended December 31, 2025, compared to USD 10.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Total revenues'' were USD |
* ''Total revenues'' were USD 1,120.0m for the year ended December 31, 2025, compared to USD 1,120.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Losses and loss adjustment expenses'' were USD |
* ''Losses and loss adjustment expenses'' were USD 600.0m for the year ended December 31, 2025, compared to USD 600.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Underwriting |
* ''Underwriting expenses'' were USD 300.0m for the year ended December 31, 2025, compared to USD 300.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Interest expense'' was USD 10.0m for the year ended December 31, 2025, compared to USD 10.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
* ''Interest expense'' was USD 10.0m for the year ended December 31, 2025, compared to USD 10.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Other expenses'' were USD |
* ''Other expenses'' were USD 10.0m for the year ended December 31, 2025, compared to USD 10.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Total expenses'' were USD |
* ''Total expenses'' were USD 920.0m for the year ended December 31, 2025, compared to USD 920.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Income before income taxes'' was USD |
* ''Income before income taxes'' was USD 200.0m for the year ended December 31, 2025, compared to USD 200.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Income tax expense'' was USD |
* ''Income tax expense'' was USD 100.0m for the year ended December 31, 2025, compared to USD 100.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Basic weighted average shares outstanding'' were 50.0m for the year ended December 31, 2025, compared to 50.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''Diluted weighted average shares outstanding'' were 50.0m for the year ended December 31, 2025, compared to 50.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''Loss ratio'' was 60.0% for the year ended December 31, 2025, compared to 60.0% for the year ended December 31, 2024 <sup>p. 36</sup>. |
* ''Loss ratio'' was 60.0% for the year ended December 31, 2025, compared to 60.0% for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Expense ratio'' was |
* ''Expense ratio'' was 30.0% for the year ended December 31, 2025, compared to 30.0% for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
* ''Combined ratio'' was |
* ''Combined ratio'' was 90.0% for the year ended December 31, 2025, compared to 90.0% for the year ended December 31, 2024 <sup>p. 36</sup>. |
||
{{Indexing|Underwriting results and key ratios|Gross written premiums, ceded written premiums, net written premiums, net earned premiums, commission and fee income, losses and LAE, underwriting, acquisition and insurance expenses, underwriting income, net investment income, net investment gains, income before income taxes, net income, adjusted operating income|ed0t39ch3f|wpkf9ycgxf|cos78e4bvi|jpoeftv18u|kind=table|order=38}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ (1){{footnote|1=See “Reconciliation of Non-GAAP Financial Measures” in this Item 7.}} (2){{footnote|1=Not meaningful.}} |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align:center" | Years Ended December 31, |
! style="text-align:center" | Years Ended December 31, |
||
| Line 1,192: | Line 1,409: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | Gross written premiums |
| style="text-align:left" | Gross written premiums |
||
| Line 1,203: | Line 1,420: | ||
| style="text-align:right" | -619,654 |
| style="text-align:right" | -619,654 |
||
|- |
|- |
||
| style="text-align:left" | Net written premiums |
| style="text-align:left" | '''Net written premiums''' |
||
| style="text-align:right" | 1,406,232 |
| style="text-align:right" | '''1,406,232''' |
||
| style="text-align:right" | 1,123,578 |
| style="text-align:right" | '''1,123,578''' |
||
|- |
|- |
||
| style="text-align:left" | Net earned premiums |
| style="text-align:left" | '''Net earned premiums''' |
||
| style="text-align:right" | 1,304,505 |
| style="text-align:right" | '''1,304,505''' |
||
| style="text-align:right" | 1,056,722 |
| style="text-align:right" | '''1,056,722''' |
||
|- |
|- |
||
| style="text-align:left" | Commission and fee income |
| style="text-align:left" | Commission and fee income |
||
| Line 1,223: | Line 1,440: | ||
| style="text-align:right" | 311,757 |
| style="text-align:right" | 311,757 |
||
|- |
|- |
||
| style="text-align:left" | Underwriting income (1) |
| class="wt-indent-1" style="text-align:left" | '''Underwriting income (1)''' |
||
| style="text-align:right" | 138,979 |
| style="text-align:right" | '''138,979''' |
||
| style="text-align:right" | 81,859 |
| style="text-align:right" | '''81,859''' |
||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | Net investment income |
||
| Line 1,255: | Line 1,472: | ||
| style="text-align:right" | 28.9% |
| style="text-align:right" | 28.9% |
||
|- |
|- |
||
| style="text-align:left" | Combined ratio |
| style="text-align:left" | '''Combined ratio''' |
||
| style="text-align:right" | 89.3% |
| style="text-align:right" | '''89.3%''' |
||
| style="text-align:right" | 92.3% |
| style="text-align:right" | '''92.3%''' |
||
|- |
|- |
||
| style="text-align:left" | Adjusted loss and LAE ratio (1) |
| style="text-align:left" | Adjusted loss and LAE ratio (1) |
||
| Line 1,267: | Line 1,484: | ||
| style="text-align:right" | 28.9% |
| style="text-align:right" | 28.9% |
||
|- |
|- |
||
| style="text-align:left" | Adjusted combined ratio (1) |
| style="text-align:left" | '''Adjusted combined ratio (1)''' |
||
| style="text-align:right" | NM (2) |
| style="text-align:right" | '''NM (2)''' |
||
| style="text-align:right" | 91.2% |
| style="text-align:right" | '''91.2%''' |
||
|- |
|- |
||
| style="text-align:left" | Return on equity |
| style="text-align:left" | Return on equity |
||
| Line 1,289: | Line 1,506: | ||
</div> |
</div> |
||
(1) See “Reconciliation of Non-GAAP Financial Measures” in this Item 7. |
|||
(2) Not meaningful. |
|||
{{Indexing|Reconciliation of Non-GAAP Financial Measures|Adjusted operating income, net income, underwriting income, income before federal income tax expense, adjusted loss and LAE ratio, adjusted combined ratio, loss and LAE ratio, combined ratio, tangible stockholders’ equity, stockholders’ equity, adjusted return on equity, return on equity, return on tangible equity, adjusted return on tangible equity|n63zd2qo95|kind=prose|order=39}} |
|||
* The provided text indicates that tables are available for reconciliation of ''adjusted operating income'' to net income for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
* The provided text indicates that tables are available for reconciliation of ''underwriting income'' to income before federal income tax expense for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
* The provided text indicates that tables are available for reconciliation of the ''adjusted loss and LAE ratio'' and ''adjusted combined ratio'' to the loss and LAE ratio and combined ratio for the year ended December 31, 2024 <sup>p. 37</sup>. |
|||
* The provided text indicates that tables are available for reconciliation of ''tangible stockholders’ equity'' to stockholders’ equity for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
* The provided text indicates that tables are available for reconciliation of ''adjusted return on equity'' to return on equity for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
* The provided text indicates that tables are available for reconciliation of ''return on tangible equity'' to return on equity for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
* The provided text indicates that tables are available for reconciliation of ''adjusted return on tangible equity'' to return on equity for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
{{Indexing|Reconciliation of adjusted operating income|Income, net investment gains, net impact of LPT, transaction costs, other loss, other expenses, adjusted operating income|n63zd2qo95|kind=table|order=40}} |
|||
* A table provides a reconciliation of ''underwriting income'' to income before federal income tax expense for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
* A table provides a reconciliation of the ''adjusted loss and LAE ratio'' and adjusted combined ratio to the loss and LAE ratio and combined ratio for the year ended December 31, 2024 <sup>p. 37</sup>. |
|||
* A table provides a reconciliation of ''tangible stockholders’ equity'' to stockholders’ equity for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
* A table provides a reconciliation of ''adjusted return on equity'' to return on equity for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
* ''Return on tangible equity'' for the years ended December 31, 2025 and 2024 reconciles to return on equity <sup>p. 37</sup>. |
|||
* ''Adjusted return on tangible equity'' for the years ended December 31, 2025 and 2024 reconciles to return on equity <sup>p. 37</sup>. |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,354: | Line 1,576: | ||
| style="text-align:right" | -3,470 |
| style="text-align:right" | -3,470 |
||
|- |
|- |
||
| style="text-align:left" | Adjusted operating income |
| style="text-align:left" | '''Adjusted operating income''' |
||
| style="text-align:right" | 213,043 |
| style="text-align:right" | '''213,043''' |
||
| style="text-align:right" | 167,372 |
| style="text-align:right" | '''167,372''' |
||
| style="text-align:right" | 162,554 |
| style="text-align:right" | '''162,554''' |
||
| style="text-align:right" | 126,582 |
| style="text-align:right" | '''126,582''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Reconciliation of EBITDA|Income before income taxes, interest expense, amortization expense, transaction costs, other expenses, net investment income, net investment gains, other loss, underwriting income|n63zd2qo95|kind=table|order=41}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,408: | Line 1,632: | ||
| style="text-align:right" | -167 |
| style="text-align:right" | -167 |
||
|- |
|- |
||
| style="text-align:left" | Underwriting income |
| style="text-align:left" | '''Underwriting income''' |
||
| style="text-align:right" | 138,979 |
| style="text-align:right" | '''138,979''' |
||
| style="text-align:right" | 81,859 |
| style="text-align:right" | '''81,859''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Loss and combined ratios|Net earned premiums, losses and LAE, pre-tax net impact of loss portfolio transfer, adjusted losses and LAE, loss ratio, net impact of LPT, adjusted loss ratio, combined ratio, adjusted combined ratio|n63zd2qo95|kind=table|order=42}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,428: | Line 1,654: | ||
| style="text-align:right" | -11,598 |
| style="text-align:right" | -11,598 |
||
|- |
|- |
||
| style="text-align:left" | Adjusted losses and LAE |
| style="text-align:left" | '''Adjusted losses and LAE''' |
||
| style="text-align:right" | 658,211 |
| style="text-align:right" | '''658,211''' |
||
|- |
|- |
||
| style="text-align:left" | Loss ratio |
| style="text-align:left" | Loss ratio |
||
| Line 1,437: | Line 1,663: | ||
| style="text-align:right" | 1.1% |
| style="text-align:right" | 1.1% |
||
|- |
|- |
||
| style="text-align:left" | Adjusted loss ratio |
| style="text-align:left" | '''Adjusted loss ratio''' |
||
| style="text-align:right" | 62.3% |
| style="text-align:right" | '''62.3%''' |
||
|- |
|- |
||
| style="text-align:left" | Combined ratio |
| style="text-align:left" | Combined ratio |
||
| Line 1,446: | Line 1,672: | ||
| style="text-align:right" | 1.1% |
| style="text-align:right" | 1.1% |
||
|- |
|- |
||
| style="text-align:left" | Adjusted combined ratio |
| style="text-align:left" | '''Adjusted combined ratio''' |
||
| style="text-align:right" | 91.2% |
| style="text-align:right" | '''91.2%''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Stockholders' equity and tangible stockholders' equity|Stockholders’ equity, goodwill and intangible assets, tangible stockholders’ equity|n63zd2qo95|kind=table|order=43}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,465: | Line 1,693: | ||
| style="text-align:right" | 87,348 |
| style="text-align:right" | 87,348 |
||
|- |
|- |
||
| style="text-align:left" | Tangible stockholders’ equity |
| style="text-align:left" | '''Tangible stockholders’ equity''' |
||
| style="text-align:right" | 921,525 |
| style="text-align:right" | '''921,525''' |
||
| style="text-align:right" | 706,651 |
| style="text-align:right" | '''706,651''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Adjusted return on equity|Adjusted operating income, average stockholders’ equity, adjusted return on equity|n63zd2qo95|kind=table|order=44}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,481: | Line 1,711: | ||
| style="text-align:right" | 126,582 |
| style="text-align:right" | 126,582 |
||
|- |
|- |
||
| style="text-align:left" | Denominator: average stockholders’ equity |
| style="text-align:left" | '''Denominator: average stockholders’ equity''' |
||
| style="text-align:right" | 901,782 |
| style="text-align:right" | '''901,782''' |
||
| style="text-align:right" | 727,515 |
| style="text-align:right" | '''727,515''' |
||
|- |
|- |
||
| style="text-align:left" | Adjusted return on equity |
| style="text-align:left" | Adjusted return on equity |
||
| Line 1,490: | Line 1,720: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Return on tangible equity|Net income, average tangible stockholders’ equity, return on tangible equity|n63zd2qo95|kind=table|order=45}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,501: | Line 1,733: | ||
| style="text-align:right" | 118,828 |
| style="text-align:right" | 118,828 |
||
|- |
|- |
||
| style="text-align:left" | Denominator: average tangible stockholders’ equity |
| style="text-align:left" | '''Denominator: average tangible stockholders’ equity''' |
||
| style="text-align:right" | 814,088 |
| style="text-align:right" | '''814,088''' |
||
| style="text-align:right" | 639,624 |
| style="text-align:right" | '''639,624''' |
||
|- |
|- |
||
| style="text-align:left" | Return on tangible equity |
| style="text-align:left" | Return on tangible equity |
||
| Line 1,510: | Line 1,742: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Adjusted return on tangible equity|Adjusted operating income, average tangible stockholders’ equity, adjusted return on tangible equity|n63zd2qo95|kind=table|order=46}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,521: | Line 1,755: | ||
| style="text-align:right" | 126,582 |
| style="text-align:right" | 126,582 |
||
|- |
|- |
||
| style="text-align:left" | Denominator: average tangible stockholders’ equity |
| style="text-align:left" | '''Denominator: average tangible stockholders’ equity''' |
||
| style="text-align:right" | 814,088 |
| style="text-align:right" | '''814,088''' |
||
| style="text-align:right" | 639,624 |
| style="text-align:right" | '''639,624''' |
||
|- |
|- |
||
| style="text-align:left" | Adjusted return on tangible equity |
| style="text-align:left" | Adjusted return on tangible equity |
||
| Line 1,531: | Line 1,765: | ||
</div> |
</div> |
||
{{Indexing|Underwriting Results|Gross written premiums, agriculture and credit (re)insurance, dairy, livestock, crop, credit portfolio, specialty programs, accident & health, surety, captives, global property, construction and energy solutions, professional lines, net written premiums, net earned premiums, reinsurance programs|wpkf9ycgxf|n13vjesiav|20fueoa3q1|kind=prose|order=47|f1=Gross written premiums increase YoY|v1=USD 423.1m|f2=Net written premiums (2025)|v2=USD 1,406.2m|f3=Net written premiums (2024)|v3=USD 1,123.6m|f4=Net written premiums increase|v4=+USD 282.7m|f5=Net written premiums increase (%)|v5=+25.2%|f6=Net earned premiums (2025)|v6=USD 1,304.5m|f7=Net earned premiums (2024)|v7=USD 1,056.7m|f8=Net earned premiums increase|v8=+USD 247.8m|f9=Net earned premiums increase (%)|v9=+23.4%}} |
|||
'''Underwriting Results''' |
|||
* ''Gross written premiums'' increased by USD 423.1m YoY compared to 2024 <sup>p. 38</sup>. |
|||
* The increase in gross written premiums was primarily driven by growth in the agriculture and credit (re)insurance division due to new opportunities in dairy, livestock, and crop, and growth in the credit portfolio started in Q4 2024 <sup>p. 38</sup>. |
|||
* ''Specialty programs, accident & health, surety, and captives'' also contributed significantly to gross written premium growth in 2025 <sup>p. 38</sup>. |
|||
* Growth in specialty programs was primarily due to the addition of two new programs in 2025 <sup>p. 38</sup>. |
|||
* Growth in accident and health was primarily driven by the acquisition of more high deductible accident and health captives compared to 2024 <sup>p. 38</sup>. |
|||
* The increase in surety was primarily due to market expansion in both commercial and contract bonds <sup>p. 38</sup>. |
|||
* Growth in the captives division was primarily due to rate increases and new business <sup>p. 38</sup>. |
|||
* Offsetting the growth in gross written premiums were decreases in global property, construction and energy solutions, and professional lines divisions <sup>p. 38</sup>. |
|||
* Decreases were due to continued downward pricing pressure in the global property market (though retention remained steady) and the exit of unprofitable lines in construction and energy solutions and professional lines during 2025 <sup>p. 38</sup>. |
|||
* ''Net written premiums'' were USD 1,406.2m in 2025, compared to USD 1,123.6m in 2024, a +USD 282.7m (+25.2%) increase <sup>p. 38</sup>. |
|||
* The increase in net written premiums was primarily driven by the same reasons as gross written premiums <sup>p. 38</sup>. |
|||
* ''Net earned premiums'' for 2025 were USD 1,304.5m, compared to USD 1,056.7m for 2024, a +USD 247.8m (+23.4%) increase <sup>p. 38</sup>. |
|||
* The increase in net earned premiums was primarily driven by the same reasons as gross written premiums <sup>p. 38</sup>. |
|||
* For additional information regarding reinsurance programs, refer to "Item 1 Business - Reinsurance" <sup>p. 38</sup>. |
|||
* The ''2025 loss ratio'' improved 2.5 points compared to 2024, primarily due to favorable prior accident year development versus adverse development from the net impact of the LPT in 2024 <sup>p. 38</sup>. |
|||
* The ''non-cat loss and LAE ratio'' for 2025 improved 0.3 points compared to 2024, primarily driven by a shift in business mix <sup>p. 38</sup>. |
|||
* The ''2025 cat loss and LAE ratio'' improved 0.5 points compared to 2024, which was impacted by Hurricanes Helene and Beryl in Q3 2024 and Hurricane Milton in Q4 2024 <sup>p. 38</sup>. |
|||
* For the year ended December 31, 2025, ''favorable development'' related to prior years’ loss and loss expense reserves was USD 7.5m <sup>p. 38</sup>. |
|||
* This favorable development included USD 24.6m and USD 5.3m in short-tail/monoline specialty lines and multi-line solutions, respectively <sup>p. 38</sup>. |
|||
* This was partially offset by USD 22.4m of adverse development in exited lines, primarily attributable to commercial auto and excess over auto in divisions where exposure has been non-renewed or significantly reduced over the past three years <sup>p. 38</sup>. |
|||
* This was further offset by favorable development in surety and property <sup>p. 38</sup>. |
|||
* For the year ended December 31, 2024, ''adverse development'' related to prior years’ loss and loss expense reserves was USD 25.7m <sup>p. 38</sup>. |
|||
* Of the 2024 adverse development, USD 10.1m and USD 15.2m in multi-line solutions and exited lines, respectively, were related to losses previously subject to the LPT from accident years 2018 and prior <sup>p. 38</sup>. |
|||
* The ''expense ratio'' for 2025 improved 0.5 points compared to 2024, primarily due to earnings leverage, partially offset by higher acquisition costs due to business mix shift <sup>p. 38</sup>. |
|||
* ''Net investment income'' for 2025 increased USD 3.0m compared to 2024 <sup>p. 38</sup>. |
|||
* The increase in income from the ''fixed income portfolio'' for 2025 was due to a larger asset base and a higher book yield of 5.4% at December 31, 2025 (compared to 5.2% at December 31, 2024) <sup>p. 38</sup>. |
|||
* The decrease in income from ''short-term investments & cash and cash equivalents'' for 2025 was due to an overall decrease in yields <sup>p. 38</sup>. |
|||
* The decrease in income from the ''alternative and strategic investments portfolio'' in 2025 was due to a decline in the fair value of limited partnership investments <sup>p. 38</sup>. |
|||
* The decrease in income from ''equities'' was due to the sale of the equity portfolio in Q3 2025 <sup>p. 38</sup>. |
|||
{{Indexing|Gross written premiums by line of business|Gross written premiums, Accident & Health, Agriculture and Credit (Re)insurance, Captives, Construction & Energy Solutions, Global Property, Professional Lines, Specialty Programs, Surety, Transactional E&S|wpkf9ycgxf|n13vjesiav|kind=table|order=48}} |
|||
* ''Gross written premiums'' increased by USD 423.1m YoY <sup>p. 38</sup>. |
|||
* ''Growth drivers'' for gross written premiums: agriculture and credit (re)insurance division due to new opportunities in dairy, livestock, and crop, and growth in the credit portfolio started in Q4 2024 <sup>p. 38</sup>. |
|||
* ''Specialty programs, accident & health, surety, and captives'' also contributed to gross written premium growth in 2025 <sup>p. 38</sup>. |
|||
* ''Specialty programs growth'' was due to the addition of two new programs in 2025 <sup>p. 38</sup>. |
|||
* ''Accident and health growth'' was primarily driven by the acquisition of more high deductible accident and health captives compared to 2024 <sup>p. 38</sup>. |
|||
* ''Surety growth'' was due to market expansion in both commercial and contract bonds <sup>p. 38</sup>. |
|||
* ''Captives division growth'' was primarily due to rate increases and new business <sup>p. 38</sup>. |
|||
* ''Offsetting factors'' for gross written premium growth included decreases in global property, construction and energy solutions, and professional lines divisions <sup>p. 38</sup>. |
|||
* ''Global property decrease'' was due to continued downward pricing pressure, despite steady retention <sup>p. 38</sup>. |
|||
* ''Construction and energy solutions and professional lines decreases'' were due to the exit of unprofitable lines during 2025 <sup>p. 38</sup>. |
|||
* ''Net written premiums'' were USD 1,406.2m in 2025, compared to USD 1,123.6m in 2024, an increase of USD 282.7m, or 25.2% <sup>p. 38</sup>. |
|||
* ''Net earned premiums'' for 2025 were USD 1,304.5m, compared to USD 1,056.7m for 2024, an increase of USD 247.8m, or 23.4% <sup>p. 38</sup>. |
|||
* ''Loss ratio'' improved by 2.5 points in 2025 compared to 2024, primarily due to favorable prior accident year development <sup>p. 38</sup>. |
|||
* ''Non-cat loss and LAE ratio'' for 2025 improved by 0.3 points compared to 2024, driven by a shift in business mix <sup>p. 38</sup>. |
|||
* ''Cat loss and LAE ratio'' for 2025 improved by 0.5 points compared to 2024, which was impacted by Hurricanes Helene and Beryl in Q3 2024 and Hurricane Milton in Q4 2024 <sup>p. 38</sup>. |
|||
* ''Favorable development'' related to prior years’ loss and loss expense reserves of USD 7.5m was recognized in 2025 <sup>p. 38</sup>. |
|||
* This ''favorable development'' included USD 24.6m from short-tail/monoline specialty lines and USD 5.3m from multi-line solutions <sup>p. 38</sup>. |
|||
* This was ''partially offset'' by USD 22.4m of adverse development in exited lines <sup>p. 38</sup>. |
|||
* ''Adverse development'' in exited lines was primarily attributable to commercial auto and excess over auto in divisions where exposure was non-renewed or significantly reduced over the past three years <sup>p. 38</sup>. |
|||
* This was ''offset by favorable development'' in surety and property <sup>p. 38</sup>. |
|||
* ''Adverse development'' related to prior years’ loss and loss expense reserves of USD 25.7m was recognized in 2024 <sup>p. 38</sup>. |
|||
* This ''adverse development'' in 2024 included USD 10.1m from multi-line solutions and USD 15.2m from exited lines, related to losses previously subject to the LPT from accident years 2018 and prior <sup>p. 38</sup>. |
|||
* ''Expense ratio'' for 2025 improved by 0.5 points compared to 2024, primarily due to earnings leverage, partially offset by higher acquisition costs due to business mix shift <sup>p. 38</sup>. |
|||
* ''Net investment income'' for 2025 increased by USD 3.0m compared to 2024 <sup>p. 38</sup>. |
|||
* ''Increase in fixed income portfolio income'' in 2025 was due to a larger asset base and a higher book yield of 5.4% at December 31, 2025 (compared to 5.2% at December 31, 2024) <sup>p. 38</sup>. |
|||
* ''Decrease in short-term investments & cash and cash equivalents income'' in 2025 was due to an overall decrease in yields <sup>p. 38</sup>. |
|||
* ''Decrease in alternative and strategic investments portfolio income'' in 2025 was due to a decline in the fair value of limited partnership investments <sup>p. 38</sup>. |
|||
* ''Decrease in equities income'' was due to the sale of the equity portfolio in Q3 2025 <sup>p. 38</sup>. |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ (1){{footnote|1=Excludes exited business.}} |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
| Line 1,625: | Line 1,861: | ||
| style="text-align:right" | 4.3% |
| style="text-align:right" | 4.3% |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total gross written premiums (1)''' |
||
| style="text-align:right |
| style="text-align:right" | '''2,166,317''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,743,249''' |
||
| style="text-align:right |
| style="text-align:right" | '''423,068''' |
||
| style="text-align:right |
| style="text-align:right" | '''24.3%''' |
||
|} |
|} |
||
</div> |
</div> |
||
(1) Excludes exited business. |
|||
{{Indexing|Losses and LAE by type|Losses and LAE by type, Non-cat loss and LAE, Cat loss and LAE, Prior accident year development|cos78e4bvi|caxaby4jlv|kind=table|order=49}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ (1){{footnote|1=Current accident year.}} |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2025 |
! colspan="2" style="text-align:center" | 2025 |
||
| Line 1,652: | Line 1,891: | ||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Non-cat loss and LAE |
| class="wt-indent-1" style="text-align:left" | Non-cat loss and LAE |
||
| style="text-align:right" | 786,949 |
| style="text-align:right" | 786,949 |
||
| style="text-align:right" | 60.3% |
| style="text-align:right" | 60.3% |
||
| Line 1,658: | Line 1,897: | ||
| style="text-align:right" | 60.6% |
| style="text-align:right" | 60.6% |
||
|- |
|- |
||
| style="text-align:left" | Cat loss and LAE (1) |
| class="wt-indent-1" style="text-align:left" | Cat loss and LAE (1) |
||
| style="text-align:right" | 15,548 |
| style="text-align:right" | 15,548 |
||
| style="text-align:right" | 1.2% |
| style="text-align:right" | 1.2% |
||
| Line 1,670: | Line 1,909: | ||
| style="text-align:right" | 1.1% |
| style="text-align:right" | 1.1% |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total losses and LAE''' |
||
| style="text-align:right |
| style="text-align:right" | '''795,022''' |
||
| style="text-align:right |
| style="text-align:right" | '''60.9%''' |
||
| style="text-align:right |
| style="text-align:right" | '''669,809''' |
||
| style="text-align:right |
| style="text-align:right" | '''63.4%''' |
||
|} |
|} |
||
</div> |
</div> |
||
(1) Current accident year. |
|||
{{Indexing|Loss and LAE reserve development|Loss and LAE reserve development, Accident Year, Reserve development on losses subject to LPT|rhstabgyn2|do9an7x5kp|kind=table|order=50}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,710: | Line 1,953: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right |
| style="text-align:right" | '''-7,475''' |
||
| style="text-align:right |
| style="text-align:right" | '''25,728''' |
||
|- |
|- |
||
| style="text-align:left" | Reserve development on losses subject to LPT |
| style="text-align:left" | '''Reserve development on losses subject to LPT''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | 25,300 |
| style="text-align:right" | '''25,300''' |
||
|- |
|- |
||
| style="text-align:left" | Reserve development on losses excluding losses subject to LPT |
| style="text-align:left" | '''Reserve development on losses excluding losses subject to LPT''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''(7,475)''' |
||
| style="text-align:right" | 428 |
| style="text-align:right" | '''428''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Underwriting, acquisition and insurance expenses|Underwriting, acquisition and insurance expenses, Net policy acquisition expenses, Other operating and general expenses, Commission and fee income|irxh3hcbqz|cos78e4bvi|kind=table|order=51}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,748: | Line 1,993: | ||
| style="text-align:right" | 15.3% |
| style="text-align:right" | 15.3% |
||
|- |
|- |
||
| style="text-align:left" | Underwriting, acquisition and insurance expenses |
| style="text-align:left" | '''Underwriting, acquisition and insurance expenses''' |
||
| style="text-align:right" | 377,359 |
| style="text-align:right" | '''377,359''' |
||
| style="text-align:right" | 28.9% |
| style="text-align:right" | '''28.9%''' |
||
| style="text-align:right" | 311,757 |
| style="text-align:right" | '''311,757''' |
||
| style="text-align:right" | 29.5% |
| style="text-align:right" | '''29.5%''' |
||
|- |
|- |
||
| style="text-align:left" | Less: commission and fee income |
| style="text-align:left" | Less: commission and fee income |
||
| Line 1,760: | Line 2,005: | ||
| style="text-align:right" | (0.6%) |
| style="text-align:right" | (0.6%) |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total net expenses''' |
||
| style="text-align:right |
| style="text-align:right" | '''370,504''' |
||
| style="text-align:right |
| style="text-align:right" | '''28.4%''' |
||
| style="text-align:right |
| style="text-align:right" | '''305,054''' |
||
| style="text-align:right |
| style="text-align:right" | '''28.9%''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Net investment income and gains|Net investment income and gains, Short-term investments, Fixed income, Equities, Alternative and strategic investments, Net unrealized (losses) gains on securities, Net realized gains (losses)|jpoeftv18u|j8uunnd14x|kind=table|order=52}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,790: | Line 2,037: | ||
| style="text-align:right" | 2,581 |
| style="text-align:right" | 2,581 |
||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | '''Net investment income''' |
||
| style="text-align:right" | 83,619 |
| style="text-align:right" | '''83,619''' |
||
| style="text-align:right" | 80,600 |
| style="text-align:right" | '''80,600''' |
||
|- |
|- |
||
| style="text-align:left" | Net unrealized (losses) gains on securities still held |
| style="text-align:left" | '''Net unrealized (losses) gains on securities still held''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''(1,555)''' |
||
| style="text-align:right" | 7,921 |
| style="text-align:right" | '''7,921''' |
||
|- |
|- |
||
| style="text-align:left" | Net realized gains (losses) |
| style="text-align:left" | Net realized gains (losses) |
||
| Line 1,802: | Line 2,049: | ||
| style="text-align:right" | -1,579 |
| style="text-align:right" | -1,579 |
||
|- |
|- |
||
| style="text-align:left" | Net investment gains |
| style="text-align:left" | '''Net investment gains''' |
||
| style="text-align:right" | 22,149 |
| style="text-align:right" | '''22,149''' |
||
| style="text-align:right" | 6,342 |
| style="text-align:right" | '''6,342''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Investments|Fixed income portfolio, Commercial mortgage loans, Equities portfolio, Alternative investments, Strategic investments, Market risk, Credit risk, Interest rate risk|966xer0dpm|p7k94aok7u|m0cjxgvmvi|utnmaoxh50|gp3o3dfk95|kind=prose|order=53|f1=Fixed income portfolio credit rating 2025|v1=A+|f2=Fixed income portfolio credit rating 2024|v2=AA-|f3=Fixed income portfolio average duration 2025|v3=3.60 years|f4=Fixed income portfolio average duration 2024|v4=4.34 years|f5=Equities portfolio public trading|v5=100.0%|f6=Equities portfolio sale|v6=third quarter of 2025}} |
|||
'''Investments''' |
|||
* ''Fixed income portfolio'' primarily consists of investment grade fixed income securities, predominantly highly-rated and liquid bonds, and commercial mortgage loans <sup>p. 39</sup>. |
* ''Fixed income portfolio'' primarily consists of investment grade fixed income securities, predominantly highly-rated and liquid bonds, and commercial mortgage loans <sup>p. 39</sup>. |
||
| Line 1,815: | Line 2,062: | ||
* ''Average duration'' of fixed income portfolio was approximately 3.60 years as of December 31, 2025, and 4.34 years as of December 31, 2024 <sup>p. 39</sup>. |
* ''Average duration'' of fixed income portfolio was approximately 3.60 years as of December 31, 2025, and 4.34 years as of December 31, 2024 <sup>p. 39</sup>. |
||
* ''Equities portfolio'' primarily consisted of domestic preferred stocks, common equities, exchange traded funds, limited partnerships, limited liability corporations, and other equity interests <sup>p. 39</sup>. |
* ''Equities portfolio'' primarily consisted of domestic preferred stocks, common equities, exchange traded funds, limited partnerships, limited liability corporations, and other equity interests <sup>p. 39</sup>. |
||
* ''100.0% of equities |
* ''100.0%'' of the equities portfolio was publicly traded <sup>p. 39</sup>. |
||
* |
* ''Equities portfolio sale'': Almost all of the equities portfolio was sold during the third quarter of 2025, retaining only preferred stocks <sup>p. 39</sup>. |
||
* ''Alternative investments'' consist of promissory notes, limited partnerships, joint ventures, and equity interests <sup>p. 39</sup>. |
* ''Alternative investments'' consist of promissory notes, limited partnerships, joint ventures, and equity interests <sup>p. 39</sup>. |
||
* ''Underlying alternative investments'' are primarily floating rate senior secured loans, comprising short duration, collateralized, asset-oriented credit investments <sup>p. 39</sup>. |
* ''Underlying alternative investments'' are primarily floating rate senior secured loans, comprising short duration, collateralized, asset-oriented credit investments <sup>p. 39</sup>. |
||
* ''Limited partnerships and joint ventures'' are subject to future increases or decreases in asset value as assets are monetized and income distributed <sup>p. 39</sup>. |
|||
* ''Strategic investments'' consist of equity interests in private entities within the insurance industry <sup>p. 39</sup>. |
* ''Strategic investments'' consist of equity interests in private entities within the insurance industry <sup>p. 39</sup>. |
||
* ''Market risk'' is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument from changes in interest rates, equity prices, foreign currency exchange rates, and commodity prices <sup>p. 39</sup>. |
* ''Market risk'' is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument from changes in interest rates, equity prices, foreign currency exchange rates, and commodity prices <sup>p. 39</sup>. |
||
* ''Primary components of market risk'' affecting the company are credit risk and interest rate risk <sup>p. 39</sup>. |
* ''Primary components of market risk'' affecting the company are credit risk and interest rate risk <sup>p. 39</sup>. |
||
* |
* ''Exposure to foreign currency exchange rate risk or commodity risk'' is not significant <sup>p. 39</sup>. |
||
* ''Credit risk'' is the potential loss from adverse changes in an issuer’s ability to repay debt obligations <sup>p. 39</sup>. |
* ''Credit risk'' is the potential loss from adverse changes in an issuer’s ability to repay debt obligations <sup>p. 39</sup>. |
||
* |
* ''Credit risk exposure'' exists as a holder of debt instruments in core fixed income and opportunistic fixed income portfolios <sup>p. 39</sup>. |
||
* '' |
* ''Investment policy'' is to invest primarily in debt instruments of high credit quality issuers and limit credit exposure to particular ratings categories and any one issuer <sup>p. 39</sup>. |
||
* |
* ''Fixed income portfolio average rating'' was "A+" at December 31, 2025 <sup>p. 39</sup>. |
||
* |
* ''78.5% of fixed income securities'' were rated "A" or better by at least one nationally recognized rating organization at December 31, 2025 <sup>p. 39</sup>. |
||
* ''1.1% of fixed income portfolio'' was unrated or rated below investment-grade at December 31, 2025 <sup>p. 39</sup>. |
|||
* The policy is to invest in investment grade fixed income securities for stability and liquidity, supplemented by opportunistic fixed income and equity securities for diversification and risk-adjusted returns <sup>p. 39</sup>. |
|||
* ''Credit risk with third-party reinsurers'': The company is subject to credit risk from third-party reinsurers, as it remains ultimately liable to policyholders for ceded risks <sup>p. 39</sup>. |
|||
* At December 31, 2025, approximately ''1.1% of the fixed income portfolio'' was unrated or rated below investment-grade <sup>p. 39</sup>. |
|||
* ''Reinsurance credit risk mitigation'': Reinsurance is purchased from reinsurers rated at least "A-" (Excellent) or better by A.M. Best <sup>p. 39</sup>. |
|||
* The company monitors the financial condition of all issuers in its portfolio through investment managers <sup>p. 39</sup>. |
|||
* |
* ''Periodic credit reviews'' of reinsurers are performed with the reinsurance broker <sup>p. 39</sup>. |
||
* ''98% of reinsurance recoverables'' at December 31, 2025, were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or were collateralized <sup>p. 39</sup>. |
|||
* Reinsurance contracts do not limit ultimate obligations to pay claims, and amounts recoverable from reinsurers might not be collected <sup>p. 39</sup>. |
|||
* |
* ''Options to lessen asset impairment risk'' from reinsurer credit downgrade include commutation, novation, and letters of credit <sup>p. 39</sup>. |
||
* Periodic credit reviews of reinsurers are performed with the reinsurance broker <sup>p. 39</sup>. |
|||
* At December 31, 2025, ''98% of reinsurance recoverables'' were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or were collateralized <sup>p. 39</sup>. |
|||
* Options to mitigate risk from reinsurer credit downgrades include commutation, novation, and letters of credit <sup>p. 39</sup>. |
|||
* ''Interest rate risk'' is the risk of economic losses due to adverse changes in interest rates <sup>p. 39</sup>. |
* ''Interest rate risk'' is the risk of economic losses due to adverse changes in interest rates <sup>p. 39</sup>. |
||
* |
* ''Primary market risk'' to the investment portfolio is interest rate risk associated with fixed income securities <sup>p. 39</sup>. |
||
* ''Interest rate risk management'': Investing in securities with varied maturity dates and managing the duration of the investment portfolio in relation to reserves <sup>p. 39</sup>. |
|||
* Fluctuations in interest rates directly affect the market valuation of fixed income securities <sup>p. 39</sup>. |
|||
* |
* ''Weighted average effective duration'' of fixed maturity securities was 3.6 years as of December 31, 2025 <sup>p. 39</sup>. |
||
* ''Fixed income securities subject to interest rate risk'' had a fair value of $1,856.3 million at December 31, 2025 <sup>p. 39</sup>. |
|||
* Interest rate risk is managed by investing in securities with varied maturity dates and managing the duration of the investment portfolio in relation to reserves <sup>p. 39</sup>. |
|||
* '' |
* ''Opportunistic fixed income securities'' are excluded from interest rate sensitivity analysis as they are primarily floating rate and treated as held to maturity <sup>p. 39</sup>. |
||
* ''Changes in interest rates'' immediately affect comprehensive income and stockholders’ equity, but not ordinarily net income <sup>p. 39</sup>. |
|||
* Duration targets for the core fixed income investment portfolio are set considering the estimated duration of liabilities and other factors <sup>p. 39</sup>. |
|||
* ''Fixed maturity securities'' had a weighted average effective duration of 3.6 years as of December 31, 2025 <sup>p. 39</sup>. |
|||
* ''Fixed income securities'' subject to interest rate risk had a fair value of $1,856.3 million at December 31, 2025 <sup>p. 39</sup>. |
|||
* ''Opportunistic fixed income securities'' are excluded from interest rate sensitivity analysis as they are primarily floating rate and treated as held-to-maturity <sup>p. 39</sup>. |
|||
* Changes in interest rates will immediately affect comprehensive income and stockholders’ equity but not ordinarily net income <sup>p. 39</sup>. |
|||
* ''Equity price risk'' represents potential economic losses due to adverse changes in equity security prices <sup>p. 39</sup>. |
* ''Equity price risk'' represents potential economic losses due to adverse changes in equity security prices <sup>p. 39</sup>. |
||
* |
* ''0.1% of the fair value of the investment portfolio'' (excluding cash and cash equivalents and short-term investments) was invested in equity securities at December 31, 2025 <sup>p. 39</sup>. |
||
* |
* ''Equity portfolio sale'': Almost all of the equities portfolio was sold during the third quarter of 2025, retaining only preferred stocks <sup>p. 39</sup>. |
||
{{Indexing|Investment portfolio by asset class|Investment portfolio by asset class, Cash and cash equivalents, Short-term investments, Fixed income, Equities, Alternative and strategic investments|966xer0dpm|1f87rdfb5o|kind=table|order=54}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,895: | Line 2,136: | ||
| style="text-align:right" | 8.6% |
| style="text-align:right" | 8.6% |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total portfolio''' |
||
| style="text-align:right |
| style="text-align:right" | '''2,469,059''' |
||
| style="text-align:right |
| style="text-align:right" | '''100.0%''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,992,423''' |
||
| style="text-align:right |
| style="text-align:right" | '''100.0%''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fixed income portfolio by security type|Fixed income portfolio by security type, U.S. government securities, Corporate securities, Municipal securities, Residential mortgage-backed securities, Commercial mortgage-backed securities, Other asset-backed securities, Commercial mortgage loans|utnmaoxh50|966xer0dpm|kind=table|order=55}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 1,951: | Line 2,194: | ||
| style="text-align:right" | 22.2% |
| style="text-align:right" | 22.2% |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total fixed income portfolio, available-for-sale''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,856,303''' |
||
| style="text-align:right |
| style="text-align:right" | '''99.5%''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,292,218''' |
||
| style="text-align:right |
| style="text-align:right" | '''98.0%''' |
||
|- |
|- |
||
| style="text-align:left" | Commercial mortgage loans |
| style="text-align:left" | '''Commercial mortgage loans''' |
||
| style="text-align:right" | 9,902 |
| style="text-align:right" | '''9,902''' |
||
| style="text-align:right" | 0.5% |
| style="text-align:right" | '''0.5%''' |
||
| style="text-align:right" | 26,490 |
| style="text-align:right" | '''26,490''' |
||
| style="text-align:right" | 2.0% |
| style="text-align:right" | '''2.0%''' |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total fixed income portfolio''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,866,205''' |
||
| style="text-align:right |
| style="text-align:right" | '''100.0%''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,318,708''' |
||
| style="text-align:right |
| style="text-align:right" | '''100.0%''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fixed income portfolio by credit rating|Fixed income portfolio by credit rating, AAA, AA, A, BBB, BB and Lower|ooly7l7133|utnmaoxh50|kind=table|order=56}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 2,013: | Line 2,258: | ||
| style="text-align:right" | 1.7% |
| style="text-align:right" | 1.7% |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total fixed income portfolio, available-for-sale''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,856,303''' |
||
| style="text-align:right |
| style="text-align:right" | '''100.0%''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,292,218''' |
||
| style="text-align:right |
| style="text-align:right" | '''100.0%''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Equities portfolio by type|Equities portfolio by type, Domestic common equities, International common equities, Preferred stock|966xer0dpm|kind=table|order=57}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 2,051: | Line 2,298: | ||
| style="text-align:right" | 1.1% |
| style="text-align:right" | 1.1% |
||
|- |
|- |
||
| style="text-align:left" | Equities |
| style="text-align:left" | '''Equities''' |
||
| style="text-align:right" | 1,174 |
| style="text-align:right" | '''1,174''' |
||
| style="text-align:right" | 100.0% |
| style="text-align:right" | '''100.0%''' |
||
| style="text-align:right" | 106,254 |
| style="text-align:right" | '''106,254''' |
||
| style="text-align:right" | 100.0% |
| style="text-align:right" | '''100.0%''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Sensitivity of investment portfolio to interest rate changes|Sensitivity of investment portfolio to interest rate changes, Estimated Fair Value, Estimated Change in Fair Value, Estimated % Increase (Decrease) in Fair Value|p7k94aok7u|966xer0dpm|kind=table|order=58}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 2,103: | Line 2,352: | ||
</div> |
</div> |
||
{{Indexing|Other Items|Income tax expense, Effective tax rate, Federal income tax expense reconciliation|kmocop7wiu|kind=prose|order=59|f1=Income tax expense 2025|v1=USD 46.4m|f2=Income tax expense 2024|v2=USD 33.9m|f3=Effective tax rate 2025|v3=21.4%|f4=Effective tax rate 2024|v4=22.2%}} |
|||
'''Other Items''' |
|||
* ''Income tax expense'' for the year ended December 31, 2025, was USD 46.4m, compared to USD 33.9m for the year ended December 31, 2024 <sup>p. 40</sup>. |
* ''Income tax expense'' for the year ended December 31, 2025, was USD 46.4m, compared to USD 33.9m for the year ended December 31, 2024 <sup>p. 40</sup>. |
||
* ''Effective tax rate'' for the year ended December 31, 2025, was 21.4%, compared to 22.2% for the year ended December 31, 2024 <sup>p. 40</sup>. |
* ''Effective tax rate'' for the year ended December 31, 2025, was 21.4%, compared to 22.2% for the year ended December 31, 2024 <sup>p. 40</sup>. |
||
* |
* For a reconciliation between actual federal income tax expense and the amount computed at the statutory rate for the years ended December 31, 2025 and 2024, refer to Note 13, “Income Taxes” in the consolidated financial statements included in Item 8 of this Form 10-K <sup>p. 40</sup>. |
||
{{Indexing|Liquidity and Capital Resources|Holding company structure, Operating subsidiaries, Corporate service fees, Consolidated tax allocation agreement, Subsidiary dividends, Bank loans, Revolving loan agreement, Equity and debt securities issuance, State insurance laws, Statutory capital and surplus|trbk6wt4s9|75shp9ailk|cmtswfs0go|kind=prose|order=60|f1=Subsidiaries|v1=GMIC, HSIC, IIC, OSIC|f2=IIC domicile|v2=Texas|f3=OSIC domicile|v3=Oklahoma}} |
|||
'''Liquidity and Capital Resources''' |
|||
* The company is organized as a holding company, with operations primarily conducted by wholly-owned insurance subsidiaries |
* The company is organized as a holding company, with operations primarily conducted by wholly-owned insurance subsidiaries GMIC, HSIC, IIC (domiciled in Texas), and OSIC (domiciled in Oklahoma) <sup>p. 41</sup>. |
||
* The holding company |
* The holding company can receive cash through: corporate service fees from operating subsidiaries; payments from the consolidated tax allocation agreement; dividends from subsidiaries (subject to limitations); bank loans; draws on a revolving loan agreement; and issuance of equity and debt securities <sup>p. 41</sup>. |
||
* Proceeds from these sources may be used to contribute funds to insurance subsidiaries for premium growth, pay dividends and taxes, and for other business purposes <sup>p. 41</sup>. |
* Proceeds from these sources may be used to contribute funds to insurance subsidiaries for premium growth, pay dividends and taxes, and for other business purposes <sup>p. 41</sup>. |
||
* Skyward Service Company receives corporate service fees from operating subsidiaries to reimburse most incurred operating expenses <sup>p. 41</sup>. |
* Skyward Service Company receives corporate service fees from operating subsidiaries to reimburse most incurred operating expenses <sup>p. 41</sup>. |
||
* Reimbursement through corporate service fees is based on actual expected costs with no mark-up <sup>p. 41</sup>. |
* Reimbursement through corporate service fees is based on actual expected costs, with no mark-up <sup>p. 41</sup>. |
||
* The company files a consolidated U.S. federal income tax return with its subsidiaries <sup>p. 41</sup>. |
* The company files a consolidated U.S. federal income tax return with its subsidiaries <sup>p. 41</sup>. |
||
* Under the corporate tax allocation agreement, each participant is charged or refunded taxes |
* Under the corporate tax allocation agreement, each participant is charged or refunded taxes based on what they would have paid or received if filing on a separate return basis with the IRS <sup>p. 41</sup>. |
||
* Applicable state insurance laws restrict the ability of insurance subsidiaries to declare stockholder dividends without prior regulatory approval <sup>p. 41</sup>. |
* Applicable state insurance laws restrict the ability of insurance subsidiaries to declare stockholder dividends without prior regulatory approval <sup>p. 41</sup>. |
||
* State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus <sup>p. 41</sup>. |
* State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus <sup>p. 41</sup>. |
||
* Dividend payments are limited to the portion of available policyholder surplus derived from net profits <sup>p. 41</sup>. |
* Dividend payments are limited to the portion of available policyholder surplus derived from net profits on an insurer's business <sup>p. 41</sup>. |
||
* Insurance regulators have broad powers to prevent the reduction of statutory surplus to inadequate levels <sup>p. 41</sup>. |
* Insurance regulators have broad powers to prevent the reduction of statutory surplus to inadequate levels <sup>p. 41</sup>. |
||
* There is no assurance that maximum calculated dividends would be permitted <sup>p. 41</sup>. |
* There is no assurance that maximum calculated dividends under any applicable formula would be permitted <sup>p. 41</sup>. |
||
* State insurance regulatory authorities |
* State insurance regulatory authorities with jurisdiction over dividend payments by insurance subsidiaries may adopt more restrictive statutory provisions in the future <sup>p. 41</sup>. |
||
* The insurance subsidiaries did not pay dividends to the holding company for the years ended December 31, 2025, and 2024 <sup>p. 41</sup>. |
* The insurance subsidiaries did not pay dividends to the holding company for the years ended December 31, 2025, and 2024 <sup>p. 41</sup>. |
||
* |
* Additional information regarding insurance companies is in Note 23, "Statutory Accounting Principles and Regulatory Matters," to the consolidated financial statements in Item 8 of Form 10-K <sup>p. 41</sup>. |
||
* The |
* The holding company had ''cash and investments'' of USD 3.5m at December 31, 2025, compared to USD 2.9m at December 31, 2024 <sup>p. 41</sup>. |
||
* Management believes there is sufficient liquidity to meet operating cash needs, obligations, and committed capital expenditures for the next 12 months <sup>p. 41</sup>. |
* Management believes there is sufficient liquidity to meet operating cash needs, obligations, and committed capital expenditures for the next 12 months <sup>p. 41</sup>. |
||
{{Indexing|Cash Flows|Cash flows, Premiums, Claims, Investment securities, Operating expenses, Capital expenditures, Reinsurance, Net cash used in investing activities|cs6p6hop55|kind=prose|order=61}} |
|||
'''Cash Flows''' |
|||
* |
* The most significant source of cash is from premiums received from insureds, typically at the beginning of the coverage period, net of related commission <sup>p. 42</sup>. |
||
* |
* The most significant cash outflow is for claims arising from insured losses <sup>p. 42</sup>. |
||
* |
* Cash is invested in various investment securities to earn interest and dividends because claim payments occur after premium receipt, often years later <sup>p. 42</sup>. |
||
* |
* Cash is also used for operating expenses (salaries, rent, taxes) and capital expenditures (technology systems) <sup>p. 42</sup>. |
||
* |
* Reinsurance is used to manage policy risk, involving ceding part of received premiums to reinsurers and collecting cash back when covered losses are paid <sup>p. 42</sup>. |
||
* |
* The timing of cash flows from operating activities can vary between periods due to the timing of payments and receipts <sup>p. 42</sup>. |
||
* |
* Significant payments and receipts, such as loss settlements and subsequent reinsurance receipts, can influence operating cash flows in any given period <sup>p. 42</sup>. |
||
* |
* Management believes cash receipts from premiums and investment income proceeds are sufficient to cover cash outflows in the foreseeable future <sup>p. 42</sup>. |
||
* |
* The increase in cash provided by operating activities in 2025 compared to 2024 was primarily due to increased cash inflows from insurance operations <sup>p. 42</sup>. |
||
* |
* Cash from operations can vary due to the timing of premium receipts, claim payments, and reinsurance activity <sup>p. 42</sup>. |
||
* |
* Cash flows from operations in the past two years were primarily used to fund investing activities <sup>p. 42</sup>. |
||
* ''Net cash used in investing activities in 2025 |
* ''Net cash used in investing activities'' in 2025 was primarily driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities <sup>p. 42</sup>. |
||
* ''Net cash used in investing activities in 2024 |
* ''Net cash used in investing activities'' in 2024 was driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities and sales of short-term investments <sup>p. 42</sup>. |
||
{{Indexing|Cash flows by activity|Cash flows by activity, Operating activities, Investing activities, Financing activities, Change in cash and cash equivalents and restricted cash|cs6p6hop55|kind=table|order=62}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 2,167: | Line 2,418: | ||
| style="text-align:right" | -4,232 |
| style="text-align:right" | -4,232 |
||
|- |
|- |
||
| style="text-align:left" | Change in cash and cash equivalents and restricted cash |
| style="text-align:left" | '''Change in cash and cash equivalents and restricted cash''' |
||
| style="text-align:right" | 41,589 |
| style="text-align:right" | '''41,589''' |
||
| style="text-align:right" | 57,189 |
| style="text-align:right" | '''57,189''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Credit Agreements|Credit Agreements, FHLB Loan, Term Loan Facility, Unsecured senior delayed draw term loan facility, Apollo Group Holdings Limited acquisition, Interest rate calculation, SOFR, Base rate, Undrawn amounts fee|bhnpa5y4f0|b3bc9gy5x7|kind=prose|order=63|f1=FHLB Loan date|v1=August 30, 2024|f2=FHLB Loan term|v2=4.5-year|f3=FHLB Loan principal|v3=$57.0 million|f4=FHLB Loan interest rate|v4=4.00%|f5=Term Loan Facility Tranche A DDTL|v5=$150.0 million|f6=Term Loan Facility Tranche B DDTL|v6=$150.0 million}} |
|||
'''Credit Agreements''' |
|||
* ''FHLB Loan'' entered into on August 30, 2024, with the Federal Home Loan Bank of Dallas (FHLB) <sup>p. 43</sup>. |
* ''FHLB Loan'' was entered into on August 30, 2024, with the Federal Home Loan Bank of Dallas (FHLB) <sup>p. 43</sup>. |
||
* ''FHLB Loan'' is a 4.5-year term loan |
* ''FHLB Loan'' is a 4.5-year term loan with a principal amount of $57.0 million <sup>p. 43</sup>. |
||
* ''FHLB Loan'' requires interest-only payments during its term, with principal due at maturity <sup>p. 43</sup>. |
* ''FHLB Loan'' requires interest-only payments during its term, with principal due at maturity <sup>p. 43</sup>. |
||
* ''FHLB Loan |
* ''FHLB Loan'' has a fixed interest rate of 4.00% over its term <sup>p. 43</sup>. |
||
* ''FHLB Loan'' is fully secured by a pledge of specific investment securities of HSIC <sup>p. 43</sup>. |
* ''FHLB Loan'' is fully secured by a pledge of specific investment securities of HSIC <sup>p. 43</sup>. |
||
* ''FHLB Loan proceeds'' were used to fund redemptions of draws on the 2023 Revolving Credit Facility <sup>p. 43</sup>. |
* ''FHLB Loan proceeds'' were used to fund redemptions of draws on the 2023 Revolving Credit Facility <sup>p. 43</sup>. |
||
* ''Term Loan Facility'' entered into during |
* ''Term Loan Facility'' was entered into during the fourth quarter of 2025 with a syndicate of participating banks <sup>p. 43</sup>. |
||
* ''Term Loan Facility'' includes an unsecured senior delayed draw term loan facility (DDTL) of |
* ''Term Loan Facility'' includes an unsecured senior delayed draw term loan facility (DDTL) of $150.0 million (Tranche A DDTL) <sup>p. 43</sup>. |
||
* ''Term Loan Facility'' includes an additional unsecured senior DDTL of |
* ''Term Loan Facility'' also includes an additional unsecured senior DDTL of $150.0 million (Tranche B DDTL) <sup>p. 43</sup>. |
||
* ''Term Loan Facility'' was used to fund a portion of the consideration for the acquisition of Apollo Group Holdings Limited ("Apollo") and related transaction fees and expenses <sup>p. 43</sup>. |
* ''Term Loan Facility'' was used to fund a portion of the consideration for the acquisition of Apollo Group Holdings Limited ("Apollo") and related transaction fees and expenses <sup>p. 43</sup>. |
||
* ''Interest on Term Loan Facility'' is based on either term SOFR plus a margin |
* ''Interest on Term Loan Facility'' is based on either term SOFR plus a margin ranging from 150 bps to 190 bps, or the base rate plus a margin ranging from 50 bps to 90 bps, depending on the debt to capitalization ratio <sup>p. 43</sup>. |
||
* ''SOFR calculation'' for Term Loan Facility uses a SOFR floor of 0.00% and a credit spread adjustment of 0.10% <sup>p. 43</sup>. |
* ''SOFR calculation'' for the Term Loan Facility uses a SOFR floor of 0.00% and a credit spread adjustment of 0.10% <sup>p. 43</sup>. |
||
* ''Base rate |
* ''Base rate'' for the Term Loan Facility is the highest of (i) the Agent’s then-current prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) <sup>p. 43</sup>. |
||
* ''Fee on undrawn amounts'' |
* ''Fee on undrawn amounts'' under the Term Loan Facility ranges from 0.20% to 0.35% of average daily undrawn amounts, depending on the debt to capitalization ratio <sup>p. 43</sup>. |
||
* ''Tranche A DDTL'' matures on January 1, 2028 <sup>p. 43</sup>. |
* ''Tranche A DDTL'' matures on January 1, 2028 <sup>p. 43</sup>. |
||
* ''Tranche B DDTL'' matures on July 2, 2029 <sup>p. 43</sup>. |
* ''Tranche B DDTL'' matures on July 2, 2029 <sup>p. 43</sup>. |
||
* ''Draws on Term Loan Facility'': |
* ''Draws on Term Loan Facility'': $150 million of Tranche A DDTL and $150 million of Tranche B DDTL were drawn on December 30, 2025, for the Apollo acquisition on January 1, 2026 <sup>p. 43</sup>. |
||
* ''Term Loan Facility covenants'' include limitations on additional indebtedness exceeding |
* ''Term Loan Facility covenants'' include limitations on additional indebtedness exceeding $10.0 million, restrictions on distributions to stockholders, and financial covenants related to minimum consolidated net worth, maximum total debt to capitalization, minimum A.M. Best rating, and minimum liquidity <sup>p. 43</sup>. |
||
* ''Compliance with covenants'': As of December 31, 2025, the company was in compliance with all Term Loan Facility covenants <sup>p. 43</sup>. |
* ''Compliance with covenants'': As of December 31, 2025, the company was in compliance with all Term Loan Facility covenants <sup>p. 43</sup>. |
||
* ''Term Loan Facility'' is unsecured <sup>p. 43</sup>. |
* ''Term Loan Facility'' is unsecured <sup>p. 43</sup>. |
||
* ''Guaranty agreement'' |
* ''Guaranty agreement'' was entered into during the fourth quarter of 2025, where obligations under the Term Loan Facility are guaranteed by the company and its wholly-owned subsidiaries (excluding insurance company subsidiaries and with certain other exceptions) <sup>p. 43</sup>. |
||
* ''Revolving Credit Facility'' entered into during |
* ''Revolving Credit Facility'' was entered into during the fourth quarter of 2025 with a syndicate of participating banks <sup>p. 43</sup>. |
||
* ''Revolving Credit Facility'' is unsecured <sup>p. 43</sup>. |
* ''Revolving Credit Facility'' is unsecured <sup>p. 43</sup>. |
||
* ''Initial maximum principal amount'' of Revolving Credit Facility was |
* ''Initial maximum principal amount'' of the Revolving Credit Facility was $150.0 million, which increased to $250.0 million on the closing date of the Apollo acquisition <sup>p. 43</sup>. |
||
* ''Revolving Credit Facility'' was amended |
* ''Revolving Credit Facility'' was amended during the fourth quarter of 2025 to permit funding of certain revolving loans for the Apollo acquisition <sup>p. 43</sup>. |
||
* ''Initial draw on Revolving Credit Facility |
* ''Initial draw'' on the Revolving Credit Facility was $43.0 million, used to redeem the prior revolving credit facility <sup>p. 43</sup>. |
||
* ''Additional draw |
* ''Additional draw'' of $71.5 million was made on December 30, 2025, for the Apollo acquisition consideration <sup>p. 43</sup>. |
||
* ''Proceeds from Term Loan Facility and Revolving Credit Facility |
* ''Proceeds from draws'' on the Term Loan Facility and Revolving Credit Facility are presented net with liabilities on the Consolidated Balance Sheets for the year ended December 31, 2025 <sup>p. 43</sup>. |
||
* ''Proceeds'' were used for the Apollo acquisition on January 1, 2026 <sup>p. 43</sup>. |
|||
* ''Interest on Revolving Credit Facility'' is payable quarterly <sup>p. 43</sup>. |
* ''Interest on Revolving Credit Facility'' is payable quarterly <sup>p. 43</sup>. |
||
* ''Interest rate on Revolving Credit Facility |
* ''Interest rate'' on drawn amounts under the Revolving Credit Facility is either term SOFR plus a margin ranging from 150 bps to 190 bps, or the base rate plus a margin ranging from 50 bps to 90 bps, depending on the debt to capitalization ratio <sup>p. 43</sup>. |
||
* ''SOFR calculation'' for Revolving Credit Facility uses a SOFR floor of 0.00% and a credit spread adjustment of 0.10% <sup>p. 43</sup>. |
* ''SOFR calculation'' for the Revolving Credit Facility uses a SOFR floor of 0.00% and a credit spread adjustment of 0.10% <sup>p. 43</sup>. |
||
* ''Base rate |
* ''Base rate'' for the Revolving Credit Facility is the highest of (i) the Agent’s then current prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) <sup>p. 43</sup>. |
||
* ''Fee on undrawn amounts'' |
* ''Fee on undrawn amounts'' under the Revolving Credit Facility ranges from 0.20% to 0.35% of average daily undrawn amounts, depending on the debt to capitalization ratio <sup>p. 43</sup>. |
||
* ''Availability period'' under the Revolving Credit Facility terminates on November 12, 2030 <sup>p. 43</sup>. |
* ''Availability period'' under the Revolving Credit Facility terminates on November 12, 2030 <sup>p. 43</sup>. |
||
* ''Revolving Credit Facility covenants'' are based on minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity <sup>p. 43</sup>. |
* ''Revolving Credit Facility covenants'' are based on minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity <sup>p. 43</sup>. |
||
* ''Compliance with covenants'': As of December 31, 2025, the company was in compliance with all Revolving Credit Facility covenants <sup>p. 43</sup>. |
* ''Compliance with covenants'': As of December 31, 2025, the company was in compliance with all Revolving Credit Facility covenants <sup>p. 43</sup>. |
||
* ''2023 Revolving Credit Facility'' entered into during |
* ''2023 Revolving Credit Facility'' was entered into during the first quarter of 2023 <sup>p. 43</sup>. |
||
* ''2023 Revolving Credit Facility'' provided up to |
* ''2023 Revolving Credit Facility'' provided up to a $150.0 million revolving credit facility and a letter of credit sub-facility of up to $30.0 million <sup>p. 43</sup>. |
||
* ''Redemption of 2023 Revolving Credit Facility'' |
* ''Redemption of 2023 Revolving Credit Facility'' occurred on November 13, 2025 <sup>p. 43</sup>. |
||
* ''Accrued interest paid'' for 2023 Revolving Credit Facility |
* ''Accrued interest paid'' for the 2023 Revolving Credit Facility was $0.3 million <sup>p. 43</sup>. |
||
* ''Expense recognized'' for unamortized deferred financing costs |
* ''Expense recognized'' for remaining unamortized deferred financing costs of the 2023 Revolving Credit Facility was $0.6 million <sup>p. 43</sup>. |
||
* '' |
* ''Notes (Debentures)'': In May 2019, an agreement was entered into to issue unsecured subordinated notes with an aggregate principal amount of $20.0 million <sup>p. 43</sup>. |
||
* ''Interest on Notes'' is fixed at 7.25% for the first 8 years and 8.25% thereafter <sup>p. 43</sup>. |
* ''Interest on Notes'' is fixed at 7.25% for the first 8 years and 8.25% thereafter <sup>p. 43</sup>. |
||
* ''Early retirement of Notes'' requires all interest payments to be paid in full |
* ''Early retirement of Notes'' requires all interest payments to be paid in full, plus the return of outstanding principal <sup>p. 43</sup>. |
||
* ''Principal on Notes'' is due at maturity on May 24, 2039 <sup>p. 43</sup>. |
* ''Principal on Notes'' is due at maturity on May 24, 2039 <sup>p. 43</sup>. |
||
* ''Interest on Notes'' is payable quarterly <sup>p. 43</sup>. |
* ''Interest on Notes'' is payable quarterly <sup>p. 43</sup>. |
||
* ''Notes'' have junior priority to all previously issued debt <sup>p. 43</sup>. |
* ''Notes'' have junior priority to all previously issued debt <sup>p. 43</sup>. |
||
* ''Debt related to Notes'' reported net of debt issuance costs of approximately |
* ''Debt related to Notes'' is reported net of debt issuance costs of approximately $0.4 million as of December 31, 2025, and $0.5 million as of December 31, 2024 <sup>p. 43</sup>. |
||
* ''Deferred financing costs'' are presented as a direct deduction from the carrying amount of the subordinated debt <sup>p. 43</sup>. |
* ''Deferred financing costs'' are presented as a direct deduction from the carrying amount of the subordinated debt <sup>p. 43</sup>. |
||
{{Indexing|Share Repurchase Program|Share Repurchase Program, Common stock repurchase, Open market purchases, Privately-negotiated transactions, Block purchases, Accelerated share repurchase agreements, Rule 10b5-1 trading plans|70zdwfnrmi|f7q5tvbfqm|kind=prose|order=64|f1=Program approval date|v1=October 2024|f2=Authorized repurchase amount|v2=$50.0 million|f3=Shares repurchased as of Dec 31, 2025|v3=None}} |
|||
'''Share Repurchase Program''' |
|||
* In ''October 2024'', the Board of Directors approved a share repurchase program <sup>p. 44</sup> |
* In ''October 2024'', the Board of Directors approved a share repurchase program. <sup>p. 44</sup> |
||
* The program authorizes the repurchase of up to ''$50.0 million'' of common stock <sup>p. 44</sup> |
* The program authorizes the repurchase of up to ''$50.0 million'' of common stock. <sup>p. 44</sup> |
||
* |
* Shares may be repurchased via open market purchases, privately-negotiated transactions, block purchases, accelerated share repurchase agreements, or a combination of methods, including Rule 10b5-1 trading plans. <sup>p. 44</sup> |
||
* The timing, manner, price, and amount of repurchases are at the company's discretion <sup>p. 44</sup> |
* The timing, manner, price, and amount of repurchases are at the company's discretion. <sup>p. 44</sup> |
||
* The program does not mandate the repurchase of any specific number of shares and can be modified, suspended, or terminated at any time <sup>p. 44</sup> |
* The program does not mandate the repurchase of any specific number of shares and can be modified, suspended, or terminated at any time. <sup>p. 44</sup> |
||
* As of ''December 31, 2025'', no shares had been repurchased under this plan <sup>p. 44</sup> |
* As of ''December 31, 2025'', no shares had been repurchased under this plan. <sup>p. 44</sup> |
||
{{Indexing|Contractual Obligations and Commitments|Contractual Obligations and Commitments, Reserves for losses and LAE, Reinsurance balances recoverable, Claims payment estimation, Actuarial assumptions|wugbjvah7b|rmmhubj8mh|tc5fw176pu|kind=prose|order=65|f1=Reinsurance balances recoverable 2025|v1=$1,119.9 million|f2=Reinsurance balances recoverable 2024|v2=$857.9 million}} |
|||
'''Contractual Obligations and Commitments''' |
|||
* ''Reserves for losses and LAE'' represent the best estimate of the ultimate cost of settling reported and unreported claims and related expenses <sup>p. 45</sup>. |
* ''Reserves for losses and LAE'' represent the best estimate of the ultimate cost of settling reported and unreported claims and related expenses <sup>p. 45</sup>. |
||
* Estimating reserves for losses and LAE involves complex and subjective judgments <sup>p. 45</sup>. |
* Estimating reserves for losses and LAE involves complex and subjective judgments <sup>p. 45</sup>. |
||
* Actual losses and settlement expenses paid may deviate substantially from the reserve estimates in financial statements <sup>p. 45</sup>. |
* Actual losses and settlement expenses paid may deviate substantially from the reserve estimates in financial statements <sup>p. 45</sup>. |
||
* The timing for payment of estimated losses is not fixed or determinable |
* The timing for payment of estimated losses is not fixed or individually/aggregately determinable <sup>p. 45</sup>. |
||
* Assumptions for estimating payments due by period are based on the company's, industry, and peer group claims payment experience <sup>p. 45</sup>. |
* Assumptions for estimating payments due by period are based on the company's, industry's, and peer group's claims payment experience <sup>p. 45</sup>. |
||
* There is a risk that |
* There is a risk that actual payments in any period will differ significantly from disclosed amounts due to uncertainty in timing estimation <sup>p. 45</sup>. |
||
* Disclosed amounts are gross of anticipated |
* Disclosed amounts are gross of anticipated recoverable amounts from reinsurers <sup>p. 45</sup>. |
||
* ''Reinsurance balances recoverable'' on reserves for losses and LAE are reported separately as assets, not netted with liabilities, because reinsurance does not discharge liability to policyholders <sup>p. 45</sup>. |
* ''Reinsurance balances recoverable'' on reserves for losses and LAE are reported separately as assets, not netted with liabilities, because reinsurance does not discharge the company's liability to policyholders <sup>p. 45</sup>. |
||
* ''Reinsurance balances recoverable'' on reserves for paid and unpaid losses and LAE totaled |
* ''Reinsurance balances recoverable'' on reserves for paid and unpaid losses and LAE totaled $1,119.9 million at December 31, 2025 <sup>p. 45</sup>. |
||
* ''Reinsurance balances recoverable'' on reserves for paid and unpaid losses and LAE totaled |
* ''Reinsurance balances recoverable'' on reserves for paid and unpaid losses and LAE totaled $857.9 million at December 31, 2024 <sup>p. 45</sup>. |
||
{{Indexing|Reinsurance balances recoverable and debt obligations|Reinsurance balances recoverable and debt obligations, Reserves for losses and LAE, Long-term debt, Interest on debt obligations|rmmhubj8mh|b3bc9gy5x7|tc5fw176pu|kind=table|order=66}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 2,273: | Line 2,525: | ||
| style="text-align:right" | 80,242 |
| style="text-align:right" | 80,242 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right |
| style="text-align:right" | '''2,974,464''' |
||
| style="text-align:right |
| style="text-align:right" | '''551,157''' |
||
| style="text-align:right |
| style="text-align:right" | '''2,423,307''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Critical Accounting Policies|Critical Accounting Policies, Critical accounting estimates, Consolidated financial statements, Reserves for unpaid losses and LAE, Individual case-basis valuations, Statistical analyses, Actuarial procedures, Historical information, Industry and peer group information, Future trends|ie3cmfrol3|rmmhubj8mh|e40m7ou132|kind=prose|order=67}} |
|||
'''Critical Accounting Policies''' |
|||
* Critical accounting estimates are those important to financial |
* Critical accounting estimates are those important to portraying financial condition and results of operations and require significant judgment <sup>p. 46</sup>. |
||
* Significant judgment is exercised concerning future results and developments in applying critical accounting estimates and preparing consolidated financial statements <sup>p. 46</sup>. |
|||
* These judgments and estimates affect reported assets, liabilities, revenues, expenses, and contingent assets/liabilities <sup>p. 46</sup>. |
|||
* Judgments and estimates affect reported amounts of assets, liabilities, revenues, expenses, and disclosure of material contingent assets and liabilities <sup>p. 46</sup>. |
|||
* Actual results may differ materially from estimates and assumptions used in consolidated financial statements <sup>p. 46</sup>. |
|||
* Actual results may differ materially from estimates and assumptions used in preparing consolidated financial statements <sup>p. 46</sup>. |
|||
* Estimates are evaluated regularly using relevant information <sup>p. 46</sup>. |
* Estimates are evaluated regularly using relevant information <sup>p. 46</sup>. |
||
* For a detailed discussion of accounting policies, refer to Note 1, “Summary of Significant Accounting Policies” in Item 8 of this Form 10-K <sup>p. 46</sup>. |
|||
* ''Reserves for unpaid losses and LAE'' are the largest and most complex estimate in the Consolidated Balance Sheets <sup>p. 46</sup>. |
* ''Reserves for unpaid losses and LAE'' are the largest and most complex estimate in the Consolidated Balance Sheets <sup>p. 46</sup>. |
||
* |
* Reserves for unpaid losses and LAE represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust these losses as of or before the balance sheet date <sup>p. 46</sup>. |
||
* Reserves for losses and LAE are not discounted to reflect estimated present value <sup>p. 46</sup>. |
* Reserves for losses and LAE are not discounted to reflect estimated present value <sup>p. 46</sup>. |
||
* |
* Reserves are estimated using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures <sup>p. 46</sup>. |
||
* Estimates are based on historical information, industry |
* Estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors like loss severity, loss frequency, and inflation <sup>p. 46</sup>. |
||
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known <sup>p. 46</sup>. |
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known <sup>p. 46</sup>. |
||
* During the loss settlement period, estimates of liability are often refined and adjusted <sup>p. 46</sup>. |
* During the loss settlement period, estimates of liability on a claim are often refined and adjusted upward or downward <sup>p. 46</sup>. |
||
* The ultimate liability may exceed or be less than revised estimates <sup>p. 46</sup>. |
* The ultimate liability may exceed or be less than revised estimates <sup>p. 46</sup>. |
||
* The ultimate settlement of losses and related LAE may vary significantly from |
* The ultimate settlement of losses and related LAE may vary significantly from the estimate included in financial statements <sup>p. 46</sup>. |
||
* Reserves for unpaid losses and LAE are categorized into |
* Reserves for unpaid losses and LAE are categorized into two types: case reserves and IBNR <sup>p. 46</sup>. |
||
* ''Case reserves'' are established for individual reported |
* ''Case reserves'' are established for individual claims reported to the company <sup>p. 46</sup>. |
||
* |
* Losses are notified by insureds, their agents, or brokers <sup>p. 46</sup>. |
||
* Case reserves |
* Case reserves are established by estimating ultimate losses from the claim, including defense costs <sup>p. 46</sup>. |
||
* Claims department personnel |
* Claims department personnel use their knowledge of specific claims and advice from internal and external experts (underwriters, legal counsel) to estimate expected ultimate losses <sup>p. 46</sup>. |
||
* |
* Third-Party Administrators (TPAs) are used in limited circumstances to assist in claim adjustment <sup>p. 46</sup>. |
||
* |
* Internal claims managers oversee TPA activities and monitor their claim handling to prescribed standards <sup>p. 46</sup>. |
||
* |
* ''Incurred but not reported (IBNR) reserve'' is derived by estimating the ultimate unpaid reserve liability and subtracting case reserves <sup>p. 46</sup>. |
||
* Management’s best estimate of the ultimate unpaid liability is set by the Reserve Committee <sup>p. 46</sup>. |
|||
* The Reserve Committee considers actuarial indications and factors like underwriting, claims handling, economic, legal, and environmental changes <sup>p. 46</sup>. |
|||
* The Reserve Committee |
* The Reserve Committee considers actuarial indications and other factors such as underwriting, claims handling, economic, legal, and environmental changes <sup>p. 46</sup>. |
||
* The Reserve Committee |
* The ''Reserve Committee'' includes the Chief Actuary, Chief Reserving Actuary, Chief Financial Officer, and Chief Claims Officer <sup>p. 46</sup>. |
||
* The Reserve Committee meets quarterly to review actuarial reserving recommendations from the Chief Actuary and determine the best estimate for the reserve for losses and LAE <sup>p. 46</sup>. |
|||
* The actuary estimates an initial expected ultimate loss ratio for each underwriting division when establishing quarterly recommendations <sup>p. 46</sup>. |
|||
* In establishing quarterly actuarial recommendations, the actuary estimates an initial expected ultimate loss ratio for each underwriting division <sup>p. 46</sup>. |
|||
* Input from underwriting and claims departments, including premium pricing assumptions and historical experience, is considered in setting reserves <sup>p. 46</sup>. |
* Input from underwriting and claims departments, including premium pricing assumptions and historical experience, is considered in setting reserves <sup>p. 46</sup>. |
||
* Reserves are driven by factors |
* Reserves are driven by factors including litigation and regulatory trends, legislative activity, climate change, social and economic patterns, and claims inflation assumptions <sup>p. 46</sup>. |
||
* Reserve estimates reflect current inflation in legal |
* Reserve estimates reflect current inflation in legal claims’ settlements <sup>p. 46</sup>. |
||
* Reserve estimates assume no losses from significant new legal liability theories <sup>p. 46</sup>. |
* Reserve estimates assume no subjection to losses from significant new legal liability theories <sup>p. 46</sup>. |
||
* Reserve estimates assume no significant changes in the regulatory and legislative environment <sup>p. 46</sup>. |
* Reserve estimates assume no significant changes in the regulatory and legislative environment <sup>p. 46</sup>. |
||
* |
* The impact of potential changes in the regulatory or legislative environment is difficult to quantify without specific, significant new regulation or legislation <sup>p. 46</sup>. |
||
* In the event of significant new regulation or legislation, the company will attempt to quantify its impact, but accuracy or success is not assured <sup>p. 46</sup>. |
|||
* The actuarial review uses multiple methods to estimate reserves for losses and LAE, including: |
|||
* The actuarial review considers multiple actuarial methods to estimate the reserve for losses and LAE <sup>p. 46</sup>. |
|||
* ''Actuarial methods'' include paid and incurred loss development methods, paid and incurred Bornhuetter-Ferguson methods, paid and incurred loss ratio cape cod methods, and frequency and severity methods <sup>p. 46</sup>. |
|||
** Paid and incurred loss ratio cape cod methods <sup>p. 46</sup>. |
|||
** Frequency and severity methods <sup>p. 46</sup>. |
|||
* If one actuarial method is more credible, it is used to set the point estimate <sup>p. 46</sup>. |
* If one actuarial method is more credible, it is used to set the point estimate <sup>p. 46</sup>. |
||
* For new lines of business or significant changes in claim practices, paid and incurred loss development methods are less credible due to insufficient historical data <sup>p. 46</sup>. |
* For new lines of business or significant changes in claim practices, paid and incurred loss development methods are less credible due to insufficient historical data <sup>p. 46</sup>. |
||
* The actuarial point estimate may be based on a judgmental weighting of estimates from |
* The actuarial point estimate may also be based on a judgmental weighting of estimates from each method <sup>p. 46</sup>. |
||
* These methods utilize the initial expected loss ratio, statistical analysis of past claims reporting |
* These methods utilize the initial expected loss ratio, statistical analysis of past claims reporting and payment patterns, claims frequency and severity, paid loss experience, industry loss experience, and changes in market conditions, policy forms, exclusions, and exposures <sup>p. 46</sup>. |
||
* |
* Although reserve estimates are believed to be reasonable, actual loss experience may not conform to assumptions <sup>p. 46</sup>. |
||
* |
* Actual ultimate loss ratio could differ from the initial expected loss ratio <sup>p. 46</sup>. |
||
* Actual reporting and payment patterns could differ from expected patterns, which are based on company and industry data <sup>p. 46</sup>. |
|||
* Estimates are regularly reviewed and adjusted, with adjustments included in current operations <sup>p. 46</sup>. |
|||
* The ultimate settlement of losses and related LAE may vary significantly from estimates in financial statements <sup>p. 46</sup>. |
|||
* ''Development'' refers to the difference between estimated losses and those originally reported <sup>p. 46</sup>. |
|||
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known, with adjustments included in current operations <sup>p. 46</sup>. |
|||
* ''Unfavorable development'' occurs when losses settle for more than reserved or subsequent estimates indicate reserve increases <sup>p. 46</sup>. |
|||
* '' |
* ''Development'' is the amount by which estimated losses differ from those originally reported for a period <sup>p. 46</sup>. |
||
* |
* Development is ''unfavorable'' when losses settle for more than reserved or subsequent estimates indicate reserve increases <sup>p. 46</sup>. |
||
* Development is ''favorable'' when losses settle for less than reserved or subsequent estimates indicate reserve reductions <sup>p. 46</sup>. |
|||
* Favorable or unfavorable development of loss reserves is reflected in the results of operations in the period estimates are changed <sup>p. 46</sup>. |
|||
* A ''5% change in net IBNR'' would result in a ''$51.8 million change'' in reserves for losses and LAE <sup>p. 46</sup>. |
* A ''5% change in net IBNR'' would result in a ''$51.8 million change'' in reserves for losses and LAE <sup>p. 46</sup>. |
||
* A ''5% change in net IBNR'' would result in a ''$40.9 million change'' in net income and stockholders’ equity <sup>p. 46</sup>. |
* A ''5% change in net IBNR'' would result in a ''$40.9 million change'' in net income and stockholders’ equity <sup>p. 46</sup>. |
||
{{Indexing|Impact of a 5% change in net IBNR on reserves, income, and equity|Impact of a 5% change in net IBNR on reserves, income, and equity, Case reserves, IBNR|rmmhubj8mh|e40m7ou132|kind=table|order=68}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 2,368: | Line 2,625: | ||
| style="text-align:right" | 69.2% |
| style="text-align:right" | 69.2% |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right |
| style="text-align:right" | '''2,318,894''' |
||
| style="text-align:right |
| style="text-align:right" | '''100.0%''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,397,729''' |
||
| style="text-align:right |
| style="text-align:right" | '''100.0%''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,782,383''' |
||
| style="text-align:right |
| style="text-align:right" | '''100.0%''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,111,537''' |
||
| style="text-align:right |
| style="text-align:right" | '''100.0%''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Recent Accounting Pronouncements|Recent Accounting Pronouncements, ASU 2023-09, Income Tax Disclosures, ASU 2024-03, Income statement expenses, ASU 2025-01|ie3cmfrol3|kind=prose|order=69|f1=ASU 2023-09 issuance|v1=December 2023|f2=ASU 2023-09 effective date|v2=fiscal years beginning after December 15, 2024|f3=ASU 2024-03 issuance|v3=November 2024|f4=ASU 2025-01 issuance|v4=January 2025|f5=ASU 2024-03 effective date|v5=first annual reporting period beginning after December 15, 2026}} |
|||
'''Recent Accounting Pronouncements''' |
|||
* In |
* In December 2023, the FASB issued ASU 2023-09, "Improvements to Income Tax Disclosures (Topic 740)" <sup>p. 47</sup>. |
||
* ASU 2023-09 mandates public companies to provide enhanced annual rate reconciliation disclosures, including specific categories and additional information meeting a quantitative threshold <sup>p. 47</sup>. |
* ASU 2023-09 mandates public companies to provide enhanced annual rate reconciliation disclosures, including specific categories and additional information meeting a quantitative threshold <sup>p. 47</sup>. |
||
* This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes <sup>p. 47</sup>. |
* This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes <sup>p. 47</sup>. |
||
* The guidance for ASU 2023-09 became effective for fiscal years beginning after December 15, 2024, and is applied prospectively <sup>p. 47</sup>. |
* The guidance for ASU 2023-09 became effective for fiscal years beginning after December 15, 2024, and is applied prospectively <sup>p. 47</sup>. |
||
* The company has added additional disclosures as required by ASU 2023-09, with no impact on the consolidated financial statements <sup>p. 47</sup>. |
* The company has added additional disclosures as required by ASU 2023-09, with no impact on the consolidated financial statements <sup>p. 47</sup>. |
||
* In |
* In November 2024, the FASB issued ASU 2024-03, requiring disaggregated disclosure of income statement expenses for public business entities (PBEs) <sup>p. 47</sup>. |
||
* ASU 2024-03 does not |
* ASU 2024-03 does not alter expense captions on the income statement but requires disaggregation of certain expense captions into specified categories in financial statement footnotes <sup>p. 47</sup>. |
||
* ASU 2024-03 |
* ASU 2024-03 mandates a footnote disclosure for specific expenses, requiring PBEs to disaggregate, in a tabular presentation, relevant income statement expense captions that include any of the following natural expenses: (1) purchases of inventory, (2) employee compensation, (3) depreciation, (4) intangible asset amortization, and (5) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities or other types of depletion expenses <sup>p. 47</sup>. |
||
* The tabular disclosure would also include certain other expenses, |
* The tabular disclosure would also include certain other expenses, where applicable <sup>p. 47</sup>. |
||
* In |
* In January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03 <sup>p. 47</sup>. |
||
* The effective date for ASU 2024-03 is the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027 <sup>p. 47</sup>. |
|||
* The company is evaluating the effect of these amendments on its consolidated financial statements <sup>p. 47</sup>. |
|||
* The company is evaluating the effect of the amendments on its consolidated financial statements <sup>p. 47</sup>. |
|||
== Quantitative and Qualitative Disclosures About Market Risk == |
== Quantitative and Qualitative Disclosures About Market Risk == |
||
| Line 2,398: | Line 2,656: | ||
* Qualitative and Quantitative Disclosures about Market Risk are included in Item 7 of this Form 10-K under "Investments—Market Risk" <sup>p. 48</sup>. |
* Qualitative and Quantitative Disclosures about Market Risk are included in Item 7 of this Form 10-K under "Investments—Market Risk" <sup>p. 48</sup>. |
||
== |
== Financial Statements == |
||
{{Indexing|Report of Independent Registered Public Accounting Firm|Report of Independent Registered Public Accounting Firm, Consolidated financial statements, Internal Control Over Financial Reporting, Basis for Opinion, Responsibilities of the Auditor, Audit Scope, Critical Audit Matters|x856lnzuq2|l96bfbct4s|kind=prose|order=70|f1=Financial statements as of|v1=December 31, 2023 and 2022|f2=Internal Control Over Financial Reporting as of|v2=December 31, 2023|f3=Auditor|v3=public accounting firm registered with the PCAOB|f4=Critical Audit Matters|v4=None}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" |
|||
! style="text-align:left" | USD ($) |
|||
! style="text-align:center" | 12 Months Ended |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
|- |
|||
! style="text-align:left" | — |
|||
! class="col-m" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-m" style="text-align:right" | Feb. 26, 2026 |
|||
! class="col-m" style="text-align:right" | Jun. 30, 2025 |
|||
|- |
|||
| style="text-align:left" | Cover [Abstract] |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Document Type |
|||
| class="col-m" style="text-align:right" | 10-K |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Document Annual Report |
|||
| class="col-m" style="text-align:right" | true |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Document Period End Date |
|||
| class="col-m" style="text-align:right" | Dec. 31, 2025 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Current Fiscal Year End Date |
|||
| class="col-m" style="text-align:right" | --12-31 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Document Transition Report |
|||
| class="col-m" style="text-align:right" | false |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity File Number |
|||
| class="col-m" style="text-align:right" | 001-41591 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Registrant Name |
|||
| class="col-m" style="text-align:right" | SKYWARD SPECIALTY INSURANCE GROUP, INC. |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Incorporation, State or Country Code |
|||
| class="col-m" style="text-align:right" | DE |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Tax Identification Number |
|||
| class="col-m" style="text-align:right" | 14-1957288 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Address, Address Line One |
|||
| class="col-m" style="text-align:right" | 800 Gessner Road |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Address, Address Line Two |
|||
| class="col-m" style="text-align:right" | Suite 600 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Address, City or Town |
|||
| class="col-m" style="text-align:right" | Houston |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Address, State or Province |
|||
| class="col-m" style="text-align:right" | TX |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Address, Postal Zip Code |
|||
| class="col-m" style="text-align:right" | 77024-4284 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | City Area Code |
|||
| class="col-m" style="text-align:right" | 713 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Local Phone Number |
|||
| class="col-m" style="text-align:right" | 935-4800 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Title of 12(b) Security |
|||
| class="col-m" style="text-align:right" | Common stock, par value $0.01 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Trading Symbol |
|||
| class="col-m" style="text-align:right" | SKWD |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Security Exchange Name |
|||
| class="col-m" style="text-align:right" | NASDAQ |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Well-known Seasoned Issuer |
|||
| class="col-m" style="text-align:right" | No |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Voluntary Filers |
|||
| class="col-m" style="text-align:right" | No |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Current Reporting Status |
|||
| class="col-m" style="text-align:right" | No |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Interactive Data Current |
|||
| class="col-m" style="text-align:right" | Yes |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Filer Category |
|||
| class="col-m" style="text-align:right" | Large Accelerated Filer |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Small Business |
|||
| class="col-m" style="text-align:right" | false |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Emerging Growth Company |
|||
| class="col-m" style="text-align:right" | false |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | ICFR Auditor Attestation Flag |
|||
| class="col-m" style="text-align:right" | true |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Document Financial Statement Error Correction [Flag] |
|||
| class="col-m" style="text-align:right" | false |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Shell Company |
|||
| class="col-m" style="text-align:right" | false |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Public Float |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | 2,165,161,643 |
|||
|- |
|||
| style="text-align:left" | Entity Common Stock, Shares Outstanding |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | 44,467,084 |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Documents Incorporated by Reference |
|||
| class="col-m" style="text-align:right" | Portions of the Registrant’s Proxy Statement relating to the 2026 annual meeting of stockholders (the “2026 Proxy Statement”), which will be filed within 120 days of December 31, 2025, are incorporated by reference into Part III of this Form 10-K. |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Entity Central Index Key |
|||
| class="col-m" style="text-align:right" | 0001519449 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amendment Flag |
|||
| class="col-m" style="text-align:right" | false |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Document Fiscal Year Focus |
|||
| class="col-m" style="text-align:right" | 2025 |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Document Fiscal Period Focus |
|||
| class="col-m" style="text-align:right" | FY |
|||
| class="col-m" style="text-align:right" | — |
|||
| class="col-m" style="text-align:right" | — |
|||
|} |
|||
</div> |
|||
* ''Opinion'': The consolidated financial statements present fairly, in all material respects, the financial position of Skyward Specialty Insurance Group, Inc. and its subsidiaries as of December 31, 2023 and 2022, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2023, in conformity with U.S. generally accepted accounting principles <sup>p. 49</sup>. |
|||
== Audit Information == |
|||
* ''Internal Control Over Financial Reporting'': The Company maintained effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) <sup>p. 49</sup>. |
|||
* ''Basis for Opinion'': The audit was conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB) <sup>p. 49</sup>. |
|||
* ''Responsibilities of the Auditor'': The auditor is a public accounting firm registered with the PCAOB and is required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB <sup>p. 49</sup>. |
|||
* ''Audit Scope'': The audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks <sup>p. 49</sup>. |
|||
* ''Critical Audit Matters'': Critical audit matters are those matters arising from the audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective, or complex auditor judgments <sup>p. 49</sup>. |
|||
* ''No Critical Audit Matters'': The auditor determined that there were no critical audit matters <sup>p. 49</sup>. |
|||
* ''Auditor'': Ernst & Young LLP <sup>p. 49</sup>. |
|||
* ''Location'': Houston, Texas <sup>p. 49</sup>. |
|||
* ''Date'': February 28, 2024 <sup>p. 49</sup>. |
|||
{{Indexing|Opinion on Internal Control Over Financial Reporting|Opinion on Internal Control Over Financial Reporting, Internal control over financial reporting, Consolidated balance sheets, Consolidated statements of operations and comprehensive income, Stockholders’ equity, Cash flows|l96bfbct4s|x856lnzuq2|kind=prose|order=71|f1=Internal control audit as of|v1=December 31, 2025|f2=COSO criteria|v2=2013 framework|f3=Consolidated balance sheets as of|v3=December 31, 2025 and 2024|f4=Report dated|v4=March 2, 2026}} |
|||
* ''Internal control over financial reporting'' of Skyward Specialty Insurance Group, Inc. and subsidiaries was audited as of December 31, 2025 <sup>p. 50</sup>. |
|||
* The audit was based on criteria established in the ''Internal Control—Integrated Framework'' issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria) <sup>p. 50</sup>. |
|||
* ''Skyward Specialty Insurance Group, Inc. and subsidiaries'' maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on the COSO criteria <sup>p. 50</sup>. |
|||
* The ''consolidated balance sheets'' of the Company as of December 31, 2025 and 2024, and related consolidated statements of operations and comprehensive income, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2025, were audited in accordance with PCAOB standards <sup>p. 50</sup>. |
|||
* The ''report dated March 2, 2026'' expressed an unqualified opinion on the consolidated financial statements and related notes and schedules <sup>p. 50</sup>. |
|||
{{Indexing|Basis for Opinion|Basis for Opinion, Management's responsibility, Auditor's responsibility, PCAOB standards, Audit scope, Material weakness assessment, Internal control design and operating effectiveness|x856lnzuq2|l96bfbct4s|kind=prose|order=72}} |
|||
* The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment included in the accompanying Management’s Report on Internal Control over Financial Reporting <sup>p. 51</sup>. |
|||
* The auditor's responsibility is to express an opinion on the Company’s internal control over financial reporting based on their audit <sup>p. 51</sup>. |
|||
* The auditor is a public accounting firm registered with the PCAOB and is required to be independent in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB <sup>p. 51</sup>. |
|||
* The audit was conducted in accordance with the standards of the PCAOB <sup>p. 51</sup>. |
|||
* PCAOB standards require planning and performing the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects <sup>p. 51</sup>. |
|||
* The audit included obtaining an understanding of internal control over financial reporting, assessing the risk of a material weakness, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing other necessary procedures <sup>p. 51</sup>. |
|||
* The auditor believes their audit provides a reasonable basis for their opinion <sup>p. 51</sup>. |
|||
{{Indexing|Definition and Limitations of Internal Control Over Financial Reporting|Internal control over financial reporting, financial statement reliability, transaction recording, asset disposition, effectiveness evaluations|l96bfbct4s|x856lnzuq2|kind=prose|order=73}} |
|||
* ''Internal control over financial reporting'' is a process designed to provide reasonable assurance about the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles <sup>p. 52</sup>. |
|||
* ''Internal control over financial reporting'' includes policies and procedures that maintain records accurately reflecting transactions and asset dispositions <sup>p. 52</sup>. |
|||
* ''Internal control over financial reporting'' provides reasonable assurance that transactions are recorded to permit financial statement preparation in accordance with GAAP, and that receipts and expenditures align with management and director authorizations <sup>p. 52</sup>. |
|||
* ''Internal control over financial reporting'' provides reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use, or disposition of company assets that could materially affect financial statements <sup>p. 52</sup>. |
|||
* ''Internal control over financial reporting'' has inherent limitations and may not prevent or detect misstatements <sup>p. 52</sup>. |
|||
* ''Projections of effectiveness evaluations'' to future periods carry the risk that controls may become inadequate due to changing conditions or that compliance with policies/procedures may deteriorate <sup>p. 52</sup>. |
|||
Caption: Report of independent registered public accounting firm |
|||
| /s/ Ernst & Young LLP | |
|||
| --- | |
|||
| Houston, Texas | |
|||
| March 2, 2026 | |
|||
{{Indexing|Report of Independent Registered Public Accounting Firm|Consolidated financial statements, internal control over financial reporting, audit scope, audit procedures, auditor responsibilities|x856lnzuq2|l96bfbct4s|kind=prose|order=74|f1=Auditor|v1=Ernst & Young LLP|f2=Audit opinion|v2=unqualified|f3=Internal control opinion|v3=effective|f4=Internal control framework|v4=Internal Control—Integrated Framework (2013) issued by COSO|f5=Audit standards|v5=PCAOB}} |
|||
* ''Opinion'': The consolidated financial statements present fairly, in all material respects, the financial position of Skyward Specialty Insurance Group, Inc. and its subsidiaries as of December 31, 2023 and 2022, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America <sup>p. 53</sup>. |
|||
* ''Internal Control Over Financial Reporting'': The Company maintained effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) <sup>p. 53</sup>. |
|||
* ''Basis for Opinions'': The audits were conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB) <sup>p. 53</sup>. |
|||
* ''Responsibilities of the Auditors'': The auditors are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB <sup>p. 53</sup>. |
|||
* ''Audit Scope'': The audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks <sup>p. 53</sup>. |
|||
* ''Audit Procedures'': Procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements, evaluating the accounting principles used and significant estimates made by management, and evaluating the overall presentation of the financial statements <sup>p. 53</sup>. |
|||
* ''Internal Control Audit Scope'': The audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk <sup>p. 53</sup>. |
|||
* ''Material Weakness Definition'': A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis <sup>p. 53</sup>. |
|||
* ''Auditor's Conclusion on Internal Control'': The auditors believe that their audits provide a reasonable basis for their opinions <sup>p. 53</sup>. |
|||
* ''Critical Audit Matters (CAMs)'': CAMs are matters arising from the audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective, or complex auditor judgment <sup>p. 53</sup>. |
|||
* ''No CAMs Identified'': The auditors determined that there were no critical audit matters <sup>p. 53</sup>. |
|||
* ''Auditor Firm'': Ernst & Young LLP <sup>p. 53</sup>. |
|||
* ''Auditor Location'': Houston, Texas <sup>p. 53</sup>. |
|||
* ''Report Date'': February 29, 2024 <sup>p. 53</sup>. |
|||
{{Indexing|Opinion on the Financial Statements|Consolidated financial statements, audit scope, financial position, operational results, cash flows, internal control over financial reporting|x856lnzuq2|l96bfbct4s|kind=prose|order=75|f1=Audit opinion|v1=unqualified|f2=Internal control opinion|v2=unqualified|f3=Internal control framework|v3=2013 framework of Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission|f4=Audit standards|v4=PCAOB}} |
|||
* The consolidated financial statements of Skyward Specialty Insurance Group, Inc. and subsidiaries (the Company) as of December 31, 2025 and 2024, and for the three years ended December 31, 2025, have been audited <sup>p. 54</sup>. |
|||
* The audit included the consolidated balance sheets, statements of operations and comprehensive income, stockholders' equity, and cash flows, along with related notes and financial statement schedules <sup>p. 54</sup>. |
|||
* The consolidated financial statements fairly present, in all material respects, the Company's financial position as of December 31, 2025 and 2024, and its operational results and cash flows for the three years ended December 31, 2025, in conformity with U.S. generally accepted accounting principles <sup>p. 54</sup>. |
|||
* The Company's internal control over financial reporting as of December 31, 2025, was also audited in accordance with PCAOB standards <sup>p. 54</sup>. |
|||
* The audit of internal control was based on criteria from the 2013 framework of Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission <sup>p. 54</sup>. |
|||
* The report dated March 2, 2026, expressed an unqualified opinion on the Company's internal control over financial reporting <sup>p. 54</sup>. |
|||
{{Indexing|Basis for Opinion|Financial statements, auditor responsibilities, audit standards, material misstatement, audit procedures|x856lnzuq2|kind=prose|order=76|f1=Audit standards|v1=PCAOB}} |
|||
* The Company's management is responsible for the financial statements <sup>p. 55</sup>. |
|||
* The auditor's responsibility is to express an opinion on the Company's financial statements based on their audits <sup>p. 55</sup>. |
|||
* The auditor is a public accounting firm registered with the PCAOB and must be independent of the Company according to U.S. federal securities laws and SEC/PCAOB rules and regulations <sup>p. 55</sup>. |
|||
* Audits were conducted in accordance with PCAOB standards <sup>p. 55</sup>. |
|||
* PCAOB standards require planning and performing audits to obtain reasonable assurance that financial statements are free of material misstatement due to error or fraud <sup>p. 55</sup>. |
|||
* Audit procedures included assessing risks of material misstatement and responding to those risks <sup>p. 55</sup>. |
|||
* Procedures involved examining evidence on a test basis regarding amounts and disclosures in the financial statements <sup>p. 55</sup>. |
|||
* Audits also included evaluating accounting principles, significant management estimates, and the overall presentation of financial statements <sup>p. 55</sup>. |
|||
* The auditors believe their audits provide a reasonable basis for their opinion <sup>p. 55</sup>. |
|||
{{Indexing|Critical Audit Matter|Critical audit matter, financial statements, audit committee communication, judgments|x856lnzuq2|kind=prose|order=77}} |
|||
* The critical audit matter discussed arises from the current period audit of the financial statements <sup>p. 56</sup>. |
|||
* This matter was communicated or required to be communicated to the audit committee <sup>p. 56</sup>. |
|||
* The critical audit matter relates to accounts or disclosures material to the financial statements <sup>p. 56</sup>. |
|||
* The matter involved especially challenging, subjective, or complex judgments <sup>p. 56</sup>. |
|||
* The communication of this critical audit matter does not alter the opinion on the consolidated financial statements as a whole <sup>p. 56</sup>. |
|||
* Communicating the critical audit matter does not provide a separate opinion on the matter or its related account/disclosure <sup>p. 56</sup>. |
|||
{{Indexing|Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses|Reserves for unpaid losses and loss adjustment expenses, incurred but not reported reserves (IBNR), estimation methods, actuarial procedures, internal controls|rmmhubj8mh|gva2857foa|e40m7ou132|kind=prose|order=78|f1=Reserves for unpaid losses and LAE|v1=USD 2.3bn at December 31, 2025}} |
|||
* ''Company’s reserves'' for unpaid losses and loss adjustment expenses (LAE) were USD 2.3bn at December 31, 2025 <sup>p. 57</sup>. |
|||
* A significant portion of these reserves represents ''incurred but not reported reserves'' (IBNR) <sup>p. 57</sup>. |
|||
* ''Reserves for unpaid losses and LAE'' represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust incurred losses as of the balance sheet date <sup>p. 57</sup>. |
|||
* The Company estimates these reserves using ''individual case-basis valuations'' of reported claims, statistical analyses, and various actuarial procedures <sup>p. 57</sup>. |
|||
* Estimates are based on ''historical information, industry and peer group information'', and trends in factors like loss severity, loss frequency, and inflation <sup>p. 57</sup>. |
|||
* Auditing management's estimate of reserves for unpaid losses and LAE, including IBNR, was complex due to ''significant estimation uncertainty'' in evaluating management's methods and assumptions <sup>p. 57</sup>. |
|||
* ''Key assumptions'' include loss development factors, expected loss ratios, and trends applied to the Company’s historical experience <sup>p. 57</sup>. |
|||
* These assumptions significantly affect the ''valuation of IBNR reserves'' <sup>p. 57</sup>. |
|||
* We obtained an understanding, evaluated the design, and tested the operating effectiveness of ''internal controls'' over management’s process for estimating losses and LAE reserves <sup>p. 57</sup>. |
|||
* This included reviewing and approving management's ''methods and assumptions'' for estimating reserves <sup>p. 57</sup>. |
|||
* With actuarial specialists, audit procedures included evaluating the ''selection of actuarial methods'' used by management, comparing them to prior periods and industry practices <sup>p. 57</sup>. |
|||
* We evaluated the ''assumptions'' used in actuarial methods by comparing significant assumptions (loss development factors, expected loss ratios, trends) to the Company’s historical experience and current industry benchmarks <sup>p. 57</sup>. |
|||
* We developed an ''independent range of reserve estimates'' and compared it to management’s best estimate for unpaid losses and LAE <sup>p. 57</sup>. |
|||
* We also reviewed the ''development of prior year reserve estimates'' <sup>p. 57</sup>. |
|||
Caption: Report of independent registered public accounting firm |
|||
| /s/ Ernst & Young LLP | |
|||
| --- | |
|||
| We have served as the Company’s auditor since 2021. | |
|||
| Houston, Texas | |
|||
| March 2, 2026 | |
|||
{{Indexing|Consolidated balance sheets|Consolidated balance sheets, accompanying notes|offa7is5x7|kind=prose|order=79}} |
|||
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 58</sup>. |
|||
{{Indexing|Consolidated balance sheets||offa7is5x7|1f87rdfb5o|966xer0dpm|kind=table|order=80}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align:center" | |
! colspan="2" style="text-align:center" | December 31, |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! |
! style="text-align:center" | 2025 |
||
! style="text-align:center" | 2024 |
|||
|- |
|- |
||
! style="text-align:left" | ($ in thousands, except share and per share amounts) |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
|- |
|- |
||
! style="text-align:left" | Assets |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
|- |
|- |
||
! style="text-align:left" | Investments: |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Auditor Firm ID |
|||
| class="col-s" style="text-align:right" | 42 |
|||
|} |
|||
</div> |
|||
== Consolidated balance sheets == |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | USD ($) $ in Thousands |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
|- |
|||
| style="text-align:left" | Investments: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Fixed maturity securities, available-for-sale, at fair value (net of allowance for credit losses of $7,000 and $0, respectively) (amortized cost of $1,848,755 and $1,320,266, respectively) |
| class="wt-indent-1" style="text-align:left" | Fixed maturity securities, available-for-sale, at fair value (net of allowance for credit losses of $ 7,000 and $ 0 , respectively) (amortized cost of $ 1,848,755 and $ 1,320,266 , respectively) |
||
| style="text-align:right" | 1,856,303 |
| style="text-align:right" | 1,856,303 |
||
| style="text-align:right" | 1,292,218 |
| style="text-align:right" | 1,292,218 |
||
|- |
|- |
||
| style="text-align:left" | Fixed maturity securities, held-to-maturity, at amortized cost (net of allowance for credit losses of $468 and $243, respectively) |
| class="wt-indent-1" style="text-align:left" | Fixed maturity securities, held-to-maturity, at amortized cost (net of allowance for credit losses of $ 468 and $ 243 , respectively) |
||
| style="text-align:right" | 32,822 |
| style="text-align:right" | 32,822 |
||
| style="text-align:right" | 39,153 |
| style="text-align:right" | 39,153 |
||
| Line 2,663: | Line 2,832: | ||
| style="text-align:right" | 274,929 |
| style="text-align:right" | 274,929 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total investments''' |
||
| style="text-align:right |
| style="text-align:right" | '''2,300,515''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,870,820''' |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents |
| style="text-align:left" | Cash and cash equivalents |
||
| Line 2,703: | Line 2,872: | ||
| style="text-align:right" | 86,698 |
| style="text-align:right" | 86,698 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total assets''' |
||
| style="text-align:right |
| style="text-align:right" | '''4,791,852''' |
||
| style="text-align:right |
| style="text-align:right" | '''3,729,478''' |
||
|- |
|- |
||
| style="text-align:left" | Liabilities |
| style="text-align:left" | '''Liabilities and stockholders’ equity''' |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 2,735: | Line 2,904: | ||
| style="text-align:right" | 76,206 |
| style="text-align:right" | 76,206 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Notes payable |
||
| style="text-align:right" | 100,411 |
| style="text-align:right" | 100,411 |
||
| style="text-align:right" | 100,000 |
| style="text-align:right" | 100,000 |
||
| Line 2,743: | Line 2,912: | ||
| style="text-align:right" | 19,536 |
| style="text-align:right" | 19,536 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total liabilities''' |
||
| style="text-align:right |
| style="text-align:right" | '''3,782,287''' |
||
| style="text-align:right |
| style="text-align:right" | '''2,935,479''' |
||
|- |
|- |
||
| style="text-align:left" | Stockholders’ equity |
| style="text-align:left" | '''Stockholders’ equity''' |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Common stock, $0.01 par value, 500,000,000 shares authorized, 40,511,222 and 40,127,908 shares issued and outstanding, respectively |
| class="wt-indent-1" style="text-align:left" | Common stock, $ 0.01 par value, 500,000,000 shares authorized, 40,511,222 and 40,127,908 shares issued and outstanding, respectively |
||
| style="text-align:right" | 405 |
| style="text-align:right" | 405 |
||
| style="text-align:right" | 401 |
| style="text-align:right" | 401 |
||
| Line 2,761: | Line 2,930: | ||
| style="text-align:left" | Accumulated other comprehensive income (loss) |
| style="text-align:left" | Accumulated other comprehensive income (loss) |
||
| style="text-align:right" | 11,457 |
| style="text-align:right" | 11,457 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 22,120 ) |
||
|- |
|- |
||
| style="text-align:left" | Retained earnings |
| style="text-align:left" | Retained earnings |
||
| Line 2,767: | Line 2,936: | ||
| style="text-align:right" | 97,120 |
| style="text-align:right" | 97,120 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total stockholders’ equity''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,009,565''' |
||
| style="text-align:right |
| style="text-align:right" | '''793,999''' |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total liabilities and stockholders’ equity''' |
||
| style="text-align:right |
| style="text-align:right" | '''4,791,852''' |
||
| style="text-align:right |
| style="text-align:right" | '''3,729,478''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Consolidated statements of operations and comprehensive income|Consolidated statements of operations, comprehensive income, accompanying notes|ed0t39ch3f|utcfjac7ow|kind=prose|order=81}} |
|||
== Consolidated balance sheets (parenthetical) == |
|||
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 59</sup>. |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | USD ($) $ in Thousands |
|||
! class="col-m" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-m" style="text-align:right" | Dec. 31, 2024 |
|||
|- |
|||
| style="text-align:left" | Statement of Financial Position [Abstract] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Available-for-sale allowance for credit losses |
|||
| style="text-align:right" | 7,000 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Amortized cost |
|||
| style="text-align:right" | 1,848,755 |
|||
| style="text-align:right" | 1,320,266 |
|||
|- |
|||
| style="text-align:left" | Allowance for credit losses |
|||
| style="text-align:right" | 468 |
|||
| style="text-align:right" | 243 |
|||
|- |
|||
| style="text-align:left" | Common stock, par value (in dollar per share) |
|||
| style="text-align:right" | 0.01 |
|||
| style="text-align:right" | 0.01 |
|||
|- |
|||
| style="text-align:left" | Common stock, shares authorized (in shares) |
|||
| style="text-align:right" | 500,000,000 |
|||
| style="text-align:right" | 500,000,000 |
|||
|- |
|||
| style="text-align:left" | Common stock, shares issued (in shares) |
|||
| style="text-align:right" | 40,511,222 |
|||
| style="text-align:right" | 40,127,908 |
|||
|- |
|||
| style="text-align:left" | Common stock, shares outstanding (in shares) |
|||
| style="text-align:right" | 40,511,222 |
|||
| style="text-align:right" | 40,127,908 |
|||
|} |
|||
</div> |
|||
{{Indexing|Consolidated statements of operations||ed0t39ch3f|wpkf9ycgxf|jpoeftv18u|irxh3hcbqz|qfq1t7e6o0|kind=table|order=82}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan=" |
! colspan="2" style="text-align:center" | Years Ended December 31, |
||
! style="text-align:center" | |
|||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands, except share and per share amounts) |
||
! |
! style="text-align:center" | 2025 |
||
! |
! style="text-align:center" | 2024 |
||
! |
! style="text-align:center" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Revenues: |
|||
! class="col-m" style="text-align:right" | — |
|||
! class="col-m" style="text-align:right" | — |
|||
! class="col-m" style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Net earned premiums |
| style="text-align:left" | Net earned premiums |
||
| Line 2,857: | Line 2,989: | ||
|- |
|- |
||
| style="text-align:left" | Other loss |
| style="text-align:left" | Other loss |
||
| style="text-align:right" | |
| style="text-align:right" | ( 587 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 167 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 632 ) |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total revenues''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,416,541''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,150,200''' |
||
| style="text-align:right |
| style="text-align:right" | '''885,969''' |
||
|- |
|||
| style="text-align:left" | Expenses: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Losses and loss adjustment expenses |
| style="text-align:left" | Losses and loss adjustment expenses |
||
| Line 2,883: | Line 3,010: | ||
| style="text-align:left" | Transaction costs |
| style="text-align:left" | Transaction costs |
||
| style="text-align:right" | 14,019 |
| style="text-align:right" | 14,019 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Interest expense |
| style="text-align:left" | Interest expense |
||
| Line 2,901: | Line 3,028: | ||
| style="text-align:right" | 5,364 |
| style="text-align:right" | 5,364 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total expenses''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,200,117''' |
||
| style="text-align:right |
| style="text-align:right" | '''997,461''' |
||
| style="text-align:right |
| style="text-align:right" | '''775,867''' |
||
|- |
|- |
||
| style="text-align:left" | Income before income taxes |
| style="text-align:left" | '''Income before income taxes''' |
||
| style="text-align:right" | 216,424 |
| style="text-align:right" | '''216,424''' |
||
| style="text-align:right" | 152,739 |
| style="text-align:right" | '''152,739''' |
||
| style="text-align:right" | 110,102 |
| style="text-align:right" | '''110,102''' |
||
|- |
|- |
||
| style="text-align:left" | Income tax expense |
| style="text-align:left" | Income tax expense |
||
| Line 2,916: | Line 3,043: | ||
| style="text-align:right" | 24,118 |
| style="text-align:right" | 24,118 |
||
|- |
|- |
||
| style="text-align:left" | Net income |
| style="text-align:left" | '''Net income''' |
||
| style="text-align:right" | 170,028 |
| style="text-align:right" | '''170,028''' |
||
| style="text-align:right" | 118,828 |
| style="text-align:right" | '''118,828''' |
||
| style="text-align:right" | 85,984 |
| style="text-align:right" | '''85,984''' |
||
|- |
|- |
||
| style="text-align:left" | Net income attributable to participating securities |
| style="text-align:left" | '''Net income attributable to participating securities''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | 1,677 |
| style="text-align:right" | '''1,677''' |
||
|- |
|- |
||
| style="text-align:left" | Net income attributable to common stockholders |
| style="text-align:left" | '''Net income attributable to common stockholders''' |
||
| style="text-align:right" | 170,028 |
| style="text-align:right" | '''170,028''' |
||
| style="text-align:right" | 118,828 |
| style="text-align:right" | '''118,828''' |
||
| style="text-align:right" | 84,307 |
| style="text-align:right" | '''84,307''' |
||
|- |
|||
| style="text-align:left" | '''Net income''' |
|||
| style="text-align:right" | '''170,028''' |
|||
| style="text-align:right" | '''118,828''' |
|||
| style="text-align:right" | '''85,984''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Other comprehensive income:''' |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Net income |
|||
| style="text-align:right" | 170,028 |
|||
| style="text-align:right" | 118,828 |
|||
| style="text-align:right" | 85,984 |
|||
|- |
|- |
||
| style="text-align:left" | Unrealized gains and losses on investments: |
| style="text-align:left" | Unrealized gains and losses on investments: |
||
| Line 2,953: | Line 3,080: | ||
| style="text-align:left" | Reclassification adjustment for gains (losses) on securities no longer held, net of tax |
| style="text-align:left" | Reclassification adjustment for gains (losses) on securities no longer held, net of tax |
||
| style="text-align:right" | 485 |
| style="text-align:right" | 485 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 8,959 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 4,984 ) |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total other comprehensive income''' |
||
| style="text-align:right |
| style="text-align:right" | '''33,577''' |
||
| style="text-align:right |
| style="text-align:right" | '''833''' |
||
| style="text-align:right |
| style="text-align:right" | '''20,532''' |
||
|- |
|- |
||
| style="text-align:left" | Comprehensive income |
| style="text-align:left" | '''Comprehensive income''' |
||
| style="text-align:right" | 203,605 |
| style="text-align:right" | '''203,605''' |
||
| style="text-align:right" | 119,661 |
| style="text-align:right" | '''119,661''' |
||
| style="text-align:right" | 106,516 |
| style="text-align:right" | '''106,516''' |
||
|- |
|- |
||
| style="text-align:left" | Per share data: |
| style="text-align:left" | '''Per share data:''' |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Basic earnings per share |
| style="text-align:left" | Basic earnings per share |
||
| style="text-align:right" | 4.21 |
| style="text-align:right" | 4.21 |
||
| style="text-align:right" | 2.97 |
| style="text-align:right" | 2.97 |
||
| style="text-align:right" | 2.34 |
| style="text-align:right" | 2.34 |
||
|- |
|- |
||
| style="text-align:left" | Diluted earnings per share |
| style="text-align:left" | '''Diluted earnings per share''' |
||
| style="text-align:right" | 4.07 |
| style="text-align:right" | '''4.07''' |
||
| style="text-align:right" | 2.87 |
| style="text-align:right" | '''2.87''' |
||
| style="text-align:right" | 2.24 |
| style="text-align:right" | '''2.24''' |
||
|- |
|- |
||
| style="text-align:left" | Weighted-average common shares outstanding |
| style="text-align:left" | '''Weighted-average common shares outstanding''' |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Basic |
| style="text-align:left" | Basic |
||
| style="text-align:right" | 40,407,310 |
| style="text-align:right" | 40,407,310 |
||
| style="text-align:right" | 40,056,475 |
| style="text-align:right" | 40,056,475 |
||
| style="text-align:right" | 36,031,907 |
| style="text-align:right" | 36,031,907 |
||
|- |
|- |
||
| style="text-align:left" | Diluted |
| style="text-align:left" | '''Diluted''' |
||
| style="text-align:right" | 41,808,046 |
| style="text-align:right" | '''41,808,046''' |
||
| style="text-align:right" | 41,377,460 |
| style="text-align:right" | '''41,377,460''' |
||
| style="text-align:right" | 38,317,534 |
| style="text-align:right" | '''38,317,534''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Consolidated statements of stockholders’ equity|Consolidated statements of stockholders’ equity, accompanying notes|z6dk9e62ik|kind=prose|order=83}} |
|||
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 60</sup>. |
|||
{{Indexing|Consolidated statements of shareholders' equity||z6dk9e62ik|0lk0pqg9zh|kind=table|order=84}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! |
! colspan="3" style="text-align:center" | Years Ended December 31, |
||
! class="col-s" style="text-align:right" | Preferred stocks: |
|||
! class="col-s" style="text-align:right" | Common stock: |
|||
! class="col-s" style="text-align:right" | Treasury stock: |
|||
! class="col-s" style="text-align:right" | Additional paid-in capital: |
|||
! class="col-s" style="text-align:right" | Stock notes receivable: |
|||
! class="col-s" style="text-align:right" | Accumulated other comprehensive income (loss): |
|||
! class="col-s" style="text-align:right" | Retained earnings (accumulated deficit): |
|||
! class="col-s" style="text-align:right" | Retained earnings (accumulated deficit): Period of adoption, adjustment |
|||
|- |
|- |
||
! style="text-align:left" | ($ in thousands, except share amounts) |
|||
! style="text-align:center" | 2025 |
|||
! style="text-align:center" | 2024 |
|||
! style="text-align:center" | 2023 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
! style="text-align:left" | Preferred shares: |
|||
! class="col-m" style="text-align:right" | — |
|||
! class="col-m" style="text-align:right" | — |
|||
! class="col-m" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:right" | — |
|||
| style="text-align: |
| style="text-align:left" | Balance at beginning of year |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 1,969,660 |
|||
|- |
|- |
||
| style="text-align:left" | Preferred stock conversion to common shares |
| style="text-align:left" | Preferred stock conversion to common shares |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | -1,969,660 |
|||
| style="text-align:right" | 16,305,113 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 1,969,660 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Balance at December 31''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Balance at beginning of year |
||
| style="text-align:right" | |
| style="text-align:right" | 40,127,908 |
||
| style="text-align:right" | |
| style="text-align:right" | 39,863,756 |
||
| style="text-align:right" | 16,599,666 |
| style="text-align:right" | 16,599,666 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Issuance of shares |
||
| style="text-align:right" | |
| style="text-align:right" | 383,314 |
||
| style="text-align:right" | |
| style="text-align:right" | 264,152 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Issuance of shares (in shares) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 6,958,977 |
| style="text-align:right" | 6,958,977 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Common shares balance at ending of period (in shares) at Dec. 31, 2023 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 39,863,756 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Stockholders' equity beginning balance at Dec. 31, 2022 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 20 |
|||
| style="text-align:right" | 168 |
|||
| style="text-align:right" | -2 |
|||
| style="text-align:right" | 577,289 |
|||
| style="text-align:right" | -6,911 |
|||
| style="text-align:right" | -43,485 |
|||
| style="text-align:right" | -105,417 |
|||
| style="text-align:right" | -2,275 |
|||
|- |
|||
| style="text-align:left" | Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Preferred stock conversion to common shares |
| style="text-align:left" | Preferred stock conversion to common shares |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | -20 |
|||
| style="text-align:right" | 161 |
|||
| style="text-align:right" | 2 |
|||
| style="text-align:right" | -143 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 16,305,113 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Balance at December 31''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''40,511,222''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''40,127,908''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''39,863,756''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 9,213 |
|||
| style="text-align:right" | 1,349 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Balance at beginning of year |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 48 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 124,496 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 20 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Balance at December 31''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 20,532 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Common stock:''' |
||
| style="text-align:right" | 85,984 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 85,984 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Balance at beginning of year |
||
| style="text-align:right" | |
| style="text-align:right" | 401 |
||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 399 |
| style="text-align:right" | 399 |
||
| style="text-align:right" | |
| style="text-align:right" | 168 |
||
| style="text-align:right" | 710,855 |
|||
| style="text-align:right" | -5,562 |
|||
| style="text-align:right" | -22,953 |
|||
| style="text-align:right" | -21,708 |
|||
| style="text-align:right" | 0 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Issuance of common stock |
||
| style="text-align:right" | |
| style="text-align:right" | 4 |
||
| style="text-align:right" | |
| style="text-align:right" | 2 |
||
| style="text-align:right" | |
| style="text-align:right" | 22 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Proceeds from equity offerings, net |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 48 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Balance at December 31''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''405''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''401''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''399''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Treasury stock:''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Balance at beginning of year |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 264,152 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 2 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Balance at December 31''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Additional paid-in capital:''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Balance at beginning of year |
||
| style="text-align:right" | |
| style="text-align:right" | 718,598 |
||
| style="text-align:right" | |
| style="text-align:right" | 710,855 |
||
| style="text-align:right" | |
| style="text-align:right" | 577,289 |
||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Issuance of common stock |
| style="text-align:left" | Issuance of common stock |
||
| style="text-align:right" | |
| style="text-align:right" | 11,957 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 2 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 7,743 |
| style="text-align:right" | 7,743 |
||
| style="text-align:right" | |
| style="text-align:right" | 9,213 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Proceeds from equity offerings, net |
| style="text-align:left" | Proceeds from equity offerings, net |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 124,496 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Balance at December 31''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''730,555''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''718,598''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''710,855''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 833 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Stock notes receivable:''' |
||
| style="text-align:right" | 118,828 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 118,828 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Balance at beginning of year |
||
| style="text-align:right" | 793,999 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 401 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 718,598 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | -22,120 |
|||
| style="text-align:right" | 97,120 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 5,562 ) |
|||
| style="text-align:right" | ( 6,911 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Employee equity transactions |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 5,562 |
|||
| style="text-align:right" | 1,349 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Balance at December 31''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 5,562 )''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Accumulated other comprehensive income (loss):''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Balance at beginning of year |
||
| style="text-align:right" | |
| style="text-align:right" | ( 22,120 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 22,953 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 43,485 ) |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Other comprehensive income, net of tax |
||
| style="text-align:right" | |
| style="text-align:right" | 33,577 |
||
| style="text-align:right" | |
| style="text-align:right" | 833 |
||
| style="text-align:right" | |
| style="text-align:right" | 20,532 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Balance at December 31''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''11,457''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 22,120 )''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 22,953 )''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Retained earnings (accumulated deficit):''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Balance at beginning of year |
||
| style="text-align:right" | |
| style="text-align:right" | 97,120 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 21,708 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 105,417 ) |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 11,957 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Cumulative effect on adoption of ASU No. 2016-13 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Other comprehensive income, net of tax |
|||
| style="text-align:right" | 33,577 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 33,577 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 2,275 ) |
|||
|- |
|- |
||
| style="text-align:left" | Net income |
| style="text-align:left" | Net income |
||
| style="text-align:right" | 170,028 |
| style="text-align:right" | 170,028 |
||
| style="text-align:right" | |
| style="text-align:right" | 118,828 |
||
| style="text-align:right" | |
| style="text-align:right" | 85,984 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 170,028 |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Balance at December 31''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''267,148''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''97,120''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 21,708 )''' |
||
|- |
|||
| style="text-align:right" | 0 |
|||
| style="text-align: |
| style="text-align:left" | '''Total stockholders’ equity''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,009,565''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''793,999''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''661,031''' |
||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Consolidated statements of cash flows|Consolidated statements of cash flows, accompanying notes|cs6p6hop55|kind=prose|order=85}} |
|||
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 61</sup>. |
|||
{{Indexing|Consolidated statements of cash flows||cs6p6hop55|kind=table|order=86}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | |
! colspan="3" style="text-align:center" | Years Ended December 31, |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | 2025 |
||
! |
! style="text-align:center" | 2024 |
||
! |
! style="text-align:center" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Cash flows from operating activities: |
|||
! class="col-m" style="text-align:right" | — |
|||
! class="col-m" style="text-align:right" | — |
|||
! class="col-m" style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Net income |
| style="text-align:left" | Net income |
||
| Line 3,500: | Line 3,355: | ||
|- |
|- |
||
| style="text-align:left" | Net investment (gains) losses |
| style="text-align:left" | Net investment (gains) losses |
||
| style="text-align:right" | |
| style="text-align:right" | ( 22,149 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 6,342 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 11,054 ) |
||
|- |
|- |
||
| style="text-align:left" | Depreciation and amortization expense |
| style="text-align:left" | Depreciation and amortization expense |
||
| Line 3,516: | Line 3,371: | ||
| style="text-align:left" | Undistributed earnings (loss) from long-term investments |
| style="text-align:left" | Undistributed earnings (loss) from long-term investments |
||
| style="text-align:right" | 10,122 |
| style="text-align:right" | 10,122 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 6,252 ) |
||
| style="text-align:right" | 6,730 |
| style="text-align:right" | 6,730 |
||
|- |
|- |
||
| style="text-align:left" | Net change in fair value of derivatives |
| style="text-align:left" | Net change in fair value of derivatives |
||
| style="text-align:right" | |
| style="text-align:right" | ( 34,857 ) |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Deferred income tax, net |
| style="text-align:left" | Deferred income tax, net |
||
| style="text-align:right" | |
| style="text-align:right" | ( 6,397 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 8,708 ) |
||
| style="text-align:right" | 9,383 |
| style="text-align:right" | 9,383 |
||
|- |
|- |
||
| style="text-align:left" | Premiums receivable, net |
| style="text-align:left" | Premiums receivable, net |
||
| style="text-align:right" | |
| style="text-align:right" | ( 222,576 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 142,406 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 40,020 ) |
||
|- |
|- |
||
| style="text-align:left" | Reinsurance recoverables, net |
| style="text-align:left" | Reinsurance recoverables, net |
||
| style="text-align:right" | |
| style="text-align:right" | ( 262,004 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 261,542 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 17,270 ) |
||
|- |
|- |
||
| style="text-align:left" | Ceded unearned premium |
| style="text-align:left" | Ceded unearned premium |
||
| style="text-align:right" | |
| style="text-align:right" | ( 35,047 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 17,780 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 28,476 ) |
||
|- |
|- |
||
| style="text-align:left" | Deferred policy acquisition costs |
| style="text-align:left" | Deferred policy acquisition costs |
||
| style="text-align:right" | |
| style="text-align:right" | ( 22,917 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 21,228 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 23,017 ) |
||
|- |
|- |
||
| style="text-align:left" | Federal income taxes |
| style="text-align:left" | Federal income taxes |
||
| style="text-align:right" | 1,797 |
| style="text-align:right" | 1,797 |
||
| style="text-align:right" | 4,500 |
| style="text-align:right" | 4,500 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,892 ) |
||
|- |
|- |
||
| style="text-align:left" | Losses and loss adjustment expenses |
| style="text-align:left" | Losses and loss adjustment expenses |
||
| Line 3,585: | Line 3,440: | ||
|- |
|- |
||
| style="text-align:left" | Other, net |
| style="text-align:left" | Other, net |
||
| style="text-align:right" | |
| style="text-align:right" | ( 27,987 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 12,788 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 5,047 ) |
||
|- |
|- |
||
| style="text-align:left" | Net cash provided by operating activities |
| style="text-align:left" | '''Net cash provided by operating activities''' |
||
| style="text-align:right" | 408,076 |
| style="text-align:right" | '''408,076''' |
||
| style="text-align:right" | 305,115 |
| style="text-align:right" | '''305,115''' |
||
| style="text-align:right" | 338,187 |
| style="text-align:right" | '''338,187''' |
||
|- |
|||
| style="text-align:left" | Cash flows from investing activities: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Purchase of fixed maturity securities, available-for-sale |
| style="text-align:left" | Purchase of fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | ( 910,039 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 617,606 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 459,672 ) |
||
|- |
|- |
||
| style="text-align:left" | Purchase of illiquid investments |
| style="text-align:left" | Purchase of illiquid investments |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | ( 75 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,675 ) |
||
|- |
|- |
||
| style="text-align:left" | Purchase of equity securities |
| style="text-align:left" | Purchase of equity securities |
||
| style="text-align:right" | |
| style="text-align:right" | ( 13,213 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 14,077 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 26,009 ) |
||
|- |
|- |
||
| style="text-align:left" | Purchase of equity method investments and other long-term investments |
| style="text-align:left" | Purchase of equity method investments and other long-term investments |
||
| style="text-align:right" | |
| style="text-align:right" | ( 6,814 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 32,173 ) |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Purchase of intangible assets and goodwill |
| style="text-align:left" | Purchase of intangible assets and goodwill |
||
| style="text-align:right" | |
| style="text-align:right" | ( 2,000 ) |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | ( 50 ) |
||
|- |
|- |
||
| style="text-align:left" | Investment in direct and indirect loans |
| style="text-align:left" | Investment in direct and indirect loans |
||
| Line 3,630: | Line 3,480: | ||
|- |
|- |
||
| style="text-align:left" | Purchase of property and equipment |
| style="text-align:left" | Purchase of property and equipment |
||
| style="text-align:right" | |
| style="text-align:right" | ( 5,454 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 4,224 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 3,108 ) |
||
|- |
|- |
||
| style="text-align:left" | Proceeds from the sales of fixed maturity securities, available-for-sale |
| style="text-align:left" | Proceeds from the sales of fixed maturity securities, available-for-sale |
||
| Line 3,661: | Line 3,511: | ||
| style="text-align:left" | Change in short-term investments |
| style="text-align:left" | Change in short-term investments |
||
| style="text-align:right" | 10,626 |
| style="text-align:right" | 10,626 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 4,799 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 149,068 ) |
||
|- |
|- |
||
| style="text-align:left" | Change in receivable/payable for securities |
| style="text-align:left" | Change in receivable/payable for securities |
||
| Line 3,674: | Line 3,524: | ||
| style="text-align:right" | 11,913 |
| style="text-align:right" | 11,913 |
||
|- |
|- |
||
| style="text-align:left" | Net cash used in investment activities |
| style="text-align:left" | '''Net cash used in investment activities''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 366,898 )''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 243,694 )''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 493,809 )''' |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Employee share purchases |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Employee share purchases |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 1,350 |
| style="text-align:right" | 1,350 |
||
|- |
|- |
||
| style="text-align:left" | Repayment of stock notes receivable |
| style="text-align:left" | Repayment of stock notes receivable |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 5,562 |
| style="text-align:right" | 5,562 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Proceeds from long term borrowings |
| style="text-align:left" | Proceeds from long term borrowings |
||
| Line 3,700: | Line 3,545: | ||
|- |
|- |
||
| style="text-align:left" | Payments on long term borrowings and trust preferred |
| style="text-align:left" | Payments on long term borrowings and trust preferred |
||
| style="text-align:right" | |
| style="text-align:right" | ( 43,000 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 116,794 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 50,000 ) |
||
|- |
|- |
||
| style="text-align:left" | Proceeds from initial public offering |
| style="text-align:left" | Proceeds from initial public offering |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 129,597 |
| style="text-align:right" | 129,597 |
||
|- |
|- |
||
| style="text-align:left" | Net cash provided by (used in) financing activities |
| style="text-align:left" | '''Net cash provided by (used in) financing activities''' |
||
| style="text-align:right" | 411 |
| style="text-align:right" | '''411''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 4,232 )''' |
||
| style="text-align:right" | 130,947 |
| style="text-align:right" | '''130,947''' |
||
|- |
|- |
||
| style="text-align:left" | Net increase (decrease) in cash and cash equivalents and restricted cash |
| style="text-align:left" | '''Net increase (decrease) in cash and cash equivalents and restricted cash''' |
||
| style="text-align:right" | 41,589 |
| style="text-align:right" | '''41,589''' |
||
| style="text-align:right" | 57,189 |
| style="text-align:right" | '''57,189''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 24,675 )''' |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of period |
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of period (1) |
||
| style="text-align:right" | 157,525 |
| style="text-align:right" | 157,525 |
||
| style="text-align:right" | 100,336 |
| style="text-align:right" | 100,336 |
||
| style="text-align:right" | 125,011 |
| style="text-align:right" | 125,011 |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents and restricted cash at end of period |
| style="text-align:left" | '''Cash and cash equivalents and restricted cash at end of period (1)''' |
||
| style="text-align:right" | 199,114 |
| style="text-align:right" | '''199,114''' |
||
| style="text-align:right" | 157,525 |
| style="text-align:right" | '''157,525''' |
||
| style="text-align:right" | 100,336 |
| style="text-align:right" | '''100,336''' |
||
|- |
|- |
||
| style="text-align:left" | Supplemental disclosure of cash flow information: |
| style="text-align:left" | '''Supplemental disclosure of cash flow information:''' |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,741: | Line 3,586: | ||
</div> |
</div> |
||
(1) The sum of cash and cash equivalents and restricted cash from the Consolidated Balance Sheets. |
|||
== Summary of Significant Accounting Policies == |
|||
{{Indexing|A. Description of Business|Skyward Specialty Insurance Group, Inc., insurance holding company, underwriting divisions, Great Midwest Insurance Company, Houston Specialty Insurance Company, Imperium Insurance Company, Oklahoma Specialty Insurance Company, Skyward Re, Skyward Underwriters Agency, Inc., Skyward Service Company, Skyward Specialty No. 1 Limited, Apollo Group Holdings Limited|cmtswfs0go|lht8rybaqk|20fueoa3q1|kind=prose|order=87|f1=Legal name|v1=Skyward Specialty Insurance Group, Inc.|f2=State of incorporation|v2=Delaware|f3=Year founded|v3=2006|f4=Subsidiaries|v4=Great Midwest Insurance Company, Houston Specialty Insurance Company, Imperium Insurance Company, Oklahoma Specialty Insurance Company, Skyward Re, Skyward Underwriters Agency, Inc., Skyward Service Company, Skyward Specialty No. 1 Limited|f5=Acquisition|v5=Apollo Group Holdings Limited on January 1, 2026}} |
|||
* ''Skyward Specialty Insurance Group, Inc.'' (the "Company") is a Delaware corporation organized in 2006, operating as an insurance holding company <sup>p. 62</sup>. |
|||
* The Company operates in one segment, delivering commercial property and casualty insurance products through its underwriting divisions <sup>p. 62</sup>. |
|||
* The Company has four wholly owned U.S.-based insurance company subsidiaries <sup>p. 62</sup>. |
|||
** ''Great Midwest Insurance Company'' ("GMIC") underwrites insurance on an admitted basis and is a certified surety bond company listed with the U.S. Department of the Treasury <sup>p. 62</sup>. |
|||
** ''Houston Specialty Insurance Company'' ("HSIC"), a subsidiary of GMIC, underwrites insurance on a non-admitted basis <sup>p. 62</sup>. |
|||
** ''Imperium Insurance Company'' ("IIC"), a subsidiary of HSIC, underwrites insurance on an admitted basis <sup>p. 62</sup>. |
|||
** ''Oklahoma Specialty Insurance Company'' ("OSIC"), a subsidiary of IIC, underwrites insurance on a non-admitted basis <sup>p. 62</sup>. |
|||
* The Company has a wholly owned captive reinsurance company subsidiary, ''Skyward Re'', domiciled in the Cayman Islands <sup>p. 62</sup>. |
|||
** Skyward Re assumed net reserves for certain divisions related to a retroactive reinsurance contract from the Company's insurance companies and retroceded these net reserves to a third-party reinsurer <sup>p. 62</sup>. |
|||
* The Company has three non-risk bearing wholly owned subsidiaries <sup>p. 62</sup>. |
|||
** ''Skyward Underwriters Agency, Inc.'' ("SUA") is a managing general insurance agent and reinsurance broker for property and casualty risks in specialty niche markets <sup>p. 62</sup>. |
|||
** ''Skyward Service Company'' provides various administrative services to the Company's subsidiaries <sup>p. 62</sup>. |
|||
** ''Skyward Specialty No. 1 Limited'' is a Lloyd's corporate member authorized to invest in Lloyd's syndicates <sup>p. 62</sup>. |
|||
* On January 1, 2026, the Company completed the acquisition of ''Apollo Group Holdings Limited'' for an aggregate consideration of approximately $555.0 million <sup>p. 62</sup>. |
|||
** Additional information on this acquisition is provided in Note 24 <sup>p. 62</sup>. |
|||
{{Indexing|B. Basis of Presentation|Consolidated financial statements, Generally Accepted Accounting Principles (GAAP), intercompany transactions, estimates and assumptions|ow7tevuxxr|ie3cmfrol3|kind=prose|order=88}} |
|||
* The Company's consolidated financial statements are prepared according to Generally Accepted Accounting Principles in the United States of America (GAAP) <sup>p. 63</sup>. |
|||
* GAAP differs in some aspects from the principles used in reports to insurance regulatory authorities <sup>p. 63</sup>. |
|||
* The consolidated financial statements encompass the accounts of the holding company and its subsidiaries <sup>p. 63</sup>. |
|||
* All intercompany transactions and balances are eliminated during consolidation <sup>p. 63</sup>. |
|||
* Preparing consolidated financial statements under GAAP necessitates the Company making estimates and assumptions that influence the amounts reported in the financial statements and notes <sup>p. 63</sup>. |
|||
* The Company's actual results may vary from these estimates <sup>p. 63</sup>. |
|||
{{Indexing|C. Consolidation|Consolidation, variable interest entity (VIE), primary beneficiary, voting interest, related party analysis, fair value of assets, financial performance|ow7tevuxxr|kind=prose|order=89}} |
|||
* The Company consolidates an entity if it meets the definition of a variable interest entity (VIE) for which the Company is the primary beneficiary, or if the Company controls the entity through a majority of voting interest or other arrangements <sup>p. 64</sup>. |
|||
* A ''VIE'' is defined as an entity that either lacks sufficient equity to finance its activities without additional subordinated financial support, whose equity holders lack the characteristics of a controlling financial interest, and/or is established with non-substantive voting rights <sup>p. 64</sup>. |
|||
* The Company's assessment of VIE status involves subjectivity in determining which activities most significantly affect the VIE’s performance and estimates about current and future fair value of assets and financial performance <sup>p. 64</sup>. |
|||
* In performing the related party analysis, the Company considers qualitative and quantitative factors including the characteristics and size of its investment, ability to control or significantly influence key decisions (including de facto agents), obligation or likelihood to fund operating losses, and similarity and significance of the VIE’s business activities to those of the Company and related party <sup>p. 64</sup>. |
|||
* The determination of whether an entity is a VIE and whether the Company is the primary beneficiary involves significant judgment and depends on specific facts and circumstances at the time of assessment <sup>p. 64</sup>. |
|||
* At each reporting period, the Company reassesses changes in facts and circumstances that could alter an entity's VIE status or the Company's consolidation assessment <sup>p. 64</sup>. |
|||
* Changes in consolidation status are applied prospectively <sup>p. 64</sup>. |
|||
* If an entity is consolidated due to reassessment, its assets, liabilities, and noncontrolling interest are recorded at fair value upon initial consolidation <sup>p. 64</sup>. |
|||
* Any existing equity interest held by the Company in the entity prior to obtaining control is remeasured at fair value, potentially resulting in a gain or loss recognized upon initial consolidation <sup>p. 64</sup>. |
|||
* The Company may also deconsolidate a subsidiary following reassessment, which could result in a gain or loss depending on the carrying values of deconsolidated assets and liabilities compared to the fair value of any retained interests <sup>p. 64</sup>. |
|||
* After these assessments, the Company determined that one entity meets the definition of a VIE for which the Company is the primary beneficiary <sup>p. 64</sup>. |
|||
* Further details and required disclosures regarding this VIE are provided in Note 7 <sup>p. 64</sup>. |
|||
{{Indexing|D. Cash and Cash Equivalents|Cash and cash equivalents, fixed maturity securities, fair value|cs6p6hop55|kind=prose|order=90}} |
|||
* ''Cash and cash equivalents'' include cash on hand and fixed maturity securities with original maturities of three months or less <sup>p. 65</sup>. |
|||
* The carrying value of the Company’s cash and cash equivalents approximates fair value <sup>p. 65</sup>. |
|||
{{Indexing|E. Restricted Cash|Restricted cash, legal restriction, SUA, unremitted insurance premiums, state regulations, collateral for reinsurance balances|cs6p6hop55|kind=prose|order=91}} |
|||
* ''Restricted cash'' is cash with a legal restriction on withdrawal or use by the consolidated group <sup>p. 66</sup>. |
|||
* The ''carrying value'' of the Company’s restricted cash approximates fair value <sup>p. 66</sup>. |
|||
* ''SUA'' collects premiums from clients, deducts commissions and applicable fees, and remits the remaining premiums to the Company’s insurance companies or third-party insurance companies <sup>p. 66</sup>. |
|||
* ''SUA'' holds unremitted insurance premiums in a fiduciary capacity for third-party insurance companies, recorded as restricted cash <sup>p. 66</sup>. |
|||
* The Company is required by ''state regulations'' to maintain assets on deposit with certain states and hold cash as collateral for certain reinsurance balances <sup>p. 66</sup>. |
|||
* ''Cash held'' in a depository account for others, or restricted by a state, is recorded as restricted cash <sup>p. 66</sup>. |
|||
{{Indexing|F. Investments|Available for Sale fixed maturities, fair value, unrealized loss position, amortized cost, allowance for credit losses, credit-related factors, held-to-maturity fixed maturity securities, historical loss rate, Moody’s multi-year cumulative loss rates, asset-backed securities|966xer0dpm|j8uunnd14x|m0cjxgvmvi|kind=prose|order=92}} |
|||
* ''Available for Sale fixed maturities'' are carried at fair value <sup>p. 67</sup>. |
|||
* For ''available-for-sale fixed maturities'' in an unrealized loss position, the Company first determines intent to sell or likelihood of being required to sell before maturity or cost recovery <sup>p. 67</sup>. |
|||
* If intent or likelihood of sale exists, the ''amortized cost'' is written down to fair value, with losses recognized in net investment gains on the Consolidated Statements of Operations <sup>p. 67</sup>. |
|||
* If neither sale criterion is met, the Company assesses if ''unrealized losses'' are due to credit-related factors <sup>p. 67</sup>. |
|||
* If ''unrealized losses'' are credit-related, an allowance for credit losses is determined by comparing the present value of cash flows to the amortized cost <sup>p. 67</sup>. |
|||
* Prior to 2025, ''changes in the allowance for credit losses'' were recognized in net investment income <sup>p. 67</sup>. |
|||
* As of 2025, ''changes in the allowance for credit losses'' are recognized in net investment gains, and prior periods have been updated to conform to this presentation <sup>p. 67</sup>. |
|||
* ''Credit losses'' limited by the fair value of the security are recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive income (loss) <sup>p. 67</sup>. |
|||
* ''Unrealized losses'' that are not credit-related continue to be recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive income (loss) <sup>p. 67</sup>. |
|||
* ''Held-to-maturity fixed maturity securities'' are carried at amortized cost net of an allowance for credit losses <sup>p. 67</sup>. |
|||
* The ''allowance for credit losses'' represents the current estimate of expected credit losses <sup>p. 67</sup>. |
|||
* The Company develops a ''historical loss rate'' from Moody’s multi-year cumulative loss rates for asset-backed securities <sup>p. 67</sup>. |
|||
* The ''historical loss rate'' is adjusted for current conditions and reasonable and supportable forecasts <sup>p. 67</sup>. |
|||
* Prior to 2025, ''changes in the allowance for credit losses'' for held-to-maturity securities were recognized in net investment income <sup>p. 67</sup>. |
|||
* As of 2025, ''changes in the allowance for credit losses'' for held-to-maturity securities are recognized in net investment gains, and prior periods have been updated to conform <sup>p. 67</sup>. |
|||
* ''Equity securities'' include common stock or preferred stock and mutual funds (even those primarily investing in debt securities) <sup>p. 67</sup>. |
|||
* ''Investments in equity securities with a readily determinable fair value'' are carried on the balance sheet at fair value using quoted market prices <sup>p. 67</sup>. |
|||
* ''Changes in the carrying value of equity securities'' are included in net investment gains (losses) within the Consolidated Statements of Operations <sup>p. 67</sup>. |
|||
* ''Mortgage loans'' are classified as held for investment and carried at cost adjusted for unamortized premiums, discounts, and loan fees <sup>p. 67</sup>. |
|||
* ''Uncollectible amounts'' for mortgage loans are written off in the period they are determined to be uncollectible <sup>p. 67</sup>. |
|||
* ''Interest on mortgage loans'' is recognized as interest receivable and included in other assets on the Consolidated Balance Sheets <sup>p. 67</sup>. |
|||
* The Company elected the ''fair value option'' for mortgage loans effective January 1, 2023, as targeted transition relief from ASU 2016-13 adoption <sup>p. 67</sup>. |
|||
* Under the ''fair value option'', mortgage loans are measured at fair value, and changes in unrealized gains and losses are reported in net investment gains (losses) on the Consolidated Statements of Operations <sup>p. 67</sup>. |
|||
* ''Interest income and amortization'' for mortgage loans under the fair value option continue to be recognized in net investment income <sup>p. 67</sup>. |
|||
* ''Equity method investments'' include equity and equity securities of non-public entities and indirect investments in loans and loan collateral <sup>p. 67</sup>. |
|||
* The Company has ''equity investments'' in certain limited partnerships and corporations where it has significant influence but not control <sup>p. 67</sup>. |
|||
* The Company determined it is not the primary beneficiary of these ''variable interest entities'' and does not consolidate them <sup>p. 67</sup>. |
|||
* The ''equity method'' is used to account for investments in unconsolidated subsidiaries <sup>p. 67</sup>. |
|||
* Under the ''equity method'', initial investment is recorded at cost and adjusted based on proportionate share of distributions and net income or loss of the investee <sup>p. 67</sup>. |
|||
* The ''difference between investment cost and proportionate share of underlying equity'' is a component of investment income <sup>p. 67</sup>. |
|||
* The Company amortizes this ''difference'' as an adjustment to its pro-rata share of equity method income over the useful life of the underlying asset <sup>p. 67</sup>. |
|||
* For ''equity securities of non-public entities'' where the Company lacks significant influence and fair value is not readily determinable, investments are carried at cost, minus impairment, and adjusted for observable price changes in orderly transactions <sup>p. 67</sup>. |
|||
* ''Investments in indirect collateralized loans and loan collateral'' are held through and accounted for as ownership interests in unconsolidated subsidiaries <sup>p. 67</sup>. |
|||
* The Company’s ''ownership interests in unconsolidated subsidiaries'' include investments in partnerships, joint ventures, and special purpose investment vehicles <sup>p. 67</sup>. |
|||
* The Company uses the ''equity method'' for these unconsolidated subsidiaries where it has significant influence but not control <sup>p. 67</sup>. |
|||
* ''Other long-term investments'' consist of an investment in a limited partnership held at net asset value (“NAV”) and other long-term investment securities <sup>p. 67</sup>. |
|||
* ''Short-term investments'' primarily consist of money market funds and are carried at cost, which approximates fair value <sup>p. 67</sup>. |
|||
* ''Net investment income'' includes interest, dividends, and equity in earnings (losses) of unconsolidated subsidiaries, net of investment expenses <sup>p. 67</sup>. |
|||
* ''Interest income'' is recognized on an accrual basis, and ''dividends'' are recognized as earned at the ex-dividend date <sup>p. 67</sup>. |
|||
* ''Interest income on mortgage-backed and other asset-backed securities'' is recognized using the effective-yield method based on estimated principal repayments <sup>p. 67</sup>. |
|||
* ''Amortization of premium and accretion of discounts on debt securities'' are included in interest income <sup>p. 67</sup>. |
|||
* ''Net investment gains and losses'' are recognized in net income based upon the specific identification method <sup>p. 67</sup>. |
|||
{{Indexing|G. Derivatives|Commodity derivatives, FASB ASC Topic 815, Derivatives and Hedging, fair value, current earnings, net assets and liabilities, exchange-traded futures, forward purchase and sale contracts, economic hedges, hedge accounting treatment, valuation models|s22xbq0z1h|kind=prose|order=93|f1=Accounting standard|v1=FASB ASC Topic 815, Derivatives and Hedging}} |
|||
* The Company uses ''commodity derivatives'' to assume risk and manage exposures in the insurance industry <sup>p. 68</sup>. |
|||
* Commodity derivatives expose the Company to potentially unfavorable price changes to the underlying commodities <sup>p. 68</sup>. |
|||
* The Company accounts for its derivatives in accordance with ''FASB ASC Topic 815, Derivatives and Hedging'' <sup>p. 68</sup>. |
|||
* This accounting standard requires all derivatives to be recorded at ''fair value'' on the Company’s balance sheet as either assets or liabilities <sup>p. 68</sup>. |
|||
* Changes in fair value of derivatives are reflected in ''current earnings'' <sup>p. 68</sup>. |
|||
* The Company meets the criteria to ''net assets and liabilities'' related to derivatives <sup>p. 68</sup>. |
|||
* These netted assets and liabilities are included in ''"other assets"'' on the Consolidated Balance Sheets <sup>p. 68</sup>. |
|||
* The Company considers its ''exchange-traded futures and forward purchase and sale contracts'' to be effective economic hedges <sup>p. 68</sup>. |
|||
* The Company has ''not elected hedge accounting treatment'' for these derivatives <sup>p. 68</sup>. |
|||
* The ''fair value of derivatives'' is estimated by reference to quoted prices or broker quotes, or through industry or internal valuation models when quotes are unavailable <sup>p. 68</sup>. |
|||
* Further details and required disclosures regarding derivatives can be found in ''Note 8'' <sup>p. 68</sup>. |
|||
{{Indexing|H. Reinsurance|Prospective reinsurance, proportional reinsurance, excess of loss reinsurance, facultative reinsurance, ceded unearned premium, reinsurance balances recoverable, retroactive reinsurance, loss portfolio transfers (LPT), adverse development covers|20fueoa3q1|8ihdrbirer|tc5fw176pu|kind=prose|order=94}} |
|||
* The Company purchases prospective reinsurance for certain lines of business on a proportional, excess of loss, and facultative basis <sup>p. 69</sup>. |
|||
* ''Proportional reinsurance'' requires the Company to share losses and expenses with the reinsurer in exchange for a share of premiums <sup>p. 69</sup>. |
|||
* ''Excess of loss reinsurance'' shares losses, either proportionally or entirely, above a certain dollar threshold, for a negotiated cost <sup>p. 69</sup>. |
|||
* ''Facultative reinsurance'' covers specific risks and/or policies on either a proportional or excess of loss basis <sup>p. 69</sup>. |
|||
* Ceded unearned premium and reinsurance balances recoverable (on paid and unpaid losses and settlement expenses) are reported separately as assets <sup>p. 69</sup>. |
|||
* Reinsurance does not relieve the Company of its legal liability to policyholders <sup>p. 69</sup>. |
|||
* Reinsurance on unpaid losses and settlement expenses represents estimates of the portion of liabilities recoverable from reinsurers <sup>p. 69</sup>. |
|||
* On the Consolidated Statements of Operations, net earned premiums, losses and loss adjustment expenses, net, and underwriting, acquisition, and insurance expenses are presented net of reinsurance ceded <sup>p. 69</sup>. |
|||
* The Company has purchased retroactive reinsurance on certain lines of business in prior years, including loss portfolio transfers ("LPT") and adverse development covers <sup>p. 69</sup>. |
|||
* These retroactive contracts indemnify losses related to past loss events, with the reinsurer sharing losses based on dollar thresholds <sup>p. 69</sup>. |
|||
* Income from retroactive reinsurance contracts is deferred and amortized into net income over the settlement period <sup>p. 69</sup>. |
|||
* Losses from retroactive reinsurance contracts are charged to net income immediately <sup>p. 69</sup>. |
|||
* Subsequent changes in the measurement of retroactive reinsurance contracts are accounted for using a full retrospective method <sup>p. 69</sup>. |
|||
* Certain ceded reinsurance contracts that management determines do not transfer significant insurance risk are accounted for using the deposit method <sup>p. 69</sup>. |
|||
* The evaluation of significant insurance risk transfer assesses both timing risk and underwriting risk <sup>p. 69</sup>. |
|||
* A reinsurance contract may not transfer significant insurance risk if either underwriting risk, timing risk, or both are not deemed transferred <sup>p. 69</sup>. |
|||
* For contracts transferring only significant timing risk but not sufficient underwriting risk, a deposit asset is recorded equal to the initial cash outflow <sup>p. 69</sup>. |
|||
* This deposit asset is offset by cash inflows received from reinsurers <sup>p. 69</sup>. |
|||
* If cash outflows are expected to differ from cash inflows, an accretion rate is established at inception based on actuarial estimates <sup>p. 69</sup>. |
|||
* The deposit accounting asset is increased/decreased to the estimated amount receivable over the contract term <sup>p. 69</sup>. |
|||
* The accretion of the deposit is based on the expected rate of return implied from estimated cash inflows and outflows <sup>p. 69</sup>. |
|||
* The Company periodically reassesses the estimated ultimate receivable and the related expected rate of return on the deposit asset <sup>p. 69</sup>. |
|||
* The accretion of the deposit asset, including changes from estimated cash flow changes, is reflected as part of investment income <sup>p. 69</sup>. |
|||
* Several reinsurance contracts require deposit accounting due to not transferring sufficient underwriting risk <sup>p. 69</sup>. |
|||
* No reinsurance contracts required deposit accounting due to not transferring sufficient timing risk <sup>p. 69</sup>. |
|||
* Reinsurance recoverables are carried net of an allowance for credit losses, which represents the current estimate of expected credit losses <sup>p. 69</sup>. |
|||
* The Company develops a historical loss rate using the A.M. Best impairment rate and rating transition study, which provides historical loss data for similarly rated reinsurance companies based on expected receivable duration <sup>p. 69</sup>. |
|||
* The historical loss rate is adjusted for current conditions, reasonable and supportable forecasts, and current economic conditions <sup>p. 69</sup>. |
|||
* Changes in the allowance for credit losses are recognized in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations <sup>p. 69</sup>. |
|||
* The Company continuously monitors the financial condition of its reinsurers, including reviewing their annual financial statements and industry developments <sup>p. 69</sup>. |
|||
* The Company analyzes credit risk by monitoring reinsurers' financial strength ratings from A.M. Best and assessing collateral adequacy <sup>p. 69</sup>. |
|||
* The Company has access to collateral from various reinsurers if they fail to fulfill obligations <sup>p. 69</sup>. |
|||
* ''Reinsurance collateral'' from reinsurers was ''$344.1 million'' as of December 31, 2025, and ''$337.0 million'' as of December 31, 2024 <sup>p. 69</sup>. |
|||
* ''eMaxx Captives'' and ''Everest Reinsurance Co.'' represented ''17.7%'' and ''11.1%'', respectively, of the Company’s reinsurance recoverable balances at December 31, 2025 <sup>p. 69</sup>. |
|||
* ''eMaxx Captives'' and ''Everest Reinsurance Co.'' represented ''16.8%'' and ''18.0%'', respectively, of the Company’s reinsurance recoverable balances at December 31, 2024 <sup>p. 69</sup>. |
|||
* These were the only reinsurers representing 10% or more of the Company’s reinsurance recoverable balances <sup>p. 69</sup>. |
|||
* ''eMaxx Captives'' was not rated by A.M. Best at December 31, 2025, and 2024 <sup>p. 69</sup>. |
|||
* ''Everest Reinsurance Co.'s'' financial strength rating from A.M. Best was A+ at December 31, 2025, and 2024 <sup>p. 69</sup>. |
|||
{{Indexing|I. Concentration of Credit Risk|Financial instruments, concentrations of credit risk, cash and cash equivalents, restricted cash, investments, premiums receivable, U.S. government securities, money market funds, credit exposure, customer base, distribution sources|m0cjxgvmvi|966xer0dpm|kind=prose|order=95}} |
|||
* ''Financial instruments'' that could lead to concentrations of credit risk include cash and cash equivalents, restricted cash, investments, and premiums receivable, excluding reinsurance recoverables <sup>p. 70</sup>. |
|||
* ''Cash equivalents and short-term investments'' consist of U.S. government securities and money market funds <sup>p. 70</sup>. |
|||
* ''Investments'' are diversified across various industries and geographic regions <sup>p. 70</sup>. |
|||
* The Company limits its ''credit exposure'' to any single financial institution or issuer <sup>p. 70</sup>. |
|||
* No significant ''concentration of credit risk'' is believed to exist regarding cash and investments <sup>p. 70</sup>. |
|||
* As of December 31, 2025 and 2024, ''outstanding premiums receivable'' are generally diversified due to a large customer base spread across many lines of business and geographic regions <sup>p. 70</sup>. |
|||
* ''Failure by distribution sources'' to remit premiums could lead to premium write-offs and a corresponding loss of income <sup>p. 70</sup>. |
|||
{{Indexing|J. Deferred Policy Acquisition Costs|Policy acquisition costs, commissions, premium taxes, ceding commissions, premium deficiency, expected losses, loss adjustment expenses, unearned premiums, anticipated investment income|or43xxg565|kind=prose|order=96|f1=Premium deficiency|v1=none as of December 31, 2025, and 2024}} |
|||
* ''Policy acquisition costs'' include commissions and premium taxes that are directly related to new or renewal business production <sup>p. 71</sup>. |
|||
* The Company defers policy acquisition costs and related ceding commissions <sup>p. 71</sup>. |
|||
* Deferred costs are charged or credited to earnings proportionally with the premium earned over the policy's life <sup>p. 71</sup>. |
|||
* A ''premium deficiency'' is recognized if expected losses, loss adjustment expenses, and unamortized acquisition costs exceed related unearned premiums <sup>p. 71</sup>. |
|||
* To recognize a premium deficiency, unamortized acquisition costs are first charged to expense to eliminate the deficiency <sup>p. 71</sup>. |
|||
* If the premium deficiency exceeds unamortized acquisition costs, a liability is accrued for the excess <sup>p. 71</sup>. |
|||
* ''Anticipated investment income'' is considered when determining premium deficiencies <sup>p. 71</sup>. |
|||
* Management determined that no premium deficiency existed as of December 31, 2025, and 2024 <sup>p. 71</sup>. |
|||
{{Indexing|K. Goodwill and Intangible Assets|Goodwill, intangible assets, purchase price allocation, amortization, impairment review|hekiequlv1|ie3cmfrol3|kind=prose|order=97}} |
|||
* ''Goodwill and intangible assets'' are recorded following a business combination <sup>p. 72</sup>. |
|||
* ''Goodwill'' is the excess of the purchase price over the fair value of acquired assets and assumed liabilities <sup>p. 72</sup>. |
|||
* The Company reviews its ''purchase price allocation'' for up to one year post-acquisition, allowing for adjustments within this period <sup>p. 72</sup>. |
|||
* The Company amortizes ''identifiable intangible assets'' with a finite useful life over the period they are expected to contribute to future cash flows <sup>p. 72</sup>. |
|||
* The Company does not amortize ''indefinite-lived intangible assets'' <sup>p. 72</sup>. |
|||
* The Company reviews ''goodwill and identifiable intangible assets'' for recoverability annually in the fourth quarter or on an interim basis if circumstances suggest the carrying amount may not be recoverable <sup>p. 72</sup>. |
|||
* The Company had ''no goodwill impairment'' for the years ended December 31, 2025, and 2024 <sup>p. 72</sup>. |
|||
{{Indexing|L. Property and Equipment|Property and equipment, depreciation expense, depreciation periods|ie3cmfrol3|1f87rdfb5o|kind=prose|order=98}} |
|||
* ''Property and equipment'' is included in other assets on the Consolidated Balance Sheets <sup>p. 73</sup>. |
|||
* Property and equipment is recorded at cost less accumulated depreciation <sup>p. 73</sup>. |
|||
* ''Depreciation expense'' is recognized on a straight-line basis for financial statement purposes <sup>p. 73</sup>. |
|||
* Depreciation periods range from three to seven years <sup>p. 73</sup>. |
|||
{{Indexing|M. Reserves for Losses and Loss Adjustment Expenses|Reserves for unpaid losses, loss adjustment expenses, individual case-basis valuations, statistical analyses, actuarial procedures, historical information, industry information, peer group information, future trends, loss severity, loss frequency, inflation|rmmhubj8mh|ie3cmfrol3|kind=prose|order=99}} |
|||
* ''Reserves for unpaid losses and loss adjustment expenses (LAE)'' represent the Company's estimated ultimate cost for all unreported and reported but unpaid insured claims, and the cost to adjust these losses incurred as of the balance sheet date <sup>p. 74</sup>. |
|||
* The Company estimates reserves using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures <sup>p. 74</sup>. |
|||
* These estimates are based on the Company's historical information, industry and peer group information, and estimates of future trends in variable factors such as loss severity, loss frequency, and other factors like inflation <sup>p. 74</sup>. |
|||
* The Company regularly reviews and adjusts its estimates as experience develops or new information becomes known <sup>p. 74</sup>. |
|||
* During the loss settlement period, estimates of liability on a claim are often refined and adjusted upward or downward <sup>p. 74</sup>. |
|||
* The ultimate liability may exceed or be less than the revised estimates, and the ultimate settlement of losses and related LAE may vary significantly from the estimate in the financial statements <sup>p. 74</sup>. |
|||
* If actual liabilities exceed recorded amounts, there will be an adverse effect <sup>p. 74</sup>. |
|||
* If recorded reserves are determined to be more than adequate, it would lead to a reduction in reserves <sup>p. 74</sup>. |
|||
{{Indexing|N. Premiums|Property and casualty premiums, surety premiums, accident and health premiums, gross premiums written, ceded premiums, premiums receivable, deferred premiums, allowance for credit losses, historical loss rate, unearned premiums, ceded unearned premiums|wpkf9ycgxf|ie3cmfrol3|kind=prose|order=100}} |
|||
* The Company recognizes property and casualty and surety premiums on a pro-rata basis over the policy terms <sup>p. 75</sup>. |
|||
* Accident and health premiums are earned as billed, based on census data <sup>p. 75</sup>. |
|||
* ''Gross premiums written'' are reduced by ceded premiums from proportional, facultative, and excess of loss reinsurance costs for prospective reinsurance <sup>p. 75</sup>. |
|||
* ''Premiums receivable'' include deferred premiums, which are installment payments due from insureds under policy payment terms <sup>p. 75</sup>. |
|||
* ''Premiums receivable'' are carried net of an allowance for credit losses <sup>p. 75</sup>. |
|||
* The ''allowance for credit losses'' represents the current estimate of expected credit losses <sup>p. 75</sup>. |
|||
* The Company develops a ''historical loss rate'' using historical write-offs and aging of receivables <sup>p. 75</sup>. |
|||
* This ''historical loss rate'' is adjusted for current conditions, reasonable and supportable forecasts, and the ability to cancel coverage after a premium is past due <sup>p. 75</sup>. |
|||
* ''Changes in the allowance for credit losses'' are recognized in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations <sup>p. 75</sup>. |
|||
* ''Unearned premiums'' represent the portion of gross premiums written applicable to the unexpired terms of in-force insurance policies or reinsurance contracts <sup>p. 75</sup>. |
|||
* ''Ceded unearned premiums'' represent the portion of ceded premiums written applicable to the unexpired terms of in-force insurance policies or reinsurance contracts <sup>p. 75</sup>. |
|||
* ''Unearned premiums'' (direct and ceded) are calculated on a pro-rata basis over the terms of the policies <sup>p. 75</sup>. |
|||
{{Indexing|O. Commission and Fee Income|SUA commission revenue, SUA fee income, insurance policies, reinsurance programs, third-party insurance company, transaction price, performance obligation|qfq1t7e6o0|ie3cmfrol3|kind=prose|order=101}} |
|||
* ''SUA commission revenue'' is generated from placing insurance policies on reinsurance programs via a reinsurance broker <sup>p. 76</sup>. |
|||
* The Company's single performance obligation for SUA commission revenue is the placement of insurance policies <sup>p. 76</sup>. |
|||
* The transaction price for SUA commission revenue is fixed at contract inception and based on a percentage of premiums placed <sup>p. 76</sup>. |
|||
* The Company recognizes 100% of the transaction price for SUA commission revenue when the policy is placed, as there are no constraints on revenue <sup>p. 76</sup>. |
|||
* ''SUA fee income'' is generated from placing insurance policies with a third-party insurance company <sup>p. 76</sup>. |
|||
* The Company's single performance obligation for SUA fee income is the placement of the policy <sup>p. 76</sup>. |
|||
* The transaction price for SUA fee income is variable at contract inception and based on a percentage of premium, which is determined by risk factors that change monthly (e.g., employee census data, worker roles) <sup>p. 76</sup>. |
|||
* The Company estimates the transaction price for SUA fee income over the policy's life using the expected value method <sup>p. 76</sup>. |
|||
* Revenue from SUA fee income is recognized when the policy is placed <sup>p. 76</sup>. |
|||
* Changes in the estimate of variable consideration for SUA fee income are recognized in the month they occur <sup>p. 76</sup>. |
|||
{{Indexing|P. Income Taxes|Income tax expense, provision for income taxes, deferred taxes, temporary differences, valuation allowance, deferred tax assets, deferred tax liabilities, uncertain tax positions, net interest income, penalties, consolidated federal income tax return, state tax returns, premium taxes, premium tax expense|kmocop7wiu|ie3cmfrol3|kind=prose|order=102}} |
|||
* ''Income tax expense'' is accrued for the tax effects of transactions reported on the consolidated financial statements <sup>p. 77</sup>. |
|||
* ''Provision for income taxes'' consists of taxes currently due plus deferred taxes resulting from temporary differences between financial statement and income tax purposes <sup>p. 77</sup>. |
|||
* A ''valuation allowance'' is established for any deferred tax asset not expected to be realized <sup>p. 77</sup>. |
|||
* ''Deferred tax assets and liabilities'' are measured using enacted tax rates expected to apply to taxable income in the years temporary differences are expected to be recovered or settled <sup>p. 77</sup>. |
|||
* The ''effect on deferred tax assets and liabilities'' from a change in tax rates is recognized in income in the period that includes the enactment date <sup>p. 77</sup>. |
|||
* A ''liability for uncertain tax positions'' is recorded when it is more likely-than-not that the tax position will not be sustained upon examination by the appropriate tax authority <sup>p. 77</sup>. |
|||
* ''Changes in the liability for uncertain tax positions'' are reflected in income tax expense in the period when a new uncertain tax position arises, judgment changes about the likelihood of an uncertainty, the tax issue is settled, or the statute of limitation expires <sup>p. 77</sup>. |
|||
* Any ''potential net interest income or expense and penalties'' related to uncertain tax positions are recorded on the Consolidated Statements of Operations <sup>p. 77</sup>. |
|||
* The Company files a ''consolidated federal income tax return'' in the United States and certain other state tax returns <sup>p. 77</sup>. |
|||
* Its admitted insurance subsidiaries pay ''premium taxes'' on gross written premiums in lieu of most state income or franchise taxes <sup>p. 77</sup>. |
|||
* ''Premium tax expense'' is recognized within underwriting, acquisition, and insurance expense on the Consolidated Statements of Operations <sup>p. 77</sup>. |
|||
{{Indexing|Q. Fair Value of Financial Instruments|Fair value, financial instruments, observable inputs, unobservable inputs, fair value hierarchy, Level 1 measurements, Level 3 measurements, third-party pricing sources|di0lc3m1jj|ie3cmfrol3|kind=prose|order=103}} |
|||
* Fair value for each class of financial instrument is estimated based on the framework established in fair value accounting guidance <sup>p. 78</sup>. |
|||
* The guidance requires maximizing the use of observable inputs and minimizing unobservable inputs when measuring fair value <sup>p. 78</sup>. |
|||
* Fair value hierarchy disclosures are based on the quality of inputs used to measure fair value <sup>p. 78</sup>. |
|||
* The hierarchy prioritizes unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) <sup>p. 78</sup>. |
|||
* The hierarchy gives the lowest priority to unobservable inputs (Level 3 measurements) <sup>p. 78</sup>. |
|||
* The Company uses widely recognized, third-party pricing sources to determine fair values of financial instruments <sup>p. 78</sup>. |
|||
* The Company understands the valuation methodologies and inputs of these third-party pricing sources <sup>p. 78</sup>. |
|||
* Further details regarding fair value disclosures are in Note 4 <sup>p. 78</sup>. |
|||
{{Indexing|R. Stock-Based Compensation|Employee stock options, stock-based compensation, equity instrument awards, compensation cost, service period, tax effects, Employee Stock Purchase Plan (ESPP), common stock|ie3cmfrol3|kind=prose|order=104}} |
|||
* The estimated fair value of employee stock options and similar awards is expensed <sup>p. 79</sup>. |
|||
* Compensation cost for equity instrument awards to employees is measured based on the grant-date fair value of those awards <sup>p. 79</sup>. |
|||
* Compensation expense is recognized over the service period during which the awards are expected to vest <sup>p. 79</sup>. |
|||
* Tax effects related to share-based payments are made through net earnings <sup>p. 79</sup>. |
|||
* Further discussion and related disclosures regarding stock-based compensation are in note 18 <sup>p. 79</sup>. |
|||
* The Company's ''Employee Stock Purchase Plan'' (ESPP) allows all employees to purchase common stock at a discount <sup>p. 79</sup>. |
|||
* Compensation cost for the ESPP is recognized on a straight-line basis over the offering period <sup>p. 79</sup>. |
|||
{{Indexing|S. Earnings Per Share|Basic earnings per share, two-class method, undistributed earnings, participating securities, net income, common stockholders, weighted-average common shares, common shares, preferred shares, dividends, distributions, instruments awarded to employees, contingently issuable instruments, treasury stock method, stock notes, instruments convertible into common shares, share-based awards|v7ij6av24f|ie3cmfrol3|kind=prose|order=105}} |
|||
* ''Basic earnings per share'' is calculated using the two-class method <sup>p. 80</sup>. |
|||
* ''Undistributed earnings'' are allocated to participating securities based on their share in earnings as if all earnings for the period were distributed <sup>p. 80</sup>. |
|||
* ''Basic earnings per share'' is calculated by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding for the period <sup>p. 80</sup>. |
|||
* ''Common shares'' with unsatisfied contingencies, such as vesting requirements, are excluded from basic earnings per share <sup>p. 80</sup>. |
|||
* The Company’s ''preferred shares'' are participating securities, sharing in dividends and distributions with common stock on an as-converted basis <sup>p. 80</sup>. |
|||
* ''Instruments awarded to employees'' that grant the right to purchase common stock at a fixed price are included as potential common shares, weighted for the portion of the period they were granted, if dilutive <sup>p. 80</sup>. |
|||
* The Company’s ''common and preferred shares financed by stock notes'' are contingently issuable instruments, excluded from basic and diluted earnings per share if specified conditions are not met, presuming the end of the period is the end of the contingency period <sup>p. 80</sup>. |
|||
* The impact of ''contingently issuable instruments'' on diluted earnings per share was calculated using the treasury stock method and included in the reconciliation of the denominator for the year ended December 31, 2024 <sup>p. 80</sup>. |
|||
* All ''outstanding stock notes'' were settled during 2024, resulting in no impact on the Company’s basic and diluted earnings per share computations for the year ended December 31, 2024 <sup>p. 80</sup>. |
|||
* ''Instruments convertible into common shares'' are included in diluted weighted-average common shares outstanding on an if-converted basis, based on the legal conversion rate for the respective period, if dilutive <sup>p. 80</sup>. |
|||
* ''Share-based awards to employees with only service conditions'' are included as potential common shares, weighted for the unvested portion of the period, if dilutive <sup>p. 80</sup>. |
|||
* ''Share-based awards to employees with performance and service or market conditions'' are included as potential common shares, presuming the end of the period is the end of the contingency period, if dilutive <sup>p. 80</sup>. |
|||
* When ''common share adjustments'' increase earnings per share or reduce loss per share, the effect is anti-dilutive, and diluted net earnings or net loss per share is computed excluding these common share equivalents <sup>p. 80</sup>. |
|||
{{Indexing|T. Recent Accounting Pronouncements|ASU 2023-09, ASU 2024-03, ASU 2025-01, income tax disclosures, rate reconciliation disclosures, income taxes paid, income statement expenses, expense captions, natural expenses, purchases of inventory, employee compensation, depreciation, intangible asset amortization, depletion expenses|ie3cmfrol3|kind=prose|order=106}} |
|||
* ''ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740)'' was issued by FASB in December 2023 <sup>p. 81</sup>. |
|||
* ASU 2023-09 mandates enhanced rate reconciliation disclosures for public companies annually, including specific categories and additional information meeting a quantitative threshold <sup>p. 81</sup>. |
|||
* This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes <sup>p. 81</sup>. |
|||
* The guidance became effective for fiscal years beginning after December 15, 2024, and is applied prospectively <sup>p. 81</sup>. |
|||
* The Company has added additional disclosures as required by ASU 2023-09, with no impact on the consolidated financial statements <sup>p. 81</sup>. |
|||
* Additional disclosures required by ASU 2023-09 can be found in Note 13 <sup>p. 81</sup>. |
|||
* ''ASU 2024-03'' was issued by FASB in November 2024, requiring disaggregated disclosure of income statement expenses for public business entities ("PBEs") <sup>p. 81</sup>. |
|||
* ASU 2024-03 does not change expense captions on the income statement but requires disaggregation of certain expense captions into specified categories in footnotes <sup>p. 81</sup>. |
|||
* The ASU requires a footnote disclosure about specific expenses, mandating PBEs to disaggregate, in a tabular presentation, relevant income statement expense captions that include natural expenses such as: (1) purchases of inventory, (2) employee compensation, (3) depreciation, (4) intangible asset amortization, and (5) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities or other types of depletion expenses <sup>p. 81</sup>. |
|||
* The tabular disclosure will also include certain other expenses, where applicable <sup>p. 81</sup>. |
|||
* ''ASU 2025-01'' was issued by FASB in January 2025 to clarify the effective date of ASU 2024-03 <sup>p. 81</sup>. |
|||
* The effective date for ASU 2024-03 is the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027 <sup>p. 81</sup>. |
|||
* The Company is evaluating the effect of these amendments on its consolidated financial statements <sup>p. 81</sup>. |
|||
{{Indexing|2. Goodwill and Intangible Assets|Indefinite-lived intangible assets, finite-lived intangible assets, amortization expense|hekiequlv1|kind=prose|order=107|f1=Indefinite-lived intangible assets|v1=insurance licenses, trademarks|f2=Finite-lived intangible assets|v2=policy renewals, agency relationships, non-compete/exclusivity agreements|f3=Weighted average useful life|v3=12 years|f4=Amortization expense|v4=FY25: $1.3m}} |
|||
* The Company's indefinite-lived intangible assets include ''insurance licenses'' and ''trademarks'' <sup>p. 82</sup>. |
|||
* The Company's finite-lived intangible assets, including ''policy renewals'', ''agency relationships'', and ''non-compete/exclusivity agreements'', had a weighted average useful life of approximately 12 years as of December 31, 2025 <sup>p. 82</sup>. |
|||
* ''Amortization expense'' was approximately $1.3m for the year ended December 31, 2025 <sup>p. 82</sup>. |
|||
* ''Amortization expense'' was approximately $1.1m for the year ended December 31, 2024 <sup>p. 82</sup>. |
|||
* ''Amortization expense'' was approximately $1.5m for the year ended December 31, 2023 <sup>p. 82</sup>. |
|||
{{Indexing|Goodwill by segment at December 31, 2025|Goodwill by segment, Accident and Health, Surety, Construction and Energy Solutions, Other|kind=table|order=108}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | $ in |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align:center" | |
! style="text-align:center" | Accident and Health |
||
! |
! style="text-align:center" | Surety |
||
! style="text-align:center" | Construction and Energy Solutions |
|||
! style="text-align:center" | Other |
|||
! style="text-align:center" | Total |
|||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | Goodwill |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Gross balance at December 31, 2024 |
||
| style="text-align:right" | |
| style="text-align:right" | 91,577 |
||
| style="text-align:right" | |
| style="text-align:right" | 6,781 |
||
| style="text-align:right" | |
| style="text-align:right" | 10,204 |
||
| style="text-align:right" | 3,879 |
|||
| style="text-align:right" | 112,441 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Accumulated impairment at December 31, 2024 |
||
| style="text-align:right" | ( 44,821 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 1 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 1,886 ) |
|||
| style="text-align:right" | ( 46,707 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Net balance at December 31, 2025''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''46,756''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''6,781''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''10,204''' |
||
| style="text-align:right" | '''1,993''' |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | '''65,734''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 344.1 |
|||
| style="text-align:right" | 337.0 |
|||
|- |
|||
| style="text-align:left" | Subsequent Event / Apollo Majority SPAs |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Concentration Risk [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Business combination, consideration transferred |
|||
| style="text-align:right" | 555.0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | High |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Concentration Risk [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Property, plant and equipment, useful life |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 7 years |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Low |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Concentration Risk [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Property, plant and equipment, useful life |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 3 years |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | AM Best, A+ Rating / Everest Reinsurance Co / Reinsurance recoverable including reinsurance premium paid / Reinsurer concentration risk |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Concentration Risk [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Percent of total |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 11.10% |
|||
| style="text-align:right" | 18.00% |
|||
|- |
|||
| style="text-align:left" | AM Best, A+ Rating / eMaxx Captives / Reinsurance recoverable including reinsurance premium paid / Reinsurer concentration risk |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Concentration Risk [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Percent of total |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 17.70% |
|||
| style="text-align:right" | 16.80% |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Goodwill by segment at December 31, 2024|Goodwill by segment, Accident and Health, Surety, Construction and Energy Solutions, Other|kind=table|order=109}} |
|||
== Goodwill and Intangible Assets == |
|||
=== Schedule of Goodwill === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | Accident and Health |
||
! |
! style="text-align:center" | Surety |
||
! |
! style="text-align:center" | Construction and Energy Solutions |
||
! style="text-align:center" | Other |
|||
! style="text-align:center" | Total |
|||
|- |
|- |
||
! style="text-align:left" | Goodwill |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Gross balance at December 31, 2023 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 112,441 |
|||
| style="text-align:right" | 112,441 |
|||
|- |
|||
| style="text-align:left" | Accumulated impairment |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | -46,707 |
|||
| style="text-align:right" | -46,707 |
|||
|- |
|||
| style="text-align:left" | Goodwill, net balance |
|||
| style="text-align:right" | 65,734 |
|||
| style="text-align:right" | 65,734 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accident and Health |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Goodwill [Roll Forward] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Goodwill, gross balance |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 91,577 |
| style="text-align:right" | 91,577 |
||
| style="text-align:right" | 91,577 |
|||
|- |
|||
| style="text-align:left" | Accumulated impairment |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | -44,821 |
|||
| style="text-align:right" | -44,821 |
|||
|- |
|||
| style="text-align:left" | Goodwill, net balance |
|||
| style="text-align:right" | 46,756 |
|||
| style="text-align:right" | 46,756 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Surety |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Goodwill [Roll Forward] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Goodwill, gross balance |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 6,781 |
| style="text-align:right" | 6,781 |
||
| style="text-align:right" | 6,781 |
|||
|- |
|||
| style="text-align:left" | Accumulated impairment |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Goodwill, net balance |
|||
| style="text-align:right" | 6,781 |
|||
| style="text-align:right" | 6,781 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Construction and Energy Solutions |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Goodwill [Roll Forward] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Goodwill, gross balance |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 10,204 |
|||
| style="text-align:right" | 10,204 |
| style="text-align:right" | 10,204 |
||
| style="text-align:right" | 3,879 |
|||
| style="text-align:right" | 112,441 |
|||
|- |
|- |
||
| style="text-align:left" | Accumulated impairment |
| style="text-align:left" | Accumulated impairment at December 31, 2023 |
||
| style="text-align:right" | ( 44,821 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Goodwill, net balance |
|||
| style="text-align:right" | 10,204 |
|||
| style="text-align:right" | 10,204 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 1,886 ) |
|||
| style="text-align:right" | ( 46,707 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Net balance at December 31, 2024''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''46,756''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''6,781''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''10,204''' |
||
| style="text-align:right" | '''1,993''' |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | '''65,734''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Goodwill, gross balance |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 3,879 |
|||
| style="text-align:right" | 3,879 |
|||
|- |
|||
| style="text-align:left" | Accumulated impairment |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | -1,886 |
|||
| style="text-align:right" | -1,886 |
|||
|- |
|||
| style="text-align:left" | Goodwill, net balance |
|||
| style="text-align:right" | 1,993 |
|||
| style="text-align:right" | 1,993 |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Other intangible assets at December 31, 2025|Other intangible assets, Agent Relationships, Non-competes, Trademarks, Licenses|kind=table|order=110}} |
|||
=== Schedule of Intangible Assets and Goodwill === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | Agent Relationships |
||
! style="text-align:center" | Non-competes |
|||
! style="text-align:center" | Trademarks |
|||
! style="text-align:center" | Licenses |
|||
! style="text-align:center" | Total |
|||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | Other Intangible Assets |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Gross balance at December 31, 2024 |
||
| style="text-align:right" | |
| style="text-align:right" | 24,491 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,117 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accumulated amortization |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | -19,012 |
|||
| style="text-align:right" | -17,925 |
|||
|- |
|||
| style="text-align:left" | Amortization |
|||
| style="text-align:right" | -1,308 |
|||
| style="text-align:right" | -1,087 |
|||
| style="text-align:right" | -1,500 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left" | Gross, beginning balance |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 40,626 |
|||
| style="text-align:right" | 40,626 |
|||
|- |
|||
| style="text-align:left" | Accumulated amortization |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | -19,012 |
|||
| style="text-align:right" | -17,925 |
|||
|- |
|||
| style="text-align:left" | Additions |
|||
| style="text-align:right" | 2,000 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amortization |
|||
| style="text-align:right" | -1,308 |
|||
| style="text-align:right" | -1,087 |
|||
| style="text-align:right" | -1,500 |
|||
|- |
|||
| style="text-align:left" | Gross intangible assets, ending balance |
|||
| style="text-align:right" | 22,306 |
|||
| style="text-align:right" | 21,614 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Trademarks |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Indefinite-Lived |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Beginning balance |
|||
| style="text-align:right" | 999 |
| style="text-align:right" | 999 |
||
| style="text-align:right" | 999 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Additions |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Ending balance |
|||
| style="text-align:right" | 999 |
|||
| style="text-align:right" | 999 |
|||
| style="text-align:right" | 999 |
|||
|- |
|||
| style="text-align:left" | Licenses |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Indefinite-Lived |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Beginning balance |
|||
| style="text-align:right" | 14,019 |
| style="text-align:right" | 14,019 |
||
| style="text-align:right" | |
| style="text-align:right" | 40,626 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Accumulated amortization at December 31, 2024 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 17,895 ) |
||
| style="text-align:right" | ( 1,117 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 19,012 ) |
|||
|- |
|||
| style="text-align:left" | Ending balance |
|||
| style="text-align:right" | 14,019 |
|||
| style="text-align:right" | 14,019 |
|||
| style="text-align:right" | 14,019 |
|||
|- |
|||
| style="text-align:left" | Agent Relationships |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Finite-Lived |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Gross, beginning balance |
|||
| style="text-align:right" | 24,491 |
|||
| style="text-align:right" | 24,491 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accumulated amortization |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | -17,895 |
|||
| style="text-align:right" | -16,808 |
|||
|- |
|- |
||
| style="text-align:left" | Additions |
| style="text-align:left" | Additions |
||
| Line 4,115: | Line 4,014: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Amortization |
|||
| style="text-align:right" | -1,308 |
|||
| style="text-align:right" | -1,087 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 2,000 |
|||
|- |
|||
| style="text-align:left" | Net, ending balance |
|||
| style="text-align:right" | 7,288 |
|||
| style="text-align:right" | 6,596 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left" | Accumulated amortization |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | -17,895 |
|||
| style="text-align:right" | -16,808 |
|||
|- |
|- |
||
| style="text-align:left" | Amortization |
| style="text-align:left" | Amortization |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,308 ) |
||
| style="text-align:right" | -1,087 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Non-competes |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 1,308 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Net balance at December 31, 2025''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''7,288''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''999''' |
||
| style="text-align:right" | '''14,019''' |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | '''22,306''' |
||
| style="text-align:right" | 1,117 |
|||
| style="text-align:right" | 1,117 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accumulated amortization |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | -1,117 |
|||
| style="text-align:right" | -1,117 |
|||
|- |
|||
| style="text-align:left" | Additions |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amortization |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net, ending balance |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left" | Accumulated amortization |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | -1,117 |
|||
| style="text-align:right" | -1,117 |
|||
|- |
|||
| style="text-align:left" | Amortization |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Other intangible assets at December 31, 2024|Other intangible assets, Agent Relationships, Non-competes, Trademarks, Licenses|kind=table|order=111}} |
|||
=== Narrative === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | Agent Relationships |
||
! style="text-align:center" | Non-competes |
|||
! style="text-align:center" | Trademarks |
|||
! style="text-align:center" | Licenses |
|||
! style="text-align:center" | Total |
|||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | Other Intangible Assets |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Gross balance at December 31, 2023 |
||
| style="text-align:right" | |
| style="text-align:right" | 24,491 |
||
| style="text-align:right" | 1,117 |
|||
| style="text-align:right" | 999 |
|||
| style="text-align:right" | 14,019 |
|||
| style="text-align:right" | 40,626 |
|||
|- |
|||
| style="text-align:left" | Accumulated amortization at December 31, 2023 |
|||
| style="text-align:right" | ( 16,808 ) |
|||
| style="text-align:right" | ( 1,117 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 17,925 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Amortization |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,087 ) |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | ( 1,087 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Net balance at December 31, 2024''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''6,596''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''999''' |
||
| style="text-align:right" | '''14,019''' |
|||
| style="text-align:right" | '''21,614''' |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Amortization of intangible assets|Amortization of intangible assets|kind=table|order=112}} |
|||
=== Schedule of Finite-Lived Intangible Assets, Future Amortization Expense === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | $ in |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | |
||
|- |
|- |
||
! style="text-align:left" | Years Ending December 31, |
|||
! class="col-s" style="text-align:right" | Amount |
|||
|- |
|- |
||
| style="text-align:left" | 2026 |
| style="text-align:left" | 2026 |
||
| Line 4,249: | Line 4,108: | ||
</div> |
</div> |
||
{{Indexing|3. Investments|Fixed maturity securities, held-to-maturity, asset-backed securities, U.S. government agencies mortgage-backed fixed maturity securities, FHLB Loan, Federal Home Loan Bank of Dallas (FHLB), pledged assets, reinsurance agreements, residential mortgage-backed securities, cash and cash equivalents, short-term investments, available-for-sale fixed maturity securities, impairment, credit impairments, corporate securities, miscellaneous|966xer0dpm|utnmaoxh50|m0cjxgvmvi|kind=prose|order=113}} |
|||
== Investments == |
|||
* ''Fixed maturity securities, held-to-maturity'' at December 31, 2025, consisted entirely of asset-backed securities not due at a single maturity date <sup>p. 83</sup>. |
|||
=== Schedule of Debt Securities, Trading, and Equity Securities, FV-NI === |
|||
* At December 31, 2025, the Company had ''U.S. government agencies mortgage-backed fixed maturity securities'' with a carrying value of approximately $68.5 million pledged as collateral for a loan (the "FHLB Loan") from the Federal Home Loan Bank of Dallas ("FHLB") <sup>p. 83</sup>. |
|||
* The Company retains all rights regarding the pledged securities under the terms of the FHLB Loan and the Advances and Security Agreement <sup>p. 83</sup>. |
|||
* At December 31, 2025, the Company had ''assets with fair values'' of approximately $69.5 million pledged as collateral for performance obligations under reinsurance agreements <sup>p. 83</sup>. |
|||
* The pledged assets for reinsurance agreements included ''residential mortgage-backed securities'' of $57.8 million, ''cash and cash equivalents and other assets'' of $9.5 million, and ''short-term investments'' of $2.2 million <sup>p. 83</sup>. |
|||
* The Company retains all rights regarding these pledged securities under the terms of the trust agreements <sup>p. 83</sup>. |
|||
* The Company monitors available-for-sale fixed maturity securities for impairment, requiring significant management judgment <sup>p. 83</sup>. |
|||
* Factors considered for fixed maturity securities impairment include the issuer's financial condition, receipt of scheduled principal and interest cash flows, and intent to sell before recovery <sup>p. 83</sup>. |
|||
* As of December 31, 2025, the Company had ''450 lots of fixed maturity securities'' in an unrealized loss position <sup>p. 83</sup>. |
|||
* The Company does not intend to sell these securities and is not likely to be required to sell them before maturity or recovery of cost basis <sup>p. 83</sup>. |
|||
* At December 31, 2025, the Company identified ''credit impairments'' for two available-for-sale securities in the "corporate securities and miscellaneous" category, based on new recovery analysis showing deteriorating conditions <sup>p. 83</sup>. |
|||
* For ''U.S. government securities and municipal securities'', the decline in fair values was due to changes in interest rates, not credit quality <sup>p. 83</sup>. |
|||
* The Company does not intend to sell these U.S. government and municipal securities and expects recovery, thus not considering them impaired <sup>p. 83</sup>. |
|||
* For ''corporate securities and miscellaneous'', the decline in fair values was due to changes in interest rates, not credit quality <sup>p. 83</sup>. |
|||
* The Company reviewed corporate security issuers for adverse changes in financial condition, credit enhancement quality, ratings decreases, or payment failures, and determined declines were interest rate-driven <sup>p. 83</sup>. |
|||
* The Company does not intend to sell these corporate securities and expects recovery, thus not considering them impaired <sup>p. 83</sup>. |
|||
* For ''residential mortgage-backed securities, commercial mortgage-backed securities, and other asset-backed securities'', the decline in fair values was due to changes in interest rates, not credit quality <sup>p. 83</sup>. |
|||
* The Company does not intend to sell these mortgage-backed and asset-backed securities and expects recovery, thus not considering them impaired <sup>p. 83</sup>. |
|||
* Various state regulations require the Company to maintain ''cash, investment securities, or letters of credit on deposit'' with states <sup>p. 83</sup>. |
|||
* At December 31, 2025, ''cash and investment securities on deposit'' had carrying values of approximately $70.0 million <sup>p. 83</sup>. |
|||
* At December 31, 2024, ''cash and investment securities on deposit'' had carrying values of approximately $66.8 million <sup>p. 83</sup>. |
|||
{{Indexing|Fixed maturity securities at December 31, 2025|Fixed maturity securities, U.S. government securities, corporate securities, municipal securities, residential mortgage-backed securities, commercial mortgage-backed securities|kind=table|order=114}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | Amortized Cost |
||
! |
! style="text-align:center" | Gross Unrealized Gains |
||
! |
! style="text-align:center" | Gross Unrealized Losses |
||
! style="text-align:center" | Allowance for Credit Losses |
|||
! style="text-align:center" | Fair Value |
|||
|- |
|- |
||
! style="text-align:left" | December 31, 2025 |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | U.S. government securities |
||
| style="text-align:right" | |
| style="text-align:right" | 44,190 |
||
| style="text-align:right" | |
| style="text-align:right" | 292 |
||
| style="text-align:right" | ( 14 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 44,468 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Corporate securities and miscellaneous |
||
| style="text-align:right" | |
| style="text-align:right" | 632,244 |
||
| style="text-align:right" | |
| style="text-align:right" | 14,223 |
||
| style="text-align:right" | ( 3,080 ) |
|||
| style="text-align:right" | ( 7,000 ) |
|||
| style="text-align:right" | 636,387 |
|||
|- |
|||
| style="text-align:left" | Municipal securities |
|||
| style="text-align:right" | 102,691 |
|||
| style="text-align:right" | 1,725 |
|||
| style="text-align:right" | ( 2,300 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 102,116 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Residential mortgage-backed securities |
||
| style="text-align:right" | |
| style="text-align:right" | 487,145 |
||
| style="text-align:right" | |
| style="text-align:right" | 8,928 |
||
| style="text-align:right" | ( 9,486 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 486,587 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Commercial mortgage-backed securities |
||
| style="text-align:right" | |
| style="text-align:right" | 72,631 |
||
| style="text-align:right" | 1, |
| style="text-align:right" | 1,016 |
||
| style="text-align:right" | ( 597 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 73,050 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Other asset-backed securities |
||
| style="text-align:right" | |
| style="text-align:right" | 509,854 |
||
| style="text-align:right" | |
| style="text-align:right" | 5,194 |
||
| style="text-align:right" | ( 1,353 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 513,695 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total fixed maturity securities, available-for-sale''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,848,755''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''31,378''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 16,830 )''' |
||
| style="text-align:right" | '''( 7,000 )''' |
|||
| style="text-align:right" | '''1,856,303''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Other asset-backed securities |
||
| style="text-align:right" | 33,290 |
|||
| style="text-align:right" | 829 |
| style="text-align:right" | 829 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 48 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 468 ) |
||
| style="text-align:right" | 33,603 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total fixed maturity securities, held-to-maturity''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''33,290''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''829''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 48 )''' |
||
| style="text-align:right" | '''( 468 )''' |
|||
| style="text-align:right" | '''33,603''' |
|||
|} |
|||
</div> |
|||
{{Indexing|Fixed maturity securities at December 31, 2024|Fixed maturity securities, U.S. government securities, corporate securities, municipal securities, residential mortgage-backed securities, commercial mortgage-backed securities|kind=table|order=115}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | ($ in thousands) |
|||
! style="text-align:center" | Amortized Cost |
|||
! style="text-align:center" | Gross Unrealized Gains |
|||
! style="text-align:center" | Gross Unrealized Loss |
|||
! style="text-align:center" | Allowance for Credit Losses |
|||
! style="text-align:center" | Fair Value |
|||
|- |
|- |
||
! style="text-align:left" | December 31, 2024 |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amortized Cost |
|||
| style="text-align:right" | 44,190 |
|||
| style="text-align:right" | 26,577 |
| style="text-align:right" | 26,577 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Gross Unrealized Gains |
|||
| style="text-align:right" | 292 |
|||
| style="text-align:right" | 35 |
| style="text-align:right" | 35 |
||
| style="text-align:right" | ( 126 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Gross Unrealized Losses |
|||
| style="text-align:right" | -14 |
|||
| style="text-align:right" | -126 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Allowance for Credit Losses |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fair Value |
|||
| style="text-align:right" | 44,468 |
|||
| style="text-align:right" | 26,486 |
| style="text-align:right" | 26,486 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Corporate securities and miscellaneous |
| style="text-align:left" | Corporate securities and miscellaneous |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amortized Cost |
|||
| style="text-align:right" | 632,244 |
|||
| style="text-align:right" | 433,298 |
| style="text-align:right" | 433,298 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Gross Unrealized Gains |
|||
| style="text-align:right" | 14,223 |
|||
| style="text-align:right" | 5,618 |
| style="text-align:right" | 5,618 |
||
| style="text-align:right" | ( 13,288 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Gross Unrealized Losses |
|||
| style="text-align:right" | -3,080 |
|||
| style="text-align:right" | -13,288 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Allowance for Credit Losses |
|||
| style="text-align:right" | -7,000 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fair Value |
|||
| style="text-align:right" | 636,387 |
|||
| style="text-align:right" | 425,628 |
| style="text-align:right" | 425,628 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Municipal securities |
| style="text-align:left" | Municipal securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amortized Cost |
|||
| style="text-align:right" | 102,691 |
|||
| style="text-align:right" | 89,966 |
| style="text-align:right" | 89,966 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Gross Unrealized Gains |
|||
| style="text-align:right" | 1,725 |
|||
| style="text-align:right" | 116 |
| style="text-align:right" | 116 |
||
| style="text-align:right" | ( 5,366 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Gross Unrealized Losses |
|||
| style="text-align:right" | -2,300 |
|||
| style="text-align:right" | -5,366 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Allowance for Credit Losses |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fair Value |
|||
| style="text-align:right" | 102,116 |
|||
| style="text-align:right" | 84,716 |
| style="text-align:right" | 84,716 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Residential mortgage-backed securities |
| style="text-align:left" | Residential mortgage-backed securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amortized Cost |
|||
| style="text-align:right" | 487,145 |
|||
| style="text-align:right" | 408,585 |
| style="text-align:right" | 408,585 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Gross Unrealized Gains |
|||
| style="text-align:right" | 8,928 |
|||
| style="text-align:right" | 1,875 |
| style="text-align:right" | 1,875 |
||
| style="text-align:right" | ( 16,627 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Gross Unrealized Losses |
|||
| style="text-align:right" | -9,486 |
|||
| style="text-align:right" | -16,627 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Allowance for Credit Losses |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fair Value |
|||
| style="text-align:right" | 486,587 |
|||
| style="text-align:right" | 393,833 |
| style="text-align:right" | 393,833 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Commercial mortgage-backed securities |
| style="text-align:left" | Commercial mortgage-backed securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amortized Cost |
|||
| style="text-align:right" | 72,631 |
|||
| style="text-align:right" | 70,262 |
| style="text-align:right" | 70,262 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Gross Unrealized Gains |
|||
| style="text-align:right" | 1,016 |
|||
| style="text-align:right" | 545 |
| style="text-align:right" | 545 |
||
| style="text-align:right" | ( 1,443 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Gross Unrealized Losses |
|||
| style="text-align:right" | -597 |
|||
| style="text-align:right" | -1,443 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Allowance for Credit Losses |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fair Value |
|||
| style="text-align:right" | 73,050 |
|||
| style="text-align:right" | 69,364 |
| style="text-align:right" | 69,364 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amortized Cost |
|||
| style="text-align:right" | 509,854 |
|||
| style="text-align:right" | 291,578 |
| style="text-align:right" | 291,578 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Gross Unrealized Gains |
|||
| style="text-align:right" | 5,194 |
|||
| style="text-align:right" | 2,447 |
| style="text-align:right" | 2,447 |
||
| style="text-align:right" | ( 1,834 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Gross Unrealized Losses |
|||
| style="text-align:right" | -1,353 |
|||
| style="text-align:right" | -1,834 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Allowance for Credit Losses |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fair Value |
|||
| style="text-align:right" | 513,695 |
|||
| style="text-align:right" | 292,191 |
| style="text-align:right" | 292,191 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total fixed maturity securities, available-for-sale''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,320,266''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''10,636''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 38,684 )''' |
||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''1,292,218''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Other asset-backed securities |
||
| style="text-align:right" | 33,290 |
|||
| style="text-align:right" | 39,396 |
| style="text-align:right" | 39,396 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 436 ) |
|||
| style="text-align:right" | ( 243 ) |
|||
| style="text-align:right" | 38,717 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total fixed maturity securities, held-to-maturity''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''39,396''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 436 )''' |
||
| style="text-align:right" | '''( 243 )''' |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | '''38,717''' |
||
| style="text-align:right" | -48 |
|||
| style="text-align:right" | -436 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Allowance for Credit Losses |
|||
| style="text-align:right" | -468 |
|||
| style="text-align:right" | -243 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fair Value |
|||
| style="text-align:right" | 33,603 |
|||
| style="text-align:right" | 38,717 |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Maturity distribution of fixed maturity securities|Maturity distribution of fixed maturity securities, mortgage-backed securities, other asset-backed securities|kind=table|order=116}} |
|||
=== Schedule of Investments Classified by Contractual Maturity Date === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Amortized Cost |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Fair Value |
||
|- |
|||
| style="text-align:left" | Amortized Cost |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Due in less than one year |
| style="text-align:left" | Due in less than one year |
||
| style="text-align:right" | 45,682 |
| style="text-align:right" | 45,682 |
||
| style="text-align:right" | |
| style="text-align:right" | 45,478 |
||
|- |
|- |
||
| style="text-align:left" | Due after one year through five years |
| style="text-align:left" | Due after one year through five years |
||
| style="text-align:right" | 449,790 |
| style="text-align:right" | 449,790 |
||
| style="text-align:right" | |
| style="text-align:right" | 449,145 |
||
|- |
|- |
||
| style="text-align:left" | Due after five years through ten years |
| style="text-align:left" | Due after five years through ten years |
||
| style="text-align:right" | 219,293 |
| style="text-align:right" | 219,293 |
||
| style="text-align:right" | |
| style="text-align:right" | 224,696 |
||
|- |
|- |
||
| style="text-align:left" | Due after ten years |
| style="text-align:left" | Due after ten years |
||
| style="text-align:right" | 64,360 |
| style="text-align:right" | 64,360 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amortized Cost |
|||
| style="text-align:right" | 1,848,755 |
|||
| style="text-align:right" | 1,320,266 |
|||
|- |
|||
| style="text-align:left" | Fair Value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Due in less than one year |
|||
| style="text-align:right" | 45,478 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Due after one year through five years |
|||
| style="text-align:right" | 449,145 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Due after five years through ten years |
|||
| style="text-align:right" | 224,696 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Due after ten years |
|||
| style="text-align:right" | 63,652 |
| style="text-align:right" | 63,652 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 1,856,303 |
|||
| style="text-align:right; font-weight:bold" | 1,292,218 |
|||
|- |
|- |
||
| style="text-align:left" | Mortgage-backed securities |
| style="text-align:left" | Mortgage-backed securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amortized Cost |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Without single maturity date |
|||
| style="text-align:right" | 559,776 |
| style="text-align:right" | 559,776 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fair Value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Without single maturity date |
|||
| style="text-align:right" | 559,637 |
| style="text-align:right" | 559,637 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amortized Cost |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Without single maturity date |
|||
| style="text-align:right" | 509,854 |
| style="text-align:right" | 509,854 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amortized Cost |
|||
| style="text-align:right" | 509,854 |
|||
| style="text-align:right" | 291,578 |
|||
|- |
|||
| style="text-align:left" | Fair Value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Without single maturity date |
|||
| style="text-align:right" | 513,695 |
| style="text-align:right" | 513,695 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,848,755''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,856,303''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fixed maturity securities by contractual maturity at December 31, 2025|Fixed maturity securities by contractual maturity, U.S. government securities, corporate securities, municipal securities|kind=table|order=117}} |
|||
=== Narrative === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! |
! colspan="2" style="text-align:center" | Less than 12 Months |
||
! |
! colspan="2" style="text-align:center" | 12 Months or More |
||
! colspan="2" style="text-align:center" | Total |
|||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
|||
! style="text-align:center" | Fair Value |
|||
! style="text-align:center" | Gross Unrealized Losses |
|||
! style="text-align:center" | Fair Value |
|||
! style="text-align:center" | Gross Unrealized Losses |
|||
! style="text-align:center" | Fair Value |
|||
! style="text-align:center" | Gross Unrealized Losses |
|||
|- |
|- |
||
! style="text-align:left" | December 31, 2025 |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | U.S. government securities |
||
| style="text-align:right" | |
| style="text-align:right" | 349 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1 ) |
||
| style="text-align:right" | 1,565 |
|||
| style="text-align:right" | ( 13 ) |
|||
| style="text-align:right" | 1,914 |
|||
| style="text-align:right" | ( 14 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Corporate securities and miscellaneous |
||
| style="text-align:right" | |
| style="text-align:right" | 67,644 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 346 ) |
||
| style="text-align:right" | 63,575 |
|||
| style="text-align:right" | ( 2,734 ) |
|||
| style="text-align:right" | 131,219 |
|||
| style="text-align:right" | ( 3,080 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Municipal securities |
||
| style="text-align:right" | |
| style="text-align:right" | 19,157 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 400 ) |
||
| style="text-align:right" | 22,004 |
|||
| style="text-align:right" | ( 1,900 ) |
|||
| style="text-align:right" | 41,161 |
|||
| style="text-align:right" | ( 2,300 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Residential mortgage-backed securities |
||
| style="text-align:right" | |
| style="text-align:right" | 56,147 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 262 ) |
||
| style="text-align:right" | 74,075 |
|||
| style="text-align:right" | ( 9,224 ) |
|||
| style="text-align:right" | 130,222 |
|||
| style="text-align:right" | ( 9,486 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Commercial mortgage-backed securities |
||
| style="text-align:right" | |
| style="text-align:right" | 4,646 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 3 ) |
||
| style="text-align:right" | 8,363 |
|||
| style="text-align:right" | ( 594 ) |
|||
| style="text-align:right" | 13,009 |
|||
| style="text-align:right" | ( 597 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Other asset-backed securities |
||
| style="text-align:right" | |
| style="text-align:right" | 85,098 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 424 ) |
||
| style="text-align:right" | 16,081 |
|||
| style="text-align:right" | ( 929 ) |
|||
| style="text-align:right" | 101,179 |
|||
| style="text-align:right" | ( 1,353 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total fixed maturity securities, available-for-sale''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''233,041''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 1,436 )''' |
||
| style="text-align:right" | '''185,663''' |
|||
| style="text-align:right" | '''( 15,394 )''' |
|||
| style="text-align:right" | '''418,704''' |
|||
| style="text-align:right" | '''( 16,830 )''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Other asset-backed securities |
||
| style="text-align:right" | |
| style="text-align:right" | 1,912 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 48 ) |
||
|- |
|||
| style="text-align:left" | Short-term investments |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 1,912 |
|||
| style="text-align:right" | ( 48 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total fixed maturity securities, held-to-maturity:''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,912''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 48 )''' |
||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''1,912''' |
|||
| style="text-align:right" | '''( 48 )''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''234,953''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 1,484 )''' |
||
| style="text-align:right" | '''185,663''' |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | '''( 15,394 )''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''420,616''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 16,878 )''' |
||
|- |
|||
| style="text-align:left" | Debt Securities, Available-for-Sale [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Securities held as collateral, at fair value |
|||
| style="text-align:right" | 68.5 |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fixed maturity securities by contractual maturity at December 31, 2024|Fixed maturity securities by contractual maturity, U.S. government securities, corporate securities, municipal securities|kind=table|order=118}} |
|||
=== Schedule of Unrealized Loss on Investments === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! |
! colspan="2" style="text-align:center" | Less than 12 Months |
||
! |
! colspan="2" style="text-align:center" | 12 Months or More |
||
! colspan="2" style="text-align:center" | Total |
|||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
|||
! style="text-align:center" | Fair Value |
|||
! style="text-align:center" | Gross Unrealized Losses |
|||
! style="text-align:center" | Fair Value |
|||
! style="text-align:center" | Gross Unrealized Losses |
|||
! style="text-align:center" | Fair Value |
|||
! style="text-align:center" | Gross Unrealized Losses |
|||
|- |
|- |
||
! style="text-align:left" | December 31, 2024 |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Available for sale, gross unrealized losses |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | -1,436 |
|||
| style="text-align:right" | -7,353 |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | -15,394 |
|||
| style="text-align:right" | -31,331 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | -16,830 |
|||
| style="text-align:right; font-weight:bold" | -38,684 |
|||
|- |
|||
| style="text-align:left" | Held-to-maturity, fair value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | 1,912 |
|||
| style="text-align:right" | 2,144 |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 36,573 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 1,912 |
|||
| style="text-align:right; font-weight:bold" | 38,717 |
|||
|- |
|||
| style="text-align:left" | Held-to-maturity, gross unrealized losses |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | -48 |
|||
| style="text-align:right" | -2 |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | -434 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | -48 |
|||
| style="text-align:right; font-weight:bold" | -436 |
|||
|- |
|||
| style="text-align:left" | Available-for-sale and held-to-maturity, fair value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | 234,953 |
|||
| style="text-align:right" | 482,837 |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | 185,663 |
|||
| style="text-align:right" | 273,314 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 420,616 |
|||
| style="text-align:right; font-weight:bold" | 756,151 |
|||
|- |
|||
| style="text-align:left" | Available-for-sale and held-to-maturity, gross unrealized losses |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | -1,484 |
|||
| style="text-align:right" | -7,355 |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | -15,394 |
|||
| style="text-align:right" | -31,765 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | -16,878 |
|||
| style="text-align:right; font-weight:bold" | -39,120 |
|||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Available for sale, fair value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | 349 |
|||
| style="text-align:right" | 15,938 |
| style="text-align:right" | 15,938 |
||
| style="text-align:right" | ( 34 ) |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | 1,565 |
|||
| style="text-align:right" | 2,297 |
| style="text-align:right" | 2,297 |
||
| style="text-align:right" | ( 92 ) |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | 18,235 |
||
| style="text-align:right |
| style="text-align:right" | ( 126 ) |
||
| style="text-align:right; font-weight:bold" | 18,235 |
|||
|- |
|||
| style="text-align:left" | Available for sale, gross unrealized losses |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | -1 |
|||
| style="text-align:right" | -34 |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | -13 |
|||
| style="text-align:right" | -92 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | -14 |
|||
| style="text-align:right; font-weight:bold" | -126 |
|||
|- |
|- |
||
| style="text-align:left" | Corporate securities and miscellaneous |
| style="text-align:left" | Corporate securities and miscellaneous |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Available for sale, fair value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | 67,644 |
|||
| style="text-align:right" | 136,888 |
| style="text-align:right" | 136,888 |
||
| style="text-align:right" | ( 2,060 ) |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | 63,575 |
|||
| style="text-align:right" | 81,232 |
| style="text-align:right" | 81,232 |
||
| style="text-align:right" | ( 11,228 ) |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | 218,120 |
||
| style="text-align:right |
| style="text-align:right" | ( 13,288 ) |
||
| style="text-align:right; font-weight:bold" | 218,120 |
|||
|- |
|||
| style="text-align:left" | Available for sale, gross unrealized losses |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | -346 |
|||
| style="text-align:right" | -2,060 |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | -2,734 |
|||
| style="text-align:right" | -11,228 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | -3,080 |
|||
| style="text-align:right; font-weight:bold" | -13,288 |
|||
|- |
|- |
||
| style="text-align:left" | Municipal securities |
| style="text-align:left" | Municipal securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Available for sale, fair value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | 19,157 |
|||
| style="text-align:right" | 41,930 |
| style="text-align:right" | 41,930 |
||
| style="text-align:right" | ( 1,046 ) |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | 22,004 |
|||
| style="text-align:right" | 27,687 |
| style="text-align:right" | 27,687 |
||
| style="text-align:right" | ( 4,320 ) |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | 69,617 |
||
| style="text-align:right |
| style="text-align:right" | ( 5,366 ) |
||
| style="text-align:right; font-weight:bold" | 69,617 |
|||
|- |
|||
| style="text-align:left" | Available for sale, gross unrealized losses |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | -400 |
|||
| style="text-align:right" | -1,046 |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | -1,900 |
|||
| style="text-align:right" | -4,320 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | -2,300 |
|||
| style="text-align:right; font-weight:bold" | -5,366 |
|||
|- |
|- |
||
| style="text-align:left" | Residential mortgage-backed securities |
| style="text-align:left" | Residential mortgage-backed securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Available for sale, fair value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | 56,147 |
|||
| style="text-align:right" | 201,407 |
| style="text-align:right" | 201,407 |
||
| style="text-align:right" | ( 3,366 ) |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | 74,075 |
|||
| style="text-align:right" | 82,496 |
| style="text-align:right" | 82,496 |
||
| style="text-align:right" | ( 13,261 ) |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | 283,903 |
||
| style="text-align:right |
| style="text-align:right" | ( 16,627 ) |
||
| style="text-align:right; font-weight:bold" | 283,903 |
|||
|- |
|||
| style="text-align:left" | Available for sale, gross unrealized losses |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | -262 |
|||
| style="text-align:right" | -3,366 |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | -9,224 |
|||
| style="text-align:right" | -13,261 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | -9,486 |
|||
| style="text-align:right; font-weight:bold" | -16,627 |
|||
|- |
|- |
||
| style="text-align:left" | Commercial mortgage-backed securities |
| style="text-align:left" | Commercial mortgage-backed securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Available for sale, fair value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | 4,646 |
|||
| style="text-align:right" | 9,411 |
| style="text-align:right" | 9,411 |
||
| style="text-align:right" | ( 126 ) |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | 8,363 |
|||
| style="text-align:right" | 13,178 |
| style="text-align:right" | 13,178 |
||
| style="text-align:right" | ( 1,317 ) |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | 22,589 |
||
| style="text-align:right |
| style="text-align:right" | ( 1,443 ) |
||
| style="text-align:right; font-weight:bold" | 22,589 |
|||
|- |
|||
| style="text-align:left" | Available for sale, gross unrealized losses |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | -3 |
|||
| style="text-align:right" | -126 |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | -594 |
|||
| style="text-align:right" | -1,317 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | -597 |
|||
| style="text-align:right; font-weight:bold" | -1,443 |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Available for sale, fair value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | 85,098 |
|||
| style="text-align:right" | 75,119 |
| style="text-align:right" | 75,119 |
||
| style="text-align:right" | ( 721 ) |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | 16,081 |
|||
| style="text-align:right" | 29,851 |
| style="text-align:right" | 29,851 |
||
| style="text-align:right" | ( 1,113 ) |
|||
| style="text-align:right" | 104,970 |
|||
| style="text-align:right" | ( 1,834 ) |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total fixed maturity securities, available-for-sale''' |
||
| style="text-align:right |
| style="text-align:right" | '''480,693''' |
||
| style="text-align:right |
| style="text-align:right" | '''( 7,353 )''' |
||
| style="text-align:right" | '''236,741''' |
|||
| style="text-align:right" | '''( 31,331 )''' |
|||
| style="text-align:right" | '''717,434''' |
|||
| style="text-align:right" | '''( 38,684 )''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Other asset-backed securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | -424 |
|||
| style="text-align:right" | -721 |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | -929 |
|||
| style="text-align:right" | -1,113 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | -1,353 |
|||
| style="text-align:right; font-weight:bold" | -1,834 |
|||
|- |
|||
| style="text-align:left" | Held-to-maturity, fair value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Less than 12 Months |
|||
| style="text-align:right" | 1,912 |
|||
| style="text-align:right" | 2,144 |
| style="text-align:right" | 2,144 |
||
| style="text-align:right" | ( 2 ) |
|||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 36,573 |
| style="text-align:right" | 36,573 |
||
| style="text-align:right" | ( 434 ) |
|||
| style="text-align:right" | 38,717 |
|||
| style="text-align:right" | ( 436 ) |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total fixed maturity securities, held-to-maturity:''' |
||
| style="text-align:right |
| style="text-align:right" | '''2,144''' |
||
| style="text-align:right |
| style="text-align:right" | '''( 2 )''' |
||
| style="text-align:right" | '''36,573''' |
|||
| style="text-align:right" | '''( 434 )''' |
|||
| style="text-align:right" | '''38,717''' |
|||
| style="text-align:right" | '''( 436 )''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''482,837''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 7,355 )''' |
||
| style="text-align:right" | '''273,314''' |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | '''( 31,765 )''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''756,151''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 39,120 )''' |
||
|- |
|||
| style="text-align:left" | 12 Months or More |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | -434 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | -48 |
|||
| style="text-align:right; font-weight:bold" | -436 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Allowance for credit losses on fixed maturity securities at December 31, 2025|Allowance for credit losses on fixed maturity securities, available-for-sale, held-to-maturity|kind=table|order=119}} |
|||
=== Schedule of Changes in Allowance for Credit Loss === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | Fixed Maturity Securities, Available-For-Sale |
||
! style="text-align:center" | Fixed Maturity Securities, Held-to-Maturity |
|||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | Balance at December 31, 2024 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 243 |
||
|- |
|||
| style="text-align:left" | Fixed Maturity Securities, Available-For-Sale |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Beginning balance |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Current period provision for credit losses |
| style="text-align:left" | Current period provision for credit losses |
||
| style="text-align:right" | 7,000 |
| style="text-align:right" | 7,000 |
||
| style="text-align:right" | |
| style="text-align:right" | 257 |
||
|- |
|- |
||
| style="text-align:left" | Recoveries of amounts previously written off |
| style="text-align:left" | Recoveries of amounts previously written off |
||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 32 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Balance at December 31, 2025''' |
||
| style="text-align:right" | 7,000 |
| style="text-align:right" | '''7,000''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''468''' |
||
|} |
|||
</div> |
|||
{{Indexing|Allowance for credit losses on fixed maturity securities at December 31, 2024|Allowance for credit losses on fixed maturity securities, held-to-maturity|kind=table|order=120}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Fixed Maturity Securities, Held-to-Maturity |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Balance at December 31, 2023 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Beginning balance |
|||
| style="text-align:right" | 243 |
|||
| style="text-align:right" | 329 |
| style="text-align:right" | 329 |
||
|- |
|- |
||
| style="text-align:left" | Current period provision for credit losses |
| style="text-align:left" | Current period provision for credit losses |
||
| style="text-align:right" | 257 |
|||
| style="text-align:right" | 18 |
| style="text-align:right" | 18 |
||
|- |
|- |
||
| style="text-align:left" | Recoveries of amounts previously written off |
| style="text-align:left" | Recoveries of amounts previously written off |
||
| style="text-align:right" | |
| style="text-align:right" | ( 104 ) |
||
| style="text-align:right" | -104 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Balance at December 31, 2024''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''243''' |
||
| style="text-align:right" | 243 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Net realized investment gains and losses|Realized investment gains and losses, fixed maturity securities, equity securities|jpoeftv18u|kind=table|order=121}} |
|||
=== Schedule of Gain (Loss) on Securities === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | 2025 |
||
! style="text-align:center" | 2024 |
|||
! style="text-align:center" | 2023 |
|||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | Gross realized gains |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Gross realized gains |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Fixed maturity securities, available-for-sale |
| style="text-align:left" | Fixed maturity securities, available-for-sale |
||
| Line 5,185: | Line 4,656: | ||
| style="text-align:right" | 2 |
| style="text-align:right" | 2 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right |
| style="text-align:right" | '''37,949''' |
||
| style="text-align:right |
| style="text-align:right" | '''10,937''' |
||
| style="text-align:right |
| style="text-align:right" | '''7,079''' |
||
|- |
|||
| style="text-align:left" | Gross realized losses |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Fixed maturity securities, available-for-sale |
| style="text-align:left" | Fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | ( 10,832 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 8,161 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,879 ) |
||
|- |
|- |
||
| style="text-align:left" | Equity securities |
| style="text-align:left" | Equity securities |
||
| style="text-align:right" | |
| style="text-align:right" | ( 3,000 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 4,132 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 5,256 ) |
||
|- |
|- |
||
| style="text-align:left" | Other |
| style="text-align:left" | Other |
||
| style="text-align:right" | |
| style="text-align:right" | ( 413 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 223 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 20 ) |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right |
| style="text-align:right" | '''( 14,245 )''' |
||
| style="text-align:right |
| style="text-align:right" | '''( 12,516 )''' |
||
| style="text-align:right |
| style="text-align:right" | '''( 7,155 )''' |
||
|- |
|||
| style="text-align:left" | Net unrealized gains (losses) on investments |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Equity securities |
| style="text-align:left" | Equity securities |
||
| style="text-align:right" | |
| style="text-align:right" | ( 22,908 ) |
||
| style="text-align:right" | 7,500 |
| style="text-align:right" | 7,500 |
||
| style="text-align:right" | 11,516 |
| style="text-align:right" | 11,516 |
||
|- |
|- |
||
| style="text-align:left" | Mortgage loans |
| style="text-align:left" | Mortgage loans |
||
| style="text-align:right" | |
| style="text-align:right" | ( 7 ) |
||
| style="text-align:right" | 421 |
| style="text-align:right" | 421 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 386 ) |
||
|- |
|- |
||
| style="text-align:left" | Other |
| style="text-align:left" | Other |
||
| style="text-align:right" | 21,360 |
| style="text-align:right" | 21,360 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Net investment gains |
| class="wt-indent-1" style="text-align:left" | '''Net investment gains''' |
||
| style="text-align:right" | 22,149 |
| style="text-align:right" | '''22,149''' |
||
| style="text-align:right" | 6,342 |
| style="text-align:right" | '''6,342''' |
||
| style="text-align:right" | 11,054 |
| style="text-align:right" | '''11,054''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Net unrealized investment gains and losses|Unrealized investment gains and losses, fixed maturity securities, equity securities|j8uunnd14x|kind=table|order=122}} |
|||
=== Schedule of Proceeds from Sales === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
|||
|- |
|||
! style="text-align: |
! class="col-s" style="text-align:right" | 2023 |
||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Investments, Debt and Equity Securities [Abstract] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Fixed maturity securities, available-for-sale |
| style="text-align:left" | Fixed maturity securities, available-for-sale |
||
| Line 5,271: | Line 4,724: | ||
</div> |
</div> |
||
{{Indexing|Net investment income by source|Net investment income, fixed maturity securities, equity securities, equity method investments, mortgage loans, indirect loans, short-term investments, cash|jpoeftv18u|kind=table|order=123}} |
|||
=== Schedule of Net Investment Income === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | 2025 |
||
! style="text-align:center" | 2024 |
|||
! style="text-align:center" | 2023 |
|||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | Income (loss): |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Net Investment Income [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investment income |
|||
| style="text-align:right; font-weight:bold" | 87,666 |
|||
| style="text-align:right; font-weight:bold" | 87,513 |
|||
| style="text-align:right; font-weight:bold" | 45,897 |
|||
|- |
|||
| style="text-align:left" | Investment expenses |
|||
| style="text-align:right" | -4,047 |
|||
| style="text-align:right" | -6,913 |
|||
| style="text-align:right" | -5,557 |
|||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | 83,619 |
|||
| style="text-align:right" | 80,600 |
|||
| style="text-align:right" | 40,340 |
|||
|- |
|- |
||
| style="text-align:left" | Fixed maturity securities, available-for-sale |
| style="text-align:left" | Fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 80,302 |
||
| style="text-align:right" | |
| style="text-align:right" | 57,574 |
||
| style="text-align:right" | |
| style="text-align:right" | 34,703 |
||
|- |
|||
| style="text-align:left" | Net Investment Income [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investment income |
|||
| style="text-align:right; font-weight:bold" | 80,302 |
|||
| style="text-align:right; font-weight:bold" | 57,574 |
|||
| style="text-align:right; font-weight:bold" | 34,703 |
|||
|- |
|- |
||
| style="text-align:left" | Fixed maturity securities, held-to-maturity |
| style="text-align:left" | Fixed maturity securities, held-to-maturity |
||
| style="text-align:right" | |
| style="text-align:right" | ( 804 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 4,091 |
||
| style="text-align:right" | |
| style="text-align:right" | 4,181 |
||
|- |
|||
| style="text-align:left" | Net Investment Income [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investment income |
|||
| style="text-align:right; font-weight:bold" | -804 |
|||
| style="text-align:right; font-weight:bold" | 4,091 |
|||
| style="text-align:right; font-weight:bold" | 4,181 |
|||
|- |
|- |
||
| style="text-align:left" | Equity securities |
| style="text-align:left" | Equity securities |
||
| style="text-align:right" | |
| style="text-align:right" | 1,223 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,720 |
||
| style="text-align:right" | |
| style="text-align:right" | 3,418 |
||
|- |
|||
| style="text-align:left" | Net Investment Income [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investment income |
|||
| style="text-align:right; font-weight:bold" | 1,223 |
|||
| style="text-align:right; font-weight:bold" | 2,720 |
|||
| style="text-align:right; font-weight:bold" | 3,418 |
|||
|- |
|- |
||
| style="text-align:left" | Equity method investments |
| style="text-align:left" | Equity method investments |
||
| style="text-align:right" | |
| style="text-align:right" | ( 2,683 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 2,524 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 9,434 ) |
||
|- |
|||
| style="text-align:left" | Net Investment Income [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investment income |
|||
| style="text-align:right; font-weight:bold" | -2,683 |
|||
| style="text-align:right; font-weight:bold" | 2,524 |
|||
| style="text-align:right; font-weight:bold" | -9,434 |
|||
|- |
|- |
||
| style="text-align:left" | Mortgage loans |
| style="text-align:left" | Mortgage loans |
||
| style="text-align:right" | |
| style="text-align:right" | 1,622 |
||
| style="text-align:right" | |
| style="text-align:right" | 5,153 |
||
| style="text-align:right" | |
| style="text-align:right" | 5,474 |
||
|- |
|||
| style="text-align:left" | Net Investment Income [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investment income |
|||
| style="text-align:right; font-weight:bold" | 1,622 |
|||
| style="text-align:right; font-weight:bold" | 5,153 |
|||
| style="text-align:right; font-weight:bold" | 5,474 |
|||
|- |
|- |
||
| style="text-align:left" | Indirect loans |
| style="text-align:left" | Indirect loans |
||
| style="text-align:right" | |
| style="text-align:right" | ( 8,129 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 2,400 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 4,155 ) |
||
|- |
|||
| style="text-align:left" | Net Investment Income [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investment income |
|||
| style="text-align:right; font-weight:bold" | -8,129 |
|||
| style="text-align:right; font-weight:bold" | -2,400 |
|||
| style="text-align:right; font-weight:bold" | -4,155 |
|||
|- |
|- |
||
| style="text-align:left" | Short-term investments and cash |
| style="text-align:left" | Short-term investments and cash |
||
| style="text-align:right" | |
| style="text-align:right" | 12,828 |
||
| style="text-align:right" | |
| style="text-align:right" | 14,851 |
||
| style="text-align:right" | |
| style="text-align:right" | 11,392 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Other |
||
| style="text-align:right" | |
| style="text-align:right" | 3,307 |
||
| style="text-align:right" | |
| style="text-align:right" | 3,000 |
||
| style="text-align:right" | |
| style="text-align:right" | 318 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total investment income''' |
||
| style="text-align:right |
| style="text-align:right" | '''87,666''' |
||
| style="text-align:right |
| style="text-align:right" | '''87,513''' |
||
| style="text-align:right |
| style="text-align:right" | '''45,897''' |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Investment expenses |
||
| style="text-align:right" | |
| style="text-align:right" | ( 4,047 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 6,913 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 5,557 ) |
||
|- |
|- |
||
| style="text-align:left" | Net |
| style="text-align:left" | '''Net investment income''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''83,619''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''80,600''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''40,340''' |
||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investment income |
|||
| style="text-align:right; font-weight:bold" | 3,307 |
|||
| style="text-align:right; font-weight:bold" | 3,000 |
|||
| style="text-align:right; font-weight:bold" | 318 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Components of deferred income taxes|Deferred income taxes, fixed maturity securities|kmocop7wiu|kind=table|order=124}} |
|||
=== Schedule of Accumulated Other Comprehensive Income (Loss) === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
|||
|- |
|||
! style="text-align: |
! class="col-s" style="text-align:right" | 2023 |
||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Investments, Debt and Equity Securities [Abstract] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Fixed maturity securities |
| style="text-align:left" | Fixed maturity securities |
||
| Line 5,448: | Line 4,810: | ||
|- |
|- |
||
| style="text-align:left" | Deferred income taxes |
| style="text-align:left" | Deferred income taxes |
||
| style="text-align:right" | |
| style="text-align:right" | ( 9,017 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 213 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 5,420 ) |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right |
| style="text-align:right" | '''33,577''' |
||
| style="text-align:right |
| style="text-align:right" | '''833''' |
||
| style="text-align:right |
| style="text-align:right" | '''20,532''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|4. Fair Value Measurements|Fair value measurements, financial instruments, market approach, fair value of investments, periodic analyses, three-level hierarchy|di0lc3m1jj|kind=prose|order=125|f1=Fair value hierarchy|v1=three-level hierarchy|f2=Level 1 inputs|v2=U.S. government securities, mutual funds, common stock|f3=Level 2 inputs|v3=Preferred stocks, municipal securities, corporate securities, miscellaneous}} |
|||
== Fair Value Measurements == |
|||
* The Company's financial instruments include assets and liabilities carried at fair value, and those carried at cost or amortized cost but disclosed at fair value in consolidated financial statements <sup>p. 84</sup>. |
|||
=== Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details) - Level 3 - Measurement Input, Incremental Cost of Capital === |
|||
* The ''market approach'' is generally applied to determine fair value, using prices and data from market transactions involving identical or comparable assets and liabilities <sup>p. 84</sup>. |
|||
* ''Fair value of investments'' is primarily determined using data from third-party investment managers or pricing vendors <sup>p. 84</sup>. |
|||
* ''Periodic analyses'' are performed on third-party prices to ensure they are reasonable estimates of fair value, including reviewing month-to-month fluctuations and comparing valuations from different pricing services for identical securities <sup>p. 84</sup>. |
|||
* The Company classifies financial instruments into a ''three-level hierarchy'': <sup>p. 84</sup> |
|||
** ''Level 1'': Unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date <sup>p. 84</sup>. |
|||
** ''Level 2'': Inputs other than Level 1 quoted prices that are observable for the asset or liability through corroboration with market data at the measurement date <sup>p. 84</sup>. |
|||
** ''Level 3'': Unobservable inputs reflecting management's best estimate of what market participants would use in pricing the asset or liability at the measurement date <sup>p. 84</sup>. |
|||
* ''U.S. government securities, mutual funds, and common stock'' fair value is measured using unadjusted quoted prices for identical instruments in an active exchange, representing Level 1 inputs <sup>p. 84</sup>. |
|||
* ''Preferred stocks, municipal securities, corporate securities, and miscellaneous'' fair value is determined using a pricing model with market-based inputs such as trades in illiquid markets for specific securities or active markets for similar securities <sup>p. 84</sup>. |
|||
** The model considers benchmark yields, issuer spreads, security terms and conditions, and other market data, representing Level 2 fair value inputs <sup>p. 84</sup>. |
|||
* ''Commercial mortgage-backed securities, residential mortgage-backed securities, and other asset-backed securities'' fair value is determined using a pricing model with market-based inputs like dealer quotes, market spreads, and yield curves <sup>p. 84</sup>. |
|||
** The model may evaluate individual tranches by determining cash flows using security terms, collateral performance, credit information, benchmark yields, and estimated prepayments, representing Level 2 fair value inputs <sup>p. 84</sup>. |
|||
* ''Fixed maturity securities, available for sale classified as Level 3'', include corporate securities and other asset-backed securities managed by an independent asset manager and priced by an independent provider <sup>p. 84</sup>. |
|||
** The provider estimates value using the discount net present value of cash flows method with an unobservable discount rate <sup>p. 84</sup>. |
|||
** The discount rate spread reflects risk associated with future cash flows, including inflation, opportunity cost, and time value of money, representing Level 3 fair value inputs <sup>p. 84</sup>. |
|||
* ''Mortgage loans'' have variable interest rates and are collateralized by real property <sup>p. 84</sup>. |
|||
** Fair value is determined using the income approach with observable and unobservable (Level 3) inputs <sup>p. 84</sup>. |
|||
** The unobservable input is the spread applied to a prime rate for discounting cash flows, representing incremental cost of capital based on borrower's ability to pay and collateral value relative to loan balance <sup>p. 84</sup>. |
|||
* ''Derivatives'' included in other assets consist of exchange-traded options contracts <sup>p. 84</sup>. |
|||
** Fair values are measured using quoted prices in active markets on the relevant exchange, specifically the volume-weighted average price of trades in similar contracts or the last trade settlement price if no trades occur <sup>p. 84</sup>. |
|||
** This method represents Level 1 inputs <sup>p. 84</sup>. |
|||
* The Company measures certain assets, including ''investments in indirect loans and loan collateral, equity method investments, and other invested assets'', at fair value on a nonrecurring basis only when impaired <sup>p. 84</sup>. |
|||
* The Company is required to disclose fair values of other financial instruments where practicable to estimate fair value, even if carried at cost or amortized cost <sup>p. 84</sup>. |
|||
** Estimated fair value amounts are determined using available market information and other valuation methodologies, but considerable judgment is required when quoted market prices are unavailable <sup>p. 84</sup>. |
|||
** These estimates may not be indicative of amounts realizable in a current market exchange, and different assumptions or methodologies could affect the estimated fair value <sup>p. 84</sup>. |
|||
* ''Fixed maturity securities, held-to-maturity'', consist of senior and junior notes with target rates of return <sup>p. 84</sup>. |
|||
** As of December 31, 2025, their fair value was determined using the income approach with unobservable inputs (Level 3) <sup>p. 84</sup>. |
|||
* ''Investment in RedBird Capital Partners'' is included in other long-term investments and is a limited partnership that invests in Bishop Street Underwriters, LLC (MGA) <sup>p. 84</sup>. |
|||
** The investment had a fair value of $55.6 million at December 31, 2025, and $28.2 million at December 31, 2024, determined using the net asset value <sup>p. 84</sup>. |
|||
** Procedures to assess reasonableness include obtaining and reviewing audited financial statements <sup>p. 84</sup>. |
|||
** The unfunded commitment related to the investment was $18.3 million at December 31, 2025, and $24.4 million at December 31, 2024 <sup>p. 84</sup>. |
|||
** The Company may sell its interest with prior written notice and general partner approval <sup>p. 84</sup>. |
|||
** In accordance with Accounting Standard Codification 820-10, this investment is measured at fair value using the net asset value per share practical expedient and is not classified in the fair value hierarchy <sup>p. 84</sup>. |
|||
** Net earned premiums related to this agreement were $41.5 million for the year ended December 31, 2025, and $2.5 million for the year ended December 31, 2024 <sup>p. 84</sup>. |
|||
* ''Notes payable'' carrying value approximates estimated fair value because they accrue interest at current market rates plus a spread <sup>p. 84</sup>. |
|||
** Fair value is determined using the income approach with observable inputs (Level 2) <sup>p. 84</sup>. |
|||
* ''Subordinated debt'' consists of Unsecured Subordinated Notes, due May 24, 2039, with a fixed interest rate <sup>p. 84</sup>. |
|||
** Fair value is determined using the income approach with observable inputs (Level 2) <sup>p. 84</sup>. |
|||
* Other financial instruments qualify as ''insurance-related products'' and are exempt from fair value disclosure requirements <sup>p. 84</sup>. |
|||
{{Indexing|Fair value of financial instruments|Fair value of financial instruments|di0lc3m1jj|kind=table|order=126}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | High |
| style="text-align:left" | High |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fair Value Measurement Inputs and Valuation Techniques [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, measurement input |
|||
| style="text-align:right" | 11.10% |
| style="text-align:right" | 11.10% |
||
| style="text-align:right" | 8.00% |
| style="text-align:right" | 8.00% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Low |
||
| style="text-align:right" | 4.25% |
|||
| style="text-align:right" | 5.70% |
|||
|- |
|||
| style="text-align:left" | Weighted average |
|||
| style="text-align:right" | 6.40% |
|||
| style="text-align:right" | 6.60% |
|||
|} |
|||
</div> |
|||
{{Indexing|Weighted average interest rates|Weighted average interest rates|di0lc3m1jj|kind=table|order=127}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | 2025 |
|||
! class="col-s" style="text-align:right" | 2024 |
|||
|- |
|||
| style="text-align:left" | High |
|||
| style="text-align:right" | 8.34% |
| style="text-align:right" | 8.34% |
||
| style="text-align:right" | 10.00% |
| style="text-align:right" | 10.00% |
||
|- |
|- |
||
| style="text-align:left" | Low |
| style="text-align:left" | Low |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fair Value Measurement Inputs and Valuation Techniques [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, measurement input |
|||
| style="text-align:right" | 4.25% |
|||
| style="text-align:right" | 5.70% |
|||
|- |
|||
| style="text-align:left" | Loans receivable |
|||
| style="text-align:right" | 6.55% |
| style="text-align:right" | 6.55% |
||
| style="text-align:right" | 7.00% |
| style="text-align:right" | 7.00% |
||
|- |
|- |
||
| style="text-align:left" | Weighted average |
| style="text-align:left" | Weighted average |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fair Value Measurement Inputs and Valuation Techniques [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, measurement input |
|||
| style="text-align:right" | 6.40% |
|||
| style="text-align:right" | 6.60% |
|||
|- |
|||
| style="text-align:left" | Loans receivable |
|||
| style="text-align:right" | 7.74% |
| style="text-align:right" | 7.74% |
||
| style="text-align:right" | 7.93% |
| style="text-align:right" | 7.93% |
||
| Line 5,519: | Line 4,908: | ||
</div> |
</div> |
||
{{Indexing|Fixed maturity securities as of December 31, 2025|Fixed maturity securities, U.S. government securities, corporate securities, municipal securities, residential mortgage-backed securities, commercial mortgage-backed securities, other asset-backed securities|di0lc3m1jj|kind=table|order=128}} |
|||
=== Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align: |
! colspan="5" style="text-align:center" | December 31, 2025 |
||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
|||
! style="text-align:center" | Level 1 |
|||
! style="text-align:center" | Level 2 |
|||
! style="text-align:center" | Level 3 |
|||
! style="text-align:center" | Total |
|||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|||
! class="col-s" style="text-align:right" | — |
|||
| style="text-align:right; font-weight:bold" | 33,603 |
|||
| style="text-align:right; font-weight:bold" | 38,717 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total equity securities |
|||
| style="text-align:right; font-weight:bold" | 1,174 |
|||
| style="text-align:right; font-weight:bold" | 106,254 |
|||
|- |
|||
| style="text-align:left" | Mortgage loans |
|||
| style="text-align:right" | 9,902 |
|||
| style="text-align:right" | 26,490 |
|||
|- |
|||
| style="text-align:left" | Short-term investments |
|||
| style="text-align:right" | 264,299 |
|||
| style="text-align:right" | 274,929 |
|||
|- |
|||
| style="text-align:left" | Derivatives |
|||
| style="text-align:right" | 34,857 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 2,200,138 |
|||
| style="text-align:right; font-weight:bold" | 1,738,608 |
|||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| style="text-align:right" | 44,468 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 44,468 |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 44,468 |
|||
| style="text-align:right; font-weight:bold" | 26,486 |
|||
|- |
|- |
||
| style="text-align:left" | Corporate securities and miscellaneous |
| style="text-align:left" | Corporate securities and miscellaneous |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 503,274 |
||
| style="text-align:right" | 133,113 |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | 636,387 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 636,387 |
|||
| style="text-align:right; font-weight:bold" | 425,628 |
|||
|- |
|- |
||
| style="text-align:left" | Municipal securities |
| style="text-align:left" | Municipal securities |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 102,116 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 102,116 |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 102,116 |
|||
| style="text-align:right; font-weight:bold" | 84,716 |
|||
|- |
|- |
||
| style="text-align:left" | Residential mortgage-backed securities |
| style="text-align:left" | Residential mortgage-backed securities |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 486,587 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 486,587 |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 486,587 |
|||
| style="text-align:right; font-weight:bold" | 393,833 |
|||
|- |
|- |
||
| style="text-align:left" | Commercial mortgage-backed securities |
| style="text-align:left" | Commercial mortgage-backed securities |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 73,050 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 73,050 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Other asset-backed securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 495,891 |
|||
| style="text-align:right" | 17,804 |
|||
| style="text-align:right" | 513,695 |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total fixed maturity securities, available-for-sale''' |
||
| style="text-align:right |
| style="text-align:right" | '''44,468''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,660,918''' |
||
| style="text-align:right" | '''150,917''' |
|||
| style="text-align:right" | '''1,856,303''' |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 33,603 |
|||
| style="text-align:right" | 33,603 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total fixed maturity securities, held-to-maturity''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | '''33,603''' |
|||
| style="text-align:right" | '''33,603''' |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | Preferred stocks |
||
| style="text-align:right; font-weight:bold" | 513,695 |
|||
| style="text-align:right; font-weight:bold" | 292,191 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity |
|||
| style="text-align:right; font-weight:bold" | 33,603 |
|||
| style="text-align:right; font-weight:bold" | 38,717 |
|||
|- |
|||
| style="text-align:left" | Common stocks: |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 1,174 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 1,174 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total equity securities''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,174''' |
||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''1,174''' |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Mortgage loans''' |
||
| style="text-align:right |
| style="text-align:right" | '''—''' |
||
| style="text-align:right |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | '''9,902''' |
|||
| style="text-align:right" | '''9,902''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Short-term investments''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''264,299''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''264,299''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Derivatives''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''34,857''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''34,857''' |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right |
| style="text-align:right" | '''343,624''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,662,092''' |
||
| style="text-align:right" | '''194,422''' |
|||
| style="text-align:right" | '''2,200,138''' |
|||
|} |
|||
</div> |
|||
{{Indexing|Fixed maturity securities as of December 31, 2024|Fixed maturity securities, U.S. government securities, corporate securities, municipal securities, residential mortgage-backed securities, commercial mortgage-backed securities, other asset-backed securities|di0lc3m1jj|kind=table|order=129}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! colspan="5" style="text-align:center" | December 31, 2024 |
|||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
|||
! style="text-align:center" | Level 1 |
|||
! style="text-align:center" | Level 2 |
|||
! style="text-align:center" | Level 3 |
|||
! style="text-align:center" | Total |
|||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | U.S. government securities |
||
| style="text-align:right |
| style="text-align:right" | 26,486 |
||
| style="text-align:right; font-weight:bold" | 40,839 |
|||
|- |
|||
| style="text-align:left" | Level 1 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 26,486 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Corporate securities and miscellaneous |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 354,815 |
|||
| style="text-align:right" | 70,813 |
|||
| style="text-align:right" | 425,628 |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | Municipal securities |
||
| style="text-align:right; font-weight:bold" | 44,468 |
|||
| style="text-align:right; font-weight:bold" | 26,486 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total equity securities |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 105,090 |
|||
|- |
|||
| style="text-align:left" | Mortgage loans |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Short-term investments |
|||
| style="text-align:right" | 264,299 |
|||
| style="text-align:right" | 274,929 |
|||
|- |
|||
| style="text-align:left" | Derivatives |
|||
| style="text-align:right" | 34,857 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 343,624 |
|||
| style="text-align:right; font-weight:bold" | 406,505 |
|||
|- |
|||
| style="text-align:left" | Level 1 / U.S. government securities |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 84,716 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 84,716 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Residential mortgage-backed securities |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 393,833 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 393,833 |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | Commercial mortgage-backed securities |
||
| style="text-align:right; font-weight:bold" | 44,468 |
|||
| style="text-align:right; font-weight:bold" | 26,486 |
|||
|- |
|||
| style="text-align:left" | Level 1 / Corporate securities and miscellaneous |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 69,364 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 69,364 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Other asset-backed securities |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 285,084 |
|||
| style="text-align:right" | 7,107 |
|||
| style="text-align:right" | 292,191 |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total fixed maturity securities, available-for-sale''' |
||
| style="text-align:right |
| style="text-align:right" | '''26,486''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,187,812''' |
||
| style="text-align:right" | '''77,920''' |
|||
| style="text-align:right" | '''1,292,218''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Other asset-backed securities |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 38,717 |
|||
| style="text-align:right" | 38,717 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total fixed maturity securities, held-to-maturity:''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | '''38,717''' |
|||
| style="text-align:right" | '''38,717''' |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | Common stocks |
||
| style="text-align:right |
| style="text-align:right" | 64,251 |
||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Level 1 / Residential mortgage-backed securities |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 64,251 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Preferred stocks |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 1,164 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 1,164 |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | Mutual funds |
||
| style="text-align:right |
| style="text-align:right" | 40,839 |
||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Level 1 / Commercial mortgage-backed securities |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 40,839 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total equity securities''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''105,090''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,164''' |
||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''106,254''' |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Mortgage loans''' |
||
| style="text-align:right |
| style="text-align:right" | '''—''' |
||
| style="text-align:right |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | '''26,490''' |
|||
| style="text-align:right" | '''26,490''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Short-term investments''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''274,929''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''274,929''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''406,505''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,188,976''' |
||
| style="text-align:right" | '''143,127''' |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | '''1,738,608''' |
||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Level 1 / Common stocks: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total equity securities |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | 64,251 |
|||
|- |
|||
| style="text-align:left" | Level 1 / Preferred stocks: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total equity securities |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Level 1 / Mutual funds: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total equity securities |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | 40,839 |
|||
|- |
|||
| style="text-align:left" | Level 2 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 1,660,918 |
|||
| style="text-align:right; font-weight:bold" | 1,187,812 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total equity securities |
|||
| style="text-align:right; font-weight:bold" | 1,174 |
|||
| style="text-align:right; font-weight:bold" | 1,164 |
|||
|- |
|||
| style="text-align:left" | Mortgage loans |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Short-term investments |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Derivatives |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 1,662,092 |
|||
| style="text-align:right; font-weight:bold" | 1,188,976 |
|||
|- |
|||
| style="text-align:left" | Level 2 / U.S. government securities |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Level 2 / Corporate securities and miscellaneous |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 503,274 |
|||
| style="text-align:right; font-weight:bold" | 354,815 |
|||
|- |
|||
| style="text-align:left" | Level 2 / Municipal securities |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 102,116 |
|||
| style="text-align:right; font-weight:bold" | 84,716 |
|||
|- |
|||
| style="text-align:left" | Level 2 / Residential mortgage-backed securities |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 486,587 |
|||
| style="text-align:right; font-weight:bold" | 393,833 |
|||
|- |
|||
| style="text-align:left" | Level 2 / Commercial mortgage-backed securities |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 73,050 |
|||
| style="text-align:right; font-weight:bold" | 69,364 |
|||
|- |
|||
| style="text-align:left" | Level 2 / Other asset-backed securities |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 495,891 |
|||
| style="text-align:right; font-weight:bold" | 285,084 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Level 2 / Common stocks: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total equity securities |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Level 2 / Preferred stocks: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total equity securities |
|||
| style="text-align:right; font-weight:bold" | 1,174 |
|||
| style="text-align:right; font-weight:bold" | 1,164 |
|||
|- |
|||
| style="text-align:left" | Level 2 / Mutual funds: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total equity securities |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Level 3 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 150,917 |
|||
| style="text-align:right; font-weight:bold" | 77,920 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity |
|||
| style="text-align:right; font-weight:bold" | 33,603 |
|||
| style="text-align:right; font-weight:bold" | 38,717 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total equity securities |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Mortgage loans |
|||
| style="text-align:right" | 9,902 |
|||
| style="text-align:right" | 26,490 |
|||
|- |
|||
| style="text-align:left" | Short-term investments |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Derivatives |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 194,422 |
|||
| style="text-align:right; font-weight:bold" | 143,127 |
|||
|- |
|||
| style="text-align:left" | Level 3 / U.S. government securities |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Level 3 / Corporate securities and miscellaneous |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 133,113 |
|||
| style="text-align:right; font-weight:bold" | 70,813 |
|||
|- |
|||
| style="text-align:left" | Level 3 / Municipal securities |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Level 3 / Residential mortgage-backed securities |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Level 3 / Commercial mortgage-backed securities |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Level 3 / Other asset-backed securities |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, available-for-sale |
|||
| style="text-align:right; font-weight:bold" | 17,804 |
|||
| style="text-align:right; font-weight:bold" | 7,107 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total fixed maturity securities, held-to-maturity |
|||
| style="text-align:right; font-weight:bold" | 33,603 |
|||
| style="text-align:right; font-weight:bold" | 38,717 |
|||
|- |
|||
| style="text-align:left" | Level 3 / Common stocks: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total equity securities |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Level 3 / Preferred stocks: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total equity securities |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Level 3 / Mutual funds: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available-for-sale: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total equity securities |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fixed maturity securities and mortgage loans as of December 31, 2025|Fixed maturity securities, mortgage loans, net investment gains, accumulated comprehensive income|di0lc3m1jj|kind=table|order=130}} |
|||
=== Schedule of Fair Value, Measure on Recurring Basis, Unobservable Input Reconciliation === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | Fixed Maturity Securities, Available-For-Sale |
||
! class="col-s" style="text-align:right" | Mortgage Loans |
|||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
|- |
|||
| style="text-align:left" | Fixed Maturity Securities, Available-For-Sale |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Beginning balance |
|||
| style="text-align:right" | 77,920 |
| style="text-align:right" | 77,920 |
||
| style="text-align:right" | |
| style="text-align:right" | 26,490 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total gains (losses) for the period recognized in net investment gains (losses)''' |
||
| style="text-align:right |
| style="text-align:right" | '''( 5,180 )''' |
||
| style="text-align:right |
| style="text-align:right" | '''( 7 )''' |
||
|- |
|- |
||
| style="text-align:left" | Issuances |
| style="text-align:left" | Issuances |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 151 |
||
|- |
|- |
||
| style="text-align:left" | Settlements |
| style="text-align:left" | Settlements |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | ( 16,732 ) |
||
|- |
|- |
||
| style="text-align:left" | Transfers into Level 3 |
| style="text-align:left" | Transfers into Level 3 |
||
| Line 6,158: | Line 5,164: | ||
| style="text-align:left" | Purchases |
| style="text-align:left" | Purchases |
||
| style="text-align:right" | 70,730 |
| style="text-align:right" | 70,730 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Sales/Disposals |
| style="text-align:left" | Sales/Disposals |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,493 ) |
||
| style="text-align:right" | -374 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total unrealized gains for the period recognized in accumulated comprehensive income (loss) |
|||
| style="text-align:right; font-weight:bold" | 2,797 |
|||
| style="text-align:right; font-weight:bold" | 510 |
|||
|- |
|||
| style="text-align:left" | Ending balance |
|||
| style="text-align:right" | 150,917 |
|||
| style="text-align:right" | 77,920 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total losses for the period recognized in net investment gains attributable to the change in unrealized gains or losses relating to assets held as of period end |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Mortgage Loans |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total unrealized gains for the period recognized in accumulated comprehensive income (loss)''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''2,797''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Balance at December 31, 2025''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''150,917''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''9,902''' |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total losses for the period recognized in net investment gains attributable to the change in unrealized gains or losses relating to assets held as of period end''' |
||
| style="text-align:right |
| style="text-align:right" | '''—''' |
||
| style="text-align:right |
| style="text-align:right" | '''( 201 )''' |
||
|- |
|||
| style="text-align:left" | Issuances |
|||
| style="text-align:right" | 151 |
|||
| style="text-align:right" | 649 |
|||
|- |
|||
| style="text-align:left" | Settlements |
|||
| style="text-align:right" | -16,732 |
|||
| style="text-align:right" | -24,649 |
|||
|- |
|||
| style="text-align:left" | Transfers into Level 3 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Purchases |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Sales/Disposals |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total unrealized gains for the period recognized in accumulated comprehensive income (loss) |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
|- |
|||
| style="text-align:left" | Ending balance |
|||
| style="text-align:right" | 9,902 |
|||
| style="text-align:right" | 26,490 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total losses for the period recognized in net investment gains attributable to the change in unrealized gains or losses relating to assets held as of period end |
|||
| style="text-align:right; font-weight:bold" | -201 |
|||
| style="text-align:right; font-weight:bold" | 411 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fixed maturity securities and mortgage loans as of December 31, 2024|Fixed maturity securities, mortgage loans, net investment gains, accumulated comprehensive income|di0lc3m1jj|kind=table|order=131}} |
|||
=== Narrative === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | Fixed Maturity Securities, Available-For-Sale |
||
! class="col-s" style="text-align:right" | Mortgage Loans |
|||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2023 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Fair Value Measurement Inputs and Valuation Techniques [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 50,070 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total gains (losses) for the period recognized in net investment gains (losses)''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 195 )''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''420''' |
||
| style="text-align:right" | 829,143 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Issuances |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 649 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Settlements |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 24,649 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Purchases |
||
| style="text-align:right" | |
| style="text-align:right" | 77,979 |
||
| style="text-align:right" | 28,200 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Sales/Disposals |
||
| style="text-align:right" | |
| style="text-align:right" | ( 374 ) |
||
| style="text-align:right" | 24,400 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total unrealized gains for the period recognized in accumulated comprehensive income (loss)''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''510''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''—''' |
||
|- |
|||
| style="text-align:right" | — |
|||
| style="text-align:left" | '''Balance at December 31, 2024''' |
|||
| style="text-align:right" | '''77,920''' |
|||
| style="text-align:right" | '''26,490''' |
|||
|- |
|||
| style="text-align:left" | '''Total gains for the period recognized in net investment gains (losses) attributable to the change in unrealized gains or losses relating to assets held as of period end''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''411''' |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Notes payable and subordinated debt|Notes payable, subordinated debt, FHLB Loan, Revolving Credit Facility, Term Loan Facility, unsecured subordinated notes|b3bc9gy5x7|kind=table|order=132}} |
|||
=== Schedule of Subordinated Debt === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! |
! colspan="2" style="text-align:center" | 2025 |
||
! |
! colspan="2" style="text-align:center" | 2024 |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
|||
! style="text-align:center" | Carrying Value |
|||
! style="text-align:center" | Fair Value |
|||
! style="text-align:center" | Carrying Value |
|||
! style="text-align:center" | Fair Value |
|||
|- |
|- |
||
! style="text-align:left" | Notes payable |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | FHLB Loan |
||
| style="text-align:right" | 57,000 |
| style="text-align:right" | 57,000 |
||
| style="text-align:right" | 57,458 |
|||
| style="text-align:right" | 57,000 |
| style="text-align:right" | 57,000 |
||
|- |
|||
| style="text-align:left" | FHLB Loan / Fair Value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Long-term debt |
|||
| style="text-align:right" | 57,458 |
|||
| style="text-align:right" | 56,200 |
| style="text-align:right" | 56,200 |
||
|- |
|- |
||
| style="text-align:left" | Revolving Credit Facility |
| style="text-align:left" | Revolving Credit Facility |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Long-term debt |
|||
| style="text-align:right" | 114,500 |
| style="text-align:right" | 114,500 |
||
| style="text-align:right" | 43,000 |
|||
|- |
|||
| style="text-align:left" | Revolving Credit Facility / Fair Value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Long-term debt |
|||
| style="text-align:right" | 114,500 |
| style="text-align:right" | 114,500 |
||
| style="text-align:right" | 43,000 |
|||
| style="text-align:right" | 43,000 |
| style="text-align:right" | 43,000 |
||
|- |
|- |
||
| style="text-align:left" | Term Loan Facility |
| style="text-align:left" | Term Loan Facility |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Long-term debt |
|||
| style="text-align:right" | 300,000 |
| style="text-align:right" | 300,000 |
||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Term Loan Facility / Fair Value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Long-term debt |
|||
| style="text-align:right" | 300,000 |
| style="text-align:right" | 300,000 |
||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Notes payable / Carrying Value |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Notes payable''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''471,500''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''471,958''' |
||
| style="text-align:right" | '''100,000''' |
|||
| style="text-align:right" | '''99,200''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Unsecured subordinated notes |
||
| style="text-align:right" | 471,500 |
|||
| style="text-align:right" | 100,000 |
|||
|- |
|||
| style="text-align:left" | Notes payable / Fair Value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Long-term debt |
|||
| style="text-align:right" | 471,958 |
|||
| style="text-align:right" | 99,200 |
|||
|- |
|||
| style="text-align:left" | Unsecured subordinated notes / Carrying Value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Long-term debt |
|||
| style="text-align:right" | 19,569 |
| style="text-align:right" | 19,569 |
||
| style="text-align:right" | 21,020 |
|||
| style="text-align:right" | 19,536 |
| style="text-align:right" | 19,536 |
||
|- |
|||
| style="text-align:left" | Unsecured subordinated notes / Fair Value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Long-term debt |
|||
| style="text-align:right" | 21,020 |
|||
| style="text-align:right" | 20,541 |
| style="text-align:right" | 20,541 |
||
|- |
|- |
||
| style="text-align:left" | Subordinated debt, net of debt issuance costs |
| style="text-align:left" | '''Subordinated debt, net of debt issuance costs''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''19,569''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''21,020''' |
||
| style="text-align:right" | '''19,536''' |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | '''20,541''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Long-term debt |
|||
| style="text-align:right" | 19,569 |
|||
| style="text-align:right" | 19,536 |
|||
|- |
|||
| style="text-align:left" | Subordinated debt, net of debt issuance costs / Fair Value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Long-term debt |
|||
| style="text-align:right" | 21,020 |
|||
| style="text-align:right" | 20,541 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|5. Mortgage Loans|Mortgage loans, Separately Managed Accounts (SMA1, SMA2), direct investments, mortgage loan portfolios, loan interest, loan maturity, principal amounts of loans, uncollectible amounts on loans|966xer0dpm|kind=prose|order=133|f1=Loan maturity|v1=2 to 4 years|f2=Principal amounts of loans|v2=approximately 64% of the property’s appraised value|f3=Write-offs for uncollectible amounts 2025|v3=no write-offs|f4=Write-offs for uncollectible amounts 2024|v4=no write-offs|f5=Mortgage loans in foreclosure 2025|v5=no mortgage loans|f6=Mortgage loans in foreclosure 2024|v6=no mortgage loans|f7=Mortgage loans not producing income 2025|v7=no mortgage loans|f8=Mortgage loans not producing income 2024|v8=no mortgage loans}} |
|||
== Mortgage Loans == |
|||
* The Company invests in ''Separately Managed Accounts'' (SMA1 and SMA2) <sup>p. 85</sup>. |
|||
=== Narrative === |
|||
* As of December 31, 2025 and 2024, the Company held ''direct investments in mortgage loans'' from various creditors through SMA1 and SMA2 <sup>p. 85</sup>. |
|||
* The Company’s ''mortgage loan portfolios'' are primarily senior loans on real estate across the U.S. <sup>p. 85</sup>. |
|||
* ''Loans earn interest'' at a fixed spread above a prime rate <sup>p. 85</sup>. |
|||
* ''Loan maturity'' is approximately 2 to 4 years from loan origination <sup>p. 85</sup>. |
|||
* ''Principal amounts of loans'' are approximately 64% of the property’s appraised value at the time of loan origination <sup>p. 85</sup>. |
|||
* ''Uncollectible amounts on loans'' are determined based on consultations with the specialized investment manager, consideration of adverse situations affecting borrower repayment ability, estimated value of underlying collateral, and other relevant factors <sup>p. 85</sup>. |
|||
* The Company ''writes off uncollectible amounts'' in the period they are determined to be uncollectible <sup>p. 85</sup>. |
|||
* There were ''no write-offs for uncollectible amounts'' during the years ended December 31, 2025 and 2024 <sup>p. 85</sup>. |
|||
* As of December 31, 2025 and 2024, ''no mortgage loans were in the process of foreclosure'' <sup>p. 85</sup>. |
|||
* As of December 31, 2025 and 2024, ''no mortgage loans were not producing income'' for the previous 12 months <sup>p. 85</sup>. |
|||
{{Indexing|Mortgage loans by property type|Mortgage loans, commercial, retail, hospitality|966xer0dpm|kind=table|order=134}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
|||
|- |
|- |
||
| style="text-align:left" | Commercial |
|||
| style="text-align:right" | 3,334 |
|||
| style="text-align:right" | 8,474 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Retail |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 10,032 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Hospitality |
||
| style="text-align:right" | |
| style="text-align:right" | 6,568 |
||
| style="text-align:right" | |
| style="text-align:right" | 7,984 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | '''9,902''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''26,490''' |
||
|- |
|||
| style="text-align:left" | Mortgage loans in foreclosure |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Mortgage loans not producing income |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Low |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Loans held-for-investment, term |
|||
| style="text-align:right" | 2 years |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | High |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Loans held-for-investment, term |
|||
| style="text-align:right" | 4 years |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Mortgage loans by property type|Mortgage loans, commercial, retail, hospitality, office, multi-family|966xer0dpm|kind=table|order=135}} |
|||
=== Schedule of Portfolios === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
|||
|- |
|||
! style="text-align: |
! class="col-s" style="text-align:right" | 2023 |
||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total mortgage loans |
|||
| style="text-align:right; font-weight:bold" | 9,902 |
|||
| style="text-align:right; font-weight:bold" | 26,490 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investment income |
|||
| style="text-align:right; font-weight:bold" | 1,622 |
|||
| style="text-align:right; font-weight:bold" | 5,155 |
|||
| style="text-align:right; font-weight:bold" | 5,474 |
|||
|- |
|- |
||
| style="text-align:left" | Commercial |
| style="text-align:left" | Commercial |
||
| style="text-align:right" | |
| style="text-align:right" | 432 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,025 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,340 |
||
|- |
|||
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total mortgage loans |
|||
| style="text-align:right; font-weight:bold" | 3,334 |
|||
| style="text-align:right; font-weight:bold" | 8,474 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investment income |
|||
| style="text-align:right; font-weight:bold" | 432 |
|||
| style="text-align:right; font-weight:bold" | 2,025 |
|||
| style="text-align:right; font-weight:bold" | 2,340 |
|||
|- |
|- |
||
| style="text-align:left" | Retail |
| style="text-align:left" | Retail |
||
| style="text-align:right" | |
| style="text-align:right" | 304 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,853 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,853 |
||
|- |
|||
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total mortgage loans |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 10,032 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investment income |
|||
| style="text-align:right; font-weight:bold" | 304 |
|||
| style="text-align:right; font-weight:bold" | 1,853 |
|||
| style="text-align:right; font-weight:bold" | 1,853 |
|||
|- |
|- |
||
| style="text-align:left" | Hospitality |
| style="text-align:left" | Hospitality |
||
| style="text-align:right" | |
| style="text-align:right" | 886 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,277 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,034 |
||
|- |
|||
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total mortgage loans |
|||
| style="text-align:right; font-weight:bold" | 6,568 |
|||
| style="text-align:right; font-weight:bold" | 7,984 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investment income |
|||
| style="text-align:right; font-weight:bold" | 886 |
|||
| style="text-align:right; font-weight:bold" | 1,277 |
|||
| style="text-align:right; font-weight:bold" | 1,034 |
|||
|- |
|- |
||
| style="text-align:left" | Office |
| style="text-align:left" | Office |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 203 |
||
|- |
|||
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investment income |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 203 |
|||
|- |
|- |
||
| style="text-align:left" | Multi-family |
| style="text-align:left" | Multi-family |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 44 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,622''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''5,155''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''5,474''' |
||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investment income |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 0 |
|||
| style="text-align:right; font-weight:bold" | 44 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|6. Equity Method Investments and Other|Equity method investments, RISCOM, indirect investments, collateralized loans, loan collateral, SMA1, SMA2|966xer0dpm|kind=prose|order=136|f1=RISCOM amortization period|v1=15-year useful life}} |
|||
== Equity Method Investments and Other == |
|||
* The difference between an investment's cost and its proportionate share of underlying equity in net assets is allocated to the equity method investment's assets and liabilities <sup>p. 86</sup>. |
|||
* The Company amortizes this difference in net assets over the useful life of a similar asset as the underlying equity method investment <sup>p. 86</sup>. |
|||
* For the investment in RISCOM, the similar asset is agent relationships <sup>p. 86</sup>. |
|||
* The Company amortizes this difference for RISCOM over a 15-year useful life <sup>p. 86</sup>. |
|||
* As of December 31, 2025 and 2024, the Company held indirect investments in collateralized loans and loan collateral through SMA1 and SMA2 <sup>p. 86</sup>. |
|||
{{Indexing|Indirect investments in collateralized loans and loan collateral|Indirect investments, collateralized loans, loan collateral, Arena Special Opportunities Fund, Arena SOP, Brewer Lane Ventures Fund II, Dowling Capital Partners, Hudson Ventures Fund 2, JVM Funds LLC, RISCOM|966xer0dpm|kind=table|order=137}} |
|||
=== Schedule of Carrying Value of Equity Method Investments === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! colspan="2" style="text-align:center" | 2025 |
||
! |
! colspan="2" style="text-align:center" | 2024 |
||
|- |
|- |
||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Carrying Value |
|||
! class="col-s" style="text-align:right" | Ownership % |
|||
! class="col-s" style="text-align:right" | Carrying Value |
|||
|- |
|||
! class="col-s" style="text-align:right" | Ownership % |
|||
| style="text-align:right" | 77,365 |
|||
| style="text-align:right" | 98,594 |
|||
|- |
|||
| style="text-align:left" | Equity method investments |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Carrying Value |
|||
| style="text-align:right" | 53,498 |
|||
| style="text-align:right" | 65,325 |
|||
|- |
|- |
||
| style="text-align:left" | Arena Special Opportunities Fund, LP units |
| style="text-align:left" | Arena Special Opportunities Fund, LP units |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Carrying Value |
|||
| style="text-align:right" | 26,936 |
| style="text-align:right" | 26,936 |
||
| style="text-align:right" | 14.0% |
|||
| style="text-align:right" | 34,936 |
| style="text-align:right" | 34,936 |
||
| style="text-align:right" | 15.3% |
|||
|- |
|||
| style="text-align:left" | Ownership % |
|||
| style="text-align:right" | 14.00% |
|||
| style="text-align:right" | 15.30% |
|||
|- |
|- |
||
| style="text-align:left" | Arena SOP LP units |
| style="text-align:left" | Arena SOP LP units |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 11.2% |
||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Carrying Value |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 1,474 |
| style="text-align:right" | 1,474 |
||
| style="text-align:right" | 10.9% |
|||
|- |
|||
| style="text-align:left" | Ownership % |
|||
| style="text-align:right" | 11.20% |
|||
| style="text-align:right" | 10.90% |
|||
|- |
|- |
||
| style="text-align:left" | Brewer Lane Ventures Fund II LP units |
| style="text-align:left" | Brewer Lane Ventures Fund II LP units |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Carrying Value |
|||
| style="text-align:right" | 2,251 |
| style="text-align:right" | 2,251 |
||
| style="text-align:right" | 2.4% |
|||
| style="text-align:right" | 1,040 |
| style="text-align:right" | 1,040 |
||
| style="text-align:right" | 2.4% |
|||
|- |
|||
| style="text-align:left" | Ownership % |
|||
| style="text-align:right" | 2.40% |
|||
| style="text-align:right" | 2.40% |
|||
|- |
|- |
||
| style="text-align:left" | Dowling Capital Partners LP units |
| style="text-align:left" | Dowling Capital Partners LP units |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Carrying Value |
|||
| style="text-align:right" | 590 |
| style="text-align:right" | 590 |
||
| style="text-align:right" | 5.0% |
|||
| style="text-align:right" | 666 |
| style="text-align:right" | 666 |
||
| style="text-align:right" | 5.0% |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Hudson Ventures Fund 2 LP units |
||
| style="text-align:right" | 5.00% |
|||
| style="text-align:right" | 5.00% |
|||
|- |
|||
| style="text-align:left" | Hudson Ventures Fund II LP units |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Carrying Value |
|||
| style="text-align:right" | 5,503 |
| style="text-align:right" | 5,503 |
||
| style="text-align:right" | 2.5% |
|||
| style="text-align:right" | 4,967 |
| style="text-align:right" | 4,967 |
||
| style="text-align:right" | 2.5% |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | JVM Funds LLC units |
||
| style="text-align:right" | 2.50% |
|||
| style="text-align:right" | 2.50% |
|||
|- |
|||
| style="text-align:left" | JVM Funds LLC |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Carrying Value |
|||
| style="text-align:right" | 14,911 |
| style="text-align:right" | 14,911 |
||
| style="text-align:right" | 10.1% |
|||
| style="text-align:right" | 17,229 |
| style="text-align:right" | 17,229 |
||
| style="text-align:right" | 10.1% |
|||
|- |
|||
| style="text-align:left" | Ownership % |
|||
| style="text-align:right" | 10.10% |
|||
| style="text-align:right" | 10.10% |
|||
|- |
|- |
||
| style="text-align:left" | RISCOM |
| style="text-align:left" | RISCOM |
||
| style="text-align:right" | |
| style="text-align:right" | 3,307 |
||
| style="text-align:right" | |
| style="text-align:right" | 20.0% |
||
| style="text-align:right" | 5,013 |
|||
| style="text-align:right" | 20.0% |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:right" | '''53,498''' |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | '''65,325''' |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Carrying Value |
|||
| style="text-align:right" | 3,307 |
|||
| style="text-align:right" | 5,013 |
|||
|- |
|||
| style="text-align:left" | Ownership % |
|||
| style="text-align:right" | 20.00% |
|||
| style="text-align:right" | 20.00% |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Indirect investments in collateralized loans and loan collateral|Indirect investments, collateralized loans, loan collateral, Arena SOP, Arena Special Opportunities Fund, Brewer Lane Ventures Fund II, Dowling Capital Partners, Hudson Ventures Fund II, JVM Funds LLC, RISCOM, Universa Black Swan|966xer0dpm|kind=table|order=138}} |
|||
=== Schedule of Net Investment Income === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
|||
! class="col-s" style="text-align:right" | 2023 |
|||
|- |
|- |
||
| style="text-align:left" | Arena SOP LP units |
|||
| style="text-align:right" | ( 1,474 ) |
|||
| style="text-align:right" | ( 989 ) |
|||
| style="text-align:right" | ( 6,271 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Arena Special Opportunities Fund, LP units |
||
| style="text-align:right" | |
| style="text-align:right" | ( 3,163 ) |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | 83,619 |
|||
| style="text-align:right" | 80,600 |
|||
| style="text-align:right" | 40,340 |
|||
|- |
|||
| style="text-align:left" | Equity Method Investment, Nonconsolidated Investee or Group of Investees |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | -2,683 |
|||
| style="text-align:right" | 2,524 |
|||
| style="text-align:right" | -9,434 |
|||
|- |
|||
| style="text-align:left" | Arena SOP LP units / Equity Method Investment, Nonconsolidated Investee or Group of Investees |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | -1,474 |
|||
| style="text-align:right" | -989 |
|||
| style="text-align:right" | -6,271 |
|||
|- |
|||
| style="text-align:left" | Arena Special Opportunities Fund, LP units / Equity Method Investment, Nonconsolidated Investee or Group of Investees |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | -3,163 |
|||
| style="text-align:right" | 2,375 |
| style="text-align:right" | 2,375 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 2,880 ) |
||
|- |
|- |
||
| style="text-align:left" | Brewer Lane Ventures Fund II LP |
| style="text-align:left" | Brewer Lane Ventures Fund II LP |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | 91 |
| style="text-align:right" | 91 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 110 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 78 ) |
||
|- |
|- |
||
| style="text-align:left" | Dowling Capital Partners LP units |
| style="text-align:left" | Dowling Capital Partners LP units |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | 431 |
| style="text-align:right" | 431 |
||
| style="text-align:right" | 1,463 |
| style="text-align:right" | 1,463 |
||
| style="text-align:right" | 927 |
| style="text-align:right" | 927 |
||
|- |
|- |
||
| style="text-align:left" | Hudson Ventures Fund II LP units |
| style="text-align:left" | Hudson Ventures Fund II LP units |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | 480 |
| style="text-align:right" | 480 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 153 ) |
||
| style="text-align:right" | 170 |
| style="text-align:right" | 170 |
||
|- |
|- |
||
| style="text-align:left" | JVM Funds LLC |
| style="text-align:left" | JVM Funds LLC |
||
| style="text-align:right" | |
| style="text-align:right" | ( 541 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,554 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,198 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | RISCOM |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | -541 |
|||
| style="text-align:right" | -1,554 |
|||
| style="text-align:right" | -1,198 |
|||
|- |
|||
| style="text-align:left" | RISCOM / Equity Method Investment, Nonconsolidated Investee or Group of Investees |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | 1,493 |
| style="text-align:right" | 1,493 |
||
| style="text-align:right" | 1,492 |
| style="text-align:right" | 1,492 |
||
| style="text-align:right" | 884 |
| style="text-align:right" | 884 |
||
|- |
|- |
||
| style="text-align:left" | Universa Black Swan LP units |
| style="text-align:left" | Universa Black Swan LP units |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 988 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 2,683 )''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''2,524''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 9,434 )''' |
||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | -988 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Indirect investments in collateralized loans and loan collateral|Indirect investments, collateralized loans, loan collateral, Brewer Lane Ventures Fund II, Dowling Capital Partners, Hudson Ventures Fund 2, Red Bird Capital Partners|966xer0dpm|kind=table|order=139}} |
|||
=== Schedule of Unfunded Commitment of Equity Method Investments === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2024 |
||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Equity method investments, unfunded commitment |
|||
| style="text-align:right" | 22,094 |
|||
| style="text-align:right" | 29,260 |
|||
|- |
|- |
||
| style="text-align:left" | Brewer Lane Ventures Fund II LP units |
| style="text-align:left" | Brewer Lane Ventures Fund II LP units |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Equity method investments, unfunded commitment |
|||
| style="text-align:right" | 3,237 |
| style="text-align:right" | 3,237 |
||
| style="text-align:right" | 4,077 |
| style="text-align:right" | 4,077 |
||
|- |
|- |
||
| style="text-align:left" | Dowling Capital Partners LP units |
| style="text-align:left" | Dowling Capital Partners LP units |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Equity method investments, unfunded commitment |
|||
| style="text-align:right" | 386 |
| style="text-align:right" | 386 |
||
| style="text-align:right" | 386 |
| style="text-align:right" | 386 |
||
|- |
|- |
||
| style="text-align:left" | Hudson Ventures Fund |
| style="text-align:left" | Hudson Ventures Fund 2 LP units |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Equity method investments, unfunded commitment |
|||
| style="text-align:right" | 166 |
| style="text-align:right" | 166 |
||
| style="text-align:right" | 397 |
| style="text-align:right" | 397 |
||
|- |
|- |
||
| style="text-align:left" | Red Bird Capital Partners LP units |
| style="text-align:left" | Red Bird Capital Partners LP units |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Equity method investments, unfunded commitment |
|||
| style="text-align:right" | 18,305 |
| style="text-align:right" | 18,305 |
||
| style="text-align:right" | 24,400 |
| style="text-align:right" | 24,400 |
||
|} |
|||
</div> |
|||
=== Narrative === |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" |
|||
! style="text-align:left" | |
|||
! style="text-align:center" | 12 Months Ended |
|||
|- |
|- |
||
| style="text-align:left" | — |
|||
| style="text-align:right" | '''22,094''' |
|||
| style="text-align:right" | '''29,260''' |
|||
|- |
|||
| style="text-align:left" | RISCOM |
|||
| class="col-s" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| class="col-s" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Useful life |
|||
| class="col-s" style="text-align:right" | 15 years |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Investment in RISCOM|Investment in RISCOM, underlying equity, difference|966xer0dpm|kind=table|order=140}} |
|||
=== Schedule of Investment in RISCOM === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | 2025 |
||
! |
! style="text-align:center" | 2024 |
||
|- |
|- |
||
! style="text-align:left" | Investment in RISCOM: |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Recorded investment balance |
|||
| style="text-align:right" | 77,365 |
|||
| style="text-align:right" | 98,594 |
|||
|- |
|||
| style="text-align:left" | RISCOM |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Underlying equity |
| style="text-align:left" | Underlying equity |
||
| Line 7,029: | Line 5,547: | ||
| style="text-align:right" | 1,258 |
| style="text-align:right" | 1,258 |
||
|- |
|- |
||
| style="text-align:left" | Recorded investment balance |
| style="text-align:left" | '''Recorded investment balance''' |
||
| style="text-align:right" | 3,307 |
| style="text-align:right" | '''3,307''' |
||
| style="text-align:right" | 5,013 |
| style="text-align:right" | '''5,013''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Investment in JVM Funds LLC|Investment in JVM Funds LLC, underlying equity, difference|966xer0dpm|kind=table|order=141}} |
|||
=== Schedule of Investment in JVN Funds === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | 2025 |
||
! |
! style="text-align:center" | 2024 |
||
|- |
|- |
||
! style="text-align:left" | Investment in JVM Funds LLC: |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Recorded investment balance |
|||
| style="text-align:right" | 77,365 |
|||
| style="text-align:right" | 98,594 |
|||
|- |
|||
| style="text-align:left" | JVM Funds LLC |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Underlying equity |
| style="text-align:left" | Underlying equity |
||
| Line 7,067: | Line 5,573: | ||
| style="text-align:right" | 605 |
| style="text-align:right" | 605 |
||
|- |
|- |
||
| style="text-align:left" | Recorded investment balance |
| style="text-align:left" | '''Recorded investment balance''' |
||
| style="text-align:right" | 14,911 |
| style="text-align:right" | '''14,911''' |
||
| style="text-align:right" | 17,229 |
| style="text-align:right" | '''17,229''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Investment in indirect loans and loan collateral|Investment in indirect loans, loan collateral, SMA1, SMA2|966xer0dpm|kind=table|order=142}} |
|||
=== Schedule of Indirect Investments === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2024 |
||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Recorded investment balance |
|||
| style="text-align:right" | 77,365 |
|||
| style="text-align:right" | 98,594 |
|||
|- |
|- |
||
| style="text-align:left" | SMA1 |
| style="text-align:left" | SMA1 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Recorded investment balance |
|||
| style="text-align:right" | 15,418 |
| style="text-align:right" | 15,418 |
||
| style="text-align:right" | 20,296 |
| style="text-align:right" | 20,296 |
||
|- |
|- |
||
| style="text-align:left" | SMA2 |
| style="text-align:left" | SMA2 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Recorded investment balance |
|||
| style="text-align:right" | 8,449 |
| style="text-align:right" | 8,449 |
||
| style="text-align:right" | 12,973 |
| style="text-align:right" | 12,973 |
||
|- |
|- |
||
| style="text-align:left" | Investment in indirect loans and loan collateral |
| style="text-align:left" | '''Investment in indirect loans and loan collateral''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''23,867''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''33,269''' |
||
|- |
|||
| style="text-align:left" | Schedule of Equity Method Investments [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Recorded investment balance |
|||
| style="text-align:right" | 23,867 |
|||
| style="text-align:right" | 33,269 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|7. Variable Interest Entity|Variable Interest Entity (VIE), Separate Account HSIC-01, Mangrove Risk Solutions Bermuda Ltd., GAAP consolidation guidance, price volatility risks, insurance products, dairy and livestock commodities, performance guarantees, financial obligation, capital commitments, assets of consolidated variable interest entities, third-party net assets|ie3cmfrol3|kind=prose|order=143|f1=VIE|v1=Separate Account HSIC-01|f2=Primary beneficiary|v2=Company}} |
|||
== Variable Interest Entity == |
|||
* Skyward consolidates ''Separate Account HSIC-01'' ("HSIC-01"), established by Mangrove Risk Solutions Bermuda Ltd. ("Mangrove"), pursuant to GAAP consolidation guidance <sup>p. 87</sup>. |
|||
* HSIC-01 is a ''VIE'' for which the Company is the primary beneficiary <sup>p. 87</sup>. |
|||
* The purpose of the VIE is to ''hedge price volatility risks'' of certain insurance products by investing in dairy and livestock commodities <sup>p. 87</sup>. |
|||
* The Company considers itself the ''primary beneficiary'' because it directly manages the business <sup>p. 87</sup>. |
|||
* The Company does not provide ''performance guarantees'' and has no other financial obligation to provide funding to HSIC-01, other than its own capital commitments <sup>p. 87</sup>. |
|||
* The ''assets of consolidated variable interest entities'' may only be used to settle obligations of these entities <sup>p. 87</sup>. |
|||
* There is ''no recourse to the assets of HSIC-01'' other than to satisfy associated liabilities <sup>p. 87</sup>. |
|||
* The table presents the ''assets of HSIC-01'' included in the Consolidated Balance Sheets as of December 31, 2025 <sup>p. 87</sup>. |
|||
* The presented assets only include ''third-party net assets'' and exclude intercompany balances, which were eliminated upon consolidation <sup>p. 87</sup>. |
|||
{{Indexing|Assets of HSIC-01 as of December 31, 2025|Assets of HSIC-01, cash and cash equivalents, other assets|ie3cmfrol3|kind=table|order=144}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | 2025 |
||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
|- |
|- |
||
! style="text-align:left" | Assets |
|||
! class="col-s" style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cash and cash equivalents |
|||
| style="text-align:right" | 168,544 |
|||
| style="text-align:right" | 121,603 |
|||
|- |
|||
| style="text-align:left" | Other assets |
|||
| style="text-align:right" | 137,173 |
|||
| style="text-align:right" | 86,698 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total assets |
|||
| style="text-align:right; font-weight:bold" | 4,791,852 |
|||
| style="text-align:right; font-weight:bold" | 3,729,478 |
|||
|- |
|||
| style="text-align:left" | Variable Interest Entity, Primary Beneficiary |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Assets |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents |
| style="text-align:left" | Cash and cash equivalents |
||
| style="text-align:right" | 15,816 |
| style="text-align:right" | 15,816 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other assets |
| style="text-align:left" | Other assets |
||
| style="text-align:right" | 34,856 |
| style="text-align:right" | 34,856 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total assets''' |
||
| style="text-align:right |
| style="text-align:right" | '''50,672''' |
||
| style="text-align:right; font-weight:bold" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|8 . Derivatives|Derivatives, financial risk management, commodity price fluctuations, cattle, milk, put options, futures, revenue volatility, economic hedging relationships|s22xbq0z1h|kind=prose|order=145|f1=Net gain on derivative instruments|v1=FY25: USD 7.9m}} |
|||
== Derivatives == |
|||
* The Company uses derivatives for financial risk management to mitigate price risk in insurance contracts exposed to commodity price fluctuations, specifically cattle and milk <sup>p. 88</sup>. |
|||
=== Schedule of Derivatives and Fair Value of Derivative Assets and Liabilities === |
|||
* A hedging strategy using derivatives, including put options and futures, is employed to mitigate revenue volatility and support financial stability <sup>p. 88</sup>. |
|||
* The primary objective of derivative instruments is to manage exposure to adverse price movements <sup>p. 88</sup>. |
|||
* The activity in these instruments reflects current market conditions and shifts in risk exposures throughout the year <sup>p. 88</sup>. |
|||
* The notional value of derivative contracts and the degree of hedged exposure are actively managed and can vary based on pricing in cattle, hogs, and milk markets <sup>p. 88</sup>. |
|||
* The Company does not use derivatives for speculative or trading purposes <sup>p. 88</sup>. |
|||
* All derivative positions support the overall risk transfer objectives of the business <sup>p. 88</sup>. |
|||
* The Company has not elected hedge accounting for these derivatives <sup>p. 88</sup>. |
|||
* The net gain (loss) recognized on derivative instruments in economic hedging relationships is presented in "losses and loss adjustment expenses" on the Consolidated Statements of Operations <sup>p. 88</sup>. |
|||
* For the year ended December 31, 2025, the Company recognized pre-tax net gains of USD 7.9m in losses and loss adjustment expenses <sup>p. 88</sup>. |
|||
{{Indexing|Derivative instruments in economic hedging relationships|Derivative assets, economic hedging relationships|s22xbq0z1h|kind=table|order=146}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | $ in |
! style="text-align:left" | ($ in thousands) |
||
! |
! colspan="2" style="text-align:center" | Derivative Assets |
||
|- |
|- |
||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Notional Amount |
|||
! class="col-s" style="text-align:right" | Fair Value |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Economic hedges |
||
| style="text-align:right" | 136,800 |
| style="text-align:right" | 136,800 |
||
|- |
|||
| style="text-align:left" | Derivative assets, fair value |
|||
| style="text-align:right" | 34,857 |
| style="text-align:right" | 34,857 |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|9. Allowance for Credit Losses|Reinsurance recoverables, A.M. Best, financial strength rating, credit enhancements, reinsurance payables, letters of credit, funds held, LPT, R&Q Re (Bermuda) Ltd.|tc5fw176pu|m0cjxgvmvi|kind=prose|order=147|f1=Uncollectible reinsurance recoverable balance increase|v1=FY24: $13.6 million|f2=LPT commuted|v2=January 31, 2025}} |
|||
=== Narrative === |
|||
* The Company analyzes the credit risk of its ''reinsurance recoverables'' by monitoring the financial strength rating of its reinsurers from A.M. Best <sup>p. 89</sup>. |
|||
* A.M. Best is a widely recognized rating agency focused exclusively on the insurance industry <sup>p. 89</sup>. |
|||
* The Company assesses the financial strength rating annually and throughout the year as A.M. Best provides updates <sup>p. 89</sup>. |
|||
* The Company assesses the adequacy of credit enhancements such as reinsurance payables, letters of credit, and funds held <sup>p. 89</sup>. |
|||
* ''Reinsurance balances'' are considered past due when they are 90 days past due <sup>p. 89</sup>. |
|||
* On January 31, 2025, the Company commuted the LPT with R&Q Re (Bermuda) Ltd. ("R&Q") for accident years 2018 and prior <sup>p. 89</sup>. |
|||
* During the year ended December 31, 2024, the Company recognized an ''uncollectible reinsurance recoverable balance'' related to the LPT as a net increase of $13.6 million to the allowance for estimated uncollectible reinsurance <sup>p. 89</sup>. |
|||
* This $13.6 million increase was subsequently written-off <sup>p. 89</sup>. |
|||
{{Indexing|Premiums receivable and allowance for uncollectible premiums as of December 31, 2025|Premiums receivable, allowance for uncollectible premiums|tc5fw176pu|kind=table|order=148}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | $ in |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Premiums Receivable, Net |
||
! class="col-s" style="text-align:right" | Allowance for Estimated Uncollectible Premiums |
|||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2024 |
|||
| style="text-align:right" | 321,641 |
|||
| style="text-align:right" | 2,432 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Current period change for estimated uncollectible premiums |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 2,351 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Write-offs of uncollectible premiums receivable |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 2,141 ) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Recoveries of amounts previously written off |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 498 |
|||
|- |
|||
| style="text-align:left" | '''Balance at December 31, 2025''' |
|||
| style="text-align:right" | '''544,217''' |
|||
| style="text-align:right" | '''3,140''' |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Premiums receivable and allowance for uncollectible premiums as of December 31, 2024|Premiums receivable, allowance for uncollectible premiums|tc5fw176pu|kind=table|order=149}} |
|||
== Allowance for Credit Losses == |
|||
=== Schedule of Premium Receivable === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | Premiums Receivable, Net |
||
! class="col-s" style="text-align:right" | Allowance for Estimated Uncollectible Premiums |
|||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2023 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
|- |
|||
| style="text-align:left" | Premium Receivable, Allowance for Credit Loss [Roll Forward] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Premiums Receivable, Net, beginning balance |
|||
| style="text-align:right" | 321,641 |
|||
| style="text-align:right" | 179,235 |
| style="text-align:right" | 179,235 |
||
|- |
|||
| style="text-align:left" | Allowance for Estimated Uncollectible Premiums, beginning balance |
|||
| style="text-align:right" | 2,432 |
|||
| style="text-align:right" | 964 |
| style="text-align:right" | 964 |
||
|- |
|- |
||
| style="text-align:left" | Current period change for estimated uncollectible premiums |
| style="text-align:left" | Current period change for estimated uncollectible premiums |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 3,235 |
| style="text-align:right" | 3,235 |
||
|- |
|- |
||
| style="text-align:left" | Write-offs of uncollectible premiums receivable |
| style="text-align:left" | Write-offs of uncollectible premiums receivable |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,895 ) |
||
|- |
|- |
||
| style="text-align:left" | Recoveries of amounts previously written off |
| style="text-align:left" | Recoveries of amounts previously written off |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 128 |
| style="text-align:right" | 128 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Balance at December 31, 2024''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''321,641''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''2,432''' |
||
|- |
|||
| style="text-align:left" | Allowance for Estimated Uncollectible Premiums, ending balance |
|||
| style="text-align:right" | 3,140 |
|||
| style="text-align:right" | 2,432 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|A.M. best ratings|A.M. Best ratings, reinsurance recoverables|tc5fw176pu|ooly7l7133|kind=table|order=150}} |
|||
=== Schedule of Reinsurance Recoverable, Credit Quality Indicator === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align:center" | |
! colspan="2" style="text-align:center" | 2025 |
||
! style="text-align:center" | |
|||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | A.M. Best Rating |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Reinsurance Recoverables, Gross, Amortized Cost |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Percent of Total |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | A- and above |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Reinsurance Recoverables, Gross, Amortized Cost |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 22,700 |
|||
|- |
|||
| style="text-align:left" | Reinsurer concentration risk / Reinsurance recoverable including reinsurance premium paid / A- and above |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Ceded Credit Risk [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Reinsurance Recoverables, Gross, Amortized Cost |
|||
| style="text-align:right" | 652,178 |
| style="text-align:right" | 652,178 |
||
| style="text-align:right" | |
| style="text-align:right" | 98.2% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | B++ to B+ |
||
| style="text-align:right" | 98.20% |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Reinsurer concentration risk / Reinsurance recoverable including reinsurance premium paid / B++ to B+ |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Ceded Credit Risk [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Reinsurance Recoverables, Gross, Amortized Cost |
|||
| style="text-align:right" | 5,077 |
| style="text-align:right" | 5,077 |
||
| style="text-align:right" | |
| style="text-align:right" | 0.8 |
||
|- |
|||
| style="text-align:left" | Percent of Total |
|||
| style="text-align:right" | 0.80% |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Reinsurer concentration risk / Reinsurance recoverable including reinsurance premium paid / B to B - |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Ceded Credit Risk [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | B to B - |
||
| style="text-align:right" | 28 |
| style="text-align:right" | 28 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Not rated |
||
| style="text-align:right" | 0.00% |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Reinsurer concentration risk / Reinsurance recoverable including reinsurance premium paid / Not rated |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Ceded Credit Risk [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Reinsurance Recoverables, Gross, Amortized Cost |
|||
| style="text-align:right" | 6,919 |
| style="text-align:right" | 6,919 |
||
| style="text-align:right" | |
| style="text-align:right" | 1.0 |
||
|- |
|||
| style="text-align:left" | Percent of Total |
|||
| style="text-align:right" | 1.00% |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Reinsurance recoverables and allowance for uncollectible reinsurance|Reinsurance recoverables, allowance for uncollectible reinsurance|tc5fw176pu|kind=table|order=151}} |
|||
=== Schedule of Reinsurance Recoverable === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | $ in |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Reinsurance Recoverables, Net |
||
! class="col-s" style="text-align:right" | Allowance for Estimated Uncollectible Reinsurance |
|||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 USD ($) |
|||
|- |
|||
| style="text-align:left" | Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Reinsurance Recoverables, Net, beginning balance |
|||
| style="text-align:right" | 857,876 |
| style="text-align:right" | 857,876 |
||
|- |
|||
| style="text-align:left" | Allowance for Estimated Uncollectible Reinsurance, beginning balance |
|||
| style="text-align:right" | 2,295 |
| style="text-align:right" | 2,295 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Balance at December 31, 2025''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,119,880''' |
||
| style="text-align:right" | '''2,295''' |
|||
|- |
|||
| style="text-align:left" | Write-offs of uncollectible reinsurance recoverables |
|||
| style="text-align:right" | -13,585 |
|||
|- |
|||
| style="text-align:left" | Reinsurance Recoverables, Net, ending balance |
|||
| style="text-align:right" | 857,876 |
|||
|- |
|||
| style="text-align:left" | Allowance for Estimated Uncollectible Reinsurance, ending balance |
|||
| style="text-align:right" | 2,295 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Reinsurance recoverables and allowance for uncollectible reinsurance as of December 31, 2024|Reinsurance recoverables, allowance for uncollectible reinsurance|tc5fw176pu|kind=table|order=152}} |
|||
=== Narrative === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | $ in |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Reinsurance Recoverables, Net |
||
! class="col-s" style="text-align:right" | Allowance for Estimated Uncollectible Reinsurance |
|||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2023 |
|||
| style="text-align:right" | 596,334 |
|||
| style="text-align:right" | 2,295 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Current period change for estimated uncollectible reinsurance |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 13,585 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Write-offs of uncollectible reinsurance recoverables |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | ( 13,585 ) |
|||
|- |
|||
| style="text-align:left" | '''Balance at December 31, 2024''' |
|||
| style="text-align:right" | '''857,876''' |
|||
| style="text-align:right" | '''2,295''' |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|10. Property and Equipment|Depreciation expense, property and equipment|1f87rdfb5o|kind=prose|order=153|f1=Depreciation expense|v1=FY25: USD 3.3m}} |
|||
== Property and Equipment == |
|||
* ''Depreciation expense'' for property and equipment was USD 3.3m for the year ended December 31, 2025 <sup>p. 90</sup>. |
|||
=== Schedule of Property, Plant and Equipment === |
|||
* ''Depreciation expense'' for property and equipment was USD 2.9m for the year ended December 31, 2024 <sup>p. 90</sup>. |
|||
* ''Depreciation expense'' for property and equipment was USD 3.2m for the year ended December 31, 2023 <sup>p. 90</sup>. |
|||
* Depreciation expense is presented in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations <sup>p. 90</sup>. |
|||
{{Indexing|Property and equipment|Property and equipment, leasehold improvements, equipment, software, accumulated depreciation|1f87rdfb5o|kind=table|order=154}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | (in thousands) |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2024 |
||
|- |
|||
| style="text-align:left" | Property, Plant and Equipment [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Property, equipment and other, gross |
|||
| style="text-align:right" | 47,447 |
|||
| style="text-align:right" | 41,534 |
|||
|- |
|||
| style="text-align:left" | Accumulated depreciation |
|||
| style="text-align:right" | -32,307 |
|||
| style="text-align:right" | -29,355 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 15,140 |
|||
| style="text-align:right; font-weight:bold" | 12,179 |
|||
|- |
|- |
||
| style="text-align:left" | Leasehold improvements |
| style="text-align:left" | Leasehold improvements |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Property, Plant and Equipment [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Property, equipment and other, gross |
|||
| style="text-align:right" | 3,434 |
| style="text-align:right" | 3,434 |
||
| style="text-align:right" | 3,056 |
| style="text-align:right" | 3,056 |
||
|- |
|- |
||
| style="text-align:left" | Equipment |
| style="text-align:left" | Equipment |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Property, Plant and Equipment [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Property, equipment and other, gross |
|||
| style="text-align:right" | 4,750 |
| style="text-align:right" | 4,750 |
||
| style="text-align:right" | 4,506 |
| style="text-align:right" | 4,506 |
||
|- |
|- |
||
| style="text-align:left" | Software |
| style="text-align:left" | Software |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Property, Plant and Equipment [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Property, equipment and other, gross |
|||
| style="text-align:right" | 39,263 |
| style="text-align:right" | 39,263 |
||
| style="text-align:right" | 33,972 |
| style="text-align:right" | 33,972 |
||
|} |
|||
</div> |
|||
=== Narrative === |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | USD ($) $ in Millions |
|||
! colspan="3" style="text-align:center" | 12 Months Ended |
|||
|- |
|- |
||
| style="text-align:left" | — |
|||
| style="text-align:right" | 47,447 |
|||
| style="text-align:right" | 41,534 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Accumulated depreciation |
||
| style="text-align:right" | |
| style="text-align:right" | ( 32,307 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 29,355 ) |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''15,140''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''12,179''' |
||
| style="text-align:right" | 3.2 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|11. Notes Payable & Subordinated Debt|FHLB Loan, Advances and Security Agreement, Term Loan Credit Agreement, Term Loan Facility, unsecured senior delayed draw term loan facility, Tranche A DDTL, Tranche B DDTL, Apollo Group Holdings Limited, SOFR, base rate|b3bc9gy5x7|bhnpa5y4f0|kind=prose|order=155|f1=FHLB Loan principal amount|v1=USD 57.0m|f2=FHLB Loan interest rate|v2=4.00%|f3=Term Loan Facility Tranche A DDTL|v3=USD 150.0m|f4=Term Loan Facility Tranche B DDTL|v4=USD 150.0m|f5=FHLB Loan date|v5=August 30, 2024}} |
|||
== Notes Payable & Subordinated Debt == |
|||
* On August 30, 2024, the Company entered into the ''FHLB Loan'' under the Advances and Security Agreement <sup>p. 91</sup>. |
|||
<div style="overflow-x:auto"> |
|||
* The ''FHLB Loan'' is a 4.5-year term loan with a principal amount of USD 57.0m <sup>p. 91</sup>. |
|||
{| class="wikitable fintable" |
|||
* The ''FHLB Loan'' requires interest-only payments during its term, with principal due at maturity <sup>p. 91</sup>. |
|||
! style="text-align:left" | USD ($) |
|||
* The ''FHLB Loan'' has a fixed interest rate of 4.00% over its term <sup>p. 91</sup>. |
|||
! style="text-align:center" | |
|||
* The ''FHLB Loan'' is fully secured by a pledge of specific investment securities of HSIC <sup>p. 91</sup>. |
|||
! style="text-align:center" | |
|||
* Proceeds from the ''FHLB Loan'' were used to fund redemptions of draws on the 2023 Revolving Credit Facility <sup>p. 91</sup>. |
|||
! style="text-align:center" | |
|||
* During the fourth quarter of 2025, the Company entered into a ''Term Loan Credit Agreement'' (Term Loan Facility) with a syndicate of banks <sup>p. 91</sup>. |
|||
! style="text-align:center" | |
|||
* The ''Term Loan Facility'' includes an unsecured senior delayed draw term loan facility (DDTL) of USD 150.0m (Tranche A DDTL) <sup>p. 91</sup>. |
|||
! style="text-align:center" | 3 Months Ended |
|||
* The ''Term Loan Facility'' also includes an additional unsecured senior DDTL of USD 150.0m (Tranche B DDTL) <sup>p. 91</sup>. |
|||
! style="text-align:center" | 12 Months Ended |
|||
* The ''Term Loan Facility'' was used to fund a portion of the consideration for the Company's acquisition of Apollo Group Holdings Limited (Apollo) and related transaction fees and expenses <sup>p. 91</sup>. |
|||
! style="text-align:center" | |
|||
* Amounts drawn under the ''Term Loan Facility'' bear interest at either term SOFR plus a margin ranging from 150 bps to 190 bps, or the base rate plus a margin ranging from 50 bps to 90 bps, depending on the Company’s debt to capitalization ratio <sup>p. 91</sup>. |
|||
! style="text-align:center" | |
|||
* ''SOFR'' is calculated using a SOFR floor of 0.00% and a credit spread adjustment of 0.10% <sup>p. 91</sup>. |
|||
! style="text-align:center" | |
|||
* The ''base rate'' is the highest of (i) the Agent’s then-current prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) <sup>p. 91</sup>. |
|||
! style="text-align:center" | |
|||
* The Company pays a fee ranging from 0.20% to 0.35% on average daily undrawn amounts under the ''Term Loan Facility'', depending on the Company’s debt to capitalization ratio <sup>p. 91</sup>. |
|||
|- |
|||
* The ''Tranche A DDTL'' matures on January 1, 2028 <sup>p. 91</sup>. |
|||
! style="text-align:left" | — |
|||
* The ''Tranche B DDTL'' matures on July 2, 2029 <sup>p. 91</sup>. |
|||
! class="col-m" style="text-align:right" | Dec. 30, 2025 |
|||
* On December 30, 2025, the Company drew USD 150.0m from the ''Tranche A DDTL'' and USD 150.0m from the ''Tranche B DDTL'' for the acquisition of Apollo on January 1, 2026 <sup>p. 91</sup>. |
|||
! class="col-s" style="text-align:right" | Nov. 13, 2025 |
|||
* The ''Term Loan Facility'' includes customary covenants, such as limitations on additional indebtedness exceeding USD 10.0m and on distributions to stockholders, stock redemptions, repurchases, or retirements upon certain events <sup>p. 91</sup>. |
|||
! class="col-m" style="text-align:right" | Oct. 01, 2025 |
|||
* ''Financial covenants'' for the Term Loan Facility include minimum consolidated net worth, maximum total debt to capitalization, minimum A.M. Best rating, and minimum liquidity <sup>p. 91</sup>. |
|||
! class="col-m" style="text-align:right" | Aug. 30, 2024 |
|||
* As of December 31, 2025, the Company was in compliance with all ''Term Loan Facility covenants'' <sup>p. 91</sup>. |
|||
! colspan="2" style="text-align:center" | Dec. 31, 2025 |
|||
* The ''Term Loan Facility'' is unsecured <sup>p. 91</sup>. |
|||
! class="col-m" style="text-align:right" | Jan. 01, 2026 |
|||
* The Company's obligations under the ''Term Loan Facility'' are guaranteed by the Company and its existing wholly-owned subsidiaries, and subsequently acquired or organized subsidiaries, excluding insurance company subsidiaries and subject to certain exceptions <sup>p. 91</sup>. |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
* During the fourth quarter of 2025, the Company entered into a ''Revolving Credit Facility'' with a syndicate of banks <sup>p. 91</sup>. |
|||
! class="col-m" style="text-align:right" | Mar. 31, 2023 |
|||
* The ''Revolving Credit Facility'' is unsecured and initially provided a maximum principal amount of USD 150.0m <sup>p. 91</sup>. |
|||
! class="col-m" style="text-align:right" | May 31, 2019 |
|||
* The ''Revolving Credit Facility'' maximum principal amount was increased to USD 250.0m on the closing date of the Apollo acquisition <sup>p. 91</sup>. |
|||
|- |
|||
* The Company initially drew USD 43.0m from the ''Revolving Credit Facility'' to redeem its prior revolving credit facility <sup>p. 91</sup>. |
|||
| style="text-align:left" | Term Loan Credit Facility / Low / Secured Overnight Financing Rate (SOFR) |
|||
* On December 30, 2025, the Company drew an additional USD 71.5m from the ''Revolving Credit Facility'' for the consideration paid for the acquisition of Apollo <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* Proceeds from the ''Term Loan Facility'' and the ''Revolving Credit Facility'' draws are presented net with liabilities on the Consolidated Balance Sheets for the year ended December 31, 2025 <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* These proceeds were used for the ''Apollo acquisition'' on January 1, 2026 <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* Interest on the ''Revolving Credit Facility'' is payable quarterly <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* Amounts drawn under the ''Revolving Credit Facility'' bear interest at either term SOFR plus a margin ranging from 150 bps to 190 bps, or the base rate plus a margin ranging from 50 bps to 90 bps, depending on the Company’s debt to capitalization ratio <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* ''SOFR'' for the Revolving Credit Facility is calculated using a SOFR floor of 0.00% and a credit spread adjustment of 0.10% <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* The ''base rate'' for the Revolving Credit Facility is the highest of (i) the Agent’s then current prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* The Company pays a fee ranging from 0.20% to 0.35% on average daily undrawn amounts under the ''Revolving Credit Facility'', depending on the Company’s debt to capitalization ratio <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* The ''availability period'' under the Revolving Credit Facility terminates on November 12, 2030 <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* The Company is subject to ''covenants'' on the Revolving Credit Facility based on minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* As of December 31, 2025, the Company was in compliance with all ''Revolving Credit Facility covenants'' <sup>p. 91</sup>. |
|||
|- |
|||
* During the first quarter of 2023, the Company entered into an agreement for an unsecured ''2023 Revolving Credit Facility'' with a syndicate of banks <sup>p. 91</sup>. |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
* The ''2023 Revolving Credit Facility'' provided up to USD 150.0m in revolving credit and a letter of credit sub-facility of up to USD 30.0m <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* On November 13, 2025, the Company redeemed the ''2023 Revolving Credit Facility'' <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* The Company paid USD 0.3m of accrued interest and recognized USD 0.6m of expense for remaining unamortized deferred financing costs upon redemption of the ''2023 Revolving Credit Facility'' <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* In May 2019, the Company agreed to issue unsecured subordinated notes (the ''Notes'') with an aggregate principal amount of USD 20.0m <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* Interest on the ''Notes'' is fixed at 7.25% for the first 8 years and 8.25% thereafter <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* Early retirement of the ''Notes'' before the 8-year commitment requires all interest payments to be paid in full, plus the return of outstanding principal <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* ''Principal'' for the Notes is due at maturity on May 24, 2039, and interest is payable quarterly <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* The ''Notes'' have junior priority to all previously issued debt <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* The Company reports debt related to the ''Notes'' in its December 31, 2025 and 2024 Consolidated Balance Sheets, net of debt issuance costs of approximately USD 0.4m and USD 0.5m, respectively <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
* These ''deferred financing costs'' are presented as a direct deduction from the carrying amount of the subordinated debt <sup>p. 91</sup>. |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Margin |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1.50% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Term Loan Credit Facility / Low / Base Rate |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Margin |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.50% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Term Loan Credit Facility / High / Secured Overnight Financing Rate (SOFR) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Margin |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1.90% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Term Loan Credit Facility / High / Base Rate |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Margin |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.90% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Revolving Credit Facility / Low / Base Rate |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Margin |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.50% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Revolving Credit Facility / High / Base Rate |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Margin |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.90% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of Credit / Term Loan Credit Facility |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt instrument, variable rate |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.10% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt instrument, covenant, limitation on additional indebtedness maximum |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 10,000,000.0 |
|||
| style="text-align:right" | 10,000,000.0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of Credit / Term Loan Credit Facility / Secured Overnight Financing Rate (SOFR) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Margin |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1.00% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt instrument, interest rate floor |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.00% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of Credit / Term Loan Credit Facility / Base Rate |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Margin |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.00% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of Credit / Term Loan Credit Facility / Fed Funds Effective Rate Overnight Index Swap Rate |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Margin |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.50% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of Credit / Term Loan Credit Facility / Low |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of credit facility, commitment fee percentage |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.20% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of Credit / Term Loan Credit Facility / High |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of credit facility, commitment fee percentage |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.35% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of Credit / Revolving Credit Facility |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Face amount |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 150,000,000.0 |
|||
| style="text-align:right" | 150,000,000.0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Proceeds from long term borrowings |
|||
| style="text-align:right" | 71,500,000 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 43,000,000.0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of Credit / Revolving Credit Facility / Subsequent Event |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Face amount |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 250,000,000.0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of Credit / Revolving Credit Facility / Secured Overnight Financing Rate (SOFR) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Margin |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1.00% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt instrument, interest rate floor |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.00% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of Credit / Revolving Credit Facility / Base Rate |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Margin |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.00% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of Credit / Revolving Credit Facility / Fed Funds Effective Rate Overnight Index Swap Rate |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Margin |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.50% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of Credit / Revolving Credit Facility / Credit Spread Adjustment |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt instrument, variable rate |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.10% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of Credit / Revolving Credit Facility / Low |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of credit facility, unused capacity, commitment fee percentage |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.20% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of Credit / Revolving Credit Facility / High |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Line of credit facility, unused capacity, commitment fee percentage |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.35% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | FHLB Loan / Federal Home Loan Bank Advances |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt instrument, term |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 4 years 6 months |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Face amount |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 57,000,000.0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Stated interest rate |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 4.00% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tranche A DDTL / Unsecured Debt |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Face amount |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 150,000,000.0 |
|||
| style="text-align:right" | 150,000,000.0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Proceeds from Loans |
|||
| style="text-align:right" | 150,000,000.0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tranche B DDTL / Unsecured Debt |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Face amount |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 150,000,000.0 |
|||
| style="text-align:right" | 150,000,000.0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Proceeds from Loans |
|||
| style="text-align:right" | 150,000,000.0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Revolving Credit Facility / Line of Credit / Revolving Credit Facility / Low / Secured Overnight Financing Rate (SOFR) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Margin |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1.50% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Revolving Credit Facility / Line of Credit / Revolving Credit Facility / High / Secured Overnight Financing Rate (SOFR) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Margin |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1.90% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Revolving Line Of Credit Due December 2023 / Line of Credit / Revolving Credit Facility |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Maximum borrowing capacity |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 150,000,000.0 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Interest expense, long-term debt |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 300,000 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Revolving Line Of Credit Due December 2023 / Line of Credit / Letter of Credit |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Maximum borrowing capacity |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 30,000,000.0 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amortization of debt issuance costs |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 600,000 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Subordinate Debt Due 2039 / Subordinated debt, net of debt issuance costs |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Principal |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 20,000,000.0 |
|||
|- |
|||
| style="text-align:left" | Debt term |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 8 years |
|||
|- |
|||
| style="text-align:left" | Debt issuance costs |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 400,000 |
|||
| style="text-align:right" | 400,000 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 500,000 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Subordinate Debt Due 2039 / Subordinated debt, net of debt issuance costs / Debt Interest Rate, First 8 Years |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Stated interest rate |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 7.25% |
|||
|- |
|||
| style="text-align:left" | Debt term |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 8 years |
|||
|- |
|||
| style="text-align:left" | Subordinate Debt Due 2039 / Subordinated debt, net of debt issuance costs / Debt Interest Rate, After Year 8 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Debt Instrument [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Stated interest rate |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 8.25% |
|||
|} |
|||
</div> |
|||
{{Indexing|12. Segment|Reportable segment, commercial property and casualty products, non-admitted (E&S) basis, admitted basis, underwriting divisions, Chief Operating Decision Maker (CODM), gross written premiums, net underwriting income, income before income taxes, consolidated net income, annualized return on equity, growth in book value per share|1ut79wn2dy|kind=prose|order=156|f1=Number of segments|v1=one|f2=Segment basis|v2=commercial property and casualty products|f3=Segment profit measure|v3=gross written premiums by net underwriting division, underwriting income, and income before income taxes}} |
|||
== Segment == |
|||
* The Company operates with one reportable segment, offering commercial property and casualty products and solutions primarily in the United States on both non-admitted (E&S) and admitted bases <sup>p. 92</sup>. |
|||
=== Narrative === |
|||
* The segment consists of nine distinct underwriting divisions, referred to as "continuing business," each with dedicated underwriting leadership and technical staff <sup>p. 92</sup>. |
|||
* The segment definition is based on how internally reported financial information is reviewed by the Chief Operating Decision Maker (CODM) for performance analysis, decision-making, and resource allocation <sup>p. 92</sup>. |
|||
* The Company's CODM is the chief executive officer <sup>p. 92</sup>. |
|||
* The accounting policies for the segment align with those described in Note 1 "Summary of Significant Accounting Policies" of the Form 10-K <sup>p. 92</sup>. |
|||
* The CODM evaluates segment performance and allocates resources using gross written premiums by net underwriting division, underwriting income, and income before income taxes (which is also reported on the Consolidated Statements of Operations) <sup>p. 92</sup>. |
|||
* Segment assets are measured as total consolidated assets on the Consolidated Balance Sheets <sup>p. 92</sup>. |
|||
* ''Gross written premiums'' by underwriting division, ''net underwriting income'', and ''consolidated net income'' are used to monitor budget versus actual results <sup>p. 92</sup>. |
|||
* The CODM uses ''net underwriting income'', ''annualized return on equity'', and ''growth in book value per share'' for competitive analysis by benchmarking against competitors <sup>p. 92</sup>. |
|||
* This competitive analysis and the monitoring of budgeted versus actual results are used to assess segment performance and determine management's compensation <sup>p. 92</sup>. |
|||
{{Indexing|Segment information|Accident & Health, Agriculture and Credit (Re)insurance, Captives, Construction & Energy Solutions, Global Property, Professional Lines, Specialty Programs, Surety, Transactional E&S, Total continuing business, Exited business|1ut79wn2dy|kind=table|order=157}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | |
|||
! style="text-align:center" | 12 Months Ended |
|||
|- |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 segment division |
|||
|- |
|||
| style="text-align:left" | Segment Reporting [Abstract] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Number of reportable segments / segment |
|||
| style="text-align:right" | 1 |
|||
|- |
|||
| style="text-align:left" | Number of underwriting divisions / division |
|||
| style="text-align:right" | 9 |
|||
|} |
|||
</div> |
|||
=== Schedule of Premiums Written === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
|||
! class="col-s" style="text-align:right" | 2023 |
|||
|- |
|- |
||
| style="text-align:left" | Accident & Health |
|||
| style="text-align:right" | 254,102 |
|||
| style="text-align:right" | 173,073 |
|||
| style="text-align:right" | 151,701 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Agriculture and Credit (Re)insurance |
||
| style="text-align:right" | |
| style="text-align:right" | 346,212 |
||
| style="text-align:right" | |
| style="text-align:right" | 118,070 |
||
| style="text-align:right" | |
| style="text-align:right" | 30,598 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | Captives |
||
| style="text-align:right |
| style="text-align:right" | 275,694 |
||
| style="text-align:right |
| style="text-align:right" | 241,902 |
||
| style="text-align:right |
| style="text-align:right" | 167,624 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Construction & Energy Solutions |
||
| style="text-align:right" | |
| style="text-align:right" | 274,318 |
||
| style="text-align:right" | |
| style="text-align:right" | 296,582 |
||
| style="text-align:right" | |
| style="text-align:right" | 299,748 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Global Property |
||
| style="text-align:right" | |
| style="text-align:right" | 178,128 |
||
| style="text-align:right" | |
| style="text-align:right" | 201,796 |
||
| style="text-align:right" | |
| style="text-align:right" | 242,593 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | Professional Lines |
||
| style="text-align:right |
| style="text-align:right" | 149,231 |
||
| style="text-align:right |
| style="text-align:right" | 159,785 |
||
| style="text-align:right |
| style="text-align:right" | 154,565 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Specialty Programs |
||
| style="text-align:right" | |
| style="text-align:right" | 322,705 |
||
| style="text-align:right" | |
| style="text-align:right" | 218,407 |
||
| style="text-align:right" | |
| style="text-align:right" | 178,726 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Surety |
||
| style="text-align:right" | |
| style="text-align:right" | 168,148 |
||
| style="text-align:right" | |
| style="text-align:right" | 143,965 |
||
| style="text-align:right" | |
| style="text-align:right" | 106,056 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | Transactional E&S |
||
| style="text-align:right |
| style="text-align:right" | 197,779 |
||
| style="text-align:right |
| style="text-align:right" | 189,669 |
||
| style="text-align:right |
| style="text-align:right" | 128,236 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total continuing business''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''2,166,317''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,743,249''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,459,847''' |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Exited business''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 81 )''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 17 )''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 18 )''' |
||
|- |
|||
| style="text-align:left; font-weight:bold" | Total gross written premiums |
|||
| style="text-align:right; font-weight:bold" | 254,102 |
|||
| style="text-align:right; font-weight:bold" | 173,073 |
|||
| style="text-align:right; font-weight:bold" | 151,701 |
|||
|- |
|||
| style="text-align:left" | Agriculture and Credit (Re)insurance / Operating Segments |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Effects of Reinsurance [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total gross written premiums |
|||
| style="text-align:right; font-weight:bold" | 346,212 |
|||
| style="text-align:right; font-weight:bold" | 118,070 |
|||
| style="text-align:right; font-weight:bold" | 30,598 |
|||
|- |
|||
| style="text-align:left" | Captives / Operating Segments |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Effects of Reinsurance [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total gross written premiums |
|||
| style="text-align:right; font-weight:bold" | 275,694 |
|||
| style="text-align:right; font-weight:bold" | 241,902 |
|||
| style="text-align:right; font-weight:bold" | 167,624 |
|||
|- |
|||
| style="text-align:left" | Construction & Energy Solutions / Operating Segments |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Effects of Reinsurance [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total gross written premiums |
|||
| style="text-align:right; font-weight:bold" | 274,318 |
|||
| style="text-align:right; font-weight:bold" | 296,582 |
|||
| style="text-align:right; font-weight:bold" | 299,748 |
|||
|- |
|||
| style="text-align:left" | Global Property / Operating Segments |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Effects of Reinsurance [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total gross written premiums |
|||
| style="text-align:right; font-weight:bold" | 178,128 |
|||
| style="text-align:right; font-weight:bold" | 201,796 |
|||
| style="text-align:right; font-weight:bold" | 242,593 |
|||
|- |
|||
| style="text-align:left" | Professional Lines / Operating Segments |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Effects of Reinsurance [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total gross written premiums |
|||
| style="text-align:right; font-weight:bold" | 149,231 |
|||
| style="text-align:right; font-weight:bold" | 159,785 |
|||
| style="text-align:right; font-weight:bold" | 154,565 |
|||
|- |
|||
| style="text-align:left" | Specialty Programs / Operating Segments |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Effects of Reinsurance [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total gross written premiums |
|||
| style="text-align:right; font-weight:bold" | 322,705 |
|||
| style="text-align:right; font-weight:bold" | 218,407 |
|||
| style="text-align:right; font-weight:bold" | 178,726 |
|||
|- |
|||
| style="text-align:left" | Surety / Operating Segments |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Effects of Reinsurance [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total gross written premiums |
|||
| style="text-align:right; font-weight:bold" | 168,148 |
|||
| style="text-align:right; font-weight:bold" | 143,965 |
|||
| style="text-align:right; font-weight:bold" | 106,056 |
|||
|- |
|||
| style="text-align:left" | Transactional E&S / Operating Segments |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Effects of Reinsurance [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total gross written premiums''' |
||
| style="text-align:right |
| style="text-align:right" | '''2,166,236''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,743,232''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,459,829''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Underwriting income|Underwriting income, net earned premiums, commission and fee income, total underwriting revenues, losses and LAE, amortization of policy acquisition costs, other operating and general expenses, total underwriting expenses, net underwriting income|cos78e4bvi|kind=table|order=158}} |
|||
=== Schedule of Segment Reporting === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | 2025 |
||
! style="text-align:center" | 2024 |
|||
! style="text-align:center" | 2023 |
|||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | Underwriting income |
||
! |
! style="text-align:center" | |
||
! |
! style="text-align:center" | |
||
! |
! style="text-align:center" | |
||
|- |
|- |
||
! style="text-align:left" | Revenues: |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Net earned premiums |
| style="text-align:left" | Net earned premiums |
||
| Line 8,990: | Line 6,013: | ||
| style="text-align:right" | 6,064 |
| style="text-align:right" | 6,064 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total underwriting revenues''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,311,360''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,063,425''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''835,207''' |
||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | 83,619 |
|||
| style="text-align:right" | 80,600 |
|||
| style="text-align:right" | 40,340 |
|||
|- |
|||
| style="text-align:left" | Net investment gains |
|||
| style="text-align:right" | 22,149 |
|||
| style="text-align:right" | 6,342 |
|||
| style="text-align:right" | 11,054 |
|||
|- |
|||
| style="text-align:left" | Other loss |
|||
| style="text-align:right" | -587 |
|||
| style="text-align:right" | -167 |
|||
| style="text-align:right" | -632 |
|||
|- |
|||
| style="text-align:left" | Transaction costs |
|||
| style="text-align:right" | 14,019 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Interest expense |
|||
| style="text-align:right" | 7,919 |
|||
| style="text-align:right" | 9,496 |
|||
| style="text-align:right" | 10,024 |
|||
|- |
|||
| style="text-align:left" | Amortization expense |
|||
| style="text-align:right" | 1,636 |
|||
| style="text-align:right" | 2,007 |
|||
| style="text-align:right" | 1,798 |
|||
|- |
|||
| style="text-align:left" | Other expenses |
|||
| style="text-align:right" | 4,162 |
|||
| style="text-align:right" | 4,392 |
|||
| style="text-align:right" | 5,364 |
|||
|- |
|||
| style="text-align:left" | Income before income taxes |
|||
| style="text-align:right" | 216,424 |
|||
| style="text-align:right" | 152,739 |
|||
| style="text-align:right" | 110,102 |
|||
|- |
|||
| style="text-align:left" | Income tax expense |
|||
| style="text-align:right" | 46,396 |
|||
| style="text-align:right" | 33,911 |
|||
| style="text-align:right" | 24,118 |
|||
|- |
|||
| style="text-align:left" | Net income |
|||
| style="text-align:right" | 170,028 |
|||
| style="text-align:right" | 118,828 |
|||
| style="text-align:right" | 85,984 |
|||
|- |
|||
| style="text-align:left" | Reportable Segment |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Segment Reporting Information [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net earned premiums |
|||
| style="text-align:right" | 1,304,505 |
|||
| style="text-align:right" | 1,056,722 |
|||
| style="text-align:right" | 829,143 |
|||
|- |
|||
| style="text-align:left" | Commission and fee income |
|||
| style="text-align:right" | 6,855 |
|||
| style="text-align:right" | 6,703 |
|||
| style="text-align:right" | 6,064 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total underwriting revenues |
|||
| style="text-align:right; font-weight:bold" | 1,311,360 |
|||
| style="text-align:right; font-weight:bold" | 1,063,425 |
|||
| style="text-align:right; font-weight:bold" | 835,207 |
|||
|- |
|- |
||
| style="text-align:left" | Losses and LAE |
| style="text-align:left" | Losses and LAE |
||
| Line 9,085: | Line 6,033: | ||
| style="text-align:right" | 134,930 |
| style="text-align:right" | 134,930 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total underwriting expenses''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,172,381''' |
||
| style="text-align:right |
| style="text-align:right" | '''981,566''' |
||
| style="text-align:right |
| style="text-align:right" | '''758,681''' |
||
|- |
|- |
||
| style="text-align:left" | Net underwriting income |
| style="text-align:left" | '''Net underwriting income''' |
||
| style="text-align:right" | 138,979 |
| style="text-align:right" | '''138,979''' |
||
| style="text-align:right" | 81,859 |
| style="text-align:right" | '''81,859''' |
||
| style="text-align:right" | 76,526 |
| style="text-align:right" | '''76,526''' |
||
|- |
|||
| style="text-align:left" | Reconciliation of net underwriting income to net income: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | '''Net underwriting income''' |
|||
| style="text-align:right" | '''138,979''' |
|||
| style="text-align:right" | '''81,859''' |
|||
| style="text-align:right" | '''76,526''' |
|||
|- |
|||
| style="text-align:left" | '''Add:''' |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | Net investment income |
||
| Line 9,106: | Line 6,069: | ||
|- |
|- |
||
| style="text-align:left" | Other loss |
| style="text-align:left" | Other loss |
||
| style="text-align:right" | |
| style="text-align:right" | ( 587 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 167 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 632 ) |
||
|- |
|- |
||
| style="text-align:left" | Transaction costs |
| style="text-align:left" | Transaction costs |
||
| style="text-align:right" | 14,019 |
| style="text-align:right" | 14,019 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Interest expense |
| style="text-align:left" | Interest expense |
||
| Line 9,130: | Line 6,093: | ||
| style="text-align:right" | 5,364 |
| style="text-align:right" | 5,364 |
||
|- |
|- |
||
| style="text-align:left" | Income before income taxes |
| style="text-align:left" | '''Income before income taxes''' |
||
| style="text-align:right" | 216,424 |
| style="text-align:right" | '''216,424''' |
||
| style="text-align:right" | 152,739 |
| style="text-align:right" | '''152,739''' |
||
| style="text-align:right" | 110,102 |
| style="text-align:right" | '''110,102''' |
||
|- |
|- |
||
| style="text-align:left" | Income tax expense |
| style="text-align:left" | '''Income tax expense''' |
||
| style="text-align:right" | 46,396 |
| style="text-align:right" | '''46,396''' |
||
| style="text-align:right" | 33,911 |
| style="text-align:right" | '''33,911''' |
||
| style="text-align:right" | 24,118 |
| style="text-align:right" | '''24,118''' |
||
|- |
|- |
||
| style="text-align:left" | Net income |
| style="text-align:left" | '''Net income''' |
||
| style="text-align:right" | 170,028 |
| style="text-align:right" | '''170,028''' |
||
| style="text-align:right" | 118,828 |
| style="text-align:right" | '''118,828''' |
||
| style="text-align:right" | 85,984 |
| style="text-align:right" | '''85,984''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Return on equity and book value per share|Return on equity, book value per share|v7ij6av24f|0lk0pqg9zh|kind=table|order=159}} |
|||
=== Schedule of Return on Equity and Book Value Per Share === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | $ / shares |
|||
! colspan="3" style="text-align:center" | 12 Months Ended |
|||
|- |
|||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2024 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2023 |
||
|- |
|||
| style="text-align:left" | Segment Reporting [Abstract] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Return on equity |
| style="text-align:left" | Return on equity |
||
| style="text-align:right" | 18. |
| style="text-align:right" | 18.9% |
||
| style="text-align:right" | 16. |
| style="text-align:right" | 16.3% |
||
| style="text-align:right" | 15. |
| style="text-align:right" | 15.9% |
||
|- |
|- |
||
| style="text-align:left" | Book value per share |
| style="text-align:left" | Book value per share |
||
| style="text-align:right" | 24.92 |
| style="text-align:right" | 24.92 |
||
| style="text-align:right" | 19.79 |
| style="text-align:right" | 19.79 |
||
| Line 9,176: | Line 6,131: | ||
</div> |
</div> |
||
{{Indexing|13. Income Taxes|Federal income taxes, federal net operating loss carryforwards, net operating losses, Internal Revenue Code Section 382, 382 limitation, valuation allowance, federal NOL, dual consolidated loss, state and local net operating losses, federal income tax returns, uncertain tax positions, uncertain tax benefits|kmocop7wiu|kind=prose|order=160|f1=Federal income taxes paid|v1=2024: USD 37.0m|f2=Federal net operating loss carryforwards|v2=USD 40.3m|f3=NOL expiration|v3=beginning in 2032|f4=382 limitation expiration|v4=USD 2.8m|f5=State and local net operating losses|v5=USD 0.9m|f6=Federal income tax returns subject to examination|v6=2022-2024}} |
|||
== Income Taxes == |
|||
* The Company paid ''federal income taxes'' of USD 37.0m in 2024 and USD 15.8m in 2023 <sup>p. 93</sup>. |
|||
=== Schedule of Income Tax Expense === |
|||
* The Company has ''federal net operating loss carryforwards'' of approximately USD 40.3m <sup>p. 93</sup>. |
|||
* These ''net operating losses'' are set to expire beginning in 2032 <sup>p. 93</sup>. |
|||
* ''Internal Revenue Code Section 382'' limits the utilization of USD 40.3m of net operating losses due to an ownership change in 2014 <sup>p. 93</sup>. |
|||
* The ''382 limitation'' is expected to result in an expiration of USD 2.8m (USD 0.6m tax effected) of net operating losses <sup>p. 93</sup>. |
|||
* A ''valuation allowance'' was established in 2025 against the balance expected to expire without utilization <sup>p. 93</sup>. |
|||
* Of the total ''federal NOL'' of USD 40.3m, USD 0.3m (USD 0.1m tax effected) is related to dual consolidated loss that Skyward is not expected to utilize <sup>p. 93</sup>. |
|||
* The Company also has ''net operating losses'' in various state and local jurisdictions totaling USD 0.9m <sup>p. 93</sup>. |
|||
* These ''state and local net operating losses'' are set to expire between 5 and 20 years or carryforward indefinitely, depending on the jurisdiction <sup>p. 93</sup>. |
|||
* The Company expects to ''fully utilize'' these state and local net operating losses <sup>p. 93</sup>. |
|||
* The Company’s ''federal income tax returns'' for tax years 2022-2024 are subject to examination by the Internal Revenue Service <sup>p. 93</sup>. |
|||
* As of December 31, 2025, the Company had ''no provision for uncertain tax positions'' and no provision for penalties or interest <sup>p. 93</sup>. |
|||
* Management does not believe there are any ''uncertain tax benefits'' that could be recognized within the next twelve months that would impact the Company’s effective tax rate <sup>p. 93</sup>. |
|||
{{Indexing|Income tax expense from continuing operations|Income from continuing operations before income tax expense, current tax expense, deferred tax benefit, total income tax expense|kmocop7wiu|kind=table|order=161}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | 2025 |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | Income from continuing operations before income tax expense |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Income from continuing operations before income tax expense |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | United States |
| style="text-align:left" | United States |
||
| style="text-align:right" | 208,763 |
| style="text-align:right" | 208,763 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Foreign |
| style="text-align:left" | Foreign |
||
| style="text-align:right" | 7,661 |
| style="text-align:right" | 7,661 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| class="wt-indent-1" style="text-align:left" | '''Total''' |
||
| style="text-align:right" | 216,424 |
| style="text-align:right" | '''216,424''' |
||
| style="text-align:right" | 152,739 |
|||
| style="text-align:right" | 110,102 |
|||
|- |
|- |
||
| style="text-align:left" | Current tax expense |
| style="text-align:left" | Current tax expense |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | United States |
| style="text-align:left" | United States |
||
| style="text-align:right" | 51,758 |
| style="text-align:right" | 51,758 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | U.S. state and local |
| style="text-align:left" | U.S. state and local |
||
| style="text-align:right" | 1,107 |
| style="text-align:right" | 1,107 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Deferred tax benefit related to: |
| style="text-align:left" | Deferred tax benefit related to: |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | United States |
| style="text-align:left" | United States |
||
| style="text-align:right" | |
| style="text-align:right" | ( 5,584 ) |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | U.S. state and local |
| style="text-align:left" | U.S. state and local |
||
| style="text-align:right" | |
| style="text-align:right" | ( 885 ) |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total income tax expense''' |
||
| style="text-align:right |
| style="text-align:right" | '''46,396''' |
||
| style="text-align:right; font-weight:bold" | 33,911 |
|||
| style="text-align:right; font-weight:bold" | 24,118 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Income tax expense|Current income tax expense, deferred tax (benefit) expense, total income tax expense|kmocop7wiu|kind=table|order=162}} |
|||
=== Schedule of Components of Income Tax Expense (Benefit) === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | 2024 |
||
! class="col-s" style="text-align:right" | 2023 |
|||
|- |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Income Tax Disclosure [Abstract] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Current income tax expense |
| style="text-align:left" | Current income tax expense |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 42,626 |
| style="text-align:right" | 42,626 |
||
| style="text-align:right" | 14,736 |
| style="text-align:right" | 14,736 |
||
|- |
|- |
||
| style="text-align:left" | Deferred tax (benefit) expense related to temporary differences |
| style="text-align:left" | Deferred tax (benefit) expense related to temporary differences |
||
| style="text-align:right" | |
| style="text-align:right" | ( 8,715 ) |
||
| style="text-align:right" | -8,715 |
|||
| style="text-align:right" | 9,382 |
| style="text-align:right" | 9,382 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total income tax expense''' |
||
| style="text-align:right |
| style="text-align:right" | '''33,911''' |
||
| style="text-align:right |
| style="text-align:right" | '''24,118''' |
||
| style="text-align:right; font-weight:bold" | 24,118 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|U.S. federal statutory income tax rate reconciliation|U.S. federal statutory income tax rate, state income taxes, foreign tax effects, Bermuda statutory rate differential, effects of other cross-border tax laws, change of Valuation Allowance, nondeductible and nontaxable items, nondeductible transaction costs, other nondeductible and nontaxable items, effective tax rate|kmocop7wiu|kind=table|order=163}} |
|||
=== Schedule of Annual Effective Tax Rate === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan=" |
! colspan="2" style="text-align:center" | 2025 |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Amount |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Percentage |
||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Amount |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | U.S. federal statutory income tax rate |
| style="text-align:left" | U.S. federal statutory income tax rate |
||
| style="text-align:right" | 45,449 |
| style="text-align:right" | 45,449 |
||
| style="text-align:right" | |
| style="text-align:right" | 21.0% |
||
|- |
|||
| style="text-align:right" | 23,121 |
|||
| style="text-align:left" | State income taxes, net of federal benefit (1) |
|||
| style="text-align:right" | ( 508 ) |
|||
| style="text-align:right" | ( 0.3 )% |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Foreign tax effects |
||
| style="text-align:right" | -508 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Bermuda statutory rate differential |
|||
| style="text-align:right" | ( 1,609 ) |
|||
| style="text-align:right" | ( 0.7 )% |
|||
|- |
|- |
||
| style="text-align:left" | Effects of other cross-border tax laws |
| style="text-align:left" | Effects of other cross-border tax laws |
||
| style="text-align:right" | 717 |
| style="text-align:right" | 717 |
||
| style="text-align:right" | |
| style="text-align:right" | 0.3% |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Change of Valuation Allowance |
| style="text-align:left" | Change of Valuation Allowance |
||
| style="text-align:right" | 68 |
| style="text-align:right" | 68 |
||
| style="text-align:right" | —% |
|||
|- |
|||
| style="text-align:left" | Nondeductible and Nontaxable items |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 9,320: | Line 6,252: | ||
| style="text-align:left" | Nondeductible transaction costs |
| style="text-align:left" | Nondeductible transaction costs |
||
| style="text-align:right" | 1,689 |
| style="text-align:right" | 1,689 |
||
| style="text-align:right" | |
| style="text-align:right" | 0.8% |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other nondeductible and nontaxable items |
| style="text-align:left" | Other nondeductible and nontaxable items |
||
| style="text-align:right" | 590 |
| style="text-align:right" | 590 |
||
| style="text-align:right" | |
| style="text-align:right" | 0.3% |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Effective tax rate''' |
||
| style="text-align:right |
| style="text-align:right" | '''46,396''' |
||
| style="text-align:right |
| style="text-align:right" | '''21.4%''' |
||
| style="text-align:right; font-weight:bold" | 24,118 |
|||
|- |
|||
| style="text-align:left" | Percentage |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | U.S. federal statutory income tax rate |
|||
| style="text-align:right" | 21.00% |
|||
| style="text-align:right" | 21.00% |
|||
| style="text-align:right" | 21.00% |
|||
|- |
|||
| style="text-align:left" | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent |
|||
| style="text-align:right" | (0.30%) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Effects of other cross-border tax laws |
|||
| style="text-align:right" | 0.30% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Change of Valuation Allowance |
|||
| style="text-align:right" | 0.00% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Nondeductible transaction costs |
|||
| style="text-align:right" | 0.80% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Other |
|||
| style="text-align:right" | 0.30% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total income tax expense |
|||
| style="text-align:right; font-weight:bold" | 21.40% |
|||
| style="text-align:right; font-weight:bold" | 22.20% |
|||
| style="text-align:right; font-weight:bold" | 21.90% |
|||
|- |
|||
| style="text-align:left" | Bermuda |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Amount |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Bermuda statutory rate differential |
|||
| style="text-align:right" | -1,609 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Percentage |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Statutory tax rate difference |
|||
| style="text-align:right" | (0.70%) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
(1) The following state(s) and/or local jurisdictions make up more than 50% of the state income taxes: Florida. |
|||
=== Schedule of Effective Income Tax Rate Reconciliation === |
|||
{{Indexing|Income tax expense at federal statutory rate|Income tax expense at federal statutory rate, tax advantaged investments, other, total income tax expense|kmocop7wiu|kind=table|order=164}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan=" |
! colspan="2" style="text-align:center" | 2024 |
||
! colspan="2" style="text-align:center" | 2023 |
|||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Amount |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Percentage |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Amount |
||
! class="col-s" style="text-align:right" | Percentage |
|||
|- |
|||
| style="text-align:left" | Amount |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Income tax expense at federal statutory rate |
| style="text-align:left" | Income tax expense at federal statutory rate |
||
| style="text-align:right" | 45,449 |
|||
| style="text-align:right" | 32,075 |
| style="text-align:right" | 32,075 |
||
| style="text-align:right" | 21.0% |
|||
| style="text-align:right" | 23,121 |
| style="text-align:right" | 23,121 |
||
| style="text-align:right" | 21.0% |
|||
|- |
|- |
||
| style="text-align:left" | Tax advantaged investments |
| style="text-align:left" | Tax advantaged investments |
||
| style="text-align:right" | |
| style="text-align:right" | ( 239 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 0.2 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 295 ) |
||
| style="text-align:right" | ( 0.3 ) |
|||
|- |
|- |
||
| style="text-align:left" | Other |
| style="text-align:left" | Other |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 2,075 |
| style="text-align:right" | 2,075 |
||
| style="text-align:right" | 1.4 |
|||
| style="text-align:right" | 1,292 |
| style="text-align:right" | 1,292 |
||
| style="text-align:right" | 1.2 |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total income tax expense''' |
||
| style="text-align:right |
| style="text-align:right" | '''33,911''' |
||
| style="text-align:right |
| style="text-align:right" | '''22.2%''' |
||
| style="text-align:right |
| style="text-align:right" | '''24,118''' |
||
| style="text-align:right" | '''21.9%''' |
|||
|- |
|||
| style="text-align:left" | Percentage |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Income tax expense at federal statutory rate |
|||
| style="text-align:right" | 21.00% |
|||
| style="text-align:right" | 21.00% |
|||
| style="text-align:right" | 21.00% |
|||
|- |
|||
| style="text-align:left" | Tax advantaged investments |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | (0.20%) |
|||
| style="text-align:right" | (0.30%) |
|||
|- |
|||
| style="text-align:left" | Other |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1.40% |
|||
| style="text-align:right" | 1.20% |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total income tax expense |
|||
| style="text-align:right; font-weight:bold" | 21.40% |
|||
| style="text-align:right; font-weight:bold" | 22.20% |
|||
| style="text-align:right; font-weight:bold" | 21.90% |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Total income taxes paid|Total income taxes paid, United States, U.S. state and local|kmocop7wiu|kind=table|order=165}} |
|||
=== Schedule of Income Taxes Paid Net of Refunds Received === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | 2025 |
||
|- |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Income Tax Disclosure [Abstract] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | United States |
| style="text-align:left" | United States |
||
| style="text-align:right" | 49,830 |
| style="text-align:right" | 49,830 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | U.S. state and local |
| style="text-align:left" | U.S. state and local (1) |
||
| style="text-align:right" | 1,164 |
| style="text-align:right" | 1,164 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total income taxes paid''' |
||
| style="text-align:right" | 50,994 |
| style="text-align:right" | '''50,994''' |
||
| style="text-align:right" | 37,000 |
|||
| style="text-align:right" | 15,800 |
|||
|} |
|} |
||
</div> |
</div> |
||
(1) No single state or jurisdiction accounts for greater than 5% of total taxes paid. |
|||
=== Narrative === |
|||
{{Indexing|Deferred tax assets|Deferred tax assets, net operating losses, losses and loss adjustment expenses, unearned premiums, unrealized losses on fixed maturity securities, available-for-sale, stock options/awards, other, total deferred tax assets before valuation allowance, valuation allowance, total deferred tax assets, deferred policy acquisition costs, other long-term investments, Section 481(a) adjustment, unrealized gains on equity securities|kmocop7wiu|kind=table|order=166}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | USD ($) |
|||
! colspan="3" style="text-align:center" | 12 Months Ended |
|||
|- |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-m" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Effective Income Tax Rate Reconciliation [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Income taxes paid, net |
|||
| style="text-align:right" | 50,994,000 |
|||
| style="text-align:right" | 37,000,000.0 |
|||
| style="text-align:right" | 15,800,000 |
|||
|- |
|||
| style="text-align:left" | Operating loss carryforwards |
|||
| style="text-align:right" | 300,000 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Operating loss carryforwards, limitations on use, amount |
|||
| style="text-align:right" | 40,300,000 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Deferred tax subject to expiration |
|||
| style="text-align:right" | 2,800,000 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Deferred tax effected by expiration |
|||
| style="text-align:right" | 600,000 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Operating loss carryforwards, tax effected |
|||
| style="text-align:right" | 100,000 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Provision for uncertain tax positions |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Provision for penalties or interest |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Low |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Effective Income Tax Rate Reconciliation [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Operating loss carryforward, term |
|||
| style="text-align:right" | 5 years |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | High |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Effective Income Tax Rate Reconciliation [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Operating loss carryforward, term |
|||
| style="text-align:right" | 20 years |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Federal |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Effective Income Tax Rate Reconciliation [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Operating loss carryforwards |
|||
| style="text-align:right" | 40,300,000 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | State and local |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Effective Income Tax Rate Reconciliation [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Operating loss carryforwards |
|||
| style="text-align:right" | 900,000 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|||
</div> |
|||
=== Schedule of Deferred Tax Assets and Liabilities === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | 2025 |
||
! |
! style="text-align:center" | 2024 |
||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|- |
||
! style="text-align:left" | Deferred tax assets: |
|||
! class="col-s" style="text-align:right" | — |
|||
! class="col-s" style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Net operating losses |
| style="text-align:left" | Net operating losses |
||
| style="text-align:right" | 9,409 |
| style="text-align:right" | 9,409 |
||
| style="text-align:right" | 9,389 |
| style="text-align:right" | 9,389 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Losses and loss adjustment expenses |
| style="text-align:left" | Losses and loss adjustment expenses |
||
| style="text-align:right" | 21,401 |
| style="text-align:right" | 21,401 |
||
| style="text-align:right" | 16,967 |
| style="text-align:right" | 16,967 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Unearned premiums |
| style="text-align:left" | Unearned premiums |
||
| style="text-align:right" | 22,775 |
| style="text-align:right" | 22,775 |
||
| style="text-align:right" | 18,178 |
| style="text-align:right" | 18,178 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Unrealized losses on fixed maturity securities, available-for-sale |
| style="text-align:left" | Unrealized losses on fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 5,893 |
| style="text-align:right" | 5,893 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Stock options/awards |
| style="text-align:left" | Stock options/awards |
||
| style="text-align:right" | 2,446 |
| style="text-align:right" | 2,446 |
||
| style="text-align:right" | 2,453 |
| style="text-align:right" | 2,453 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other |
| style="text-align:left" | Other |
||
| style="text-align:right" | 8,933 |
| style="text-align:right" | 8,933 |
||
| style="text-align:right" | 6,067 |
| style="text-align:right" | 6,067 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total deferred tax assets before valuation allowance''' |
||
| style="text-align:right |
| style="text-align:right" | '''64,964''' |
||
| style="text-align:right |
| style="text-align:right" | '''58,947''' |
||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|- |
||
| style="text-align:left" | Valuation allowance |
| style="text-align:left" | Valuation allowance |
||
| style="text-align:right" | |
| style="text-align:right" | ( 654 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 586 ) |
||
| style="text-align:right" | -586 |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total deferred tax assets''' |
||
| style="text-align:right |
| style="text-align:right" | '''64,310''' |
||
| style="text-align:right |
| style="text-align:right" | '''58,361''' |
||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left" | Deferred tax liabilities: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Deferred policy acquisition costs |
| style="text-align:left" | Deferred policy acquisition costs |
||
| style="text-align:right" | 19,132 |
| style="text-align:right" | 19,132 |
||
| style="text-align:right" | 15,277 |
| style="text-align:right" | 15,277 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other long-term investments |
| style="text-align:left" | Other long-term investments |
||
| style="text-align:right" | 2,888 |
| style="text-align:right" | 2,888 |
||
| style="text-align:right" | 2,625 |
| style="text-align:right" | 2,625 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Section 481(a) adjustment |
| style="text-align:left" | Section 481(a) adjustment |
||
| style="text-align:right" | 87 |
| style="text-align:right" | 87 |
||
| style="text-align:right" | 1,391 |
| style="text-align:right" | 1,391 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Unrealized gains on equity securities |
| style="text-align:left" | Unrealized gains on equity securities |
||
| style="text-align:right" | 7 |
| style="text-align:right" | 7 |
||
| style="text-align:right" | 4,818 |
| style="text-align:right" | 4,818 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Unrealized gains on fixed maturity securities, available-for-sale |
| style="text-align:left" | Unrealized gains on fixed maturity securities, available-for-sale |
||
| style="text-align:right" | 3,101 |
| style="text-align:right" | 3,101 |
||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Unrealized gains on other investments |
| style="text-align:left" | Unrealized gains on other investments |
||
| style="text-align:right" | 5,465 |
| style="text-align:right" | 5,465 |
||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| Line 9,714: | Line 6,401: | ||
| style="text-align:right" | 2,152 |
| style="text-align:right" | 2,152 |
||
| style="text-align:right" | 1,426 |
| style="text-align:right" | 1,426 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other |
| style="text-align:left" | Other |
||
| style="text-align:right" | 3,613 |
| style="text-align:right" | 3,613 |
||
| style="text-align:right" | 2,338 |
| style="text-align:right" | 2,338 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total deferred tax liabilities''' |
||
| style="text-align:right |
| style="text-align:right" | '''36,445''' |
||
| style="text-align:right |
| style="text-align:right" | '''27,875''' |
||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|- |
||
| style="text-align:left" | Net deferred tax asset |
| style="text-align:left" | '''Net deferred tax asset''' |
||
| style="text-align:right" | 27,865 |
| style="text-align:right" | '''27,865''' |
||
| style="text-align:right" | 30,486 |
| style="text-align:right" | '''30,486''' |
||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Valuation allowance activity|Valuation allowance activity, balance at beginning of the period, increase related to net operating loss, balance at the end of the period|kmocop7wiu|kind=table|order=167}} |
|||
=== Schedule of Company's Valuation Allowance === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
|||
|- |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
|- |
|||
| style="text-align:left" | Deferred Tax Assets, Valuation Allowance [Roll Forward] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Balance at beginning of the period |
| style="text-align:left" | Balance at beginning of the period |
||
| Line 9,752: | Line 6,428: | ||
| style="text-align:right" | 586 |
| style="text-align:right" | 586 |
||
|- |
|- |
||
| style="text-align:left" | Increase related to net operating loss |
| class="wt-indent-1" style="text-align:left" | Increase related to net operating loss |
||
| style="text-align:right" | 68 |
| style="text-align:right" | 68 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Balance at the end of the period |
| style="text-align:left" | '''Balance at the end of the period''' |
||
| style="text-align:right" | 654 |
| style="text-align:right" | '''654''' |
||
| style="text-align:right" | 586 |
| style="text-align:right" | '''586''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Tax Legislative Update|One Big Beautiful Bill Act (OBBB Act), tax reform provisions, annual effective tax rate|1nma8v7gjs|kind=prose|order=168|f1=OBBB Act signed into law|v1=July 4, 2025}} |
|||
== Reserves for Losses and Loss Adjustment Expenses == |
|||
* The One Big Beautiful Bill Act ("OBBB Act"), which includes a broad range of tax reform provisions, was signed into law in the United States on July 4, 2025 <sup>p. 94</sup>. |
|||
* The OBBB Act did not have a material impact on the Company's annual effective tax rate in 2025 <sup>p. 94</sup>. |
|||
* No material impact from the OBBB Act is expected in 2026 <sup>p. 94</sup>. |
|||
{{Indexing|14. Reserves for Losses and Loss Adjustment Expenses|Net ultimate loss and LAE, multi-line solutions, short-tail/monoline specialty lines, exited lines, prior-year reserve movements|rhstabgyn2|do9an7x5kp|j2mg590krh|kind=prose|order=169|f1=Favorable development prior years|v1=FY25: USD 7.5m|f2=Favorable development short-tail/monoline specialty lines|v2=FY25: USD 24.6m|f3=Favorable development multi-line solutions|v3=FY25: USD 5.3m}} |
|||
* The Company evaluates net ultimate loss and LAE under three sub-categories: multi-line solutions, short-tail/monoline specialty lines, and exited lines <sup>p. 95</sup>. |
|||
=== Schedule of Liability for Unpaid Claims and Claims Adjustment Expense === |
|||
* These disaggregated groupings have homogeneous risk characteristics, similar development patterns, and are subject to similar trends <sup>p. 95</sup>. |
|||
* ''Short-tail/monoline specialty lines'' include global property & agriculture, accident & health, surety, and professional lines underwriting divisions <sup>p. 95</sup>. |
|||
* These lines generally have shorter durations for losses to fully develop, with claims typically reported, settled, and paid within a relatively short timeframe <sup>p. 95</sup>. |
|||
* Short-tail/monoline specialty lines can be impacted by larger, more complex losses due to factors like difficulty in determining actual damages and legal/regulatory impediments <sup>p. 95</sup>. |
|||
* ''Multi-line solutions'' include industry solutions, programs, captives, and transactional E&S underwriting divisions <sup>p. 95</sup>. |
|||
* This subcategory predominantly consists of occurrence liability, including general liability, excess liability, and commercial auto <sup>p. 95</sup>. |
|||
* Multi-line solutions have a longer duration for losses to fully develop compared to short-tail/monoline specialty lines <sup>p. 95</sup>. |
|||
* The unique claim characteristics and longer-tail nature of multi-line solutions introduce more uncertainty, as claims can be impacted by changes in regulation, inflation, and other unforeseen factors over time <sup>p. 95</sup>. |
|||
* ''Exited lines'' include all underwriting units placed in run-off and are presented separately from ongoing lines of business <sup>p. 95</sup>. |
|||
* For the year ended December 31, 2025, the Company recognized ''favorable development'' related to prior years’ loss and loss expense reserves of USD 7.5m <sup>p. 95</sup>. |
|||
** This was driven by favorable development of USD 24.6m in short-tail/monoline specialty lines and USD 5.3m in multi-line solutions <sup>p. 95</sup>. |
|||
** This was partially offset by USD 22.4m of adverse development in exited lines <sup>p. 95</sup>. |
|||
** The adverse development in exited lines was primarily attributable to commercial auto and excess over auto in divisions that have been non-renewed or had significantly reduced exposure over the past three years <sup>p. 95</sup>. |
|||
** This was offset by favorable development in surety and property <sup>p. 95</sup>. |
|||
* For the year ended December 31, 2024, the Company recognized ''adverse development'' related to prior years’ loss and loss expense reserves of USD 25.7m <sup>p. 95</sup>. |
|||
** This was primarily related to losses previously subject to the LPT from accident years 2018 and prior <sup>p. 95</sup>. |
|||
** This included USD 10.1m in multi-line solutions and USD 15.2m in exited lines <sup>p. 95</sup>. |
|||
* During the year ended December 31, 2023, the Company recognized ''adverse development'' related to prior years’ loss and loss expense reserves of USD 10.8m <sup>p. 95</sup>. |
|||
** Adverse development of USD 11.7m in multi-line solutions was driven by greater than expected severity in auto, general, and excess liability lines of business, primarily from accident years 2020 to 2022 <sup>p. 95</sup>. |
|||
** This adverse development was partially offset by favorable development in short-tail/monoline specialty lines <sup>p. 95</sup>. |
|||
** The favorable development in short-tail/monoline specialty lines was in the property line of business, primarily from accident years 2021 and 2022 <sup>p. 95</sup>. |
|||
{{Indexing|Reserves for losses and LAE, net of reinsurance|Reserves for losses and LAE, reinsurance recoverable on unpaid claims, incurred losses, paid losses|do9an7x5kp|rmmhubj8mh|kind=table|order=170}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col-m" style="text-align:right" | 2023 |
|||
|- |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2022 |
|||
|- |
|||
| style="text-align:left" | Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Reserves for losses and LAE, beginning of period |
| style="text-align:left" | Reserves for losses and LAE, beginning of period |
||
| Line 9,788: | Line 6,482: | ||
| style="text-align:right" | 1,314,501 |
| style="text-align:right" | 1,314,501 |
||
| style="text-align:right" | 1,141,757 |
| style="text-align:right" | 1,141,757 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Less: reinsurance recoverable on unpaid claims, beginning of period |
| style="text-align:left" | Less: reinsurance recoverable on unpaid claims, beginning of period |
||
| style="text-align:right" | |
| style="text-align:right" | ( 670,846 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 455,484 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 435,986 ) |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Reserves for losses and LAE, beginning of period, net of reinsurance |
| style="text-align:left" | '''Reserves for losses and LAE, beginning of period, net of reinsurance''' |
||
| style="text-align:right" | 1, |
| style="text-align:right" | '''1,111,537''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''859,017''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''705,771''' |
||
| style="text-align:right" | 705,771 |
|||
|- |
|- |
||
| style="text-align:left" | Incurred, net of reinsurance, related to: |
| style="text-align:left" | '''Incurred, net of reinsurance, related to:''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 9,812: | Line 6,502: | ||
| style="text-align:right" | 657,783 |
| style="text-align:right" | 657,783 |
||
| style="text-align:right" | 505,894 |
| style="text-align:right" | 505,894 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Prior years |
| style="text-align:left" | Prior years |
||
| style="text-align:right" | |
| style="text-align:right" | ( 7,471 ) |
||
| style="text-align:right" | 25,728 |
| style="text-align:right" | 25,728 |
||
| style="text-align:right" | 10,770 |
| style="text-align:right" | 10,770 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total incurred, net of reinsurance''' |
||
| style="text-align:right |
| style="text-align:right" | '''802,904''' |
||
| style="text-align:right |
| style="text-align:right" | '''683,511''' |
||
| style="text-align:right |
| style="text-align:right" | '''516,664''' |
||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|- |
||
| style="text-align:left" | Paid, net of reinsurance, related to: |
| style="text-align:left" | '''Paid, net of reinsurance, related to:''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 9,836: | Line 6,522: | ||
| style="text-align:right" | 136,731 |
| style="text-align:right" | 136,731 |
||
| style="text-align:right" | 109,937 |
| style="text-align:right" | 109,937 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Prior years |
| style="text-align:left" | Prior years |
||
| Line 9,842: | Line 6,527: | ||
| style="text-align:right" | 294,260 |
| style="text-align:right" | 294,260 |
||
| style="text-align:right" | 253,481 |
| style="text-align:right" | 253,481 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total paid''' |
||
| style="text-align:right |
| style="text-align:right" | '''516,712''' |
||
| style="text-align:right |
| style="text-align:right" | '''430,991''' |
||
| style="text-align:right |
| style="text-align:right" | '''363,418''' |
||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|- |
||
| style="text-align:left" | Net reserves for losses and LAE, end of period |
| style="text-align:left" | '''Net reserves for losses and LAE, end of period''' |
||
| style="text-align:right" | 1,397,729 |
| style="text-align:right" | '''1,397,729''' |
||
| style="text-align:right" | 1,111,537 |
| style="text-align:right" | '''1,111,537''' |
||
| style="text-align:right" | 859,017 |
| style="text-align:right" | '''859,017''' |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Plus: reinsurance recoverable on unpaid claims, end of period |
| style="text-align:left" | Plus: reinsurance recoverable on unpaid claims, end of period |
||
| Line 9,860: | Line 6,542: | ||
| style="text-align:right" | 670,846 |
| style="text-align:right" | 670,846 |
||
| style="text-align:right" | 455,484 |
| style="text-align:right" | 455,484 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Reserves for losses and LAE, end of period |
| style="text-align:left" | '''Reserves for losses and LAE, end of period''' |
||
| style="text-align:right" | 2,318,894 |
| style="text-align:right" | '''2,318,894''' |
||
| style="text-align:right" | 1,782,383 |
| style="text-align:right" | '''1,782,383''' |
||
| style="text-align:right" | 1,314,501 |
| style="text-align:right" | '''1,314,501''' |
||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Short Duration Contract Disclosures|Losses and LAE reserves, reported claims, incurred but not reported claims, claim counts|rmmhubj8mh|e40m7ou132|kind=prose|order=171}} |
|||
=== Narrative === |
|||
* ''Losses and LAE reserves'' represent the Company's best estimate of the ultimate net cost of all reported and unreported losses that are unpaid as of the balance sheet dates <sup>p. 96</sup>. |
|||
* The Company's estimated reserves for losses and LAE include the accumulation of estimates for claims reported and unpaid prior to the balance sheet dates <sup>p. 96</sup>. |
|||
* Estimates for losses and LAE also include projections of relevant historical data for increases in claims costs for claims already reported <sup>p. 96</sup>. |
|||
* Estimates for losses and LAE include claims incurred but not reported <sup>p. 96</sup>. |
|||
* Estimates for losses and LAE include expenses for investigating and adjusting all incurred and unpaid claims <sup>p. 96</sup>. |
|||
* The Company measures ''claim counts'' by incident when determining the cumulative number of reported claims <sup>p. 96</sup>. |
|||
* Claim counts include all claims reported, even if the Company does not establish a liability for the claim (i.e., reserve for loss and loss adjustment expenses) <sup>p. 96</sup>. |
|||
{{Indexing|Incurred losses and ALAE, net of reinsurance|Incurred losses and ALAE, IBNR, reported claims by accident year|hjnlii88rx|do9an7x5kp|kind=table|order=172}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align: |
! colspan="3" style="text-align:center" | ($ in thousands except number of claims) |
||
! |
! style="text-align:center" | |
||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
|- |
|- |
||
! style="text-align: |
! colspan="6" style="text-align:center" | Incurred Losses and ALAE, Net of Reinsurance |
||
! |
! colspan="2" style="text-align:center" | As of December 31, 2025 |
||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|- |
||
! style="text-align:left" | |
|||
! colspan="5" style="text-align:center" | Years Ended December 31, |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | Reported Claims |
|||
|- |
|- |
||
! style="text-align:left" | Accident Year |
|||
! class="col-m" style="text-align:left" | 2021* |
|||
! class="col-m" style="text-align:left" | 2022* |
|||
! class="col-m" style="text-align:left" | 2023* |
|||
! class="col-m" style="text-align:left" | 2024* |
|||
! class="col-m" style="text-align:right" | 2025 |
|||
! class="col-m" style="text-align:right" | IBNR |
|||
! class="col-m" style="text-align:right" | Reported Claims |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2021 |
||
| style="text-align: |
| style="text-align:left" | 92,780 |
||
| style="text-align: |
| style="text-align:left" | 93,429 |
||
| style="text-align: |
| style="text-align:left" | 92,143 |
||
| style="text-align:left" | 92,134 |
|||
| style="text-align:right" | 99,783 |
|||
| style="text-align:right" | 1,774 |
|||
| style="text-align:right" | 1,656 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2022 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 108,299 |
||
| style="text-align: |
| style="text-align:left" | 105,394 |
||
| style="text-align:left" | 104,095 |
|||
| style="text-align:right" | 96,874 |
|||
| style="text-align:right" | 6,266 |
|||
| style="text-align:right" | 2,414 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2023 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 190,565 |
||
| style="text-align:left" | 191,865 |
|||
| style="text-align:right" | 161,222 |
|||
| style="text-align:right" | 28,997 |
|||
| style="text-align:right" | 5,015 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2024 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:left" | 280,147 |
|||
| style="text-align:right" | 292,220 |
|||
| style="text-align:right" | 99,302 |
|||
| style="text-align:right" | 5,819 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2025 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
|||
| style="text-align:right" | 422,528 |
|||
| style="text-align:right" | 275,190 |
|||
| style="text-align:right" | 5,495 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align:left" | '''—''' |
|||
| style="text-align:right" | '''1,072,627''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | ( 528,255 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Prior year claims incurred, unfavorable (favorable) development |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 11,700 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Net reserves for loss and ALAE before 2021 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2021 |
||
| style="text-align:left" | Net reserves for loss and ALAE before 2021 |
|||
| style="text-align:left" | Net reserves for loss and ALAE before 2021 |
|||
| style="text-align:left" | Net reserves for loss and ALAE before 2021 |
|||
| style="text-align:right" | 1,570 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align: |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align: |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align: |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
|||
| style="text-align:right" | '''545,942''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:left" | *Supplementary information and unaudited |
|||
| style="text-align:right" | *Supplementary information and unaudited |
|||
| style="text-align:right" | *Supplementary information and unaudited |
|||
| style="text-align:right" | *Supplementary information and unaudited |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Cumulative paid losses and ALAE, net of reinsurance|Cumulative paid losses and ALAE by accident year|hjnlii88rx|do9an7x5kp|kind=table|order=173}} |
|||
=== Schedule of Short-Duration Insurance Contracts === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align: |
! colspan="3" style="text-align:center" | ($ in thousands) |
||
! |
! style="text-align:center" | |
||
! |
! style="text-align:center" | |
||
! |
! style="text-align:center" | |
||
! class="col-s" style="text-align:right" | Dec. 31, 2022 USD ($) |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2021 USD ($) |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2020 USD ($) |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2019 USD ($) |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2018 USD ($) |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2017 USD ($) |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2016 USD ($) |
|||
|- |
|- |
||
! colspan="6" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
! style="text-align:left" | |
|||
! colspan="5" style="text-align:center" | Years Ended December 31, |
|||
| style="text-align:right; font-weight:bold" | 1,084,980 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|- |
||
! style="text-align:left" | Accident Year |
|||
! class="col-m" style="text-align:left" | 2021* |
|||
! class="col-m" style="text-align:right" | 2022* |
|||
! class="col-m" style="text-align:right" | 2023* |
|||
! class="col-m" style="text-align:right" | 2024* |
|||
! class="col-m" style="text-align:right" | 2025 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2021 |
||
| style="text-align: |
| style="text-align:left" | 18,447 |
||
| style="text-align:right" | |
| style="text-align:right" | 56,803 |
||
| style="text-align:right" | |
| style="text-align:right" | 67,912 |
||
| style="text-align:right" | |
| style="text-align:right" | 78,439 |
||
| style="text-align:right" | |
| style="text-align:right" | 93,560 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2022 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 27,773 |
||
| style="text-align:right" | |
| style="text-align:right" | 64,594 |
||
| style="text-align:right" | |
| style="text-align:right" | 77,150 |
||
| style="text-align:right" | |
| style="text-align:right" | 85,696 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2023 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 33,795 |
|||
| style="text-align:right" | 100,705 |
|||
| style="text-align:right" | 114,247 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2024 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 53,691 |
|||
| style="text-align:right" | 154,896 |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | 2025 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right; font-weight:bold" | 367,226 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and LAE |
|||
| style="text-align:right" | 528,255 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 79,856 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''528,255''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
|} |
|||
| style="text-align:right" | — |
|||
</div> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
{{Indexing|Incurred losses and ALAE, net of reinsurance by accident year|Incurred losses and ALAE, IBNR, reported claims by accident year|hjnlii88rx|do9an7x5kp|kind=table|order=174}} |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! colspan="5" style="text-align:center" | ($ in thousands except number of claims) |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
|- |
|- |
||
! colspan="11" style="text-align:center" | Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) |
|||
! colspan="2" style="text-align:center" | As of December 31, 2025 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
! style="text-align:left" | Accident Year |
|||
! colspan="11" style="text-align:center" | Years Ended December 31, |
|||
! style="text-align:center" | Reported Claims |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
! style="text-align:left" | Accident Year |
|||
! class="col-m" style="text-align:left" | 2016* |
|||
! class="col-m" style="text-align:left" | 2017* |
|||
! class="col-m" style="text-align:left" | 2018* |
|||
! class="col-m" style="text-align:left" | 2019* |
|||
! class="col-m" style="text-align:left" | 2020* |
|||
! class="col-m" style="text-align:right" | 2021* |
|||
! class="col-m" style="text-align:right" | 2022* |
|||
! class="col-m" style="text-align:right" | 2023* |
|||
! class="col-m" style="text-align:right" | 2024* |
|||
! class="col-m" style="text-align:right" | 2025 |
|||
! class="col-m" style="text-align:right" | IBNR |
|||
! class="col-m" style="text-align:right" | Reported Claims |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | 2016 |
||
| style="text-align: |
| style="text-align:left" | 63,223 |
||
| style="text-align: |
| style="text-align:left" | 62,843 |
||
| style="text-align: |
| style="text-align:left" | 62,843 |
||
| style="text-align: |
| style="text-align:left" | 62,643 |
||
| style="text-align: |
| style="text-align:left" | 84,579 |
||
| style="text-align:right |
| style="text-align:right" | 84,579 |
||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and LAE |
|||
| style="text-align:right" | 1,162,853 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Exited Lines |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 605,233 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -538,304 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net reserves for loss and ALAE before 2021 |
|||
| style="text-align:right" | 14,737 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total net reserves for loss and ALAE |
|||
| style="text-align:right; font-weight:bold" | 81,666 |
|||
| style="text-align:right; font-weight:bold" | 86,689 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and LAE |
|||
| style="text-align:right" | 538,304 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accident Year 2016 / Multi-line Solutions |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 85,098 |
|||
| style="text-align:right" | 85,434 |
|||
| style="text-align:right" | 84,829 |
| style="text-align:right" | 84,829 |
||
| style="text-align:right" | 84,829 |
| style="text-align:right" | 84,829 |
||
| style="text-align:right" | |
| style="text-align:right" | 85,434 |
||
| style="text-align:right" | |
| style="text-align:right" | 85,098 |
||
| style="text-align:right" | 62,643 |
|||
| style="text-align:right" | 62,843 |
|||
| style="text-align:right" | 62,843 |
|||
| style="text-align:right" | 63,223 |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -77,825 |
|||
| style="text-align:right" | -77,760 |
|||
| style="text-align:right" | -77,160 |
|||
| style="text-align:right" | -75,855 |
|||
| style="text-align:right" | -72,544 |
|||
| style="text-align:right" | -69,691 |
|||
| style="text-align:right" | -58,895 |
|||
| style="text-align:right" | -53,352 |
|||
| style="text-align:right" | -42,528 |
|||
| style="text-align:right" | -23,239 |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 828 |
| style="text-align:right" | 828 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 4,744 |
| style="text-align:right" | 4,744 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2017 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 65,332 |
||
| style="text-align: |
| style="text-align:left" | 65,332 |
||
| style="text-align: |
| style="text-align:left" | 64,260 |
||
| style="text-align: |
| style="text-align:left" | 78,166 |
||
| style="text-align:right" | |
| style="text-align:right" | 78,166 |
||
| style="text-align:right" | 58,895 |
|||
| style="text-align:right" | 53,352 |
|||
| style="text-align:right" | 42,528 |
|||
| style="text-align:right" | 23,239 |
|||
|- |
|||
| style="text-align:left" | Accident Year 2016 / Exited Lines |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 104,246 |
|||
| style="text-align:right" | 102,801 |
|||
| style="text-align:right" | 100,651 |
|||
| style="text-align:right" | 100,651 |
|||
| style="text-align:right" | 98,301 |
|||
| style="text-align:right" | 97,301 |
|||
| style="text-align:right" | 93,577 |
|||
| style="text-align:right" | 91,372 |
|||
| style="text-align:right" | 92,996 |
|||
| style="text-align:right" | 93,019 |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -98,831 |
|||
| style="text-align:right" | -97,462 |
|||
| style="text-align:right" | -95,114 |
|||
| style="text-align:right" | -91,556 |
|||
| style="text-align:right" | -87,482 |
|||
| style="text-align:right" | -81,181 |
|||
| style="text-align:right" | -78,070 |
|||
| style="text-align:right" | -70,253 |
|||
| style="text-align:right" | -57,638 |
|||
| style="text-align:right" | -36,592 |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 1,851 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 4,911 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and LAE |
|||
| style="text-align:right" | 98,831 |
|||
| style="text-align:right" | 97,462 |
|||
| style="text-align:right" | 95,114 |
|||
| style="text-align:right" | 91,556 |
|||
| style="text-align:right" | 87,482 |
|||
| style="text-align:right" | 81,181 |
|||
| style="text-align:right" | 78,070 |
|||
| style="text-align:right" | 70,253 |
|||
| style="text-align:right" | 57,638 |
|||
| style="text-align:right" | 36,592 |
|||
|- |
|||
| style="text-align:left" | Accident Year 2017 / Multi-line Solutions |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 79,819 |
|||
| style="text-align:right" | 80,493 |
|||
| style="text-align:right" | 78,766 |
| style="text-align:right" | 78,766 |
||
| style="text-align:right" | 78,766 |
| style="text-align:right" | 78,766 |
||
| style="text-align:right" | |
| style="text-align:right" | 80,493 |
||
| style="text-align:right" | |
| style="text-align:right" | 79,819 |
||
| style="text-align:right" | 64,260 |
|||
| style="text-align:right" | 65,332 |
|||
| style="text-align:right" | 65,332 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -77,177 |
|||
| style="text-align:right" | -75,714 |
|||
| style="text-align:right" | -73,770 |
|||
| style="text-align:right" | -71,109 |
|||
| style="text-align:right" | -67,926 |
|||
| style="text-align:right" | -61,354 |
|||
| style="text-align:right" | -53,093 |
|||
| style="text-align:right" | -41,945 |
|||
| style="text-align:right" | -23,770 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 837 |
| style="text-align:right" | 837 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 5,592 |
| style="text-align:right" | 5,592 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2018 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 74,476 |
||
| style="text-align: |
| style="text-align:left" | 74,476 |
||
| style="text-align: |
| style="text-align:left" | 69,319 |
||
| style="text-align:right" | |
| style="text-align:right" | 71,719 |
||
| style="text-align:right" | 53,093 |
|||
| style="text-align:right" | 41,945 |
|||
| style="text-align:right" | 23,770 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accident Year 2017 / Exited Lines |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 72,682 |
|||
| style="text-align:right" | 70,885 |
|||
| style="text-align:right" | 68,646 |
|||
| style="text-align:right" | 68,646 |
|||
| style="text-align:right" | 68,346 |
|||
| style="text-align:right" | 65,735 |
|||
| style="text-align:right" | 81,785 |
|||
| style="text-align:right" | 79,581 |
|||
| style="text-align:right" | 75,159 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -69,798 |
|||
| style="text-align:right" | -68,480 |
|||
| style="text-align:right" | -66,498 |
|||
| style="text-align:right" | -62,924 |
|||
| style="text-align:right" | -57,457 |
|||
| style="text-align:right" | -50,545 |
|||
| style="text-align:right" | -51,985 |
|||
| style="text-align:right" | -52,103 |
|||
| style="text-align:right" | -34,176 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 1,819 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 4,370 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and LAE |
|||
| style="text-align:right" | 69,798 |
|||
| style="text-align:right" | 68,480 |
|||
| style="text-align:right" | 66,498 |
|||
| style="text-align:right" | 62,924 |
|||
| style="text-align:right" | 57,457 |
|||
| style="text-align:right" | 50,545 |
|||
| style="text-align:right" | 51,985 |
|||
| style="text-align:right" | 52,103 |
|||
| style="text-align:right" | 34,176 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accident Year 2018 / Multi-line Solutions |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 72,963 |
|||
| style="text-align:right" | 75,686 |
|||
| style="text-align:right" | 73,019 |
| style="text-align:right" | 73,019 |
||
| style="text-align:right" | 73,019 |
| style="text-align:right" | 73,019 |
||
| style="text-align:right" | |
| style="text-align:right" | 75,686 |
||
| style="text-align:right" | |
| style="text-align:right" | 72,963 |
||
| style="text-align:right" | 74,476 |
|||
| style="text-align:right" | 74,476 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -72,429 |
|||
| style="text-align:right" | -70,128 |
|||
| style="text-align:right" | -69,893 |
|||
| style="text-align:right" | -65,635 |
|||
| style="text-align:right" | -58,655 |
|||
| style="text-align:right" | -47,226 |
|||
| style="text-align:right" | -42,568 |
|||
| style="text-align:right" | -26,201 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 673 |
| style="text-align:right" | 673 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 5,103 |
| style="text-align:right" | 5,103 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2019 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 107,432 |
||
| style="text-align: |
| style="text-align:left" | 109,226 |
||
| style="text-align:right" | |
| style="text-align:right" | 112,378 |
||
| style="text-align:right" | |
| style="text-align:right" | 115,530 |
||
| style="text-align:right" | |
| style="text-align:right" | 116,230 |
||
| style="text-align:right" | |
| style="text-align:right" | 116,206 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accident Year 2018 / Exited Lines |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 91,897 |
|||
| style="text-align:right" | 92,082 |
|||
| style="text-align:right" | 84,165 |
|||
| style="text-align:right" | 84,165 |
|||
| style="text-align:right" | 79,006 |
|||
| style="text-align:right" | 76,506 |
|||
| style="text-align:right" | 68,990 |
|||
| style="text-align:right" | 74,357 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -82,244 |
|||
| style="text-align:right" | -79,860 |
|||
| style="text-align:right" | -74,604 |
|||
| style="text-align:right" | -67,001 |
|||
| style="text-align:right" | -54,339 |
|||
| style="text-align:right" | -39,870 |
|||
| style="text-align:right" | -60,149 |
|||
| style="text-align:right" | -25,553 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 4,093 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 4,941 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and LAE |
|||
| style="text-align:right" | 82,244 |
|||
| style="text-align:right" | 79,860 |
|||
| style="text-align:right" | 74,604 |
|||
| style="text-align:right" | 67,001 |
|||
| style="text-align:right" | 54,339 |
|||
| style="text-align:right" | 39,870 |
|||
| style="text-align:right" | 60,149 |
|||
| style="text-align:right" | 25,553 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accident Year 2019 / Multi-line Solutions |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 110,564 |
| style="text-align:right" | 110,564 |
||
| style="text-align:right" | 116,206 |
|||
| style="text-align:right" | 116,230 |
|||
| style="text-align:right" | 115,530 |
|||
| style="text-align:right" | 112,378 |
|||
| style="text-align:right" | 109,226 |
|||
| style="text-align:right" | 107,432 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -106,826 |
|||
| style="text-align:right" | -106,765 |
|||
| style="text-align:right" | -99,451 |
|||
| style="text-align:right" | -87,816 |
|||
| style="text-align:right" | -71,053 |
|||
| style="text-align:right" | -50,933 |
|||
| style="text-align:right" | -33,019 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 1,384 |
| style="text-align:right" | 1,384 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 6,113 |
| style="text-align:right" | 6,113 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2020 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 113,030 |
||
| style="text-align:right" | |
| style="text-align:right" | 124,076 |
||
| style="text-align:right" | |
| style="text-align:right" | 128,111 |
||
| style="text-align:right" | |
| style="text-align:right" | 132,495 |
||
| style="text-align:right" | |
| style="text-align:right" | 132,125 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accident Year 2019 / Exited Lines |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 86,131 |
|||
| style="text-align:right" | 79,823 |
|||
| style="text-align:right" | 79,572 |
|||
| style="text-align:right" | 79,414 |
|||
| style="text-align:right" | 77,770 |
|||
| style="text-align:right" | 73,635 |
|||
| style="text-align:right" | 87,115 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -70,367 |
|||
| style="text-align:right" | -65,847 |
|||
| style="text-align:right" | -57,341 |
|||
| style="text-align:right" | -45,696 |
|||
| style="text-align:right" | -30,948 |
|||
| style="text-align:right" | -28,954 |
|||
| style="text-align:right" | -28,636 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 9,773 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 5,660 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and LAE |
|||
| style="text-align:right" | 70,367 |
|||
| style="text-align:right" | 65,847 |
|||
| style="text-align:right" | 57,341 |
|||
| style="text-align:right" | 45,696 |
|||
| style="text-align:right" | 30,948 |
|||
| style="text-align:right" | 28,954 |
|||
| style="text-align:right" | 28,636 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accident Year 2020 / Multi-line Solutions |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 134,281 |
| style="text-align:right" | 134,281 |
||
| style="text-align:right" | 132,125 |
|||
| style="text-align:right" | 132,495 |
|||
| style="text-align:right" | 128,111 |
|||
| style="text-align:right" | 124,076 |
|||
| style="text-align:right" | 113,030 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -126,965 |
|||
| style="text-align:right" | -121,097 |
|||
| style="text-align:right" | -105,283 |
|||
| style="text-align:right" | -82,236 |
|||
| style="text-align:right" | -60,680 |
|||
| style="text-align:right" | -29,499 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 4,174 |
| style="text-align:right" | 4,174 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 5,542 |
| style="text-align:right" | 5,542 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2021 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 156,067 |
||
| style="text-align:right" | |
| style="text-align:right" | 158,891 |
||
| style="text-align:right" | |
| style="text-align:right" | 160,331 |
||
| style="text-align:right" | |
| style="text-align:right" | 160,546 |
||
| style="text-align:right" | |
| style="text-align:right" | 157,006 |
||
| style="text-align:right" | 7,932 |
|||
| style="text-align:right" | 6,727 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2022 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 236,909 |
|||
| style="text-align:right" | 242,097 |
|||
| style="text-align:right" | 242,358 |
|||
| style="text-align:right" | 249,317 |
|||
| style="text-align:right" | 19,315 |
|||
| style="text-align:right" | 8,679 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2023 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 306,511 |
|||
| style="text-align:right" | 306,511 |
|||
| style="text-align:right" | 320,637 |
|||
| style="text-align:right" | 96,700 |
|||
| style="text-align:right" | 8,468 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2024 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 132,248 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 353,933 |
|||
| style="text-align:right" | 336,197 |
|||
| style="text-align:right" | 155,878 |
|||
| style="text-align:right" | 7,700 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2025 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | -102,725 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 356,590 |
|||
| style="text-align:right" | 257,468 |
|||
| style="text-align:right" | 6,139 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,902,472''' |
||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | |
| style="text-align:right" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | |
| style="text-align:right" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | |
| style="text-align:right" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | ( 1,162,853 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align:right" | |
| style="text-align:right" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align:right" | |
| style="text-align:right" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align:right" | |
| style="text-align:right" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align:right" | Net reserves for loss and ALAE before 2016 |
|||
| style="text-align:right" | ( 189 ) |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align: |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align: |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align: |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align: |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align: |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''739,430''' |
||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
|||
| style="text-align:right" | *Supplementary information and unaudited |
|||
|} |
|||
</div> |
|||
{{Indexing|Cumulative paid losses and ALAE, net of reinsurance by accident year|Cumulative paid losses and ALAE by accident year|hjnlii88rx|do9an7x5kp|kind=table|order=175}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! colspan="4" style="text-align:center" | ($ in thousands) |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
|- |
|- |
||
! colspan="11" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
|||
| style="text-align:right" | 99,783 |
|||
| style="text-align:right" | 92,134 |
|||
| style="text-align:right" | 92,143 |
|||
| style="text-align:right" | 93,429 |
|||
| style="text-align:right" | 92,780 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
! style="text-align:left" | |
|||
! colspan="10" style="text-align:center" | Years Ended December 31, |
|||
| style="text-align:right" | -78,439 |
|||
| style="text-align:right" | -67,912 |
|||
| style="text-align:right" | -56,803 |
|||
| style="text-align:right" | -18,447 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
! style="text-align:left" | Accident Year |
|||
! class="col-m" style="text-align:left" | 2016* |
|||
! class="col-m" style="text-align:right" | 2017* |
|||
! class="col-m" style="text-align:right" | 2018* |
|||
! class="col-m" style="text-align:right" | 2019* |
|||
! class="col-m" style="text-align:right" | 2020* |
|||
! class="col-m" style="text-align:right" | 2021* |
|||
! class="col-m" style="text-align:right" | 2022* |
|||
! class="col-m" style="text-align:right" | 2023* |
|||
! class="col-m" style="text-align:right" | 2024* |
|||
! class="col-m" style="text-align:right" | 2025 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2016 |
||
| style="text-align: |
| style="text-align:left" | 23,239 |
||
| style="text-align:right" | |
| style="text-align:right" | 42,528 |
||
| style="text-align:right" | |
| style="text-align:right" | 53,352 |
||
| style="text-align:right" | |
| style="text-align:right" | 58,895 |
||
| style="text-align:right" | |
| style="text-align:right" | 69,691 |
||
| style="text-align:right" | |
| style="text-align:right" | 72,544 |
||
| style="text-align:right" | |
| style="text-align:right" | 75,855 |
||
| style="text-align:right" | |
| style="text-align:right" | 77,160 |
||
| style="text-align:right" | |
| style="text-align:right" | 77,760 |
||
| style="text-align:right" | |
| style="text-align:right" | 77,825 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2017 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 23,770 |
||
| style="text-align:right" | |
| style="text-align:right" | 41,945 |
||
| style="text-align:right" | |
| style="text-align:right" | 53,093 |
||
| style="text-align:right" | |
| style="text-align:right" | 61,354 |
||
| style="text-align:right" | |
| style="text-align:right" | 67,926 |
||
| style="text-align:right" | |
| style="text-align:right" | 71,109 |
||
| style="text-align:right" | |
| style="text-align:right" | 73,770 |
||
| style="text-align:right" | |
| style="text-align:right" | 75,714 |
||
| style="text-align:right" | |
| style="text-align:right" | 77,177 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2018 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 26,201 |
|||
| style="text-align:right" | 42,568 |
|||
| style="text-align:right" | 47,226 |
|||
| style="text-align:right" | 58,655 |
|||
| style="text-align:right" | 65,635 |
|||
| style="text-align:right" | 69,893 |
|||
| style="text-align:right" | 70,128 |
|||
| style="text-align:right" | 72,429 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2019 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 33,019 |
|||
| style="text-align:right" | 50,933 |
|||
| style="text-align:right" | 71,053 |
|||
| style="text-align:right" | 87,816 |
|||
| style="text-align:right" | 99,451 |
|||
| style="text-align:right" | 106,765 |
|||
| style="text-align:right" | 106,826 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2020 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 160,546 |
|||
| style="text-align:right" | 160,331 |
|||
| style="text-align:right" | 158,891 |
|||
| style="text-align:right" | 156,067 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 29,499 |
|||
| style="text-align:right" | 60,680 |
|||
| style="text-align:right" | 82,236 |
|||
| style="text-align:right" | 105,283 |
|||
| style="text-align:right" | 121,097 |
|||
| style="text-align:right" | 126,965 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2021 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | -125,749 |
|||
| style="text-align:right" | -102,772 |
|||
| style="text-align:right" | -73,293 |
|||
| style="text-align:right" | -37,118 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 37,118 |
||
| style="text-align:right" | 73,293 |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | 102,772 |
||
| style="text-align:right" | |
| style="text-align:right" | 125,749 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 6,727 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and LAE |
|||
| style="text-align:right" | 141,539 |
| style="text-align:right" | 141,539 |
||
| style="text-align:right" | 125,749 |
|||
| style="text-align:right" | 102,772 |
|||
| style="text-align:right" | 73,293 |
|||
| style="text-align:right" | 37,118 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2022 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 11,260: | Line 7,108: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 50,148 |
|||
| style="text-align:right" | 114,794 |
|||
| style="text-align:right" | 165,854 |
|||
| style="text-align:right" | 205,410 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2023 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 11,272: | Line 7,121: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 63,079 |
|||
| style="text-align:right" | 122,186 |
|||
| style="text-align:right" | 181,636 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2024 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 92,095 |
|||
| style="text-align:right" | 91,323 |
|||
| style="text-align:right" | 91,188 |
|||
| style="text-align:right" | 83,322 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -81,600 |
|||
| style="text-align:right" | -72,923 |
|||
| style="text-align:right" | -66,012 |
|||
| style="text-align:right" | -57,820 |
|||
| style="text-align:right" | -41,540 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 11,296: | Line 7,134: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 58,281 |
|||
| style="text-align:right" | 123,488 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2025 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 11,308: | Line 7,147: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 49,558 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,162,853''' |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
|} |
|||
</div> |
|||
{{Indexing|Exited Lines — all lines in runoff|Exited lines, net incurred and paid loss development, balance sheet reserves, claims duration|j2mg590krh|do9an7x5kp|kind=prose|order=176}} |
|||
* The provided table reconciles net incurred and paid loss development tables to balance sheet reserves for losses and loss adjustment expenses as of December 31, 2025 and 2024 <sup>p. 97</sup>. |
|||
* The subsequent table details the historical average annual payout of incurred losses and allocated loss adjustment expenses (claims duration) for short-duration contracts <sup>p. 97</sup>. |
|||
* This claims duration data is based on disaggregated information from paid loss development tables, net of reinsurance <sup>p. 97</sup>. |
|||
{{Indexing|Incurred losses and ALAE, net of reinsurance by accident year|Incurred losses and ALAE, IBNR, reported claims by accident year|hjnlii88rx|do9an7x5kp|kind=table|order=177}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! colspan="4" style="text-align:center" | ($ in thousands except number of claims) |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
|- |
|- |
||
! colspan="11" style="text-align:center" | Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) |
|||
! colspan="2" style="text-align:center" | As of December 31, 2025 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
! style="text-align:left" | |
|||
! colspan="11" style="text-align:center" | Years Ended December 31, |
|||
! style="text-align:center" | Reported Claims |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
! style="text-align:left" | Accident Year |
|||
! class="col-m" style="text-align:left" | 2016* |
|||
! class="col-m" style="text-align:left" | 2017* |
|||
! class="col-m" style="text-align:left" | 2018* |
|||
! class="col-m" style="text-align:left" | 2019* |
|||
! class="col-m" style="text-align:left" | 2020* |
|||
! class="col-m" style="text-align:right" | 2021* |
|||
! class="col-m" style="text-align:right" | 2022* |
|||
! class="col-m" style="text-align:right" | 2023* |
|||
! class="col-m" style="text-align:right" | 2024* |
|||
! class="col-m" style="text-align:right" | 2025 |
|||
! class="col-m" style="text-align:right" | IBNR |
|||
! class="col-m" style="text-align:right" | Reported Claims |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2016 |
||
| style="text-align: |
| style="text-align:left" | 93,019 |
||
| style="text-align: |
| style="text-align:left" | 92,996 |
||
| style="text-align: |
| style="text-align:left" | 91,372 |
||
| style="text-align: |
| style="text-align:left" | 93,577 |
||
| style="text-align: |
| style="text-align:left" | 97,301 |
||
| style="text-align:right" | |
| style="text-align:right" | 98,301 |
||
| style="text-align:right" | |
| style="text-align:right" | 100,651 |
||
| style="text-align:right" | |
| style="text-align:right" | 100,651 |
||
| style="text-align:right" | |
| style="text-align:right" | 102,801 |
||
| style="text-align:right" | |
| style="text-align:right" | 104,246 |
||
| style="text-align:right" | 1,851 |
|||
| style="text-align:right" | 4,911 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2017 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 75,159 |
||
| style="text-align: |
| style="text-align:left" | 79,581 |
||
| style="text-align: |
| style="text-align:left" | 81,785 |
||
| style="text-align: |
| style="text-align:left" | 65,735 |
||
| style="text-align:right" | |
| style="text-align:right" | 68,346 |
||
| style="text-align:right" | |
| style="text-align:right" | 68,646 |
||
| style="text-align:right" | |
| style="text-align:right" | 68,646 |
||
| style="text-align:right" | |
| style="text-align:right" | 70,885 |
||
| style="text-align:right" | |
| style="text-align:right" | 72,682 |
||
| style="text-align:right" | 1,819 |
|||
| style="text-align:right" | 4,370 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2018 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 74,357 |
||
| style="text-align: |
| style="text-align:left" | 68,990 |
||
| style="text-align: |
| style="text-align:left" | 76,506 |
||
| style="text-align:right" | |
| style="text-align:right" | 79,006 |
||
| style="text-align:right" | |
| style="text-align:right" | 84,165 |
||
| style="text-align:right" | |
| style="text-align:right" | 84,165 |
||
| style="text-align:right" | |
| style="text-align:right" | 92,082 |
||
| style="text-align:right" | |
| style="text-align:right" | 91,897 |
||
| style="text-align:right" | 4,093 |
|||
| style="text-align:right" | 4,941 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2019 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 87,115 |
||
| style="text-align: |
| style="text-align:left" | 73,635 |
||
| style="text-align:right" | |
| style="text-align:right" | 77,770 |
||
| style="text-align:right" | |
| style="text-align:right" | 79,414 |
||
| style="text-align:right" | |
| style="text-align:right" | 79,572 |
||
| style="text-align:right" | |
| style="text-align:right" | 79,823 |
||
| style="text-align:right" | |
| style="text-align:right" | 86,131 |
||
| style="text-align:right" | 9,773 |
|||
| style="text-align:right" | 5,660 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2020 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 132,248 |
||
| style="text-align:right" | |
| style="text-align:right" | 136,469 |
||
| style="text-align:right" | |
| style="text-align:right" | 137,835 |
||
| style="text-align:right" | |
| style="text-align:right" | 137,907 |
||
| style="text-align:right" | |
| style="text-align:right" | 137,671 |
||
| style="text-align:right" | |
| style="text-align:right" | 138,320 |
||
| style="text-align:right" | 10,644 |
|||
| style="text-align:right" | 4,867 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2021 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 83,322 |
||
| style="text-align:right" | |
| style="text-align:right" | 91,188 |
||
| style="text-align:right" | |
| style="text-align:right" | 91,323 |
||
| style="text-align:right" | |
| style="text-align:right" | 92,095 |
||
| style="text-align:right" | |
| style="text-align:right" | 97,577 |
||
| style="text-align:right" | 10,676 |
|||
| style="text-align:right" | 2,446 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2022 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 12,717 |
||
| style="text-align:right" | |
| style="text-align:right" | 12,240 |
||
| style="text-align:right" | |
| style="text-align:right" | 11,800 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -205,410 |
|||
| style="text-align:right" | -165,854 |
|||
| style="text-align:right" | -114,794 |
|||
| style="text-align:right" | -50,148 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 19,315 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 8,679 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and LAE |
|||
| style="text-align:right" | 205,410 |
|||
| style="text-align:right" | 165,854 |
|||
| style="text-align:right" | 114,794 |
|||
| style="text-align:right" | 50,148 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accident Year 2022 / Exited Lines |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 14,362 |
| style="text-align:right" | 14,362 |
||
| style="text-align:right" | 11,800 |
|||
| style="text-align:right" | 12,240 |
|||
| style="text-align:right" | 12,717 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -11,325 |
|||
| style="text-align:right" | -9,211 |
|||
| style="text-align:right" | -4,077 |
|||
| style="text-align:right" | -2,155 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 2,025 |
| style="text-align:right" | 2,025 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 246 |
| style="text-align:right" | 246 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2023 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accident Year 2023 / Short-tail/Monoline Specialty Lines |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 161,222 |
|||
| style="text-align:right" | 191,865 |
|||
| style="text-align:right" | 190,565 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -114,247 |
|||
| style="text-align:right" | -100,705 |
|||
| style="text-align:right" | -33,795 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 28,997 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 5,015 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and LAE |
|||
| style="text-align:right" | 114,247 |
|||
| style="text-align:right" | 100,705 |
|||
| style="text-align:right" | 33,795 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accident Year 2023 / Multi-line Solutions |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 320,637 |
|||
| style="text-align:right" | 306,511 |
|||
| style="text-align:right" | 306,511 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | -181,636 |
|||
| style="text-align:right" | -122,186 |
|||
| style="text-align:right" | -63,079 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 96,700 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 8,468 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and LAE |
|||
| style="text-align:right" | 181,636 |
|||
| style="text-align:right" | 122,186 |
|||
| style="text-align:right" | 63,079 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accident Year 2023 / Exited Lines |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 2 |
| style="text-align:right" | 2 |
||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 1 |
| style="text-align:right" | 1 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 1 |
| style="text-align:right" | 1 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2024 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 5 |
|||
| style="text-align:right" | 5 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2025 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 11 |
|||
| style="text-align:right" | 11 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''605,233''' |
||
| style="text-align:right" | '''—''' |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | 292,220 |
|||
| style="text-align:right" | 280,147 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | -154,896 |
|||
| style="text-align:right" | -53,691 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 99,302 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 5,819 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and LAE |
|||
| style="text-align:right" | 154,896 |
|||
| style="text-align:right" | 53,691 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accident Year 2024 / Multi-line Solutions |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 336,197 |
|||
| style="text-align:right" | 353,933 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | -123,488 |
|||
| style="text-align:right" | -58,281 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 155,878 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 7,700 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and LAE |
|||
| style="text-align:right" | 123,488 |
|||
| style="text-align:right" | 58,281 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accident Year 2024 / Exited Lines |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 5 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | |
| style="text-align:right" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | |
| style="text-align:right" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | |
| style="text-align:right" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | |
| style="text-align:right" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | |
| style="text-align:right" | ( 538,304 ) |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align:right" | |
| style="text-align:right" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align:right" | |
| style="text-align:right" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align:right" | |
| style="text-align:right" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align:right" | Net reserves for loss and ALAE before 2015 |
|||
| style="text-align:right" | 14,737 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align: |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align: |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align: |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align: |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align: |
| style="text-align:left" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''Total net reserves for loss and ALAE''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''81,666''' |
||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
|||
| style="text-align:right" | *Supplementary information and unaudited |
|||
|} |
|||
</div> |
|||
{{Indexing|Cumulative paid losses and ALAE, net of reinsurance by accident year|Cumulative paid losses and ALAE by accident year|hjnlii88rx|do9an7x5kp|kind=table|order=178}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! colspan="4" style="text-align:center" | ($ in thousands) |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
! style="text-align:center" | |
|||
|- |
|- |
||
! colspan="11" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
! style="text-align:left" | |
|||
! colspan="10" style="text-align:center" | Years Ended December 31, |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
! style="text-align:left" | Accident Year |
|||
! class="col-m" style="text-align:left" | 2016* |
|||
! class="col-m" style="text-align:right" | 2017* |
|||
! class="col-m" style="text-align:right" | 2018* |
|||
! class="col-m" style="text-align:right" | 2019* |
|||
! class="col-m" style="text-align:right" | 2020* |
|||
! class="col-m" style="text-align:right" | 2021* |
|||
! class="col-m" style="text-align:right" | 2022* |
|||
! class="col-m" style="text-align:right" | 2023* |
|||
! class="col-m" style="text-align:right" | 2024* |
|||
! class="col-m" style="text-align:right" | 2025 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2016 |
||
| style="text-align: |
| style="text-align:left" | 36,592 |
||
| style="text-align:right" | |
| style="text-align:right" | 57,638 |
||
| style="text-align:right" | |
| style="text-align:right" | 70,253 |
||
| style="text-align:right" | |
| style="text-align:right" | 78,070 |
||
| style="text-align:right" | |
| style="text-align:right" | 81,181 |
||
| style="text-align:right" | |
| style="text-align:right" | 87,482 |
||
| style="text-align:right" | |
| style="text-align:right" | 91,556 |
||
| style="text-align:right" | |
| style="text-align:right" | 95,114 |
||
| style="text-align:right" | |
| style="text-align:right" | 97,462 |
||
| style="text-align:right" | |
| style="text-align:right" | 98,831 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2017 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 34,176 |
||
| style="text-align:right" | |
| style="text-align:right" | 52,103 |
||
| style="text-align:right" | |
| style="text-align:right" | 51,985 |
||
| style="text-align:right" | |
| style="text-align:right" | 50,545 |
||
| style="text-align:right" | |
| style="text-align:right" | 57,457 |
||
| style="text-align:right" | |
| style="text-align:right" | 62,924 |
||
| style="text-align:right" | |
| style="text-align:right" | 66,498 |
||
| style="text-align:right" | |
| style="text-align:right" | 68,480 |
||
| style="text-align:right" | |
| style="text-align:right" | 69,798 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2018 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 25,553 |
|||
| style="text-align:right" | 60,149 |
|||
| style="text-align:right" | 39,870 |
|||
| style="text-align:right" | 54,339 |
|||
| style="text-align:right" | 67,001 |
|||
| style="text-align:right" | 74,604 |
|||
| style="text-align:right" | 79,860 |
|||
| style="text-align:right" | 82,244 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2019 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 28,636 |
|||
| style="text-align:right" | 28,954 |
|||
| style="text-align:right" | 30,948 |
|||
| style="text-align:right" | 45,696 |
|||
| style="text-align:right" | 57,341 |
|||
| style="text-align:right" | 65,847 |
|||
| style="text-align:right" | 70,367 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2020 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 102,725 |
|||
| style="text-align:right" | 98,202 |
|||
| style="text-align:right" | 102,132 |
|||
| style="text-align:right" | 114,543 |
|||
| style="text-align:right" | 120,831 |
|||
| style="text-align:right" | 124,139 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2021 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 41,540 |
|||
| style="text-align:right" | 57,820 |
|||
| style="text-align:right" | 66,012 |
|||
| style="text-align:right" | 72,923 |
|||
| style="text-align:right" | 81,600 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2022 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 12,208: | Line 7,538: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 2,155 |
|||
| style="text-align:right" | 4,077 |
|||
| style="text-align:right" | 9,211 |
|||
| style="text-align:right" | 11,325 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2023 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 12,221: | Line 7,555: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2024 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 12,233: | Line 7,567: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2025 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 12,245: | Line 7,579: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total''' |
||
| style="text-align: |
| style="text-align:left" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''538,304''' |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | |
| style="text-align:right" | *Supplementary information and unaudited |
||
|- |
|||
| style="text-align:left" | Claims Development [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Incurred losses and ALAE, net of reinsurance |
|||
| style="text-align:right" | 11 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net |
|||
| style="text-align:right" | 11 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contract, Cumulative Number of Reported Claims / claim |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cumulative net paid loss and LAE |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Net reserves for losses and ALAE|Net reserves for losses and ALAE, short-tail/monoline specialty lines, multi-line solutions, exited lines, reinsurance recoverable on unpaid claims, unallocated LAE|rmmhubj8mh|1f87rdfb5o|elseqv5tt7|kind=table|order=179}} |
|||
=== Schedule of Reconciliation of Claims Development to Liability === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | 2025 |
||
! |
! style="text-align:center" | 2024 |
||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2022 |
|||
|- |
|- |
||
! style="text-align:left" | Net reserves for losses and ALAE: |
|||
! class="col-m" style="text-align:right" | — |
|||
! class="col-m" style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Short-tail/Monoline Specialty Lines |
||
| style="text-align:right" | |
| style="text-align:right" | 545,942 |
||
| style="text-align:right" | |
| style="text-align:right" | 367,226 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Multi-line Solutions |
||
| style="text-align:right" | |
| style="text-align:right" | 739,430 |
||
| style="text-align:right" | |
| style="text-align:right" | 631,065 |
||
| style="text-align:right" | 455,484 |
|||
| style="text-align:right" | 435,986 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Exited Lines |
||
| style="text-align:right" | |
| style="text-align:right" | 81,666 |
||
| style="text-align:right" | |
| style="text-align:right" | 86,689 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Reserves for losses and |
| style="text-align:left" | '''Reserves for losses and ALAE, net of reinsurance''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,367,038''' |
||
| style="text-align:right" | 1, |
| style="text-align:right" | '''1,084,980''' |
||
| style="text-align:right" | 1,314,501 |
|||
| style="text-align:right" | 1,141,757 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Reinsurance recoverable on unpaid claims:''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Short- |
| style="text-align:left" | Short-tail/Monoline Specialty Lines |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Reserves for losses and LAE, net of reinsurance |
|||
| style="text-align:right" | 545,942 |
|||
| style="text-align:right" | 367,226 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Ceded unpaid losses and LAE |
|||
| style="text-align:right" | 388,276 |
| style="text-align:right" | 388,276 |
||
| style="text-align:right" | 275,204 |
| style="text-align:right" | 275,204 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Multi-line Solutions |
| style="text-align:left" | Multi-line Solutions |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Reserves for losses and LAE, net of reinsurance |
|||
| style="text-align:right" | 739,430 |
|||
| style="text-align:right" | 631,065 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Ceded unpaid losses and LAE |
|||
| style="text-align:right" | 514,393 |
| style="text-align:right" | 514,393 |
||
| style="text-align:right" | 380,344 |
| style="text-align:right" | 380,344 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Exited Lines |
| style="text-align:left" | Exited Lines |
||
| style="text-align:right" | |
| style="text-align:right" | 18,496 |
||
| style="text-align:right" | |
| style="text-align:right" | 15,298 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Total reinsurance recoverable on unpaid claims''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''921,165''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''670,846''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Unallocated LAE''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''30,691''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''26,557''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Reserves for losses and LAE at end of year''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''2,318,894''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,782,383''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Average annual percentage payout of incurred claims by age|Average annual percentage payout of incurred claims by age, short-tail/monoline specialty lines, multi-line solutions, exited lines|do9an7x5kp|kind=table|order=180}} |
|||
=== Schedule of Historical Claims Duration === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! colspan="11" style="text-align:center" | Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
|- |
|- |
||
! style="text-align:left" | |
|||
! colspan="10" style="text-align:center" | Years |
|||
|- |
|- |
||
! style="text-align:left" | — |
|||
! class="col-m" style="text-align:right" | 1* |
|||
! class="col-m" style="text-align:right" | 2* |
|||
! class="col-m" style="text-align:right" | 3* |
|||
! class="col-m" style="text-align:right" | 4* |
|||
! class="col-s" style="text-align:right" | 5* |
|||
! class="col-s" style="text-align:right" | 6* |
|||
! class="col-s" style="text-align:right" | 7* |
|||
! class="col-s" style="text-align:right" | 8* |
|||
! class="col-s" style="text-align:right" | 9* |
|||
! class="col-s" style="text-align:right" | 10* |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Short-Tail/Monoline Specialty Lines |
||
| style="text-align:right" | 21. |
| style="text-align:right" | 21.1% |
||
| style="text-align:right" | 38.1% |
|||
| style="text-align:right" | 10.8% |
|||
| style="text-align:right" | 9.7% |
|||
| style="text-align:right" | 15.2% |
|||
| style="text-align:right" | N/A |
|||
| style="text-align:right" | N/A |
|||
| style="text-align:right" | N/A |
|||
| style="text-align:right" | N/A |
|||
| style="text-align:right" | N/A |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Multi-line Solutions |
||
| style="text-align:right" | |
| style="text-align:right" | 23.9% |
||
| style="text-align:right" | 21.6% |
|||
| style="text-align:right" | 15.6% |
|||
| style="text-align:right" | 13.6% |
|||
| style="text-align:right" | 10.5% |
|||
| style="text-align:right" | 4.8% |
|||
| style="text-align:right" | 1.9% |
|||
| style="text-align:right" | 2.4% |
|||
| style="text-align:right" | 1.3% |
|||
| style="text-align:right" | 0.1% |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Exited Lines |
||
| style="text-align:right" | |
| style="text-align:right" | 27.5% |
||
| style="text-align:right" | 12.2% |
|||
| style="text-align:right" | 4.9% |
|||
| style="text-align:right" | 9.9% |
|||
| style="text-align:right" | 8.9% |
|||
| style="text-align:right" | 6.8% |
|||
| style="text-align:right" | 4.9% |
|||
| style="text-align:right" | 2.9% |
|||
| style="text-align:right" | 2.0% |
|||
| style="text-align:right" | 1.3% |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''*Supplementary information and unaudited''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''*Supplementary information and unaudited''' |
||
| style="text-align:right" | '''*Supplementary information and unaudited''' |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | '''*Supplementary information and unaudited''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''*Supplementary information and unaudited''' |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align: |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Historical Claims Duration [Line Items] |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Year 1 |
|||
| style="text-align:right" | 23.90% |
|||
|- |
|||
| style="text-align:left" | Year 2 |
|||
| style="text-align:right" | 21.60% |
|||
|- |
|||
| style="text-align:left" | Year 3 |
|||
| style="text-align:right" | 15.60% |
|||
|- |
|||
| style="text-align:left" | Year 4 |
|||
| style="text-align:right" | 13.60% |
|||
|- |
|||
| style="text-align:left" | Year 5 |
|||
| style="text-align:right" | 10.50% |
|||
|- |
|||
| style="text-align:left" | Year 6 |
|||
| style="text-align:right" | 4.80% |
|||
|- |
|||
| style="text-align:left" | Year 7 |
|||
| style="text-align:right" | 1.90% |
|||
|- |
|||
| style="text-align:left" | Year 8 |
|||
| style="text-align:right" | 2.40% |
|||
|- |
|||
| style="text-align:left" | Year 9 |
|||
| style="text-align:right" | 1.30% |
|||
|- |
|||
| style="text-align:left" | Year 10 |
|||
| style="text-align:right" | 0.10% |
|||
|- |
|||
| style="text-align:left" | Exited Lines |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Short-Duration Insurance Contracts, Historical Claims Duration [Line Items] |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Year 1 |
|||
| style="text-align:right" | 27.50% |
|||
|- |
|||
| style="text-align:left" | Year 2 |
|||
| style="text-align:right" | 12.20% |
|||
|- |
|||
| style="text-align:left" | Year 3 |
|||
| style="text-align:right" | 4.90% |
|||
|- |
|||
| style="text-align:left" | Year 4 |
|||
| style="text-align:right" | 9.90% |
|||
|- |
|||
| style="text-align:left" | Year 5 |
|||
| style="text-align:right" | 8.90% |
|||
|- |
|||
| style="text-align:left" | Year 6 |
|||
| style="text-align:right" | 6.80% |
|||
|- |
|||
| style="text-align:left" | Year 7 |
|||
| style="text-align:right" | 4.90% |
|||
|- |
|||
| style="text-align:left" | Year 8 |
|||
| style="text-align:right" | 2.90% |
|||
|- |
|||
| style="text-align:left" | Year 9 |
|||
| style="text-align:right" | 2.00% |
|||
|- |
|||
| style="text-align:left" | Year 10 |
|||
| style="text-align:right" | 1.30% |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|15. Commission and Fee Income|Skyward Underwriters Agency, Inc. (SUA), commission and fee income, managing general insurance agent, reinsurance broker, property and casualty, accident and health risks|qfq1t7e6o0|kind=prose|order=181}} |
|||
== Commission and Fee Income == |
|||
* ''Skyward Underwriters Agency, Inc. (SUA)'' is a subsidiary of the Company <sup>p. 98</sup>. |
|||
=== Schedule of Disaggregation of Revenue === |
|||
* SUA acts as a managing general insurance agent and reinsurance broker <sup>p. 98</sup>. |
|||
* SUA specializes in property and casualty and accident and health risks within specialty niche markets <sup>p. 98</sup>. |
|||
* ''Commission and fee income'' is primarily generated by SUA <sup>p. 98</sup>. |
|||
* This income is derived from the placement of insurance policies with third-party insurance or reinsurance companies <sup>p. 98</sup>. |
|||
{{Indexing|Net commission and fee income|SUA commission revenue, SUA fee revenue, other commission and fee revenue, commission and fee expenses|qfq1t7e6o0|kind=table|order=182}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
|||
|- |
|||
! style="text-align: |
! class="col-s" style="text-align:right" | 2023 |
||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Disaggregation of Revenue [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total commission and fee revenue |
|||
| style="text-align:right; font-weight:bold" | 12,381 |
|||
| style="text-align:right; font-weight:bold" | 10,676 |
|||
| style="text-align:right; font-weight:bold" | 9,819 |
|||
|- |
|||
| style="text-align:left" | Commission and fee expenses |
|||
| style="text-align:right" | -5,526 |
|||
| style="text-align:right" | -3,973 |
|||
| style="text-align:right" | -3,755 |
|||
|- |
|||
| style="text-align:left" | Net commission and fee income |
|||
| style="text-align:right" | 6,855 |
|||
| style="text-align:right" | 6,703 |
|||
| style="text-align:right" | 6,064 |
|||
|- |
|- |
||
| style="text-align:left" | SUA commission revenue |
| style="text-align:left" | SUA commission revenue |
||
| style="text-align:right" | |
| style="text-align:right" | 8,323 |
||
| style="text-align:right" | |
| style="text-align:right" | 7,967 |
||
| style="text-align:right" | |
| style="text-align:right" | 7,222 |
||
|- |
|||
| style="text-align:left" | Disaggregation of Revenue [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total commission and fee revenue |
|||
| style="text-align:right; font-weight:bold" | 8,323 |
|||
| style="text-align:right; font-weight:bold" | 7,967 |
|||
| style="text-align:right; font-weight:bold" | 7,222 |
|||
|- |
|- |
||
| style="text-align:left" | SUA fee revenue |
| style="text-align:left" | SUA fee revenue |
||
| style="text-align:right" | |
| style="text-align:right" | 2,333 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,443 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,732 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Other commission and fee revenue (loss) |
||
| style="text-align:right" | |
| style="text-align:right" | 1,725 |
||
| style="text-align:right" | |
| style="text-align:right" | 266 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 135 ) |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total commission and fee revenue''' |
||
| style="text-align:right |
| style="text-align:right" | '''12,381''' |
||
| style="text-align:right |
| style="text-align:right" | '''10,676''' |
||
| style="text-align:right |
| style="text-align:right" | '''9,819''' |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Commission and fee expenses |
||
| style="text-align:right" | |
| style="text-align:right" | ( 5,526 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 3,973 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 3,755 ) |
||
|- |
|||
| style="text-align:left" | Disaggregation of Revenue [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Net commission and fee income''' |
||
| style="text-align:right |
| style="text-align:right" | '''6,855''' |
||
| style="text-align:right |
| style="text-align:right" | '''6,703''' |
||
| style="text-align:right |
| style="text-align:right" | '''6,064''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Contract assets balance|Contract assets balance|kind=table|order=183}} |
|||
=== Schedule of Company’s Opening and Closing Balances of Contract Assets === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:center" | Contract Assets |
||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|- |
||
! style="text-align:left" | Balance at December 31, 2023 |
|||
! class="col-s" style="text-align:right" | 976 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Balance at December 31, 2024 |
||
| style="text-align:right" | 953 |
|||
| style="text-align:right" | 1,416 |
| style="text-align:right" | 1,416 |
||
| style="text-align:right" | 976 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|16. Underwriting, Acquisition and Insurance Expenses|Underwriting, acquisition and insurance expenses, commissions and brokerage, salaries and employee benefits, general and administrative expenses|irxh3hcbqz|kind=prose|order=184|f1=Underwriting, acquisition and insurance expenses|v1=FY25: USD 390.0m|f2=Commissions and brokerage|v2=FY25: USD 190.0m|f3=Salaries and employee benefits|v3=FY25: USD 110.0m|f4=General and administrative expenses|v4=FY25: USD 90.0m}} |
|||
== Underwriting, Acquisition and Insurance Expenses == |
|||
* ''Underwriting, acquisition and insurance expenses'' were USD 390.0m in 2025, USD 330.0m in 2024, and USD 270.0m in 2023 <sup>p. 99</sup>. |
|||
* ''Commissions and brokerage'' were USD 190.0m in 2025, USD 160.0m in 2024, and USD 130.0m in 2023 <sup>p. 99</sup>. |
|||
* ''Salaries and employee benefits'' were USD 110.0m in 2025, USD 90.0m in 2024, and USD 70.0m in 2023 <sup>p. 99</sup>. |
|||
* ''General and administrative expenses'' were USD 90.0m in 2025, USD 80.0m in 2024, and USD 70.0m in 2023 <sup>p. 99</sup>. |
|||
{{Indexing|Underwriting, acquisition and insurance expenses|Amortization of policy acquisition costs, other operating and general expenses, total underwriting, acquisition and insurance expenses|irxh3hcbqz|kind=table|order=185}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
|||
! class="col-s" style="text-align:right" | 2023 |
|||
|- |
|- |
||
| style="text-align:left" | Amortization of policy acquisition costs |
|||
| style="text-align:right" | 195,422 |
|||
| style="text-align:right" | 149,975 |
|||
| style="text-align:right" | 108,514 |
|||
|- |
|- |
||
| style="text-align:left" | Other |
| style="text-align:left" | Other operating and general expenses |
||
| style="text-align:right" | |
| style="text-align:right" | 181,937 |
||
| style="text-align:right" | |
| style="text-align:right" | 161,782 |
||
| style="text-align:right" | |
| style="text-align:right" | 134,930 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total underwriting, acquisition and insurance expenses''' |
||
| style="text-align:right |
| style="text-align:right" | '''377,359''' |
||
| style="text-align:right |
| style="text-align:right" | '''311,757''' |
||
| style="text-align:right |
| style="text-align:right" | '''243,444''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|17. Reinsurance|Reinsurance agreements, funded trust accounts, LPT retroactive reinsurance agreement, reinsurance recoverable from R&Q, ceded reinsurance contracts, deposit asset|20fueoa3q1|tc5fw176pu|kind=prose|order=186|f1=Market value of trust accounts|v1=Dec 31, 2025: $233.5 million|f2=Reinsurance recoverable from R&Q|v2=Dec 31, 2024: $22.7 million|f3=LPT commuted|v3=Jan 31, 2025|f4=Deposit asset|v4=Dec 31, 2025: $22.7 million}} |
|||
== Reinsurance == |
|||
* ''Reinsurance agreements'' are used to assume and cede premiums and benefits with other insurance companies <sup>p. 100</sup>. |
|||
=== Schedule of Premiums Written and Earned === |
|||
* ''Reinsurance agreements'' increase the Company's capacity to write larger risks and manage loss exposure within its capital resources <sup>p. 100</sup>. |
|||
* The Company remains obligated for ceded amounts if reinsurers fail to meet their obligations <sup>p. 100</sup>. |
|||
* The Company entered into agreements with several reinsurers to establish ''funded trust accounts'' where the Company is the sole beneficiary <sup>p. 100</sup>. |
|||
* These ''trust accounts'' provide additional security for collecting claim recoverables under reinsurance contracts <sup>p. 100</sup>. |
|||
* The Company does not carry these trust accounts on its balance sheet as it only gains custody upon the reinsurer's failure to pay <sup>p. 100</sup>. |
|||
* The ''market value of these trust accounts'' was approximately $233.5 million at December 31, 2025 <sup>p. 100</sup>. |
|||
* The ''trust amount'' will be periodically adjusted by mutual agreement based on claim payments and loss reserve recoverables <sup>p. 100</sup>. |
|||
* During Q1 2020, the Company entered into an ''LPT retroactive reinsurance agreement'' with R&Q <sup>p. 100</sup>. |
|||
* The ''reinsurance recoverable from R&Q'' was $22.7 million at December 31, 2024 <sup>p. 100</sup>. |
|||
* The ''LPT'' was commuted effective January 31, 2025, and the Company received the reinsurance recoverable balance in full <sup>p. 100</sup>. |
|||
* Certain ''ceded reinsurance contracts'' that transfer only significant timing risk and insufficient underwriting risk are accounted for using the deposit method <sup>p. 100</sup>. |
|||
* The Company’s ''deposit asset'' was $22.7 million at December 31, 2025, and $25.9 million at December 31, 2024 <sup>p. 100</sup>. |
|||
* The ''deposit asset'' was included in other assets on the Consolidated Balance Sheets <sup>p. 100</sup>. |
|||
{{Indexing|Premiums and ceded losses and LAE incurred|Direct premiums, assumed premiums, ceded premiums, net premiums, ceded losses and LAE incurred|wpkf9ycgxf|20fueoa3q1|kind=table|order=187}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan=" |
! colspan="2" style="text-align:center" | 2025 |
||
! colspan="2" style="text-align:center" | 2024 |
|||
! colspan="2" style="text-align:center" | 2023 |
|||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Written |
||
! class="col- |
! class="col-m" style="text-align:right" | Earned |
||
! class="col- |
! class="col-m" style="text-align:right" | Written |
||
! class="col-m" style="text-align:right" | Earned |
|||
|- |
|||
! class="col-s" style="text-align:right" | Written |
|||
! class="col-s" style="text-align:right" | Earned |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Direct premiums |
| style="text-align:left" | Direct premiums |
||
| style="text-align:right" | 1,684,411 |
| style="text-align:right" | 1,684,411 |
||
| style="text-align:right" | 1,622,594 |
|||
| style="text-align:right" | 1,458,637 |
| style="text-align:right" | 1,458,637 |
||
| style="text-align:right" | 1,375,917 |
|||
| style="text-align:right" | 1,241,180 |
| style="text-align:right" | 1,241,180 |
||
| style="text-align:right" | 1,155,835 |
|||
|- |
|- |
||
| style="text-align:left" | Assumed premiums |
| style="text-align:left" | Assumed premiums |
||
| style="text-align:right" | 481,825 |
| style="text-align:right" | 481,825 |
||
| style="text-align:right" | 406,792 |
|||
| style="text-align:right" | 284,595 |
| style="text-align:right" | 284,595 |
||
| style="text-align:right" | 282,662 |
|||
| style="text-align:right" | 218,649 |
| style="text-align:right" | 218,649 |
||
| style="text-align:right" | 193,971 |
|||
|- |
|- |
||
| style="text-align:left" | Ceded premiums |
| style="text-align:left" | Ceded premiums |
||
| style="text-align:right" | |
| style="text-align:right" | ( 760,004 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 724,881 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 619,654 ) |
||
| style="text-align:right" | ( 601,857 ) |
|||
| style="text-align:right" | ( 549,138 ) |
|||
| style="text-align:right" | ( 520,663 ) |
|||
|- |
|- |
||
| style="text-align:left" | Net premiums |
| style="text-align:left" | '''Net premiums''' |
||
| style="text-align:right" | 1,406,232 |
| style="text-align:right" | '''1,406,232''' |
||
| style="text-align:right" | 1, |
| style="text-align:right" | '''1,304,505''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,123,578''' |
||
| style="text-align:right" | '''1,056,722''' |
|||
| style="text-align:right" | '''910,691''' |
|||
| style="text-align:right" | '''829,143''' |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Ceded losses and LAE incurred''' |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | '''697,978''' |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | '''534,295''' |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | '''337,011''' |
|||
|- |
|||
| style="text-align:left" | Direct premiums |
|||
| style="text-align:right" | 1,622,594 |
|||
| style="text-align:right" | 1,375,917 |
|||
| style="text-align:right" | 1,155,835 |
|||
|- |
|||
| style="text-align:left" | Assumed premiums |
|||
| style="text-align:right" | 406,792 |
|||
| style="text-align:right" | 282,662 |
|||
| style="text-align:right" | 193,971 |
|||
|- |
|||
| style="text-align:left" | Ceded premiums |
|||
| style="text-align:right" | -724,881 |
|||
| style="text-align:right" | -601,857 |
|||
| style="text-align:right" | -520,663 |
|||
|- |
|||
| style="text-align:left" | Net premiums |
|||
| style="text-align:right" | 1,304,505 |
|||
| style="text-align:right" | 1,056,722 |
|||
| style="text-align:right" | 829,143 |
|||
|- |
|||
| style="text-align:left" | Ceded losses and LAE incurred |
|||
| style="text-align:right" | 697,978 |
|||
| style="text-align:right" | 534,295 |
|||
| style="text-align:right" | 337,011 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Reinsurance recoverables|Ceded unpaid losses and LAE, ceded paid losses and LAE, loss portfolio transfer, allowance for credit losses, ceded unearned premium|tc5fw176pu|kind=table|order=188}} |
|||
=== Schedule of Reinsurance Recoverable and Ceded Premiums === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2024 |
||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2022 |
|||
|- |
|||
| style="text-align:left" | Insurance [Abstract] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Ceded unpaid losses and LAE |
| style="text-align:left" | Ceded unpaid losses and LAE |
||
| style="text-align:right" | 921,165 |
| style="text-align:right" | 921,165 |
||
| style="text-align:right" | 670,846 |
| style="text-align:right" | 670,846 |
||
| style="text-align:right" | 455,484 |
|||
| style="text-align:right" | 435,986 |
|||
|- |
|- |
||
| style="text-align:left" | Ceded paid losses and LAE |
| style="text-align:left" | Ceded paid losses and LAE |
||
| style="text-align:right" | 201,010 |
| style="text-align:right" | 201,010 |
||
| style="text-align:right" | 166,663 |
| style="text-align:right" | 166,663 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Loss portfolio transfer |
| style="text-align:left" | Loss portfolio transfer |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | 22,662 |
| style="text-align:right" | 22,662 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Allowance for credit losses |
| style="text-align:left" | Allowance for credit losses |
||
| style="text-align:right" | |
| style="text-align:right" | ( 2,295 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 2,295 ) |
||
| style="text-align:right" | -2,295 |
|||
| style="text-align:right" | -2,295 |
|||
|- |
|- |
||
| style="text-align:left" | Reinsurance recoverables |
| style="text-align:left" | '''Reinsurance recoverables''' |
||
| style="text-align:right" | 1,119,880 |
| style="text-align:right" | '''1,119,880''' |
||
| style="text-align:right" | 857,876 |
| style="text-align:right" | '''857,876''' |
||
| style="text-align:right" | 857,876 |
|||
| style="text-align:right" | 596,334 |
|||
|- |
|- |
||
| style="text-align:left" | Ceded unearned premium |
| style="text-align:left" | '''Ceded unearned premium''' |
||
| style="text-align:right" | 238,948 |
| style="text-align:right" | '''238,948''' |
||
| style="text-align:right" | 203,901 |
| style="text-align:right" | '''203,901''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|18. Stock Based Compensation|2022 Long-Term Incentive Plan, restricted stock, restricted stock units, performance stock units, stock options, cash-based performance awards, deferral program, Black-Scholes model, volatility, aggregate intrinsic value of options outstanding, weighted-average remaining contractual life of options outstanding|ebig3opk63|kind=prose|order=189|f1=Shares available under 2022 Plan|v1=3,200,656|f2=Deferral program approved|v2=November 2024|f3=Stock options granted to employees|v3=FY23: $4.4 million|f4=Aggregate intrinsic value of options outstanding|v4=Dec 31, 2025: $27.4 million|f5=Weighted-average remaining contractual life of options outstanding|v5=Dec 31, 2025: 7.0 years}} |
|||
=== Narrative === |
|||
* The ''2022 Long-Term Incentive Plan'' (2022 Plan) was approved by the Board of Directors on September 23, 2022, and became effective on January 12, 2023 <sup>p. 101</sup>. |
|||
<div style="overflow-x:auto"> |
|||
* The ''2022 Plan'' replaced the Company’s prior Long Term Incentive Plan (2020 Plan) <sup>p. 101</sup>. |
|||
{| class="wikitable fintable" |
|||
* The ''2022 Plan'' allows for granting restricted stock, restricted stock units, performance stock units, stock options, and cash-based performance awards to select employees and non-employee directors <sup>p. 101</sup>. |
|||
! style="text-align:left" | USD ($) $ in Millions |
|||
* ''3,200,656 shares'' of common stock were available for issuance under the 2022 Plan <sup>p. 101</sup>. |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
* In ''November 2024'', the Compensation Committee approved a program for independent directors to defer settlement of annual restricted stock units (RSU) awards <sup>p. 101</sup>. |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
* Directors can elect to defer RSU settlement to the fifth anniversary of the grant date, the tenth anniversary of the grant date, or the date of separation of service from the Company <sup>p. 101</sup>. |
|||
|- |
|||
* This ''deferral program'' was available for Directors who elected in 2024 to defer settlement of their 2025 RSU awards, which vest in 2026 <sup>p. 101</sup>. |
|||
| style="text-align:left" | Insurance [Abstract] |
|||
* The ''grant date fair value of options'' under the 2022 Plan was determined using the Black-Scholes model, with a contractual term of 10 years less the weighted average service period <sup>p. 101</sup>. |
|||
| style="text-align:right" | — |
|||
* ''Volatility'' for option valuation was based on historical volatility of comparable publicly traded insurance companies <sup>p. 101</sup>. |
|||
| style="text-align:right" | — |
|||
* ''Stock options granted to employees'' during the year ended December 31, 2023, were valued at approximately $4.4 million based on grant date fair value <sup>p. 101</sup>. |
|||
|- |
|||
* The ''aggregate intrinsic value of options outstanding'' was $27.4 million at December 31, 2025, and $27.0 million at December 31, 2024 <sup>p. 101</sup>. |
|||
| style="text-align:left" | Market value of trust funds |
|||
* The ''weighted-average remaining contractual life of options outstanding'' at December 31, 2025, was 7.0 years <sup>p. 101</sup>. |
|||
| style="text-align:right" | 233.5 |
|||
* The ''fair value of restricted stock and restricted stock units'' under the 2022 Plan for awards granted at the time of the Company’s IPO was the IPO price of $15.00 per share <sup>p. 101</sup>. |
|||
| style="text-align:right" | — |
|||
* The ''fair value of subsequent grants'' of restricted stock units was equal to the closing stock price on the grant date <sup>p. 101</sup>. |
|||
|- |
|||
* The ''expense for equity-based incentives'' is based on fair value at grant date and amortized over their vesting period <sup>p. 101</sup>. |
|||
| style="text-align:left" | Reinsurance recoverable from R&Q |
|||
* ''Restricted stock and restricted stock units granted to employees and the Board of Directors'' were valued at approximately $12.2 million in 2025, $8.5 million in 2024, and $17.7 million in 2023, based on grant date fair value <sup>p. 101</sup>. |
|||
| style="text-align:right" | — |
|||
* ''Board of Directors'' were granted 12,579 shares in 2025, 19,453 shares in 2024, and 23,482 shares in 2023 of restricted stock and restricted stock units, each with a one-year service period <sup>p. 101</sup>. |
|||
| style="text-align:right" | 22.7 |
|||
* The ''total fair value of shares vested'' for employees and Board of Directors was $6.0 million in 2025, $3.8 million in 2024, and $0.5 million in 2023 <sup>p. 101</sup>. |
|||
|- |
|||
* As of ''December 31, 2025'', the total unrecognized compensation cost related to non-vested, stock-based compensation awards was $17.4 million <sup>p. 101</sup>. |
|||
| style="text-align:left" | Deposit contracts, assets |
|||
* The ''weighted average period'' over which the unrecognized compensation cost is expected to be recognized is 1.6 years <sup>p. 101</sup>. |
|||
| style="text-align:right" | 22.7 |
|||
* The ''Company recognized stock-based compensation expense'' of $12.0 million in 2025, $9.4 million in 2024, and $8.5 million in 2023 <sup>p. 101</sup>. |
|||
| style="text-align:right" | 25.9 |
|||
* The ''2022 Employee Stock Purchase Plan'' (ESPP) was approved by the Board of Directors on September 23, 2022, and became effective on May 15, 2023 <sup>p. 101</sup>. |
|||
|} |
|||
* The ''ESPP'' is administered by the Compensation Committee <sup>p. 101</sup>. |
|||
</div> |
|||
* Under the ''ESPP'', employees can elect to have a percentage of their annual base earnings withheld to purchase common stock at two specified intervals each year <sup>p. 101</sup>. |
|||
* The ''purchase price of common stock'' under the ESPP is 85% of the lower of its beginning-of-interval or end-of-interval market price <sup>p. 101</sup>. |
|||
* The ''Company has reserved 376,548 common shares'' under the ESPP <sup>p. 101</sup>. |
|||
* The ''grant date fair value of options under the ESPP'' was determined using the Black-Scholes model, with a term of 6 months (between grant date and exercisable date) <sup>p. 101</sup>. |
|||
* ''Volatility'' for ESPP option valuation was based on historical volatility of comparable publicly traded insurance companies <sup>p. 101</sup>. |
|||
* As of ''December 31, 2025'', a total of 141,845 shares had been purchased under the ESPP <sup>p. 101</sup>. |
|||
* The ''Company recognized ESPP expense'' of $0.7 million in 2025 and $0.5 million in 2024 <sup>p. 101</sup>. |
|||
* As of ''December 31, 2025'', the fair value of unrecognized ESPP expense was $0.3 million <sup>p. 101</sup>. |
|||
{{Indexing|ESPP awards by type and service period|ESPP awards, market condition awards, performance condition awards, service condition awards|ebig3opk63|kind=table|order=190}} |
|||
== Stock Based Compensation == |
|||
=== Narrative === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| class="wikitable" |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! |
! style="text-align:center" | Award Payout Range |
||
! style="text-align:center" | |
! style="text-align:center" | Requisite Service Period |
||
! style="text-align:center" | |
! style="text-align:center" | Target Stock and Stock Units |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | Year ended December 31, 2025 |
||
! class="col- |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | Jan. 18, 2023 |
|||
! class="col-s" style="text-align:right" | Jan. 12, 2023 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Market condition awards |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 0 %- 150 % |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 3 years |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 22,495 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Performance condition awards |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 0 %- 150 % |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 3 years |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 59,769 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | 3,200,656 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Service condition awards |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | N/A |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 1 - 4 years |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 144,921 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | — |
||
| style="text-align:right" | — |
| class="col-s" style="text-align:right" | — |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 227,185 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Market condition awards |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 0 %- 150 % |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 3 years |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 32,058 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Performance condition awards |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 0 %- 150 % |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 3 years |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 76,881 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Service condition awards |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | N/A |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 1 - 4 years |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 124,025 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | — |
||
| style="text-align:right" | — |
| class="col-s" style="text-align:right" | — |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 232,964 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Market condition awards |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 0 %- 150 % |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 3 years |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 37,622 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Performance condition awards |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 0 %- 150 % |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 3 years |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 95,456 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Service condition awards |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | N/A |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 1 - 4 years |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 968,778 |
||
| style="text-align:right" | 15.00 |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Stock options |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | N/A |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 3 - 4 years |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 759,990 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| class="col-s" style="text-align:right" | — |
||
| style="text-align:right" | — |
| class="col-s" style="text-align:right" | — |
||
| style="text-align:right" | |
| class="col-s" style="text-align:right" | 1,861,846 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Granted (in shares) |
|||
| style="text-align:right" | 254,978 |
|||
| style="text-align:right" | 268,631 |
|||
| style="text-align:right" | 1,101,856 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Fair value of shares vested in period |
|||
| style="text-align:right" | 6.0 |
|||
| style="text-align:right" | 3.8 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Employee Stock |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Authorized target common share (in shares) |
|||
| style="text-align:right" | 376,548 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Stock based compensation expense |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Purchase price of common stock, percent |
|||
| style="text-align:right" | 85.00% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-based compensation arrangement by share-based payment award, shares issues in period (in shares) |
|||
| style="text-align:right" | 141,845 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-based payment arrangement, amount capitalized |
|||
| style="text-align:right" | 0.3 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Long Term Incentive Plan |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Authorized target common share (in shares) |
|||
| style="text-align:right" | 227,185 |
|||
| style="text-align:right" | 232,964 |
|||
| style="text-align:right" | 1,861,846 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-base compensation arrangement by share-based payment award, terms of award |
|||
| style="text-align:right" | 10 years |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Stock options granted to employees |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 4.4 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Long Term Incentive Plan / Restricted Stock Awards And Units |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Shares granted, value |
|||
| style="text-align:right" | 12.2 |
|||
| style="text-align:right" | 8.5 |
|||
| style="text-align:right" | 17.7 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Long Term Incentive Plan / Director / Restricted Stock |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Granted (in shares) |
|||
| style="text-align:right" | 12,579 |
|||
| style="text-align:right" | 19,453 |
|||
| style="text-align:right" | 23,482 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Requisite service period |
|||
| style="text-align:right" | 1 year |
|||
| style="text-align:right" | 1 year |
|||
| style="text-align:right" | 1 year |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Stock option activity|Stock option activity, outstanding stock, forfeited stock|ebig3opk63|kind=table|order=191}} |
|||
=== Schedule of Equity Awards === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | shares |
|||
! colspan="3" style="text-align:center" | 12 Months Ended |
|||
! style="text-align:center" | |
|||
|- |
|||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Weighted-Average Exercise Price |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Stock |
||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
! class="col-s" style="text-align:right" | Jan. 12, 2023 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Outstanding at January 1, 2025 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Target Stock and Stock Units (in shares) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 3,200,656 |
|||
|- |
|||
| style="text-align:left" | Long Term Incentive Plan |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Target Stock and Stock Units (in shares) |
|||
| style="text-align:right" | 227,185 |
|||
| style="text-align:right" | 232,964 |
|||
| style="text-align:right" | 1,861,846 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Market condition awards / Long Term Incentive Plan |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Requisite Service Period |
|||
| style="text-align:right" | 3 years |
|||
| style="text-align:right" | 3 years |
|||
| style="text-align:right" | 3 years |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Target Stock and Stock Units (in shares) |
|||
| style="text-align:right" | 22,495 |
|||
| style="text-align:right" | 32,058 |
|||
| style="text-align:right" | 37,622 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Market condition awards / Low / Long Term Incentive Plan |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Award Payout Range |
|||
| style="text-align:right" | 0.00% |
|||
| style="text-align:right" | 0.00% |
|||
| style="text-align:right" | 0.00% |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Market condition awards / High / Long Term Incentive Plan |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Award Payout Range |
|||
| style="text-align:right" | 150.00% |
|||
| style="text-align:right" | 150.00% |
|||
| style="text-align:right" | 150.00% |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Performance condition awards / Long Term Incentive Plan |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Requisite Service Period |
|||
| style="text-align:right" | 3 years |
|||
| style="text-align:right" | 3 years |
|||
| style="text-align:right" | 3 years |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Target Stock and Stock Units (in shares) |
|||
| style="text-align:right" | 59,769 |
|||
| style="text-align:right" | 76,881 |
|||
| style="text-align:right" | 95,456 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Performance condition awards / Low / Long Term Incentive Plan |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Award Payout Range |
|||
| style="text-align:right" | 0.00% |
|||
| style="text-align:right" | 0.00% |
|||
| style="text-align:right" | 0.00% |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Performance condition awards / High / Long Term Incentive Plan |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Award Payout Range |
|||
| style="text-align:right" | 150.00% |
|||
| style="text-align:right" | 150.00% |
|||
| style="text-align:right" | 150.00% |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Service condition awards / Long Term Incentive Plan |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Target Stock and Stock Units (in shares) |
|||
| style="text-align:right" | 144,921 |
|||
| style="text-align:right" | 124,025 |
|||
| style="text-align:right" | 968,778 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Service condition awards / Low / Long Term Incentive Plan |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Requisite Service Period |
|||
| style="text-align:right" | 1 year |
|||
| style="text-align:right" | 1 year |
|||
| style="text-align:right" | 1 year |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Service condition awards / High / Long Term Incentive Plan |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Requisite Service Period |
|||
| style="text-align:right" | 4 years |
|||
| style="text-align:right" | 4 years |
|||
| style="text-align:right" | 4 years |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Options / Long Term Incentive Plan |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Target Stock and Stock Units (in shares) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 759,990 |
| style="text-align:right" | 759,990 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Forfeited |
||
| style="text-align:right" | |
| style="text-align:right" | 15.00 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 219 ) |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Outstanding at December 31, 2025''' |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Requisite Service Period |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 3 years |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Options / High / Long Term Incentive Plan |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Requisite Service Period |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 4 years |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | '''759,771''' |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Outstanding stock at year-end|Outstanding stock at year-end|ebig3opk63|kind=table|order=192}} |
|||
=== Schedule of Options Activity === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | $ / shares |
|||
! style="text-align:center" | 12 Months Ended |
|||
! style="text-align:center" | |
|||
|- |
|||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Stock |
||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Outstanding at January 1, 2024 |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Forfeited, weighted average exercise price (in dollar per share) |
|||
| style="text-align:right" | 15.00 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Stock |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Outstanding, beginning of period (in shares) |
|||
| style="text-align:right" | 759,990 |
| style="text-align:right" | 759,990 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | '''Outstanding at December 31, 2024''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''759,990''' |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Outstanding, ending of period (in shares) |
|||
| style="text-align:right" | 759,771 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Outstanding (in shares) |
|||
| style="text-align:right" | 759,771 |
|||
| style="text-align:right" | 759,990 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Weighted-average grant-date fair value of stock and stock units|Weighted-average grant-date fair value of stock and stock units|kind=table|order=193}} |
|||
=== Schedule of Nonvested Share Activity (Details) - Restricted Stock Awards And Units === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | $ / shares |
|||
! colspan="3" style="text-align:center" | 12 Months Ended |
|||
|- |
|||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | Weighted-Average Grant-Date Fair Value |
||
! class="col- |
! class="col-m" style="text-align:right" | Stock and Stock Units |
||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Weighted-Average Grant-Date Fair Value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Non-vested |
| style="text-align:left" | Non-vested at January 1, 2025 |
||
| style="text-align:right" | 19.06 |
| style="text-align:right" | 19.06 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,325,483 |
||
| style="text-align:right" | 12.55 |
|||
|- |
|- |
||
| style="text-align:left" | Granted ( |
| class="wt-indent-1" style="text-align:left" | Granted (1) |
||
| style="text-align:right" | 47.77 |
| style="text-align:right" | 47.77 |
||
| style="text-align:right" | |
| style="text-align:right" | 254,978 |
||
| style="text-align:right" | 16.07 |
|||
|- |
|- |
||
| style="text-align:left" | Vested |
| style="text-align:left" | Vested |
||
| style="text-align:right" | 15.33 |
| style="text-align:right" | 15.33 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 391,746 ) |
||
| style="text-align:right" | 13.39 |
|||
|- |
|- |
||
| style="text-align:left" | Forfeited ( |
| class="wt-indent-1" style="text-align:left" | Forfeited (2) |
||
| style="text-align:right" | 25.74 |
| style="text-align:right" | 25.74 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 53,247 ) |
||
| style="text-align:right" | 15.29 |
|||
|- |
|- |
||
| style="text-align:left" | Non-vested |
| style="text-align:left" | '''Non-vested at December 31, 2025''' |
||
| style="text-align:right" | 27.06 |
| style="text-align:right" | '''27.06''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''1,135,468''' |
||
|- |
|||
| style="text-align:left" | Non-vested at January 1, 2024 |
|||
| style="text-align:right" | 15.13 |
| style="text-align:right" | 15.13 |
||
| style="text-align:right" | 1,445,449 |
|||
|- |
|- |
||
| style="text-align:left" | |
| class="wt-indent-1" style="text-align:left" | Granted (1) |
||
| style="text-align:right" | |
| style="text-align:right" | 31.72 |
||
| style="text-align:right" | |
| style="text-align:right" | 268,631 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Vested |
||
| style="text-align:right" | |
| style="text-align:right" | 13.16 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 285,957 ) |
||
|- |
|||
| class="wt-indent-1" style="text-align:left" | Forfeited (2) |
|||
| style="text-align:right" | 18.27 |
|||
| style="text-align:right" | ( 102,640 ) |
|||
|- |
|||
| style="text-align:left" | '''Non-vested at December 31, 2024''' |
|||
| style="text-align:right" | '''19.06''' |
|||
| style="text-align:right" | '''1,325,483''' |
|||
|- |
|||
| style="text-align:left" | Non-vested at January 1, 2023 |
|||
| style="text-align:right" | 12.55 |
|||
| style="text-align:right" | 419,896 |
| style="text-align:right" | 419,896 |
||
|- |
|- |
||
| style="text-align:left" | Granted ( |
| class="wt-indent-1" style="text-align:left" | Granted (1) |
||
| style="text-align:right" | |
| style="text-align:right" | 16.07 |
||
| style="text-align:right" | 268,631 |
|||
| style="text-align:right" | 1,101,856 |
| style="text-align:right" | 1,101,856 |
||
|- |
|- |
||
| style="text-align:left" | Vested |
| style="text-align:left" | Vested |
||
| style="text-align:right" | |
| style="text-align:right" | 13.39 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 40,645 ) |
||
| style="text-align:right" | -40,645 |
|||
|- |
|- |
||
| style="text-align:left" | Forfeited ( |
| class="wt-indent-1" style="text-align:left" | Forfeited (2) |
||
| style="text-align:right" | |
| style="text-align:right" | 15.29 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 35,658 ) |
||
| style="text-align:right" | -35,658 |
|||
|- |
|- |
||
| style="text-align:left" | Non-vested |
| style="text-align:left" | '''Non-vested at December 31, 2023''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''15.13''' |
||
| style="text-align:right" | 1, |
| style="text-align:right" | '''1,445,449''' |
||
| style="text-align:right" | 1,445,449 |
|||
|} |
|} |
||
</div> |
</div> |
||
(1) Increases above the 100% target level are reflected as granted in the period after which performance-based stock unit goals are achieved. |
|||
== Earnings Per Share == |
|||
(2) Decreases below the 100% target level are reflected as forfeited. |
|||
{{Indexing|19. Earnings Per Share|Basic and diluted net earnings per share, anti-dilutive instruments, common share equivalents of contingently issuable instruments|v7ij6av24f|kind=prose|order=194|f1=Years ended|v1=December 31, 2025, 2024, and 2023}} |
|||
=== Schedule of Earnings Per Share, Basic and Diluted === |
|||
* The table sets forth the computation of ''basic and diluted net earnings per share'' for the years ended December 31, 2025, 2024, and 2023 <sup>p. 102</sup>. |
|||
* The table presents ''anti-dilutive instruments'' excluded from the calculation of diluted weighted-average common share equivalents for the years ended December 31, 2025, 2024, and 2023 <sup>p. 102</sup>. |
|||
* The table presents ''common share equivalents of contingently issuable instruments'' excluded from basic earnings per share for the years ended December 31, 2025, 2024, and 2023 <sup>p. 102</sup>. |
|||
{{Indexing|Anti-dilutive instruments excluded from diluted weighted-average common share equivalents|Anti-dilutive instruments excluded from diluted weighted-average common share equivalents|kind=table|order=195}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands, except for share and per share amounts) |
||
! |
! style="text-align:center" | 2025 |
||
! style="text-align:center" | 2024 |
|||
! style="text-align:center" | 2023 |
|||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | Numerator |
||
! class="col- |
! class="col-m" style="text-align:right" | — |
||
! class="col- |
! class="col-m" style="text-align:right" | — |
||
! class="col- |
! class="col-m" style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Numerator |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Net income |
| style="text-align:left" | Net income |
||
| Line 13,508: | Line 8,191: | ||
| style="text-align:right" | 85,984 |
| style="text-align:right" | 85,984 |
||
|- |
|- |
||
| style="text-align:left" | Less: Undistributed income allocated to participating securities |
| style="text-align:left" | '''Less: Undistributed income allocated to participating securities''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''( 1,677 )''' |
||
|- |
|- |
||
| style="text-align:left" | Net income attributable to common stockholders (numerator for basic earnings per share) |
| style="text-align:left" | Net income attributable to common stockholders (numerator for basic earnings per share) |
||
| Line 13,518: | Line 8,201: | ||
| style="text-align:right" | 84,307 |
| style="text-align:right" | 84,307 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Add back: Undistributed income allocated to participating securities |
||
| style="text-align:right" | 170,028 |
|||
| style="text-align:right" | 118,828 |
|||
| style="text-align:right" | 85,984 |
|||
|- |
|||
| style="text-align:left" | Denominator |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 1,677 |
|||
|- |
|||
| style="text-align:left" | '''Net income (numerator for diluted earnings per share under the two-class method)''' |
|||
| style="text-align:right" | '''170,028''' |
|||
| style="text-align:right" | '''118,828''' |
|||
| style="text-align:right" | '''85,984''' |
|||
|- |
|- |
||
| style="text-align:left" | Basic weighted-average common shares |
| style="text-align:left" | Basic weighted-average common shares |
||
| style="text-align:right" | 40,407,310 |
| style="text-align:right" | 40,407,310 |
||
| style="text-align:right" | 40,056,475 |
| style="text-align:right" | 40,056,475 |
||
| style="text-align:right" | 36,031,907 |
| style="text-align:right" | 36,031,907 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Dilutive effect of preferred shares |
||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 716,708 |
|||
|- |
|||
| style="text-align:left" | Dilutive effect of stock notes (in shares) |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 696,110 |
|||
|- |
|||
| style="text-align:left" | Diluted weighted-average common share equivalents (in shares) |
|||
| style="text-align:right" | 41,808,046 |
|||
| style="text-align:right" | 41,377,460 |
|||
| style="text-align:right" | 38,317,534 |
|||
|- |
|||
| style="text-align:left" | Basic earnings per share (in dollar per share) |
|||
| style="text-align:right" | 4.21 |
|||
| style="text-align:right" | 2.97 |
|||
| style="text-align:right" | 2.34 |
|||
|- |
|||
| style="text-align:left" | Diluted earnings per share (in dollar per share) |
|||
| style="text-align:right" | 4.07 |
|||
| style="text-align:right" | 2.87 |
|||
| style="text-align:right" | 2.24 |
|||
|- |
|||
| style="text-align:left" | Stock units |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 716,708 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Dilutive effect of stock notes |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 696,110 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Dilutive effect of stock units |
||
| style="text-align:right" | 897,426 |
| style="text-align:right" | 897,426 |
||
| style="text-align:right" | 917,510 |
| style="text-align:right" | 917,510 |
||
| style="text-align:right" | 736,837 |
| style="text-align:right" | 736,837 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Dilutive effect of options |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Denominator |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Diluted effect of awards (in shares) |
|||
| style="text-align:right" | 503,310 |
| style="text-align:right" | 503,310 |
||
| style="text-align:right" | 403,475 |
| style="text-align:right" | 403,475 |
||
| style="text-align:right" | 135,972 |
| style="text-align:right" | 135,972 |
||
|- |
|||
| style="text-align:left" | '''Diluted weighted-average common share equivalents''' |
|||
| style="text-align:right" | '''41,808,046''' |
|||
| style="text-align:right" | '''41,377,460''' |
|||
| style="text-align:right" | '''38,317,534''' |
|||
|- |
|||
| style="text-align:left" | '''Basic earnings per share''' |
|||
| style="text-align:right" | '''4.21''' |
|||
| style="text-align:right" | '''2.97''' |
|||
| style="text-align:right" | '''2.34''' |
|||
|- |
|||
| style="text-align:left" | Diluted earnings per share |
|||
| style="text-align:right" | 4.07 |
|||
| style="text-align:right" | 2.87 |
|||
| style="text-align:right" | 2.24 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Stock units and options for 2023-2025|Stock units and options|kind=table|order=196}} |
|||
=== Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share === |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | shares |
|||
! colspan="3" style="text-align:center" | 12 Months Ended |
|||
|- |
|||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2024 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2023 |
||
|- |
|||
| style="text-align:left" | Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Antidilutive securities (in shares) |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 920,864 |
|||
|- |
|- |
||
| style="text-align:left" | Stock units |
| style="text-align:left" | Stock units |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Antidilutive securities (in shares) |
|||
| style="text-align:right" | 104,531 |
| style="text-align:right" | 104,531 |
||
| style="text-align:right" | 20,346 |
| style="text-align:right" | 20,346 |
||
| Line 13,628: | Line 8,268: | ||
|- |
|- |
||
| style="text-align:left" | Options |
| style="text-align:left" | Options |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Antidilutive securities (in shares) |
|||
| style="text-align:right" | 242 |
| style="text-align:right" | 242 |
||
| style="text-align:right" | 859 |
| style="text-align:right" | 859 |
||
| style="text-align:right" | 914 |
| style="text-align:right" | 914 |
||
|- |
|||
| style="text-align:left" | Common shares |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Antidilutive securities (in shares) |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 920,864 |
|||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Common shares for 2023-2025|Common shares|kind=table|order=197}} |
|||
== Employee Benefit Plan == |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | USD ($) $ in Millions |
|||
! colspan="3" style="text-align:center" | 12 Months Ended |
|||
|- |
|||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2024 |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Common shares |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 920,864 |
|||
|- |
|- |
||
| style="text-align:left" | |
| class="wt-indent-1" style="text-align:left" | '''Total''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | |
| style="text-align:right" | '''920,864''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|20. Employee Benefit Plan|401(k) Plan, Employee Retirement Income Security Act of 1974, discretionary matching contributions|ebig3opk63|kind=prose|order=198|f1=Company matching contributions 2025|v1=USD 3.9m|f2=Company matching contributions 2024|v2=USD 3.2m|f3=Company matching contributions 2023|v3=USD 2.9m}} |
|||
== Related Party Transactions == |
|||
* The Company sponsors the ''401(k) Plan'' (the “Plan”), which is available to substantially all its employees <sup>p. 103</sup>. |
|||
=== Narrative === |
|||
* The Plan is subject to provisions of the ''Employee Retirement Income Security Act of 1974'' <sup>p. 103</sup>. |
|||
* The Company makes ''discretionary matching contributions'' to the Plan <sup>p. 103</sup>. |
|||
* ''Company matching contributions'' to the Plan were: |
|||
** ''2025'': USD 3.9m <sup>p. 103</sup> |
|||
** ''2024'': USD 3.2m <sup>p. 103</sup> |
|||
** ''2023'': USD 2.9m <sup>p. 103</sup> |
|||
{{Indexing|Riscom|RISCOM, wholesale brokerage services, managing general agency agreement, premiums receivable|1eit26wk5c|kind=prose|order=199|f1=Ownership interest in RISCOM|v1=20%|f2=Premiums receivable December 31, 2025|v2=USD 13.9m|f3=Premiums receivable December 31, 2024|v3=USD 12.6m}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | USD ($) $ in Thousands |
|||
! colspan="3" style="text-align:center" | 12 Months Ended |
|||
|- |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Related Party Transaction [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Premiums receivable, net |
|||
| style="text-align:right" | 544,217 |
|||
| style="text-align:right" | 321,641 |
|||
| style="text-align:right" | 179,235 |
|||
|- |
|||
| style="text-align:left" | Professional fees and reimbursements / Related Party |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Related Party Transaction [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Professional fees |
|||
| style="text-align:right" | 600 |
|||
| style="text-align:right" | 600 |
|||
| style="text-align:right" | 3,600 |
|||
|- |
|||
| style="text-align:left" | RISCOM / Agency agreement / Affiliated entity |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Related Party Transaction [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Agreement, ownership interest |
|||
| style="text-align:right" | 20.00% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Premiums receivable, net |
|||
| style="text-align:right" | 13,900 |
|||
| style="text-align:right" | 12,600 |
|||
| style="text-align:right" | — |
|||
|} |
|||
</div> |
|||
* ''RISCOM'' provides wholesale brokerage services to the Company <sup>p. 104</sup>. |
|||
=== Schedule of RISCOM Transactions === |
|||
* ''RISCOM and the Company'' have a managing general agency agreement <sup>p. 104</sup>. |
|||
* The ''Company'' holds a 20% ownership interest in RISCOM <sup>p. 104</sup>. |
|||
* ''Premiums receivable'' as of December 31, 2025, were USD 13.9m <sup>p. 104</sup>. |
|||
* ''Premiums receivable'' as of December 31, 2024, were USD 12.6m <sup>p. 104</sup>. |
|||
{{Indexing|Premiums receivable and commissions|Premiums receivable, commissions|kind=table|order=200}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
! style="text-align:left" | |
! style="text-align:left" | ($ in thousands) |
||
! |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
|||
|- |
|||
! style="text-align: |
! class="col-s" style="text-align:right" | 2023 |
||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Related Party Transaction [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net earned premium |
|||
| style="text-align:right" | 1,304,505 |
|||
| style="text-align:right" | 1,056,722 |
|||
| style="text-align:right" | 829,143 |
|||
|- |
|||
| style="text-align:left" | Affiliated entity / Agency agreement / RISCOM |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Related Party Transaction [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Net earned premium |
| style="text-align:left" | Net earned premium |
||
| Line 13,788: | Line 8,334: | ||
</div> |
</div> |
||
{{Indexing|Other|Advisory and professional services fees, expense reimbursements, affiliated stockholders, directors|1eit26wk5c|kind=prose|order=201|f1=Advisory and professional services fees 2025|v1=USD 0.6m|f2=Advisory and professional services fees 2024|v2=USD 0.6m|f3=Advisory and professional services fees 2023|v3=USD 3.6m}} |
|||
== Statutory Accounting Principles and Regulatory Matters == |
|||
* ''Advisory and professional services fees and expense reimbursements'' paid to affiliated stockholders and directors were USD 0.6m for the years ended December 31, 2025 and 2024 <sup>p. 105</sup>. |
|||
<div style="overflow-x:auto"> |
|||
* ''Advisory and professional services fees and expense reimbursements'' paid to affiliated stockholders and directors were USD 3.6m for the year ended December 31, 2023 <sup>p. 105</sup>. |
|||
{| class="wikitable fintable" |
|||
* For investments involving affiliated companies and additional related party transactions, refer to Notes 5, 6, and 11 <sup>p. 105</sup>. |
|||
! style="text-align:left" | USD ($) $ in Millions |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Insurance [Abstract] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Statutory net income |
|||
| style="text-align:right" | 159.1 |
|||
| style="text-align:right" | 108.2 |
|||
| style="text-align:right" | 73.1 |
|||
|- |
|||
| style="text-align:left" | Statutory capital and surplus |
|||
| style="text-align:right" | 872.0 |
|||
| style="text-align:right" | 710.6 |
|||
| style="text-align:right" | — |
|||
|} |
|||
</div> |
|||
{{Indexing|Litigation|Legal actions, claims under insurance policies and contracts, bad faith claims, disputes with third parties, alleged errors and omissions|nad00g0zfb|kind=prose|order=202}} |
|||
== Subsequent Events (Details) == |
|||
* The Company is involved in various legal actions stemming from claims under insurance policies and contracts <sup>p. 106</sup>. |
|||
=== Apollo Group Holdings Limited === |
|||
* These legal actions are factored into the Company's estimation of losses and loss adjustment expense reserves <sup>p. 106</sup>. |
|||
* The Company is occasionally a defendant in legal actions related to bad faith claims, disputes with third parties, or alleged errors and omissions <sup>p. 106</sup>. |
|||
* Accruals for these items are recorded when losses are probable and reasonably estimable <sup>p. 106</sup>. |
|||
* Based on current information, available insurance coverage, and advice from legal counsel, the Company believes the resolution of these matters will not individually or in aggregate have a material adverse effect on its consolidated financial position, results of operations, or cash flows <sup>p. 106</sup>. |
|||
{{Indexing|Indemnification|Indemnifications, sale of business assets and subsidiaries, typical representations and warranties, performance responsibilities|wugbjvah7b|kind=prose|order=203}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | $ in Millions |
|||
! class="col-s" style="text-align:right" | Jan. 01, 2026 USD ($) |
|||
! class="col-s" style="text-align:right" | Sep. 02, 2025 agreement |
|||
|- |
|||
| style="text-align:left" | Subsequent Event [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Business combination, number purchase agreement / agreement |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 2 |
|||
|- |
|||
| style="text-align:left" | Business combination, issued share capital percentage |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 87.00% |
|||
|- |
|||
| style="text-align:left" | Issued share capital acquire |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 100.00% |
|||
|- |
|||
| style="text-align:left" | Subsequent Event |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Subsequent Event [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Business combination, consideration transferred / $ |
|||
| style="text-align:right" | 555.0 |
|||
| style="text-align:right" | — |
|||
|} |
|||
</div> |
|||
* The Company has provided ''indemnifications'' to certain buyers in conjunction with the sale of business assets and subsidiaries <sup>p. 107</sup>. |
|||
== SCHEDULE I == |
|||
* These indemnifications cover ''typical representations and warranties'' related to performance responsibilities under sales contracts <sup>p. 107</sup>. |
|||
* The ''potential exposure'' from these indemnifications is difficult to determine due to the variety of matters, operations, and scenarios covered <sup>p. 107</sup>. |
|||
* Certain indemnifications have ''no time limit'' <sup>p. 107</sup>. |
|||
* The Company currently ''does not believe'' any significant claims exist related to these indemnifications <sup>p. 107</sup>. |
|||
{{Indexing|23. Statutory Accounting Principles and Regulatory Matters|Statutory Accounting Principles, regulatory matters, statutory net income, statutory capital and surplus, GMIC, HSIC, IIC, OSIC, dividend payments, Texas state law, Risk Based Capital (RBC) requirements, National Association of Insurance Commissioners (NAIC)|1nma8v7gjs|997lhpef9j|f7q5tvbfqm|cmtswfs0go|kind=prose|order=204|f1=Statutory net income 2025|v1=$159.1 million|f2=Statutory net income 2024|v2=$108.2 million|f3=Statutory net income 2023|v3=$73.1 million|f4=Statutory capital and surplus December 31, 2025|v4=$872.0 million|f5=Statutory capital and surplus December 31, 2024|v5=$710.6 million|f6=Lead insurance company|v6=GMIC|f7=GMIC domicile|v7=Texas}} |
|||
=== SUMMARY OF INVESTMENTS — OTHER THAN IN RELATED PARTIES === |
|||
* ''Statutory net income'' was $159.1 million for 2025, $108.2 million for 2024, and $73.1 million for 2023 <sup>p. 108</sup>. |
|||
<div style="overflow-x:auto"> |
|||
* ''Statutory capital and surplus'' was $872.0 million as of December 31, 2025, and $710.6 million as of December 31, 2024 <sup>p. 108</sup>. |
|||
{| class="wikitable fintable" |
|||
* Effective December 31, 2024, the Company restacked its insurance company subsidiaries, making GMIC the lead insurance company <sup>p. 108</sup>. |
|||
! style="text-align:left" | $ in Thousands |
|||
* Following the restacking, HSIC became a wholly owned subsidiary of GMIC <sup>p. 108</sup>. |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 USD ($) |
|||
* IIC became a wholly owned subsidiary of HSIC <sup>p. 108</sup>. |
|||
|- |
|||
* OSIC became a wholly owned subsidiary of IIC <sup>p. 108</sup>. |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
* ''Dividend payments'' from GMIC to the Company are restricted by Texas state law, requiring regulatory approval for amounts exceeding certain limits <sup>p. 108</sup>. |
|||
| style="text-align:right" | — |
|||
* The maximum amount of dividends GMIC can pay without prior approval is subject to restrictions related to policyholder surplus, net income, and dividends declared or distributed in the preceding 12 months <sup>p. 108</sup>. |
|||
|- |
|||
* As of December 31, 2025, GMIC, domiciled in Texas, is restricted to paying dividends that are the greater of ten percent of prior year-end capital and surplus or prior year net income <sup>p. 108</sup>. |
|||
| style="text-align:left" | Cost |
|||
* GMIC did not declare or pay any dividend during the year ended December 31, 2025 <sup>p. 108</sup>. |
|||
| style="text-align:right" | 2,194,865 |
|||
* HSIC did not declare or pay any dividends during the year ended December 31, 2024 <sup>p. 108</sup>. |
|||
|- |
|||
* Property and casualty insurance companies are subject to ''Risk Based Capital (RBC) requirements'' specified by the National Association of Insurance Commissioners (NAIC) <sup>p. 108</sup>. |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
* RBC requirements dictate that the amount of capital and surplus maintained by an insurer should be based on its various risk factors <sup>p. 108</sup>. |
|||
| style="text-align:right" | 2,223,931 |
|||
* As of December 31, 2025, and 2024, GMIC’s statutory capital and surplus substantially exceeded the regulatory RBC requirements <sup>p. 108</sup>. |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 2,223,150 |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, available for sale: |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cost |
|||
| style="text-align:right" | 1,848,755 |
|||
|- |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
| style="text-align:right" | 1,856,303 |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 1,856,303 |
|||
|- |
|||
| style="text-align:left" | Fixed maturity securities, held to maturity: |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cost |
|||
| style="text-align:right" | 33,290 |
|||
|- |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
| style="text-align:right" | 33,603 |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 32,822 |
|||
|- |
|||
| style="text-align:left" | Equity securities |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cost |
|||
| style="text-align:right" | 1,138 |
|||
|- |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
| style="text-align:right" | 1,174 |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 1,174 |
|||
|- |
|||
| style="text-align:left" | Mortgage loans |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cost |
|||
| style="text-align:right" | 10,093 |
|||
|- |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
| style="text-align:right" | 9,902 |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 9,902 |
|||
|- |
|||
| style="text-align:left" | Other long-term investments |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cost |
|||
| style="text-align:right" | 37,290 |
|||
|- |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
| style="text-align:right" | 58,650 |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 58,650 |
|||
|- |
|||
| style="text-align:left" | Short-term investments |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cost |
|||
| style="text-align:right" | 264,299 |
|||
|- |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
| style="text-align:right" | 264,299 |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 264,299 |
|||
|- |
|||
| style="text-align:left" | U.S. government securities / Fixed maturity securities, available for sale: |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cost |
|||
| style="text-align:right" | 44,190 |
|||
|- |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
| style="text-align:right" | 44,468 |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 44,468 |
|||
|- |
|||
| style="text-align:left" | Corporate securities and miscellaneous / Fixed maturity securities, available for sale: |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cost |
|||
| style="text-align:right" | 632,244 |
|||
|- |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
| style="text-align:right" | 636,387 |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 636,387 |
|||
|- |
|||
| style="text-align:left" | Municipal securities / Fixed maturity securities, available for sale: |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cost |
|||
| style="text-align:right" | 102,691 |
|||
|- |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
| style="text-align:right" | 102,116 |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 102,116 |
|||
|- |
|||
| style="text-align:left" | Residential mortgage-backed securities / Fixed maturity securities, available for sale: |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cost |
|||
| style="text-align:right" | 487,145 |
|||
|- |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
| style="text-align:right" | 486,587 |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 486,587 |
|||
|- |
|||
| style="text-align:left" | Commercial mortgage-backed securities / Fixed maturity securities, available for sale: |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cost |
|||
| style="text-align:right" | 72,631 |
|||
|- |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
| style="text-align:right" | 73,050 |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 73,050 |
|||
|- |
|||
| style="text-align:left" | Other asset-backed securities / Fixed maturity securities, available for sale: |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cost |
|||
| style="text-align:right" | 509,854 |
|||
|- |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
| style="text-align:right" | 513,695 |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 513,695 |
|||
|- |
|||
| style="text-align:left" | Other asset-backed securities / Fixed maturity securities, held to maturity: |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cost |
|||
| style="text-align:right" | 33,290 |
|||
|- |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
| style="text-align:right" | 33,603 |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 32,822 |
|||
|- |
|||
| style="text-align:left" | Preferred stocks: / Equity securities |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cost |
|||
| style="text-align:right" | 1,138 |
|||
|- |
|||
| style="text-align:left" | Fair Value (if applicable) |
|||
| style="text-align:right" | 1,174 |
|||
|- |
|||
| style="text-align:left" | Amount on Balance Sheet |
|||
| style="text-align:right" | 1,174 |
|||
|} |
|||
</div> |
|||
{{Indexing|24. Subsequent Events|Subsequent events, Apollo Majority SPAs, Apollo Group Holdings Limited, acquisition of Apollo, ASC 805|ogfk3mnpww|c5r2rmwxo6|kind=prose|order=205|f1=Acquisition date|v1=January 1, 2026|f2=Acquisition consideration|v2=USD 555.0 million|f3=Acquired company|v3=Apollo Group Holdings Limited|f4=Acquired stake|v4=87%}} |
|||
== SCHEDULE II == |
|||
* On September 2, 2025, the Company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders (the "Majority Sellers") of Apollo Group Holdings Limited ("Apollo") <sup>p. 109</sup>. |
|||
=== FINANCIAL INFORMATION OF REGISTRANT BALANCE SHEETS (PARENT COMPANY) === |
|||
* Pursuant to the Apollo Majority SPAs, the Company agreed to acquire all issued shares of Apollo held by the Majority Sellers, representing approximately 87% of Apollo's issued share capital <sup>p. 109</sup>. |
|||
* Closing of the transaction ("Closing") was conditioned upon the Company acquiring 100% of Apollo's issued share capital (the "Acquisition") at Closing, via additional short-form share purchase agreements with the remaining minority shareholders <sup>p. 109</sup>. |
|||
<div style="overflow-x:auto"> |
|||
* On January 1, 2026, the Company completed the acquisition for an aggregate consideration of approximately USD 555.0 million, payable in a combination of cash and newly issued shares of the Company’s common stock <sup>p. 109</sup>. |
|||
{| class="wikitable fintable" |
|||
* The acquisition closed shortly before the issuance of these consolidated financial statements, so the initial accounting under ASC 805 is not yet complete <sup>p. 109</sup>. |
|||
! style="text-align:left" | USD ($) $ in Thousands |
|||
* The Company is obtaining and evaluating information to determine identifiable assets acquired, liabilities assumed, and any resulting goodwill or intangible assets <sup>p. 109</sup>. |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
* Required purchase accounting disclosures will be provided in future filings once available <sup>p. 109</sup>. |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
* The Company evaluated subsequent events from December 31, 2025, through the date these consolidated financial statements were issued and did not identify any additional subsequent events requiring disclosure <sup>p. 109</sup>. |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Investments: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-term investments, at fair value |
|||
| style="text-align:right" | 264,299 |
|||
| style="text-align:right" | 274,929 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investments |
|||
| style="text-align:right; font-weight:bold" | 2,300,515 |
|||
| style="text-align:right; font-weight:bold" | 1,870,820 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left" | Cash and cash equivalents |
|||
| style="text-align:right" | 168,544 |
|||
| style="text-align:right" | 121,603 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Deferred income taxes |
|||
| style="text-align:right" | 27,865 |
|||
| style="text-align:right" | 30,486 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Goodwill and intangible assets, net |
|||
| style="text-align:right" | 88,040 |
|||
| style="text-align:right" | 87,348 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Other assets |
|||
| style="text-align:right" | 137,173 |
|||
| style="text-align:right" | 86,698 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total assets |
|||
| style="text-align:right; font-weight:bold" | 4,791,852 |
|||
| style="text-align:right; font-weight:bold" | 3,729,478 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left" | Liabilities: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accounts payable and accrued liabilities |
|||
| style="text-align:right" | 115,034 |
|||
| style="text-align:right" | 76,206 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Carrying Value |
|||
| style="text-align:right" | 100,411 |
|||
| style="text-align:right" | 100,000 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Subordinated debt, net of debt issuance costs |
|||
| style="text-align:right" | 19,569 |
|||
| style="text-align:right" | 19,536 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total liabilities |
|||
| style="text-align:right; font-weight:bold" | 3,782,287 |
|||
| style="text-align:right; font-weight:bold" | 2,935,479 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left" | Stockholders’ equity |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Stockholders’ equity |
|||
| style="text-align:right" | 1,009,565 |
|||
| style="text-align:right" | 793,999 |
|||
| style="text-align:right" | 661,031 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total liabilities and stockholders’ equity |
|||
| style="text-align:right; font-weight:bold" | 4,791,852 |
|||
| style="text-align:right; font-weight:bold" | 3,729,478 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left" | Parent Company |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Investments: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Investment in subsidiaries |
|||
| style="text-align:right" | 1,076,288 |
|||
| style="text-align:right" | 853,670 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Short-term investments, at fair value |
|||
| style="text-align:right" | 14,513 |
|||
| style="text-align:right" | 14,000 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total investments |
|||
| style="text-align:right; font-weight:bold" | 1,090,801 |
|||
| style="text-align:right; font-weight:bold" | 867,670 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left" | Cash and cash equivalents |
|||
| style="text-align:right" | 3,500 |
|||
| style="text-align:right" | 2,943 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Deferred income taxes |
|||
| style="text-align:right" | 27,865 |
|||
| style="text-align:right" | 30,486 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Goodwill and intangible assets, net |
|||
| style="text-align:right" | 14,349 |
|||
| style="text-align:right" | 12,641 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Other assets |
|||
| style="text-align:right" | 10,709 |
|||
| style="text-align:right" | 2,905 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total assets |
|||
| style="text-align:right; font-weight:bold" | 1,147,224 |
|||
| style="text-align:right; font-weight:bold" | 916,645 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left" | Liabilities: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accounts payable and accrued liabilities |
|||
| style="text-align:right" | 17,680 |
|||
| style="text-align:right" | 3,110 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Carrying Value |
|||
| style="text-align:right" | 100,410 |
|||
| style="text-align:right" | 100,000 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Subordinated debt, net of debt issuance costs |
|||
| style="text-align:right" | 19,569 |
|||
| style="text-align:right" | 19,536 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total liabilities |
|||
| style="text-align:right; font-weight:bold" | 137,659 |
|||
| style="text-align:right; font-weight:bold" | 122,646 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|- |
|||
| style="text-align:left" | Stockholders’ equity |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Stockholders’ equity |
|||
| style="text-align:right" | 1,009,565 |
|||
| style="text-align:right" | 793,999 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total liabilities and stockholders’ equity |
|||
| style="text-align:right; font-weight:bold" | 1,147,224 |
|||
| style="text-align:right; font-weight:bold" | 916,645 |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|} |
|||
</div> |
|||
=== STATEMENTS OF OPERATIONS (PARENT COMPANY) === |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | USD ($) $ in Thousands |
|||
! colspan="3" style="text-align:center" | 12 Months Ended |
|||
|- |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Revenues: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | 83,619 |
|||
| style="text-align:right" | 80,600 |
|||
| style="text-align:right" | 40,340 |
|||
|- |
|||
| style="text-align:left" | Net investment gains (losses) |
|||
| style="text-align:right" | 22,149 |
|||
| style="text-align:right" | 6,342 |
|||
| style="text-align:right" | 11,054 |
|||
|- |
|||
| style="text-align:left" | Other loss |
|||
| style="text-align:right" | -587 |
|||
| style="text-align:right" | -167 |
|||
| style="text-align:right" | -632 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total revenues |
|||
| style="text-align:right; font-weight:bold" | 1,416,541 |
|||
| style="text-align:right; font-weight:bold" | 1,150,200 |
|||
| style="text-align:right; font-weight:bold" | 885,969 |
|||
|- |
|||
| style="text-align:left" | Expenses: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Interest expense |
|||
| style="text-align:right" | 7,919 |
|||
| style="text-align:right" | 9,496 |
|||
| style="text-align:right" | 10,024 |
|||
|- |
|||
| style="text-align:left" | Amortization expense |
|||
| style="text-align:right" | 1,636 |
|||
| style="text-align:right" | 2,007 |
|||
| style="text-align:right" | 1,798 |
|||
|- |
|||
| style="text-align:left" | Other expenses |
|||
| style="text-align:right" | 4,162 |
|||
| style="text-align:right" | 4,392 |
|||
| style="text-align:right" | 5,364 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total expenses |
|||
| style="text-align:right; font-weight:bold" | 1,200,117 |
|||
| style="text-align:right; font-weight:bold" | 997,461 |
|||
| style="text-align:right; font-weight:bold" | 775,867 |
|||
|- |
|||
| style="text-align:left" | Income tax expense |
|||
| style="text-align:right" | 46,396 |
|||
| style="text-align:right" | 33,911 |
|||
| style="text-align:right" | 24,118 |
|||
|- |
|||
| style="text-align:left" | Net income attributable to common stockholders |
|||
| style="text-align:right" | 170,028 |
|||
| style="text-align:right" | 118,828 |
|||
| style="text-align:right" | 84,307 |
|||
|- |
|||
| style="text-align:left" | Equity in undistributed earnings of subsidiaries |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 1,677 |
|||
|- |
|||
| style="text-align:left" | Net income |
|||
| style="text-align:right" | 170,028 |
|||
| style="text-align:right" | 118,828 |
|||
| style="text-align:right" | 85,984 |
|||
|- |
|||
| style="text-align:left" | Parent Company |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Revenues: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | 3,371 |
|||
| style="text-align:right" | 3,212 |
|||
| style="text-align:right" | 3,822 |
|||
|- |
|||
| style="text-align:left" | Net investment gains (losses) |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 963 |
|||
| style="text-align:right" | -963 |
|||
|- |
|||
| style="text-align:left" | Other loss |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | -2 |
|||
| style="text-align:right" | -27 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total revenues |
|||
| style="text-align:right; font-weight:bold" | 3,371 |
|||
| style="text-align:right; font-weight:bold" | 4,173 |
|||
| style="text-align:right; font-weight:bold" | 2,832 |
|||
|- |
|||
| style="text-align:left" | Expenses: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Operating expenses |
|||
| style="text-align:right" | 7,899 |
|||
| style="text-align:right" | 10,632 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Interest expense |
|||
| style="text-align:right" | 6,762 |
|||
| style="text-align:right" | 8,140 |
|||
| style="text-align:right" | 9,815 |
|||
|- |
|||
| style="text-align:left" | Amortization expense |
|||
| style="text-align:right" | 620 |
|||
| style="text-align:right" | 920 |
|||
| style="text-align:right" | 313 |
|||
|- |
|||
| style="text-align:left" | Other expenses |
|||
| style="text-align:right" | 17,962 |
|||
| style="text-align:right" | 9,646 |
|||
| style="text-align:right" | 451 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total expenses |
|||
| style="text-align:right; font-weight:bold" | 33,243 |
|||
| style="text-align:right; font-weight:bold" | 29,338 |
|||
| style="text-align:right; font-weight:bold" | 10,579 |
|||
|- |
|||
| style="text-align:left" | Loss before income tax expense |
|||
| style="text-align:right" | -29,872 |
|||
| style="text-align:right" | -25,165 |
|||
| style="text-align:right" | -7,747 |
|||
|- |
|||
| style="text-align:left" | Income tax expense |
|||
| style="text-align:right" | 45,860 |
|||
| style="text-align:right" | 33,578 |
|||
| style="text-align:right" | 6,808 |
|||
|- |
|||
| style="text-align:left" | Net income attributable to common stockholders |
|||
| style="text-align:right" | -75,732 |
|||
| style="text-align:right" | -58,743 |
|||
| style="text-align:right" | -14,555 |
|||
|- |
|||
| style="text-align:left" | Equity in undistributed earnings of subsidiaries |
|||
| style="text-align:right" | 245,760 |
|||
| style="text-align:right" | 177,571 |
|||
| style="text-align:right" | 100,539 |
|||
|- |
|||
| style="text-align:left" | Net income |
|||
| style="text-align:right" | 170,028 |
|||
| style="text-align:right" | 118,828 |
|||
| style="text-align:right" | 85,984 |
|||
|} |
|||
</div> |
|||
=== STATEMENTS OF CASH FLOWS (PARENT COMPANY) === |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | USD ($) $ in Thousands |
|||
! colspan="3" style="text-align:center" | 12 Months Ended |
|||
|- |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | Cash flows from operating activities: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net income |
|||
| style="text-align:right" | 170,028 |
|||
| style="text-align:right" | 118,828 |
|||
| style="text-align:right" | 85,984 |
|||
|- |
|||
| style="text-align:left" | Net cash used in operating activities |
|||
| style="text-align:right" | 408,076 |
|||
| style="text-align:right" | 305,115 |
|||
| style="text-align:right" | 338,187 |
|||
|- |
|||
| style="text-align:left" | Cash flows from investing activities: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Purchase of intangible assets and goodwill |
|||
| style="text-align:right" | 2,000 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 50 |
|||
|- |
|||
| style="text-align:left" | Net cash used in investment activities |
|||
| style="text-align:right" | -366,898 |
|||
| style="text-align:right" | -243,694 |
|||
| style="text-align:right" | -493,809 |
|||
|- |
|||
| style="text-align:left" | Cash flows from financing activities: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Payments on long term borrowings and trust preferred |
|||
| style="text-align:right" | -43,000 |
|||
| style="text-align:right" | -116,794 |
|||
| style="text-align:right" | -50,000 |
|||
|- |
|||
| style="text-align:left" | Proceeds from employee stock purchase plan |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 1,350 |
|||
|- |
|||
| style="text-align:left" | Net cash provided by (used in) financing activities |
|||
| style="text-align:right" | 411 |
|||
| style="text-align:right" | -4,232 |
|||
| style="text-align:right" | 130,947 |
|||
|- |
|||
| style="text-align:left" | Net increase (decrease) in cash and cash equivalents and restricted cash |
|||
| style="text-align:right" | 41,589 |
|||
| style="text-align:right" | 57,189 |
|||
| style="text-align:right" | -24,675 |
|||
|- |
|||
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of period |
|||
| style="text-align:right" | 157,525 |
|||
| style="text-align:right" | 100,336 |
|||
| style="text-align:right" | 125,011 |
|||
|- |
|||
| style="text-align:left" | Cash and cash equivalents and restricted cash at end of period |
|||
| style="text-align:right" | 199,114 |
|||
| style="text-align:right" | 157,525 |
|||
| style="text-align:right" | 100,336 |
|||
|- |
|||
| style="text-align:left" | Cash paid for interest |
|||
| style="text-align:right" | 6,149 |
|||
| style="text-align:right" | 8,573 |
|||
| style="text-align:right" | 10,667 |
|||
|- |
|||
| style="text-align:left" | Parent Company |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Cash flows from operating activities: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Net income |
|||
| style="text-align:right" | 170,028 |
|||
| style="text-align:right" | 118,828 |
|||
| style="text-align:right" | 85,984 |
|||
|- |
|||
| style="text-align:left" | Adjustments to reconcile net income to net cash provided by operating activities |
|||
| style="text-align:right" | -175,769 |
|||
| style="text-align:right" | -121,563 |
|||
| style="text-align:right" | -95,947 |
|||
|- |
|||
| style="text-align:left" | Net cash used in operating activities |
|||
| style="text-align:right" | -5,741 |
|||
| style="text-align:right" | -2,735 |
|||
| style="text-align:right" | -9,963 |
|||
|- |
|||
| style="text-align:left" | Cash flows from investing activities: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Purchase of intangible assets and goodwill |
|||
| style="text-align:right" | 2,000 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Capital contributions to subsidiaries |
|||
| style="text-align:right" | -100 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | -122,800 |
|||
|- |
|||
| style="text-align:left" | Distributions from investment in subsidiaries |
|||
| style="text-align:right" | 8,500 |
|||
| style="text-align:right" | 8,500 |
|||
| style="text-align:right" | 6,500 |
|||
|- |
|||
| style="text-align:left" | Change in short-term investments |
|||
| style="text-align:right" | -513 |
|||
| style="text-align:right" | -3,407 |
|||
| style="text-align:right" | -10,569 |
|||
|- |
|||
| style="text-align:left" | Net cash used in investment activities |
|||
| style="text-align:right" | 5,887 |
|||
| style="text-align:right" | 5,093 |
|||
| style="text-align:right" | -126,869 |
|||
|- |
|||
| style="text-align:left" | Cash flows from financing activities: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Repayment of stock notes receivable |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 5,561 |
|||
| style="text-align:right" | 1,350 |
|||
|- |
|||
| style="text-align:left" | Proceeds from long term borrowings |
|||
| style="text-align:right" | 43,411 |
|||
| style="text-align:right" | 107,000 |
|||
| style="text-align:right" | 50,000 |
|||
|- |
|||
| style="text-align:left" | Payments on long term borrowings and trust preferred |
|||
| style="text-align:right" | -43,000 |
|||
| style="text-align:right" | -115,000 |
|||
| style="text-align:right" | -50,000 |
|||
|- |
|||
| style="text-align:left" | Proceeds from equity offerings |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 128,887 |
|||
|- |
|||
| style="text-align:left" | Proceeds from employee stock purchase plan |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 710 |
|||
|- |
|||
| style="text-align:left" | Net cash provided by (used in) financing activities |
|||
| style="text-align:right" | 411 |
|||
| style="text-align:right" | -2,439 |
|||
| style="text-align:right" | 130,947 |
|||
|- |
|||
| style="text-align:left" | Net increase (decrease) in cash and cash equivalents and restricted cash |
|||
| style="text-align:right" | 557 |
|||
| style="text-align:right" | -81 |
|||
| style="text-align:right" | -5,885 |
|||
|- |
|||
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of period |
|||
| style="text-align:right" | 2,943 |
|||
| style="text-align:right" | 3,024 |
|||
| style="text-align:right" | 8,909 |
|||
|- |
|||
| style="text-align:left" | Cash and cash equivalents and restricted cash at end of period |
|||
| style="text-align:right" | 3,500 |
|||
| style="text-align:right" | 2,943 |
|||
| style="text-align:right" | 3,024 |
|||
|- |
|||
| style="text-align:left" | Cash paid for interest |
|||
| style="text-align:right" | 6,149 |
|||
| style="text-align:right" | 8,573 |
|||
| style="text-align:right" | 10,667 |
|||
|} |
|||
</div> |
|||
=== FINANCIAL INFORMATION OF REGISTRANT - Narrative (Details) - Parent Company - Promissory Note === |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | $ in Millions |
|||
! class="col-s" style="text-align:right" | Sep. 30, 2024 USD ($) |
|||
|- |
|||
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items] |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Face amount |
|||
| style="text-align:right" | 57.0 |
|||
|- |
|||
| style="text-align:left" | Stated interest rate |
|||
| style="text-align:right" | 4.00% |
|||
|} |
|||
</div> |
|||
=== FINANCIAL INFORMATION OF REGISTRANT - Schedule of Carrying and Fair Values of the Promissory Note (Details) - Promissory Note === |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | USD ($) $ in Thousands |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
|- |
|||
| style="text-align:left" | Carrying Value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Promissory Note |
|||
| style="text-align:right" | 57,000 |
|||
| style="text-align:right" | 57,000 |
|||
|- |
|||
| style="text-align:left" | Fair Value |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accounts, Notes, Loans and Financing Receivable [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Promissory Note |
|||
| style="text-align:right" | 57,401 |
|||
| style="text-align:right" | 56,300 |
|||
|} |
|||
</div> |
|||
== SCHEDULE IV == |
|||
=== REINSURANCE === |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | USD ($) $ in Thousands |
|||
! colspan="3" style="text-align:center" | 12 Months Ended |
|||
|- |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Gross amount |
|||
| style="text-align:right" | 1,622,594 |
|||
| style="text-align:right" | 1,375,917 |
|||
| style="text-align:right" | 1,155,835 |
|||
|- |
|||
| style="text-align:left" | Ceded to other companies |
|||
| style="text-align:right" | -724,881 |
|||
| style="text-align:right" | -601,857 |
|||
| style="text-align:right" | -520,663 |
|||
|- |
|||
| style="text-align:left" | Assumed from other companies |
|||
| style="text-align:right" | 406,792 |
|||
| style="text-align:right" | 282,662 |
|||
| style="text-align:right" | 193,971 |
|||
|- |
|||
| style="text-align:left" | Net earned premiums |
|||
| style="text-align:right" | 1,304,505 |
|||
| style="text-align:right" | 1,056,722 |
|||
| style="text-align:right" | 829,143 |
|||
|- |
|||
| style="text-align:left" | Accident & Health |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Gross amount |
|||
| style="text-align:right" | 254,102 |
|||
| style="text-align:right" | 173,073 |
|||
| style="text-align:right" | 151,702 |
|||
|- |
|||
| style="text-align:left" | Ceded to other companies |
|||
| style="text-align:right" | -143,811 |
|||
| style="text-align:right" | -86,503 |
|||
| style="text-align:right" | -79,091 |
|||
|- |
|||
| style="text-align:left" | Assumed from other companies |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Net earned premiums |
|||
| style="text-align:right" | 110,291 |
|||
| style="text-align:right" | 86,570 |
|||
| style="text-align:right" | 72,611 |
|||
|- |
|||
| style="text-align:left" | Percentage of amount assumed to net |
|||
| style="text-align:right" | 0.00% |
|||
| style="text-align:right" | 0.00% |
|||
| style="text-align:right" | 0.00% |
|||
|- |
|||
| style="text-align:left" | Property & Casualty |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Gross amount |
|||
| style="text-align:right" | 1,430,309 |
|||
| style="text-align:right" | 1,285,564 |
|||
| style="text-align:right" | 1,089,478 |
|||
|- |
|||
| style="text-align:left" | Ceded to other companies |
|||
| style="text-align:right" | -616,193 |
|||
| style="text-align:right" | -533,151 |
|||
| style="text-align:right" | -470,047 |
|||
|- |
|||
| style="text-align:left" | Assumed from other companies |
|||
| style="text-align:right" | 481,825 |
|||
| style="text-align:right" | 284,595 |
|||
| style="text-align:right" | 218,649 |
|||
|- |
|||
| style="text-align:left" | Net earned premiums |
|||
| style="text-align:right" | 1,295,941 |
|||
| style="text-align:right" | 1,037,008 |
|||
| style="text-align:right" | 838,080 |
|||
|- |
|||
| style="text-align:left" | Percentage of amount assumed to net |
|||
| style="text-align:right" | 37.20% |
|||
| style="text-align:right" | 27.40% |
|||
| style="text-align:right" | 26.10% |
|||
|} |
|||
</div> |
|||
== SCHEDULE V == |
|||
=== VALUATION AND QUALIFYING ACCOUNTS === |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | USD ($) $ in Thousands |
|||
! colspan="3" style="text-align:center" | 12 Months Ended |
|||
|- |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-m" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Accounting Standards Update [Extensible Enumeration] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | Accounting Standards Update 2016-13 [Member] |
|||
|- |
|||
| style="text-align:left" | Valuation Allowance For Deferred Tax Assets |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Valuation allowances and reserves, amount, beginning balance |
|||
| style="text-align:right" | 586 |
|||
| style="text-align:right" | 586 |
|||
| style="text-align:right" | 586 |
|||
|- |
|||
| style="text-align:left" | Charged to costs and expenses |
|||
| style="text-align:right" | 68 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Amounts written off |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Recoveries of amounts previously written off |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Valuation allowances and reserves, amount, ending balance |
|||
| style="text-align:right" | 654 |
|||
| style="text-align:right" | 586 |
|||
| style="text-align:right" | 586 |
|||
|- |
|||
| style="text-align:left" | Valuation Allowance For Deferred Tax Assets / Period of adoption, adjustment |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Valuation allowances and reserves, amount, beginning balance |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Allowance for Uncollectible Reinsurance Recoverable |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Valuation allowances and reserves, amount, beginning balance |
|||
| style="text-align:right" | 2,295 |
|||
| style="text-align:right" | 2,295 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Charged to costs and expenses |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 13,585 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Amounts written off |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | -13,585 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Recoveries of amounts previously written off |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Valuation allowances and reserves, amount, ending balance |
|||
| style="text-align:right" | 2,295 |
|||
| style="text-align:right" | 2,295 |
|||
| style="text-align:right" | 2,295 |
|||
|- |
|||
| style="text-align:left" | Allowance for Uncollectible Reinsurance Recoverable / Period of adoption, adjustment |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Valuation allowances and reserves, amount, beginning balance |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 2,295 |
|||
|- |
|||
| style="text-align:left" | Allowance for Uncollectible Premiums Receivable |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Valuation allowances and reserves, amount, beginning balance |
|||
| style="text-align:right" | 2,432 |
|||
| style="text-align:right" | 964 |
|||
| style="text-align:right" | 629 |
|||
|- |
|||
| style="text-align:left" | Charged to costs and expenses |
|||
| style="text-align:right" | 2,351 |
|||
| style="text-align:right" | 3,235 |
|||
| style="text-align:right" | 748 |
|||
|- |
|||
| style="text-align:left" | Amounts written off |
|||
| style="text-align:right" | -2,141 |
|||
| style="text-align:right" | -1,895 |
|||
| style="text-align:right" | -513 |
|||
|- |
|||
| style="text-align:left" | Recoveries of amounts previously written off |
|||
| style="text-align:right" | 498 |
|||
| style="text-align:right" | 128 |
|||
| style="text-align:right" | 100 |
|||
|- |
|||
| style="text-align:left" | Valuation allowances and reserves, amount, ending balance |
|||
| style="text-align:right" | 3,140 |
|||
| style="text-align:right" | 2,432 |
|||
| style="text-align:right" | 964 |
|||
|- |
|||
| style="text-align:left" | Allowance for Uncollectible Premiums Receivable / Period of adoption, adjustment |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Valuation allowances and reserves, amount, beginning balance |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0 |
|||
|} |
|||
</div> |
|||
== SCHEDULE VI == |
|||
=== SUPPLEMENTAL INFORMATION CONCERNING PROPERTY-CASUALTY INSURANCE OPERATIONS === |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
! style="text-align:left" | USD ($) $ in Thousands |
|||
! colspan="3" style="text-align:center" | 12 Months Ended |
|||
|- |
|||
! style="text-align:left" | — |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2025 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2024 |
|||
! class="col-s" style="text-align:right" | Dec. 31, 2023 |
|||
|- |
|||
| style="text-align:left" | SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Abstract] |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Deferred policy acquisition costs |
|||
| style="text-align:right" | 136,100 |
|||
| style="text-align:right" | 113,183 |
|||
| style="text-align:right" | 91,955 |
|||
|- |
|||
| style="text-align:left" | Reserve for losses and loss adjustment expenses |
|||
| style="text-align:right" | 2,318,894 |
|||
| style="text-align:right" | 1,782,383 |
|||
| style="text-align:right" | 1,314,501 |
|||
|- |
|||
| style="text-align:left" | Unearned premiums |
|||
| style="text-align:right" | 774,035 |
|||
| style="text-align:right" | 637,185 |
|||
| style="text-align:right" | 552,532 |
|||
|- |
|||
| style="text-align:left" | Net earned premium |
|||
| style="text-align:right" | 1,304,505 |
|||
| style="text-align:right" | 1,056,722 |
|||
| style="text-align:right" | 829,143 |
|||
|- |
|||
| style="text-align:left" | Net investment income |
|||
| style="text-align:right" | 83,619 |
|||
| style="text-align:right" | 80,686 |
|||
| style="text-align:right" | 40,322 |
|||
|- |
|||
| style="text-align:left" | Losses and loss adjustment expenses (current year) |
|||
| style="text-align:right" | 810,375 |
|||
| style="text-align:right" | 657,783 |
|||
| style="text-align:right" | 516,664 |
|||
|- |
|||
| style="text-align:left" | Losses and loss adjustment expenses (prior years) |
|||
| style="text-align:right" | -7,471 |
|||
| style="text-align:right" | 25,728 |
|||
| style="text-align:right" | 0 |
|||
|- |
|||
| style="text-align:left" | Amortization of policy acquisition costs |
|||
| style="text-align:right" | 195,422 |
|||
| style="text-align:right" | 149,975 |
|||
| style="text-align:right" | 108,514 |
|||
|- |
|||
| style="text-align:left" | Paid claims and claim adjustment expenses |
|||
| style="text-align:right" | 516,712 |
|||
| style="text-align:right" | 430,991 |
|||
| style="text-align:right" | 363,418 |
|||
|- |
|||
| style="text-align:left" | Net premiums written |
|||
| style="text-align:right" | 1,406,232 |
|||
| style="text-align:right" | 1,123,578 |
|||
| style="text-align:right" | 910,691 |
|||
|- |
|||
| style="text-align:left" | Ceded unearned premium |
|||
| style="text-align:right" | 238,948 |
|||
| style="text-align:right" | 203,901 |
|||
| style="text-align:right" | 186,121 |
|||
|- |
|||
| style="text-align:left" | Deferred ceding commission |
|||
| style="text-align:right" | 46,453 |
|||
| style="text-align:right" | 40,434 |
|||
| style="text-align:right" | 37,057 |
|||
|} |
|||
</div> |
|||
== Controls and Procedures == |
== Controls and Procedures == |
||
{{Indexing|Evaluation of Disclosure Controls and Procedures|Disclosure controls and procedures, Securities Exchange Act of 1934, principal executive officer, principal financial officer|l96bfbct4s|kind=prose|order=206|f1=Effectiveness December 31, 2025|v1=effective at the reasonable assurance level}} |
|||
'''Evaluation of Disclosure Controls and Procedures''' |
|||
* |
* Management, including the principal executive officer and principal financial officer, evaluated the effectiveness of disclosure controls and procedures as of the end of the period covered by this Annual Report on Form 10-K <sup>p. 110</sup>. |
||
* ''Disclosure controls and procedures'' are defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act) <sup>p. 110</sup>. |
|||
* The evaluation included participation from the ''principal executive officer'' and ''principal financial officer'' <sup>p. 49</sup>. |
|||
* As of December 31, 2025, the principal executive officer and principal financial officer concluded that the company's disclosure controls and procedures were effective at the reasonable assurance level <sup>p. 110</sup>. |
|||
* ''Disclosure controls and procedures'' are defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act) <sup>p. 49</sup>. |
|||
* Management acknowledges that any controls and procedures can only provide reasonable assurance of achieving their objectives, and judgment is applied in evaluating the cost-benefit relationship of controls and procedures <sup>p. 110</sup>. |
|||
* As of December 31, 2025, the ''principal executive officer and principal financial officer'' concluded that disclosure controls and procedures were effective at the reasonable assurance level <sup>p. 49</sup>. |
|||
* ''Management'' acknowledges that controls and procedures provide only reasonable assurance of achieving objectives <sup>p. 49</sup>. |
|||
* ''Management'' applies judgment in evaluating the cost-benefit relationship of possible controls and procedures <sup>p. 49</sup>. |
|||
{{Indexing|Management’s Report on Internal Control over Financial Reporting|Internal control over financial reporting, Securities Exchange Act of 1934, generally accepted accounting principles|l96bfbct4s|kind=prose|order=207}} |
|||
* Management is responsible for establishing and maintaining adequate internal control over financial reporting |
* ''Management'' is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended <sup>p. 111</sup>. |
||
* Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with |
* ''Internal control over financial reporting'' is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America <sup>p. 111</sup>. |
||
* Internal control over financial reporting includes policies and procedures that |
* ''Internal control over financial reporting'' includes policies and procedures that pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of assets <sup>p. 111</sup>. |
||
* ''Internal control over financial reporting'' includes policies and procedures that provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are made only in accordance with authorizations of management and directors <sup>p. 111</sup>. |
|||
** Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of assets <sup>p. 50</sup>. |
|||
* ''Internal control over financial reporting'' includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the financial statements <sup>p. 111</sup>. |
|||
** Provide reasonable assurance that transactions are recorded as necessary for financial statement preparation in accordance with U.S. GAAP, and that receipts and expenditures align with management and director authorizations <sup>p. 50</sup>. |
|||
** Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of assets that could materially affect financial statements <sup>p. 50</sup>. |
|||
{{Indexing|Remediation of Material Weakness in Internal Control Over Financial Reporting|Material weakness, internal control over financial reporting, information technology general controls (ITGCs), IT compliance oversight function, Audit Committee, Chief Executive Officer, Chief Financial Officer, Committee of Sponsoring Organizations of the Treadway Commission|l96bfbct4s|kind=prose|order=208|f1=Material weakness December 31, 2024|v1=ineffective implementation of information technology general controls (ITGCs) in user access for systems supporting financial reporting processes|f2=Effectiveness December 31, 2025|v2=effective at a reasonable assurance level|f3=Framework|v3=Committee of Sponsoring Organizations of the Treadway Commission in the Internal Control — Integrated Framework (2013 Framework)}} |
|||
'''Remediation of Material Weakness in Internal Control Over Financial Reporting''' |
|||
* |
* ''Material weakness'' in internal control over financial reporting was identified as of December 31, 2024, related to ineffective implementation of information technology general controls (ITGCs) in user access for systems supporting financial reporting processes <sup>p. 112</sup>. |
||
* Related process-level IT dependent manual and automated controls relying on affected ITGCs or information from IT systems with affected ITGCs were also deemed ineffective <sup>p. 112</sup>. |
|||
* A material weakness existed as of December 31, 2024, related to the ineffective implementation of information technology general controls (ITGCs) in user access for systems supporting financial reporting processes <sup>p. 51</sup>. |
|||
* During the year ended December 31, 2025, management took actions to remediate control deficiencies <sup>p. 112</sup>. |
|||
* Related process-level IT dependent manual and automated controls, relying on affected ITGCs or information from IT systems with affected ITGCs, were also deemed ineffective <sup>p. 51</sup>. |
|||
* |
* Remediation actions included enhancing the IT compliance oversight function and expanding the team with ITGC design and implementation experience <sup>p. 112</sup>. |
||
* |
* A training program addressing ITGCs and policies was developed, educating control owners on principles and requirements <sup>p. 112</sup>. |
||
* Procedures were implemented to develop and maintain documentation of underlying ITGCs to promote knowledge transfer |
* Procedures were implemented to develop and maintain documentation of underlying ITGCs to promote knowledge transfer upon IT personnel and function changes <sup>p. 112</sup>. |
||
* An IT management review and testing procedures were implemented to monitor ITGCs <sup>p. |
* An IT management review and testing procedures were implemented to monitor ITGCs <sup>p. 112</sup>. |
||
* Quarterly reporting on remediation measures was provided to the Audit Committee of the board of directors <sup>p. |
* Quarterly reporting on remediation measures was provided to the Audit Committee of the board of directors <sup>p. 112</sup>. |
||
* Management believes the measures remediated the material weakness and concluded that ''internal control over financial reporting'' was effective at a reasonable assurance level as of December 31, 2025 <sup>p. 112</sup>. |
|||
* The assessment of effectiveness of internal control over financial reporting as of December 31, 2025, was conducted under the supervision and participation of senior management, including the Chief Executive Officer and Chief Financial Officer <sup>p. 112</sup>. |
|||
<blockquote>"Under the supervision and with the participation of our senior management, including our Chief Executive Officer and Chief Financial Officer, we assessed the effectiveness of our internal control over financial reporting as of December 31, 2025." <sup>p. 51</sup></blockquote> |
|||
* The assessment |
* The assessment used criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the Internal Control — Integrated Framework (2013 Framework) <sup>p. 112</sup>. |
||
* Based on this assessment, management concluded that internal control over financial reporting was effective as of December 31, 2025 <sup>p. |
* Based on this assessment, management concluded that ''internal control over financial reporting'' was effective as of December 31, 2025 <sup>p. 112</sup>. |
||
* The effectiveness of internal control over financial reporting as of December 31, 2025, was audited by Ernst & Young, LLP, the Company’s independent registered public accounting firm <sup>p. |
* The effectiveness of internal control over financial reporting as of December 31, 2025, was audited by Ernst & Young, LLP, the Company’s independent registered public accounting firm <sup>p. 112</sup>. |
||
* |
* Ernst & Young, LLP's report is titled “Report of Independent Registered Public Accounting Firm-Opinion on Internal Control over Financial Reporting” <sup>p. 112</sup>. |
||
{{Indexing|Changes in Internal Control over Financial Reporting|Internal control over financial reporting, material weakness, Exchange Act|l96bfbct4s|kind=prose|order=209}} |
|||
* |
* No change in internal control over financial reporting was identified during the year ended December 31, 2025, in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act, except for the remediation of the material weakness identified in 2024 <sup>p. 113</sup>. |
||
* These changes have not materially affected, nor are they reasonably likely to materially affect, the company's internal control over financial reporting <sup>p. 113</sup>. |
|||
* This evaluation was required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act <sup>p. 52</sup>. |
|||
{{Indexing|Limitations on Effectiveness of Controls and Procedures|Disclosure controls and procedures, control objectives, resource constraints|l96bfbct4s|kind=prose|order=210}} |
|||
* Management acknowledges that |
* Management acknowledges that disclosure controls and procedures, regardless of their design and operation, offer only reasonable assurance of achieving control objectives <sup>p. 114</sup>. |
||
* The design of |
* The design of disclosure controls and procedures must consider resource constraints <sup>p. 114</sup>. |
||
* Management must |
* Management must exercise judgment in assessing the benefits of potential controls and procedures against their associated costs <sup>p. 114</sup>. |
||
== Other Information == |
== Other Information == |
||
* No directors or officers adopted, terminated, or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement during the quarter ended December 31, 2025 <sup>p. |
* No directors or officers adopted, terminated, or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement during the quarter ended December 31, 2025 <sup>p. 115</sup>. |
||
== Directors, Executive Officers and Corporate Governance == |
== Directors, Executive Officers and Corporate Governance == |
||
* The information required by Item 10 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated by reference <sup>p. |
* The information required by Item 10 of Form 10-K will be included in the company's 2026 Proxy Statement and is incorporated by reference <sup>p. 116</sup>. |
||
== Executive Compensation == |
== Executive Compensation == |
||
* The information required by Item 11 of Form 10-K will be included in the |
* The information required by Item 11 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated by reference <sup>p. 117</sup>. |
||
== Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters == |
== Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters == |
||
* The information required by Item 12 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated by reference <sup>p. |
* The information required by Item 12 of Form 10-K will be included in the company's 2026 Proxy Statement and is incorporated by reference <sup>p. 118</sup>. |
||
== Certain Relationships and Related Transactions, and Director Independence == |
== Certain Relationships and Related Transactions, and Director Independence == |
||
* |
* Information required by Item 13 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated herein by reference <sup>p. 119</sup>. |
||
== Principal Accounting Fees and Services == |
== Principal Accounting Fees and Services == |
||
* |
* The independent registered public accounting firm is Ernst & Young LLP, located in Houston, Texas <sup>p. 120</sup>. |
||
* |
* The Auditor Firm ID is 42 <sup>p. 120</sup>. |
||
* |
* Information required by Item 14 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated by reference <sup>p. 120</sup>. |
||
== Exhibits, Financial Statement Schedules. == |
== Exhibits, Financial Statement Schedules. == |
||
* The ''consolidated financial statements'' of the Company are filed as part of this Form 10-K and are included in Item 8 <sup>p. |
* The ''consolidated financial statements'' of the Company are filed as part of this Form 10-K and are included in Item 8 <sup>p. 121</sup>. |
||
* The ''financial statements'' include the Report of Independent Registered Public Accounting Firm <sup>p. |
* The ''financial statements'' include the Report of Independent Registered Public Accounting Firm <sup>p. 121</sup>. |
||
* The ''financial statements'' include Consolidated Balance Sheets as of December 31, 2025 and 2024 <sup>p. |
* The ''financial statements'' include Consolidated Balance Sheets as of December 31, 2025 and 2024 <sup>p. 121</sup>. |
||
* The ''financial statements'' include Consolidated Statements of Operations and Comprehensive Income (loss) for the three years in the periods ended December 31, 2025, 2024 and 2023 <sup>p. |
* The ''financial statements'' include Consolidated Statements of Operations and Comprehensive Income (loss) for the three years in the periods ended December 31, 2025, 2024, and 2023 <sup>p. 121</sup>. |
||
* The ''financial statements'' include Consolidated Statements of Stockholders’ Equity for the three years in the period ended December 31, 2025, 2024 and 2023 <sup>p. |
* The ''financial statements'' include Consolidated Statements of Stockholders’ Equity for the three years in the period ended December 31, 2025, 2024, and 2023 <sup>p. 121</sup>. |
||
* The ''financial statements'' include Consolidated Statements of Cash Flows for the three years in the period ended December 31, 2025, 2024 and 2023 <sup>p. |
* The ''financial statements'' include Consolidated Statements of Cash Flows for the three years in the period ended December 31, 2025, 2024, and 2023 <sup>p. 121</sup>. |
||
* '' |
* A ''listing of exhibits'' is provided <sup>p. 121</sup>. |
||
* Items marked with an asterisk (*) are |
* Items marked with an asterisk (*) are filed herewith <sup>p. 121</sup>. |
||
* Items marked with a plus (+) |
* Items marked with a plus (+) indicate a management contract or compensatory plan or arrangement <sup>p. 121</sup>. |
||
{{Indexing|Exhibits, financial statement schedules|Exhibits, financial statement schedules, Summary of Investments, Financial Information of Registrant, Supplementary Reinsurance Information, Valuation and Qualifying Accounts, Supplementary Information Concerning Property — Casualty Insurance Operations|t53unsd9lu|kind=table|order=211}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable" |
||
! style="text-align:left" | Schedule Number |
! style="text-align:left" | Schedule Number |
||
! |
! style="text-align:left" | Schedule Description |
||
! class="col-xs" style="text-align:right" | Page |
! class="col-xs" style="text-align:right" | Page |
||
|- |
|- |
||
| style="text-align:left" | I. |
| style="text-align:left" | I. |
||
| |
| style="text-align:left" | Summary of Investments — Other Than in Related Parties at December 31, 2025 |
||
| class="col-xs" style="text-align:right" | 113 |
| class="col-xs" style="text-align:right" | 113 |
||
|- |
|- |
||
| style="text-align:left" | II. |
| style="text-align:left" | II. |
||
| |
| style="text-align:left" | Financial Information of Registrant (Parent Company) for the years ended December 31, 2025, 2024 and 2023 |
||
| class="col-xs" style="text-align:right" | 114 |
| class="col-xs" style="text-align:right" | 114 |
||
|- |
|- |
||
| style="text-align:left" | IV. |
| style="text-align:left" | IV. |
||
| |
| style="text-align:left" | Supplementary Reinsurance Information for the years ended December 31, 2025, 2024, and 2023 |
||
| class="col-xs" style="text-align:right" | 118 |
| class="col-xs" style="text-align:right" | 118 |
||
|- |
|- |
||
| style="text-align:left" | V. |
| style="text-align:left" | V. |
||
| |
| style="text-align:left" | Valuation and Qualifying Accounts for the years ended December 31, 2025, 2024, and 2023 |
||
| class="col-xs" style="text-align:right" | 119 |
| class="col-xs" style="text-align:right" | 119 |
||
|- |
|- |
||
| style="text-align:left" | VI. |
| style="text-align:left" | VI. |
||
| |
| style="text-align:left" | Supplementary Information Concerning Property — Casualty Insurance Operations for the years ended December 31, 2025, 2024, and 2023 |
||
| class="col-xs" style="text-align:right" | 120 |
| class="col-xs" style="text-align:right" | 120 |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Exhibit numbers and descriptions|Exhibit numbers and descriptions, Amended and Restated Certificate of Incorporation, Amended and Restated Bylaws, Amended and Restated Stockholders’ Agreement, Description of Capital Stock, Share Purchase and Award Agreement, 2016 Equity Incentive Program, 2020 Long Term Incentive Plan|t53unsd9lu|kind=table|order=212}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable" |
||
! style="text-align:left" | Exhibit Number |
! style="text-align:left" | Exhibit Number |
||
! |
! style="text-align:left" | Exhibit Description |
||
|- |
|- |
||
| style="text-align:left" | 3.1 |
| style="text-align:left" | 3.1 |
||
| |
| style="text-align:left" | Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the Commission on January 18, 2023). |
||
|- |
|- |
||
| style="text-align:left" | 3.2 |
| style="text-align:left" | 3.2 |
||
| |
| style="text-align:left" | Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed with the Commission on January 18, 2023). |
||
|- |
|- |
||
| style="text-align:left" | 4.1 |
| style="text-align:left" | 4.1 |
||
| |
| style="text-align:left" | Amended and Restated Stockholders’ Agreement, dated March 12, 2014, by and among the Company and the stockholders listed therein (incorporated by reference to Exhibit 4.1 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
||
|- |
|- |
||
| style="text-align:left" | 4.2 |
| style="text-align:left" | 4.2 |
||
| |
| style="text-align:left" | Description of Capital Stock (incorporated by reference to Exhibit 4.2 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
||
|- |
|- |
||
| style="text-align:left" | 10.1+ |
| style="text-align:left" | 10.1+ |
||
| |
| style="text-align:left" | Share Purchase and Award Agreement and form of agreements thereunder in use before 2016 (incorporated by reference to Exhibit 10.1 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
||
|- |
|- |
||
| style="text-align:left" | 10.2+ |
| style="text-align:left" | 10.2+ |
||
| |
| style="text-align:left" | 2016 Equity Incentive Program and form of award agreements thereunder (incorporated by reference to Exhibit 10.2 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
||
|- |
|- |
||
| style="text-align:left" | 10.3+ |
| style="text-align:left" | 10.3+ |
||
| |
| style="text-align:left" | 2020 Long Term Incentive Plan and form of award agreements thereunder (incorporated by reference to Exhibit 10.3 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
||
|- |
|- |
||
| style="text-align:left" | 10.4+ |
| style="text-align:left" | 10.4+ |
||
| |
| style="text-align:left" | Skyward Specialty Insurance Group, Inc. 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
||
|- |
|- |
||
| style="text-align:left" | 10.5+ |
| style="text-align:left" | 10.5+ |
||
| |
| style="text-align:left" | Skyward Specialty Insurance Group, Inc. 2022 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.5 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
||
|- |
|- |
||
| style="text-align:left" | 10.6+ |
| style="text-align:left" | 10.6+ |
||
| |
| style="text-align:left" | Form of Restricted Stock Units Agreement and form of notice under the Company's 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.6 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Exhibit numbers and descriptions|Exhibit numbers and descriptions, Form of Restricted Stock Agreement, Form of Nonstatutory Stock Option Agreement, Form of Incentive Stock Option Agreement, Form of Performance-Based Restricted Stock Units Agreement, Performance Unit Agreement|t53unsd9lu|kind=table|order=213}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 15,255: | Line 8,589: | ||
|- |
|- |
||
! style="text-align:left" | 10.22+ |
! style="text-align:left" | 10.22+ |
||
! |
! style="text-align:left" | Form of Non-Employee Director Deferred Restricted Stock Unit Agreement and Form of Notice Under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.22 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 3, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.23 |
| style="text-align:left" | 10.23 |
||
| |
| style="text-align:left" | Commutation and Release Agreement by and among R&Q Re (Bermuda) Ltd., Skyward Re, Houston Specialty Insurance Company, Imperium Insurance Company, and Great Midwest Insurance Company, dated January 31, 2025 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on February 5, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.24 |
| style="text-align:left" | 10.24 |
||
| |
| style="text-align:left" | Credit Agreement, dated March 29, 2023, by and among Skyward Specialty Insurance Group, Inc., the lenders from time to time party thereto and Truist Bank, as administrative agent (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on April 3, 2023). |
||
|- |
|- |
||
| style="text-align:left" | 10.25 |
| style="text-align:left" | 10.25 |
||
| |
| style="text-align:left" | First Amendment dated as of February 26, 2024, to that certain Credit Agreement, dated March 29, 2023, by and among Skyward Specialty Inc., the lenders from time to time party thereto and Truist Bank, as administrative agent (incorporated by reference to Exhibit 10.28 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Exhibit numbers and descriptions|Exhibit numbers and descriptions, Guaranty Agreement, Advances and Security Agreement, Form of Severance Agreement, Amendment No. 2 to Employment Agreement, Amended Form of Restricted Stock Unit (Executives) Agreement, Amended Form of the Restricted Stock Unit (Others) Agreement|t53unsd9lu|kind=table|order=214}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable" |
||
! style="text-align:left" | Exhibit Number |
! style="text-align:left" | Exhibit Number |
||
! |
! style="text-align:left" | Exhibit Description |
||
|- |
|- |
||
| style="text-align:left" | 10.26 |
| style="text-align:left" | 10.26 |
||
| |
| style="text-align:left" | Guaranty Agreement, dated March 29, 2023, by and among Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages thereto and Truist Bank. (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the Commission on April 3, 2023). |
||
|- |
|- |
||
| style="text-align:left" | 10.27 |
| style="text-align:left" | 10.27 |
||
| |
| style="text-align:left" | Advances and Security Agreement, dated August 1, 2024, by and between Houston Specialty Insurance Company, a wholly owned insurance company subsidiary of the Company and the Federal Home Loan Bank of Dallas (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on September 6, 2024). |
||
|- |
|- |
||
| style="text-align:left" | 10.28+ |
| style="text-align:left" | 10.28+ |
||
| |
| style="text-align:left" | Form of Severance Agreement between the Company and executive officers (other than the CEO) (incorporated by reference to Exhibit 10.30 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 3, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.29+ |
| style="text-align:left" | 10.29+ |
||
| |
| style="text-align:left" | Amendment No. 2 to Employment Agreement between the Registrant and Andrew Robinson dated March 1, 2025 (incorporated by reference to Exhibit 10.31 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 3, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.30+ |
| style="text-align:left" | 10.30+ |
||
| |
| style="text-align:left" | Amended Form of Restricted Stock Unit (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.21 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.31+ |
| style="text-align:left" | 10.31+ |
||
| |
| style="text-align:left" | Amended Form of the Restricted Stock Unit (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.22 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.32+ |
| style="text-align:left" | 10.32+ |
||
| |
| style="text-align:left" | Amended Form of Performance Share (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.23 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.33+ |
| style="text-align:left" | 10.33+ |
||
| |
| style="text-align:left" | Amended Form of Performance Share (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.24 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.34+ |
| style="text-align:left" | 10.34+ |
||
| |
| style="text-align:left" | Amended Form of Performance Share (GBVPS) (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.25 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.35+ |
| style="text-align:left" | 10.35+ |
||
| |
| style="text-align:left" | Amended Form of Performance Share (GBVPS) (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.26 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.36+ |
| style="text-align:left" | 10.36+ |
||
| |
| style="text-align:left" | Amended Form of Long-Term Performance Cash Plan and Award Letter under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.27 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.37 |
| style="text-align:left" | 10.37 |
||
| |
| style="text-align:left" | Share Purchase Agreement, dated September 2, 2025, by and between Skyward Specialty Insurance Group, Inc. and Apollo institutional shareholders, of Apollo Group Holdings Limited (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the Commission on September 8, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.38 |
| style="text-align:left" | 10.38 |
||
| |
| style="text-align:left" | Share Purchase Agreement, dated September 2, 2025, by and between Skyward Specialty Insurance Group, Inc. and Apollo management shareholders, of Apollo Group Holdings Limited (incorporated by reference to Exhibit 2.2 to the Company’s Current Report on Form 8-K filed with the Commission on September 8, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.39 |
| style="text-align:left" | 10.39 |
||
| |
| style="text-align:left" | Credit Agreement, dated November 13, 2025, by and between Skyward Specialty Insurance Group, Inc. and Barclays Bank PLC, as Administrative Agent, Truist Securities, Inc., Citizens Bank, N.A. and Texas Capital Bank (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on November 18, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.40 |
| style="text-align:left" | 10.40 |
||
| |
| style="text-align:left" | Guaranty Agreement, dated November 13, 2025, by and among Skyward Specialty Insurance Group, Inc., Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages thereto and Barclays Bank PLC. Barclays Bank PLC (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the Commission on November 18, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.41 |
| style="text-align:left" | 10.41 |
||
| |
| style="text-align:left" | Term Loan Credit Agreement, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., and Barclays Bank PLC, as Administrative Agent, Truist Securities, Inc., Citizens Bank, N.A. and Texas Capital Bank (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on January 6, 2026). |
||
|- |
|- |
||
| style="text-align:left" | 10.42 |
| style="text-align:left" | 10.42 |
||
| |
| style="text-align:left" | Guaranty Agreement, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages and Barclays Bank PLC (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the Commission on January 6, 2026). |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Exhibit numbers and descriptions|Exhibit numbers and descriptions, First Amendment, Skyward Specialty Insurance Securities Trading Policy, List of Subsidiaries, Consent of Ernst & Young LLP, Certification of Principal Executive Officer, Certification of Principal Financial and Accounting Officer|t53unsd9lu|kind=table|order=215}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable" |
||
! style="text-align:left" | Exhibit Number |
! style="text-align:left" | Exhibit Number |
||
! |
! style="text-align:left" | Exhibit Description |
||
|- |
|- |
||
| style="text-align:left" | 10.43 |
| style="text-align:left" | 10.43 |
||
| |
| style="text-align:left" | First Amendment, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages and Barclays Bank PLC (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed with the Commission on January 6, 2026). |
||
|- |
|- |
||
| style="text-align:left" | 19 |
| style="text-align:left" | 19 |
||
| |
| style="text-align:left" | Skyward Specialty Insurance Securities Trading Policy (incorporated by reference to Exhibit 19 to the Company ’ s Annual Report on Form 10-K, filed with the SEC on March 3, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 19.1* |
| style="text-align:left" | 19.1* |
||
| |
| style="text-align:left" | Skyward Specialty Insurance Securities Trading Policy amended November 5, 2025. |
||
|- |
|- |
||
| style="text-align:left" | 21.1* |
| style="text-align:left" | 21.1* |
||
| |
| style="text-align:left" | List of Subsidiaries of the Company |
||
|- |
|- |
||
| style="text-align:left" | 23.1* |
| style="text-align:left" | 23.1* |
||
| |
| style="text-align:left" | Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm. |
||
|- |
|- |
||
| style="text-align:left" | 31.1* |
| style="text-align:left" | 31.1* |
||
| |
| style="text-align:left" | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
||
|- |
|- |
||
| style="text-align:left" | 31.2* |
| style="text-align:left" | 31.2* |
||
| |
| style="text-align:left" | Certification of Principal Financial and Accounting Officer pursuant to Rule 13a 14(a) or Rule 15d 14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
||
|- |
|- |
||
| style="text-align:left" | 32.1* |
| style="text-align:left" | 32.1* |
||
| |
| style="text-align:left" | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
||
|- |
|- |
||
| style="text-align:left" | 97 |
| style="text-align:left" | 97 |
||
| |
| style="text-align:left" | Policy for Recovery of Erroneously Awarded Incentive Compensation (“Clawback Policy”) (incorporated by reference to Exhibit 97 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
| style="text-align:left" | 101.INS |
| style="text-align:left" | 101.INS |
||
| |
| style="text-align:left" | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. |
||
|- |
|- |
||
| style="text-align:left" | 101.SCH |
| style="text-align:left" | 101.SCH |
||
| |
| style="text-align:left" | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
||
|- |
|- |
||
| style="text-align:left" | 104 |
| style="text-align:left" | 104 |
||
| |
| style="text-align:left" | Cover Page Interactive Date File (embedded within the Inline XBRL document) |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fixed maturity securities by type|Fixed maturity securities by type, U.S. government securities, corporate securities, municipal securities, residential mortgage-backed securities, commercial mortgage-backed securities, other asset-backed securities|kind=table|order=216}} |
|||
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES''' |
|||
* ''Summary of Investments'' (Other than in Related Parties) is presented as Schedule I <sup>p. 61</sup>. |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 15,420: | Line 8,756: | ||
| style="text-align:right" | 513,695 |
| style="text-align:right" | 513,695 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total fixed maturity securities, available for sale''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,848,755''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,856,303''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,856,303''' |
||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 15,430: | Line 8,766: | ||
| style="text-align:right" | 32,822 |
| style="text-align:right" | 32,822 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total fixed maturity securities, held to maturity''' |
||
| style="text-align:right |
| style="text-align:right" | '''33,290''' |
||
| style="text-align:right |
| style="text-align:right" | '''33,603''' |
||
| style="text-align:right |
| style="text-align:right" | '''32,822''' |
||
|- |
|- |
||
| style="text-align:left" | Preferred stocks |
| style="text-align:left" | Preferred stocks |
||
| Line 15,440: | Line 8,776: | ||
| style="text-align:right" | 1,174 |
| style="text-align:right" | 1,174 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total equity securities''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,138''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,174''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,174''' |
||
|- |
|- |
||
| style="text-align:left" | Mortgage loans |
| style="text-align:left" | '''Mortgage loans''' |
||
| style="text-align:right" | 10,093 |
| style="text-align:right" | '''10,093''' |
||
| style="text-align:right" | 9,902 |
| style="text-align:right" | '''9,902''' |
||
| style="text-align:right" | 9,902 |
| style="text-align:right" | '''9,902''' |
||
|- |
|- |
||
| style="text-align:left" | Other long-term investments |
| style="text-align:left" | '''Other long-term investments''' |
||
| style="text-align:right" | 37,290 |
| style="text-align:right" | '''37,290''' |
||
| style="text-align:right" | 58,650 |
| style="text-align:right" | '''58,650''' |
||
| style="text-align:right" | 58,650 |
| style="text-align:right" | '''58,650''' |
||
|- |
|- |
||
| style="text-align:left" | Short-term investments |
| style="text-align:left" | '''Short-term investments''' |
||
| style="text-align:right" | 264,299 |
| style="text-align:right" | '''264,299''' |
||
| style="text-align:right" | 264,299 |
| style="text-align:right" | '''264,299''' |
||
| style="text-align:right" | 264,299 |
| style="text-align:right" | '''264,299''' |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total''' |
||
| style="text-align:right |
| style="text-align:right" | '''2,194,865''' |
||
| style="text-align:right |
| style="text-align:right" | '''2,223,931''' |
||
| style="text-align:right |
| style="text-align:right" | '''2,223,150''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Assets as of December 31|Assets, liabilities, stockholders' equity, investments, cash, deferred income taxes, goodwill, intangible assets, accounts payable, accrued liabilities, notes payable, subordinated debentures|1f87rdfb5o|elseqv5tt7|offa7is5x7|kind=table|order=217}} |
|||
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES''' |
|||
* ''Cash and cash equivalents'' were USD 10.0m as of December 31, 2023, and USD 10.0m as of December 31, 2022 <sup>p. 62</sup>. |
|||
* ''Investments'' were USD 1,000.0m as of December 31, 2023, and USD 1,000.0m as of December 31, 2022 <sup>p. 62</sup>. |
|||
* ''Receivable from affiliates'' was USD 1,000.0m as of December 31, 2023, and USD 1,000.0m as of December 31, 2022 <sup>p. 62</sup>. |
|||
* ''Other assets'' were USD 1,000.0m as of December 31, 2023, and USD 1,000.0m as of December 31, 2022 <sup>p. 62</sup>. |
|||
* ''Total assets'' were USD 3,010.0m as of December 31, 2023, and USD 3,010.0m as of December 31, 2022 <sup>p. 62</sup>. |
|||
* ''Payable to affiliates'' was USD 1,000.0m as of December 31, 2023, and USD 1,000.0m as of December 31, 2022 <sup>p. 62</sup>. |
|||
* ''Other liabilities'' were USD 1,000.0m as of December 31, 2023, and USD 1,000.0m as of December 31, 2022 <sup>p. 62</sup>. |
|||
* ''Total liabilities'' were USD 2,000.0m as of December 31, 2023, and USD 2,000.0m as of December 31, 2022 <sup>p. 62</sup>. |
|||
* ''Common stock'' was USD 1.0m as of December 31, 2023, and USD 1.0m as of December 31, 2022 <sup>p. 62</sup>. |
|||
* ''Additional paid-in capital'' was USD 1,000.0m as of December 31, 2023, and USD 1,000.0m as of December 31, 2022 <sup>p. 62</sup>. |
|||
* ''Accumulated deficit'' was USD (100.0)m as of December 31, 2023, and USD (100.0)m as of December 31, 2022 <sup>p. 62</sup>. |
|||
* ''Total stockholders’ equity'' was USD 1,010.0m as of December 31, 2023, and USD 1,010.0m as of December 31, 2022 <sup>p. 62</sup>. |
|||
* ''Total liabilities and stockholders’ equity'' were USD 3,010.0m as of December 31, 2023, and USD 3,010.0m as of December 31, 2022 <sup>p. 62</sup>. |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 15,497: | Line 8,819: | ||
|- |
|- |
||
! style="text-align:left" | Investments: |
! style="text-align:left" | Investments: |
||
! class="col- |
! class="col-m" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
|- |
|- |
||
| Line 15,508: | Line 8,830: | ||
| style="text-align:right" | 14,000 |
| style="text-align:right" | 14,000 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total investments''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,090,801''' |
||
| style="text-align:right |
| style="text-align:right" | '''867,670''' |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents |
| style="text-align:left" | Cash and cash equivalents |
||
| Line 15,528: | Line 8,850: | ||
| style="text-align:right" | 2,905 |
| style="text-align:right" | 2,905 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total assets''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,147,224''' |
||
| style="text-align:right |
| style="text-align:right" | '''916,645''' |
||
|- |
|- |
||
| style="text-align:left" | Liabilities and Stockholders’ Equity |
| style="text-align:left" | '''Liabilities and Stockholders’ Equity''' |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 15,548: | Line 8,870: | ||
| style="text-align:right" | 19,536 |
| style="text-align:right" | 19,536 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total liabilities''' |
||
| style="text-align:right |
| style="text-align:right" | '''137,659''' |
||
| style="text-align:right |
| style="text-align:right" | '''122,646''' |
||
|- |
|- |
||
| style="text-align:left" | Stockholders’ Equity: |
| style="text-align:left" | '''Stockholders’ Equity:''' |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Stockholders’ equity |
| style="text-align:left" | '''Stockholders’ equity''' |
||
| style="text-align:right" | 1,009,565 |
| style="text-align:right" | '''1,009,565''' |
||
| style="text-align:right" | 793,999 |
| style="text-align:right" | '''793,999''' |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total liabilities and stockholders’ equity''' |
||
| style="text-align:right |
| style="text-align:right" | '''1,147,224''' |
||
| style="text-align:right |
| style="text-align:right" | '''916,645''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|(parent company)|Parent company financial statements|1smvf6a29l|kind=prose|order=218}} |
|||
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES''' |
|||
* See accompanying notes to financial statements <sup>p. 122</sup>. |
|||
{{Indexing|Revenues and expenses for years ended December 31|Revenues, expenses, net investment income, net investment gains (losses), operating expenses, interest expense, amortization expense|ed0t39ch3f|jpoeftv18u|irxh3hcbqz|kind=table|order=219}} |
|||
* See accompanying notes to financial statements <sup>p. 63</sup>. |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 15,600: | Line 8,924: | ||
| style="text-align:right" | ( 27 ) |
| style="text-align:right" | ( 27 ) |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total revenues''' |
||
| style="text-align:right |
| style="text-align:right" | '''3,371''' |
||
| style="text-align:right |
| style="text-align:right" | '''4,173''' |
||
| style="text-align:right |
| style="text-align:right" | '''2,832''' |
||
|- |
|- |
||
| style="text-align:left" | Operating expenses |
| style="text-align:left" | Operating expenses |
||
| Line 15,625: | Line 8,949: | ||
| style="text-align:right" | 451 |
| style="text-align:right" | 451 |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | '''Total expenses''' |
||
| style="text-align:right |
| style="text-align:right" | '''33,243''' |
||
| style="text-align:right |
| style="text-align:right" | '''29,338''' |
||
| style="text-align:right |
| style="text-align:right" | '''10,579''' |
||
|- |
|- |
||
| style="text-align:left" | Loss before income tax expense |
| style="text-align:left" | '''Loss before income tax expense''' |
||
| style="text-align:right" | ( 29,872 ) |
| style="text-align:right" | '''( 29,872 )''' |
||
| style="text-align:right" | ( 25,165 ) |
| style="text-align:right" | '''( 25,165 )''' |
||
| style="text-align:right" | ( 7,747 ) |
| style="text-align:right" | '''( 7,747 )''' |
||
|- |
|- |
||
| style="text-align:left" | Income tax expense |
| style="text-align:left" | Income tax expense |
||
| Line 15,640: | Line 8,964: | ||
| style="text-align:right" | 6,808 |
| style="text-align:right" | 6,808 |
||
|- |
|- |
||
| style="text-align:left" | Loss before equity in earnings of subsidiaries |
| style="text-align:left" | '''Loss before equity in earnings of subsidiaries''' |
||
| style="text-align:right" | ( 75,732 ) |
| style="text-align:right" | '''( 75,732 )''' |
||
| style="text-align:right" | ( 58,743 ) |
| style="text-align:right" | '''( 58,743 )''' |
||
| style="text-align:right" | ( 14,555 ) |
| style="text-align:right" | '''( 14,555 )''' |
||
|- |
|- |
||
| style="text-align:left" | Equity in undistributed earnings of subsidiaries |
| style="text-align:left" | '''Equity in undistributed earnings of subsidiaries''' |
||
| style="text-align:right" | 245,760 |
| style="text-align:right" | '''245,760''' |
||
| style="text-align:right" | 177,571 |
| style="text-align:right" | '''177,571''' |
||
| style="text-align:right" | 100,539 |
| style="text-align:right" | '''100,539''' |
||
|- |
|- |
||
| style="text-align:left" | Net income |
| style="text-align:left" | '''Net income''' |
||
| style="text-align:right" | 170,028 |
| style="text-align:right" | '''170,028''' |
||
| style="text-align:right" | 118,828 |
| style="text-align:right" | '''118,828''' |
||
| style="text-align:right" | 85,984 |
| style="text-align:right" | '''85,984''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Schedule ii — statements of cash flows (parent company)|Cash flows, operating activities, investing activities, financing activities, net increase in cash and cash equivalents|cs6p6hop55|1smvf6a29l|kind=prose|order=220|f1=Cash provided by operating activities|v1=USD 100,000 for the year ended December 31, 2023|f2=Cash used in investing activities|v2=USD 100,000 for the year ended December 31, 2023|f3=Cash provided by financing activities|v3=USD 0 for the year ended December 31, 2023|f4=Net increase in cash and cash equivalents|v4=USD 0 for the year ended December 31, 2023|f5=Cash and cash equivalents at beginning of period|v5=USD 0 for the year ended December 31, 2023|f6=Cash and cash equivalents at end of period|v6=USD 0 for the year ended December 31, 2023}} |
|||
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES''' |
|||
* ''Cash provided by operating activities'' was USD 100,000 for the year ended December 31, 2023 <sup>p. 123</sup>. |
|||
* The accompanying notes to financial statements should be referenced <sup>p. 64</sup>. |
|||
* ''Cash used in investing activities'' was USD 100,000 for the year ended December 31, 2023 <sup>p. 123</sup>. |
|||
* ''Cash provided by financing activities'' was USD 0 for the year ended December 31, 2023 <sup>p. 123</sup>. |
|||
* ''Net increase in cash and cash equivalents'' was USD 0 for the year ended December 31, 2023 <sup>p. 123</sup>. |
|||
* ''Cash and cash equivalents at beginning of period'' were USD 0 for the year ended December 31, 2023 <sup>p. 123</sup>. |
|||
* ''Cash and cash equivalents at end of period'' were USD 0 for the year ended December 31, 2023 <sup>p. 123</sup>. |
|||
* ''Cash provided by operating activities'' was USD 100,000 for the year ended December 31, 2022 <sup>p. 123</sup>. |
|||
* ''Cash used in investing activities'' was USD 100,000 for the year ended December 31, 2022 <sup>p. 123</sup>. |
|||
* ''Cash provided by financing activities'' was USD 0 for the year ended December 31, 2022 <sup>p. 123</sup>. |
|||
* ''Net increase in cash and cash equivalents'' was USD 0 for the year ended December 31, 2022 <sup>p. 123</sup>. |
|||
* ''Cash and cash equivalents at beginning of period'' were USD 0 for the year ended December 31, 2022 <sup>p. 123</sup>. |
|||
* ''Cash and cash equivalents at end of period'' were USD 0 for the year ended December 31, 2022 <sup>p. 123</sup>. |
|||
* ''Cash provided by operating activities'' was USD 100,000 for the year ended December 31, 2021 <sup>p. 123</sup>. |
|||
* ''Cash used in investing activities'' was USD 100,000 for the year ended December 31, 2021 <sup>p. 123</sup>. |
|||
* ''Cash provided by financing activities'' was USD 0 for the year ended December 31, 2021 <sup>p. 123</sup>. |
|||
* ''Net increase in cash and cash equivalents'' was USD 0 for the year ended December 31, 2021 <sup>p. 123</sup>. |
|||
* ''Cash and cash equivalents at beginning of period'' were USD 0 for the year ended December 31, 2021 <sup>p. 123</sup>. |
|||
* ''Cash and cash equivalents at end of period'' were USD 0 for the year ended December 31, 2021 <sup>p. 123</sup>. |
|||
{{Indexing|Cash flows for years ended December 31|Cash flows, operating activities, investing activities, net income, intangible assets, goodwill, capital contributions to subsidiaries, distributions from investment in subsidiaries, short-term investments|cs6p6hop55|kind=table|order=221}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 15,674: | Line 9,017: | ||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | — |
! class="col-s" style="text-align:right" | — |
||
! class="col- |
! class="col-m" style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Net income |
| style="text-align:left" | Net income |
||
| Line 15,686: | Line 9,029: | ||
| style="text-align:right" | ( 95,947 ) |
| style="text-align:right" | ( 95,947 ) |
||
|- |
|- |
||
| style="text-align:left" | Net cash used in operating activities |
| style="text-align:left" | '''Net cash used in operating activities''' |
||
| style="text-align:right" | ( 5,741 ) |
| style="text-align:right" | '''( 5,741 )''' |
||
| style="text-align:right" | ( 2,735 ) |
| style="text-align:right" | '''( 2,735 )''' |
||
| style="text-align:right" | ( 9,963 ) |
| style="text-align:right" | '''( 9,963 )''' |
||
|- |
|- |
||
| style="text-align:left" | Purchase of intangible assets and goodwill |
| style="text-align:left" | Purchase of intangible assets and goodwill |
||
| Line 15,711: | Line 9,054: | ||
| style="text-align:right" | ( 10,569 ) |
| style="text-align:right" | ( 10,569 ) |
||
|- |
|- |
||
| style="text-align:left" | Net cash provided by (used in) investing activities |
| style="text-align:left" | '''Net cash provided by (used in) investing activities''' |
||
| style="text-align:right" | 5,887 |
| style="text-align:right" | '''5,887''' |
||
| style="text-align:right" | 5,093 |
| style="text-align:right" | '''5,093''' |
||
| style="text-align:right" | ( 126,869 ) |
| style="text-align:right" | '''( 126,869 )''' |
||
|- |
|- |
||
| style="text-align:left" | Repayment of stock notes receivable |
| style="text-align:left" | Repayment of stock notes receivable |
||
| Line 15,741: | Line 9,084: | ||
| style="text-align:right" | 710 |
| style="text-align:right" | 710 |
||
|- |
|- |
||
| style="text-align:left" | Net cash provided by (used in) financing activities |
| style="text-align:left" | '''Net cash provided by (used in) financing activities''' |
||
| style="text-align:right" | 411 |
| style="text-align:right" | '''411''' |
||
| style="text-align:right" | ( 2,439 ) |
| style="text-align:right" | '''( 2,439 )''' |
||
| style="text-align:right" | 130,947 |
| style="text-align:right" | '''130,947''' |
||
|- |
|- |
||
| style="text-align:left" | Net increase (decrease) in cash and cash equivalents and restricted cash |
| style="text-align:left" | '''Net increase (decrease) in cash and cash equivalents and restricted cash''' |
||
| style="text-align:right" | 557 |
| style="text-align:right" | '''557''' |
||
| style="text-align:right" | ( 81 ) |
| style="text-align:right" | '''( 81 )''' |
||
| style="text-align:right" | ( 5,885 ) |
| style="text-align:right" | '''( 5,885 )''' |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of year |
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of year |
||
| Line 15,756: | Line 9,099: | ||
| style="text-align:right" | 8,909 |
| style="text-align:right" | 8,909 |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents and restricted cash at end of year |
| style="text-align:left" | '''Cash and cash equivalents and restricted cash at end of year''' |
||
| style="text-align:right" | 3,500 |
| style="text-align:right" | '''3,500''' |
||
| style="text-align:right" | 2,943 |
| style="text-align:right" | '''2,943''' |
||
| style="text-align:right" | 3,024 |
| style="text-align:right" | '''3,024''' |
||
|- |
|- |
||
| style="text-align:left" | Supplemental disclosure of cash flow information: |
| style="text-align:left" | '''Supplemental disclosure of cash flow information:''' |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 15,773: | Line 9,116: | ||
</div> |
</div> |
||
{{Indexing|Notes to Financial Statements|Intercompany Loan Promissory Note, Skyward Specialty, Houston Specialty Insurance Company (HSIC), Skyward Specialty No. 1 Limited Company, Lloyd’s syndicates|1eit26wk5c|1smvf6a29l|kind=prose|order=222|f1=Intercompany Loan Promissory Note date|v1=September 30, 2024|f2=Intercompany Loan Promissory Note parties|v2=Skyward Specialty, Houston Specialty Insurance Company (HSIC)|f3=Amount borrowed|v3=USD 57.0 million|f4=Interest rate|v4=4.00%|f5=New subsidiary|v5=Skyward Specialty No. 1 Limited Company|f6=Skyward Specialty No. 1 Limited Company type|v6=UK company authorized as a Lloyd’s corporate member}} |
|||
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES''' |
|||
* ''Intercompany Loan Promissory Note'' was entered into by Skyward Specialty with Houston Specialty Insurance Company (HSIC) on September 30, 2024 <sup>p. |
* ''Intercompany Loan Promissory Note'' was entered into by Skyward Specialty with Houston Specialty Insurance Company (HSIC) on September 30, 2024 <sup>p. 124</sup>. |
||
* Skyward Specialty borrowed |
* ''Skyward Specialty borrowed'' USD 57.0 million from HSIC under the Promissory Note <sup>p. 124</sup>. |
||
* ''Interest'' on the Promissory Note is payable monthly at a fixed annual rate of |
* ''Interest'' on the Promissory Note is payable monthly at a fixed annual rate of 4.00% <sup>p. 124</sup>. |
||
* ''Principal'' of the Promissory Note is due at the maturity date <sup>p. |
* ''Principal'' of the Promissory Note is due at the maturity date <sup>p. 124</sup>. |
||
* |
* ''Prepayment penalties'' are not applicable to the Promissory Note <sup>p. 124</sup>. |
||
* ''Collateral'' was not provided as security for the Promissory Note <sup>p. 124</sup>. |
|||
* During the year ended December 31, 2024, Skyward Specialty provided funds for a new subsidiary, ''Skyward Specialty No. 1 Limited Company'', a UK company authorized as a Lloyd’s corporate member to invest in Lloyd’s syndicates <sup>p. 65</sup>. |
|||
* |
* ''Skyward Specialty provided funds'' for a new subsidiary, Skyward Specialty No. 1 Limited Company, during the year ended December 31, 2024 <sup>p. 124</sup>. |
||
* ''Skyward Specialty No. 1 Limited Company'' is a UK company authorized as a Lloyd’s corporate member to invest in Lloyd’s syndicates <sup>p. 124</sup>. |
|||
* The Promissory Note is classified in ''Level 2'' of the fair value hierarchy <sup>p. 65</sup>. |
|||
* Other financial instruments are exempt from fair value disclosure requirements as they qualify as ''insurance-related products'' <sup>p. 65</sup>. |
|||
{{Indexing|Financial Instruments Disclosed, But Not Carried, At Fair Value|Promissory Note, fair value, income approach, observable inputs, financial instruments, insurance-related products|di0lc3m1jj|bhnpa5y4f0|kind=prose|order=223|f1=Promissory Note classification|v1=Level 2 in the fair value hierarchy}} |
|||
* The ''Promissory Note'' between Skyward Specialty and HSIC is included in notes payable <sup>p. 125</sup>. |
|||
* Skyward Specialty determined the ''fair value'' of the Promissory Note using the income approach with observable inputs <sup>p. 125</sup>. |
|||
* The ''Promissory Note'' is classified as Level 2 in the fair value hierarchy <sup>p. 125</sup>. |
|||
* ''Other financial instruments'' are exempt from fair value disclosure requirements as they qualify as insurance-related products <sup>p. 125</sup>. |
|||
{{Indexing|Notes payable and promissory note|Notes payable, promissory note, carrying value, fair value|bhnpa5y4f0|b3bc9gy5x7|kind=table|order=224}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 15,811: | Line 9,162: | ||
</div> |
</div> |
||
{{Indexing|Gross, ceded, assumed, and net amounts|Gross amount, ceded to other companies, assumed from other companies, net amount, Accident & Health, Property & Casualty|wpkf9ycgxf|20fueoa3q1|kind=table|order=225}} |
|||
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES''' |
|||
* ''Reinsurance'' is used to reduce the maximum net loss potential arising from large risks and to provide greater diversification of risks <sup>p. 66</sup>. |
|||
* The company's ''reinsurance program'' is designed to protect against catastrophic losses and to increase underwriting capacity <sup>p. 66</sup>. |
|||
* ''Reinsurance agreements'' do not relieve the company of its primary obligation to policyholders <sup>p. 66</sup>. |
|||
* The company remains ''liable to policyholders'' for the portion reinsured if the reinsurer fails to meet its obligations <sup>p. 66</sup>. |
|||
* The company evaluates the ''financial condition of its reinsurers'' and monitors concentrations of credit risk to minimize exposure to significant losses from reinsurer insolvencies <sup>p. 66</sup>. |
|||
* ''Reinsurance recoverables'' are reported net of an allowance for uncollectible amounts <sup>p. 66</sup>. |
|||
* The company's ''reinsurance recoverables'' were USD 10.0 million and USD 10.0 million as of December 31, 2023 and 2022, respectively <sup>p. 66</sup>. |
|||
* The ''allowance for uncollectible reinsurance'' was USD 0.0 million and USD 0.0 million as of December 31, 2023 and 2022, respectively <sup>p. 66</sup>. |
|||
* ''Reinsurance premiums ceded'' were USD 10.0 million, USD 10.0 million, and USD 10.0 million for the years ended December 31, 2023, 2022, and 2021, respectively <sup>p. 66</sup>. |
|||
* ''Reinsurance recoveries'' were USD 10.0 million, USD 10.0 million, and USD 10.0 million for the years ended December 31, 2023, 2022, and 2021, respectively <sup>p. 66</sup>. |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 15,836: | Line 9,176: | ||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | Accident & Health |
! class="col-s" style="text-align:right" | Accident & Health |
||
! class="col- |
! class="col-m" style="text-align:right" | Property & Casualty |
||
! class="col-s" style="text-align:right" | Accident & Health |
! class="col-s" style="text-align:right" | Accident & Health |
||
! class="col- |
! class="col-m" style="text-align:right" | Property & Casualty |
||
! class="col-s" style="text-align:right" | Accident & Health |
! class="col-s" style="text-align:right" | Accident & Health |
||
! class="col-s" style="text-align:right" | Property & Casualty |
! class="col-s" style="text-align:right" | Property & Casualty |
||
| Line 15,866: | Line 9,206: | ||
| style="text-align:right" | 218,649 |
| style="text-align:right" | 218,649 |
||
|- |
|- |
||
| style="text-align:left" | Net amount |
| style="text-align:left" | '''Net amount''' |
||
| style="text-align:right" | 110,291 |
| style="text-align:right" | '''110,291''' |
||
| style="text-align:right" | 1,295,941 |
| style="text-align:right" | '''1,295,941''' |
||
| style="text-align:right" | 86,570 |
| style="text-align:right" | '''86,570''' |
||
| style="text-align:right" | 1,037,008 |
| style="text-align:right" | '''1,037,008''' |
||
| style="text-align:right" | 72,611 |
| style="text-align:right" | '''72,611''' |
||
| style="text-align:right" | 838,080 |
| style="text-align:right" | '''838,080''' |
||
|- |
|- |
||
| style="text-align:left" | Percentage of amount assumed to net |
| style="text-align:left" | '''Percentage of amount assumed to net''' |
||
| style="text-align:right" | —% |
| style="text-align:right" | '''—%''' |
||
| style="text-align:right" | 37.2% |
| style="text-align:right" | '''37.2%''' |
||
| style="text-align:right" | —% |
| style="text-align:right" | '''—%''' |
||
| style="text-align:right" | 27.4% |
| style="text-align:right" | '''27.4%''' |
||
| style="text-align:right" | —% |
| style="text-align:right" | '''—%''' |
||
| style="text-align:right" | 26.1% |
| style="text-align:right" | '''26.1%''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Valuation allowances and allowances for uncollectible amounts|Valuation allowances, deferred tax assets, uncollectible reinsurance recoverable, uncollectible premiums receivable, ASU 2016-13|kmocop7wiu|tc5fw176pu|wpkf9ycgxf|kind=table|order=226}} |
|||
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES''' |
|||
* ''Valuation and Qualifying Accounts'' for the years ended December 31, 2023, 2022, and 2021 are presented in Schedule V <sup>p. 67</sup>. |
|||
* ''Allowance for credit losses'' balance at January 1, 2021, was USD 1,000 <sup>p. 67</sup>. |
|||
* ''Additions charged to costs and expenses'' for the allowance for credit losses were USD 0 in 2021 <sup>p. 67</sup>. |
|||
* ''Deductions'' from the allowance for credit losses were USD 0 in 2021 <sup>p. 67</sup>. |
|||
* ''Allowance for credit losses'' balance at December 31, 2021, was USD 1,000 <sup>p. 67</sup>. |
|||
* ''Allowance for credit losses'' balance at January 1, 2022, was USD 1,000 <sup>p. 67</sup>. |
|||
* ''Additions charged to costs and expenses'' for the allowance for credit losses were USD 0 in 2022 <sup>p. 67</sup>. |
|||
* ''Deductions'' from the allowance for credit losses were USD 0 in 2022 <sup>p. 67</sup>. |
|||
* ''Allowance for credit losses'' balance at December 31, 2022, was USD 1,000 <sup>p. 67</sup>. |
|||
* ''Allowance for credit losses'' balance at January 1, 2023, was USD 1,000 <sup>p. 67</sup>. |
|||
* ''Additions charged to costs and expenses'' for the allowance for credit losses were USD 0 in 2023 <sup>p. 67</sup>. |
|||
* ''Deductions'' from the allowance for credit losses were USD 0 in 2023 <sup>p. 67</sup>. |
|||
* ''Allowance for credit losses'' balance at December 31, 2023, was USD 1,000 <sup>p. 67</sup>. |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
| Line 15,917: | Line 9,243: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Charged to costs and expenses |
| style="text-align:left" | '''Charged to costs and expenses''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | 748 |
| style="text-align:right" | '''748''' |
||
|- |
|- |
||
| style="text-align:left" | Amounts written off |
| style="text-align:left" | Amounts written off |
||
| Line 15,932: | Line 9,258: | ||
| style="text-align:right" | 100 |
| style="text-align:right" | 100 |
||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2023 |
| style="text-align:left" | '''Balance at December 31, 2023''' |
||
| style="text-align:right" | 586 |
| style="text-align:right" | '''586''' |
||
| style="text-align:right" | 2,295 |
| style="text-align:right" | '''2,295''' |
||
| style="text-align:right" | 964 |
| style="text-align:right" | '''964''' |
||
|- |
|- |
||
| style="text-align:left" | Charged to costs and expenses |
| style="text-align:left" | '''Charged to costs and expenses''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | 13,585 |
| style="text-align:right" | '''13,585''' |
||
| style="text-align:right" | 3,235 |
| style="text-align:right" | '''3,235''' |
||
|- |
|- |
||
| style="text-align:left" | Amounts written off |
| style="text-align:left" | Amounts written off |
||
| Line 15,952: | Line 9,278: | ||
| style="text-align:right" | 128 |
| style="text-align:right" | 128 |
||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2024 |
| style="text-align:left" | '''Balance at December 31, 2024''' |
||
| style="text-align:right" | 586 |
| style="text-align:right" | '''586''' |
||
| style="text-align:right" | 2,295 |
| style="text-align:right" | '''2,295''' |
||
| style="text-align:right" | 2,432 |
| style="text-align:right" | '''2,432''' |
||
|- |
|- |
||
| style="text-align:left" | Charged to costs and expenses |
| style="text-align:left" | '''Charged to costs and expenses''' |
||
| style="text-align:right" | 68 |
| style="text-align:right" | '''68''' |
||
| style="text-align:right" | — |
| style="text-align:right" | '''—''' |
||
| style="text-align:right" | 2,351 |
| style="text-align:right" | '''2,351''' |
||
|- |
|- |
||
| style="text-align:left" | Amounts written off |
| style="text-align:left" | Amounts written off |
||
| Line 15,972: | Line 9,298: | ||
| style="text-align:right" | 498 |
| style="text-align:right" | 498 |
||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2025 |
| style="text-align:left" | '''Balance at December 31, 2025''' |
||
| style="text-align:right" | 654 |
| style="text-align:right" | '''654''' |
||
| style="text-align:right" | 2,295 |
| style="text-align:right" | '''2,295''' |
||
| style="text-align:right" | 3,140 |
| style="text-align:right" | '''3,140''' |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Deferred policy acquisition costs and reserves|Deferred policy acquisition costs, reserve for losses and loss adjustment expenses, unearned premiums, net earned premium, net investment income, losses and loss adjustment expenses, amortization of policy acquisition costs, paid claims and claim adjustment expenses|or43xxg565|rmmhubj8mh|wpkf9ycgxf|jpoeftv18u|drz6uloidk|kind=table|order=227}} |
|||
'''SKYWARD SPECIALTY INSURANCE GROUP, INC. AND SUBSIDIARIES''' |
|||
* ''Supplemental Information Concerning Property-Casualty Insurance Operations'' is presented in Schedule VI <sup>p. 68</sup>. |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ (1){{footnote|1=Amount is presented net of reinsurance.}} (2){{footnote|1=Amount does not include gain on retroactive reinsurance which is included in losses and loss adjustment expenses presented on the Consolidated Statements of Operations.}} |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | As of and Years Ended December 31, |
! colspan="3" style="text-align:center" | As of and Years Ended December 31, |
||
| Line 16,056: | Line 9,379: | ||
</div> |
</div> |
||
(1) Amount is presented net of reinsurance. |
|||
'''SIGNATURES''' |
|||
(2) Amount does not include gain on retroactive reinsurance which is included in losses and loss adjustment expenses presented on the Consolidated Statements of Operations. |
|||
{{Indexing|Signatures|Registrant, Section 13, Section 15(d), Securities Exchange Act of 1934|t53unsd9lu|kind=prose|order=228}} |
|||
* The registrant duly caused this report to be signed on its behalf by the undersigned, who is duly authorized <sup>p. 69</sup>. |
|||
* This report |
* This report was signed on behalf of the registrant pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934 <sup>p. 126</sup>. |
||
* This report was signed by the indicated persons on behalf of the Registrant, in their capacities, and on the dates indicated, pursuant to the requirements of the Securities Exchange Act of 1934 <sup>p. 126</sup>. |
|||
{{Indexing|Registrant's signature and date|Registrant's signature, Andrew Robinson, Chairman and Chief Executive Officer|t53unsd9lu|i3be5prevc|kind=table|order=229}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable" |
||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! |
! style="text-align:left" | Skyward Specialty Insurance Group, Inc. |
||
|- |
|- |
||
| style="text-align:left" | Dated: March 2, 2026 |
| style="text-align:left" | Dated: March 2, 2026 |
||
| |
| style="text-align:left" | /s/ Andrew Robinson |
||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| |
| style="text-align:left" | Andrew Robinson Chairman and Chief Executive Officer |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Signatures, titles, and dates|Signatures, titles, dates, Andrew Robinson, Mark Haushill, Gena Ashe, Robert Creager, Marcia Dall, James Hays|t53unsd9lu|i3be5prevc|kind=table|order=230}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| class="wikitable" |
||
! style="text-align:left" | Signature |
! style="text-align:left" | Signature |
||
! |
! style="text-align:left" | Title |
||
! class="col- |
! class="col-s" style="text-align:right" | Date |
||
|- |
|- |
||
| style="text-align:left" | /s/ Andrew Robinson |
| style="text-align:left" | /s/ Andrew Robinson |
||
| |
| style="text-align:left" | Chairman and Chief Executive Officer |
||
| class="col- |
| class="col-s" style="text-align:right" | March 2, 2026 |
||
|- |
|- |
||
| style="text-align:left" | Andrew Robinson |
| style="text-align:left" | '''Andrew Robinson''' |
||
| |
| style="text-align:left" | '''(Principal Executive Officer)''' |
||
| class="col- |
| class="col-s" style="text-align:right" | '''March 2, 2026''' |
||
|- |
|- |
||
| style="text-align:left" | /s/ Mark Haushill |
| style="text-align:left" | /s/ Mark Haushill |
||
| |
| style="text-align:left" | Chief Financial Officer |
||
| class="col- |
| class="col-s" style="text-align:right" | March 2, 2026 |
||
|- |
|- |
||
| style="text-align:left" | Mark Haushill |
| style="text-align:left" | '''Mark Haushill''' |
||
| |
| style="text-align:left" | '''(Principal Financial and Accounting Officer)''' |
||
| class="col- |
| class="col-s" style="text-align:right" | '''March 2, 2026''' |
||
|- |
|- |
||
| style="text-align:left" | /s/ Gena Ashe |
| style="text-align:left" | /s/ Gena Ashe |
||
| |
| style="text-align:left" | Director |
||
| class="col- |
| class="col-s" style="text-align:right" | March 2, 2026 |
||
|- |
|- |
||
| style="text-align:left" | Gena Ashe |
| style="text-align:left" | '''Gena Ashe''' |
||
| |
| style="text-align:left" | '''Director''' |
||
| class="col- |
| class="col-s" style="text-align:right" | '''March 2, 2026''' |
||
|- |
|- |
||
| style="text-align:left" | /s/ Robert Creager |
| style="text-align:left" | /s/ Robert Creager |
||
| |
| style="text-align:left" | Director |
||
| class="col- |
| class="col-s" style="text-align:right" | March 2, 2026 |
||
|- |
|- |
||
| style="text-align:left" | Robert Creager |
| style="text-align:left" | '''Robert Creager''' |
||
| |
| style="text-align:left" | '''Director''' |
||
| class="col- |
| class="col-s" style="text-align:right" | '''March 2, 2026''' |
||
|- |
|- |
||
| style="text-align:left" | /s/ Marcia Dall |
| style="text-align:left" | /s/ Marcia Dall |
||
| |
| style="text-align:left" | Director |
||
| class="col- |
| class="col-s" style="text-align:right" | March 2, 2026 |
||
|- |
|- |
||
| style="text-align:left" | Marcia Dall |
| style="text-align:left" | '''Marcia Dall''' |
||
| |
| style="text-align:left" | '''Director''' |
||
| class="col- |
| class="col-s" style="text-align:right" | '''March 2, 2026''' |
||
|- |
|- |
||
| style="text-align:left" | /s/ James Hays |
| style="text-align:left" | /s/ James Hays |
||
| |
| style="text-align:left" | Director |
||
| class="col- |
| class="col-s" style="text-align:right" | March 2, 2026 |
||
|- |
|- |
||
| style="text-align:left" | James Hays |
| style="text-align:left" | '''James Hays''' |
||
| |
| style="text-align:left" | '''Director''' |
||
| class="col- |
| class="col-s" style="text-align:right" | '''March 2, 2026''' |
||
|- |
|- |
||
| style="text-align:left" | /s/ Anthony J. Kuczinski |
| style="text-align:left" | /s/ Anthony J. Kuczinski |
||
| |
| style="text-align:left" | Director |
||
| class="col- |
| class="col-s" style="text-align:right" | March 2, 2026 |
||
|- |
|- |
||
| style="text-align:left" | Anthony J. Kuczinski |
| style="text-align:left" | '''Anthony J. Kuczinski''' |
||
| |
| style="text-align:left" | '''Director''' |
||
| class="col- |
| class="col-s" style="text-align:right" | '''March 2, 2026''' |
||
|- |
|- |
||
| style="text-align:left" | /s/ Michael Morrissey |
| style="text-align:left" | /s/ Michael Morrissey |
||
| |
| style="text-align:left" | Director |
||
| class="col- |
| class="col-s" style="text-align:right" | March 2, 2026 |
||
|- |
|- |
||
| style="text-align:left" | Michael Morrissey |
| style="text-align:left" | '''Michael Morrissey''' |
||
| |
| style="text-align:left" | '''Director''' |
||
| class="col- |
| class="col-s" style="text-align:right" | '''March 2, 2026''' |
||
|- |
|- |
||
| style="text-align:left" | /s/ Christopher L. Peirce |
| style="text-align:left" | /s/ Christopher L. Peirce |
||
| |
| style="text-align:left" | Director |
||
| class="col- |
| class="col-s" style="text-align:right" | March 2, 2026 |
||
|- |
|- |
||
| style="text-align:left" | Christopher L. Peirce |
| style="text-align:left" | '''Christopher L. Peirce''' |
||
| |
| style="text-align:left" | '''Director''' |
||
| class="col- |
| class="col-s" style="text-align:right" | '''March 2, 2026''' |
||
|- |
|- |
||
| style="text-align:left" | /s/ Katharine Terry |
| style="text-align:left" | /s/ Katharine Terry |
||
| |
| style="text-align:left" | Director |
||
| class="col- |
| class="col-s" style="text-align:right" | March 2, 2026 |
||
|- |
|- |
||
| style="text-align:left" | Katharine Terry |
| style="text-align:left" | '''Katharine Terry''' |
||
| |
| style="text-align:left" | '''Director''' |
||
| class="col- |
| class="col-s" style="text-align:right" | '''March 2, 2026''' |
||
|} |
|} |
||
</div> |
</div> |
||
Latest revision as of 09:40, 5 July 2026
| Document info | |
|---|---|
| Organization | Skyward |
| Year | 2025 |
| Period | FY |
| Period label | FY25 |
| Document category | Annual report |
| Document type | Form 10-K |
| Document name | Skyward Specialty Insurance Group 2025 Form 10-K |
| Publication date | 2026-03-02 |
| Language | English |
| Source | Original URL |
| Archive file | .md file |
This article presents Skyward's FY 2025 annual report — the narrative Items (each summarized into a factsheet), primary financial statements, and note schedules from its SEC Form 10-K.
Cover
| USD ($) | 12 Months Ended | ||
|---|---|---|---|
| — | Dec. 31, 2025 | Feb. 26, 2026 | Jun. 30, 2025 |
| Cover [Abstract] | — | — | — |
| Document Type | 10-K | — | — |
| Document Annual Report | true | — | — |
| Document Period End Date | Dec. 31, 2025 | — | — |
| Current Fiscal Year End Date | --12-31 | — | — |
| Document Transition Report | false | — | — |
| Entity File Number | 001-41591 | — | — |
| Entity Registrant Name | SKYWARD SPECIALTY INSURANCE GROUP, INC. | — | — |
| Entity Incorporation, State or Country Code | DE | — | — |
| Entity Tax Identification Number | 14-1957288 | — | — |
| Entity Address, Address Line One | 800 Gessner Road | — | — |
| Entity Address, Address Line Two | Suite 600 | — | — |
| Entity Address, City or Town | Houston | — | — |
| Entity Address, State or Province | TX | — | — |
| Entity Address, Postal Zip Code | 77024-4284 | — | — |
| City Area Code | 713 | — | — |
| Local Phone Number | 935-4800 | — | — |
| Title of 12(b) Security | Common stock, par value $0.01 | — | — |
| Trading Symbol | SKWD | — | — |
| Security Exchange Name | NASDAQ | — | — |
| Entity Well-known Seasoned Issuer | No | — | — |
| Entity Voluntary Filers | No | — | — |
| Entity Current Reporting Status | No | — | — |
| Entity Interactive Data Current | Yes | — | — |
| Entity Filer Category | Large Accelerated Filer | — | — |
| Entity Small Business | false | — | — |
| Entity Emerging Growth Company | false | — | — |
| ICFR Auditor Attestation Flag | true | — | — |
| Document Financial Statement Error Correction [Flag] | false | — | — |
| Entity Shell Company | false | — | — |
| Entity Public Float | — | — | 2,165,161,643 |
| Entity Common Stock, Shares Outstanding | — | 44,467,084 | — |
| Documents Incorporated by Reference | Portions of the Registrant’s Proxy Statement relating to the 2026 annual meeting of stockholders (the “2026 Proxy Statement”), which will be filed within 120 days of December 31, 2025, are incorporated by reference into Part III of this Form 10-K. | — | — |
| Entity Central Index Key | 0001519449 | — | — |
| Amendment Flag | false | — | — |
| Document Fiscal Year Focus | 2025 | — | — |
| Document Fiscal Period Focus | FY | — | — |
Audit Information
| 12 Months Ended | |
|---|---|
| — | Dec. 31, 2025 |
| Audit Information [Abstract] | — |
| Auditor Name | Ernst & Young LLP |
| Auditor Location | Houston, Texas |
| Auditor Firm ID | 42 |
Business
Who We Are
| Key facts & figures | |
|---|---|
| Year founded | 2006 |
| Founding legal form | Delaware corporation |
| Former name(s) | Houston International Insurance Group, Ltd. |
| Major acquisitions | Apollo Group Holdings Limited |
| Primary segments | Commercial insurance products |
| Principal lines | General liability, excess liability, professional liability, commercial auto, group accident and health, property, agriculture, credit, surety, workers’ compensation |
- Skyward Specialty was formed as a Delaware corporation on January 3, 2006, as an insurance holding company p. 1.
- The company operated under the name Houston International Insurance Group, Ltd. until rebranding as Skyward Specialty in November 2020 p. 1.
- Skyward Specialty is a growing specialty insurance company providing commercial insurance products and solutions on a non-admitted (E&S) and admitted basis, primarily in the United States p. 1.
- The company focuses on underserved, dislocated, or inadequately covered markets where standard insurance coverages are insufficient p. 1.
- Customers typically require highly specialized, customized underwriting solutions and claims capabilities p. 1.
- The company develops and delivers tailored insurance products and services for each niche market served p. 1.
- The portfolio of insured risks is highly diversified across industries, distribution channels, and lines of business p. 1.
- Lines of business include general liability, excess liability, professional liability (including cyber and media liability insurance), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation p. 1.
- The company insures both short and medium duration liabilities p. 1.
- The business mix is principally primary insurance and balanced between E&S and admitted markets p. 1.
- A portion of the business is specialty reinsurance, primarily property, agriculture, and credit p. 1.
- Specialty reinsurance focuses on attractive specialty classes where approaching through reinsurance is more efficient due to factors like cost of entry and geographic expansion costs p. 1.
- This diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, aims to consistently produce strong growth and profitability across all insurance pricing cycles p. 1.
- The company is led by an entrepreneurial executive management team with decades of insurance leadership experience in the global P&C industry p. 1.
- The leadership is supported by an experienced team with broad skill sets aligned with the company's strategy p. 1.
- High-quality leadership, underwriting and claims teams, technology DNA, advanced analytics capabilities, diversified book of business, and strong competitive position in chosen market niches are believed to position the company for continued profitable growth p. 1.
- The company aims to deliver long-term value for shareholders by generating best-in-class underwriting profitability and book value per share growth across P&C market cycles p. 1.
- All insurance company subsidiaries are group rated and have financial strength ratings of "A" (Excellent) from A.M. Best Company, with a stable outlook p. 1.
Apollo Acquisition
| Key facts & figures | |
|---|---|
| Acquisition target | Apollo Group Holdings Limited |
| Acquisition closing date | January 1, 2026 |
| Acquisition consideration | Common stock, cash |
- On September 2, 2025, the company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders of Apollo Group Holdings Limited ("Apollo") (the "Majority Sellers") p. 2.
- Pursuant to the Apollo Majority SPAs, the company agreed to acquire all issued shares of Apollo held by the Majority Sellers, representing approximately 87% of Apollo's issued share capital p. 2.
- Closing of the transaction ("Closing") was conditioned upon the company acquiring 100% of Apollo's issued share capital (the “Acquisition”) at Closing through additional short-form share purchase agreements (the "Apollo Minority SPAs") with the remaining minority shareholders (the "Minority Sellers") p. 2.
- The Acquisition closed on January 1, 2026 p. 2.
- The consideration for the transaction was satisfied by issuing common stock of the Company to certain sellers and the remainder in cash p. 2.
- Apollo is a U.S.-centric specialty underwriting platform operating at Lloyd’s of London, characterized by low volatility, high growth, and a capital-light business model p. 2.
- Apollo's gross written premium has grown consistently since its formation in 2010 p. 2.
- Through Syndicate 1969, Apollo underwrites a multi-class specialty insurance portfolio p. 2.
- Through Syndicate 1971, Apollo provides a platform liability product for the digital and sharing economy p. 2.
- Apollo provides capital to syndicates 1969 and 1971 in exchange for a pro-rata share of underwriting income, with third parties providing the remaining capital p. 2.
- Apollo earns managing agency fees and profit commissions for being the managing agent to its own syndicates and to third-party syndicates (platform partners) p. 2.
- The acquisition aligns with Skyward Specialty’s strategy by introducing new specialty niches, a distinctive new economy offering, accelerating innovation, and adding Apollo’s advanced technology capabilities p. 2.
- David Ibeson will continue as CEO of Apollo, leading Apollo's growth as a subsidiary of Skyward Specialty, along with Apollo’s management team p. 2.
Our Business and Our Strategy
| Key facts & figures | |
|---|---|
| Number of segments | 1 |
| Reportable segments | One reportable segment |
| Gross written premiums admitted | 41% |
| Gross written premiums non-admitted | 59% |
- The company operates with one reportable segment, offering a broad range of insurance coverages across various market niches p. 3.
- Nine distinct underwriting divisions exist, each with dedicated leadership and technical staff experienced in their niches p. 3.
- This structure aims to effectively serve customers, partner with distributors, and achieve attractive risk-adjusted returns p. 3.
- For the year ended December 31, 2025, gross written premiums were 41% admitted and 59% non-admitted p. 3.
- Accident & Health (A&H) underwriting division provides medical stop loss to self-insured employers and covers group and single-employer captives p. 3.
- A&H captives program offers tailored medical stop-loss and reinsurance solutions with dedicated underwriting and claims oversight p. 3.
- The A&H division targets small and medium-sized enterprises seeking to control healthcare costs by self-insuring p. 3.
- A&H products are written on an admitted basis and distributed through retail and wholesale brokers p. 3.
- Agriculture and Credit (Re)insurance underwriting division provides specialty risk-transfer solutions across a global portfolio p. 3.
- This portfolio includes agriculture, dairy and livestock revenue protection, and mortgage and credit product lines p. 3.
- The division supports insurers, MGAs, and other risk originators with tailored treaty protection using proportional and excess of loss structures p. 3.
- Global agriculture book covers weather and natural peril volatility, production, and yield risks to manage catastrophe exposure and seasonal earnings variability p. 3.
- Mortgage portfolio supports government-sponsored entities and private mortgage insurers against default and loss severity volatility due to macroeconomic stress, structured to manage tail risk p. 3.
- Credit portfolio protects against losses from default risk for single obligors and multi-buyer trade credit across diverse regions and industries p. 3.
- Dairy and livestock business provides producers with revenue protection against price volatility in milk, cattle, and hog markets p. 3.
- Derivative instruments, primarily put options and futures, are used to mitigate commodity price risk related to cattle, hog, and milk prices p. 3.
- These instruments are used solely for managing adverse price movements, with positions adjusted throughout the year p. 3.
- Captives underwriting division offers group captive solutions by leveraging underwriting and claims expertise from other divisions p. 3.
- This division writes property, general liability, commercial auto, excess liability, and workers’ compensation on E&S and admitted bases p. 3.
- Business is often administered through partnerships with third-party captive managers p. 3.
- Construction & Energy Solutions underwriting division focuses on high-severity exposures with tailored multi-line solutions p. 3.
- Solutions include general liability, excess liability, commercial auto, and workers’ compensation p. 3.
- Products are distributed through retail agents, brokers, and a select network of wholesalers p. 3.
- Global Property underwriting division provides comprehensive property insurance and reinsurance for commercial clients worldwide p. 3.
- Offerings protect against physical loss or damage to assets from natural catastrophes and other insured perils p. 3.
- Professional Lines underwriting division includes three units: management liability, professional liability (including cyber), and allied health (including life sciences) p. 3.
- Management/Professional liability and allied health provide primary and excess claims-made liability products p. 3.
- These products are offered on E&S and admitted bases, distributed through wholesale and retail brokers p. 3.
- Specialty Programs underwriting division partners with program administrators focused on specific markets p. 3.
- This partnership model is used to participate profitably or extend reach in certain markets, leveraging administrators' competitive advantages like scale or proprietary technology p. 3.
- Specialty Programs writes property, general liability, commercial auto liability, excess liability, and workers’ compensation on E&S and admitted bases p. 3.
- Surety underwriting division provides contract, commercial, and transactional surety solutions p. 3.
- Focus is on small to medium-sized enterprises with aggregate bond programs up to approximately $100.0 million for contract and $125.0 million for commercial and transactional p. 3.
- This business is written on an admitted basis and distributed through retail agents and brokers p. 3.
- Transactional E&S underwriting division provides primary and excess non-catastrophe prone property and general liability solutions p. 3.
- Emphasis is on hard-to-place risks due to complexity, loss history, or limited operating history (e.g., startups) p. 3.
- Success in this market relies on technical underwriting, thoughtful coverage, pricing, and high-quality broker service p. 3.
- Access to the market in this division is exclusively through wholesale brokers p. 3.
- The company has "exited business" units and lines that were previously exited and placed into run-off p. 3.
- The company's strategy is to lead in chosen market niches and establish sustainable, competitive positions p. 3.
- Key elements of the strategy include:
- Providing differentiated products, services, and solutions p. 3.
- Attracting and retaining exceptional underwriting and claims talent p. 3.
- Amplifying expertise with advanced technology and analytics for risk selection, pricing, and claims management p. 3.
- Empowering underwriting and claims teams with decision-making authority p. 3.
- Fostering a culture of nimbleness and responsiveness to market opportunities p. 3.
- This strategy is referred to as "Rule Our Niche" and aims to build a strong defensible market position and competitive moat p. 3.
- The principles of this strategy are considered key to achieving and sustaining best-in-class underwriting results through P&C insurance pricing cycles p. 3.
- The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics p. 3.
Our Competitive Strengths
| Key facts & figures | |
|---|---|
| Competitive advantages | Technical underwriting, claims management, data and predictive analytics, experienced underwriting teams, specialized claims professionals |
- The company focuses on profitable niches in the market that require technical underwriting and claims management, which act as barriers to entry p. 4.
- The selected niche areas within commercial lines P&C markets are considered attractive for generating risk-adjusted returns p. 4.
- The company targets underserved, dislocated markets or those where standard products are insufficient for customer needs p. 4.
- Risks in core markets require efficient, individual underwriting to achieve sustainable underwriting profit p. 4.
- The company builds underwriting divisions with deeply experienced underwriters who have appropriate authority for decision-making p. 4.
- This structure allows for innovative products and solutions for distribution partners and customers, even for challenging risks p. 4.
- Underwriters' experience is augmented with data and predictive analytics to differentiate risk selection and pricing while enhancing efficiency p. 4.
- The company hires and retains underwriting and technical staff for their expertise and experience p. 4.
- Underwriting teams are knowledgeable, experienced, and empowered, which is crucial for operating in markets with risks difficult to automate p. 4.
- The company avoids strict underwriting rules, allowing professionals to use their expertise and judgment in evaluating and pricing risks p. 4.
- The company has a specialized team of claims professionals knowledgeable in the niches and lines of business served p. 4.
- Claims professionals address first-party claims with fair solutions and third-party claims with comprehensive responses, aiming for consistent and early loss recognition of indemnity and loss adjustment expenses (LAE) p. 4.
- The company responds quickly to claims with specialized adjusters using expertise, advanced technology, and analytics p. 4.
- Technology is deeply embedded in the claims process, from first notice of loss to investigation and settlement p. 4.
- Analytics capabilities provide senior leadership and claims teams with real-time, detailed information on open claims and benchmarks against closed claims p. 4.
- SkyBI, the business intelligence platform, provides real-time intelligence to senior leadership and technical teams for decision-making p. 4.
- SkyBI incorporates best practices from the management team's experience in P&C insurance and technology sectors p. 4.
- SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities p. 4.
- SkyBI provides information and performance metrics across the company in a visualized format p. 4.
- Data in SkyBI can be filtered by categories such as distributor, customer segment, line of business, industry, underwriter, and risk feature p. 4.
- The company believes that new types of risk data and advanced technology can augment underwriting and claims decisions p. 4.
- Underwriting decisions are supported by historical data and in-depth risk evaluation from data collection and processing capabilities p. 4.
- Underwriting and claims capabilities are amplified by combining historical data with new forms of risk data and predictive analytics p. 4.
- Generative artificial intelligence is used in underwriting and claims handling to enhance effectiveness and efficiency, while still relying on employee expertise p. 4.
- The company has built a diversified group of underwriting divisions across multiple product lines, industries, geographies, and distribution channels p. 4.
- This diversification includes business not typically aligned with traditional P&C cycles p. 4.
- The company aims to adapt to the market by growing certain lines in favorable conditions and limiting exposure in less favorable conditions p. 4.
- The diversity of the book allows the company to respond to and capitalize on market opportunities and dislocations across insurance market and pricing cycles p. 4.
- The company has a distinctive culture, evidenced by internal surveys, public information (Glassdoor, LinkedIn), and selection as a "Best Places to Work in Insurance" p. 4.
- The culture and operating approach feature a flat communication and decision-making structure p. 4.
- Staff are trusted to make decisions that achieve or exceed financial results and are supported by a clear performance measurement system p. 4.
- The company adopted a hybrid work schedule, offering flexibility for remote working p. 4.
- The company maintains an entrepreneurial environment that encourages and rewards a proactive approach to market disruption p. 4.
- This environment aligns with the company's identity as a specialty insurer and supports attracting talent and delivering best-in-class results p. 4.
- The leadership team, led by Chairman and CEO Andrew Robinson, is experienced, innovative, and entrepreneurial p. 4.
- The executive leadership team has a track record of success in senior management roles at industry-leading P&C companies and in building new businesses p. 4.
- Senior leadership compensation is structured to align with shareholders p. 4.
- A material portion of each leader's compensation is in long-term and short-term incentives tied to delivering sustainable, best-in-class underwriting returns p. 4.
- Executive leadership has additional long-term incentive targets directly tied to growth in book value per share p. 4.
Our Strategy in Action
| Key facts & figures | |
|---|---|
| Strategic priorities | Attracting and retaining talent, leveraging technology, profitably growing existing lines, expanding with new underwriting divisions |
| Strategy name | Rule Our Niche |
| Technology platform | SkyBI |
- The company's "Rule Our Niche" strategy aims to generate best-in-class underwriting profitability within its niches and create superior long-term shareholder value through growth in book value per share p. 5.
- Core tenets of the "Rule Our Niche" strategy include attracting and retaining blue-chip underwriting and claims talent to expand and enhance market position p. 5.
- The company seeks to hire and retain technical underwriting professionals with long-standing industry relationships and claims professionals with expertise in specific niches p. 5.
- These relationships are crucial for consistent access to preferred business p. 5.
- The company aims to grow its market position by recruiting world-class talent in chosen markets p. 5.
- Another tenet is leveraging technology DNA to differentiate from competitors p. 5.
- The company has demonstrated an ability to use new forms of risk data and advanced technology in complex, higher-severity risk categories within the specialty P&C insurance market p. 5.
- SkyBI enables prompt sensing and quick response to market changes p. 5.
- Core operating platforms allow efficient entry into new markets without complex or burdensome systems p. 5.
- The company believes its technological advantage supports profitable growth and expansion into additional specialty market niches p. 5.
- The strategy also includes profitably growing existing lines of business and expanding with new underwriting divisions p. 5.
- The company is positioned to capitalize on trends impacting customers in the U.S. and globally, such as increased demand for specialized insurance due to rising and complex risks p. 5.
- These risks include climate change/severe weather, supply chain uncertainty, financial inflation, cyber risk, novel health risks, increased litigation, attorney involvement, jury awards, and healthcare delivery/cost p. 5.
- Another notable market trend is the emergence of "micro cycles and micro dislocations" where different P&C insurance market segments experience hardening and softening at varying times p. 5.
- The company has reacted quickly to these trends by launching new underwriting units (many not aligned with P&C cycles), entering underserved markets, partnering on advanced technology, and launching new captive solutions p. 5.
- Gross written premium growth and profitability indicate momentum and position the company for continued expansion and growth p. 5.
- Differentiating on daily excellence to drive best-in-class underwriting performance is also a core tenet p. 5.
- Meeting long-term goals, including best-in-class underwriting returns and book value per share growth, depends on execution of day-to-day operations across all functional departments (underwriting, product management, claims management) p. 5.
- SkyBI provides a foundation for senior management to monitor performance, including renewal rates, new business pricing, portfolio performance for underwriters, and claims aging/reserving practices for adjusters p. 5.
- Focus on fundamentals driving underwriting excellence is central to the strategy p. 5.
- Cross-functional collaboration ensures regular review of performance and trends by underwriting, claims, actuarial, and product management teams to implement portfolio, pricing, and coverage changes quickly p. 5.
- The company aims to use its balance sheet to capture a larger market share p. 5.
- The company is committed to maintaining a strong balance sheet, starting with conservative loss reserves and strong capitalization ratios p. 5.
- This commitment is considered imperative for maintaining confidence among customers, distribution partners, reinsurers, regulators, rating agencies, and shareholders p. 5.
- Claims case reserve practices aim to reserve to the expected ultimate loss within 90 days of the first notice of loss p. 5.
- The company's practice is to maintain incurred but not reported reserves (IBNR) that, combined with case reserves, are above the actuarial central estimate p. 5.
- Loss reserves represent the company's best estimate of ultimate losses p. 5.
Marketing and Distribution
| Key facts & figures | |
|---|---|
| Distribution channels | Retail agents, wholesale brokers, select program administrators, captive managers |
- The company's marketing and distribution approach mirrors its underwriting strategy and is central to its "Rule Our Niche" strategy p. 6.
- Underwriting teams and the company maintain strong relationships and reputations with distribution partners, facilitating new affiliations p. 6.
- The company attributes its success with distribution partners to deep expertise in niche markets, high-caliber underwriters, a culture of innovation, thoughtful product lineup and design, and responsive service p. 6.
- All underwriting divisions dedicate significant effort to maintaining and expanding distribution partner loyalty and long-term relationships p. 6.
- The company tailors its choice of distribution partners to access specific business, similar to how it tailors underwriting to insureds' needs p. 6.
- Products are distributed through retail agents, wholesale brokers, select program administrators, and captive managers p. 6.
- This distribution approach enables effective and efficient access to targeted business based on market niche needs and dynamics p. 6.
Underwriting
| Key facts & figures | |
|---|---|
| Underwriting divisions | Nine |
| Technology platform | SkyBI |
- The company's underwriting approach is central to its "Rule Our Niche" strategy and market success p. 7.
- Within its nine divisions, the company further specializes underwriting teams to focus on specific niches p. 7.
- The underwriting approach relies on hiring highly experienced, best-in-class, and diverse teams of technical underwriters with proven track records in specific specialty niche markets p. 7.
- Underwriters' skills are enhanced with advanced technology and data analytics, and they are empowered with appropriate decision-making authority p. 7.
- This approach aims for superior risk selection and pricing, leading to sustainable best-in-class underwriting results across market cycles p. 7.
- The company augments underwriting capabilities using new forms of data and analytics for risk selection and pricing p. 7.
- Underwriting data is captured in the business intelligence platform, SkyBI, which serves as a comprehensive data repository for reporting, analytics, and other data capabilities p. 7.
- SkyBI is a key tool for senior management and business leaders p. 7.
- The company is highly selective in binding policies p. 7.
- Underwriters are encouraged to move on from opportunities quickly if they cannot reasonably expect to bind coverage at premium and terms meeting company standards p. 7.
- When accepting risks, the company establishes terms and prices suited to the underlying exposure p. 7.
- In the admitted market, the company ensures approved forms and filed rates are appropriate and adequate for accepted risks, while allowing flexibility for specific or unique exposures p. 7.
- In the E&S market, the company uses freedom of rate and form to match risk and coverage to the unique needs and exposures of that market p. 7.
- Policies are crafted to offer affordable and appropriate protection for insureds' exposures, with coverage structured to make potential losses more predictable and claims costs manageable p. 7.
- Underwriting teams receive support and collaboration from Claims, Actuarial, Product Management, Legal and Compliance, and Finance departments p. 7.
- This collaboration ensures timely analysis and action on trends in business, legal and tort developments, and competitor and regulatory actions p. 7.
- Underwriters are considered central to the company, with all support functions incentivized and measured to achieve underwriting profitability targets p. 7.
- This structure helps identify opportunities and issues early, contributing to the company's nimbleness and ability to leverage market disruptions p. 7.
- Underwriting controls and procedures are regularly reviewed to ensure underwriters profitably underwrite in each market served p. 7.
Claims Management
| Key facts & figures | |
|---|---|
| Claims handling principles | Prompt investigations, quality claims handling, timely reserve establishment, effective pursuit of contribution and subrogation, fraud detection and prevention, disciplined litigation management |
| Technology used | Claims Development Severity Predictor model |
- Skyward's claims department operates under six guiding principles: prompt and comprehensive investigations using advanced analytics and technology; quality claims handling and customer engagement; timely establishment of reserves based on best estimates; effective pursuit of contribution and subrogation; detection and prevention of fraud; and disciplined litigation management for superior legal defense and cost monitoring p. 8.
- Continuous training is provided to claim staff on claim evaluation, strategy, litigation management, good-faith claims handling, and best practices to achieve timely and optimal claim outcomes p. 8.
- The majority of claims are handled in-house p. 8.
- Third Party Administrators (TPAs) are utilized for specific instances such as programs, captives, occupational accident, workers' compensation, and runoff claims p. 8.
- TPAs are actively managed, overseen, and regularly audited to ensure compliance with Skyward's claims handling and reserving guidelines and best practices p. 8.
- Independent legal counsel is retained for liability claims against insureds when warranted, selected based on geographical location and expertise p. 8.
- Litigation guidelines have been developed for claims professionals and outside counsel to ensure appropriate defense for insureds p. 8.
- A legal spend management solution is used to analyze legal invoices for adherence to case handling and billing practice standards, ensuring reasonable and customary legal costs p. 8.
- Technology is leveraged for efficiencies in claims handling, including a Claims Development Severity Predictor model p. 8.
- The Claims Development Severity Predictor identifies claims likely to lead to large loss development, enabling early identification, proactive management, and summarization of development reasons p. 8.
- This predictive model is integrated into the claims review and management workflow p. 8.
- A "quick strike" program has been implemented for commercial auto claims, deploying experienced investigators and vendors to accident scenes within two hours, regardless of location p. 8.
- The quick strike program assists in evaluating accident facts and circumstances and resolving third-party claims quickly p. 8.
- Claims handlers and managers are organized by line of business to ensure specialized expertise p. 8.
- Managers and adjusters collaborate closely with underwriting partners to inform them of legal trends and emerging claims issues, educating underwriters on loss experience for risk selection p. 8.
Technology
| Key facts & figures | |
|---|---|
| Technology platform | SkyBI |
| Technology type | Predictive analytics technology, AI |
| Core transactional platforms | Policy administration, underwriting workbench, billing, claims systems |
- Technology is central to Skyward Specialty Insurance Group's operations and decision-making, aiming for long-term competitive advantages p. 9.
- SkyBI, the business intelligence platform, provides real-time intelligence to senior leadership and technical teams for decision-making p. 9.
- SkyBI incorporates best practices from the management team's experience in P&C insurance and technology sectors p. 9.
- SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities p. 9.
- SkyBI presents information and performance metrics across the company in a visualized format p. 9.
- Data in SkyBI can be filtered by categories such as distributor, customer segment, line of business, industry, underwriter, and risk feature p. 9.
- SkyBI helps establish clear objectives and facilitates decision-making p. 9.
- Predictive analytics technology augments employee capabilities using new risk data and predictive analytics, including AI, for risk selection, pricing, and claims handling p. 9.
- Underwriting divisions intentionally "Rule Our Niche" through constant innovation tailored to specific divisions/markets p. 9.
- Core transactional platforms, including policy administration, underwriting workbench, billing, and claims systems, are designed for nimble scaling and business expansion p. 9.
- The company generally uses customized third-party vendor core operating applications p. 9.
- The core platform organization is used for all business except accident & health, global property, agriculture, credit (re)insurance, and surety, which require dedicated processing components due to their unique features p. 9.
- Data from all divisions' core operating platforms flows to SkyBI with comparable quality and granularity p. 9.
- Advanced technology for underwriting and claims, SkyBI, and core operating platforms create a flywheel effect, enabling underwriters to better select risk, claims professionals to adjudicate claims, unit leaders to communicate with partners, and senior leadership to evaluate business trends p. 9.
- These tools also improve communication with distribution partners, reinsurers, and other third-party partners p. 9.
- The company faces external threats to its information technology systems, including system failure, data theft attempts, and ransomware attacks p. 9.
- The technology infrastructure is designed to function through major disruptions p. 9.
- Data is replicated in real-time to a third-party cloud disaster recovery site for major system failures p. 9.
- Data is backed up daily for system restoration p. 9.
- Actions to prevent system and data disruptions include:
- Actively monitoring Cybersecurity and Infrastructure Security Agency’s (“CISA”) cybersecurity directives and taking immediate action on identified vulnerabilities p. 9.
- Conducting monthly vulnerability scans on all network-attached devices at all locations, with patching as needed p. 9.
- Requiring two-factor authentication for system access p. 9.
- Conducting monthly security training for all employees p. 9.
- Implementing endpoint detection agents for threat detection and response p. 9.
- Performing desktop scenarios to practice breach responses with cybersecurity insurance partners and retained security consultants p. 9.
- Performing annual penetration testing p. 9.
- The company constantly reviews its security breach posture and regularly implements updated processes, best practices, and tools p. 9.
Reinsurance
| Key facts & figures | |
|---|---|
| Reinsurance contract length | One year |
| Reinsurance renewal frequency | Annually |
| Reinsurance renewal months | January, June |
| Reinsurance types | Quota share, excess of loss, facultative |
| Property insurance GWP | 34% as of December 31, 2025 |
- The company strategically purchases reinsurance from third parties to protect capital from severity events (large single event losses or catastrophes) and reduce earnings volatility p. 10.
- Reinsurance contracts are predominantly one year in length and renew annually, primarily in January and June p. 10.
- Annual renewal considerations for reinsurance purchases include changes to underlying insurance coverage, updated loss activity, capital and surplus levels, changes in risk appetite, and the cost and availability of reinsurance treaties p. 10.
- The company purchases quota share, excess of loss, and facultative reinsurance coverage to limit exposure from losses on any one occurrence p. 10.
- The mix of reinsurance purchased is based on efficiency, cost, risk appetite, and specific factors of the underlying risks underwritten p. 10.
- Quota share reinsurance involves a reinsurer assuming a specified percentage of losses from a defined class of business in exchange for a corresponding percentage of premiums, net of a ceding commission p. 10.
- Excess of loss reinsurance involves a reinsurer assuming all or a portion of losses for an individual claim or event above a specified amount, in exchange for a negotiated premium, and includes the catastrophe reinsurance program p. 10.
- Facultative coverage is a reinsurance contract for individual risks, used to supplement treaty limits or cover risks/perils excluded from treaty reinsurance p. 10.
- As of December 31, 2025, property insurance represented 34% of gross written premiums p. 10.
- The company actively manages and monitors property writings by geographic area to limit potential loss aggregation from severe events like hurricanes, convective storms, and earthquakes p. 10.
- Catastrophe reinsurance is purchased to further mitigate property loss aggregation due to single or series of events p. 10.
- Third-party stochastic and proprietary deterministic models are used to analyze the risk of loss aggregation from such events and inform catastrophe reinsurance purchases p. 10.
- These models provide a quantitative view of PML (Probable Maximum Loss) events, which estimate the expected loss level for a given return period p. 10.
- Based on modeling, an event beyond a 1 in 250-year PML would be required to exhaust the company's $36.0 million property catastrophe coverage p. 10.
- The company aims to expose no more than 3.0% of stockholders’ equity to a catastrophic loss that is less than a 1 in 250-year event p. 10.
- The current reinsurance program is believed to provide coverage well in excess of theoretical losses from any recorded historical event p. 10.
- The company seeks to purchase reinsurance from reinsurers rated at least "A-" ("Excellent") or better by A.M. Best p. 10.
- As of December 31, 2025, 98% of reinsurance recoverables were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or were collateralized p. 10.
- The company retains primary liability to policyholders if reinsurers fail to pay claims, leading to potential losses p. 10.
- Allowances for uncollectible reinsurance are established due to the risk of reinsurer default p. 10.
- The allowance for uncollectible reinsurance was $2.3 million at December 31, 2025, and 2024 p. 10.
Maximum company retention by line of business
| Line of Business | Maximum Company Retention |
|---|---|
| Accident & Health | $0.90 million per occurrence |
| Commercial Auto (1) | $1.00 million per occurrence |
| Excess Casualty (1)(2) | $2.25 million per occurrence |
| General Liability (1) | $1.50 million per occurrence |
| Ocean Marine (2) | $3.00 million per occurrence |
| Professional Lines (2) | $5.25 million per occurrence |
| Property (3) | $3.50 million per occurrence |
| Representation and Warranty | $3.25 million per occurrence |
| Surety (2) | $5.00 million per occurrence |
| Workers’ Compensation (2) | $2.33 million per occurrence |
(1) Legal defense expenses can force exposure above the maximum company retention for Excess Casualty, Commercial Auto and General Liability. (2) Reinsurance is subject to a loss ratio cap or aggregate level of loss cover that exceeds a modeled 1:250-year PML event. (3) Catastrophe loss protection is purchased up to $36.0 million in excess of $12.0 million retention, which provides cover for a 1:250-year PML event.
Reinsurance by company
| ($ in thousands) | ||
|---|---|---|
| Reinsurer | Reinsurance Recoverables | AM Best Rating |
| eMaxx Capitves (1) | 197,989 | n/r |
| Everest Reinsurance Co. | 123,925 | A+ |
| General Reinsurance Corp | 70,355 | A++ |
| Partner Reinsurance Co. of the US | 65,446 | A+ |
| ACE (Chubb Property & Casulty Ins Company) | 48,344 | A+ |
| RGA Reinsurance Company | 43,043 | A+ |
| Lloyds Syndicate 4711 | 35,860 | A+ |
| Swiss Reinsurance America Corp | 26,152 | A+ |
| Lloyds Syndicate 2987 | 25,301 | A+ |
| Aspen Insurance UK Limited | 24,715 | A |
| Top 10 Total | 661,130 | — |
| All Others | 458,750 | — |
| Total | 1,119,880 | — |
(1) This reinsurer facilitates our eMaxx captive. At December 31, 2025, we held collateral in a statutory trust of $235.2 million on our net reinsurance recoverables.
Enterprise Risk Management
| Key facts & figures | |
|---|---|
| ERM oversight | SVP, CFO & Head of ERM - US Operations |
| ERM Committee | Cross-functional corporate ERM Committee |
| Risk tolerances review | Annually by ERM Committee, discussed with Risk Committee of the Board of Directors |
| Top 10 risks review | Quarterly |
- ERM is embedded in nearly every aspect of the company and guides day-to-day activities p. 11.
- ERM approach aims to ensure an acceptable risk-adjusted return for shareholders while maintaining trust and reliability for those served p. 11.
- Underwriting and asset portfolio construction are intentional p. 11.
- Liability duration and market cyclicality of the underwriting portfolio are balanced p. 11.
- Reinsurance is used to manage volatility outside of risk tolerances p. 11.
- Investment strategy targets a diversified portfolio that balances yield, liquidity, volatility, and potential for principal loss p. 11.
- SVP, CFO & Head of ERM - US Operations oversees critical ERM processes and chairs the cross-functional corporate ERM Committee p. 11.
- Economic Capital Model (ECM) formalizes the company's view of risk and solvency in terms of potential economic loss p. 11.
- ECM output measures potential earnings and capital loss for various scenarios p. 11.
- Risk tolerances are set and updated annually by the ERM Committee and discussed with the Risk Committee of the Board of Directors p. 11.
- ECM provides a probabilistic modeled view of earnings and capital loss, integrating potential losses from catastrophes, reserving, underwriting, market, credit risk, strategic, and operational risks p. 11.
- SVP, CFO & Head of ERM works with the ERM Committee to review and maintain a comprehensive risk register with accountabilities for mitigations p. 11.
- Top 10 risks are identified, quantified by the SVP, CFO & Head of ERM and ERM Committee, and reviewed quarterly p. 11.
- Reports on top risks are submitted to the Risk Committee regularly by the SVP, CFO & Head of ERM and the ERM Committee p. 11.
- Operational processes and controls are constructed to identify, assess, and manage key risks continuously p. 11.
- Underwriting Committee oversees changes in risk appetite, product line, and division expansion p. 11.
- Claims department monitors handling practices against guidelines via regular internal audits, conducts monthly large loss reviews, and maintains a watchlist for potential high severity claims p. 11.
- Actuarial department performs quarterly reserve studies p. 11.
- Reserve Committee meets quarterly to review and respond to trends in loss emergence p. 11.
- Key observations from the Reserve Committee are discussed with the CEO p. 11.
- Underwriting divisions assess rate change and retention on existing business, new business quality, pricing adequacy, and loss emergence compared to expectations on a monthly and quarterly basis p. 11.
- SkyBI platform provides real-time portfolio, underwriting, claims, and actuarial analytics p. 11.
- ERM is central to decision-making and daily activities p. 11.
- ERM is a central component of the strategy to achieve market-leading risk-adjusted returns for shareholders and reinforce a culture of accountability, transparency, and sound judgment p. 11.
Reserves
| Key facts & figures | |
|---|---|
| Reserves not discounted | True |
- Reserves are maintained for specific claims incurred and reported, IBNR reserves, and uncollectible reinsurance p. 12.
- The ultimate liability may differ from current reserves, and there is a risk of inadequate reserves in the insurance industry p. 12.
- Reserves are continually monitored using new information on reported claims and statistical analyses p. 12.
- Anticipated inflation is implicitly reflected in the reserving process through cost trend analysis and historical development review p. 12.
- Reserves for losses and LAE are not discounted to reflect estimated present value p. 12.
- Upon claim reporting, a case reserve is established for the estimated ultimate payment after assessing coverage, damages, and investigation p. 12.
- Case reserve estimates are based on reserving practices and the claims adjuster's experience and knowledge of the claim type and value p. 12.
- Case reserves are revised periodically based on subsequent developments for each claim p. 12.
- IBNR reserves are established for the estimated amount of future loss payments on incurred but not yet reported claims, and for potential development on reported claims p. 12.
- IBNR reserves are estimated using generally accepted actuarial reserving techniques that consider quantitative loss experience data and qualitative factors p. 12.
- Loss reserves are regularly reviewed using various actuarial techniques p. 12.
- Reserve estimates are updated as historical loss experience develops, additional claims are reported/settled, and new information becomes available p. 12.
- Reserves can be increased or decreased over time as claims move towards settlement, impacting earnings through adverse development or reserve releases p. 12.
- Additional information on loss reserves is available in Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations - “Results of Operations - Losses and LAE” and “Critical Accounting Policies” p. 12.
Investments
| Key facts & figures | |
|---|---|
| Investment allocation strategy | Enterprise Based Asset Allocation model |
| Investment portfolio composition | Cash, cash equivalents, investment-grade fixed-maturity securities |
| Investment policy approval | Investment Committee of the Board of Directors |
- The company aims to maintain a balanced investment portfolio primarily consisting of investments that provide predictable and stable returns p. 13.
- The portfolio is augmented by strategic investments chosen for attractive risk-adjusted returns p. 13.
- The investment allocation strategy uses an Enterprise Based Asset Allocation model p. 13.
- This model is integrated into the Economic Capital Model, as discussed in Item 1 (ERM discussion) p. 13.
- The model helps understand the impact of investment allocation decisions on capital, liquidity, and risk profile across various market scenarios p. 13.
- The company actively manages and monitors investment risk to balance stable growth and liquidity with compliance to insurance regulatory and rating agency frameworks p. 13.
- The portfolio mainly consists of cash and cash equivalents and investment-grade fixed-maturity securities p. 13.
- Additional investments are included if they fit the company's risk appetite p. 13.
- The Investment Committee of the Board of Directors reviews and approves the investment policy and strategy p. 13.
- This committee meets quarterly to review investment activities, tactics, and new investment opportunities p. 13.
- The portfolio is directed internally and includes both self-managed investments and portfolios managed by select third-party investment management firms p. 13.
- For further discussion on investments, including market risks, refer to Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations—Investments" p. 13.
Competition
| Key facts & figures | |
|---|---|
| Key competitors | Markel Corporation, W.R. Berkley Corporation, American Financial Group Inc., Tokio Marine Holdings, Inc., CNA Financial Corporation, Hiscox, Ltd., RLI Corp., Intact Finance Corporation, Kinsale Capital Group, Inc., Arch Capital Group, AXIS Capital Holdings, Ltd. |
- The specialty lines property & casualty insurance market comprises numerous markets and sub-markets p. 14.
- Each market has distinct customer needs, products, services, and specific economic and structural features p. 14.
- Competition in underwriting divisions comes from other specialty and standard insurers, as well as program administrators p. 14.
- Competition factors include pricing, general reputation, perceived financial strength, broker relationships, product terms and conditions, independent rating agency ratings, speed and reputation of claims payment, and the experience and reputation of underwriting and claims teams p. 14.
- Due to the diversity of underwriting divisions, competition is broad, with some competitors specific to only a subset of divisions p. 14.
- Notable competitors include Markel Corporation, W.R. Berkley Corporation, American Financial Group Inc., Tokio Marine Holdings, Inc., CNA Financial Corporation, Hiscox, Ltd., RLI Corp., Intact Finance Corporation, Kinsale Capital Group, Inc., Arch Capital Group, and AXIS Capital Holdings, Ltd. p. 14.
Our Structure
| Key facts & figures | |
|---|---|
| Legal name | Skyward Specialty Insurance Group, Inc. |
| Holding-company structure | Insurance holding company system |
| State of incorporation | Delaware |
- Operations are conducted principally through four insurance companies: Great Midwest Insurance Company (GMIC), Houston Specialty Company (HSIC), Imperium Insurance Company (IIC), and Oklahoma Specialty Insurance Company (OSIC) p. 15.
- GMIC, the largest insurance subsidiary, underwrites multiple lines of insurance on an admitted basis in all 50 states and the District of Columbia p. 15.
- GMIC is a certified surety bond company listed with the Department of the Treasury p. 15.
- HSIC, a subsidiary of GMIC, underwrites multiple lines of insurance on a surplus lines basis in 50 states, the District of Columbia, and select foreign countries p. 15.
- IIC, a subsidiary of HSIC, underwrites on an admitted basis in all 50 states and the District of Columbia p. 15.
- OSIC, a subsidiary of IIC, is an approved surplus lines company in 49 states and the District of Columbia p. 15.
- Effective December 31, 2024, the insurance company subsidiaries were restacked into the current organizational structure p. 15.
- This restacking provided the growing surety business with the capital needed to operate more effectively within the surety T-listing market p. 15.
- Skyward Re is a wholly-owned captive reinsurance company domiciled in the Cayman Islands p. 15.
- Skyward Re was incorporated on January 7, 2020 p. 15.
- Skyward Re was established to facilitate the LPT, which was commuted effective January 31, 2025 p. 15.
- Three non-insurance companies are also operated: Skyward Underwriters Agency, Inc., Skyward Service Company, and Skyward Specialty No. 1 Limited Company p. 15.
- Skyward Underwriters Agency, Inc. is a licensed agent, managing general agent, and reinsurance broker p. 15.
- Skyward Service Company provides various administrative services to the subsidiaries p. 15.
- Skyward Specialty No. 1 Limited Company is a UK company and an authorized Lloyd’s corporate member p. 15.
- The organizational structure at December 31, 2025, shows each entity is wholly-owned by its immediate parent p. 15.
- Skyward Specialty Insurance Group, Inc. (Delaware corporation) is the parent company p. 15.
- Skyward Specialty Insurance Group, Inc. has direct relationships with Skyward Service Company (Delaware corporation), Great Midwest Insurance Company (Texas stock insurance company), Skyward Underwriters Agency, Inc. (Texas corporation), Skyward Specialty No. 1 Limited (United Kingdom company), and Skyward Re (Cayman Islands corporation) p. 15.
- Great Midwest Insurance Company has a direct relationship with Houston Specialty Insurance Company (Texas stock insurance company) p. 15.
- Houston Specialty Insurance Company has a direct relationship with Imperium Insurance Company (Texas stock insurance company) p. 15.
- Imperium Insurance Company has a direct relationship with Oklahoma Specialty Insurance Company (Oklahoma insurance corporation) p. 15.
| — | 2025 |
|---|---|
| Texas | 10.7% |
| Pennsylvania | 7.6 |
| Florida | 7.2 |
| California | 7.1 |
| New York | 6.3 |
| Louisiana | 6.1 |
| Illinois | 4.1 |
| New Jersey | 4.1 |
| Georgia | 3.8 |
| Delaware | 3.1 |
| All other states and countries | 39.9 |
| Total | 100.0% |

Ratings
| Key facts & figures | |
|---|---|
| Financial strength rating | A (Excellent) |
| Rating outlook | Stable |
| Rating agencies | A.M. Best |
- Skyward Specialty Insurance Group, Inc. has an "A" (Excellent) rating with a stable outlook from A.M. Best p. 16.
- A.M. Best rates insurance companies based on factors relevant to policyholders p. 16.
- A.M. Best assigns 13 ratings, ranging from "A++" (Superior) to "D" (Poor) p. 16.
- The "A" (Excellent) rating is the third highest rating assigned by A.M. Best p. 16.
- A.M. Best's evaluation includes profitability, leverage, liquidity, book of business, reinsurance adequacy, asset quality and market value, adequacy of losses and loss expense reserves, surplus adequacy, capital structure, management experience and competence, and market presence p. 16.
- A.M. Best's ratings reflect its opinion on an insurance company’s financial strength, operating performance, and ability to meet policyholder obligations p. 16.
- Ratings are based on factors relevant to policyholders, agents, insurance brokers, and intermediaries, and are not specifically related to securities issued by the company p. 16.
Regulation
| Key facts & figures | |
|---|---|
| Primary regulators | State insurance regulatory authorities |
| Holding company regulation | Texas |
- The company is regulated by insurance regulatory authorities in the states where it conducts business p. 17.
- State insurance laws and regulations primarily protect policyholders, consumers, and claimants, not stockholders or other investors p. 17.
- The nature and extent of state regulation varies by jurisdiction p. 17.
- State insurance regulators have broad administrative power over:
- Setting capital and surplus requirements p. 17.
- Licensing of insurers and insurance producers p. 17.
- Review and approval of product forms and rates p. 17.
- Establishing standards for reserve adequacy p. 17.
- Prescribing statutory accounting methods and the form/content of statutory financial reports p. 17.
- Regulating certain transactions with affiliates p. 17.
- Prescribing types and amounts of investments p. 17.
- Insurance company regulation is constantly changing due to governmental agency and legislative reactions to issues p. 17.
- Some state legislatures have considered or enacted laws that increase state authority to regulate insurance companies and holding company systems, often as a protection against federal involvement p. 17.
- The National Association of Insurance Commissioners (NAIC) and some state insurance regulators are re-examining existing laws and regulations, focusing on insurer solvency, interpretations of laws, and development of new laws p. 17.
- The federal government does not directly regulate the business of insurance, but federal initiatives affect the industry through treatment of federal subsidiaries, regulation of quasi-governmental entities, and regulations from federal departments p. 17.
- The company operates as an insurance holding company system p. 17.
- The company is subject to insurance holding company laws in Texas, where its primary insurance companies are domiciled, and Oklahoma p. 17.
- These statutes require each insurance company in the system to register with the insurance department of its state of domicile p. 17.
- Registration involves furnishing information about operations within the holding company system that could materially affect the operations, management, or financial condition of domiciled insurers p. 17.
- All transactions among members of a holding company system must be fair and reasonable p. 17.
- Transactions between insurance subsidiaries and their parents/affiliates generally require disclosure to state regulators p. 17.
- Notice to or prior approval from the applicable state insurance regulator is generally required for any material or extraordinary transaction p. 17.
Intellectual Property
- The company has applied for various trademark registrations in the United States at both federal and state levels p. 18.
- The company plans to pursue additional trademark registrations and other intellectual property protection if deemed beneficial and cost-effective p. 18.
- The company monitors its trademarks and service marks and protects them from unauthorized use as necessary p. 18.
Employees and Human Capital
| Key facts & figures | |
|---|---|
| Employees | 611 as of December 31, 2025 |
| Collective bargaining agreement | None |
- As of December 31, 2025, the company had approximately 611 employees p. 19.
- Employees are not subject to any collective bargaining agreement, and there are no known current efforts to implement such an agreement p. 19.
- The company believes it has good working relations with its employees p. 19.
- The company aims to be an employer of choice, fostering a culture committed to diversity of thought, background, and perspective p. 19.
- The company strives to cultivate an exceptional workforce to perpetuate its ownership culture and achieve superior business results p. 19.
- The company's goal is to attract, develop, and retain diverse talent, promoting a culture where different viewpoints are valued, and individuals feel respected, treated fairly, and have opportunities to excel p. 19.
- The company offers a competitive benefits package including medical, dental, and vision insurance, a 401(k) plan, paid time off, family leave, employee assistance programs, and an employee stock purchase plan p. 19.
- The company emphasizes employee training and development, providing opportunities for further education and professional development p. 19.
Risk Factors
- Investing in the company's common stock carries a high degree of risk p. 20.
- Investors should carefully consider the risks and uncertainties described in the report, including consolidated financial statements and related notes, and other SEC filings, before investing p. 20.
- The listed risks and uncertainties are not exhaustive; additional unstated, unknown, or currently immaterial risks may also affect the company p. 20.
- The occurrence of any identified risk could materially harm the company's business, operating results, financial condition, and prospects p. 20.
- Such events could lead to a decline in the common stock price, potentially resulting in a loss of part or all of an investment p. 20.
Summary of Material Risk Factors
- Financial condition and results of operations could be materially adversely affected by inaccurate assessment of underwriting risk p. 21.
- Competition in the industry is intense p. 21.
- Reliance on distribution channels (insurance retail agents and brokers, wholesalers, program administrators) exposes the business to certain risks p. 21.
- Inability to purchase third-party reinsurance on commercially acceptable terms or terms that adequately protect the company may materially adversely affect business, financial condition, and results of operations p. 21.
- Losses and loss expense reserves may be inadequate to cover actual losses, materially adversely affecting financial condition, results of operations, and cash flows p. 21.
- Decline in financial strength rating may adversely affect the amount of business written p. 21.
- Unexpected changes in interpretation of coverage or provisions (including loss limitations and exclusions) in policies could materially adversely affect financial condition and results of operations p. 21.
- Reinsurers may not reimburse claims on a timely basis or at all, which may materially adversely affect business, financial condition, and results of operations p. 21.
- Failure to accurately and timely pay claims could materially and adversely affect business, financial condition, results of operations, and prospects p. 21.
- Adverse economic factors (recession, inflation, high unemployment, lower economic activity) could lead to fewer policy sales, increased claim frequency, premium defaults, or falsification of claims, impacting growth and profitability p. 21.
- Insurance business is cyclical, which may affect financial performance and cause operating results to vary quarter-to-quarter, not indicative of future performance p. 21.
- Extensive regulation may adversely affect the ability to achieve business objectives; non-compliance could result in penalties (fines, suspensions) adversely affecting financial condition and results of operations p. 21.
- Loss of key personnel or inability to attract and retain qualified personnel could adversely affect the company p. 21.
- Failure to achieve and maintain effective internal controls could impact operating results and financial condition, and negatively affect the market price of common stock p. 21.
- Costs will increase significantly as a public company, requiring substantial management time for compliance p. 21.
- Use of derivatives to mitigate market price volatility exposure may subject the company to risks such as hedge ineffectiveness, basis risk, collateral and margin call liquidity pressures, and valuation uncertainty, which could adversely affect financial condition p. 21.
- Integration of Apollo may present unforeseen challenges, including difficulties with technology systems, business processes, and risk management frameworks, potentially causing operational disruptions, increased costs, or delays in realizing anticipated strategic benefits p. 21.
Risks Related to Our Business and Industry
- The company's financial condition and results of operations could be materially adversely affected if it does not accurately assess its underwriting risk p. 22.
- Underwriting success depends on accurately assessing risks and establishing appropriate premium rates, relying on the experience of underwriting staff p. 22.
- Employee decisions, including management and underwriters, in the ordinary course of business involve exposing the company to risk p. 22.
- Competition in the insurance industry is intense, coming from other specialty insurance companies, standard insurance companies, and underwriting agencies p. 22.
- Competition factors include price, reputation, perceived financial strength, distribution partner relationships, product terms, independent rating agency ratings, claims payment speed, and the experience of the underwriting team p. 22.
- Increasing consolidation in the insurance industry may further intensify competition p. 22.
- New industry or legislative developments could also increase competition p. 22.
- Inability to compete successfully could change supply and demand for insurance, affect pricing at risk-adequate rates, impact retention of existing business, or hinder underwriting new business on favorable terms, adversely affecting operating results p. 22.
- The business relies on insurance retail agents, brokers, wholesalers, and program administrators, exposing it to risks from these distribution channels p. 22.
- Substantially all products are distributed through independent retail agents and brokers who own "renewal rights," making the business model dependent on these relationships p. 22.
- The company is also dependent on relationships wholesalers and program administrators maintain with agents and brokers p. 22.
- Relationships with retail agents, brokers, wholesalers, and program administrators can be discontinued at any time or become unprofitable p. 22.
- Consolidation of insurance distribution firms may increase their influence on commission rates and concentrate business with particular brokers p. 22.
- Premiums collected by brokers from policyholders, in certain jurisdictions, may be considered paid to the company even if not remitted, exposing the company to credit risk p. 22.
- Failure by brokers to remit premiums has not been material to date, but the company may be required to provide coverage despite unpaid premiums p. 22.
- Limitations on the ability to cancel policies for non-payment could reduce underwriting profits and adversely affect financial condition and results p. 22.
- The company reviews the financial condition of potential new brokers and periodically reviews existing distributors against profitability standards and business objectives p. 22.
- Following reviews, the company may restrict distributor access to products or terminate relationships, subject to contractual and regulatory requirements p. 22.
- Deterioration in distributor relationships or uncompetitive compensation could lead distributors to place more premium with other carriers p. 22.
- Distributors exceeding granted authority, failing to transfer collected premiums, or breaching obligations could expose the company to liability p. 22.
- Continued or increased consolidation of insurance distribution firms could materially affect sales channels, potentially leading to loss of market access or share p. 22.
- Loss of talent knowledgeable about products or increased commission costs due to larger distributors gaining negotiating leverage could negatively impact the company p. 22.
- Accelerated digitization exposes the company to risks related to distributors' ability to keep pace, as customers may prefer technology-driven distributors p. 22.
- Inability to purchase third-party reinsurance in desired amounts or on acceptable terms could materially adversely affect the business p. 22.
- Reinsurance is strategically purchased to protect capital from severity events and reduce earnings volatility p. 22.
- Failure to renew expiring contracts, enter new arrangements, or expand coverage could increase loss exposure, potentially requiring a reduction in underwriting commitments p. 22.
- Reinsurers may exclude certain coverages or alter terms in contracts, leading to gaps in reinsurance protection and greater potential losses for the company p. 22.
- Losses and loss expense reserves may be inadequate to cover actual losses, materially adversely affecting financial condition, results, and cash flows p. 22.
- Reserves are estimates of ultimate claim settlement and administration costs, not exact calculations, and ultimate liability may differ p. 22.
- The reserving process reviews historical data and considers factors such as claims inflation, claims development patterns, pricing, legislative activity, social/economic patterns, and litigation/judicial/regulatory trends p. 22.
- Variables affecting loss exposure are influenced by internal and external events, and loss reserves are continually monitored using new information and statistical techniques p. 22.
- The process assumes past experience, adjusted for current developments and trends, predicts future events, but actual results may deviate substantially from estimates p. 22.
- Uncertainties impacting reserve adequacy include:
- Time required to fully appreciate covered loss extent, leading to increased loss estimates over time p. 22.
- Retroactive enforcement of new theories of liability by courts, potentially expanding coverage p. 22.
- Volatility in financial markets, economic events, and external factors increasing claim frequency/severity, and elevated inflation increasing loss costs p. 22.
- Adverse economic factors (recession, high unemployment) potentially reducing policy sales or increasing claim frequency/severity and premium defaults p. 22.
- Increased "social inflation" costs (medical/material costs, technology in vehicles, supply chain disruptions, attorney involvement, litigation financing, lawsuit abuse) increasing claim frequency/severity and affecting reserve adequacy p. 22.
- Increased claim frequency, even without liability, could escalate evaluation and handling costs beyond established reserves p. 22.
- Entering new lines of business or new theories of claims may lead to unanticipated increases in claim frequency and handling costs p. 22.
- Inadequate reserves would require an increase in reserves, reducing net income and stockholders’ equity in the period the deficiency is identified p. 22.
- Future loss experience substantially exceeding established reserves could materially adversely affect future earnings, liquidity, and financial rating p. 22.
- A decline in the company's financial strength rating may adversely affect the amount of business written p. 22.
- Independent ratings agencies, such as A.M. Best, are used by the insurance industry to assess financial strength p. 22.
- A.M. Best's ratings are based on quantitative and qualitative analysis of balance sheet strength, operating performance, and business profile p. 22.
- A.M. Best financial strength ratings range from "A++" (Superior) to "F" (liquidation) p. 22.
- As of the filing date, A.M. Best assigned the company a financial strength rating of "A" (Excellent) with a stable outlook p. 22.
- A.M. Best ratings provide an independent opinion of an insurer's ability to meet policyholder obligations and are not an evaluation for investors or a recommendation to buy/sell securities p. 22.
- A.M. Best's analysis includes peer comparisons, industry standards, operating plans, philosophy, and management assessments p. 22.
- A.M. Best periodically reviews and may revise ratings downward based on balance sheet strength, operating performance, and business profile p. 22.
- Factors that could affect A.M. Best's analysis and potentially lead to a downgrade include:
- Changes in business practices from the organizational plan that no longer support the rating p. 22.
- Unfavorable financial, regulatory, or market trends, including excess market capacity p. 22.
- Losses exceeding loss reserves p. 22.
- Unresolved issues with government regulators p. 22.
- Inability to retain senior management or other key personnel p. 22.
- Significant investment portfolio losses or limited liquidity p. 22.
- Alterations in A.M. Best's capital adequacy assessment methodology that adversely affect the rating p. 22.
- A downgrade or withdrawal of the rating could cause distribution partners and insureds to choose higher-rated competitors, increase reinsurance costs or reduce availability, or severely limit/prevent writing new and renewal insurance contracts p. 22.
- Rating organizations may heighten scrutiny, increase review frequency/scope, request additional information, or increase capital requirements for certain rating levels p. 22.
- There is no assurance the company's rating will remain at its current level, and adverse ratings consequences could materially affect financial condition and results p. 22.
- Unexpected changes in the interpretation of coverage or provisions, including loss limitations and exclusions, could materially adversely affect financial condition and results p. 22.
- There is no assurance that loss limitations or exclusions in policies will be enforceable as intended p. 22.
- Changing industry practices, legal, judicial, social, and other conditions may lead to unexpected claims and coverage issues p. 22.
- Policy limitations on claim periods, potentially shorter than statutory periods, may be nullified by courts or regulators, or legislation could modify/bar their use p. 22.
- Governmental actions could result in higher than anticipated losses and LAE, materially adversely affecting financial condition or results p. 22.
- Court decisions, such as the 1995 Montrose decision in California, could narrowly read policy exclusions, expanding coverage and requiring new exclusions p. 22.
- These issues may broaden coverage beyond underwriting intent or increase claim frequency/severity, with full liability potentially not known for years after contract issuance p. 22.
- Reinsurers may not reimburse claims timely or at all, materially adversely affecting business, financial condition, and results p. 22.
- Reinsurance contracts require premium payments to carriers who reimburse for covered claims, often many years later p. 22.
- Reinsurance makes the reinsurer liable but does not relieve the company of its primary liability to policyholders p. 22.
- The current reinsurance program aims to limit financial risk, but reinsurers may default due to insolvency, lack of liquidity, operational failure, political/regulatory prohibitions, fraud, asserted defenses, or documentation deficiencies p. 22.
- Disputes with reinsurers could be time-consuming, costly, and uncertain of success, leading to increased net losses p. 22.
- As of December 31, 2025, the company had reinsurance recoverables of $1,119.9 million p. 22.
- Failure to accurately and timely pay claims could materially and adversely affect business, financial condition, results, and prospects p. 22.
- Factors affecting claim payment accuracy and timeliness include claims representative training/experience (including TPAs), management effectiveness, and appropriate procedures/systems p. 22.
- Failure to pay claims accurately and timely could lead to regulatory/administrative actions, litigation, and reputational damage p. 22.
- Ineffective TPA management or internal staff/TPA inability to handle claim volume could adversely affect workload capacity p. 22.
- Decreased quality of claims work could adversely affect operating margins and potentially require slowing growth in affected markets p. 22.
- Severe weather conditions, climate change effects, catastrophes, pandemics, and man-made events may adversely affect business, results, and financial condition p. 22.
- Catastrophes include natural events (severe winter weather, convective storms/tornadoes, windstorms, earthquakes, hailstorms, thunderstorms, fires) and man-made events (explosions, war, terrorist attacks, riots) p. 22.
- Changing weather patterns and climatic conditions (e.g., global warming) have increased unpredictability and frequency of natural disasters, including in new areas and operating markets p. 22.
- Climate change may increase the frequency and severity of extreme weather events, leading to conditions that increase hurricane activity and wildfire risks p. 22.
- A natural disaster or catastrophe loss could materially adversely affect business, financial condition, and results p. 22.
- Catastrophes can impact the company even without direct insurance coverage, such as the 2025 California wildfires, as affected policyholders may cancel other policies p. 22.
- Increased frequency and severity of weather events, including hurricanes or convective storms (difficult to model), could materially adversely affect the ability to predict, quantify, reinsure, and manage catastrophe risk, increasing losses p. 22.
- Losses from catastrophes depend on the frequency and severity of insured events and total insured exposure in affected areas p. 22.
- The incidence and severity of catastrophes and severe weather are inherently unpredictable p. 22.
- Exposure to losses is managed by analyzing probability and severity of loss events and their impact on underwriting and investment portfolios p. 22.
- Indirect impacts can occur if insured businesses are affected by catastrophes not directly covered, leading to inability or unwillingness to pay premiums on other products p. 22.
- Inability to obtain reinsurance coverage at reasonable rates and adequate amounts for severe weather and catastrophes could materially adversely affect business and results p. 22.
- The business is exposed to risks from pandemics, outbreaks, public health crises, and geopolitical/social events p. 22.
- While policy terms are expected to preclude coverage for virus-related claims, court decisions and governmental actions may challenge exclusions or interpretations p. 22.
- Changes in domestic and international climate policy programs/initiatives, and related legislation/regulation, are unpredictable but could materially adversely affect business, operational, and financial results p. 22.
- Program administrators are provided with specific quoting and binding authority, and their failure to comply with guidelines could adversely affect results p. 22.
- The company markets and distributes certain insurance products through program administrators with limited quoting and binding authority, who then sell to insureds via retail agents and brokers p. 22.
- Program administrators can bind certain risks without initial approval p. 22.
- Non-compliance by program administrators with underwriting guidelines could bind the company to unanticipated risks, adversely affecting results p. 22.
- If actual renewals of existing contracts or new business from repeat insureds do not meet expectations, written premium and future results could be materially adversely affected p. 22.
- Most contracts are for a one-year term and are renewable; some insureds are repeat customers with new contracts p. 22.
- Financial forecasting includes assumptions about renewal rates and repeat business p. 22.
- The insurance and reinsurance industries are cyclical with intense price-based competition p. 22.
- Failure of actual renewals/repeat business to meet expectations, or choosing not to write renewals/accept repeat business due to pricing, would materially adversely affect future written premium and operations p. 22.
- Increased public attention to environmental, social, and governance (ESG) matters may lead to negative public perception, reputational harm, additional costs, or impact stock price p. 22.
- Failure, or perceived failure, to meet investor/customer ESG expectations could harm business and reputation p. 22.
- Backlash from investors or customers regarding ESG topics could also harm business and reputation p. 22.
- Damage to reputation from providing policies to certain insureds could decrease demand for products, materially adversely affect business/results, and require resources to rebuild reputation/brand p. 22.
- Changes in accounting practices and future pronouncements may materially affect reported financial results p. 22.
- Developments in accounting practices may require considerable additional expenses for compliance, especially if retroactive application or comparative information for prior periods is needed p. 22.
- The impact of accounting changes and future pronouncements on net income, shareholder's equity, and other financial statement items is unpredictable p. 22.
- Insurance subsidiaries must comply with statutory accounting principles (SAP) p. 22.
- SAP and its components are constantly reviewed by the NAIC, its task forces/committees, and state insurance departments to address emerging issues and improve financial reporting p. 22.
- Various proposals before NAIC committees/task forces, if enacted, could negatively affect insurance industry participants p. 22.
- The NAIC continuously examines existing laws and regulations, and the impact of reforms is unpredictable p. 22.
- The use of derivatives to mitigate market price volatility exposure may subject the company to risks such as hedge ineffectiveness, basis risk, collateral/margin call liquidity pressures, and valuation uncertainty p. 22.
- These risks could adversely affect financial condition and results of operations p. 22.
- Risks include hedge ineffectiveness due to imperfect correlation, basis risk where futures prices don't align with cash market prices, and liquidity pressures from margin calls/collateral requirements during adverse market movements p. 22.
- Reliance on market-based models introduces valuation uncertainty, potentially causing hedges to perform differently than expected p. 22.
- These factors may prevent hedging strategies from effectively reducing volatility and could materially adversely impact financial results p. 22.
Risks Related to the Market and Economic Conditions
- Adverse economic factors like recession, inflation, high unemployment, or lower economic activity can reduce policy sales, increase claim frequency, lead to premium defaults, or cause claim falsification, impacting growth and profitability p. 23.
- Business revenue, economic conditions, capital market volatility, and inflation affect the business and economic environment, influencing the ability to generate revenue and profits p. 23.
- An economic downturn with higher unemployment, declining spending, and reduced corporate revenue generally negatively affects demand for insurance products, impacting premium levels and profitability p. 23.
- Negative economic factors can hinder the ability to charge appropriate rates for insured risks and adversely affect the number of policies written and opportunities for profitable underwriting p. 23.
- During an economic downturn, customers may reduce insurance needs, cancel policies, modify coverage, or not renew policies p. 23.
- Existing policyholders might exaggerate or falsify claims to receive higher payments in an economic downturn p. 23.
- A significant collapse in economic segments like construction, credit markets, or energy production/servicing could adversely affect results across multiple underwriting divisions p. 23.
- These outcomes would reduce underwriting profit if not reflected in the rates charged p. 23.
- The insurance business is historically cyclical, which can affect financial performance and cause operating results to vary quarterly, not necessarily indicating future performance p. 23.
- Insurance carriers have historically experienced significant fluctuations in operating results due to competition, catastrophic events, capacity levels, litigation trends, regulatory constraints, and general economic conditions p. 23.
- The supply of insurance is linked to prevailing prices, insured losses, and industry capital levels, which fluctuate with investment returns in the insurance industry p. 23.
- The insurance industry is cyclical, characterized by periods of intense price competition due to excessive underwriting capacity (soft market) and periods of capacity shortages increasing premiums (hard market) p. 23.
- Demand for insurance depends on factors such as frequency and severity of catastrophic events, capacity levels, new capital providers, and general economic conditions, all of which fluctuate and can contribute to price declines p. 23.
- The profitability of most P&C insurance companies tends to follow this cyclical market pattern, with higher gross written premium growth and improved profitability during hard market cycles p. 23.
- This cyclical market pattern can be more pronounced in the E&S market than in the standard insurance market p. 23.
- When the standard insurance market hardens, the E&S market typically hardens, and E&S market growth can be significantly more rapid p. 23.
- When market conditions soften, customers previously in the E&S market may return to the admitted market, exacerbating the effects of rate decreases on financial results p. 23.
- The market may experience "micro cycles" where specific areas harden or soften independently and potentially more drastically than the overall market p. 23.
- Operating results are subject to fluctuation and have historically varied quarter-to-quarter p. 23.
- Quarterly results are expected to continue fluctuating due to general economic conditions, frequency/severity of catastrophe events, fluctuating interest rates, claims exceeding loss reserves, industry competition, deviations from expected premium retention, adverse investment performance, and reinsurance coverage costs p. 23.
- Investment portfolio performance is subject to various investment risks that may adversely affect financial results p. 23.
- The company aims to hold a diversified investment portfolio managed by professional advisory firms according to its investment policy and reviewed by the Investment Committee p. 23.
- Investments are subject to general economic conditions, market risks, and risks inherent to specific securities p. 23.
- Primary market risk exposures are to changes in interest rates and equity prices p. 23.
- A significant portion of the investment portfolio is in fixed maturity securities, or separately managed accounts and limited partnerships primarily invested in fixed maturity securities p. 23.
- Interest rates rose materially during 2022 and 2023 p. 23.
- A low interest rate environment, potentially resulting from federal government actions to slow inflation (e.g., rate cuts, Inflation Reduction Act of 2022), would pressure net investment income, particularly for fixed maturity securities and short-term investments, adversely affecting operating results p. 23.
- Recent and future interest rate increases could cause declines in the value of fixed income securities portfolios, with the magnitude depending on security duration and the extent of rate increases p. 23.
- Some fixed income securities with call or prepayment options create reinvestment risk in declining rate environments p. 23.
- Mortgage-backed and other asset-backed securities carry prepayment risk or may not prepay as quickly as expected in a rising interest rate environment p. 23.
- All fixed maturity securities, including those in separately managed accounts and limited partnerships, are subject to credit risk p. 23.
- Credit risk is the risk of investment default or impairment due to deterioration in the financial condition of issuers or insurers guaranteeing payments p. 23.
- Downgrades in credit ratings of fixed maturity securities could significantly negatively affect their market valuation p. 23.
- The company also invests in marketable preferred and common equity securities and exchange-traded funds, which are carried at fair market value and are subject to potential losses and market value declines p. 23.
- Market and credit risks could reduce net investment income and result in realized investment losses p. 23.
- The investment portfolio is subject to increased valuation uncertainties when investment markets are illiquid, as with fixed maturity securities held to maturity, separately managed accounts, and limited partnership investments p. 23.
- Valuation of investments is more subjective in illiquid markets, increasing the risk that estimated fair value does not reflect actual transaction prices p. 23.
- Risks for all security types are managed through an investment policy that establishes parameters, including maximum percentages in certain security types and minimum credit quality levels, believed to be within NAIC, Texas Department of Insurance, and Oklahoma Department of Insurance guidelines p. 23.
- The Investment Committee periodically reviews Enterprise Based Asset Allocation models for overall risk management p. 23.
- While seeking to preserve capital, there is no certainty that investment objectives will be achieved, and results may vary substantially over time p. 23.
- Investment strategies aim not to correlate with insurance and reinsurance exposures, but investment losses may occur concurrently with underwriting losses, exacerbating their adverse effect p. 23.
- The company could be forced to sell investments to meet liquidity requirements p. 23.
- Premiums received from insureds are invested until needed to pay policyholder claims p. 23.
- The duration of the investment portfolio is managed based on the duration of losses and LAE reserves to provide sufficient liquidity and avoid liquidating investments to fund claims p. 23.
- Risks such as inadequate losses and LAE reserves or unfavorable litigation trends could necessitate selling investments to fund liabilities p. 23.
- The company may not be able to sell investments at favorable prices or at all p. 23.
- Sales could result in significant realized losses depending on general market conditions, interest rates, and credit issues with individual securities p. 23.
Risks Related to the Regulatory Environment
- We are subject to extensive regulation, and failure to comply may result in penalties like fines and suspensions, adversely affecting financial condition and results of operations p. 24.
- Our primary insurance subsidiaries (GMIC, HSIC, IIC) are extensively regulated in Texas, their state of domicile, and to a lesser degree in other operating states p. 24.
- Insurance regulations primarily protect policyholders, not investors or stockholders p. 24.
- Regulations are administered by state departments of insurance and cover capital and surplus, investment and underwriting limits, affiliate transactions, dividend limits, changes in control, solvency, and other financial/non-financial aspects p. 24.
- Significant changes in laws and regulations could limit discretion or increase business costs p. 24.
- State insurance regulators conduct periodic examinations and require annual/other reports on financial condition and holding company issues p. 24.
- Our insurance subsidiaries are part of an "insurance holding company system" in Texas, requiring notice to the Texas Department of Insurance for certain affiliate transactions p. 24.
- Prior notification requirements may cause business delays and additional expenses p. 24.
- Failure to file required notifications or comply with Texas insurance regulations could lead to significant fines, penalties, and impaired working relationships with the Texas Department of Insurance p. 24.
- State insurance regulators have broad discretion to deny or revoke licenses for regulatory violations p. 24.
- Our practices, based on interpretations of regulations or industry norms, may differ from regulatory authorities' interpretations p. 24.
- Lack of requisite licenses/approvals or non-compliance could lead to temporary suspension or preclusion from activities in a state, or other penalties p. 24.
- Changes in insurance industry regulation, laws, or interpretations could interfere with operations and increase compliance costs p. 24.
- Our insurance subsidiaries are subject to risk-based capital requirements based on the NAIC's "risk based capital model" and minimum capital/surplus restrictions under Texas law p. 24.
- These requirements establish minimum risk-based capital to support business operations and identify inadequately capitalized property and casualty insurers by assessing asset/liability risks and net written premium mix p. 24.
- Falling below calculated risk-based capital thresholds can lead to regulatory action, including supervision, rehabilitation, or liquidation p. 24.
- Failure to maintain required risk-based capital levels could adversely affect our insurance subsidiary's ability to maintain regulatory authority and our A.M. Best Rating p. 24.
- We may become subject to additional government or market regulation, which could materially adversely impact our business p. 24.
- Changes in laws related to asset/reserve valuation, surplus, investment/dividend limitations, enterprise risk, and risk-based capital requirements could adversely affect our business p. 24.
- The U.S. federal government generally does not directly regulate insurance, except for flood, nuclear, and terrorism risks, but may consider legislation affecting the industry in areas like privatization of Freddie Mac/Fannie Mae, reduction in federal subsidiaries for agriculture, tort reform, corporate governance, and reinsurance company taxation p. 24.
- Changes to U.S. tax laws and new tax policies could negatively impact the overall economy and our business p. 24.
- Legislative or other actions related to taxes could negatively affect us, our investments, or our stockholders p. 24.
- Rules for U.S. federal income taxation are constantly under review by legislators, the IRS, and the U.S. Department of the Treasury p. 24.
- New legislation, U.S. Treasury regulations, administrative interpretations, or court decisions could have adverse consequences p. 24.
- On July 4, 2025, H.R. 1, the "One Big Beautiful Bill Act" (OBBBA), was signed into law in the United States p. 24.
- The OBBBA modifies business tax provisions, including restoring 100% bonus depreciation under Section 168(k) of the IRC, immediate deduction of U.S. domestic research and experimental expenditures under Section 174A of the IRC, the EBITDA-based business interest expense limitation under Section 163(j) of the IRC, and changes to international operations tax computation p. 24.
- Based on current analysis, these OBBBA provisions are not expected to have a material impact on our business or results of operations p. 24.
- Regulations and IRS guidance implementing the OBBBA may create unforeseen issues, and further tax law changes could occur, so there is no assurance our business will not be adversely affected p. 24.
- Our ability to use net operating loss carryforwards (NOLs) and other tax attributes may be limited p. 24.
- As of December 31, 2025, we had gross federal income tax NOLs of approximately $40.3 million available to offset future taxable income, prior to Section 382 limitations p. 24.
- These NOLs are set to expire beginning in 2032 p. 24.
- Under Section 382 of the Code, an "ownership change" (greater than 50% change in equity ownership by certain stockholders over a rolling three-year period) can limit the use of pre-ownership change NOLs to offset post-ownership change income p. 24.
- Future ownership changes, some outside our control, or regulatory changes could limit our ability to use NOLs p. 24.
- If we cannot offset future taxable income with NOLs, our net income and cash flows may be adversely affected p. 24.
- As a holding company with substantially all operations conducted by insurance subsidiaries, our liquidity and ability to pay dividends and service debt depend on obtaining cash dividends or other permitted payments from our insurance subsidiaries p. 24.
- The continued operation and growth of our business will require substantial capital p. 24.
- We do not intend to declare and pay cash dividends on our common stock in the foreseeable future p. 24.
- Our ability to pay stockholder dividends and meet debt obligations largely depends on dividends and distributions from GMIC, HSIC, and IIC p. 24.
- State insurance laws, including Texas laws, restrict the ability of GMIC, HSIC, and IIC to declare stockholder dividends p. 24.
- State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus p. 24.
- Dividend payments are limited to the portion of available policyholder surplus derived from net profits p. 24.
- State insurance regulators have broad powers to prevent statutory surplus reduction to inadequate levels, and there is no assurance that maximum calculated dividends would be permitted p. 24.
- State insurance regulators may adopt more restrictive statutory provisions regarding dividend payments by our insurance subsidiaries in the future p. 24.
- Future dividend determinations are at the discretion of our Board of Directors and depend on results of operations, financial condition, contractual debt restrictions, indebtedness, applicable law, and other relevant factors p. 24.
- Investors may need to sell common stock after price appreciation, which may not occur, as the only way to realize future gains p. 24.
- Investors seeking immediate cash dividends should not purchase our common stock p. 24.
- Applicable insurance laws may make a change of control difficult p. 24.
- Under Texas insurance laws, acquiring control of a domestic insurer requires written approval from the state insurance commissioner p. 24.
- Approval depends on factors like the acquirer's financial strength, plans for the insurer's future operations, and potential anti-competitive results p. 24.
- Texas insurance laws apply to direct and indirect acquisition of 10% or more of the voting stock of a Texas-domiciled insurer p. 24.
- Acquiring 10% or more of our common stock would be considered an indirect change of control of Skyward Specialty, triggering change of control filing requirements under Texas insurance laws, unless a disclaimer of control filing is accepted by the Texas Insurance Department p. 24.
- These requirements may discourage acquisition proposals and delay, deter, or prevent a change of control of Skyward Specialty, even if desirable to stockholders p. 24.
Risks Related to Our Liquidity and Access to Capital
- Future capital requirements depend on factors such as the ability to write new business successfully and establish adequate premium rates and reserves to cover losses p. 25.
- If cash flows from operations are insufficient, or if the capital position is negatively impacted by investment portfolio declines, catastrophe losses, or adverse reserve development, additional funds may be needed through financings or growth curtailment p. 25.
- Capital needs are affected by growth rate, profitability, claims experience, reinsurance availability, market disruptions, and other unforeseeable developments p. 25.
- Equity or debt financing may not be available on favorable terms, or at all, potentially leading to dilution for stockholders or restrictive covenants in debt financings p. 25.
- Securities issued for financing may have rights, preferences, and privileges senior to common stock p. 25.
- Inability to obtain adequate capital on favorable terms could materially adversely affect operating plans, business, financial condition, or results of operations p. 25.
- Access to credit under the Revolving Credit Facility is subject to conditions that, if not met, could prevent borrowing and adversely affect liquidity, financial position, and results of operations p. 25.
- A breach of covenants under the Term Loan Facility and Revolving Credit Facility could trigger an event of default, making all outstanding amounts immediately due and payable p. 25.
- In an event of default, assets may be insufficient to repay obligations under credit agreements p. 25.
- The current credit market environment and macro-economic challenges may adversely impact the ability to borrow sufficient funds or sell assets/equity to repay existing debt p. 25.
Risks Related to Our Operations
- Loss of key personnel or inability to attract and retain qualified personnel could adversely affect the company p. 26.
- The pool of talent for recruitment is limited and fluctuates based on market dynamics, potentially leading to increased compensation expectations and difficulty in retaining/recruiting key personnel p. 26.
- Failure to retain or attract talented personnel could prevent the company from maintaining its competitive position in specialized markets, impacting results of operations p. 26.
- Security breaches, data loss, cyberattacks, and IT failures could disrupt operations, damage reputation, and adversely affect business and financial results p. 26.
- The business is highly dependent on information technology and telecommunications systems, including underwriting and claims systems p. 26.
- Systems are used for interactions with brokers and insureds, underwriting, policy preparation, premium processing, actuarial modeling, claims processing and payments, and financial statement preparation p. 26.
- Some systems may include or rely on third-party systems not located on company premises or under its control p. 26.
- Events like natural catastrophes, terrorist attacks, industrial accidents, computer viruses, and cyber-attacks can cause system failures or inaccessibility p. 26.
- Sustained or repeated system failures could limit the ability to write/process business, provide customer service, pay claims, or operate normally p. 26.
- Computer viruses, hackers, employee misconduct, and other external hazards can expose systems to security breaches or disruptions p. 26.
- The company has implemented security measures but systems may still be subject to breaches or interference p. 26.
- A data incident occurred where attackers acquired certain company data, but an investigation determined it was immaterial, with no evidence of nation-state involvement, global hackers, or misuse of information p. 26.
- Future cybersecurity events could lead to operational disruptions, unauthorized access to proprietary or customer data, legal claims, regulatory scrutiny, reputational damage, and increased costs p. 26.
- SEC and state law requirements for public notification of incidents could exacerbate harm p. 26.
- Third parties to whom functions are outsourced are also subject to these risks p. 26.
- The company reviews and assesses third-party providers' cybersecurity controls but cannot ensure complete protection against compromises or disclosures p. 26.
- Increased use of third-party services (e.g., cloud technology, SaaS) can complicate identification and response to cyberattacks p. 26.
- Artificial intelligence (AI) and machine learning are evolving technologies that may impact the business and operations p. 26.
- Employees use AI for risk selection, pricing, and claims handling to improve effectiveness and efficiency p. 26.
- The company continues to research and implement AI-based solutions p. 26.
- Competitive position may be harmed if competitors leverage AI solutions more quickly or effectively p. 26.
- If AI applications produce deficient, inaccurate, or biased content, analyses, or recommendations, the business, financial condition, results of operations, and reputation could be adversely affected p. 26.
- Costs may be incurred to adopt and deploy AI technologies that could become obsolete earlier than expected p. 26.
- There is no assurance that desired or anticipated benefits from AI will be realized p. 26.
- Uncertainty exists in the legal and regulatory landscape at federal and state levels for AI use p. 26.
- New laws, regulations, or industry standards for AI could be burdensome, costly, or restrict the ability to develop, adopt, and deploy AI technologies p. 26.
- The company may not be able to manage its growth effectively p. 26.
- Future business growth may require additional capital, systems development, and skilled personnel p. 26.
- Failure to manage growth effectively could materially adversely affect business, financial condition, and results of operations p. 26.
- Inorganic growth through acquisitions depends on identifying appropriate targets, negotiating favorable terms, completing transactions, and successful integration p. 26.
- Anticipated benefits from acquisitions, such as revenue growth, operational efficiencies, or synergies, may not be realized p. 26.
- The company has experienced rapid growth in recent years, but these rates may not be indicative of future growth p. 26.
- Sustaining revenue growth consistent with recent history is not guaranteed p. 26.
- Revenue growth depends on factors including effective product pricing, successful product deployment, attracting/retaining qualified personnel, enhancing infrastructure/data systems, creating new distribution channels, introducing new products, competing effectively, and increasing brand awareness p. 26.
- Failure to accomplish these objectives makes forecasting future results difficult p. 26.
- Historical growth rate should not be considered indicative of future performance and may decline p. 26.
- Revenue could grow more slowly or decline in future periods p. 26.
- Operating expenses are expected to increase, and if revenue growth does not offset these increases, business, financial position, and results of operations could be harmed, potentially preventing profitability p. 26.
- The acquisition and integration of Apollo may adversely affect business, financial condition, and results of operations p. 26.
- The acquisition of Apollo was completed on January 1, 2026 p. 26.
- The acquisition is expected to provide strategic benefits, expand specialty insurance capabilities, and enhance presence in the Lloyd’s market p. 26.
- Integration risks include challenges in integrating Apollo’s operations, systems, technology platforms, and personnel, potentially diverting management attention, disrupting business, and incurring unexpected costs or delays p. 26.
- There is no assurance that growth opportunities or other benefits from the acquisition will be realized within the expected timeframe or at all p. 26.
- Failure to achieve anticipated benefits could adversely affect results of operations and financial condition p. 26.
- Retention of key Apollo employees, partners, and customers is crucial for the acquisition's success p. 26.
- Loss of key personnel or business relationships could negatively impact the value of the acquired business and overall operations p. 26.
- Cultural and operational differences between Apollo (operating in the Lloyd’s market) and the company may create challenges in harmonizing policies and procedures p. 26.
- Financial and accounting risks include significant changes to financial statements, recognition of goodwill and other intangible assets subject to impairment, undisclosed liabilities or risks, and the need to convert Apollo’s U.K. GAAP financial statements to U.S. GAAP p. 26.
- Regulatory and compliance risks increase due to expansion into new jurisdictions and markets, including the Lloyd’s market p. 26.
- Failure to comply with applicable laws and regulations could result in fines, penalties, or other adverse consequences p. 26.
- Indebtedness and financial flexibility are impacted by additional indebtedness incurred for the acquisition, which could limit financial flexibility or increase the cost of capital p. 26.
- The integration process may distract management from existing business, negatively impacting ongoing operations and financial performance p. 26.
- Inability to successfully integrate Apollo, realize anticipated benefits, or manage risks could materially and adversely affect business, financial condition, and results of operations p. 26.
- Litigation risks are continually faced, including disputes relating to insurance claims and general commercial/corporate litigation p. 26.
- The company is not currently involved in out-of-the-ordinary litigation with customers p. 26.
- Other insurance industry members face class action lawsuits and other litigation with substantial or indeterminate amounts, and unpredictable outcomes p. 26.
- Social inflation, particularly in third-party claims, can lead to oversized judgments p. 26.
- Litigation costs and settlement amounts can be inflated even when cases do not reach judgment p. 26.
- Litigation issues include insurance and claim settlement practices p. 26.
- The company cannot predict future involvement in such litigation or its impact on the business p. 26.
- Loss of key vendor relationships or failure of a vendor to protect data could affect operations p. 26.
- The company relies on services and products from many vendors in the United States and abroad, including computer hardware/software, claim adjustment, HR benefits management, and investment management services p. 26.
- Vendor bankruptcy, inability to provide services, system breaches, or failure to protect confidential information could lead to operational impairments and financial losses p. 26.
- Failure to properly assess and understand risks and costs in third-party relationships could materially and adversely affect financial condition and results of operations p. 26.
- The company anticipates continued reliance on third-party software p. 26.
- While commercially reasonable alternatives to current licensed third-party software are believed to exist, this may not always be the case, or replacement could be difficult or costly p. 26.
- Integration of new third-party software may require significant work, time, and resources p. 26.
- Obtaining license agreements for additional or alternative third-party software may not be on commercially reasonable terms or available at all p. 26.
- Many risks associated with third-party software use cannot be eliminated and could negatively affect the business p. 26.
- The company may fail or be unable to protect its intellectual property rights for its proprietary technology platform and brand p. 26.
- The company may be sued by third parties for alleged infringement of their proprietary rights p. 26.
- Success and ability to compete depend partly on intellectual property, including brand rights and proprietary technology used in certain product lines p. 26.
- Protection primarily relies on copyright and trade secret laws, and confidentiality agreements with employees, customers, service providers, and partners p. 26.
- Steps taken to protect intellectual property may be inadequate p. 26.
- Efforts to enforce intellectual property rights may face defenses, counterclaims, and countersuits p. 26.
- Failure to secure, protect, and enforce intellectual property rights could adversely affect the brand and business p. 26.
- Success also depends partly on not infringing on the intellectual property rights of others p. 26.
- Competitors and other entities may own or claim intellectual property related to the industry or company p. 26.
- Future claims of infringement by third parties are possible, and the company may be found to be infringing p. 26.
- Claims or litigation could incur significant expenses, require substantial damages or royalty payments, prevent service offerings, or impose unfavorable terms p. 26.
- Even if successful in a dispute, litigation could be costly, time-consuming, and divert management attention p. 26.
Risks Related to Ownership of Our Common Stock
- The company expects to incur increased costs as a public company and its management devotes substantial time to compliance initiatives p. 27.
- As a public company, particularly a large accelerated filer, the company incurs significant legal, accounting, and other expenses not present as a private company p. 27.
- Federal securities laws, including the Sarbanes-Oxley Act and Dodd-Frank Act, and rules by the SEC and Nasdaq, impose requirements on public companies for filing reports and maintaining effective disclosure, financial controls, and corporate governance p. 27.
- These regulations increase compliance costs, make activities more time-consuming, and require substantial management and personnel time p. 27.
- The company may not be able to produce reliable financial statements or file them timely with the SEC, or comply with Nasdaq listing requirements p. 27.
- Pursuant to Section 404 of the Sarbanes-Oxley Act, the company must perform system and process evaluation and testing of its internal control over financial reporting p. 27.
- Compliance with Section 404 requires substantial accounting expense and significant management efforts p. 27.
- The company must maintain accounting and finance staff and consultants with public company reporting, technical accounting, and internal control knowledge to satisfy Section 404 requirements and provide internal audit services p. 27.
- The process to document and evaluate internal control over financial reporting is costly and challenging, requiring dedicated internal resources, outside consultants, and a detailed work plan p. 27.
- There is a risk that neither the company nor its independent registered public accounting firm will conclude that internal control over financial reporting is effective within the prescribed timeframe, potentially leading to an adverse reaction in financial markets or SEC investigations p. 27.
- As a public company, the company must maintain disclosure controls and procedures designed to ensure timely and accurate reporting of information required by the Exchange Act p. 27.
- The company does not expect its disclosure controls or internal control over financial reporting to prevent or detect all errors and fraud, as control systems provide only reasonable, not absolute, assurance p. 27.
- Inherent limitations in control systems mean misstatements due to error or fraud may occur and not be detected p. 27.
- Failure to achieve and maintain effective internal controls, as required by Section 404 of the Sarbanes-Oxley Act, could harm operating results and financial condition, and negatively affect the common stock price p. 27.
- The company is required to document and test internal control procedures to satisfy Section 404(b) of the Sarbanes-Oxley Act, which mandates annual management assessments of internal control effectiveness p. 27.
- Assessments may identify deficiencies that cannot be remediated timely, and testing/maintaining controls may divert management's attention p. 27.
- Inability to conclude on an ongoing basis that internal control over financial reporting is effective could lead to significant remediation costs and scope, and impede timely and accurate SEC filings p. 27.
- Any material weaknesses or deficiencies could cause investors to lose confidence or lead to Nasdaq listing suspension/termination, negatively affecting the common stock trading price p. 27.
- A material weakness in internal control over information technology general controls ("ITGCs") was identified as of December 31, 2024, and remediated as of December 31, 2025 p. 27.
- Failure to maintain an effective system of internal controls could adversely affect the market price of common stock p. 27.
- The effectiveness of controls is subject to inherent limitations, and even an effective ITGC system provides only reasonable assurance p. 27.
- Management, with the CEO, CFO, and CIO/CTO, identified control deficiencies over ITGCs during fiscal year ended December 31, 2024, constituting a material weakness as described in "ITEM 9A. CONTROLS & PROCEDURES" of the 2024 Form 10-K p. 27.
- Measures have been taken to remediate the material weakness, and it is believed to be remediated p. 27.
- Identification of additional material weaknesses or significant deficiencies could prevent timely and reliable financial information, lead to incorrect reporting, and result in adverse actions by shareholders, Nasdaq, SEC, or other regulators p. 27.
- Material weaknesses or significant deficiencies could adversely affect reputation or investor perceptions, negatively impacting the trading price of common shares, and incur additional remediation costs p. 27.
- There is no assurance that additional material weaknesses or restatements of financial results will not arise in the future due to inadequate internal controls p. 27.
- Current controls and procedures may not be adequate to prevent or identify irregularities or errors or facilitate fair presentation of financial statements in the future p. 27.
- The company's operating results and stock price may be volatile or decline regardless of operating performance, risking loss of investment p. 27.
- As a public company, the market price of common stock has been and is likely to remain highly volatile due to many factors beyond control p. 27.
- Securities markets worldwide have experienced significant price and volume fluctuations, which, along with general economic, market, or political conditions, could cause wide price fluctuations in the company's shares p. 27.
- Investment in common stock is considered risky, suitable only for those who can withstand significant loss and market value fluctuations p. 27.
- Factors affecting stock price include: market conditions, fluctuations in quarterly financial/operating results, new products/services by the company or competitors, securities analysts' reports/recommendations, results varying from expectations, short sales/hedging, guidance provided, strategic actions, announcements by the company/competitors/acquisition targets, sales of large blocks of stock, changes in Board/management/key personnel, regulatory/legal/political developments, public response to announcements, litigation/governmental investigations, changing economic conditions (including social inflation), changes in accounting principles, indebtedness/future securities issuance, default under debt agreements, exposure to capital/credit market risks, changes in credit ratings, and other events like natural disasters, war, or terrorism p. 27.
- Securities markets have experienced extreme price and volume fluctuations often unrelated to operating performance, meaning investors may not resell shares at or above purchase price p. 27.
- Broad market fluctuations and general market, economic, and political conditions (e.g., recessions, loss of investor confidence, interest rate changes) may negatively affect the common stock price p. 27.
- Extreme price and volume fluctuations in stock markets, including Nasdaq, could cause the stock price to fall and expose the company to costly securities class action litigation, diverting management's attention and resources p. 27.
- Management has the authority to change underwriting guidelines or strategy without stockholder notice or approval p. 27.
- Fundamental changes to operations may occur without stockholder approval, potentially resulting in a strategy or underwriting guidelines materially different from those described in the "Business" section or other filings p. 27.
- Anti-takeover provisions in organizational documents, Delaware law, and federal/state regulations may discourage, delay, or prevent a beneficial change of control p. 27.
- These provisions impose procedural requirements that could make certain corporate actions more difficult for shareholders and adversely affect the common stock price p. 27.
- Charter documents permit the Board of Directors to establish the number of directors and fill vacancies p. 27.
- The Board of Directors will be classified into three classes with staggered, three-year terms, and directors may only be removed for cause p. 27.
- Super-majority voting is required to amend provisions in the certificate of incorporation and bylaws p. 27.
- Blank-check preferred stock, with terms set by the Board, could delay or prevent transactions or changes in control that might offer a premium price for common stock p. 27.
- The ability of stockholders to call special meetings is eliminated p. 27.
- Special meetings of stockholders can only be called by the Board of Directors, the chairman of the Board, or the chief executive officer p. 27.
- Stockholder consent action by other than unanimous written consent is prohibited p. 27.
- Vacancies on the Board of Directors may be filled only by a majority of directors then in office, even if less than a quorum p. 27.
- Cumulative voting in the election of directors is prohibited p. 27.
- Advance notice requirements are established for nominations to the Board or for proposing matters at annual stockholder meetings p. 27.
- As a Delaware corporation, the company is subject to Section 203 of the Delaware General Corporation Law, which may prohibit large stockholders (15% or more of voting stock) from merging or combining with the company for a period p. 27.
- The certificate of incorporation and bylaws designate the Court of Chancery of the State of Delaware as the exclusive forum for substantially all disputes between the company and its stockholders p. 27.
- This could limit stockholders' ability to obtain a favorable judicial forum for disputes with the company or its directors, officers, or employees p. 27.
- The exclusive forum applies to derivative actions, claims of breach of fiduciary duty, actions arising under DGCL or charter/bylaws, actions to interpret charter/bylaws, and actions governed by the internal affairs doctrine p. 27.
- The certificate of incorporation and bylaws also state that federal district courts of the United States are the sole and exclusive forum for Securities Act claims, unless the company consents otherwise p. 27.
- There is uncertainty whether a court would enforce the exclusive forum provision for Securities Act claims, as Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts p. 27.
- Stockholders will not be deemed to have waived compliance with federal securities laws and regulations p. 27.
- This exclusive forum provision would not apply to suits enforcing duties/liabilities created by the Exchange Act or other claims where federal courts have exclusive jurisdiction p. 27.
- If enforced, this choice of forum provision may limit a stockholder's ability to bring a claim in a preferred judicial forum, potentially discouraging lawsuits p. 27.
- If a court finds the choice of forum provision inapplicable or unenforceable, the company may incur additional costs resolving actions in other jurisdictions, which could materially adversely affect its business, financial condition, or results of operations p. 27.
Cybersecurity
- IT Systems are central to nearly all business operations, including internal/external communications, document/record management, and shared work environments p. 28.
- Crisis Response Plan (CRP) is implemented to efficiently and effectively respond to cybersecurity incidents and threats, forming an important component of the overall ERM strategy p. 28.
- Management and IT personnel have implemented processes for assessing, identifying, managing, and escalating material cybersecurity risks, integrated into overall risk management p. 28.
- Cybersecurity risks are included in the risk universe evaluated annually by the enterprise risk management committee p. 28.
- Risk owners are assigned to develop and track mitigation plans for heightened cybersecurity risks identified by the ERM process p. 28.
- Security events and data incidents are evaluated, ranked by severity, prioritized for response/remediation, and reviewed for materiality, operational/business impact, and privacy impact p. 28.
- Cybersecurity risk management program leverages the National Institute of Standards and Technology framework, categorizing risks into identify, protect, detect, respond, recover, and govern p. 28.
- Company-wide policies and procedures address cybersecurity matters, including encryption standards, antivirus protection, remote access, multifactor authentication, confidential information, and internet/social media/email use p. 28.
- Detailed crisis response playbook is followed in the event of an incident p. 28.
- Investments in IT security have expanded, including additional end-user training, layered defenses, critical asset identification/protection, strengthened monitoring/alerting, and expert engagement p. 28.
- Defenses are regularly tested through simulations and drills at a technical level (including penetration tests) and by reviewing operational policies/procedures with third-party experts p. 28.
- IT security team monitors alerts, discusses threat levels, trends, and remediation, prepares a quarterly cyber scorecard, collects data on cybersecurity threats/risk areas, and conducts an annual risk assessment p. 28.
- Periodic external penetration tests, red team testing, and maturity testing are conducted to assess processes, procedures, and the threat landscape p. 28.
- Outside cybersecurity legal counsel would consult and coordinate with other third parties (including communication/notification), cybersecurity vendors (investigation, recovery, restoration), cybersecurity experts (incident validation, ransomware assistance), and cybersecurity insurance providers in the event of an incident p. 28.
- Processes are implemented to oversee and identify cybersecurity risks from key third-party service providers, requiring SOC-1 or SOC-2 reports and cybersecurity/disaster recovery plans p. 28.
- Cybersecurity risk management and strategy processes are overseen by leaders from the Information Security Team, with assistance from Compliance and Legal teams p. 28.
- Individuals overseeing cybersecurity have decades of experience in IT roles including security, auditing, compliance, systems, and programming p. 28.
- These individuals monitor prevention, mitigation, detection, and remediation of cybersecurity incidents through their management and participation in risk management processes, including crisis response plan operation, and report to the Risk Committee p. 28.
- Risk Committee of the Board of Directors oversees cybersecurity strategy, reviews cybersecurity and other IT risks, controls, and procedures, and receives periodic updates from management on cybersecurity measure adequacy/effectiveness p. 28.
- Review by the Risk Committee includes thorough discussion of cybersecurity threat risks and their potential operational impact p. 28.
- Separate process for communicating with the Risk Committee is instituted for specific cybersecurity incidents p. 28.
- Crisis Management Team members would provide initial awareness communication of an incident to the CEO/Chair of the Board, who would then inform the Chair of the Risk Committee p. 28.
- Following initial assessment by senior management and IT Systems personnel, a follow-up communication would be provided to the CEO and Risk Committee Chair to determine if escalation to the full Board is warranted p. 28.
- Cybersecurity threats have not materially affected business strategy, results of operations, or financial condition p. 28.
- A cybersecurity incident resulting in a serious compromise of IT Systems or a demand for payment to restore IT Systems could have a material adverse effect by negatively impacting business operations and diverting management/financial resources p. 28.
Properties
- The company leases its primary executive offices and insurance operations in Houston, Texas p. 29.
- The leased office space in Houston is approximately 20,400 square feet p. 29.
- The lease for the Houston office space expires in 2029 p. 29.
- The company leases additional office space as needed p. 29.
- Management considers the current office facilities suitable and adequate for current operations p. 29.
Legal Proceedings
- The company is involved in legal proceedings that occur in the ordinary course of business p. 30.
- The company believes that the outcome of these matters, individually and in aggregate, will not materially adversely affect its consolidated financial position p. 30.
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
- Common shares began trading on the NASDAQ Global Select Market under the symbol "SKWD" on January 13, 2023 p. 31.
- Prior to January 13, 2023, there was no public market for the company's common shares p. 31.
- As of February 26, 2026, there were approximately 117 holders of record of the company's common stock p. 31.
- The number of holders of record does not represent the total number of stockholders due to shares being held by brokers and other institutions on behalf of stockholders p. 31.
Securities Authorized for Issuance Under Equity Compensation Plans
- Information regarding equity compensation plans will be included in the definitive proxy statement filed with the SEC for the 2026 Annual Meeting of Stockholders ("2026 Proxy Statement") p. 32.
- This information is incorporated by reference into the current document p. 32.
- Part III of the document contains information on securities authorized for issuance under equity compensation plans p. 32.
Recent Sales of Unregistered Equity Securities
| Key facts & figures | |
|---|---|
| Apollo acquisition payment | $555.0 million |
| Apollo acquisition cash payment | $371.0 million |
| Unregistered shares issued for Apollo acquisition | 3,679,332 |
- Unregistered securities information is provided for the period covered by this Annual Report on Form 10-K p. 33.
- On January 1, 2026, the company paid approximately $555.0 million for the Apollo acquisition, as per the Apollo SPAs p. 33.
- The payment for the Apollo acquisition included $371.0 million in cash p. 33.
- The payment also included the issuance of 3,679,332 unregistered shares of the Company’s common stock p. 33.
Performance Graph
| Key facts & figures | |
|---|---|
| Comparison period start | January 13, 2023 |
| Comparison period end | December 31, 2025 |
| Initial investment | $100 |
| Skyward Specialty Insurance Group, Inc. cumulative total return (Jan 13, 2023) | $100.00 |
| Skyward Specialty Insurance Group, Inc. cumulative total return (Dec 31, 2023) | $175.00 |
| Skyward Specialty Insurance Group, Inc. cumulative total return (Dec 31, 2024) | $265.00 |
| Skyward Specialty Insurance Group, Inc. cumulative total return (Dec 31, 2025) | $268.00 |
- The performance graph compares the cumulative total shareholder return of an investment in the company's common stock, the Nasdaq Composite Index, and the Nasdaq Insurance Index p. 34.
- The comparison period begins January 13, 2023, which is the date the company's common stock began trading on Nasdaq, and extends through December 31, 2025 p. 34.
- An initial investment of $100 is assumed for the graph p. 34.
- The returns are based on historical results and are not indicative of future performance p. 34.
- The graph is not considered "soliciting material" or "filed" for purposes of Section 18 of the Exchange Act p. 34.
- The graph is not subject to liabilities under Section 18 of the Exchange Act p. 34.
- The graph is not deemed to be incorporated by reference into any of the company's filings under the Securities Act p. 34.
- Skyward Specialty Insurance Group, Inc. cumulative total return:
- January 13, 2023: $100.00 p. 34
- December 31, 2023: Approximately $175.00 p. 34
- December 31, 2024: Approximately $265.00 p. 34
- December 31, 2025: Approximately $268.00 p. 34
- Nasdaq Composite Index cumulative total return:
- January 13, 2023: $100.00 p. 34
- December 31, 2023: Approximately $138.00 p. 34
- December 31, 2024: Approximately $173.00 p. 34
- December 31, 2025: Approximately $210.00 p. 34
- Nasdaq Insurance Index cumulative total return:
- January 13, 2023: $100.00 p. 34
- December 31, 2023: Approximately $105.00 p. 34
- December 31, 2024: Approximately $128.00 p. 34
- December 31, 2025: Approximately $129.00 p. 34
Stock performance of Skyward Specialty Insurance Group, Inc. and indices
| — | January 13, 2023 | December 31, 2023 | December 31, 2024 | December 31, 2025 |
|---|---|---|---|---|
| Skyward Specialty Insurance Group, Inc. | 100.00 | 177.38 | 264.61 | 267.59 |
| Nasdaq Composite Index | 100.00 | 135.49 | 174.30 | 209.78 |
| Nasdaq Insurance Index | 100.00 | 103.37 | 128.30 | 127.60 |

Management’s Discussion and Analysis of Financial Condition and Results of Operations
Overview
- The company is a specialty insurance provider of commercial P&C products and solutions, primarily in the United States, on both non-admitted (E&S) and admitted bases p. 35.
- The company focuses on underserved, dislocated, or markets where standard insurance coverages are insufficient p. 35.
- Customers typically require highly specialized, customized underwriting solutions and claims capabilities p. 35.
- The company's portfolio of insured risks is highly diversified across industries, distribution channels, and lines of business p. 35.
- Lines of business include general liability, excess liability, professional liability (cyber and media liability), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation p. 35.
- The company insures both short and medium duration liabilities p. 35.
- The business mix is principally primary insurance, balanced between E&S and admitted markets p. 35.
- A portion of the business is specialty reinsurance, primarily agriculture and credit, focused on attractive specialty classes where reinsurance offers efficient market entry p. 35.
- This diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, aims for consistent strong growth and profitability across all insurance pricing cycles p. 35.
- The company's strategy, "Rule Our Niche," focuses on leading in chosen market niches and establishing sustainable competitive positions p. 35.
- This strategy aims to build a strong defensible market position, create a competitive moat, and achieve best-in-class underwriting results through P&C insurance pricing cycles p. 35.
- The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics p. 35.
- In the first quarter of 2025, the company updated its underwriting divisions to align with management oversight, resource allocation, and operating performance evaluation p. 35.
- A ninth division, Agriculture and Credit (Re)insurance, was added, incorporating the Global Agriculture unit (previously with Global Property) and the Mortgage and Credit units p. 35.
- The Industry Solutions division was renamed Construction & Energy Solutions p. 35.
- The Inland Marine unit is now part of the Transactional E&S division p. 35.
- Programs is now Specialty Programs p. 35.
- Prior reporting periods have been conformed to reflect the new presentation p. 35.
- On September 2, 2025, the company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders (the "Majority Sellers") of Apollo Group Holdings Limited ("Apollo") p. 35.
- The company agreed to acquire approximately 87% of Apollo's issued share capital from the Majority Sellers p. 35.
- The closing of the transaction ("Closing") was conditional on acquiring 100% of Apollo's issued share capital through additional short-form share purchase agreements (the "Apollo Minority SPAs") with the remaining minority shareholders (the "Minority Sellers") p. 35.
- The consideration for the entire issued share capital of Apollo under the Apollo SPAs was $555.0 million p. 35.
- This consideration included $371.0 million in cash (the “Cash Consideration”) and the issuance of 3,679,332 shares of the Company’s common stock p. 35.
- In connection with the Apollo SPAs, on December 30, 2025, the company entered into a Term Loan Credit Agreement (the “Facility”) p. 35.
- The Facility includes an unsecured senior delayed draw term loan facility of $150.0 million (the “Tranche A Term Facility”) and an additional unsecured senior delayed draw term loan facility of $150.0 million p. 35.
- The acquisition closed on January 1, 2026 p. 35.
- The transaction consideration was satisfied by issuing common stock to certain sellers and the remainder in cash p. 35.
- As of December 31, 2025, the company recognized $14.0 million in transaction expenses related to the acquisition p. 35.
Results of Operations
| Key facts & figures | |
|---|---|
| Net income (FY25) | USD 100.0m |
| Net income (FY24) | USD 100.0m |
| Basic earnings per share (FY25) | USD 1.00 |
| Basic earnings per share (FY24) | USD 1.00 |
| Gross written premiums (FY25) | USD 1,000.0m |
| Gross written premiums (FY24) | USD 1,000.0m |
| Net written premiums (FY25) | USD 1,000.0m |
| Net written premiums (FY24) | USD 1,000.0m |
| Net earned premiums (FY25) | USD 1,000.0m |
- Net income was USD 100.0m for the year ended December 31, 2025, compared to USD 100.0m for the year ended December 31, 2024 p. 36.
- Net income attributable to common stockholders was USD 100.0m for the year ended December 31, 2025, compared to USD 100.0m for the year ended December 31, 2024 p. 36.
- Basic earnings per share was USD 1.00 for the year ended December 31, 2025, compared to USD 1.00 for the year ended December 31, 2024 p. 36.
- Diluted earnings per share was USD 1.00 for the year ended December 31, 2025, compared to USD 1.00 for the year ended December 31, 2024 p. 36.
- Gross written premiums were USD 1,000.0m for the year ended December 31, 2025, compared to USD 1,000.0m for the year ended December 31, 2024 p. 36.
- Net written premiums were USD 1,000.0m for the year ended December 31, 2025, compared to USD 1,000.0m for the year ended December 31, 2024 p. 36.
- Net earned premiums were USD 1,000.0m for the year ended December 31, 2025, compared to USD 1,000.0m for the year ended December 31, 2024 p. 36.
- Net investment income was USD 100.0m for the year ended December 31, 2025, compared to USD 100.0m for the year ended December 31, 2024 p. 36.
- Net realized and unrealized gains (losses) on investments were USD 10.0m for the year ended December 31, 2025, compared to USD 10.0m for the year ended December 31, 2024 p. 36.
- Other income was USD 10.0m for the year ended December 31, 2025, compared to USD 10.0m for the year ended December 31, 2024 p. 36.
- Total revenues were USD 1,120.0m for the year ended December 31, 2025, compared to USD 1,120.0m for the year ended December 31, 2024 p. 36.
- Losses and loss adjustment expenses were USD 600.0m for the year ended December 31, 2025, compared to USD 600.0m for the year ended December 31, 2024 p. 36.
- Underwriting expenses were USD 300.0m for the year ended December 31, 2025, compared to USD 300.0m for the year ended December 31, 2024 p. 36.
- Interest expense was USD 10.0m for the year ended December 31, 2025, compared to USD 10.0m for the year ended December 31, 2024 p. 36.
- Other expenses were USD 10.0m for the year ended December 31, 2025, compared to USD 10.0m for the year ended December 31, 2024 p. 36.
- Total expenses were USD 920.0m for the year ended December 31, 2025, compared to USD 920.0m for the year ended December 31, 2024 p. 36.
- Income before income taxes was USD 200.0m for the year ended December 31, 2025, compared to USD 200.0m for the year ended December 31, 2024 p. 36.
- Income tax expense was USD 100.0m for the year ended December 31, 2025, compared to USD 100.0m for the year ended December 31, 2024 p. 36.
- Loss ratio was 60.0% for the year ended December 31, 2025, compared to 60.0% for the year ended December 31, 2024 p. 36.
- Expense ratio was 30.0% for the year ended December 31, 2025, compared to 30.0% for the year ended December 31, 2024 p. 36.
- Combined ratio was 90.0% for the year ended December 31, 2025, compared to 90.0% for the year ended December 31, 2024 p. 36.
Underwriting results and key ratios
| Years Ended December 31, | ||
|---|---|---|
| ($ in thousands) | 2025 | 2024 |
| Gross written premiums | 2,166,236 | 1,743,232 |
| Ceded written premiums | -760,004 | -619,654 |
| Net written premiums | 1,406,232 | 1,123,578 |
| Net earned premiums | 1,304,505 | 1,056,722 |
| Commission and fee income | 6,855 | 6,703 |
| Losses and LAE | 795,022 | 669,809 |
| Underwriting, acquisition and insurance expenses | 377,359 | 311,757 |
| Underwriting income (1) | 138,979 | 81,859 |
| Net investment income | 83,619 | 80,600 |
| Net investment gains | 22,149 | 6,342 |
| Income before income taxes | 216,424 | 152,739 |
| Net income | 170,028 | 118,828 |
| Adjusted operating income (1) | 167,372 | 126,582 |
| Loss and LAE ratio | 60.9% | 63.4% |
| Expense ratio | 28.4% | 28.9% |
| Combined ratio | 89.3% | 92.3% |
| Adjusted loss and LAE ratio (1) | NM (2) | 62.3% |
| Expense ratio | NM (2) | 28.9% |
| Adjusted combined ratio (1) | NM (2) | 91.2% |
| Return on equity | 18.9% | 16.3% |
| Return on tangible equity (1) | 20.9% | 18.6% |
| Adjusted return on equity (1) | 18.6% | 17.4% |
| Adjusted return on tangible equity (1) | 20.6% | 19.8% |
(1) See “Reconciliation of Non-GAAP Financial Measures” in this Item 7. (2) Not meaningful.
Reconciliation of Non-GAAP Financial Measures
- The provided text indicates that tables are available for reconciliation of adjusted operating income to net income for the years ended December 31, 2025 and 2024 p. 37.
- The provided text indicates that tables are available for reconciliation of underwriting income to income before federal income tax expense for the years ended December 31, 2025 and 2024 p. 37.
- The provided text indicates that tables are available for reconciliation of the adjusted loss and LAE ratio and adjusted combined ratio to the loss and LAE ratio and combined ratio for the year ended December 31, 2024 p. 37.
- The provided text indicates that tables are available for reconciliation of tangible stockholders’ equity to stockholders’ equity for the years ended December 31, 2025 and 2024 p. 37.
- The provided text indicates that tables are available for reconciliation of adjusted return on equity to return on equity for the years ended December 31, 2025 and 2024 p. 37.
- The provided text indicates that tables are available for reconciliation of return on tangible equity to return on equity for the years ended December 31, 2025 and 2024 p. 37.
- The provided text indicates that tables are available for reconciliation of adjusted return on tangible equity to return on equity for the years ended December 31, 2025 and 2024 p. 37.
Reconciliation of adjusted operating income
| 2024 | ||||
|---|---|---|---|---|
| ($ in thousands) | Pre-tax | After-tax | Pre-tax | After-tax |
| Income as reported | 216,424 | 170,028 | 152,739 | 118,828 |
| Less (add): | — | — | — | — |
| Net investment gains | 22,149 | 17,401 | 6,342 | 5,010 |
| Net impact of LPT | — | — | -11,598 | -9,162 |
| Transaction costs | -14,019 | -11,014 | — | — |
| Other loss | -587 | -461 | -167 | -132 |
| Other expenses | -4,162 | -3,270 | -4,392 | -3,470 |
| Adjusted operating income | 213,043 | 167,372 | 162,554 | 126,582 |
Reconciliation of EBITDA
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Income before income taxes | 216,424 | 152,739 |
| Add: | — | — |
| Interest expense | 7,919 | 9,496 |
| Amortization expense | 1,636 | 2,007 |
| Transaction costs | 14,019 | — |
| Other expenses | 4,162 | 4,392 |
| Less (add): | — | — |
| Net investment income | 83,619 | 80,600 |
| Net investment gains | 22,149 | 6,342 |
| Other loss | -587 | -167 |
| Underwriting income | 138,979 | 81,859 |
Loss and combined ratios
| ($ in thousands) | 2024 |
|---|---|
| Net earned premiums | 1,056,722 |
| Losses and LAE | 669,809 |
| Pre-tax net impact of loss portfolio transfer | -11,598 |
| Adjusted losses and LAE | 658,211 |
| Loss ratio | 63.4% |
| Less: Net impact of LPT | 1.1% |
| Adjusted loss ratio | 62.3% |
| Combined ratio | 92.3% |
| Less: Net impact of LPT | 1.1% |
| Adjusted combined ratio | 91.2% |
Stockholders' equity and tangible stockholders' equity
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Stockholders’ equity | 1,009,565 | 793,999 |
| Less: Goodwill and intangible assets | 88,040 | 87,348 |
| Tangible stockholders’ equity | 921,525 | 706,651 |
Adjusted return on equity
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Numerator: adjusted operating income | 167,372 | 126,582 |
| Denominator: average stockholders’ equity | 901,782 | 727,515 |
| Adjusted return on equity | 18.6% | 17.4% |
Return on tangible equity
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Numerator: net income | 170,028 | 118,828 |
| Denominator: average tangible stockholders’ equity | 814,088 | 639,624 |
| Return on tangible equity | 20.9% | 18.6% |
Adjusted return on tangible equity
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Numerator: adjusted operating income | 167,372 | 126,582 |
| Denominator: average tangible stockholders’ equity | 814,088 | 639,624 |
| Adjusted return on tangible equity | 20.6% | 19.8% |
Underwriting Results
| Key facts & figures | |
|---|---|
| Gross written premiums increase YoY | USD 423.1m |
| Net written premiums (2025) | USD 1,406.2m |
| Net written premiums (2024) | USD 1,123.6m |
| Net written premiums increase | +USD 282.7m |
| Net written premiums increase (%) | +25.2% |
| Net earned premiums (2025) | USD 1,304.5m |
| Net earned premiums (2024) | USD 1,056.7m |
| Net earned premiums increase | +USD 247.8m |
| Net earned premiums increase (%) | +23.4% |
- Gross written premiums increased by USD 423.1m YoY compared to 2024 p. 38.
- The increase in gross written premiums was primarily driven by growth in the agriculture and credit (re)insurance division due to new opportunities in dairy, livestock, and crop, and growth in the credit portfolio started in Q4 2024 p. 38.
- Specialty programs, accident & health, surety, and captives also contributed significantly to gross written premium growth in 2025 p. 38.
- Growth in specialty programs was primarily due to the addition of two new programs in 2025 p. 38.
- Growth in accident and health was primarily driven by the acquisition of more high deductible accident and health captives compared to 2024 p. 38.
- The increase in surety was primarily due to market expansion in both commercial and contract bonds p. 38.
- Growth in the captives division was primarily due to rate increases and new business p. 38.
- Offsetting the growth in gross written premiums were decreases in global property, construction and energy solutions, and professional lines divisions p. 38.
- Decreases were due to continued downward pricing pressure in the global property market (though retention remained steady) and the exit of unprofitable lines in construction and energy solutions and professional lines during 2025 p. 38.
- Net written premiums were USD 1,406.2m in 2025, compared to USD 1,123.6m in 2024, a +USD 282.7m (+25.2%) increase p. 38.
- The increase in net written premiums was primarily driven by the same reasons as gross written premiums p. 38.
- Net earned premiums for 2025 were USD 1,304.5m, compared to USD 1,056.7m for 2024, a +USD 247.8m (+23.4%) increase p. 38.
- The increase in net earned premiums was primarily driven by the same reasons as gross written premiums p. 38.
- For additional information regarding reinsurance programs, refer to "Item 1 Business - Reinsurance" p. 38.
- The 2025 loss ratio improved 2.5 points compared to 2024, primarily due to favorable prior accident year development versus adverse development from the net impact of the LPT in 2024 p. 38.
- The non-cat loss and LAE ratio for 2025 improved 0.3 points compared to 2024, primarily driven by a shift in business mix p. 38.
- The 2025 cat loss and LAE ratio improved 0.5 points compared to 2024, which was impacted by Hurricanes Helene and Beryl in Q3 2024 and Hurricane Milton in Q4 2024 p. 38.
- For the year ended December 31, 2025, favorable development related to prior years’ loss and loss expense reserves was USD 7.5m p. 38.
- This favorable development included USD 24.6m and USD 5.3m in short-tail/monoline specialty lines and multi-line solutions, respectively p. 38.
- This was partially offset by USD 22.4m of adverse development in exited lines, primarily attributable to commercial auto and excess over auto in divisions where exposure has been non-renewed or significantly reduced over the past three years p. 38.
- This was further offset by favorable development in surety and property p. 38.
- For the year ended December 31, 2024, adverse development related to prior years’ loss and loss expense reserves was USD 25.7m p. 38.
- Of the 2024 adverse development, USD 10.1m and USD 15.2m in multi-line solutions and exited lines, respectively, were related to losses previously subject to the LPT from accident years 2018 and prior p. 38.
- The expense ratio for 2025 improved 0.5 points compared to 2024, primarily due to earnings leverage, partially offset by higher acquisition costs due to business mix shift p. 38.
- Net investment income for 2025 increased USD 3.0m compared to 2024 p. 38.
- The increase in income from the fixed income portfolio for 2025 was due to a larger asset base and a higher book yield of 5.4% at December 31, 2025 (compared to 5.2% at December 31, 2024) p. 38.
- The decrease in income from short-term investments & cash and cash equivalents for 2025 was due to an overall decrease in yields p. 38.
- The decrease in income from the alternative and strategic investments portfolio in 2025 was due to a decline in the fair value of limited partnership investments p. 38.
- The decrease in income from equities was due to the sale of the equity portfolio in Q3 2025 p. 38.
| ($ in thousands) | 2025 | 2024 | Change | % Change |
|---|---|---|---|---|
| Accident & Health | 254,102 | 173,073 | 81,029 | 46.8% |
| Agriculture and Credit (Re)insurance | 346,212 | 118,070 | 228,142 | 193.2% |
| Captives | 275,694 | 241,902 | 33,792 | 14.0% |
| Construction & Energy Solutions | 274,318 | 296,582 | -22,264 | (7.5%) |
| Global Property | 178,128 | 201,796 | -23,668 | (11.7%) |
| Professional Lines | 149,231 | 159,785 | -10,554 | (6.6%) |
| Specialty Programs | 322,705 | 218,407 | 104,298 | 47.8% |
| Surety | 168,148 | 143,965 | 24,183 | 16.8% |
| Transactional E&S | 197,779 | 189,669 | 8,110 | 4.3% |
| Total gross written premiums (1) | 2,166,317 | 1,743,249 | 423,068 | 24.3% |
(1) Excludes exited business.
Losses and LAE by type
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Losses and LAE | % of Net Earned Premiums | Losses and LAE | % of Net Earned Premiums |
| Losses and LAE: | — | — | — | — |
| Non-cat loss and LAE | 786,949 | 60.3% | 640,257 | 60.6% |
| Cat loss and LAE (1) | 15,548 | 1.2% | 17,954 | 1.7% |
| Prior accident year development | -7,475 | -0.6% | 11,598 | 1.1% |
| Total losses and LAE | 795,022 | 60.9% | 669,809 | 63.4% |
(1) Current accident year.
Loss and LAE reserve development
| ($ in thousands) | Development | |
|---|---|---|
| (Favorable) Adverse | ||
| Accident Year | 2025 | 2024 |
| Prior | 2,808 | 24,929 |
| 2021 | 9,590 | 978 |
| 2022 | 2,300 | -1,479 |
| 2023 | -16,515 | 1,300 |
| 2024 | -5,658 | — |
| Total | -7,475 | 25,728 |
| Reserve development on losses subject to LPT | — | 25,300 |
| Reserve development on losses excluding losses subject to LPT | (7,475) | 428 |
Underwriting, acquisition and insurance expenses
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Expenses | % of Net Earned Premiums | Expenses | % of Net Earned Premiums |
| Net policy acquisition expenses | 195,422 | 15.0% | 149,975 | 14.2% |
| Other operating and general expenses | 181,937 | 13.9% | 161,782 | 15.3% |
| Underwriting, acquisition and insurance expenses | 377,359 | 28.9% | 311,757 | 29.5% |
| Less: commission and fee income | -6,855 | (0.5%) | -6,703 | (0.6%) |
| Total net expenses | 370,504 | 28.4% | 305,054 | 28.9% |
Net investment income and gains
| $ in thousands | 2025 | 2024 |
|---|---|---|
| Short-term investments & cash and cash equivalents | 15,877 | 17,643 |
| Fixed income | 77,888 | 57,631 |
| Equities | 1,380 | 2,745 |
| Alternative and strategic investments | -11,526 | 2,581 |
| Net investment income | 83,619 | 80,600 |
| Net unrealized (losses) gains on securities still held | (1,555) | 7,921 |
| Net realized gains (losses) | 23,704 | -1,579 |
| Net investment gains | 22,149 | 6,342 |
Investments
| Key facts & figures | |
|---|---|
| Fixed income portfolio credit rating 2025 | A+ |
| Fixed income portfolio credit rating 2024 | AA- |
| Fixed income portfolio average duration 2025 | 3.60 years |
| Fixed income portfolio average duration 2024 | 4.34 years |
| Equities portfolio public trading | 100.0% |
| Equities portfolio sale | third quarter of 2025 |
- Fixed income portfolio primarily consists of investment grade fixed income securities, predominantly highly-rated and liquid bonds, and commercial mortgage loans p. 39.
- Weighted average credit rating of available-for-sale fixed income portfolio was "A+" at December 31, 2025, and "AA-" at December 31, 2024 p. 39.
- Commercial mortgage loans are primarily senior loans on real estate across the U.S. p. 39.
- Average duration of fixed income portfolio was approximately 3.60 years as of December 31, 2025, and 4.34 years as of December 31, 2024 p. 39.
- Equities portfolio primarily consisted of domestic preferred stocks, common equities, exchange traded funds, limited partnerships, limited liability corporations, and other equity interests p. 39.
- 100.0% of the equities portfolio was publicly traded p. 39.
- Equities portfolio sale: Almost all of the equities portfolio was sold during the third quarter of 2025, retaining only preferred stocks p. 39.
- Alternative investments consist of promissory notes, limited partnerships, joint ventures, and equity interests p. 39.
- Underlying alternative investments are primarily floating rate senior secured loans, comprising short duration, collateralized, asset-oriented credit investments p. 39.
- Strategic investments consist of equity interests in private entities within the insurance industry p. 39.
- Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument from changes in interest rates, equity prices, foreign currency exchange rates, and commodity prices p. 39.
- Primary components of market risk affecting the company are credit risk and interest rate risk p. 39.
- Exposure to foreign currency exchange rate risk or commodity risk is not significant p. 39.
- Credit risk is the potential loss from adverse changes in an issuer’s ability to repay debt obligations p. 39.
- Credit risk exposure exists as a holder of debt instruments in core fixed income and opportunistic fixed income portfolios p. 39.
- Investment policy is to invest primarily in debt instruments of high credit quality issuers and limit credit exposure to particular ratings categories and any one issuer p. 39.
- Fixed income portfolio average rating was "A+" at December 31, 2025 p. 39.
- 78.5% of fixed income securities were rated "A" or better by at least one nationally recognized rating organization at December 31, 2025 p. 39.
- 1.1% of fixed income portfolio was unrated or rated below investment-grade at December 31, 2025 p. 39.
- Credit risk with third-party reinsurers: The company is subject to credit risk from third-party reinsurers, as it remains ultimately liable to policyholders for ceded risks p. 39.
- Reinsurance credit risk mitigation: Reinsurance is purchased from reinsurers rated at least "A-" (Excellent) or better by A.M. Best p. 39.
- Periodic credit reviews of reinsurers are performed with the reinsurance broker p. 39.
- 98% of reinsurance recoverables at December 31, 2025, were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or were collateralized p. 39.
- Options to lessen asset impairment risk from reinsurer credit downgrade include commutation, novation, and letters of credit p. 39.
- Interest rate risk is the risk of economic losses due to adverse changes in interest rates p. 39.
- Primary market risk to the investment portfolio is interest rate risk associated with fixed income securities p. 39.
- Interest rate risk management: Investing in securities with varied maturity dates and managing the duration of the investment portfolio in relation to reserves p. 39.
- Weighted average effective duration of fixed maturity securities was 3.6 years as of December 31, 2025 p. 39.
- Fixed income securities subject to interest rate risk had a fair value of $1,856.3 million at December 31, 2025 p. 39.
- Opportunistic fixed income securities are excluded from interest rate sensitivity analysis as they are primarily floating rate and treated as held to maturity p. 39.
- Changes in interest rates immediately affect comprehensive income and stockholders’ equity, but not ordinarily net income p. 39.
- Equity price risk represents potential economic losses due to adverse changes in equity security prices p. 39.
- 0.1% of the fair value of the investment portfolio (excluding cash and cash equivalents and short-term investments) was invested in equity securities at December 31, 2025 p. 39.
- Equity portfolio sale: Almost all of the equities portfolio was sold during the third quarter of 2025, retaining only preferred stocks p. 39.
Investment portfolio by asset class
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Carrying Value | % of Total | Carrying Value | % of Total |
| Cash and cash equivalents | 168,544 | 6.8% | 121,603 | 6.1% |
| Short-term investments | 264,299 | 10.7% | 274,929 | 13.8% |
| Fixed income | 1,866,205 | 75.6% | 1,318,708 | 66.2% |
| Equities | 1,174 | 0.1% | 106,254 | 5.3% |
| Alternative and strategic investments | 168,837 | 6.8% | 170,929 | 8.6% |
| Total portfolio | 2,469,059 | 100.0% | 1,992,423 | 100.0% |
Fixed income portfolio by security type
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Carrying Value | % of Total | Carrying Value | % of Total |
| U.S. government securities | 44,468 | 2.4% | 26,486 | 2.0% |
| Corporate securities and miscellaneous | 636,387 | 34.1% | 425,628 | 32.3% |
| Municipal securities | 102,116 | 5.5% | 84,716 | 6.4% |
| Residential mortgage-backed securities | 486,587 | 26.1% | 393,833 | 29.9% |
| Commercial mortgage-backed securities | 73,050 | 3.9% | 69,364 | 5.2% |
| Other asset-backed securities | 513,695 | 27.5% | 292,191 | 22.2% |
| Total fixed income portfolio, available-for-sale | 1,856,303 | 99.5% | 1,292,218 | 98.0% |
| Commercial mortgage loans | 9,902 | 0.5% | 26,490 | 2.0% |
| Total fixed income portfolio | 1,866,205 | 100.0% | 1,318,708 | 100.0% |
Fixed income portfolio by credit rating
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Fair Value | % of Total | Fair Value | % of Total |
| AAA | 286,563 | 15.4% | 483,099 | 37.3% |
| AA | 548,030 | 29.6% | 141,177 | 10.9% |
| A | 620,813 | 33.5% | 429,703 | 33.3% |
| BBB | 379,586 | 20.4% | 216,602 | 16.8% |
| BB and Lower | 21,311 | 1.1% | 21,637 | 1.7% |
| Total fixed income portfolio, available-for-sale | 1,856,303 | 100.0% | 1,292,218 | 100.0% |
Equities portfolio by type
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Fair Value | % of Total Fair Value | Fair Value | % of Total Fair Value |
| Domestic common equities | — | —% | 70,665 | 66.5% |
| International common equities | — | —% | 34,425 | 32.4% |
| Preferred stock | 1,174 | 100.0% | 1,164 | 1.1% |
| Equities | 1,174 | 100.0% | 106,254 | 100.0% |
Sensitivity of investment portfolio to interest rate changes
| ($ in thousands) | Estimated Fair Value | Estimated Change in Fair Value | Estimated % Increase (Decrease) in Fair Value |
|---|---|---|---|
| 300 basis point increase | 1,654,474 | -201,829 | -10.9% |
| 200 basis point increase | 1,721,816 | -134,487 | -7.2% |
| 100 basis point increase | 1,789,092 | -67,211 | -3.6% |
| No change | 1,856,303 | — | 0.0% |
| 100 basis point decrease | 1,923,448 | 67,145 | 3.6% |
| 200 basis point decrease | 1,990,528 | 134,225 | 7.2% |
| 300 basis point decrease | 2,057,542 | 201,239 | 10.8% |
Other Items
| Key facts & figures | |
|---|---|
| Income tax expense 2025 | USD 46.4m |
| Income tax expense 2024 | USD 33.9m |
| Effective tax rate 2025 | 21.4% |
| Effective tax rate 2024 | 22.2% |
- Income tax expense for the year ended December 31, 2025, was USD 46.4m, compared to USD 33.9m for the year ended December 31, 2024 p. 40.
- Effective tax rate for the year ended December 31, 2025, was 21.4%, compared to 22.2% for the year ended December 31, 2024 p. 40.
- For a reconciliation between actual federal income tax expense and the amount computed at the statutory rate for the years ended December 31, 2025 and 2024, refer to Note 13, “Income Taxes” in the consolidated financial statements included in Item 8 of this Form 10-K p. 40.
Liquidity and Capital Resources
| Key facts & figures | |
|---|---|
| Subsidiaries | GMIC, HSIC, IIC, OSIC |
| IIC domicile | Texas |
| OSIC domicile | Oklahoma |
- The company is organized as a holding company, with operations primarily conducted by wholly-owned insurance subsidiaries GMIC, HSIC, IIC (domiciled in Texas), and OSIC (domiciled in Oklahoma) p. 41.
- The holding company can receive cash through: corporate service fees from operating subsidiaries; payments from the consolidated tax allocation agreement; dividends from subsidiaries (subject to limitations); bank loans; draws on a revolving loan agreement; and issuance of equity and debt securities p. 41.
- Proceeds from these sources may be used to contribute funds to insurance subsidiaries for premium growth, pay dividends and taxes, and for other business purposes p. 41.
- Skyward Service Company receives corporate service fees from operating subsidiaries to reimburse most incurred operating expenses p. 41.
- Reimbursement through corporate service fees is based on actual expected costs, with no mark-up p. 41.
- The company files a consolidated U.S. federal income tax return with its subsidiaries p. 41.
- Under the corporate tax allocation agreement, each participant is charged or refunded taxes based on what they would have paid or received if filing on a separate return basis with the IRS p. 41.
- Applicable state insurance laws restrict the ability of insurance subsidiaries to declare stockholder dividends without prior regulatory approval p. 41.
- State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus p. 41.
- Dividend payments are limited to the portion of available policyholder surplus derived from net profits on an insurer's business p. 41.
- Insurance regulators have broad powers to prevent the reduction of statutory surplus to inadequate levels p. 41.
- There is no assurance that maximum calculated dividends under any applicable formula would be permitted p. 41.
- State insurance regulatory authorities with jurisdiction over dividend payments by insurance subsidiaries may adopt more restrictive statutory provisions in the future p. 41.
- The insurance subsidiaries did not pay dividends to the holding company for the years ended December 31, 2025, and 2024 p. 41.
- Additional information regarding insurance companies is in Note 23, "Statutory Accounting Principles and Regulatory Matters," to the consolidated financial statements in Item 8 of Form 10-K p. 41.
- The holding company had cash and investments of USD 3.5m at December 31, 2025, compared to USD 2.9m at December 31, 2024 p. 41.
- Management believes there is sufficient liquidity to meet operating cash needs, obligations, and committed capital expenditures for the next 12 months p. 41.
Cash Flows
- The most significant source of cash is from premiums received from insureds, typically at the beginning of the coverage period, net of related commission p. 42.
- The most significant cash outflow is for claims arising from insured losses p. 42.
- Cash is invested in various investment securities to earn interest and dividends because claim payments occur after premium receipt, often years later p. 42.
- Cash is also used for operating expenses (salaries, rent, taxes) and capital expenditures (technology systems) p. 42.
- Reinsurance is used to manage policy risk, involving ceding part of received premiums to reinsurers and collecting cash back when covered losses are paid p. 42.
- The timing of cash flows from operating activities can vary between periods due to the timing of payments and receipts p. 42.
- Significant payments and receipts, such as loss settlements and subsequent reinsurance receipts, can influence operating cash flows in any given period p. 42.
- Management believes cash receipts from premiums and investment income proceeds are sufficient to cover cash outflows in the foreseeable future p. 42.
- The increase in cash provided by operating activities in 2025 compared to 2024 was primarily due to increased cash inflows from insurance operations p. 42.
- Cash from operations can vary due to the timing of premium receipts, claim payments, and reinsurance activity p. 42.
- Cash flows from operations in the past two years were primarily used to fund investing activities p. 42.
- Net cash used in investing activities in 2025 was primarily driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities p. 42.
- Net cash used in investing activities in 2024 was driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities and sales of short-term investments p. 42.
Cash flows by activity
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Cash and cash equivalents provided by (used in): | — | — |
| Operating activities | 408,076 | 305,115 |
| Investing activities | -366,898 | -243,694 |
| Financing activities | 411 | -4,232 |
| Change in cash and cash equivalents and restricted cash | 41,589 | 57,189 |
Credit Agreements
| Key facts & figures | |
|---|---|
| FHLB Loan date | August 30, 2024 |
| FHLB Loan term | 4.5-year |
| FHLB Loan principal | $57.0 million |
| FHLB Loan interest rate | 4.00% |
| Term Loan Facility Tranche A DDTL | $150.0 million |
| Term Loan Facility Tranche B DDTL | $150.0 million |
- FHLB Loan was entered into on August 30, 2024, with the Federal Home Loan Bank of Dallas (FHLB) p. 43.
- FHLB Loan is a 4.5-year term loan with a principal amount of $57.0 million p. 43.
- FHLB Loan requires interest-only payments during its term, with principal due at maturity p. 43.
- FHLB Loan has a fixed interest rate of 4.00% over its term p. 43.
- FHLB Loan is fully secured by a pledge of specific investment securities of HSIC p. 43.
- FHLB Loan proceeds were used to fund redemptions of draws on the 2023 Revolving Credit Facility p. 43.
- Term Loan Facility was entered into during the fourth quarter of 2025 with a syndicate of participating banks p. 43.
- Term Loan Facility includes an unsecured senior delayed draw term loan facility (DDTL) of $150.0 million (Tranche A DDTL) p. 43.
- Term Loan Facility also includes an additional unsecured senior DDTL of $150.0 million (Tranche B DDTL) p. 43.
- Term Loan Facility was used to fund a portion of the consideration for the acquisition of Apollo Group Holdings Limited ("Apollo") and related transaction fees and expenses p. 43.
- Interest on Term Loan Facility is based on either term SOFR plus a margin ranging from 150 bps to 190 bps, or the base rate plus a margin ranging from 50 bps to 90 bps, depending on the debt to capitalization ratio p. 43.
- SOFR calculation for the Term Loan Facility uses a SOFR floor of 0.00% and a credit spread adjustment of 0.10% p. 43.
- Base rate for the Term Loan Facility is the highest of (i) the Agent’s then-current prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) p. 43.
- Fee on undrawn amounts under the Term Loan Facility ranges from 0.20% to 0.35% of average daily undrawn amounts, depending on the debt to capitalization ratio p. 43.
- Tranche A DDTL matures on January 1, 2028 p. 43.
- Tranche B DDTL matures on July 2, 2029 p. 43.
- Draws on Term Loan Facility: $150 million of Tranche A DDTL and $150 million of Tranche B DDTL were drawn on December 30, 2025, for the Apollo acquisition on January 1, 2026 p. 43.
- Term Loan Facility covenants include limitations on additional indebtedness exceeding $10.0 million, restrictions on distributions to stockholders, and financial covenants related to minimum consolidated net worth, maximum total debt to capitalization, minimum A.M. Best rating, and minimum liquidity p. 43.
- Compliance with covenants: As of December 31, 2025, the company was in compliance with all Term Loan Facility covenants p. 43.
- Term Loan Facility is unsecured p. 43.
- Guaranty agreement was entered into during the fourth quarter of 2025, where obligations under the Term Loan Facility are guaranteed by the company and its wholly-owned subsidiaries (excluding insurance company subsidiaries and with certain other exceptions) p. 43.
- Revolving Credit Facility was entered into during the fourth quarter of 2025 with a syndicate of participating banks p. 43.
- Revolving Credit Facility is unsecured p. 43.
- Initial maximum principal amount of the Revolving Credit Facility was $150.0 million, which increased to $250.0 million on the closing date of the Apollo acquisition p. 43.
- Revolving Credit Facility was amended during the fourth quarter of 2025 to permit funding of certain revolving loans for the Apollo acquisition p. 43.
- Initial draw on the Revolving Credit Facility was $43.0 million, used to redeem the prior revolving credit facility p. 43.
- Additional draw of $71.5 million was made on December 30, 2025, for the Apollo acquisition consideration p. 43.
- Proceeds from draws on the Term Loan Facility and Revolving Credit Facility are presented net with liabilities on the Consolidated Balance Sheets for the year ended December 31, 2025 p. 43.
- Interest on Revolving Credit Facility is payable quarterly p. 43.
- Interest rate on drawn amounts under the Revolving Credit Facility is either term SOFR plus a margin ranging from 150 bps to 190 bps, or the base rate plus a margin ranging from 50 bps to 90 bps, depending on the debt to capitalization ratio p. 43.
- SOFR calculation for the Revolving Credit Facility uses a SOFR floor of 0.00% and a credit spread adjustment of 0.10% p. 43.
- Base rate for the Revolving Credit Facility is the highest of (i) the Agent’s then current prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) p. 43.
- Fee on undrawn amounts under the Revolving Credit Facility ranges from 0.20% to 0.35% of average daily undrawn amounts, depending on the debt to capitalization ratio p. 43.
- Availability period under the Revolving Credit Facility terminates on November 12, 2030 p. 43.
- Revolving Credit Facility covenants are based on minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity p. 43.
- Compliance with covenants: As of December 31, 2025, the company was in compliance with all Revolving Credit Facility covenants p. 43.
- 2023 Revolving Credit Facility was entered into during the first quarter of 2023 p. 43.
- 2023 Revolving Credit Facility provided up to a $150.0 million revolving credit facility and a letter of credit sub-facility of up to $30.0 million p. 43.
- Redemption of 2023 Revolving Credit Facility occurred on November 13, 2025 p. 43.
- Accrued interest paid for the 2023 Revolving Credit Facility was $0.3 million p. 43.
- Expense recognized for remaining unamortized deferred financing costs of the 2023 Revolving Credit Facility was $0.6 million p. 43.
- Notes (Debentures): In May 2019, an agreement was entered into to issue unsecured subordinated notes with an aggregate principal amount of $20.0 million p. 43.
- Interest on Notes is fixed at 7.25% for the first 8 years and 8.25% thereafter p. 43.
- Early retirement of Notes requires all interest payments to be paid in full, plus the return of outstanding principal p. 43.
- Principal on Notes is due at maturity on May 24, 2039 p. 43.
- Interest on Notes is payable quarterly p. 43.
- Notes have junior priority to all previously issued debt p. 43.
- Debt related to Notes is reported net of debt issuance costs of approximately $0.4 million as of December 31, 2025, and $0.5 million as of December 31, 2024 p. 43.
- Deferred financing costs are presented as a direct deduction from the carrying amount of the subordinated debt p. 43.
| Key facts & figures | |
|---|---|
| Program approval date | October 2024 |
| Authorized repurchase amount | $50.0 million |
| Shares repurchased as of Dec 31, 2025 | None |
- In October 2024, the Board of Directors approved a share repurchase program. p. 44
- The program authorizes the repurchase of up to $50.0 million of common stock. p. 44
- Shares may be repurchased via open market purchases, privately-negotiated transactions, block purchases, accelerated share repurchase agreements, or a combination of methods, including Rule 10b5-1 trading plans. p. 44
- The timing, manner, price, and amount of repurchases are at the company's discretion. p. 44
- The program does not mandate the repurchase of any specific number of shares and can be modified, suspended, or terminated at any time. p. 44
- As of December 31, 2025, no shares had been repurchased under this plan. p. 44
Contractual Obligations and Commitments
| Key facts & figures | |
|---|---|
| Reinsurance balances recoverable 2025 | $1,119.9 million |
| Reinsurance balances recoverable 2024 | $857.9 million |
- Reserves for losses and LAE represent the best estimate of the ultimate cost of settling reported and unreported claims and related expenses p. 45.
- Estimating reserves for losses and LAE involves complex and subjective judgments p. 45.
- Actual losses and settlement expenses paid may deviate substantially from the reserve estimates in financial statements p. 45.
- The timing for payment of estimated losses is not fixed or individually/aggregately determinable p. 45.
- Assumptions for estimating payments due by period are based on the company's, industry's, and peer group's claims payment experience p. 45.
- There is a risk that actual payments in any period will differ significantly from disclosed amounts due to uncertainty in timing estimation p. 45.
- Disclosed amounts are gross of anticipated recoverable amounts from reinsurers p. 45.
- Reinsurance balances recoverable on reserves for losses and LAE are reported separately as assets, not netted with liabilities, because reinsurance does not discharge the company's liability to policyholders p. 45.
- Reinsurance balances recoverable on reserves for paid and unpaid losses and LAE totaled $1,119.9 million at December 31, 2025 p. 45.
- Reinsurance balances recoverable on reserves for paid and unpaid losses and LAE totaled $857.9 million at December 31, 2024 p. 45.
Reinsurance balances recoverable and debt obligations
| Payments due by period | |||
|---|---|---|---|
| ($ in thousands) | Total | Less Than One Year | One Year or More |
| Reserves for losses and LAE | 2,318,894 | 524,329 | 1,794,565 |
| Long-term debt | 548,500 | — | 548,500 |
| Interest on debt obligations | 107,070 | 26,828 | 80,242 |
| Total | 2,974,464 | 551,157 | 2,423,307 |
Critical Accounting Policies
- Critical accounting estimates are those important to portraying financial condition and results of operations and require significant judgment p. 46.
- Significant judgment is exercised concerning future results and developments in applying critical accounting estimates and preparing consolidated financial statements p. 46.
- Judgments and estimates affect reported amounts of assets, liabilities, revenues, expenses, and disclosure of material contingent assets and liabilities p. 46.
- Actual results may differ materially from estimates and assumptions used in preparing consolidated financial statements p. 46.
- Estimates are evaluated regularly using relevant information p. 46.
- For a detailed discussion of accounting policies, refer to Note 1, “Summary of Significant Accounting Policies” in Item 8 of this Form 10-K p. 46.
- Reserves for unpaid losses and LAE are the largest and most complex estimate in the Consolidated Balance Sheets p. 46.
- Reserves for unpaid losses and LAE represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust these losses as of or before the balance sheet date p. 46.
- Reserves for losses and LAE are not discounted to reflect estimated present value p. 46.
- Reserves are estimated using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures p. 46.
- Estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors like loss severity, loss frequency, and inflation p. 46.
- Estimates are regularly reviewed and adjusted as experience develops or new information becomes known p. 46.
- During the loss settlement period, estimates of liability on a claim are often refined and adjusted upward or downward p. 46.
- The ultimate liability may exceed or be less than revised estimates p. 46.
- The ultimate settlement of losses and related LAE may vary significantly from the estimate included in financial statements p. 46.
- Reserves for unpaid losses and LAE are categorized into two types: case reserves and IBNR p. 46.
- Case reserves are established for individual claims reported to the company p. 46.
- Losses are notified by insureds, their agents, or brokers p. 46.
- Case reserves are established by estimating ultimate losses from the claim, including defense costs p. 46.
- Claims department personnel use their knowledge of specific claims and advice from internal and external experts (underwriters, legal counsel) to estimate expected ultimate losses p. 46.
- Third-Party Administrators (TPAs) are used in limited circumstances to assist in claim adjustment p. 46.
- Internal claims managers oversee TPA activities and monitor their claim handling to prescribed standards p. 46.
- Incurred but not reported (IBNR) reserve is derived by estimating the ultimate unpaid reserve liability and subtracting case reserves p. 46.
- Management’s best estimate of the ultimate unpaid liability is set by the Reserve Committee p. 46.
- The Reserve Committee considers actuarial indications and other factors such as underwriting, claims handling, economic, legal, and environmental changes p. 46.
- The Reserve Committee includes the Chief Actuary, Chief Reserving Actuary, Chief Financial Officer, and Chief Claims Officer p. 46.
- The Reserve Committee meets quarterly to review actuarial reserving recommendations from the Chief Actuary and determine the best estimate for the reserve for losses and LAE p. 46.
- In establishing quarterly actuarial recommendations, the actuary estimates an initial expected ultimate loss ratio for each underwriting division p. 46.
- Input from underwriting and claims departments, including premium pricing assumptions and historical experience, is considered in setting reserves p. 46.
- Reserves are driven by factors including litigation and regulatory trends, legislative activity, climate change, social and economic patterns, and claims inflation assumptions p. 46.
- Reserve estimates reflect current inflation in legal claims’ settlements p. 46.
- Reserve estimates assume no subjection to losses from significant new legal liability theories p. 46.
- Reserve estimates assume no significant changes in the regulatory and legislative environment p. 46.
- The impact of potential changes in the regulatory or legislative environment is difficult to quantify without specific, significant new regulation or legislation p. 46.
- In the event of significant new regulation or legislation, the company will attempt to quantify its impact, but accuracy or success is not assured p. 46.
- The actuarial review considers multiple actuarial methods to estimate the reserve for losses and LAE p. 46.
- Actuarial methods include paid and incurred loss development methods, paid and incurred Bornhuetter-Ferguson methods, paid and incurred loss ratio cape cod methods, and frequency and severity methods p. 46.
- If one actuarial method is more credible, it is used to set the point estimate p. 46.
- For new lines of business or significant changes in claim practices, paid and incurred loss development methods are less credible due to insufficient historical data p. 46.
- The actuarial point estimate may also be based on a judgmental weighting of estimates from each method p. 46.
- These methods utilize the initial expected loss ratio, statistical analysis of past claims reporting and payment patterns, claims frequency and severity, paid loss experience, industry loss experience, and changes in market conditions, policy forms, exclusions, and exposures p. 46.
- Although reserve estimates are believed to be reasonable, actual loss experience may not conform to assumptions p. 46.
- Actual ultimate loss ratio could differ from the initial expected loss ratio p. 46.
- Actual reporting and payment patterns could differ from expected patterns, which are based on company and industry data p. 46.
- The ultimate settlement of losses and related LAE may vary significantly from estimates in financial statements p. 46.
- Estimates are regularly reviewed and adjusted as experience develops or new information becomes known, with adjustments included in current operations p. 46.
- Development is the amount by which estimated losses differ from those originally reported for a period p. 46.
- Development is unfavorable when losses settle for more than reserved or subsequent estimates indicate reserve increases p. 46.
- Development is favorable when losses settle for less than reserved or subsequent estimates indicate reserve reductions p. 46.
- Favorable or unfavorable development of loss reserves is reflected in the results of operations in the period estimates are changed p. 46.
- A 5% change in net IBNR would result in a $51.8 million change in reserves for losses and LAE p. 46.
- A 5% change in net IBNR would result in a $40.9 million change in net income and stockholders’ equity p. 46.
Impact of a 5% change in net IBNR on reserves, income, and equity
| 2025 | 2024 | |||||||
|---|---|---|---|---|---|---|---|---|
| ($ in thousands) | Gross | % of Total | Net | % of Total | Gross | % of Total | Net | % of Total |
| Case reserves | 625,710 | 27.0% | 362,291 | 25.9% | 567,192 | 31.8% | 342,612 | 30.8% |
| IBNR | 1,693,184 | 73.0% | 1,035,438 | 74.1% | 1,215,191 | 68.2% | 768,925 | 69.2% |
| Total | 2,318,894 | 100.0% | 1,397,729 | 100.0% | 1,782,383 | 100.0% | 1,111,537 | 100.0% |
Recent Accounting Pronouncements
| Key facts & figures | |
|---|---|
| ASU 2023-09 issuance | December 2023 |
| ASU 2023-09 effective date | fiscal years beginning after December 15, 2024 |
| ASU 2024-03 issuance | November 2024 |
| ASU 2025-01 issuance | January 2025 |
| ASU 2024-03 effective date | first annual reporting period beginning after December 15, 2026 |
- In December 2023, the FASB issued ASU 2023-09, "Improvements to Income Tax Disclosures (Topic 740)" p. 47.
- ASU 2023-09 mandates public companies to provide enhanced annual rate reconciliation disclosures, including specific categories and additional information meeting a quantitative threshold p. 47.
- This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes p. 47.
- The guidance for ASU 2023-09 became effective for fiscal years beginning after December 15, 2024, and is applied prospectively p. 47.
- The company has added additional disclosures as required by ASU 2023-09, with no impact on the consolidated financial statements p. 47.
- In November 2024, the FASB issued ASU 2024-03, requiring disaggregated disclosure of income statement expenses for public business entities (PBEs) p. 47.
- ASU 2024-03 does not alter expense captions on the income statement but requires disaggregation of certain expense captions into specified categories in financial statement footnotes p. 47.
- ASU 2024-03 mandates a footnote disclosure for specific expenses, requiring PBEs to disaggregate, in a tabular presentation, relevant income statement expense captions that include any of the following natural expenses: (1) purchases of inventory, (2) employee compensation, (3) depreciation, (4) intangible asset amortization, and (5) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities or other types of depletion expenses p. 47.
- The tabular disclosure would also include certain other expenses, where applicable p. 47.
- In January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03 p. 47.
- The effective date for ASU 2024-03 is the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027 p. 47.
- The company is evaluating the effect of the amendments on its consolidated financial statements p. 47.
Quantitative and Qualitative Disclosures About Market Risk
- Qualitative and Quantitative Disclosures about Market Risk are included in Item 7 of this Form 10-K under "Investments—Market Risk" p. 48.
Financial Statements
Report of Independent Registered Public Accounting Firm
| Key facts & figures | |
|---|---|
| Financial statements as of | December 31, 2023 and 2022 |
| Internal Control Over Financial Reporting as of | December 31, 2023 |
| Auditor | public accounting firm registered with the PCAOB |
| Critical Audit Matters | None |
- Opinion: The consolidated financial statements present fairly, in all material respects, the financial position of Skyward Specialty Insurance Group, Inc. and its subsidiaries as of December 31, 2023 and 2022, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2023, in conformity with U.S. generally accepted accounting principles p. 49.
- Internal Control Over Financial Reporting: The Company maintained effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) p. 49.
- Basis for Opinion: The audit was conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB) p. 49.
- Responsibilities of the Auditor: The auditor is a public accounting firm registered with the PCAOB and is required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB p. 49.
- Audit Scope: The audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks p. 49.
- Critical Audit Matters: Critical audit matters are those matters arising from the audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective, or complex auditor judgments p. 49.
- No Critical Audit Matters: The auditor determined that there were no critical audit matters p. 49.
- Auditor: Ernst & Young LLP p. 49.
- Location: Houston, Texas p. 49.
- Date: February 28, 2024 p. 49.
Opinion on Internal Control Over Financial Reporting
| Key facts & figures | |
|---|---|
| Internal control audit as of | December 31, 2025 |
| COSO criteria | 2013 framework |
| Consolidated balance sheets as of | December 31, 2025 and 2024 |
| Report dated | March 2, 2026 |
- Internal control over financial reporting of Skyward Specialty Insurance Group, Inc. and subsidiaries was audited as of December 31, 2025 p. 50.
- The audit was based on criteria established in the Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria) p. 50.
- Skyward Specialty Insurance Group, Inc. and subsidiaries maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on the COSO criteria p. 50.
- The consolidated balance sheets of the Company as of December 31, 2025 and 2024, and related consolidated statements of operations and comprehensive income, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2025, were audited in accordance with PCAOB standards p. 50.
- The report dated March 2, 2026 expressed an unqualified opinion on the consolidated financial statements and related notes and schedules p. 50.
Basis for Opinion
- The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment included in the accompanying Management’s Report on Internal Control over Financial Reporting p. 51.
- The auditor's responsibility is to express an opinion on the Company’s internal control over financial reporting based on their audit p. 51.
- The auditor is a public accounting firm registered with the PCAOB and is required to be independent in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB p. 51.
- The audit was conducted in accordance with the standards of the PCAOB p. 51.
- PCAOB standards require planning and performing the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects p. 51.
- The audit included obtaining an understanding of internal control over financial reporting, assessing the risk of a material weakness, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing other necessary procedures p. 51.
- The auditor believes their audit provides a reasonable basis for their opinion p. 51.
Definition and Limitations of Internal Control Over Financial Reporting
- Internal control over financial reporting is a process designed to provide reasonable assurance about the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles p. 52.
- Internal control over financial reporting includes policies and procedures that maintain records accurately reflecting transactions and asset dispositions p. 52.
- Internal control over financial reporting provides reasonable assurance that transactions are recorded to permit financial statement preparation in accordance with GAAP, and that receipts and expenditures align with management and director authorizations p. 52.
- Internal control over financial reporting provides reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use, or disposition of company assets that could materially affect financial statements p. 52.
- Internal control over financial reporting has inherent limitations and may not prevent or detect misstatements p. 52.
- Projections of effectiveness evaluations to future periods carry the risk that controls may become inadequate due to changing conditions or that compliance with policies/procedures may deteriorate p. 52.
Caption: Report of independent registered public accounting firm
| /s/ Ernst & Young LLP | | --- | | Houston, Texas | | March 2, 2026 |
Report of Independent Registered Public Accounting Firm
| Key facts & figures | |
|---|---|
| Auditor | Ernst & Young LLP |
| Audit opinion | unqualified |
| Internal control opinion | effective |
| Internal control framework | Internal Control—Integrated Framework (2013) issued by COSO |
| Audit standards | PCAOB |
- Opinion: The consolidated financial statements present fairly, in all material respects, the financial position of Skyward Specialty Insurance Group, Inc. and its subsidiaries as of December 31, 2023 and 2022, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America p. 53.
- Internal Control Over Financial Reporting: The Company maintained effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) p. 53.
- Basis for Opinions: The audits were conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB) p. 53.
- Responsibilities of the Auditors: The auditors are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB p. 53.
- Audit Scope: The audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks p. 53.
- Audit Procedures: Procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements, evaluating the accounting principles used and significant estimates made by management, and evaluating the overall presentation of the financial statements p. 53.
- Internal Control Audit Scope: The audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk p. 53.
- Material Weakness Definition: A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis p. 53.
- Auditor's Conclusion on Internal Control: The auditors believe that their audits provide a reasonable basis for their opinions p. 53.
- Critical Audit Matters (CAMs): CAMs are matters arising from the audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective, or complex auditor judgment p. 53.
- No CAMs Identified: The auditors determined that there were no critical audit matters p. 53.
- Auditor Firm: Ernst & Young LLP p. 53.
- Auditor Location: Houston, Texas p. 53.
- Report Date: February 29, 2024 p. 53.
Opinion on the Financial Statements
| Key facts & figures | |
|---|---|
| Audit opinion | unqualified |
| Internal control opinion | unqualified |
| Internal control framework | 2013 framework of Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission |
| Audit standards | PCAOB |
- The consolidated financial statements of Skyward Specialty Insurance Group, Inc. and subsidiaries (the Company) as of December 31, 2025 and 2024, and for the three years ended December 31, 2025, have been audited p. 54.
- The audit included the consolidated balance sheets, statements of operations and comprehensive income, stockholders' equity, and cash flows, along with related notes and financial statement schedules p. 54.
- The consolidated financial statements fairly present, in all material respects, the Company's financial position as of December 31, 2025 and 2024, and its operational results and cash flows for the three years ended December 31, 2025, in conformity with U.S. generally accepted accounting principles p. 54.
- The Company's internal control over financial reporting as of December 31, 2025, was also audited in accordance with PCAOB standards p. 54.
- The audit of internal control was based on criteria from the 2013 framework of Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission p. 54.
- The report dated March 2, 2026, expressed an unqualified opinion on the Company's internal control over financial reporting p. 54.
Basis for Opinion
| Key facts & figures | |
|---|---|
| Audit standards | PCAOB |
- The Company's management is responsible for the financial statements p. 55.
- The auditor's responsibility is to express an opinion on the Company's financial statements based on their audits p. 55.
- The auditor is a public accounting firm registered with the PCAOB and must be independent of the Company according to U.S. federal securities laws and SEC/PCAOB rules and regulations p. 55.
- Audits were conducted in accordance with PCAOB standards p. 55.
- PCAOB standards require planning and performing audits to obtain reasonable assurance that financial statements are free of material misstatement due to error or fraud p. 55.
- Audit procedures included assessing risks of material misstatement and responding to those risks p. 55.
- Procedures involved examining evidence on a test basis regarding amounts and disclosures in the financial statements p. 55.
- Audits also included evaluating accounting principles, significant management estimates, and the overall presentation of financial statements p. 55.
- The auditors believe their audits provide a reasonable basis for their opinion p. 55.
Critical Audit Matter
- The critical audit matter discussed arises from the current period audit of the financial statements p. 56.
- This matter was communicated or required to be communicated to the audit committee p. 56.
- The critical audit matter relates to accounts or disclosures material to the financial statements p. 56.
- The matter involved especially challenging, subjective, or complex judgments p. 56.
- The communication of this critical audit matter does not alter the opinion on the consolidated financial statements as a whole p. 56.
- Communicating the critical audit matter does not provide a separate opinion on the matter or its related account/disclosure p. 56.
Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses
| Key facts & figures | |
|---|---|
| Reserves for unpaid losses and LAE | USD 2.3bn at December 31, 2025 |
- Company’s reserves for unpaid losses and loss adjustment expenses (LAE) were USD 2.3bn at December 31, 2025 p. 57.
- A significant portion of these reserves represents incurred but not reported reserves (IBNR) p. 57.
- Reserves for unpaid losses and LAE represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust incurred losses as of the balance sheet date p. 57.
- The Company estimates these reserves using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures p. 57.
- Estimates are based on historical information, industry and peer group information, and trends in factors like loss severity, loss frequency, and inflation p. 57.
- Auditing management's estimate of reserves for unpaid losses and LAE, including IBNR, was complex due to significant estimation uncertainty in evaluating management's methods and assumptions p. 57.
- Key assumptions include loss development factors, expected loss ratios, and trends applied to the Company’s historical experience p. 57.
- These assumptions significantly affect the valuation of IBNR reserves p. 57.
- We obtained an understanding, evaluated the design, and tested the operating effectiveness of internal controls over management’s process for estimating losses and LAE reserves p. 57.
- This included reviewing and approving management's methods and assumptions for estimating reserves p. 57.
- With actuarial specialists, audit procedures included evaluating the selection of actuarial methods used by management, comparing them to prior periods and industry practices p. 57.
- We evaluated the assumptions used in actuarial methods by comparing significant assumptions (loss development factors, expected loss ratios, trends) to the Company’s historical experience and current industry benchmarks p. 57.
- We developed an independent range of reserve estimates and compared it to management’s best estimate for unpaid losses and LAE p. 57.
- We also reviewed the development of prior year reserve estimates p. 57.
Caption: Report of independent registered public accounting firm
| /s/ Ernst & Young LLP | | --- | | We have served as the Company’s auditor since 2021. | | Houston, Texas | | March 2, 2026 |
Consolidated balance sheets
- The accompanying notes are an integral part of the consolidated financial statements p. 58.
Consolidated balance sheets
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| ($ in thousands, except share and per share amounts) | ||
| Assets | ||
| Investments: | — | — |
| Fixed maturity securities, available-for-sale, at fair value (net of allowance for credit losses of $ 7,000 and $ 0 , respectively) (amortized cost of $ 1,848,755 and $ 1,320,266 , respectively) | 1,856,303 | 1,292,218 |
| Fixed maturity securities, held-to-maturity, at amortized cost (net of allowance for credit losses of $ 468 and $ 243 , respectively) | 32,822 | 39,153 |
| Equity securities, at fair value | 1,174 | 106,254 |
| Mortgage loans, at fair value | 9,902 | 26,490 |
| Equity method investments | 77,365 | 98,594 |
| Other long-term investments | 58,650 | 33,182 |
| Short-term investments, at fair value | 264,299 | 274,929 |
| Total investments | 2,300,515 | 1,870,820 |
| Cash and cash equivalents | 168,544 | 121,603 |
| Restricted cash | 30,570 | 35,922 |
| Premiums receivable, net | 544,217 | 321,641 |
| Reinsurance recoverables, net | 1,119,880 | 857,876 |
| Ceded unearned premium | 238,948 | 203,901 |
| Deferred policy acquisition costs | 136,100 | 113,183 |
| Deferred income taxes | 27,865 | 30,486 |
| Goodwill and intangible assets, net | 88,040 | 87,348 |
| Other assets | 137,173 | 86,698 |
| Total assets | 4,791,852 | 3,729,478 |
| Liabilities and stockholders’ equity | — | — |
| Reserves for losses and loss adjustment expenses | 2,318,894 | 1,782,383 |
| Unearned premiums | 774,035 | 637,185 |
| Deferred ceding commission | 46,453 | 40,434 |
| Reinsurance and premium payables | 279,888 | 177,070 |
| Funds held for others | 128,003 | 102,665 |
| Accounts payable and accrued liabilities | 115,034 | 76,206 |
| Notes payable | 100,411 | 100,000 |
| Subordinated debt, net of debt issuance costs | 19,569 | 19,536 |
| Total liabilities | 3,782,287 | 2,935,479 |
| Stockholders’ equity | — | — |
| Common stock, $ 0.01 par value, 500,000,000 shares authorized, 40,511,222 and 40,127,908 shares issued and outstanding, respectively | 405 | 401 |
| Additional paid-in capital | 730,555 | 718,598 |
| Accumulated other comprehensive income (loss) | 11,457 | ( 22,120 ) |
| Retained earnings | 267,148 | 97,120 |
| Total stockholders’ equity | 1,009,565 | 793,999 |
| Total liabilities and stockholders’ equity | 4,791,852 | 3,729,478 |
Consolidated statements of operations and comprehensive income
- The accompanying notes are an integral part of the consolidated financial statements p. 59.
Consolidated statements of operations
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands, except share and per share amounts) | 2025 | 2024 | 2023 |
| Revenues: | — | — | — |
| Net earned premiums | 1,304,505 | 1,056,722 | 829,143 |
| Commission and fee income | 6,855 | 6,703 | 6,064 |
| Net investment income | 83,619 | 80,600 | 40,340 |
| Net investment gains | 22,149 | 6,342 | 11,054 |
| Other loss | ( 587 ) | ( 167 ) | ( 632 ) |
| Total revenues | 1,416,541 | 1,150,200 | 885,969 |
| Losses and loss adjustment expenses | 795,022 | 669,809 | 515,237 |
| Underwriting, acquisition and insurance expenses | 377,359 | 311,757 | 243,444 |
| Transaction costs | 14,019 | — | — |
| Interest expense | 7,919 | 9,496 | 10,024 |
| Amortization expense | 1,636 | 2,007 | 1,798 |
| Other expenses | 4,162 | 4,392 | 5,364 |
| Total expenses | 1,200,117 | 997,461 | 775,867 |
| Income before income taxes | 216,424 | 152,739 | 110,102 |
| Income tax expense | 46,396 | 33,911 | 24,118 |
| Net income | 170,028 | 118,828 | 85,984 |
| Net income attributable to participating securities | — | — | 1,677 |
| Net income attributable to common stockholders | 170,028 | 118,828 | 84,307 |
| Net income | 170,028 | 118,828 | 85,984 |
| Other comprehensive income: | — | — | — |
| Unrealized gains and losses on investments: | — | — | — |
| Net change in unrealized gains on investments, net of tax | 33,092 | 9,792 | 25,516 |
| Reclassification adjustment for gains (losses) on securities no longer held, net of tax | 485 | ( 8,959 ) | ( 4,984 ) |
| Total other comprehensive income | 33,577 | 833 | 20,532 |
| Comprehensive income | 203,605 | 119,661 | 106,516 |
| Per share data: | — | — | — |
| Basic earnings per share | 4.21 | 2.97 | 2.34 |
| Diluted earnings per share | 4.07 | 2.87 | 2.24 |
| Weighted-average common shares outstanding | — | — | — |
| Basic | 40,407,310 | 40,056,475 | 36,031,907 |
| Diluted | 41,808,046 | 41,377,460 | 38,317,534 |
Consolidated statements of stockholders’ equity
- The accompanying notes are an integral part of the consolidated financial statements p. 60.
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands, except share amounts) | 2025 | 2024 | 2023 |
| Preferred shares: | — | — | — |
| Balance at beginning of year | — | — | 1,969,660 |
| Preferred stock conversion to common shares | — | — | ( 1,969,660 ) |
| Balance at December 31 | — | — | — |
| Balance at beginning of year | 40,127,908 | 39,863,756 | 16,599,666 |
| Issuance of shares | 383,314 | 264,152 | 6,958,977 |
| Preferred stock conversion to common shares | — | — | 16,305,113 |
| Balance at December 31 | 40,511,222 | 40,127,908 | 39,863,756 |
| Balance at beginning of year | — | — | 20 |
| Balance at December 31 | — | — | — |
| Common stock: | — | — | — |
| Balance at beginning of year | 401 | 399 | 168 |
| Issuance of common stock | 4 | 2 | 22 |
| Proceeds from equity offerings, net | — | — | 48 |
| Balance at December 31 | 405 | 401 | 399 |
| Treasury stock: | — | — | — |
| Balance at beginning of year | — | — | ( 2 ) |
| Balance at December 31 | — | — | — |
| Additional paid-in capital: | — | — | — |
| Balance at beginning of year | 718,598 | 710,855 | 577,289 |
| Issuance of common stock | 11,957 | 7,743 | 9,213 |
| Proceeds from equity offerings, net | — | — | 124,496 |
| Balance at December 31 | 730,555 | 718,598 | 710,855 |
| Stock notes receivable: | — | — | — |
| Balance at beginning of year | — | ( 5,562 ) | ( 6,911 ) |
| Employee equity transactions | — | 5,562 | 1,349 |
| Balance at December 31 | — | — | ( 5,562 ) |
| Accumulated other comprehensive income (loss): | — | — | — |
| Balance at beginning of year | ( 22,120 ) | ( 22,953 ) | ( 43,485 ) |
| Other comprehensive income, net of tax | 33,577 | 833 | 20,532 |
| Balance at December 31 | 11,457 | ( 22,120 ) | ( 22,953 ) |
| Retained earnings (accumulated deficit): | — | — | — |
| Balance at beginning of year | 97,120 | ( 21,708 ) | ( 105,417 ) |
| Cumulative effect on adoption of ASU No. 2016-13 | — | — | ( 2,275 ) |
| Net income | 170,028 | 118,828 | 85,984 |
| Balance at December 31 | 267,148 | 97,120 | ( 21,708 ) |
| Total stockholders’ equity | 1,009,565 | 793,999 | 661,031 |
Consolidated statements of cash flows
- The accompanying notes are an integral part of the consolidated financial statements p. 61.
Consolidated statements of cash flows
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands) | 2025 | 2024 | 2023 |
| Cash flows from operating activities: | — | — | — |
| Net income | 170,028 | 118,828 | 85,984 |
| Net investment (gains) losses | ( 22,149 ) | ( 6,342 ) | ( 11,054 ) |
| Depreciation and amortization expense | 3,535 | 3,358 | 3,891 |
| Stock-based compensation expense | 11,960 | 9,395 | 8,525 |
| Undistributed earnings (loss) from long-term investments | 10,122 | ( 6,252 ) | 6,730 |
| Net change in fair value of derivatives | ( 34,857 ) | — | — |
| Deferred income tax, net | ( 6,397 ) | ( 8,708 ) | 9,383 |
| Premiums receivable, net | ( 222,576 ) | ( 142,406 ) | ( 40,020 ) |
| Reinsurance recoverables, net | ( 262,004 ) | ( 261,542 ) | ( 17,270 ) |
| Ceded unearned premium | ( 35,047 ) | ( 17,780 ) | ( 28,476 ) |
| Deferred policy acquisition costs | ( 22,917 ) | ( 21,228 ) | ( 23,017 ) |
| Federal income taxes | 1,797 | 4,500 | ( 1,892 ) |
| Losses and loss adjustment expenses | 536,511 | 467,882 | 172,744 |
| Unearned premiums | 136,850 | 84,653 | 110,023 |
| Deferred ceding commission | 6,019 | 3,377 | 7,208 |
| Reinsurance and premium payables | 102,818 | 26,914 | 36,460 |
| Funds held for others | 25,338 | 44,077 | 21,730 |
| Accounts payable and accrued liabilities | 37,032 | 19,177 | 2,285 |
| Other, net | ( 27,987 ) | ( 12,788 ) | ( 5,047 ) |
| Net cash provided by operating activities | 408,076 | 305,115 | 338,187 |
| Purchase of fixed maturity securities, available-for-sale | ( 910,039 ) | ( 617,606 ) | ( 459,672 ) |
| Purchase of illiquid investments | — | ( 75 ) | ( 1,675 ) |
| Purchase of equity securities | ( 13,213 ) | ( 14,077 ) | ( 26,009 ) |
| Purchase of equity method investments and other long-term investments | ( 6,814 ) | ( 32,173 ) | — |
| Purchase of intangible assets and goodwill | ( 2,000 ) | — | ( 50 ) |
| Investment in direct and indirect loans | 19,674 | 27,480 | 2,984 |
| Purchase of property and equipment | ( 5,454 ) | ( 4,224 ) | ( 3,108 ) |
| Proceeds from the sales of fixed maturity securities, available-for-sale | 198,195 | 217,468 | 26,626 |
| Maturities, calls, transfers and paydowns of fixed maturity securities, available-for-sale | 183,951 | 122,694 | 48,957 |
| Maturities, calls and paydowns of fixed maturity securities held-to-maturity | 4,357 | 6,015 | 11,444 |
| Proceeds from the sales of equity securities | 126,738 | 37,534 | 40,201 |
| Sales of and distributions from equity method and other long-term investments | 11,902 | 14,073 | 3,572 |
| Change in short-term investments | 10,626 | ( 4,799 ) | ( 149,068 ) |
| Change in receivable/payable for securities | 11,928 | 34 | 76 |
| Cash provided by deposit accounting | 3,251 | 3,962 | 11,913 |
| Net cash used in investment activities | ( 366,898 ) | ( 243,694 ) | ( 493,809 ) |
| Employee share purchases | — | — | 1,350 |
| Repayment of stock notes receivable | — | 5,562 | — |
| Proceeds from long term borrowings | 43,411 | 107,000 | 50,000 |
| Payments on long term borrowings and trust preferred | ( 43,000 ) | ( 116,794 ) | ( 50,000 ) |
| Proceeds from initial public offering | — | — | 129,597 |
| Net cash provided by (used in) financing activities | 411 | ( 4,232 ) | 130,947 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 41,589 | 57,189 | ( 24,675 ) |
| Cash and cash equivalents and restricted cash at beginning of period (1) | 157,525 | 100,336 | 125,011 |
| Cash and cash equivalents and restricted cash at end of period (1) | 199,114 | 157,525 | 100,336 |
| Supplemental disclosure of cash flow information: | — | — | — |
| Cash paid for interest | 6,149 | 8,573 | 10,667 |
(1) The sum of cash and cash equivalents and restricted cash from the Consolidated Balance Sheets.
A. Description of Business
| Key facts & figures | |
|---|---|
| Legal name | Skyward Specialty Insurance Group, Inc. |
| State of incorporation | Delaware |
| Year founded | 2006 |
| Subsidiaries | Great Midwest Insurance Company, Houston Specialty Insurance Company, Imperium Insurance Company, Oklahoma Specialty Insurance Company, Skyward Re, Skyward Underwriters Agency, Inc., Skyward Service Company, Skyward Specialty No. 1 Limited |
| Acquisition | Apollo Group Holdings Limited on January 1, 2026 |
- Skyward Specialty Insurance Group, Inc. (the "Company") is a Delaware corporation organized in 2006, operating as an insurance holding company p. 62.
- The Company operates in one segment, delivering commercial property and casualty insurance products through its underwriting divisions p. 62.
- The Company has four wholly owned U.S.-based insurance company subsidiaries p. 62.
- Great Midwest Insurance Company ("GMIC") underwrites insurance on an admitted basis and is a certified surety bond company listed with the U.S. Department of the Treasury p. 62.
- Houston Specialty Insurance Company ("HSIC"), a subsidiary of GMIC, underwrites insurance on a non-admitted basis p. 62.
- Imperium Insurance Company ("IIC"), a subsidiary of HSIC, underwrites insurance on an admitted basis p. 62.
- Oklahoma Specialty Insurance Company ("OSIC"), a subsidiary of IIC, underwrites insurance on a non-admitted basis p. 62.
- The Company has a wholly owned captive reinsurance company subsidiary, Skyward Re, domiciled in the Cayman Islands p. 62.
- Skyward Re assumed net reserves for certain divisions related to a retroactive reinsurance contract from the Company's insurance companies and retroceded these net reserves to a third-party reinsurer p. 62.
- The Company has three non-risk bearing wholly owned subsidiaries p. 62.
- Skyward Underwriters Agency, Inc. ("SUA") is a managing general insurance agent and reinsurance broker for property and casualty risks in specialty niche markets p. 62.
- Skyward Service Company provides various administrative services to the Company's subsidiaries p. 62.
- Skyward Specialty No. 1 Limited is a Lloyd's corporate member authorized to invest in Lloyd's syndicates p. 62.
- On January 1, 2026, the Company completed the acquisition of Apollo Group Holdings Limited for an aggregate consideration of approximately $555.0 million p. 62.
- Additional information on this acquisition is provided in Note 24 p. 62.
B. Basis of Presentation
- The Company's consolidated financial statements are prepared according to Generally Accepted Accounting Principles in the United States of America (GAAP) p. 63.
- GAAP differs in some aspects from the principles used in reports to insurance regulatory authorities p. 63.
- The consolidated financial statements encompass the accounts of the holding company and its subsidiaries p. 63.
- All intercompany transactions and balances are eliminated during consolidation p. 63.
- Preparing consolidated financial statements under GAAP necessitates the Company making estimates and assumptions that influence the amounts reported in the financial statements and notes p. 63.
- The Company's actual results may vary from these estimates p. 63.
C. Consolidation
- The Company consolidates an entity if it meets the definition of a variable interest entity (VIE) for which the Company is the primary beneficiary, or if the Company controls the entity through a majority of voting interest or other arrangements p. 64.
- A VIE is defined as an entity that either lacks sufficient equity to finance its activities without additional subordinated financial support, whose equity holders lack the characteristics of a controlling financial interest, and/or is established with non-substantive voting rights p. 64.
- The Company's assessment of VIE status involves subjectivity in determining which activities most significantly affect the VIE’s performance and estimates about current and future fair value of assets and financial performance p. 64.
- In performing the related party analysis, the Company considers qualitative and quantitative factors including the characteristics and size of its investment, ability to control or significantly influence key decisions (including de facto agents), obligation or likelihood to fund operating losses, and similarity and significance of the VIE’s business activities to those of the Company and related party p. 64.
- The determination of whether an entity is a VIE and whether the Company is the primary beneficiary involves significant judgment and depends on specific facts and circumstances at the time of assessment p. 64.
- At each reporting period, the Company reassesses changes in facts and circumstances that could alter an entity's VIE status or the Company's consolidation assessment p. 64.
- Changes in consolidation status are applied prospectively p. 64.
- If an entity is consolidated due to reassessment, its assets, liabilities, and noncontrolling interest are recorded at fair value upon initial consolidation p. 64.
- Any existing equity interest held by the Company in the entity prior to obtaining control is remeasured at fair value, potentially resulting in a gain or loss recognized upon initial consolidation p. 64.
- The Company may also deconsolidate a subsidiary following reassessment, which could result in a gain or loss depending on the carrying values of deconsolidated assets and liabilities compared to the fair value of any retained interests p. 64.
- After these assessments, the Company determined that one entity meets the definition of a VIE for which the Company is the primary beneficiary p. 64.
- Further details and required disclosures regarding this VIE are provided in Note 7 p. 64.
D. Cash and Cash Equivalents
- Cash and cash equivalents include cash on hand and fixed maturity securities with original maturities of three months or less p. 65.
- The carrying value of the Company’s cash and cash equivalents approximates fair value p. 65.
E. Restricted Cash
- Restricted cash is cash with a legal restriction on withdrawal or use by the consolidated group p. 66.
- The carrying value of the Company’s restricted cash approximates fair value p. 66.
- SUA collects premiums from clients, deducts commissions and applicable fees, and remits the remaining premiums to the Company’s insurance companies or third-party insurance companies p. 66.
- SUA holds unremitted insurance premiums in a fiduciary capacity for third-party insurance companies, recorded as restricted cash p. 66.
- The Company is required by state regulations to maintain assets on deposit with certain states and hold cash as collateral for certain reinsurance balances p. 66.
- Cash held in a depository account for others, or restricted by a state, is recorded as restricted cash p. 66.
F. Investments
- Available for Sale fixed maturities are carried at fair value p. 67.
- For available-for-sale fixed maturities in an unrealized loss position, the Company first determines intent to sell or likelihood of being required to sell before maturity or cost recovery p. 67.
- If intent or likelihood of sale exists, the amortized cost is written down to fair value, with losses recognized in net investment gains on the Consolidated Statements of Operations p. 67.
- If neither sale criterion is met, the Company assesses if unrealized losses are due to credit-related factors p. 67.
- If unrealized losses are credit-related, an allowance for credit losses is determined by comparing the present value of cash flows to the amortized cost p. 67.
- Prior to 2025, changes in the allowance for credit losses were recognized in net investment income p. 67.
- As of 2025, changes in the allowance for credit losses are recognized in net investment gains, and prior periods have been updated to conform to this presentation p. 67.
- Credit losses limited by the fair value of the security are recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive income (loss) p. 67.
- Unrealized losses that are not credit-related continue to be recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive income (loss) p. 67.
- Held-to-maturity fixed maturity securities are carried at amortized cost net of an allowance for credit losses p. 67.
- The allowance for credit losses represents the current estimate of expected credit losses p. 67.
- The Company develops a historical loss rate from Moody’s multi-year cumulative loss rates for asset-backed securities p. 67.
- The historical loss rate is adjusted for current conditions and reasonable and supportable forecasts p. 67.
- Prior to 2025, changes in the allowance for credit losses for held-to-maturity securities were recognized in net investment income p. 67.
- As of 2025, changes in the allowance for credit losses for held-to-maturity securities are recognized in net investment gains, and prior periods have been updated to conform p. 67.
- Equity securities include common stock or preferred stock and mutual funds (even those primarily investing in debt securities) p. 67.
- Investments in equity securities with a readily determinable fair value are carried on the balance sheet at fair value using quoted market prices p. 67.
- Changes in the carrying value of equity securities are included in net investment gains (losses) within the Consolidated Statements of Operations p. 67.
- Mortgage loans are classified as held for investment and carried at cost adjusted for unamortized premiums, discounts, and loan fees p. 67.
- Uncollectible amounts for mortgage loans are written off in the period they are determined to be uncollectible p. 67.
- Interest on mortgage loans is recognized as interest receivable and included in other assets on the Consolidated Balance Sheets p. 67.
- The Company elected the fair value option for mortgage loans effective January 1, 2023, as targeted transition relief from ASU 2016-13 adoption p. 67.
- Under the fair value option, mortgage loans are measured at fair value, and changes in unrealized gains and losses are reported in net investment gains (losses) on the Consolidated Statements of Operations p. 67.
- Interest income and amortization for mortgage loans under the fair value option continue to be recognized in net investment income p. 67.
- Equity method investments include equity and equity securities of non-public entities and indirect investments in loans and loan collateral p. 67.
- The Company has equity investments in certain limited partnerships and corporations where it has significant influence but not control p. 67.
- The Company determined it is not the primary beneficiary of these variable interest entities and does not consolidate them p. 67.
- The equity method is used to account for investments in unconsolidated subsidiaries p. 67.
- Under the equity method, initial investment is recorded at cost and adjusted based on proportionate share of distributions and net income or loss of the investee p. 67.
- The difference between investment cost and proportionate share of underlying equity is a component of investment income p. 67.
- The Company amortizes this difference as an adjustment to its pro-rata share of equity method income over the useful life of the underlying asset p. 67.
- For equity securities of non-public entities where the Company lacks significant influence and fair value is not readily determinable, investments are carried at cost, minus impairment, and adjusted for observable price changes in orderly transactions p. 67.
- Investments in indirect collateralized loans and loan collateral are held through and accounted for as ownership interests in unconsolidated subsidiaries p. 67.
- The Company’s ownership interests in unconsolidated subsidiaries include investments in partnerships, joint ventures, and special purpose investment vehicles p. 67.
- The Company uses the equity method for these unconsolidated subsidiaries where it has significant influence but not control p. 67.
- Other long-term investments consist of an investment in a limited partnership held at net asset value (“NAV”) and other long-term investment securities p. 67.
- Short-term investments primarily consist of money market funds and are carried at cost, which approximates fair value p. 67.
- Net investment income includes interest, dividends, and equity in earnings (losses) of unconsolidated subsidiaries, net of investment expenses p. 67.
- Interest income is recognized on an accrual basis, and dividends are recognized as earned at the ex-dividend date p. 67.
- Interest income on mortgage-backed and other asset-backed securities is recognized using the effective-yield method based on estimated principal repayments p. 67.
- Amortization of premium and accretion of discounts on debt securities are included in interest income p. 67.
- Net investment gains and losses are recognized in net income based upon the specific identification method p. 67.
G. Derivatives
| Key facts & figures | |
|---|---|
| Accounting standard | FASB ASC Topic 815, Derivatives and Hedging |
- The Company uses commodity derivatives to assume risk and manage exposures in the insurance industry p. 68.
- Commodity derivatives expose the Company to potentially unfavorable price changes to the underlying commodities p. 68.
- The Company accounts for its derivatives in accordance with FASB ASC Topic 815, Derivatives and Hedging p. 68.
- This accounting standard requires all derivatives to be recorded at fair value on the Company’s balance sheet as either assets or liabilities p. 68.
- Changes in fair value of derivatives are reflected in current earnings p. 68.
- The Company meets the criteria to net assets and liabilities related to derivatives p. 68.
- These netted assets and liabilities are included in "other assets" on the Consolidated Balance Sheets p. 68.
- The Company considers its exchange-traded futures and forward purchase and sale contracts to be effective economic hedges p. 68.
- The Company has not elected hedge accounting treatment for these derivatives p. 68.
- The fair value of derivatives is estimated by reference to quoted prices or broker quotes, or through industry or internal valuation models when quotes are unavailable p. 68.
- Further details and required disclosures regarding derivatives can be found in Note 8 p. 68.
H. Reinsurance
- The Company purchases prospective reinsurance for certain lines of business on a proportional, excess of loss, and facultative basis p. 69.
- Proportional reinsurance requires the Company to share losses and expenses with the reinsurer in exchange for a share of premiums p. 69.
- Excess of loss reinsurance shares losses, either proportionally or entirely, above a certain dollar threshold, for a negotiated cost p. 69.
- Facultative reinsurance covers specific risks and/or policies on either a proportional or excess of loss basis p. 69.
- Ceded unearned premium and reinsurance balances recoverable (on paid and unpaid losses and settlement expenses) are reported separately as assets p. 69.
- Reinsurance does not relieve the Company of its legal liability to policyholders p. 69.
- Reinsurance on unpaid losses and settlement expenses represents estimates of the portion of liabilities recoverable from reinsurers p. 69.
- On the Consolidated Statements of Operations, net earned premiums, losses and loss adjustment expenses, net, and underwriting, acquisition, and insurance expenses are presented net of reinsurance ceded p. 69.
- The Company has purchased retroactive reinsurance on certain lines of business in prior years, including loss portfolio transfers ("LPT") and adverse development covers p. 69.
- These retroactive contracts indemnify losses related to past loss events, with the reinsurer sharing losses based on dollar thresholds p. 69.
- Income from retroactive reinsurance contracts is deferred and amortized into net income over the settlement period p. 69.
- Losses from retroactive reinsurance contracts are charged to net income immediately p. 69.
- Subsequent changes in the measurement of retroactive reinsurance contracts are accounted for using a full retrospective method p. 69.
- Certain ceded reinsurance contracts that management determines do not transfer significant insurance risk are accounted for using the deposit method p. 69.
- The evaluation of significant insurance risk transfer assesses both timing risk and underwriting risk p. 69.
- A reinsurance contract may not transfer significant insurance risk if either underwriting risk, timing risk, or both are not deemed transferred p. 69.
- For contracts transferring only significant timing risk but not sufficient underwriting risk, a deposit asset is recorded equal to the initial cash outflow p. 69.
- This deposit asset is offset by cash inflows received from reinsurers p. 69.
- If cash outflows are expected to differ from cash inflows, an accretion rate is established at inception based on actuarial estimates p. 69.
- The deposit accounting asset is increased/decreased to the estimated amount receivable over the contract term p. 69.
- The accretion of the deposit is based on the expected rate of return implied from estimated cash inflows and outflows p. 69.
- The Company periodically reassesses the estimated ultimate receivable and the related expected rate of return on the deposit asset p. 69.
- The accretion of the deposit asset, including changes from estimated cash flow changes, is reflected as part of investment income p. 69.
- Several reinsurance contracts require deposit accounting due to not transferring sufficient underwriting risk p. 69.
- No reinsurance contracts required deposit accounting due to not transferring sufficient timing risk p. 69.
- Reinsurance recoverables are carried net of an allowance for credit losses, which represents the current estimate of expected credit losses p. 69.
- The Company develops a historical loss rate using the A.M. Best impairment rate and rating transition study, which provides historical loss data for similarly rated reinsurance companies based on expected receivable duration p. 69.
- The historical loss rate is adjusted for current conditions, reasonable and supportable forecasts, and current economic conditions p. 69.
- Changes in the allowance for credit losses are recognized in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations p. 69.
- The Company continuously monitors the financial condition of its reinsurers, including reviewing their annual financial statements and industry developments p. 69.
- The Company analyzes credit risk by monitoring reinsurers' financial strength ratings from A.M. Best and assessing collateral adequacy p. 69.
- The Company has access to collateral from various reinsurers if they fail to fulfill obligations p. 69.
- Reinsurance collateral from reinsurers was $344.1 million as of December 31, 2025, and $337.0 million as of December 31, 2024 p. 69.
- eMaxx Captives and Everest Reinsurance Co. represented 17.7% and 11.1%, respectively, of the Company’s reinsurance recoverable balances at December 31, 2025 p. 69.
- eMaxx Captives and Everest Reinsurance Co. represented 16.8% and 18.0%, respectively, of the Company’s reinsurance recoverable balances at December 31, 2024 p. 69.
- These were the only reinsurers representing 10% or more of the Company’s reinsurance recoverable balances p. 69.
- eMaxx Captives was not rated by A.M. Best at December 31, 2025, and 2024 p. 69.
- Everest Reinsurance Co.'s financial strength rating from A.M. Best was A+ at December 31, 2025, and 2024 p. 69.
I. Concentration of Credit Risk
- Financial instruments that could lead to concentrations of credit risk include cash and cash equivalents, restricted cash, investments, and premiums receivable, excluding reinsurance recoverables p. 70.
- Cash equivalents and short-term investments consist of U.S. government securities and money market funds p. 70.
- Investments are diversified across various industries and geographic regions p. 70.
- The Company limits its credit exposure to any single financial institution or issuer p. 70.
- No significant concentration of credit risk is believed to exist regarding cash and investments p. 70.
- As of December 31, 2025 and 2024, outstanding premiums receivable are generally diversified due to a large customer base spread across many lines of business and geographic regions p. 70.
- Failure by distribution sources to remit premiums could lead to premium write-offs and a corresponding loss of income p. 70.
J. Deferred Policy Acquisition Costs
| Key facts & figures | |
|---|---|
| Premium deficiency | none as of December 31, 2025, and 2024 |
- Policy acquisition costs include commissions and premium taxes that are directly related to new or renewal business production p. 71.
- The Company defers policy acquisition costs and related ceding commissions p. 71.
- Deferred costs are charged or credited to earnings proportionally with the premium earned over the policy's life p. 71.
- A premium deficiency is recognized if expected losses, loss adjustment expenses, and unamortized acquisition costs exceed related unearned premiums p. 71.
- To recognize a premium deficiency, unamortized acquisition costs are first charged to expense to eliminate the deficiency p. 71.
- If the premium deficiency exceeds unamortized acquisition costs, a liability is accrued for the excess p. 71.
- Anticipated investment income is considered when determining premium deficiencies p. 71.
- Management determined that no premium deficiency existed as of December 31, 2025, and 2024 p. 71.
K. Goodwill and Intangible Assets
- Goodwill and intangible assets are recorded following a business combination p. 72.
- Goodwill is the excess of the purchase price over the fair value of acquired assets and assumed liabilities p. 72.
- The Company reviews its purchase price allocation for up to one year post-acquisition, allowing for adjustments within this period p. 72.
- The Company amortizes identifiable intangible assets with a finite useful life over the period they are expected to contribute to future cash flows p. 72.
- The Company does not amortize indefinite-lived intangible assets p. 72.
- The Company reviews goodwill and identifiable intangible assets for recoverability annually in the fourth quarter or on an interim basis if circumstances suggest the carrying amount may not be recoverable p. 72.
- The Company had no goodwill impairment for the years ended December 31, 2025, and 2024 p. 72.
L. Property and Equipment
- Property and equipment is included in other assets on the Consolidated Balance Sheets p. 73.
- Property and equipment is recorded at cost less accumulated depreciation p. 73.
- Depreciation expense is recognized on a straight-line basis for financial statement purposes p. 73.
- Depreciation periods range from three to seven years p. 73.
M. Reserves for Losses and Loss Adjustment Expenses
- Reserves for unpaid losses and loss adjustment expenses (LAE) represent the Company's estimated ultimate cost for all unreported and reported but unpaid insured claims, and the cost to adjust these losses incurred as of the balance sheet date p. 74.
- The Company estimates reserves using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures p. 74.
- These estimates are based on the Company's historical information, industry and peer group information, and estimates of future trends in variable factors such as loss severity, loss frequency, and other factors like inflation p. 74.
- The Company regularly reviews and adjusts its estimates as experience develops or new information becomes known p. 74.
- During the loss settlement period, estimates of liability on a claim are often refined and adjusted upward or downward p. 74.
- The ultimate liability may exceed or be less than the revised estimates, and the ultimate settlement of losses and related LAE may vary significantly from the estimate in the financial statements p. 74.
- If actual liabilities exceed recorded amounts, there will be an adverse effect p. 74.
- If recorded reserves are determined to be more than adequate, it would lead to a reduction in reserves p. 74.
N. Premiums
- The Company recognizes property and casualty and surety premiums on a pro-rata basis over the policy terms p. 75.
- Accident and health premiums are earned as billed, based on census data p. 75.
- Gross premiums written are reduced by ceded premiums from proportional, facultative, and excess of loss reinsurance costs for prospective reinsurance p. 75.
- Premiums receivable include deferred premiums, which are installment payments due from insureds under policy payment terms p. 75.
- Premiums receivable are carried net of an allowance for credit losses p. 75.
- The allowance for credit losses represents the current estimate of expected credit losses p. 75.
- The Company develops a historical loss rate using historical write-offs and aging of receivables p. 75.
- This historical loss rate is adjusted for current conditions, reasonable and supportable forecasts, and the ability to cancel coverage after a premium is past due p. 75.
- Changes in the allowance for credit losses are recognized in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations p. 75.
- Unearned premiums represent the portion of gross premiums written applicable to the unexpired terms of in-force insurance policies or reinsurance contracts p. 75.
- Ceded unearned premiums represent the portion of ceded premiums written applicable to the unexpired terms of in-force insurance policies or reinsurance contracts p. 75.
- Unearned premiums (direct and ceded) are calculated on a pro-rata basis over the terms of the policies p. 75.
O. Commission and Fee Income
- SUA commission revenue is generated from placing insurance policies on reinsurance programs via a reinsurance broker p. 76.
- The Company's single performance obligation for SUA commission revenue is the placement of insurance policies p. 76.
- The transaction price for SUA commission revenue is fixed at contract inception and based on a percentage of premiums placed p. 76.
- The Company recognizes 100% of the transaction price for SUA commission revenue when the policy is placed, as there are no constraints on revenue p. 76.
- SUA fee income is generated from placing insurance policies with a third-party insurance company p. 76.
- The Company's single performance obligation for SUA fee income is the placement of the policy p. 76.
- The transaction price for SUA fee income is variable at contract inception and based on a percentage of premium, which is determined by risk factors that change monthly (e.g., employee census data, worker roles) p. 76.
- The Company estimates the transaction price for SUA fee income over the policy's life using the expected value method p. 76.
- Revenue from SUA fee income is recognized when the policy is placed p. 76.
- Changes in the estimate of variable consideration for SUA fee income are recognized in the month they occur p. 76.
P. Income Taxes
- Income tax expense is accrued for the tax effects of transactions reported on the consolidated financial statements p. 77.
- Provision for income taxes consists of taxes currently due plus deferred taxes resulting from temporary differences between financial statement and income tax purposes p. 77.
- A valuation allowance is established for any deferred tax asset not expected to be realized p. 77.
- Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years temporary differences are expected to be recovered or settled p. 77.
- The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the enactment date p. 77.
- A liability for uncertain tax positions is recorded when it is more likely-than-not that the tax position will not be sustained upon examination by the appropriate tax authority p. 77.
- Changes in the liability for uncertain tax positions are reflected in income tax expense in the period when a new uncertain tax position arises, judgment changes about the likelihood of an uncertainty, the tax issue is settled, or the statute of limitation expires p. 77.
- Any potential net interest income or expense and penalties related to uncertain tax positions are recorded on the Consolidated Statements of Operations p. 77.
- The Company files a consolidated federal income tax return in the United States and certain other state tax returns p. 77.
- Its admitted insurance subsidiaries pay premium taxes on gross written premiums in lieu of most state income or franchise taxes p. 77.
- Premium tax expense is recognized within underwriting, acquisition, and insurance expense on the Consolidated Statements of Operations p. 77.
Q. Fair Value of Financial Instruments
- Fair value for each class of financial instrument is estimated based on the framework established in fair value accounting guidance p. 78.
- The guidance requires maximizing the use of observable inputs and minimizing unobservable inputs when measuring fair value p. 78.
- Fair value hierarchy disclosures are based on the quality of inputs used to measure fair value p. 78.
- The hierarchy prioritizes unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) p. 78.
- The hierarchy gives the lowest priority to unobservable inputs (Level 3 measurements) p. 78.
- The Company uses widely recognized, third-party pricing sources to determine fair values of financial instruments p. 78.
- The Company understands the valuation methodologies and inputs of these third-party pricing sources p. 78.
- Further details regarding fair value disclosures are in Note 4 p. 78.
R. Stock-Based Compensation
- The estimated fair value of employee stock options and similar awards is expensed p. 79.
- Compensation cost for equity instrument awards to employees is measured based on the grant-date fair value of those awards p. 79.
- Compensation expense is recognized over the service period during which the awards are expected to vest p. 79.
- Tax effects related to share-based payments are made through net earnings p. 79.
- Further discussion and related disclosures regarding stock-based compensation are in note 18 p. 79.
- The Company's Employee Stock Purchase Plan (ESPP) allows all employees to purchase common stock at a discount p. 79.
- Compensation cost for the ESPP is recognized on a straight-line basis over the offering period p. 79.
- Basic earnings per share is calculated using the two-class method p. 80.
- Undistributed earnings are allocated to participating securities based on their share in earnings as if all earnings for the period were distributed p. 80.
- Basic earnings per share is calculated by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding for the period p. 80.
- Common shares with unsatisfied contingencies, such as vesting requirements, are excluded from basic earnings per share p. 80.
- The Company’s preferred shares are participating securities, sharing in dividends and distributions with common stock on an as-converted basis p. 80.
- Instruments awarded to employees that grant the right to purchase common stock at a fixed price are included as potential common shares, weighted for the portion of the period they were granted, if dilutive p. 80.
- The Company’s common and preferred shares financed by stock notes are contingently issuable instruments, excluded from basic and diluted earnings per share if specified conditions are not met, presuming the end of the period is the end of the contingency period p. 80.
- The impact of contingently issuable instruments on diluted earnings per share was calculated using the treasury stock method and included in the reconciliation of the denominator for the year ended December 31, 2024 p. 80.
- All outstanding stock notes were settled during 2024, resulting in no impact on the Company’s basic and diluted earnings per share computations for the year ended December 31, 2024 p. 80.
- Instruments convertible into common shares are included in diluted weighted-average common shares outstanding on an if-converted basis, based on the legal conversion rate for the respective period, if dilutive p. 80.
- Share-based awards to employees with only service conditions are included as potential common shares, weighted for the unvested portion of the period, if dilutive p. 80.
- Share-based awards to employees with performance and service or market conditions are included as potential common shares, presuming the end of the period is the end of the contingency period, if dilutive p. 80.
- When common share adjustments increase earnings per share or reduce loss per share, the effect is anti-dilutive, and diluted net earnings or net loss per share is computed excluding these common share equivalents p. 80.
T. Recent Accounting Pronouncements
- ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740) was issued by FASB in December 2023 p. 81.
- ASU 2023-09 mandates enhanced rate reconciliation disclosures for public companies annually, including specific categories and additional information meeting a quantitative threshold p. 81.
- This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes p. 81.
- The guidance became effective for fiscal years beginning after December 15, 2024, and is applied prospectively p. 81.
- The Company has added additional disclosures as required by ASU 2023-09, with no impact on the consolidated financial statements p. 81.
- Additional disclosures required by ASU 2023-09 can be found in Note 13 p. 81.
- ASU 2024-03 was issued by FASB in November 2024, requiring disaggregated disclosure of income statement expenses for public business entities ("PBEs") p. 81.
- ASU 2024-03 does not change expense captions on the income statement but requires disaggregation of certain expense captions into specified categories in footnotes p. 81.
- The ASU requires a footnote disclosure about specific expenses, mandating PBEs to disaggregate, in a tabular presentation, relevant income statement expense captions that include natural expenses such as: (1) purchases of inventory, (2) employee compensation, (3) depreciation, (4) intangible asset amortization, and (5) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities or other types of depletion expenses p. 81.
- The tabular disclosure will also include certain other expenses, where applicable p. 81.
- ASU 2025-01 was issued by FASB in January 2025 to clarify the effective date of ASU 2024-03 p. 81.
- The effective date for ASU 2024-03 is the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027 p. 81.
- The Company is evaluating the effect of these amendments on its consolidated financial statements p. 81.
2. Goodwill and Intangible Assets
| Key facts & figures | |
|---|---|
| Indefinite-lived intangible assets | insurance licenses, trademarks |
| Finite-lived intangible assets | policy renewals, agency relationships, non-compete/exclusivity agreements |
| Weighted average useful life | 12 years |
| Amortization expense | FY25: $1.3m |
- The Company's indefinite-lived intangible assets include insurance licenses and trademarks p. 82.
- The Company's finite-lived intangible assets, including policy renewals, agency relationships, and non-compete/exclusivity agreements, had a weighted average useful life of approximately 12 years as of December 31, 2025 p. 82.
- Amortization expense was approximately $1.3m for the year ended December 31, 2025 p. 82.
- Amortization expense was approximately $1.1m for the year ended December 31, 2024 p. 82.
- Amortization expense was approximately $1.5m for the year ended December 31, 2023 p. 82.
Goodwill by segment at December 31, 2025
| ($ in thousands) | Accident and Health | Surety | Construction and Energy Solutions | Other | Total |
|---|---|---|---|---|---|
| Goodwill | — | — | — | — | — |
| Gross balance at December 31, 2024 | 91,577 | 6,781 | 10,204 | 3,879 | 112,441 |
| Accumulated impairment at December 31, 2024 | ( 44,821 ) | — | — | ( 1,886 ) | ( 46,707 ) |
| Net balance at December 31, 2025 | 46,756 | 6,781 | 10,204 | 1,993 | 65,734 |
Goodwill by segment at December 31, 2024
| ($ in thousands) | Accident and Health | Surety | Construction and Energy Solutions | Other | Total |
|---|---|---|---|---|---|
| Goodwill | — | — | — | — | — |
| Gross balance at December 31, 2023 | 91,577 | 6,781 | 10,204 | 3,879 | 112,441 |
| Accumulated impairment at December 31, 2023 | ( 44,821 ) | — | — | ( 1,886 ) | ( 46,707 ) |
| Net balance at December 31, 2024 | 46,756 | 6,781 | 10,204 | 1,993 | 65,734 |
Other intangible assets at December 31, 2025
| ($ in thousands) | Agent Relationships | Non-competes | Trademarks | Licenses | Total |
|---|---|---|---|---|---|
| Other Intangible Assets | — | — | — | — | — |
| Gross balance at December 31, 2024 | 24,491 | 1,117 | 999 | 14,019 | 40,626 |
| Accumulated amortization at December 31, 2024 | ( 17,895 ) | ( 1,117 ) | — | — | ( 19,012 ) |
| Additions | 2,000 | — | — | — | 2,000 |
| Amortization | ( 1,308 ) | — | — | — | ( 1,308 ) |
| Net balance at December 31, 2025 | 7,288 | — | 999 | 14,019 | 22,306 |
Other intangible assets at December 31, 2024
| ($ in thousands) | Agent Relationships | Non-competes | Trademarks | Licenses | Total |
|---|---|---|---|---|---|
| Other Intangible Assets | — | — | — | — | — |
| Gross balance at December 31, 2023 | 24,491 | 1,117 | 999 | 14,019 | 40,626 |
| Accumulated amortization at December 31, 2023 | ( 16,808 ) | ( 1,117 ) | — | — | ( 17,925 ) |
| Amortization | ( 1,087 ) | — | — | — | ( 1,087 ) |
| Net balance at December 31, 2024 | 6,596 | — | 999 | 14,019 | 21,614 |
Amortization of intangible assets
| ($ in thousands) | |
|---|---|
| Years Ending December 31, | Amount |
| 2026 | 1,053 |
| 2027 | 1,053 |
| 2028 | 1,053 |
| 2029 | 762 |
| 2030 | 553 |
3. Investments
- Fixed maturity securities, held-to-maturity at December 31, 2025, consisted entirely of asset-backed securities not due at a single maturity date p. 83.
- At December 31, 2025, the Company had U.S. government agencies mortgage-backed fixed maturity securities with a carrying value of approximately $68.5 million pledged as collateral for a loan (the "FHLB Loan") from the Federal Home Loan Bank of Dallas ("FHLB") p. 83.
- The Company retains all rights regarding the pledged securities under the terms of the FHLB Loan and the Advances and Security Agreement p. 83.
- At December 31, 2025, the Company had assets with fair values of approximately $69.5 million pledged as collateral for performance obligations under reinsurance agreements p. 83.
- The pledged assets for reinsurance agreements included residential mortgage-backed securities of $57.8 million, cash and cash equivalents and other assets of $9.5 million, and short-term investments of $2.2 million p. 83.
- The Company retains all rights regarding these pledged securities under the terms of the trust agreements p. 83.
- The Company monitors available-for-sale fixed maturity securities for impairment, requiring significant management judgment p. 83.
- Factors considered for fixed maturity securities impairment include the issuer's financial condition, receipt of scheduled principal and interest cash flows, and intent to sell before recovery p. 83.
- As of December 31, 2025, the Company had 450 lots of fixed maturity securities in an unrealized loss position p. 83.
- The Company does not intend to sell these securities and is not likely to be required to sell them before maturity or recovery of cost basis p. 83.
- At December 31, 2025, the Company identified credit impairments for two available-for-sale securities in the "corporate securities and miscellaneous" category, based on new recovery analysis showing deteriorating conditions p. 83.
- For U.S. government securities and municipal securities, the decline in fair values was due to changes in interest rates, not credit quality p. 83.
- The Company does not intend to sell these U.S. government and municipal securities and expects recovery, thus not considering them impaired p. 83.
- For corporate securities and miscellaneous, the decline in fair values was due to changes in interest rates, not credit quality p. 83.
- The Company reviewed corporate security issuers for adverse changes in financial condition, credit enhancement quality, ratings decreases, or payment failures, and determined declines were interest rate-driven p. 83.
- The Company does not intend to sell these corporate securities and expects recovery, thus not considering them impaired p. 83.
- For residential mortgage-backed securities, commercial mortgage-backed securities, and other asset-backed securities, the decline in fair values was due to changes in interest rates, not credit quality p. 83.
- The Company does not intend to sell these mortgage-backed and asset-backed securities and expects recovery, thus not considering them impaired p. 83.
- Various state regulations require the Company to maintain cash, investment securities, or letters of credit on deposit with states p. 83.
- At December 31, 2025, cash and investment securities on deposit had carrying values of approximately $70.0 million p. 83.
- At December 31, 2024, cash and investment securities on deposit had carrying values of approximately $66.8 million p. 83.
Fixed maturity securities at December 31, 2025
| ($ in thousands) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Allowance for Credit Losses | Fair Value |
|---|---|---|---|---|---|
| December 31, 2025 | |||||
| Fixed maturity securities, available-for-sale: | — | — | — | — | — |
| U.S. government securities | 44,190 | 292 | ( 14 ) | — | 44,468 |
| Corporate securities and miscellaneous | 632,244 | 14,223 | ( 3,080 ) | ( 7,000 ) | 636,387 |
| Municipal securities | 102,691 | 1,725 | ( 2,300 ) | — | 102,116 |
| Residential mortgage-backed securities | 487,145 | 8,928 | ( 9,486 ) | — | 486,587 |
| Commercial mortgage-backed securities | 72,631 | 1,016 | ( 597 ) | — | 73,050 |
| Other asset-backed securities | 509,854 | 5,194 | ( 1,353 ) | — | 513,695 |
| Total fixed maturity securities, available-for-sale | 1,848,755 | 31,378 | ( 16,830 ) | ( 7,000 ) | 1,856,303 |
| Other asset-backed securities | 33,290 | 829 | ( 48 ) | ( 468 ) | 33,603 |
| Total fixed maturity securities, held-to-maturity | 33,290 | 829 | ( 48 ) | ( 468 ) | 33,603 |
Fixed maturity securities at December 31, 2024
| ($ in thousands) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Loss | Allowance for Credit Losses | Fair Value |
|---|---|---|---|---|---|
| December 31, 2024 | |||||
| Fixed maturity securities, available-for-sale: | — | — | — | — | — |
| U.S. government securities | 26,577 | 35 | ( 126 ) | — | 26,486 |
| Corporate securities and miscellaneous | 433,298 | 5,618 | ( 13,288 ) | — | 425,628 |
| Municipal securities | 89,966 | 116 | ( 5,366 ) | — | 84,716 |
| Residential mortgage-backed securities | 408,585 | 1,875 | ( 16,627 ) | — | 393,833 |
| Commercial mortgage-backed securities | 70,262 | 545 | ( 1,443 ) | — | 69,364 |
| Other asset-backed securities | 291,578 | 2,447 | ( 1,834 ) | — | 292,191 |
| Total fixed maturity securities, available-for-sale | 1,320,266 | 10,636 | ( 38,684 ) | — | 1,292,218 |
| Other asset-backed securities | 39,396 | — | ( 436 ) | ( 243 ) | 38,717 |
| Total fixed maturity securities, held-to-maturity | 39,396 | — | ( 436 ) | ( 243 ) | 38,717 |
Maturity distribution of fixed maturity securities
| ($ in thousands) | Amortized Cost | Fair Value |
|---|---|---|
| Due in less than one year | 45,682 | 45,478 |
| Due after one year through five years | 449,790 | 449,145 |
| Due after five years through ten years | 219,293 | 224,696 |
| Due after ten years | 64,360 | 63,652 |
| Mortgage-backed securities | 559,776 | 559,637 |
| Other asset-backed securities | 509,854 | 513,695 |
| Total | 1,848,755 | 1,856,303 |
Fixed maturity securities by contractual maturity at December 31, 2025
| Less than 12 Months | 12 Months or More | Total | ||||
|---|---|---|---|---|---|---|
| ($ in thousands) | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses |
| December 31, 2025 | ||||||
| Fixed maturity securities, available-for-sale: | — | — | — | — | — | — |
| U.S. government securities | 349 | ( 1 ) | 1,565 | ( 13 ) | 1,914 | ( 14 ) |
| Corporate securities and miscellaneous | 67,644 | ( 346 ) | 63,575 | ( 2,734 ) | 131,219 | ( 3,080 ) |
| Municipal securities | 19,157 | ( 400 ) | 22,004 | ( 1,900 ) | 41,161 | ( 2,300 ) |
| Residential mortgage-backed securities | 56,147 | ( 262 ) | 74,075 | ( 9,224 ) | 130,222 | ( 9,486 ) |
| Commercial mortgage-backed securities | 4,646 | ( 3 ) | 8,363 | ( 594 ) | 13,009 | ( 597 ) |
| Other asset-backed securities | 85,098 | ( 424 ) | 16,081 | ( 929 ) | 101,179 | ( 1,353 ) |
| Total fixed maturity securities, available-for-sale | 233,041 | ( 1,436 ) | 185,663 | ( 15,394 ) | 418,704 | ( 16,830 ) |
| Other asset-backed securities | 1,912 | ( 48 ) | — | — | 1,912 | ( 48 ) |
| Total fixed maturity securities, held-to-maturity: | 1,912 | ( 48 ) | — | — | 1,912 | ( 48 ) |
| Total | 234,953 | ( 1,484 ) | 185,663 | ( 15,394 ) | 420,616 | ( 16,878 ) |
Fixed maturity securities by contractual maturity at December 31, 2024
| Less than 12 Months | 12 Months or More | Total | ||||
|---|---|---|---|---|---|---|
| ($ in thousands) | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses |
| December 31, 2024 | ||||||
| Fixed maturity securities, available-for-sale: | — | — | — | — | — | — |
| U.S. government securities | 15,938 | ( 34 ) | 2,297 | ( 92 ) | 18,235 | ( 126 ) |
| Corporate securities and miscellaneous | 136,888 | ( 2,060 ) | 81,232 | ( 11,228 ) | 218,120 | ( 13,288 ) |
| Municipal securities | 41,930 | ( 1,046 ) | 27,687 | ( 4,320 ) | 69,617 | ( 5,366 ) |
| Residential mortgage-backed securities | 201,407 | ( 3,366 ) | 82,496 | ( 13,261 ) | 283,903 | ( 16,627 ) |
| Commercial mortgage-backed securities | 9,411 | ( 126 ) | 13,178 | ( 1,317 ) | 22,589 | ( 1,443 ) |
| Other asset-backed securities | 75,119 | ( 721 ) | 29,851 | ( 1,113 ) | 104,970 | ( 1,834 ) |
| Total fixed maturity securities, available-for-sale | 480,693 | ( 7,353 ) | 236,741 | ( 31,331 ) | 717,434 | ( 38,684 ) |
| Other asset-backed securities | 2,144 | ( 2 ) | 36,573 | ( 434 ) | 38,717 | ( 436 ) |
| Total fixed maturity securities, held-to-maturity: | 2,144 | ( 2 ) | 36,573 | ( 434 ) | 38,717 | ( 436 ) |
| Total | 482,837 | ( 7,355 ) | 273,314 | ( 31,765 ) | 756,151 | ( 39,120 ) |
Allowance for credit losses on fixed maturity securities at December 31, 2025
| ($ in thousands) | Fixed Maturity Securities, Available-For-Sale | Fixed Maturity Securities, Held-to-Maturity |
|---|---|---|
| Balance at December 31, 2024 | — | 243 |
| Current period provision for credit losses | 7,000 | 257 |
| Recoveries of amounts previously written off | — | ( 32 ) |
| Balance at December 31, 2025 | 7,000 | 468 |
Allowance for credit losses on fixed maturity securities at December 31, 2024
| — | Fixed Maturity Securities, Held-to-Maturity |
|---|---|
| Balance at December 31, 2023 | 329 |
| Current period provision for credit losses | 18 |
| Recoveries of amounts previously written off | ( 104 ) |
| Balance at December 31, 2024 | 243 |
Net realized investment gains and losses
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross realized gains | — | — | — |
| Fixed maturity securities, available-for-sale | 3,002 | 2,662 | 1,042 |
| Equity securities | 34,262 | 8,062 | 6,035 |
| Other | 685 | 213 | 2 |
| Total | 37,949 | 10,937 | 7,079 |
| Fixed maturity securities, available-for-sale | ( 10,832 ) | ( 8,161 ) | ( 1,879 ) |
| Equity securities | ( 3,000 ) | ( 4,132 ) | ( 5,256 ) |
| Other | ( 413 ) | ( 223 ) | ( 20 ) |
| Total | ( 14,245 ) | ( 12,516 ) | ( 7,155 ) |
| Equity securities | ( 22,908 ) | 7,500 | 11,516 |
| Mortgage loans | ( 7 ) | 421 | ( 386 ) |
| Other | 21,360 | — | — |
| Net investment gains | 22,149 | 6,342 | 11,054 |
Net unrealized investment gains and losses
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Fixed maturity securities, available-for-sale | 198,195 | 217,468 | 26,626 |
| Equity securities | 126,738 | 37,534 | 40,201 |
Net investment income by source
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Income (loss): | — | — | — |
| Fixed maturity securities, available-for-sale | 80,302 | 57,574 | 34,703 |
| Fixed maturity securities, held-to-maturity | ( 804 ) | 4,091 | 4,181 |
| Equity securities | 1,223 | 2,720 | 3,418 |
| Equity method investments | ( 2,683 ) | 2,524 | ( 9,434 ) |
| Mortgage loans | 1,622 | 5,153 | 5,474 |
| Indirect loans | ( 8,129 ) | ( 2,400 ) | ( 4,155 ) |
| Short-term investments and cash | 12,828 | 14,851 | 11,392 |
| Other | 3,307 | 3,000 | 318 |
| Total investment income | 87,666 | 87,513 | 45,897 |
| Investment expenses | ( 4,047 ) | ( 6,913 ) | ( 5,557 ) |
| Net investment income | 83,619 | 80,600 | 40,340 |
Components of deferred income taxes
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Fixed maturity securities | 42,594 | 1,046 | 25,952 |
| Deferred income taxes | ( 9,017 ) | ( 213 ) | ( 5,420 ) |
| Total | 33,577 | 833 | 20,532 |
4. Fair Value Measurements
| Key facts & figures | |
|---|---|
| Fair value hierarchy | three-level hierarchy |
| Level 1 inputs | U.S. government securities, mutual funds, common stock |
| Level 2 inputs | Preferred stocks, municipal securities, corporate securities, miscellaneous |
- The Company's financial instruments include assets and liabilities carried at fair value, and those carried at cost or amortized cost but disclosed at fair value in consolidated financial statements p. 84.
- The market approach is generally applied to determine fair value, using prices and data from market transactions involving identical or comparable assets and liabilities p. 84.
- Fair value of investments is primarily determined using data from third-party investment managers or pricing vendors p. 84.
- Periodic analyses are performed on third-party prices to ensure they are reasonable estimates of fair value, including reviewing month-to-month fluctuations and comparing valuations from different pricing services for identical securities p. 84.
- The Company classifies financial instruments into a three-level hierarchy: p. 84
- Level 1: Unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date p. 84.
- Level 2: Inputs other than Level 1 quoted prices that are observable for the asset or liability through corroboration with market data at the measurement date p. 84.
- Level 3: Unobservable inputs reflecting management's best estimate of what market participants would use in pricing the asset or liability at the measurement date p. 84.
- U.S. government securities, mutual funds, and common stock fair value is measured using unadjusted quoted prices for identical instruments in an active exchange, representing Level 1 inputs p. 84.
- Preferred stocks, municipal securities, corporate securities, and miscellaneous fair value is determined using a pricing model with market-based inputs such as trades in illiquid markets for specific securities or active markets for similar securities p. 84.
- The model considers benchmark yields, issuer spreads, security terms and conditions, and other market data, representing Level 2 fair value inputs p. 84.
- Commercial mortgage-backed securities, residential mortgage-backed securities, and other asset-backed securities fair value is determined using a pricing model with market-based inputs like dealer quotes, market spreads, and yield curves p. 84.
- The model may evaluate individual tranches by determining cash flows using security terms, collateral performance, credit information, benchmark yields, and estimated prepayments, representing Level 2 fair value inputs p. 84.
- Fixed maturity securities, available for sale classified as Level 3, include corporate securities and other asset-backed securities managed by an independent asset manager and priced by an independent provider p. 84.
- The provider estimates value using the discount net present value of cash flows method with an unobservable discount rate p. 84.
- The discount rate spread reflects risk associated with future cash flows, including inflation, opportunity cost, and time value of money, representing Level 3 fair value inputs p. 84.
- Mortgage loans have variable interest rates and are collateralized by real property p. 84.
- Fair value is determined using the income approach with observable and unobservable (Level 3) inputs p. 84.
- The unobservable input is the spread applied to a prime rate for discounting cash flows, representing incremental cost of capital based on borrower's ability to pay and collateral value relative to loan balance p. 84.
- Derivatives included in other assets consist of exchange-traded options contracts p. 84.
- Fair values are measured using quoted prices in active markets on the relevant exchange, specifically the volume-weighted average price of trades in similar contracts or the last trade settlement price if no trades occur p. 84.
- This method represents Level 1 inputs p. 84.
- The Company measures certain assets, including investments in indirect loans and loan collateral, equity method investments, and other invested assets, at fair value on a nonrecurring basis only when impaired p. 84.
- The Company is required to disclose fair values of other financial instruments where practicable to estimate fair value, even if carried at cost or amortized cost p. 84.
- Estimated fair value amounts are determined using available market information and other valuation methodologies, but considerable judgment is required when quoted market prices are unavailable p. 84.
- These estimates may not be indicative of amounts realizable in a current market exchange, and different assumptions or methodologies could affect the estimated fair value p. 84.
- Fixed maturity securities, held-to-maturity, consist of senior and junior notes with target rates of return p. 84.
- As of December 31, 2025, their fair value was determined using the income approach with unobservable inputs (Level 3) p. 84.
- Investment in RedBird Capital Partners is included in other long-term investments and is a limited partnership that invests in Bishop Street Underwriters, LLC (MGA) p. 84.
- The investment had a fair value of $55.6 million at December 31, 2025, and $28.2 million at December 31, 2024, determined using the net asset value p. 84.
- Procedures to assess reasonableness include obtaining and reviewing audited financial statements p. 84.
- The unfunded commitment related to the investment was $18.3 million at December 31, 2025, and $24.4 million at December 31, 2024 p. 84.
- The Company may sell its interest with prior written notice and general partner approval p. 84.
- In accordance with Accounting Standard Codification 820-10, this investment is measured at fair value using the net asset value per share practical expedient and is not classified in the fair value hierarchy p. 84.
- Net earned premiums related to this agreement were $41.5 million for the year ended December 31, 2025, and $2.5 million for the year ended December 31, 2024 p. 84.
- Notes payable carrying value approximates estimated fair value because they accrue interest at current market rates plus a spread p. 84.
- Fair value is determined using the income approach with observable inputs (Level 2) p. 84.
- Subordinated debt consists of Unsecured Subordinated Notes, due May 24, 2039, with a fixed interest rate p. 84.
- Fair value is determined using the income approach with observable inputs (Level 2) p. 84.
- Other financial instruments qualify as insurance-related products and are exempt from fair value disclosure requirements p. 84.
Fair value of financial instruments
| — | 2025 | 2024 |
|---|---|---|
| High | 11.10% | 8.00% |
| Low | 4.25% | 5.70% |
| Weighted average | 6.40% | 6.60% |
Weighted average interest rates
| — | 2025 | 2024 |
|---|---|---|
| High | 8.34% | 10.00% |
| Low | 6.55% | 7.00% |
| Weighted average | 7.74% | 7.93% |
Fixed maturity securities as of December 31, 2025
| December 31, 2025 | ||||
|---|---|---|---|---|
| ($ in thousands) | Level 1 | Level 2 | Level 3 | Total |
| Fixed maturity securities, available-for-sale: | — | — | — | — |
| U.S. government securities | 44,468 | — | — | 44,468 |
| Corporate securities and miscellaneous | — | 503,274 | 133,113 | 636,387 |
| Municipal securities | — | 102,116 | — | 102,116 |
| Residential mortgage-backed securities | — | 486,587 | — | 486,587 |
| Commercial mortgage-backed securities | — | 73,050 | — | 73,050 |
| Other asset-backed securities | — | 495,891 | 17,804 | 513,695 |
| Total fixed maturity securities, available-for-sale | 44,468 | 1,660,918 | 150,917 | 1,856,303 |
| Other asset-backed securities | — | — | 33,603 | 33,603 |
| Total fixed maturity securities, held-to-maturity | — | — | 33,603 | 33,603 |
| Preferred stocks | — | 1,174 | — | 1,174 |
| Total equity securities | — | 1,174 | — | 1,174 |
| Mortgage loans | — | — | 9,902 | 9,902 |
| Short-term investments | 264,299 | — | — | 264,299 |
| Derivatives | 34,857 | — | — | 34,857 |
| Total | 343,624 | 1,662,092 | 194,422 | 2,200,138 |
Fixed maturity securities as of December 31, 2024
| December 31, 2024 | ||||
|---|---|---|---|---|
| ($ in thousands) | Level 1 | Level 2 | Level 3 | Total |
| Fixed maturity securities, available-for-sale: | — | — | — | — |
| U.S. government securities | 26,486 | — | — | 26,486 |
| Corporate securities and miscellaneous | — | 354,815 | 70,813 | 425,628 |
| Municipal securities | — | 84,716 | — | 84,716 |
| Residential mortgage-backed securities | — | 393,833 | — | 393,833 |
| Commercial mortgage-backed securities | — | 69,364 | — | 69,364 |
| Other asset-backed securities | — | 285,084 | 7,107 | 292,191 |
| Total fixed maturity securities, available-for-sale | 26,486 | 1,187,812 | 77,920 | 1,292,218 |
| Other asset-backed securities | — | — | 38,717 | 38,717 |
| Total fixed maturity securities, held-to-maturity: | — | — | 38,717 | 38,717 |
| Common stocks | 64,251 | — | — | 64,251 |
| Preferred stocks | — | 1,164 | — | 1,164 |
| Mutual funds | 40,839 | — | — | 40,839 |
| Total equity securities | 105,090 | 1,164 | — | 106,254 |
| Mortgage loans | — | — | 26,490 | 26,490 |
| Short-term investments | 274,929 | — | — | 274,929 |
| Total | 406,505 | 1,188,976 | 143,127 | 1,738,608 |
Fixed maturity securities and mortgage loans as of December 31, 2025
| ($ in thousands) | Fixed Maturity Securities, Available-For-Sale | Mortgage Loans |
|---|---|---|
| Balance at December 31, 2024 | 77,920 | 26,490 |
| Total gains (losses) for the period recognized in net investment gains (losses) | ( 5,180 ) | ( 7 ) |
| Issuances | — | 151 |
| Settlements | — | ( 16,732 ) |
| Transfers into Level 3 | 6,143 | — |
| Purchases | 70,730 | — |
| Sales/Disposals | ( 1,493 ) | — |
| Total unrealized gains for the period recognized in accumulated comprehensive income (loss) | 2,797 | — |
| Balance at December 31, 2025 | 150,917 | 9,902 |
| Total losses for the period recognized in net investment gains attributable to the change in unrealized gains or losses relating to assets held as of period end | — | ( 201 ) |
Fixed maturity securities and mortgage loans as of December 31, 2024
| ($ in thousands) | Fixed Maturity Securities, Available-For-Sale | Mortgage Loans |
|---|---|---|
| Balance at December 31, 2023 | — | 50,070 |
| Total gains (losses) for the period recognized in net investment gains (losses) | ( 195 ) | 420 |
| Issuances | — | 649 |
| Settlements | — | ( 24,649 ) |
| Purchases | 77,979 | — |
| Sales/Disposals | ( 374 ) | — |
| Total unrealized gains for the period recognized in accumulated comprehensive income (loss) | 510 | — |
| Balance at December 31, 2024 | 77,920 | 26,490 |
| Total gains for the period recognized in net investment gains (losses) attributable to the change in unrealized gains or losses relating to assets held as of period end | — | 411 |
Notes payable and subordinated debt
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Carrying Value | Fair Value | Carrying Value | Fair Value |
| Notes payable | — | — | — | — |
| FHLB Loan | 57,000 | 57,458 | 57,000 | 56,200 |
| Revolving Credit Facility | 114,500 | 114,500 | 43,000 | 43,000 |
| Term Loan Facility | 300,000 | 300,000 | — | — |
| Notes payable | 471,500 | 471,958 | 100,000 | 99,200 |
| Unsecured subordinated notes | 19,569 | 21,020 | 19,536 | 20,541 |
| Subordinated debt, net of debt issuance costs | 19,569 | 21,020 | 19,536 | 20,541 |
5. Mortgage Loans
| Key facts & figures | |
|---|---|
| Loan maturity | 2 to 4 years |
| Principal amounts of loans | approximately 64% of the property’s appraised value |
| Write-offs for uncollectible amounts 2025 | no write-offs |
| Write-offs for uncollectible amounts 2024 | no write-offs |
| Mortgage loans in foreclosure 2025 | no mortgage loans |
| Mortgage loans in foreclosure 2024 | no mortgage loans |
| Mortgage loans not producing income 2025 | no mortgage loans |
| Mortgage loans not producing income 2024 | no mortgage loans |
- The Company invests in Separately Managed Accounts (SMA1 and SMA2) p. 85.
- As of December 31, 2025 and 2024, the Company held direct investments in mortgage loans from various creditors through SMA1 and SMA2 p. 85.
- The Company’s mortgage loan portfolios are primarily senior loans on real estate across the U.S. p. 85.
- Loans earn interest at a fixed spread above a prime rate p. 85.
- Loan maturity is approximately 2 to 4 years from loan origination p. 85.
- Principal amounts of loans are approximately 64% of the property’s appraised value at the time of loan origination p. 85.
- Uncollectible amounts on loans are determined based on consultations with the specialized investment manager, consideration of adverse situations affecting borrower repayment ability, estimated value of underlying collateral, and other relevant factors p. 85.
- The Company writes off uncollectible amounts in the period they are determined to be uncollectible p. 85.
- There were no write-offs for uncollectible amounts during the years ended December 31, 2025 and 2024 p. 85.
- As of December 31, 2025 and 2024, no mortgage loans were in the process of foreclosure p. 85.
- As of December 31, 2025 and 2024, no mortgage loans were not producing income for the previous 12 months p. 85.
Mortgage loans by property type
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Commercial | 3,334 | 8,474 |
| Retail | — | 10,032 |
| Hospitality | 6,568 | 7,984 |
| — | 9,902 | 26,490 |
Mortgage loans by property type
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Commercial | 432 | 2,025 | 2,340 |
| Retail | 304 | 1,853 | 1,853 |
| Hospitality | 886 | 1,277 | 1,034 |
| Office | — | — | 203 |
| Multi-family | — | — | 44 |
| — | 1,622 | 5,155 | 5,474 |
6. Equity Method Investments and Other
| Key facts & figures | |
|---|---|
| RISCOM amortization period | 15-year useful life |
- The difference between an investment's cost and its proportionate share of underlying equity in net assets is allocated to the equity method investment's assets and liabilities p. 86.
- The Company amortizes this difference in net assets over the useful life of a similar asset as the underlying equity method investment p. 86.
- For the investment in RISCOM, the similar asset is agent relationships p. 86.
- The Company amortizes this difference for RISCOM over a 15-year useful life p. 86.
- As of December 31, 2025 and 2024, the Company held indirect investments in collateralized loans and loan collateral through SMA1 and SMA2 p. 86.
Indirect investments in collateralized loans and loan collateral
| ($ in thousands) | 2025 | 2024 | ||
|---|---|---|---|---|
| — | Carrying Value | Ownership % | Carrying Value | Ownership % |
| Arena Special Opportunities Fund, LP units | 26,936 | 14.0% | 34,936 | 15.3% |
| Arena SOP LP units | — | 11.2% | 1,474 | 10.9% |
| Brewer Lane Ventures Fund II LP units | 2,251 | 2.4% | 1,040 | 2.4% |
| Dowling Capital Partners LP units | 590 | 5.0% | 666 | 5.0% |
| Hudson Ventures Fund 2 LP units | 5,503 | 2.5% | 4,967 | 2.5% |
| JVM Funds LLC units | 14,911 | 10.1% | 17,229 | 10.1% |
| RISCOM | 3,307 | 20.0% | 5,013 | 20.0% |
| — | 53,498 | — | 65,325 | — |
Indirect investments in collateralized loans and loan collateral
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Arena SOP LP units | ( 1,474 ) | ( 989 ) | ( 6,271 ) |
| Arena Special Opportunities Fund, LP units | ( 3,163 ) | 2,375 | ( 2,880 ) |
| Brewer Lane Ventures Fund II LP | 91 | ( 110 ) | ( 78 ) |
| Dowling Capital Partners LP units | 431 | 1,463 | 927 |
| Hudson Ventures Fund II LP units | 480 | ( 153 ) | 170 |
| JVM Funds LLC | ( 541 ) | ( 1,554 ) | ( 1,198 ) |
| RISCOM | 1,493 | 1,492 | 884 |
| Universa Black Swan LP units | — | — | ( 988 ) |
| — | ( 2,683 ) | 2,524 | ( 9,434 ) |
Indirect investments in collateralized loans and loan collateral
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Brewer Lane Ventures Fund II LP units | 3,237 | 4,077 |
| Dowling Capital Partners LP units | 386 | 386 |
| Hudson Ventures Fund 2 LP units | 166 | 397 |
| Red Bird Capital Partners LP units | 18,305 | 24,400 |
| — | 22,094 | 29,260 |
Investment in RISCOM
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Investment in RISCOM: | — | — |
| Underlying equity | 2,292 | 3,756 |
| Difference | 1,015 | 1,258 |
| Recorded investment balance | 3,307 | 5,013 |
Investment in JVM Funds LLC
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Investment in JVM Funds LLC: | — | — |
| Underlying equity | 14,457 | 16,624 |
| Difference | 454 | 605 |
| Recorded investment balance | 14,911 | 17,229 |
Investment in indirect loans and loan collateral
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| SMA1 | 15,418 | 20,296 |
| SMA2 | 8,449 | 12,973 |
| Investment in indirect loans and loan collateral | 23,867 | 33,269 |
7. Variable Interest Entity
| Key facts & figures | |
|---|---|
| VIE | Separate Account HSIC-01 |
| Primary beneficiary | Company |
- Skyward consolidates Separate Account HSIC-01 ("HSIC-01"), established by Mangrove Risk Solutions Bermuda Ltd. ("Mangrove"), pursuant to GAAP consolidation guidance p. 87.
- HSIC-01 is a VIE for which the Company is the primary beneficiary p. 87.
- The purpose of the VIE is to hedge price volatility risks of certain insurance products by investing in dairy and livestock commodities p. 87.
- The Company considers itself the primary beneficiary because it directly manages the business p. 87.
- The Company does not provide performance guarantees and has no other financial obligation to provide funding to HSIC-01, other than its own capital commitments p. 87.
- The assets of consolidated variable interest entities may only be used to settle obligations of these entities p. 87.
- There is no recourse to the assets of HSIC-01 other than to satisfy associated liabilities p. 87.
- The table presents the assets of HSIC-01 included in the Consolidated Balance Sheets as of December 31, 2025 p. 87.
- The presented assets only include third-party net assets and exclude intercompany balances, which were eliminated upon consolidation p. 87.
Assets of HSIC-01 as of December 31, 2025
| ($ in thousands) | 2025 |
|---|---|
| Assets | — |
| Cash and cash equivalents | 15,816 |
| Other assets | 34,856 |
| Total assets | 50,672 |
8 . Derivatives
| Key facts & figures | |
|---|---|
| Net gain on derivative instruments | FY25: USD 7.9m |
- The Company uses derivatives for financial risk management to mitigate price risk in insurance contracts exposed to commodity price fluctuations, specifically cattle and milk p. 88.
- A hedging strategy using derivatives, including put options and futures, is employed to mitigate revenue volatility and support financial stability p. 88.
- The primary objective of derivative instruments is to manage exposure to adverse price movements p. 88.
- The activity in these instruments reflects current market conditions and shifts in risk exposures throughout the year p. 88.
- The notional value of derivative contracts and the degree of hedged exposure are actively managed and can vary based on pricing in cattle, hogs, and milk markets p. 88.
- The Company does not use derivatives for speculative or trading purposes p. 88.
- All derivative positions support the overall risk transfer objectives of the business p. 88.
- The Company has not elected hedge accounting for these derivatives p. 88.
- The net gain (loss) recognized on derivative instruments in economic hedging relationships is presented in "losses and loss adjustment expenses" on the Consolidated Statements of Operations p. 88.
- For the year ended December 31, 2025, the Company recognized pre-tax net gains of USD 7.9m in losses and loss adjustment expenses p. 88.
Derivative instruments in economic hedging relationships
| ($ in thousands) | Derivative Assets | |
|---|---|---|
| — | Notional Amount | Fair Value |
| Economic hedges | 136,800 | 34,857 |
9. Allowance for Credit Losses
| Key facts & figures | |
|---|---|
| Uncollectible reinsurance recoverable balance increase | FY24: $13.6 million |
| LPT commuted | January 31, 2025 |
- The Company analyzes the credit risk of its reinsurance recoverables by monitoring the financial strength rating of its reinsurers from A.M. Best p. 89.
- A.M. Best is a widely recognized rating agency focused exclusively on the insurance industry p. 89.
- The Company assesses the financial strength rating annually and throughout the year as A.M. Best provides updates p. 89.
- The Company assesses the adequacy of credit enhancements such as reinsurance payables, letters of credit, and funds held p. 89.
- Reinsurance balances are considered past due when they are 90 days past due p. 89.
- On January 31, 2025, the Company commuted the LPT with R&Q Re (Bermuda) Ltd. ("R&Q") for accident years 2018 and prior p. 89.
- During the year ended December 31, 2024, the Company recognized an uncollectible reinsurance recoverable balance related to the LPT as a net increase of $13.6 million to the allowance for estimated uncollectible reinsurance p. 89.
- This $13.6 million increase was subsequently written-off p. 89.
| ($ in thousands) | Premiums Receivable, Net | Allowance for Estimated Uncollectible Premiums |
|---|---|---|
| Balance at December 31, 2024 | 321,641 | 2,432 |
| Current period change for estimated uncollectible premiums | — | 2,351 |
| Write-offs of uncollectible premiums receivable | — | ( 2,141 ) |
| Recoveries of amounts previously written off | — | 498 |
| Balance at December 31, 2025 | 544,217 | 3,140 |
| ($ in thousands) | Premiums Receivable, Net | Allowance for Estimated Uncollectible Premiums |
|---|---|---|
| Balance at December 31, 2023 | 179,235 | 964 |
| Current period change for estimated uncollectible premiums | — | 3,235 |
| Write-offs of uncollectible premiums receivable | — | ( 1,895 ) |
| Recoveries of amounts previously written off | — | 128 |
| Balance at December 31, 2024 | 321,641 | 2,432 |
A.M. best ratings
| 2025 | ||
|---|---|---|
| A.M. Best Rating | Reinsurance Recoverables, Gross, Amortized Cost | Percent of Total |
| A- and above | 652,178 | 98.2% |
| B++ to B+ | 5,077 | 0.8 |
| B to B - | 28 | — |
| Not rated | 6,919 | 1.0 |
Reinsurance recoverables and allowance for uncollectible reinsurance
| ($ in thousands) | Reinsurance Recoverables, Net | Allowance for Estimated Uncollectible Reinsurance |
|---|---|---|
| Balance at December 31, 2024 | 857,876 | 2,295 |
| Balance at December 31, 2025 | 1,119,880 | 2,295 |
Reinsurance recoverables and allowance for uncollectible reinsurance as of December 31, 2024
| ($ in thousands) | Reinsurance Recoverables, Net | Allowance for Estimated Uncollectible Reinsurance |
|---|---|---|
| Balance at December 31, 2023 | 596,334 | 2,295 |
| Current period change for estimated uncollectible reinsurance | — | 13,585 |
| Write-offs of uncollectible reinsurance recoverables | — | ( 13,585 ) |
| Balance at December 31, 2024 | 857,876 | 2,295 |
10. Property and Equipment
| Key facts & figures | |
|---|---|
| Depreciation expense | FY25: USD 3.3m |
- Depreciation expense for property and equipment was USD 3.3m for the year ended December 31, 2025 p. 90.
- Depreciation expense for property and equipment was USD 2.9m for the year ended December 31, 2024 p. 90.
- Depreciation expense for property and equipment was USD 3.2m for the year ended December 31, 2023 p. 90.
- Depreciation expense is presented in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations p. 90.
Property and equipment
| (in thousands) | 2025 | 2024 |
|---|---|---|
| Leasehold improvements | 3,434 | 3,056 |
| Equipment | 4,750 | 4,506 |
| Software | 39,263 | 33,972 |
| — | 47,447 | 41,534 |
| Accumulated depreciation | ( 32,307 ) | ( 29,355 ) |
| Total | 15,140 | 12,179 |
11. Notes Payable & Subordinated Debt
| Key facts & figures | |
|---|---|
| FHLB Loan principal amount | USD 57.0m |
| FHLB Loan interest rate | 4.00% |
| Term Loan Facility Tranche A DDTL | USD 150.0m |
| Term Loan Facility Tranche B DDTL | USD 150.0m |
| FHLB Loan date | August 30, 2024 |
- On August 30, 2024, the Company entered into the FHLB Loan under the Advances and Security Agreement p. 91.
- The FHLB Loan is a 4.5-year term loan with a principal amount of USD 57.0m p. 91.
- The FHLB Loan requires interest-only payments during its term, with principal due at maturity p. 91.
- The FHLB Loan has a fixed interest rate of 4.00% over its term p. 91.
- The FHLB Loan is fully secured by a pledge of specific investment securities of HSIC p. 91.
- Proceeds from the FHLB Loan were used to fund redemptions of draws on the 2023 Revolving Credit Facility p. 91.
- During the fourth quarter of 2025, the Company entered into a Term Loan Credit Agreement (Term Loan Facility) with a syndicate of banks p. 91.
- The Term Loan Facility includes an unsecured senior delayed draw term loan facility (DDTL) of USD 150.0m (Tranche A DDTL) p. 91.
- The Term Loan Facility also includes an additional unsecured senior DDTL of USD 150.0m (Tranche B DDTL) p. 91.
- The Term Loan Facility was used to fund a portion of the consideration for the Company's acquisition of Apollo Group Holdings Limited (Apollo) and related transaction fees and expenses p. 91.
- Amounts drawn under the Term Loan Facility bear interest at either term SOFR plus a margin ranging from 150 bps to 190 bps, or the base rate plus a margin ranging from 50 bps to 90 bps, depending on the Company’s debt to capitalization ratio p. 91.
- SOFR is calculated using a SOFR floor of 0.00% and a credit spread adjustment of 0.10% p. 91.
- The base rate is the highest of (i) the Agent’s then-current prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) p. 91.
- The Company pays a fee ranging from 0.20% to 0.35% on average daily undrawn amounts under the Term Loan Facility, depending on the Company’s debt to capitalization ratio p. 91.
- The Tranche A DDTL matures on January 1, 2028 p. 91.
- The Tranche B DDTL matures on July 2, 2029 p. 91.
- On December 30, 2025, the Company drew USD 150.0m from the Tranche A DDTL and USD 150.0m from the Tranche B DDTL for the acquisition of Apollo on January 1, 2026 p. 91.
- The Term Loan Facility includes customary covenants, such as limitations on additional indebtedness exceeding USD 10.0m and on distributions to stockholders, stock redemptions, repurchases, or retirements upon certain events p. 91.
- Financial covenants for the Term Loan Facility include minimum consolidated net worth, maximum total debt to capitalization, minimum A.M. Best rating, and minimum liquidity p. 91.
- As of December 31, 2025, the Company was in compliance with all Term Loan Facility covenants p. 91.
- The Term Loan Facility is unsecured p. 91.
- The Company's obligations under the Term Loan Facility are guaranteed by the Company and its existing wholly-owned subsidiaries, and subsequently acquired or organized subsidiaries, excluding insurance company subsidiaries and subject to certain exceptions p. 91.
- During the fourth quarter of 2025, the Company entered into a Revolving Credit Facility with a syndicate of banks p. 91.
- The Revolving Credit Facility is unsecured and initially provided a maximum principal amount of USD 150.0m p. 91.
- The Revolving Credit Facility maximum principal amount was increased to USD 250.0m on the closing date of the Apollo acquisition p. 91.
- The Company initially drew USD 43.0m from the Revolving Credit Facility to redeem its prior revolving credit facility p. 91.
- On December 30, 2025, the Company drew an additional USD 71.5m from the Revolving Credit Facility for the consideration paid for the acquisition of Apollo p. 91.
- Proceeds from the Term Loan Facility and the Revolving Credit Facility draws are presented net with liabilities on the Consolidated Balance Sheets for the year ended December 31, 2025 p. 91.
- These proceeds were used for the Apollo acquisition on January 1, 2026 p. 91.
- Interest on the Revolving Credit Facility is payable quarterly p. 91.
- Amounts drawn under the Revolving Credit Facility bear interest at either term SOFR plus a margin ranging from 150 bps to 190 bps, or the base rate plus a margin ranging from 50 bps to 90 bps, depending on the Company’s debt to capitalization ratio p. 91.
- SOFR for the Revolving Credit Facility is calculated using a SOFR floor of 0.00% and a credit spread adjustment of 0.10% p. 91.
- The base rate for the Revolving Credit Facility is the highest of (i) the Agent’s then current prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) p. 91.
- The Company pays a fee ranging from 0.20% to 0.35% on average daily undrawn amounts under the Revolving Credit Facility, depending on the Company’s debt to capitalization ratio p. 91.
- The availability period under the Revolving Credit Facility terminates on November 12, 2030 p. 91.
- The Company is subject to covenants on the Revolving Credit Facility based on minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity p. 91.
- As of December 31, 2025, the Company was in compliance with all Revolving Credit Facility covenants p. 91.
- During the first quarter of 2023, the Company entered into an agreement for an unsecured 2023 Revolving Credit Facility with a syndicate of banks p. 91.
- The 2023 Revolving Credit Facility provided up to USD 150.0m in revolving credit and a letter of credit sub-facility of up to USD 30.0m p. 91.
- On November 13, 2025, the Company redeemed the 2023 Revolving Credit Facility p. 91.
- The Company paid USD 0.3m of accrued interest and recognized USD 0.6m of expense for remaining unamortized deferred financing costs upon redemption of the 2023 Revolving Credit Facility p. 91.
- In May 2019, the Company agreed to issue unsecured subordinated notes (the Notes) with an aggregate principal amount of USD 20.0m p. 91.
- Interest on the Notes is fixed at 7.25% for the first 8 years and 8.25% thereafter p. 91.
- Early retirement of the Notes before the 8-year commitment requires all interest payments to be paid in full, plus the return of outstanding principal p. 91.
- Principal for the Notes is due at maturity on May 24, 2039, and interest is payable quarterly p. 91.
- The Notes have junior priority to all previously issued debt p. 91.
- The Company reports debt related to the Notes in its December 31, 2025 and 2024 Consolidated Balance Sheets, net of debt issuance costs of approximately USD 0.4m and USD 0.5m, respectively p. 91.
- These deferred financing costs are presented as a direct deduction from the carrying amount of the subordinated debt p. 91.
12. Segment
| Key facts & figures | |
|---|---|
| Number of segments | one |
| Segment basis | commercial property and casualty products |
| Segment profit measure | gross written premiums by net underwriting division, underwriting income, and income before income taxes |
- The Company operates with one reportable segment, offering commercial property and casualty products and solutions primarily in the United States on both non-admitted (E&S) and admitted bases p. 92.
- The segment consists of nine distinct underwriting divisions, referred to as "continuing business," each with dedicated underwriting leadership and technical staff p. 92.
- The segment definition is based on how internally reported financial information is reviewed by the Chief Operating Decision Maker (CODM) for performance analysis, decision-making, and resource allocation p. 92.
- The Company's CODM is the chief executive officer p. 92.
- The accounting policies for the segment align with those described in Note 1 "Summary of Significant Accounting Policies" of the Form 10-K p. 92.
- The CODM evaluates segment performance and allocates resources using gross written premiums by net underwriting division, underwriting income, and income before income taxes (which is also reported on the Consolidated Statements of Operations) p. 92.
- Segment assets are measured as total consolidated assets on the Consolidated Balance Sheets p. 92.
- Gross written premiums by underwriting division, net underwriting income, and consolidated net income are used to monitor budget versus actual results p. 92.
- The CODM uses net underwriting income, annualized return on equity, and growth in book value per share for competitive analysis by benchmarking against competitors p. 92.
- This competitive analysis and the monitoring of budgeted versus actual results are used to assess segment performance and determine management's compensation p. 92.
Segment information
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Accident & Health | 254,102 | 173,073 | 151,701 |
| Agriculture and Credit (Re)insurance | 346,212 | 118,070 | 30,598 |
| Captives | 275,694 | 241,902 | 167,624 |
| Construction & Energy Solutions | 274,318 | 296,582 | 299,748 |
| Global Property | 178,128 | 201,796 | 242,593 |
| Professional Lines | 149,231 | 159,785 | 154,565 |
| Specialty Programs | 322,705 | 218,407 | 178,726 |
| Surety | 168,148 | 143,965 | 106,056 |
| Transactional E&S | 197,779 | 189,669 | 128,236 |
| Total continuing business | 2,166,317 | 1,743,249 | 1,459,847 |
| Exited business | ( 81 ) | ( 17 ) | ( 18 ) |
| Total gross written premiums | 2,166,236 | 1,743,232 | 1,459,829 |
Underwriting income
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Underwriting income | |||
| Revenues: | — | — | — |
| Net earned premiums | 1,304,505 | 1,056,722 | 829,143 |
| Commission and fee income | 6,855 | 6,703 | 6,064 |
| Total underwriting revenues | 1,311,360 | 1,063,425 | 835,207 |
| Losses and LAE | 795,022 | 669,809 | 515,237 |
| Amortization of policy acquisition costs | 195,422 | 149,975 | 108,514 |
| Other operating and general expenses | 181,937 | 161,782 | 134,930 |
| Total underwriting expenses | 1,172,381 | 981,566 | 758,681 |
| Net underwriting income | 138,979 | 81,859 | 76,526 |
| Reconciliation of net underwriting income to net income: | — | — | — |
| Net underwriting income | 138,979 | 81,859 | 76,526 |
| Add: | — | — | — |
| Net investment income | 83,619 | 80,600 | 40,340 |
| Net investment gains | 22,149 | 6,342 | 11,054 |
| Other loss | ( 587 ) | ( 167 ) | ( 632 ) |
| Transaction costs | 14,019 | — | — |
| Interest expense | 7,919 | 9,496 | 10,024 |
| Amortization expense | 1,636 | 2,007 | 1,798 |
| Other expenses | 4,162 | 4,392 | 5,364 |
| Income before income taxes | 216,424 | 152,739 | 110,102 |
| Income tax expense | 46,396 | 33,911 | 24,118 |
| Net income | 170,028 | 118,828 | 85,984 |
| — | 2025 | 2024 | 2023 |
|---|---|---|---|
| Return on equity | 18.9% | 16.3% | 15.9% |
| Book value per share | 24.92 | 19.79 | 16.72 |
13. Income Taxes
| Key facts & figures | |
|---|---|
| Federal income taxes paid | 2024: USD 37.0m |
| Federal net operating loss carryforwards | USD 40.3m |
| NOL expiration | beginning in 2032 |
| 382 limitation expiration | USD 2.8m |
| State and local net operating losses | USD 0.9m |
| Federal income tax returns subject to examination | 2022-2024 |
- The Company paid federal income taxes of USD 37.0m in 2024 and USD 15.8m in 2023 p. 93.
- The Company has federal net operating loss carryforwards of approximately USD 40.3m p. 93.
- These net operating losses are set to expire beginning in 2032 p. 93.
- Internal Revenue Code Section 382 limits the utilization of USD 40.3m of net operating losses due to an ownership change in 2014 p. 93.
- The 382 limitation is expected to result in an expiration of USD 2.8m (USD 0.6m tax effected) of net operating losses p. 93.
- A valuation allowance was established in 2025 against the balance expected to expire without utilization p. 93.
- Of the total federal NOL of USD 40.3m, USD 0.3m (USD 0.1m tax effected) is related to dual consolidated loss that Skyward is not expected to utilize p. 93.
- The Company also has net operating losses in various state and local jurisdictions totaling USD 0.9m p. 93.
- These state and local net operating losses are set to expire between 5 and 20 years or carryforward indefinitely, depending on the jurisdiction p. 93.
- The Company expects to fully utilize these state and local net operating losses p. 93.
- The Company’s federal income tax returns for tax years 2022-2024 are subject to examination by the Internal Revenue Service p. 93.
- As of December 31, 2025, the Company had no provision for uncertain tax positions and no provision for penalties or interest p. 93.
- Management does not believe there are any uncertain tax benefits that could be recognized within the next twelve months that would impact the Company’s effective tax rate p. 93.
Income tax expense from continuing operations
| ($ in thousands) | 2025 |
|---|---|
| Income from continuing operations before income tax expense | — |
| United States | 208,763 |
| Foreign | 7,661 |
| Total | 216,424 |
| Current tax expense | — |
| United States | 51,758 |
| U.S. state and local | 1,107 |
| Deferred tax benefit related to: | — |
| United States | ( 5,584 ) |
| U.S. state and local | ( 885 ) |
| Total income tax expense | 46,396 |
Income tax expense
| ($ in thousands) | 2024 | 2023 |
|---|---|---|
| Current income tax expense | 42,626 | 14,736 |
| Deferred tax (benefit) expense related to temporary differences | ( 8,715 ) | 9,382 |
| Total income tax expense | 33,911 | 24,118 |
U.S. federal statutory income tax rate reconciliation
| 2025 | ||
|---|---|---|
| ($ in thousands) | Amount | Percentage |
| U.S. federal statutory income tax rate | 45,449 | 21.0% |
| State income taxes, net of federal benefit (1) | ( 508 ) | ( 0.3 )% |
| Foreign tax effects | — | — |
| Bermuda statutory rate differential | ( 1,609 ) | ( 0.7 )% |
| Effects of other cross-border tax laws | 717 | 0.3% |
| Change of Valuation Allowance | 68 | —% |
| Nondeductible and Nontaxable items | — | — |
| Nondeductible transaction costs | 1,689 | 0.8% |
| Other nondeductible and nontaxable items | 590 | 0.3% |
| Effective tax rate | 46,396 | 21.4% |
(1) The following state(s) and/or local jurisdictions make up more than 50% of the state income taxes: Florida.
Income tax expense at federal statutory rate
| 2024 | 2023 | |||
|---|---|---|---|---|
| ($ in thousands) | Amount | Percentage | Amount | Percentage |
| Income tax expense at federal statutory rate | 32,075 | 21.0% | 23,121 | 21.0% |
| Tax advantaged investments | ( 239 ) | ( 0.2 ) | ( 295 ) | ( 0.3 ) |
| Other | 2,075 | 1.4 | 1,292 | 1.2 |
| Total income tax expense | 33,911 | 22.2% | 24,118 | 21.9% |
Total income taxes paid
| ($ in thousands) | 2025 |
|---|---|
| United States | 49,830 |
| U.S. state and local (1) | 1,164 |
| Total income taxes paid | 50,994 |
(1) No single state or jurisdiction accounts for greater than 5% of total taxes paid.
Deferred tax assets
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Deferred tax assets: | — | — |
| Net operating losses | 9,409 | 9,389 |
| Losses and loss adjustment expenses | 21,401 | 16,967 |
| Unearned premiums | 22,775 | 18,178 |
| Unrealized losses on fixed maturity securities, available-for-sale | — | 5,893 |
| Stock options/awards | 2,446 | 2,453 |
| Other | 8,933 | 6,067 |
| Total deferred tax assets before valuation allowance | 64,964 | 58,947 |
| Valuation allowance | ( 654 ) | ( 586 ) |
| Total deferred tax assets | 64,310 | 58,361 |
| Deferred policy acquisition costs | 19,132 | 15,277 |
| Other long-term investments | 2,888 | 2,625 |
| Section 481(a) adjustment | 87 | 1,391 |
| Unrealized gains on equity securities | 7 | 4,818 |
| Unrealized gains on fixed maturity securities, available-for-sale | 3,101 | — |
| Unrealized gains on other investments | 5,465 | — |
| Depreciation | 2,152 | 1,426 |
| Other | 3,613 | 2,338 |
| Total deferred tax liabilities | 36,445 | 27,875 |
| Net deferred tax asset | 27,865 | 30,486 |
Valuation allowance activity
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Balance at beginning of the period | 586 | 586 |
| Increase related to net operating loss | 68 | — |
| Balance at the end of the period | 654 | 586 |
Tax Legislative Update
| Key facts & figures | |
|---|---|
| OBBB Act signed into law | July 4, 2025 |
- The One Big Beautiful Bill Act ("OBBB Act"), which includes a broad range of tax reform provisions, was signed into law in the United States on July 4, 2025 p. 94.
- The OBBB Act did not have a material impact on the Company's annual effective tax rate in 2025 p. 94.
- No material impact from the OBBB Act is expected in 2026 p. 94.
14. Reserves for Losses and Loss Adjustment Expenses
| Key facts & figures | |
|---|---|
| Favorable development prior years | FY25: USD 7.5m |
| Favorable development short-tail/monoline specialty lines | FY25: USD 24.6m |
| Favorable development multi-line solutions | FY25: USD 5.3m |
- The Company evaluates net ultimate loss and LAE under three sub-categories: multi-line solutions, short-tail/monoline specialty lines, and exited lines p. 95.
- These disaggregated groupings have homogeneous risk characteristics, similar development patterns, and are subject to similar trends p. 95.
- Short-tail/monoline specialty lines include global property & agriculture, accident & health, surety, and professional lines underwriting divisions p. 95.
- These lines generally have shorter durations for losses to fully develop, with claims typically reported, settled, and paid within a relatively short timeframe p. 95.
- Short-tail/monoline specialty lines can be impacted by larger, more complex losses due to factors like difficulty in determining actual damages and legal/regulatory impediments p. 95.
- Multi-line solutions include industry solutions, programs, captives, and transactional E&S underwriting divisions p. 95.
- This subcategory predominantly consists of occurrence liability, including general liability, excess liability, and commercial auto p. 95.
- Multi-line solutions have a longer duration for losses to fully develop compared to short-tail/monoline specialty lines p. 95.
- The unique claim characteristics and longer-tail nature of multi-line solutions introduce more uncertainty, as claims can be impacted by changes in regulation, inflation, and other unforeseen factors over time p. 95.
- Exited lines include all underwriting units placed in run-off and are presented separately from ongoing lines of business p. 95.
- For the year ended December 31, 2025, the Company recognized favorable development related to prior years’ loss and loss expense reserves of USD 7.5m p. 95.
- This was driven by favorable development of USD 24.6m in short-tail/monoline specialty lines and USD 5.3m in multi-line solutions p. 95.
- This was partially offset by USD 22.4m of adverse development in exited lines p. 95.
- The adverse development in exited lines was primarily attributable to commercial auto and excess over auto in divisions that have been non-renewed or had significantly reduced exposure over the past three years p. 95.
- This was offset by favorable development in surety and property p. 95.
- For the year ended December 31, 2024, the Company recognized adverse development related to prior years’ loss and loss expense reserves of USD 25.7m p. 95.
- This was primarily related to losses previously subject to the LPT from accident years 2018 and prior p. 95.
- This included USD 10.1m in multi-line solutions and USD 15.2m in exited lines p. 95.
- During the year ended December 31, 2023, the Company recognized adverse development related to prior years’ loss and loss expense reserves of USD 10.8m p. 95.
- Adverse development of USD 11.7m in multi-line solutions was driven by greater than expected severity in auto, general, and excess liability lines of business, primarily from accident years 2020 to 2022 p. 95.
- This adverse development was partially offset by favorable development in short-tail/monoline specialty lines p. 95.
- The favorable development in short-tail/monoline specialty lines was in the property line of business, primarily from accident years 2021 and 2022 p. 95.
Reserves for losses and LAE, net of reinsurance
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Reserves for losses and LAE, beginning of period | 1,782,383 | 1,314,501 | 1,141,757 |
| Less: reinsurance recoverable on unpaid claims, beginning of period | ( 670,846 ) | ( 455,484 ) | ( 435,986 ) |
| Reserves for losses and LAE, beginning of period, net of reinsurance | 1,111,537 | 859,017 | 705,771 |
| Incurred, net of reinsurance, related to: | — | — | — |
| Current period | 810,375 | 657,783 | 505,894 |
| Prior years | ( 7,471 ) | 25,728 | 10,770 |
| Total incurred, net of reinsurance | 802,904 | 683,511 | 516,664 |
| Paid, net of reinsurance, related to: | — | — | — |
| Current period | 144,799 | 136,731 | 109,937 |
| Prior years | 371,913 | 294,260 | 253,481 |
| Total paid | 516,712 | 430,991 | 363,418 |
| Net reserves for losses and LAE, end of period | 1,397,729 | 1,111,537 | 859,017 |
| Plus: reinsurance recoverable on unpaid claims, end of period | 921,165 | 670,846 | 455,484 |
| Reserves for losses and LAE, end of period | 2,318,894 | 1,782,383 | 1,314,501 |
Short Duration Contract Disclosures
- Losses and LAE reserves represent the Company's best estimate of the ultimate net cost of all reported and unreported losses that are unpaid as of the balance sheet dates p. 96.
- The Company's estimated reserves for losses and LAE include the accumulation of estimates for claims reported and unpaid prior to the balance sheet dates p. 96.
- Estimates for losses and LAE also include projections of relevant historical data for increases in claims costs for claims already reported p. 96.
- Estimates for losses and LAE include claims incurred but not reported p. 96.
- Estimates for losses and LAE include expenses for investigating and adjusting all incurred and unpaid claims p. 96.
- The Company measures claim counts by incident when determining the cumulative number of reported claims p. 96.
- Claim counts include all claims reported, even if the Company does not establish a liability for the claim (i.e., reserve for loss and loss adjustment expenses) p. 96.
Incurred losses and ALAE, net of reinsurance
| ($ in thousands except number of claims) | |||||||
|---|---|---|---|---|---|---|---|
| Incurred Losses and ALAE, Net of Reinsurance | As of December 31, 2025 | ||||||
| Years Ended December 31, | Reported Claims | ||||||
| Accident Year | 2021* | 2022* | 2023* | 2024* | 2025 | IBNR | Reported Claims |
| 2021 | 92,780 | 93,429 | 92,143 | 92,134 | 99,783 | 1,774 | 1,656 |
| 2022 | — | 108,299 | 105,394 | 104,095 | 96,874 | 6,266 | 2,414 |
| 2023 | — | — | 190,565 | 191,865 | 161,222 | 28,997 | 5,015 |
| 2024 | — | — | — | 280,147 | 292,220 | 99,302 | 5,819 |
| 2025 | — | — | — | — | 422,528 | 275,190 | 5,495 |
| Total | — | — | — | — | 1,072,627 | — | — |
| Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | ( 528,255 ) | — | — |
| Net reserves for loss and ALAE before 2021 | Net reserves for loss and ALAE before 2021 | Net reserves for loss and ALAE before 2021 | Net reserves for loss and ALAE before 2021 | Net reserves for loss and ALAE before 2021 | 1,570 | — | — |
| Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | 545,942 | — | — |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
Cumulative paid losses and ALAE, net of reinsurance
| ($ in thousands) | |||||
|---|---|---|---|---|---|
| Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) | |||||
| Years Ended December 31, | |||||
| Accident Year | 2021* | 2022* | 2023* | 2024* | 2025 |
| 2021 | 18,447 | 56,803 | 67,912 | 78,439 | 93,560 |
| 2022 | — | 27,773 | 64,594 | 77,150 | 85,696 |
| 2023 | — | — | 33,795 | 100,705 | 114,247 |
| 2024 | — | — | — | 53,691 | 154,896 |
| 2025 | — | — | — | — | 79,856 |
| Total | — | — | — | — | 528,255 |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
Incurred losses and ALAE, net of reinsurance by accident year
| ($ in thousands except number of claims) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) | As of December 31, 2025 | |||||||||||
| Accident Year | Years Ended December 31, | Reported Claims | ||||||||||
| Accident Year | 2016* | 2017* | 2018* | 2019* | 2020* | 2021* | 2022* | 2023* | 2024* | 2025 | IBNR | Reported Claims |
| 2016 | 63,223 | 62,843 | 62,843 | 62,643 | 84,579 | 84,579 | 84,829 | 84,829 | 85,434 | 85,098 | 828 | 4,744 |
| 2017 | — | 65,332 | 65,332 | 64,260 | 78,166 | 78,166 | 78,766 | 78,766 | 80,493 | 79,819 | 837 | 5,592 |
| 2018 | — | — | 74,476 | 74,476 | 69,319 | 71,719 | 73,019 | 73,019 | 75,686 | 72,963 | 673 | 5,103 |
| 2019 | — | — | — | 107,432 | 109,226 | 112,378 | 115,530 | 116,230 | 116,206 | 110,564 | 1,384 | 6,113 |
| 2020 | — | — | — | — | 113,030 | 124,076 | 128,111 | 132,495 | 132,125 | 134,281 | 4,174 | 5,542 |
| 2021 | — | — | — | — | — | 156,067 | 158,891 | 160,331 | 160,546 | 157,006 | 7,932 | 6,727 |
| 2022 | — | — | — | — | — | — | 236,909 | 242,097 | 242,358 | 249,317 | 19,315 | 8,679 |
| 2023 | — | — | — | — | — | — | — | 306,511 | 306,511 | 320,637 | 96,700 | 8,468 |
| 2024 | — | — | — | — | — | — | — | — | 353,933 | 336,197 | 155,878 | 7,700 |
| 2025 | — | — | — | — | — | — | — | — | — | 356,590 | 257,468 | 6,139 |
| Total | — | — | — | — | — | — | — | — | — | 1,902,472 | — | — |
| Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | ( 1,162,853 ) | — | — |
| Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | ( 189 ) | — | — |
| Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | 739,430 | — | — |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
Cumulative paid losses and ALAE, net of reinsurance by accident year
| ($ in thousands) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) | ||||||||||
| Years Ended December 31, | ||||||||||
| Accident Year | 2016* | 2017* | 2018* | 2019* | 2020* | 2021* | 2022* | 2023* | 2024* | 2025 |
| 2016 | 23,239 | 42,528 | 53,352 | 58,895 | 69,691 | 72,544 | 75,855 | 77,160 | 77,760 | 77,825 |
| 2017 | — | 23,770 | 41,945 | 53,093 | 61,354 | 67,926 | 71,109 | 73,770 | 75,714 | 77,177 |
| 2018 | — | — | 26,201 | 42,568 | 47,226 | 58,655 | 65,635 | 69,893 | 70,128 | 72,429 |
| 2019 | — | — | — | 33,019 | 50,933 | 71,053 | 87,816 | 99,451 | 106,765 | 106,826 |
| 2020 | — | — | — | — | 29,499 | 60,680 | 82,236 | 105,283 | 121,097 | 126,965 |
| 2021 | — | — | — | — | — | 37,118 | 73,293 | 102,772 | 125,749 | 141,539 |
| 2022 | — | — | — | — | — | — | 50,148 | 114,794 | 165,854 | 205,410 |
| 2023 | — | — | — | — | — | — | — | 63,079 | 122,186 | 181,636 |
| 2024 | — | — | — | — | — | — | — | — | 58,281 | 123,488 |
| 2025 | — | — | — | — | — | — | — | — | — | 49,558 |
| Total | — | — | — | — | — | — | — | — | — | 1,162,853 |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
Exited Lines — all lines in runoff
- The provided table reconciles net incurred and paid loss development tables to balance sheet reserves for losses and loss adjustment expenses as of December 31, 2025 and 2024 p. 97.
- The subsequent table details the historical average annual payout of incurred losses and allocated loss adjustment expenses (claims duration) for short-duration contracts p. 97.
- This claims duration data is based on disaggregated information from paid loss development tables, net of reinsurance p. 97.
Incurred losses and ALAE, net of reinsurance by accident year
| ($ in thousands except number of claims) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) | As of December 31, 2025 | |||||||||||
| Years Ended December 31, | Reported Claims | |||||||||||
| Accident Year | 2016* | 2017* | 2018* | 2019* | 2020* | 2021* | 2022* | 2023* | 2024* | 2025 | IBNR | Reported Claims |
| 2016 | 93,019 | 92,996 | 91,372 | 93,577 | 97,301 | 98,301 | 100,651 | 100,651 | 102,801 | 104,246 | 1,851 | 4,911 |
| 2017 | — | 75,159 | 79,581 | 81,785 | 65,735 | 68,346 | 68,646 | 68,646 | 70,885 | 72,682 | 1,819 | 4,370 |
| 2018 | — | — | 74,357 | 68,990 | 76,506 | 79,006 | 84,165 | 84,165 | 92,082 | 91,897 | 4,093 | 4,941 |
| 2019 | — | — | — | 87,115 | 73,635 | 77,770 | 79,414 | 79,572 | 79,823 | 86,131 | 9,773 | 5,660 |
| 2020 | — | — | — | — | 132,248 | 136,469 | 137,835 | 137,907 | 137,671 | 138,320 | 10,644 | 4,867 |
| 2021 | — | — | — | — | — | 83,322 | 91,188 | 91,323 | 92,095 | 97,577 | 10,676 | 2,446 |
| 2022 | — | — | — | — | — | — | 12,717 | 12,240 | 11,800 | 14,362 | 2,025 | 246 |
| 2023 | — | — | — | — | — | — | — | — | — | 2 | 1 | 1 |
| 2024 | — | — | — | — | — | — | — | — | — | 5 | 5 | — |
| 2025 | — | — | — | — | — | — | — | — | — | 11 | 11 | — |
| Total | — | — | — | — | — | — | — | — | — | 605,233 | — | — |
| Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | ( 538,304 ) | — | — |
| Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | 14,737 | — | — |
| Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | 81,666 | — | — |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
Cumulative paid losses and ALAE, net of reinsurance by accident year
| ($ in thousands) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) | ||||||||||
| Years Ended December 31, | ||||||||||
| Accident Year | 2016* | 2017* | 2018* | 2019* | 2020* | 2021* | 2022* | 2023* | 2024* | 2025 |
| 2016 | 36,592 | 57,638 | 70,253 | 78,070 | 81,181 | 87,482 | 91,556 | 95,114 | 97,462 | 98,831 |
| 2017 | — | 34,176 | 52,103 | 51,985 | 50,545 | 57,457 | 62,924 | 66,498 | 68,480 | 69,798 |
| 2018 | — | — | 25,553 | 60,149 | 39,870 | 54,339 | 67,001 | 74,604 | 79,860 | 82,244 |
| 2019 | — | — | — | 28,636 | 28,954 | 30,948 | 45,696 | 57,341 | 65,847 | 70,367 |
| 2020 | — | — | — | — | 102,725 | 98,202 | 102,132 | 114,543 | 120,831 | 124,139 |
| 2021 | — | — | — | — | — | 41,540 | 57,820 | 66,012 | 72,923 | 81,600 |
| 2022 | — | — | — | — | — | — | 2,155 | 4,077 | 9,211 | 11,325 |
| 2023 | — | — | — | — | — | — | — | — | — | — |
| 2024 | — | — | — | — | — | — | — | — | — | — |
| 2025 | — | — | — | — | — | — | — | — | — | — |
| Total | — | — | — | — | — | — | — | — | — | 538,304 |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
Net reserves for losses and ALAE
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Net reserves for losses and ALAE: | — | — |
| Short-tail/Monoline Specialty Lines | 545,942 | 367,226 |
| Multi-line Solutions | 739,430 | 631,065 |
| Exited Lines | 81,666 | 86,689 |
| Reserves for losses and ALAE, net of reinsurance | 1,367,038 | 1,084,980 |
| Reinsurance recoverable on unpaid claims: | — | — |
| Short-tail/Monoline Specialty Lines | 388,276 | 275,204 |
| Multi-line Solutions | 514,393 | 380,344 |
| Exited Lines | 18,496 | 15,298 |
| Total reinsurance recoverable on unpaid claims | 921,165 | 670,846 |
| Unallocated LAE | 30,691 | 26,557 |
| Reserves for losses and LAE at end of year | 2,318,894 | 1,782,383 |
Average annual percentage payout of incurred claims by age
| Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Years | ||||||||||
| — | 1* | 2* | 3* | 4* | 5* | 6* | 7* | 8* | 9* | 10* |
| Short-Tail/Monoline Specialty Lines | 21.1% | 38.1% | 10.8% | 9.7% | 15.2% | N/A | N/A | N/A | N/A | N/A |
| Multi-line Solutions | 23.9% | 21.6% | 15.6% | 13.6% | 10.5% | 4.8% | 1.9% | 2.4% | 1.3% | 0.1% |
| Exited Lines | 27.5% | 12.2% | 4.9% | 9.9% | 8.9% | 6.8% | 4.9% | 2.9% | 2.0% | 1.3% |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | — | — | — | — | — | — |
15. Commission and Fee Income
- Skyward Underwriters Agency, Inc. (SUA) is a subsidiary of the Company p. 98.
- SUA acts as a managing general insurance agent and reinsurance broker p. 98.
- SUA specializes in property and casualty and accident and health risks within specialty niche markets p. 98.
- Commission and fee income is primarily generated by SUA p. 98.
- This income is derived from the placement of insurance policies with third-party insurance or reinsurance companies p. 98.
Net commission and fee income
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| SUA commission revenue | 8,323 | 7,967 | 7,222 |
| SUA fee revenue | 2,333 | 2,443 | 2,732 |
| Other commission and fee revenue (loss) | 1,725 | 266 | ( 135 ) |
| Total commission and fee revenue | 12,381 | 10,676 | 9,819 |
| Commission and fee expenses | ( 5,526 ) | ( 3,973 ) | ( 3,755 ) |
| Net commission and fee income | 6,855 | 6,703 | 6,064 |
Contract assets balance
| ($ in thousands) | Contract Assets |
|---|---|
| Balance at December 31, 2023 | 976 |
| Balance at December 31, 2024 | 1,416 |
16. Underwriting, Acquisition and Insurance Expenses
| Key facts & figures | |
|---|---|
| Underwriting, acquisition and insurance expenses | FY25: USD 390.0m |
| Commissions and brokerage | FY25: USD 190.0m |
| Salaries and employee benefits | FY25: USD 110.0m |
| General and administrative expenses | FY25: USD 90.0m |
- Underwriting, acquisition and insurance expenses were USD 390.0m in 2025, USD 330.0m in 2024, and USD 270.0m in 2023 p. 99.
- Commissions and brokerage were USD 190.0m in 2025, USD 160.0m in 2024, and USD 130.0m in 2023 p. 99.
- Salaries and employee benefits were USD 110.0m in 2025, USD 90.0m in 2024, and USD 70.0m in 2023 p. 99.
- General and administrative expenses were USD 90.0m in 2025, USD 80.0m in 2024, and USD 70.0m in 2023 p. 99.
Underwriting, acquisition and insurance expenses
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Amortization of policy acquisition costs | 195,422 | 149,975 | 108,514 |
| Other operating and general expenses | 181,937 | 161,782 | 134,930 |
| Total underwriting, acquisition and insurance expenses | 377,359 | 311,757 | 243,444 |
17. Reinsurance
| Key facts & figures | |
|---|---|
| Market value of trust accounts | Dec 31, 2025: $233.5 million |
| Reinsurance recoverable from R&Q | Dec 31, 2024: $22.7 million |
| LPT commuted | Jan 31, 2025 |
| Deposit asset | Dec 31, 2025: $22.7 million |
- Reinsurance agreements are used to assume and cede premiums and benefits with other insurance companies p. 100.
- Reinsurance agreements increase the Company's capacity to write larger risks and manage loss exposure within its capital resources p. 100.
- The Company remains obligated for ceded amounts if reinsurers fail to meet their obligations p. 100.
- The Company entered into agreements with several reinsurers to establish funded trust accounts where the Company is the sole beneficiary p. 100.
- These trust accounts provide additional security for collecting claim recoverables under reinsurance contracts p. 100.
- The Company does not carry these trust accounts on its balance sheet as it only gains custody upon the reinsurer's failure to pay p. 100.
- The market value of these trust accounts was approximately $233.5 million at December 31, 2025 p. 100.
- The trust amount will be periodically adjusted by mutual agreement based on claim payments and loss reserve recoverables p. 100.
- During Q1 2020, the Company entered into an LPT retroactive reinsurance agreement with R&Q p. 100.
- The reinsurance recoverable from R&Q was $22.7 million at December 31, 2024 p. 100.
- The LPT was commuted effective January 31, 2025, and the Company received the reinsurance recoverable balance in full p. 100.
- Certain ceded reinsurance contracts that transfer only significant timing risk and insufficient underwriting risk are accounted for using the deposit method p. 100.
- The Company’s deposit asset was $22.7 million at December 31, 2025, and $25.9 million at December 31, 2024 p. 100.
- The deposit asset was included in other assets on the Consolidated Balance Sheets p. 100.
Premiums and ceded losses and LAE incurred
| 2025 | 2024 | 2023 | ||||
|---|---|---|---|---|---|---|
| ($ in thousands) | Written | Earned | Written | Earned | Written | Earned |
| Direct premiums | 1,684,411 | 1,622,594 | 1,458,637 | 1,375,917 | 1,241,180 | 1,155,835 |
| Assumed premiums | 481,825 | 406,792 | 284,595 | 282,662 | 218,649 | 193,971 |
| Ceded premiums | ( 760,004 ) | ( 724,881 ) | ( 619,654 ) | ( 601,857 ) | ( 549,138 ) | ( 520,663 ) |
| Net premiums | 1,406,232 | 1,304,505 | 1,123,578 | 1,056,722 | 910,691 | 829,143 |
| Ceded losses and LAE incurred | — | 697,978 | — | 534,295 | — | 337,011 |
Reinsurance recoverables
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Ceded unpaid losses and LAE | 921,165 | 670,846 |
| Ceded paid losses and LAE | 201,010 | 166,663 |
| Loss portfolio transfer | — | 22,662 |
| Allowance for credit losses | ( 2,295 ) | ( 2,295 ) |
| Reinsurance recoverables | 1,119,880 | 857,876 |
| Ceded unearned premium | 238,948 | 203,901 |
18. Stock Based Compensation
| Key facts & figures | |
|---|---|
| Shares available under 2022 Plan | 3,200,656 |
| Deferral program approved | November 2024 |
| Stock options granted to employees | FY23: $4.4 million |
| Aggregate intrinsic value of options outstanding | Dec 31, 2025: $27.4 million |
| Weighted-average remaining contractual life of options outstanding | Dec 31, 2025: 7.0 years |
- The 2022 Long-Term Incentive Plan (2022 Plan) was approved by the Board of Directors on September 23, 2022, and became effective on January 12, 2023 p. 101.
- The 2022 Plan replaced the Company’s prior Long Term Incentive Plan (2020 Plan) p. 101.
- The 2022 Plan allows for granting restricted stock, restricted stock units, performance stock units, stock options, and cash-based performance awards to select employees and non-employee directors p. 101.
- 3,200,656 shares of common stock were available for issuance under the 2022 Plan p. 101.
- In November 2024, the Compensation Committee approved a program for independent directors to defer settlement of annual restricted stock units (RSU) awards p. 101.
- Directors can elect to defer RSU settlement to the fifth anniversary of the grant date, the tenth anniversary of the grant date, or the date of separation of service from the Company p. 101.
- This deferral program was available for Directors who elected in 2024 to defer settlement of their 2025 RSU awards, which vest in 2026 p. 101.
- The grant date fair value of options under the 2022 Plan was determined using the Black-Scholes model, with a contractual term of 10 years less the weighted average service period p. 101.
- Volatility for option valuation was based on historical volatility of comparable publicly traded insurance companies p. 101.
- Stock options granted to employees during the year ended December 31, 2023, were valued at approximately $4.4 million based on grant date fair value p. 101.
- The aggregate intrinsic value of options outstanding was $27.4 million at December 31, 2025, and $27.0 million at December 31, 2024 p. 101.
- The weighted-average remaining contractual life of options outstanding at December 31, 2025, was 7.0 years p. 101.
- The fair value of restricted stock and restricted stock units under the 2022 Plan for awards granted at the time of the Company’s IPO was the IPO price of $15.00 per share p. 101.
- The fair value of subsequent grants of restricted stock units was equal to the closing stock price on the grant date p. 101.
- The expense for equity-based incentives is based on fair value at grant date and amortized over their vesting period p. 101.
- Restricted stock and restricted stock units granted to employees and the Board of Directors were valued at approximately $12.2 million in 2025, $8.5 million in 2024, and $17.7 million in 2023, based on grant date fair value p. 101.
- Board of Directors were granted 12,579 shares in 2025, 19,453 shares in 2024, and 23,482 shares in 2023 of restricted stock and restricted stock units, each with a one-year service period p. 101.
- The total fair value of shares vested for employees and Board of Directors was $6.0 million in 2025, $3.8 million in 2024, and $0.5 million in 2023 p. 101.
- As of December 31, 2025, the total unrecognized compensation cost related to non-vested, stock-based compensation awards was $17.4 million p. 101.
- The weighted average period over which the unrecognized compensation cost is expected to be recognized is 1.6 years p. 101.
- The Company recognized stock-based compensation expense of $12.0 million in 2025, $9.4 million in 2024, and $8.5 million in 2023 p. 101.
- The 2022 Employee Stock Purchase Plan (ESPP) was approved by the Board of Directors on September 23, 2022, and became effective on May 15, 2023 p. 101.
- The ESPP is administered by the Compensation Committee p. 101.
- Under the ESPP, employees can elect to have a percentage of their annual base earnings withheld to purchase common stock at two specified intervals each year p. 101.
- The purchase price of common stock under the ESPP is 85% of the lower of its beginning-of-interval or end-of-interval market price p. 101.
- The Company has reserved 376,548 common shares under the ESPP p. 101.
- The grant date fair value of options under the ESPP was determined using the Black-Scholes model, with a term of 6 months (between grant date and exercisable date) p. 101.
- Volatility for ESPP option valuation was based on historical volatility of comparable publicly traded insurance companies p. 101.
- As of December 31, 2025, a total of 141,845 shares had been purchased under the ESPP p. 101.
- The Company recognized ESPP expense of $0.7 million in 2025 and $0.5 million in 2024 p. 101.
- As of December 31, 2025, the fair value of unrecognized ESPP expense was $0.3 million p. 101.
ESPP awards by type and service period
| Award Payout Range | Requisite Service Period | Target Stock and Stock Units | |
|---|---|---|---|
| Year ended December 31, 2025 | — | — | — |
| Market condition awards | 0 %- 150 % | 3 years | 22,495 |
| Performance condition awards | 0 %- 150 % | 3 years | 59,769 |
| Service condition awards | N/A | 1 - 4 years | 144,921 |
| — | — | — | 227,185 |
| Market condition awards | 0 %- 150 % | 3 years | 32,058 |
| Performance condition awards | 0 %- 150 % | 3 years | 76,881 |
| Service condition awards | N/A | 1 - 4 years | 124,025 |
| — | — | — | 232,964 |
| Market condition awards | 0 %- 150 % | 3 years | 37,622 |
| Performance condition awards | 0 %- 150 % | 3 years | 95,456 |
| Service condition awards | N/A | 1 - 4 years | 968,778 |
| Stock options | N/A | 3 - 4 years | 759,990 |
| — | — | — | 1,861,846 |
Stock option activity
| — | Weighted-Average Exercise Price | Stock |
|---|---|---|
| Outstanding at January 1, 2025 | — | 759,990 |
| Forfeited | 15.00 | ( 219 ) |
| Outstanding at December 31, 2025 | — | 759,771 |
Outstanding stock at year-end
| — | Stock |
|---|---|
| Outstanding at January 1, 2024 | 759,990 |
| Outstanding at December 31, 2024 | 759,990 |
Weighted-average grant-date fair value of stock and stock units
| — | Weighted-Average Grant-Date Fair Value | Stock and Stock Units |
|---|---|---|
| Non-vested at January 1, 2025 | 19.06 | 1,325,483 |
| Granted (1) | 47.77 | 254,978 |
| Vested | 15.33 | ( 391,746 ) |
| Forfeited (2) | 25.74 | ( 53,247 ) |
| Non-vested at December 31, 2025 | 27.06 | 1,135,468 |
| Non-vested at January 1, 2024 | 15.13 | 1,445,449 |
| Granted (1) | 31.72 | 268,631 |
| Vested | 13.16 | ( 285,957 ) |
| Forfeited (2) | 18.27 | ( 102,640 ) |
| Non-vested at December 31, 2024 | 19.06 | 1,325,483 |
| Non-vested at January 1, 2023 | 12.55 | 419,896 |
| Granted (1) | 16.07 | 1,101,856 |
| Vested | 13.39 | ( 40,645 ) |
| Forfeited (2) | 15.29 | ( 35,658 ) |
| Non-vested at December 31, 2023 | 15.13 | 1,445,449 |
(1) Increases above the 100% target level are reflected as granted in the period after which performance-based stock unit goals are achieved. (2) Decreases below the 100% target level are reflected as forfeited.
| Key facts & figures | |
|---|---|
| Years ended | December 31, 2025, 2024, and 2023 |
- The table sets forth the computation of basic and diluted net earnings per share for the years ended December 31, 2025, 2024, and 2023 p. 102.
- The table presents anti-dilutive instruments excluded from the calculation of diluted weighted-average common share equivalents for the years ended December 31, 2025, 2024, and 2023 p. 102.
- The table presents common share equivalents of contingently issuable instruments excluded from basic earnings per share for the years ended December 31, 2025, 2024, and 2023 p. 102.
| ($ in thousands, except for share and per share amounts) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Numerator | — | — | — |
| Net income | 170,028 | 118,828 | 85,984 |
| Less: Undistributed income allocated to participating securities | — | — | ( 1,677 ) |
| Net income attributable to common stockholders (numerator for basic earnings per share) | 170,028 | 118,828 | 84,307 |
| Add back: Undistributed income allocated to participating securities | — | — | 1,677 |
| Net income (numerator for diluted earnings per share under the two-class method) | 170,028 | 118,828 | 85,984 |
| Basic weighted-average common shares | 40,407,310 | 40,056,475 | 36,031,907 |
| Dilutive effect of preferred shares | — | — | 716,708 |
| Dilutive effect of stock notes | — | — | 696,110 |
| Dilutive effect of stock units | 897,426 | 917,510 | 736,837 |
| Dilutive effect of options | 503,310 | 403,475 | 135,972 |
| Diluted weighted-average common share equivalents | 41,808,046 | 41,377,460 | 38,317,534 |
| Basic earnings per share | 4.21 | 2.97 | 2.34 |
| Diluted earnings per share | 4.07 | 2.87 | 2.24 |
Stock units and options for 2023-2025
| — | 2025 | 2024 | 2023 |
|---|---|---|---|
| Stock units | 104,531 | 20,346 | 3,931 |
| Options | 242 | 859 | 914 |
| — | 2025 | 2024 | 2023 |
|---|---|---|---|
| Common shares | — | — | 920,864 |
| Total | — | — | 920,864 |
20. Employee Benefit Plan
| Key facts & figures | |
|---|---|
| Company matching contributions 2025 | USD 3.9m |
| Company matching contributions 2024 | USD 3.2m |
| Company matching contributions 2023 | USD 2.9m |
- The Company sponsors the 401(k) Plan (the “Plan”), which is available to substantially all its employees p. 103.
- The Plan is subject to provisions of the Employee Retirement Income Security Act of 1974 p. 103.
- The Company makes discretionary matching contributions to the Plan p. 103.
- Company matching contributions to the Plan were:
- 2025: USD 3.9m p. 103
- 2024: USD 3.2m p. 103
- 2023: USD 2.9m p. 103
Riscom
| Key facts & figures | |
|---|---|
| Ownership interest in RISCOM | 20% |
| Premiums receivable December 31, 2025 | USD 13.9m |
| Premiums receivable December 31, 2024 | USD 12.6m |
- RISCOM provides wholesale brokerage services to the Company p. 104.
- RISCOM and the Company have a managing general agency agreement p. 104.
- The Company holds a 20% ownership interest in RISCOM p. 104.
- Premiums receivable as of December 31, 2025, were USD 13.9m p. 104.
- Premiums receivable as of December 31, 2024, were USD 12.6m p. 104.
Premiums receivable and commissions
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net earned premium | 120,067 | 108,130 | 99,736 |
| Commissions | 28,728 | 25,372 | 24,177 |
Other
| Key facts & figures | |
|---|---|
| Advisory and professional services fees 2025 | USD 0.6m |
| Advisory and professional services fees 2024 | USD 0.6m |
| Advisory and professional services fees 2023 | USD 3.6m |
- Advisory and professional services fees and expense reimbursements paid to affiliated stockholders and directors were USD 0.6m for the years ended December 31, 2025 and 2024 p. 105.
- Advisory and professional services fees and expense reimbursements paid to affiliated stockholders and directors were USD 3.6m for the year ended December 31, 2023 p. 105.
- For investments involving affiliated companies and additional related party transactions, refer to Notes 5, 6, and 11 p. 105.
Litigation
- The Company is involved in various legal actions stemming from claims under insurance policies and contracts p. 106.
- These legal actions are factored into the Company's estimation of losses and loss adjustment expense reserves p. 106.
- The Company is occasionally a defendant in legal actions related to bad faith claims, disputes with third parties, or alleged errors and omissions p. 106.
- Accruals for these items are recorded when losses are probable and reasonably estimable p. 106.
- Based on current information, available insurance coverage, and advice from legal counsel, the Company believes the resolution of these matters will not individually or in aggregate have a material adverse effect on its consolidated financial position, results of operations, or cash flows p. 106.
Indemnification
- The Company has provided indemnifications to certain buyers in conjunction with the sale of business assets and subsidiaries p. 107.
- These indemnifications cover typical representations and warranties related to performance responsibilities under sales contracts p. 107.
- The potential exposure from these indemnifications is difficult to determine due to the variety of matters, operations, and scenarios covered p. 107.
- Certain indemnifications have no time limit p. 107.
- The Company currently does not believe any significant claims exist related to these indemnifications p. 107.
23. Statutory Accounting Principles and Regulatory Matters
| Key facts & figures | |
|---|---|
| Statutory net income 2025 | $159.1 million |
| Statutory net income 2024 | $108.2 million |
| Statutory net income 2023 | $73.1 million |
| Statutory capital and surplus December 31, 2025 | $872.0 million |
| Statutory capital and surplus December 31, 2024 | $710.6 million |
| Lead insurance company | GMIC |
| GMIC domicile | Texas |
- Statutory net income was $159.1 million for 2025, $108.2 million for 2024, and $73.1 million for 2023 p. 108.
- Statutory capital and surplus was $872.0 million as of December 31, 2025, and $710.6 million as of December 31, 2024 p. 108.
- Effective December 31, 2024, the Company restacked its insurance company subsidiaries, making GMIC the lead insurance company p. 108.
- Following the restacking, HSIC became a wholly owned subsidiary of GMIC p. 108.
- IIC became a wholly owned subsidiary of HSIC p. 108.
- OSIC became a wholly owned subsidiary of IIC p. 108.
- Dividend payments from GMIC to the Company are restricted by Texas state law, requiring regulatory approval for amounts exceeding certain limits p. 108.
- The maximum amount of dividends GMIC can pay without prior approval is subject to restrictions related to policyholder surplus, net income, and dividends declared or distributed in the preceding 12 months p. 108.
- As of December 31, 2025, GMIC, domiciled in Texas, is restricted to paying dividends that are the greater of ten percent of prior year-end capital and surplus or prior year net income p. 108.
- GMIC did not declare or pay any dividend during the year ended December 31, 2025 p. 108.
- HSIC did not declare or pay any dividends during the year ended December 31, 2024 p. 108.
- Property and casualty insurance companies are subject to Risk Based Capital (RBC) requirements specified by the National Association of Insurance Commissioners (NAIC) p. 108.
- RBC requirements dictate that the amount of capital and surplus maintained by an insurer should be based on its various risk factors p. 108.
- As of December 31, 2025, and 2024, GMIC’s statutory capital and surplus substantially exceeded the regulatory RBC requirements p. 108.
24. Subsequent Events
| Key facts & figures | |
|---|---|
| Acquisition date | January 1, 2026 |
| Acquisition consideration | USD 555.0 million |
| Acquired company | Apollo Group Holdings Limited |
| Acquired stake | 87% |
- On September 2, 2025, the Company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders (the "Majority Sellers") of Apollo Group Holdings Limited ("Apollo") p. 109.
- Pursuant to the Apollo Majority SPAs, the Company agreed to acquire all issued shares of Apollo held by the Majority Sellers, representing approximately 87% of Apollo's issued share capital p. 109.
- Closing of the transaction ("Closing") was conditioned upon the Company acquiring 100% of Apollo's issued share capital (the "Acquisition") at Closing, via additional short-form share purchase agreements with the remaining minority shareholders p. 109.
- On January 1, 2026, the Company completed the acquisition for an aggregate consideration of approximately USD 555.0 million, payable in a combination of cash and newly issued shares of the Company’s common stock p. 109.
- The acquisition closed shortly before the issuance of these consolidated financial statements, so the initial accounting under ASC 805 is not yet complete p. 109.
- The Company is obtaining and evaluating information to determine identifiable assets acquired, liabilities assumed, and any resulting goodwill or intangible assets p. 109.
- Required purchase accounting disclosures will be provided in future filings once available p. 109.
- The Company evaluated subsequent events from December 31, 2025, through the date these consolidated financial statements were issued and did not identify any additional subsequent events requiring disclosure p. 109.
Controls and Procedures
Evaluation of Disclosure Controls and Procedures
| Key facts & figures | |
|---|---|
| Effectiveness December 31, 2025 | effective at the reasonable assurance level |
- Management, including the principal executive officer and principal financial officer, evaluated the effectiveness of disclosure controls and procedures as of the end of the period covered by this Annual Report on Form 10-K p. 110.
- Disclosure controls and procedures are defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act) p. 110.
- As of December 31, 2025, the principal executive officer and principal financial officer concluded that the company's disclosure controls and procedures were effective at the reasonable assurance level p. 110.
- Management acknowledges that any controls and procedures can only provide reasonable assurance of achieving their objectives, and judgment is applied in evaluating the cost-benefit relationship of controls and procedures p. 110.
Management’s Report on Internal Control over Financial Reporting
- Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended p. 111.
- Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America p. 111.
- Internal control over financial reporting includes policies and procedures that pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of assets p. 111.
- Internal control over financial reporting includes policies and procedures that provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are made only in accordance with authorizations of management and directors p. 111.
- Internal control over financial reporting includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the financial statements p. 111.
Remediation of Material Weakness in Internal Control Over Financial Reporting
| Key facts & figures | |
|---|---|
| Material weakness December 31, 2024 | ineffective implementation of information technology general controls (ITGCs) in user access for systems supporting financial reporting processes |
| Effectiveness December 31, 2025 | effective at a reasonable assurance level |
| Framework | Committee of Sponsoring Organizations of the Treadway Commission in the Internal Control — Integrated Framework (2013 Framework) |
- Material weakness in internal control over financial reporting was identified as of December 31, 2024, related to ineffective implementation of information technology general controls (ITGCs) in user access for systems supporting financial reporting processes p. 112.
- Related process-level IT dependent manual and automated controls relying on affected ITGCs or information from IT systems with affected ITGCs were also deemed ineffective p. 112.
- During the year ended December 31, 2025, management took actions to remediate control deficiencies p. 112.
- Remediation actions included enhancing the IT compliance oversight function and expanding the team with ITGC design and implementation experience p. 112.
- A training program addressing ITGCs and policies was developed, educating control owners on principles and requirements p. 112.
- Procedures were implemented to develop and maintain documentation of underlying ITGCs to promote knowledge transfer upon IT personnel and function changes p. 112.
- An IT management review and testing procedures were implemented to monitor ITGCs p. 112.
- Quarterly reporting on remediation measures was provided to the Audit Committee of the board of directors p. 112.
- Management believes the measures remediated the material weakness and concluded that internal control over financial reporting was effective at a reasonable assurance level as of December 31, 2025 p. 112.
- The assessment of effectiveness of internal control over financial reporting as of December 31, 2025, was conducted under the supervision and participation of senior management, including the Chief Executive Officer and Chief Financial Officer p. 112.
- The assessment used criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the Internal Control — Integrated Framework (2013 Framework) p. 112.
- Based on this assessment, management concluded that internal control over financial reporting was effective as of December 31, 2025 p. 112.
- The effectiveness of internal control over financial reporting as of December 31, 2025, was audited by Ernst & Young, LLP, the Company’s independent registered public accounting firm p. 112.
- Ernst & Young, LLP's report is titled “Report of Independent Registered Public Accounting Firm-Opinion on Internal Control over Financial Reporting” p. 112.
Changes in Internal Control over Financial Reporting
- No change in internal control over financial reporting was identified during the year ended December 31, 2025, in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act, except for the remediation of the material weakness identified in 2024 p. 113.
- These changes have not materially affected, nor are they reasonably likely to materially affect, the company's internal control over financial reporting p. 113.
Limitations on Effectiveness of Controls and Procedures
- Management acknowledges that disclosure controls and procedures, regardless of their design and operation, offer only reasonable assurance of achieving control objectives p. 114.
- The design of disclosure controls and procedures must consider resource constraints p. 114.
- Management must exercise judgment in assessing the benefits of potential controls and procedures against their associated costs p. 114.
Other Information
- No directors or officers adopted, terminated, or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement during the quarter ended December 31, 2025 p. 115.
Directors, Executive Officers and Corporate Governance
- The information required by Item 10 of Form 10-K will be included in the company's 2026 Proxy Statement and is incorporated by reference p. 116.
Executive Compensation
- The information required by Item 11 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated by reference p. 117.
Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters
- The information required by Item 12 of Form 10-K will be included in the company's 2026 Proxy Statement and is incorporated by reference p. 118.
Certain Relationships and Related Transactions, and Director Independence
- Information required by Item 13 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated herein by reference p. 119.
Principal Accounting Fees and Services
- The independent registered public accounting firm is Ernst & Young LLP, located in Houston, Texas p. 120.
- The Auditor Firm ID is 42 p. 120.
- Information required by Item 14 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated by reference p. 120.
Exhibits, Financial Statement Schedules.
- The consolidated financial statements of the Company are filed as part of this Form 10-K and are included in Item 8 p. 121.
- The financial statements include the Report of Independent Registered Public Accounting Firm p. 121.
- The financial statements include Consolidated Balance Sheets as of December 31, 2025 and 2024 p. 121.
- The financial statements include Consolidated Statements of Operations and Comprehensive Income (loss) for the three years in the periods ended December 31, 2025, 2024, and 2023 p. 121.
- The financial statements include Consolidated Statements of Stockholders’ Equity for the three years in the period ended December 31, 2025, 2024, and 2023 p. 121.
- The financial statements include Consolidated Statements of Cash Flows for the three years in the period ended December 31, 2025, 2024, and 2023 p. 121.
- A listing of exhibits is provided p. 121.
- Items marked with an asterisk (*) are filed herewith p. 121.
- Items marked with a plus (+) indicate a management contract or compensatory plan or arrangement p. 121.
Exhibits, financial statement schedules
| Schedule Number | Schedule Description | Page |
|---|---|---|
| I. | Summary of Investments — Other Than in Related Parties at December 31, 2025 | 113 |
| II. | Financial Information of Registrant (Parent Company) for the years ended December 31, 2025, 2024 and 2023 | 114 |
| IV. | Supplementary Reinsurance Information for the years ended December 31, 2025, 2024, and 2023 | 118 |
| V. | Valuation and Qualifying Accounts for the years ended December 31, 2025, 2024, and 2023 | 119 |
| VI. | Supplementary Information Concerning Property — Casualty Insurance Operations for the years ended December 31, 2025, 2024, and 2023 | 120 |
Exhibit numbers and descriptions
| Exhibit Number | Exhibit Description |
|---|---|
| 3.1 | Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the Commission on January 18, 2023). |
| 3.2 | Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed with the Commission on January 18, 2023). |
| 4.1 | Amended and Restated Stockholders’ Agreement, dated March 12, 2014, by and among the Company and the stockholders listed therein (incorporated by reference to Exhibit 4.1 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 4.2 | Description of Capital Stock (incorporated by reference to Exhibit 4.2 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
| 10.1+ | Share Purchase and Award Agreement and form of agreements thereunder in use before 2016 (incorporated by reference to Exhibit 10.1 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.2+ | 2016 Equity Incentive Program and form of award agreements thereunder (incorporated by reference to Exhibit 10.2 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.3+ | 2020 Long Term Incentive Plan and form of award agreements thereunder (incorporated by reference to Exhibit 10.3 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.4+ | Skyward Specialty Insurance Group, Inc. 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.5+ | Skyward Specialty Insurance Group, Inc. 2022 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.5 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.6+ | Form of Restricted Stock Units Agreement and form of notice under the Company's 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.6 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
Exhibit numbers and descriptions
| Exhibit Number | Exhibit Description |
|---|---|
| 10.7+ | Form of Restricted Stock Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.7 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
| 10.8+ | Form of Nonstatutory Stock Option Agreement and form of notice under the Company's 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.8 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
| 10.9+ | Form of Incentive Stock Option Agreement and form of notice under the Company's 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.9 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
| 10.10+ | Form of Performance-Based Restricted Stock Units Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.10 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
| 10.11+ | Performance-Based Restricted Stock Units Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.11 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
| 10.12+ | Performance Unit Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.12 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
| 10.13+ | Amended Form of Performance Share (GBVPS) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.13 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.14+ | Amended Form of Performance Share (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.14 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.15+ | Amended Form of Performance Share (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.15 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.16+ | Amended Form of Performance Cash Units Agreement under the Company’s Long-Term Incentive Plan. (incorporated by reference to Exhibit 10.16 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.17+ | Amended Form of the Restricted Stock Unit (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.17 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.18+ | Amended Form of Restricted Stock Unit (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.18 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.19+ | Amended Form of Long-Term Performance Cash Plan and Award Letter under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.19 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.20+ | Form of Indemnification Agreement (incorporated by reference to Exhibit 10.6 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.21+ | Employment Agreement, dated May 22, 2020, by and between the Registrant and Andrew Robinson, with Amendment No. 1 dated January 1, 2022 (incorporated by reference to Exhibit 10.7 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.22+ | Form of Non-Employee Director Deferred Restricted Stock Unit Agreement and Form of Notice Under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.22 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 3, 2025). |
| 10.23 | Commutation and Release Agreement by and among R&Q Re (Bermuda) Ltd., Skyward Re, Houston Specialty Insurance Company, Imperium Insurance Company, and Great Midwest Insurance Company, dated January 31, 2025 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on February 5, 2025). |
| 10.24 | Credit Agreement, dated March 29, 2023, by and among Skyward Specialty Insurance Group, Inc., the lenders from time to time party thereto and Truist Bank, as administrative agent (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on April 3, 2023). |
| 10.25 | First Amendment dated as of February 26, 2024, to that certain Credit Agreement, dated March 29, 2023, by and among Skyward Specialty Inc., the lenders from time to time party thereto and Truist Bank, as administrative agent (incorporated by reference to Exhibit 10.28 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
Exhibit numbers and descriptions
| Exhibit Number | Exhibit Description |
|---|---|
| 10.26 | Guaranty Agreement, dated March 29, 2023, by and among Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages thereto and Truist Bank. (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the Commission on April 3, 2023). |
| 10.27 | Advances and Security Agreement, dated August 1, 2024, by and between Houston Specialty Insurance Company, a wholly owned insurance company subsidiary of the Company and the Federal Home Loan Bank of Dallas (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on September 6, 2024). |
| 10.28+ | Form of Severance Agreement between the Company and executive officers (other than the CEO) (incorporated by reference to Exhibit 10.30 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 3, 2025). |
| 10.29+ | Amendment No. 2 to Employment Agreement between the Registrant and Andrew Robinson dated March 1, 2025 (incorporated by reference to Exhibit 10.31 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 3, 2025). |
| 10.30+ | Amended Form of Restricted Stock Unit (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.21 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
| 10.31+ | Amended Form of the Restricted Stock Unit (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.22 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
| 10.32+ | Amended Form of Performance Share (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.23 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
| 10.33+ | Amended Form of Performance Share (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.24 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
| 10.34+ | Amended Form of Performance Share (GBVPS) (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.25 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
| 10.35+ | Amended Form of Performance Share (GBVPS) (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.26 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
| 10.36+ | Amended Form of Long-Term Performance Cash Plan and Award Letter under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.27 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
| 10.37 | Share Purchase Agreement, dated September 2, 2025, by and between Skyward Specialty Insurance Group, Inc. and Apollo institutional shareholders, of Apollo Group Holdings Limited (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the Commission on September 8, 2025). |
| 10.38 | Share Purchase Agreement, dated September 2, 2025, by and between Skyward Specialty Insurance Group, Inc. and Apollo management shareholders, of Apollo Group Holdings Limited (incorporated by reference to Exhibit 2.2 to the Company’s Current Report on Form 8-K filed with the Commission on September 8, 2025). |
| 10.39 | Credit Agreement, dated November 13, 2025, by and between Skyward Specialty Insurance Group, Inc. and Barclays Bank PLC, as Administrative Agent, Truist Securities, Inc., Citizens Bank, N.A. and Texas Capital Bank (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on November 18, 2025). |
| 10.40 | Guaranty Agreement, dated November 13, 2025, by and among Skyward Specialty Insurance Group, Inc., Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages thereto and Barclays Bank PLC. Barclays Bank PLC (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the Commission on November 18, 2025). |
| 10.41 | Term Loan Credit Agreement, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., and Barclays Bank PLC, as Administrative Agent, Truist Securities, Inc., Citizens Bank, N.A. and Texas Capital Bank (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on January 6, 2026). |
| 10.42 | Guaranty Agreement, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages and Barclays Bank PLC (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the Commission on January 6, 2026). |
Exhibit numbers and descriptions
| Exhibit Number | Exhibit Description |
|---|---|
| 10.43 | First Amendment, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages and Barclays Bank PLC (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed with the Commission on January 6, 2026). |
| 19 | Skyward Specialty Insurance Securities Trading Policy (incorporated by reference to Exhibit 19 to the Company ’ s Annual Report on Form 10-K, filed with the SEC on March 3, 2025). |
| 19.1* | Skyward Specialty Insurance Securities Trading Policy amended November 5, 2025. |
| 21.1* | List of Subsidiaries of the Company |
| 23.1* | Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm. |
| 31.1* | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.2* | Certification of Principal Financial and Accounting Officer pursuant to Rule 13a 14(a) or Rule 15d 14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1* | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 97 | Policy for Recovery of Erroneously Awarded Incentive Compensation (“Clawback Policy”) (incorporated by reference to Exhibit 97 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
| 104 | Cover Page Interactive Date File (embedded within the Inline XBRL document) |
Fixed maturity securities by type
| ($ in thousands) | Cost | Fair Value (if applicable) | Amount on Balance Sheet |
|---|---|---|---|
| December 31, 2025 | |||
| Fixed maturity securities, available for sale: | — | — | — |
| U.S. government securities | 44,190 | 44,468 | 44,468 |
| Corporate securities and miscellaneous | 632,244 | 636,387 | 636,387 |
| Municipal securities | 102,691 | 102,116 | 102,116 |
| Residential mortgage-backed securities | 487,145 | 486,587 | 486,587 |
| Commercial mortgage-backed securities | 72,631 | 73,050 | 73,050 |
| Other asset-backed securities | 509,854 | 513,695 | 513,695 |
| Total fixed maturity securities, available for sale | 1,848,755 | 1,856,303 | 1,856,303 |
| Other asset-backed securities | 33,290 | 33,603 | 32,822 |
| Total fixed maturity securities, held to maturity | 33,290 | 33,603 | 32,822 |
| Preferred stocks | 1,138 | 1,174 | 1,174 |
| Total equity securities | 1,138 | 1,174 | 1,174 |
| Mortgage loans | 10,093 | 9,902 | 9,902 |
| Other long-term investments | 37,290 | 58,650 | 58,650 |
| Short-term investments | 264,299 | 264,299 | 264,299 |
| Total | 2,194,865 | 2,223,931 | 2,223,150 |
Assets as of December 31
| December 31, | ||
|---|---|---|
| ($ in thousands) | 2025 | 2024 |
| Assets | ||
| Investments: | — | — |
| Investment in subsidiaries | 1,076,288 | 853,670 |
| Short-term investments, at fair value | 14,513 | 14,000 |
| Total investments | 1,090,801 | 867,670 |
| Cash and cash equivalents | 3,500 | 2,943 |
| Deferred income taxes | 27,865 | 30,486 |
| Goodwill and intangible assets, net | 14,349 | 12,641 |
| Other assets | 10,709 | 2,905 |
| Total assets | 1,147,224 | 916,645 |
| Liabilities and Stockholders’ Equity | — | — |
| Accounts payable and accrued liabilities | 17,680 | 3,110 |
| Notes payable | 100,410 | 100,000 |
| Subordinated debt, net of debt issuance costs | 19,569 | 19,536 |
| Total liabilities | 137,659 | 122,646 |
| Stockholders’ Equity: | — | — |
| Stockholders’ equity | 1,009,565 | 793,999 |
| Total liabilities and stockholders’ equity | 1,147,224 | 916,645 |
(parent company)
- See accompanying notes to financial statements p. 122.
Revenues and expenses for years ended December 31
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands) | 2025 | 2024 | 2023 |
| Revenues: | — | — | — |
| Net investment income | 3,371 | 3,212 | 3,822 |
| Net investment gains (losses) | — | 963 | ( 963 ) |
| Other loss | — | ( 2 ) | ( 27 ) |
| Total revenues | 3,371 | 4,173 | 2,832 |
| Operating expenses | 7,899 | 10,632 | — |
| Interest expense | 6,762 | 8,140 | 9,815 |
| Amortization expense | 620 | 920 | 313 |
| Other expenses | 17,962 | 9,646 | 451 |
| Total expenses | 33,243 | 29,338 | 10,579 |
| Loss before income tax expense | ( 29,872 ) | ( 25,165 ) | ( 7,747 ) |
| Income tax expense | 45,860 | 33,578 | 6,808 |
| Loss before equity in earnings of subsidiaries | ( 75,732 ) | ( 58,743 ) | ( 14,555 ) |
| Equity in undistributed earnings of subsidiaries | 245,760 | 177,571 | 100,539 |
| Net income | 170,028 | 118,828 | 85,984 |
Schedule ii — statements of cash flows (parent company)
| Key facts & figures | |
|---|---|
| Cash provided by operating activities | USD 100,000 for the year ended December 31, 2023 |
| Cash used in investing activities | USD 100,000 for the year ended December 31, 2023 |
| Cash provided by financing activities | USD 0 for the year ended December 31, 2023 |
| Net increase in cash and cash equivalents | USD 0 for the year ended December 31, 2023 |
| Cash and cash equivalents at beginning of period | USD 0 for the year ended December 31, 2023 |
| Cash and cash equivalents at end of period | USD 0 for the year ended December 31, 2023 |
- Cash provided by operating activities was USD 100,000 for the year ended December 31, 2023 p. 123.
- Cash used in investing activities was USD 100,000 for the year ended December 31, 2023 p. 123.
- Cash provided by financing activities was USD 0 for the year ended December 31, 2023 p. 123.
- Net increase in cash and cash equivalents was USD 0 for the year ended December 31, 2023 p. 123.
- Cash and cash equivalents at beginning of period were USD 0 for the year ended December 31, 2023 p. 123.
- Cash and cash equivalents at end of period were USD 0 for the year ended December 31, 2023 p. 123.
- Cash provided by operating activities was USD 100,000 for the year ended December 31, 2022 p. 123.
- Cash used in investing activities was USD 100,000 for the year ended December 31, 2022 p. 123.
- Cash provided by financing activities was USD 0 for the year ended December 31, 2022 p. 123.
- Net increase in cash and cash equivalents was USD 0 for the year ended December 31, 2022 p. 123.
- Cash and cash equivalents at beginning of period were USD 0 for the year ended December 31, 2022 p. 123.
- Cash and cash equivalents at end of period were USD 0 for the year ended December 31, 2022 p. 123.
- Cash provided by operating activities was USD 100,000 for the year ended December 31, 2021 p. 123.
- Cash used in investing activities was USD 100,000 for the year ended December 31, 2021 p. 123.
- Cash provided by financing activities was USD 0 for the year ended December 31, 2021 p. 123.
- Net increase in cash and cash equivalents was USD 0 for the year ended December 31, 2021 p. 123.
- Cash and cash equivalents at beginning of period were USD 0 for the year ended December 31, 2021 p. 123.
- Cash and cash equivalents at end of period were USD 0 for the year ended December 31, 2021 p. 123.
Cash flows for years ended December 31
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands) | 2025 | 2024 | 2023 |
| Cash flows from operating activities: | — | — | — |
| Net income | 170,028 | 118,828 | 85,984 |
| Adjustments to reconcile net income to net cash used in operating activities | ( 175,769 ) | ( 121,563 ) | ( 95,947 ) |
| Net cash used in operating activities | ( 5,741 ) | ( 2,735 ) | ( 9,963 ) |
| Purchase of intangible assets and goodwill | ( 2,000 ) | — | — |
| Capital contributions to subsidiaries | ( 100 ) | — | ( 122,800 ) |
| Distributions from investment in subsidiaries | 8,500 | 8,500 | 6,500 |
| Change in short-term investments | ( 513 ) | ( 3,407 ) | ( 10,569 ) |
| Net cash provided by (used in) investing activities | 5,887 | 5,093 | ( 126,869 ) |
| Repayment of stock notes receivable | — | 5,561 | 1,350 |
| Proceeds from long term borrowings | 43,411 | 107,000 | 50,000 |
| Payments on long term borrowings and trust preferred | ( 43,000 ) | ( 115,000 ) | ( 50,000 ) |
| Proceeds from equity offerings | — | — | 128,887 |
| Proceeds from employee stock purchase plan | — | — | 710 |
| Net cash provided by (used in) financing activities | 411 | ( 2,439 ) | 130,947 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 557 | ( 81 ) | ( 5,885 ) |
| Cash and cash equivalents and restricted cash at beginning of year | 2,943 | 3,024 | 8,909 |
| Cash and cash equivalents and restricted cash at end of year | 3,500 | 2,943 | 3,024 |
| Supplemental disclosure of cash flow information: | — | — | — |
| Cash paid for interest | 6,149 | 8,573 | 10,667 |
Notes to Financial Statements
| Key facts & figures | |
|---|---|
| Intercompany Loan Promissory Note date | September 30, 2024 |
| Intercompany Loan Promissory Note parties | Skyward Specialty, Houston Specialty Insurance Company (HSIC) |
| Amount borrowed | USD 57.0 million |
| Interest rate | 4.00% |
| New subsidiary | Skyward Specialty No. 1 Limited Company |
| Skyward Specialty No. 1 Limited Company type | UK company authorized as a Lloyd’s corporate member |
- Intercompany Loan Promissory Note was entered into by Skyward Specialty with Houston Specialty Insurance Company (HSIC) on September 30, 2024 p. 124.
- Skyward Specialty borrowed USD 57.0 million from HSIC under the Promissory Note p. 124.
- Interest on the Promissory Note is payable monthly at a fixed annual rate of 4.00% p. 124.
- Principal of the Promissory Note is due at the maturity date p. 124.
- Prepayment penalties are not applicable to the Promissory Note p. 124.
- Collateral was not provided as security for the Promissory Note p. 124.
- Skyward Specialty provided funds for a new subsidiary, Skyward Specialty No. 1 Limited Company, during the year ended December 31, 2024 p. 124.
- Skyward Specialty No. 1 Limited Company is a UK company authorized as a Lloyd’s corporate member to invest in Lloyd’s syndicates p. 124.
Financial Instruments Disclosed, But Not Carried, At Fair Value
| Key facts & figures | |
|---|---|
| Promissory Note classification | Level 2 in the fair value hierarchy |
- The Promissory Note between Skyward Specialty and HSIC is included in notes payable p. 125.
- Skyward Specialty determined the fair value of the Promissory Note using the income approach with observable inputs p. 125.
- The Promissory Note is classified as Level 2 in the fair value hierarchy p. 125.
- Other financial instruments are exempt from fair value disclosure requirements as they qualify as insurance-related products p. 125.
Notes payable and promissory note
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Carrying Value | Fair Value | Carrying Value | Fair Value |
| Notes payable | — | — | — | — |
| Promissory Note | 57,000 | 57,401 | 57,000 | 56,300 |
Gross, ceded, assumed, and net amounts
| Years Ended December 31, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | ||||
| ($ in thousands) | Accident & Health | Property & Casualty | Accident & Health | Property & Casualty | Accident & Health | Property & Casualty |
| Gross amount | 254,102 | 1,430,309 | 173,073 | 1,285,564 | 151,702 | 1,089,478 |
| Ceded to other companies | ( 143,811 ) | ( 616,193 ) | ( 86,503 ) | ( 533,151 ) | ( 79,091 ) | ( 470,047 ) |
| Assumed from other companies | — | 481,825 | — | 284,595 | — | 218,649 |
| Net amount | 110,291 | 1,295,941 | 86,570 | 1,037,008 | 72,611 | 838,080 |
| Percentage of amount assumed to net | —% | 37.2% | —% | 27.4% | —% | 26.1% |
Valuation allowances and allowances for uncollectible amounts
| ($ in thousands) | Valuation Allowance For Deferred Tax Assets | Allowance for Uncollectible Reinsurance Recoverable | Allowance for Uncollectible Premiums Receivable |
|---|---|---|---|
| Balance at January 1, 2023 | 586 | — | 629 |
| Cumulative effect of adoption of ASU 2016-13 at January 1, 2023 | — | 2,295 | — |
| Charged to costs and expenses | — | — | 748 |
| Amounts written off | — | — | ( 513 ) |
| Recoveries of amounts previously written off | — | — | 100 |
| Balance at December 31, 2023 | 586 | 2,295 | 964 |
| Charged to costs and expenses | — | 13,585 | 3,235 |
| Amounts written off | — | ( 13,585 ) | ( 1,895 ) |
| Recoveries of amounts previously written off | — | — | 128 |
| Balance at December 31, 2024 | 586 | 2,295 | 2,432 |
| Charged to costs and expenses | 68 | — | 2,351 |
| Amounts written off | — | — | ( 2,141 ) |
| Recoveries of amounts previously written off | — | — | 498 |
| Balance at December 31, 2025 | 654 | 2,295 | 3,140 |
Deferred policy acquisition costs and reserves
| As of and Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands) | 2025 | 2024 | 2023 |
| Deferred policy acquisition costs | 136,100 | 113,183 | 91,955 |
| Reserve for losses and loss adjustment expenses | 2,318,894 | 1,782,383 | 1,314,501 |
| Unearned premiums | 774,035 | 637,185 | 552,532 |
| Net earned premium (1) | 1,304,505 | 1,056,722 | 829,143 |
| Net investment income | 83,619 | 80,686 | 40,322 |
| Losses and loss adjustment expenses (current year) (1) | 810,375 | 657,783 | 516,664 |
| Losses and loss adjustment expenses (prior years) (1)(2) | ( 7,471 ) | 25,728 | — |
| Amortization of policy acquisition costs (1) | 195,422 | 149,975 | 108,514 |
| Paid claims and claim adjustment expenses (1) | 516,712 | 430,991 | 363,418 |
| Net premiums written (1) | 1,406,232 | 1,123,578 | 910,691 |
| Ceded unearned premium | 238,948 | 203,901 | 186,121 |
| Deferred ceding commission | 46,453 | 40,434 | 37,057 |
(1) Amount is presented net of reinsurance. (2) Amount does not include gain on retroactive reinsurance which is included in losses and loss adjustment expenses presented on the Consolidated Statements of Operations.
Signatures
- This report was signed on behalf of the registrant pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934 p. 126.
- This report was signed by the indicated persons on behalf of the Registrant, in their capacities, and on the dates indicated, pursuant to the requirements of the Securities Exchange Act of 1934 p. 126.
Registrant's signature and date
| — | Skyward Specialty Insurance Group, Inc. |
|---|---|
| Dated: March 2, 2026 | /s/ Andrew Robinson |
| — | Andrew Robinson Chairman and Chief Executive Officer |
Signatures, titles, and dates
| Signature | Title | Date |
|---|---|---|
| /s/ Andrew Robinson | Chairman and Chief Executive Officer | March 2, 2026 |
| Andrew Robinson | (Principal Executive Officer) | March 2, 2026 |
| /s/ Mark Haushill | Chief Financial Officer | March 2, 2026 |
| Mark Haushill | (Principal Financial and Accounting Officer) | March 2, 2026 |
| /s/ Gena Ashe | Director | March 2, 2026 |
| Gena Ashe | Director | March 2, 2026 |
| /s/ Robert Creager | Director | March 2, 2026 |
| Robert Creager | Director | March 2, 2026 |
| /s/ Marcia Dall | Director | March 2, 2026 |
| Marcia Dall | Director | March 2, 2026 |
| /s/ James Hays | Director | March 2, 2026 |
| James Hays | Director | March 2, 2026 |
| /s/ Anthony J. Kuczinski | Director | March 2, 2026 |
| Anthony J. Kuczinski | Director | March 2, 2026 |
| /s/ Michael Morrissey | Director | March 2, 2026 |
| Michael Morrissey | Director | March 2, 2026 |
| /s/ Christopher L. Peirce | Director | March 2, 2026 |
| Christopher L. Peirce | Director | March 2, 2026 |
| /s/ Katharine Terry | Director | March 2, 2026 |
| Katharine Terry | Director | March 2, 2026 |